Citrus Sinensis ID: 001858
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1003 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.961 | 0.954 | 0.452 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.946 | 0.920 | 0.452 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.961 | 0.940 | 0.459 | 0.0 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.846 | 0.866 | 0.364 | 1e-136 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.881 | 0.753 | 0.340 | 1e-128 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.852 | 0.763 | 0.329 | 1e-123 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.887 | 0.712 | 0.328 | 1e-123 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.916 | 0.809 | 0.319 | 1e-122 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.914 | 0.877 | 0.326 | 1e-121 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.879 | 0.773 | 0.322 | 1e-121 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 806 bits (2082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/988 (45%), Positives = 638/988 (64%), Gaps = 24/988 (2%)
Query: 30 ALSNETDRVALLAIKSQL-QDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSV 88
++ETDR ALL KSQ+ +D + SSWN+S +C W GVTCG+++ RV L L +
Sbjct: 19 GFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQL 78
Query: 89 GGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCS 148
GG +SP +GNLSFL ++L N G IP E+G+LSRL+ L + N G IP L +CS
Sbjct: 79 GGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCS 138
Query: 149 NLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENK 208
L+N + N L G +P+ +G L LN+ N + G+LP S+GN++ L+QL + N
Sbjct: 139 RLLNLRLDSNRLGGSVPSELGSL-TNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNN 197
Query: 209 LYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFN 267
L G IP + QL + L + NNFSG+ PP ++N+SSL+ + + N F GRL ++G
Sbjct: 198 LEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL 257
Query: 268 LPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN 327
LP L +G N TGSIP + SN S L L ++ N+ +G + F ++PN+ L L N
Sbjct: 258 LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTN 316
Query: 328 NLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGT 386
+LGS S DL+F+T LTNC++LETLG+ NR GG LP SIANLS + + +G ISG+
Sbjct: 317 SLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGS 376
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
IP +I NL N+ L L+ N L+G +P ++G+L+NL+ L +N L G IP IGN++ L
Sbjct: 377 IPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLE 436
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG 506
+L L N +G +P+SLGNC +L+ L + NKL GT+P +I++I L L D+S N + G
Sbjct: 437 TLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRL-DMSGNSLIG 495
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSI 566
S+P +G L+NL L + N+ SG++P TL +C ++E L ++ N F G IP L L +
Sbjct: 496 SLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGV 554
Query: 567 EVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCG 626
+ +DLS N+LSG IPEY S LEYLNLS+N+ EG+VP KG+F N T +S++ N LCG
Sbjct: 555 KEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCG 614
Query: 627 GLDELHLPAC----------HNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQ 676
G+ L C H++R +K I + V I +++LL + SV LI + R++ +
Sbjct: 615 GIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGV-SVGITLLLLLFMASVTLIWLRKRKKNK 673
Query: 677 TQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI 736
+ T ++E +SY +L ATN FS SN++G GSFG VY+ L + VAVKV+
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733
Query: 737 NLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL 796
N++++G++KSF+AECE+LK+IRHRNL+K++T CSSIDF+G++F+AL+Y++M +GSL+ WL
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793
Query: 797 Q----QSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852
+ + L L++RLNI+IDVAS ++YLH HC PI H DLKPSNVLLD D+ A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853
Query: 853 HVSDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910
HVSDFGLA+ L FD SS G++GT+GY APEYG+GG S+ GDVYSFGILLLE
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLE 913
Query: 911 MFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIG 970
MFTG+RPT+ +F TL+ + K ALPE++++IVD ++L + ECLT V +G
Sbjct: 914 MFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVG 973
Query: 971 VLCSMESPSERIHMADAVKNLCAAREKY 998
+ C ESP R+ + VK L + RE++
Sbjct: 974 LRCCEESPMNRLATSIVVKELISIRERF 1001
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/994 (45%), Positives = 629/994 (63%), Gaps = 45/994 (4%)
Query: 31 LSNETDRVALLAIKSQLQD--PMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSV 88
SNETD ALL KSQ+ + + +SWN+S C W GVTCG+R RVI L L +
Sbjct: 26 FSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKL 85
Query: 89 GGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCS 148
G +SP +GNLSFLR +NLA N+ IP ++GRL RL+ L + +N G IPS+LS+CS
Sbjct: 86 TGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCS 145
Query: 149 NLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENK 208
L + N+L +P+ +G KL L++++N LTG P S+GN+++LQ+L N+
Sbjct: 146 RLSTVDLSSNHLGHGVPSELGSLS-KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQ 204
Query: 209 LYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFN 267
+ G IP+ + +L + F +A N+FSG PP ++NISSLE +SL N F G L + G+
Sbjct: 205 MRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYL 264
Query: 268 LPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN 327
LP L+ L++G N TG+IP++ +N S+L ++S N+ SG + + F L N+ L + N
Sbjct: 265 LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNN 324
Query: 328 NLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGT 386
+LG+ S L+FI + NC++LE L + NR GG LP SIANLST +T + +G N ISGT
Sbjct: 325 SLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGT 384
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
IP +I NL ++ L LE N L+G +P + G+L+NLQ +D +N + G IP GN++ L
Sbjct: 385 IPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQ 444
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG 506
L L N+ G IP SLG C+ L+ L + N+L GT+P +IL+I +L+ +DLS+N ++G
Sbjct: 445 KLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTG 503
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP--SSLISLK 564
P VG L+ L+ L S N+ SG++P + C S+E+L MQ NSF G+IP S L+SLK
Sbjct: 504 HFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLK 563
Query: 565 SIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKL 624
++ D S NNLSG+IP YL L L LNLS N FEG+VPT GVF N T +S+ N +
Sbjct: 564 NV---DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNI 620
Query: 625 CGGLDELHLPAC-HNTRPRKAK-ITILK-----VLIPVIVLLTILSVGLIVVCTRRRKQT 677
CGG+ E+ L C PRK K +++ K + I + LL I+ V + +R+K+
Sbjct: 621 CGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 678 QKS------STLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPV 731
S ST L M + VSY EL+ AT+ FS +NLIG G+FG V++G LG + V
Sbjct: 681 NASDGNPSDSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLV 738
Query: 732 AVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGS 791
AVKV+NL + G+ KSF+AECE K IRHRNL+K+ITVCSS+D +G+DF+ALVY++M GS
Sbjct: 739 AVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGS 798
Query: 792 LEDWLQ-----QSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846
L+ WLQ + ND +L ++LNI+IDVASA+EYLH HC P+ H D+KPSN+LL
Sbjct: 799 LDMWLQLEDLERVNDH-SRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILL 857
Query: 847 DHDMVAHVSDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSF 904
D D+ AHVSDFGLA+ L +DR SS G++GT+GY APEYGMGG S+ GDVYSF
Sbjct: 858 DDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSF 917
Query: 905 GILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLT 964
GILLLEMF+G++PT F LH + K L + G A I+E L
Sbjct: 918 GILLLEMFSGKKPTDESFAGDYNLHSYTKSIL----------SGCTSSGGSNA-IDEGLR 966
Query: 965 AVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998
V+++G+ CS E P +R+ +AV+ L + R K+
Sbjct: 967 LVLQVGIKCSEEYPRDRMRTDEAVRELISIRSKF 1000
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/989 (45%), Positives = 640/989 (64%), Gaps = 25/989 (2%)
Query: 31 LSNETDRVALLAIKSQLQDPMGIT-SSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVG 89
L+ ETD+ ALL KSQ+ + + SWN+S+ +C WTGV CG +H RV + L +
Sbjct: 35 LTEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLT 94
Query: 90 GFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSN 149
G +SP+VGNLSFLR +NLA N HG IP+E+G L RL+ L + N F G IP LS+CS+
Sbjct: 95 GVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSS 154
Query: 150 LINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKL 209
L + N+L +P G KL L++ N LTG+ P S+GN+++LQ L N++
Sbjct: 155 LSTLDLSSNHLEQGVPLEFGSL-SKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQI 213
Query: 210 YGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNL 268
G IP + +L+ + F +A N F+G+ PP I+N+SSL +S+ N F G L + G L
Sbjct: 214 EGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLL 273
Query: 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNN 328
P L+IL +G N+ TG+IP++ SN S+L L++ NH +GK+ + F L N+ L L N+
Sbjct: 274 PNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNS 333
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTI 387
LG+ S GDLDF+ LTNCS+L+ L + N+ GG LP IANLST +T +++G N ISG+I
Sbjct: 334 LGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSI 393
Query: 388 PLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447
P I NL ++ L L N LTG +P ++GEL L+ + +N L G IP S+GN+S L
Sbjct: 394 PHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTY 453
Query: 448 LWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGS 507
L+L N+ +G+IPSSLG+C L+ LN+ NKL G++P +++E+ +L +L++S NL+ G
Sbjct: 454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGP 512
Query: 508 IPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIE 567
+ +G LK L+ LD+S N+ SG+IP TL++C SLE+L +Q NSF G IP + L +
Sbjct: 513 LRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLR 571
Query: 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGG 627
LDLS NNLSG IPEY+ + S L+ LNLS N+F+G VPT+GVF N + +S+ N LCGG
Sbjct: 572 FLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGG 631
Query: 628 LDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVGL-----------IVVCTRRRKQ 676
+ L L C PR+ ++ K++ + + + L + V + R
Sbjct: 632 IPSLQLQPCSVELPRRHS-SVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANN 690
Query: 677 TQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI 736
+ + ++ + +SY EL K T FS SNLIG G+FG V++G LG VA+KV+
Sbjct: 691 NENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVL 750
Query: 737 NLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL 796
NL ++G+ KSF+AECEAL IRHRNL+K++T+CSS DF+G+DF+ALVY++M +G+L+ WL
Sbjct: 751 NLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWL 810
Query: 797 QQSNDQVDGN----LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852
+ GN L L RLNI+IDVASA+ YLH +C PI H D+KPSN+LLD D+ A
Sbjct: 811 HPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTA 870
Query: 853 HVSDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910
HVSDFGLA+ L FDR SS G++GT+GY APEYGMGG+ S+ GDVYSFGI+LLE
Sbjct: 871 HVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLE 930
Query: 911 MFTGRRPTHTMFNDGLTLHGFVKMALPEK-VMEIVDFALLLDPGNERAKIEECLTAVVRI 969
+FTG+RPT+ +F DGLTLH F K AL ++ ++I D +L + + ECLT V R+
Sbjct: 931 IFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRV 990
Query: 970 GVLCSMESPSERIHMADAVKNLCAAREKY 998
GV CS ESP RI MA+A+ L + RE +
Sbjct: 991 GVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 339/929 (36%), Positives = 501/929 (53%), Gaps = 80/929 (8%)
Query: 129 LVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQ 188
+++D ++SG + S + +I + +L GEI I L L+++ N G+
Sbjct: 49 MLVDVCNWSGVKCNKES--TQVIELDISGRDLGGEISPSIAN-LTGLTVLDLSRNFFVGK 105
Query: 189 LPPSIGNI-STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLP-PIF---NI 243
+PP IG++ TL+QL + EN L+G IP+ LG L L +L + N +G +P +F +
Sbjct: 106 IPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSS 165
Query: 244 SSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGN 303
SSL+ I L N G +PLN +L +L+ L++ N LTG++P S SN++NL ++L N
Sbjct: 166 SSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESN 225
Query: 304 HFSGKVGID-FSSLPNITRLNLGQNNLGS--GSIGDLDFITLLTNCSKLETLGLNSNRFG 360
SG++ S +P + L L N+ S + F L N S L+ L L N G
Sbjct: 226 MLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLG 285
Query: 361 GSLPRSIANLST-ITIIAMGLNQISGTIPLEI---------------------RNLANIY 398
G + S+ +LS + I + N+I G+IP EI R L +
Sbjct: 286 GEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLS 345
Query: 399 ALGLEY---NQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNL 455
L Y N LTG IP +G++ L LD S NNL G IPDS GNLS L L L N+L
Sbjct: 346 KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHL 405
Query: 456 QGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE-ITTLSSLLDLSSNLISGSIPLVVGN 514
G +P SLG C NL +L++S N LTGT+P +++ + L L+LSSN +SG IPL +
Sbjct: 406 SGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSK 465
Query: 515 LKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCN 574
+ ++ +D+S N SG+IP L SC +LE+L + N F ++PSSL L ++ LD+S N
Sbjct: 466 MDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFN 525
Query: 575 NLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLP 634
L+G IP + S L++LN S+N G V KG FS T S + + LCG + +
Sbjct: 526 RLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ-- 583
Query: 635 ACHNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQKSSTLLSMEQ------ 688
AC + + + + + +L + L+ +R + K+ T+ + E+
Sbjct: 584 ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLV-----QRSRFGKNLTVYAKEEVEDEEK 638
Query: 689 ------QFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG 742
++P +SY +L AT F+ S+LIG G FG VY+G L + VAVKV++ K
Sbjct: 639 QNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNN-TKVAVKVLDPKTAL 697
Query: 743 SIK-SFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSND 801
SF EC+ LK RHRNLI+IIT CS F ALV M +GSLE L +
Sbjct: 698 EFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHL-YPGE 751
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
NL+LIQ +NI DVA I YLHH+ +VH DLKPSN+LLD +M A V+DFG+++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 862 FLFDRPIQETSSSSIGIK---------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
+ + ++ET S+ + G+VGY+APEYGMG S GDVYSFG+LLLE+
Sbjct: 812 LV--QGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 869
Query: 913 TGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFAL-LLDPGNERAKIE----ECLTAVV 967
+GRRPT + N+G +LH F+K P+ + I++ AL P + K E E + ++
Sbjct: 870 SGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMI 929
Query: 968 RIGVLCSMESPSERIHMADAVKNLCAARE 996
+G++C+ +PS R M D + +E
Sbjct: 930 ELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-128, Method: Compositional matrix adjust.
Identities = 332/976 (34%), Positives = 524/976 (53%), Gaps = 92/976 (9%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
+G L+ L ++L+ N L G+IP + G L L+ LVL N G IP+ + +CS+L+ +
Sbjct: 212 IGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLEL 271
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
N LTG+IPA +G ++L+ L + +N+LT +P S+ ++ L LG+ EN L G I E
Sbjct: 272 YDNQLTGKIPAELGN-LVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISE 330
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLT---NRFEGRLPLNIGFNLPKLK 272
+G L L L++ NNF+G P +I++L +++LT N G LP ++G L L+
Sbjct: 331 EIGFLESLEVLTLHSNNFTGEFPQ--SITNLRNLTVLTVGFNNISGELPADLGL-LTNLR 387
Query: 273 ILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSG 332
L N LTG IP S SN + L +L+LS N +G++ F + N+T +++G+N+ +G
Sbjct: 388 NLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHF-TG 445
Query: 333 SIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIR 392
I D F NCS LETL + N G+L I L + I+ + N ++G IP EI
Sbjct: 446 EIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG 500
Query: 393 NLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI------------- 439
NL ++ L L N TG IP + L LQ L +N+L G IP+ +
Sbjct: 501 NLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560
Query: 440 -----------GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
L +L L L N G+IP+SL + L ++S N LTGT+P ++L
Sbjct: 561 NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620
Query: 489 -EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCT---SLEY 544
+ + L+ S+NL++G+IP +G L+ + ++D+S N FSG IP +L +C +L++
Sbjct: 621 ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680
Query: 545 ----------------------LKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582
L + NSF G IP S ++ + LDLS NNL+G+IPE
Sbjct: 681 SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740
Query: 583 YLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPR 642
L +LS L++L L+ N+ +G VP GVF N L+ N LCG L
Sbjct: 741 SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSH 800
Query: 643 KAKIT--ILKVLIPVIVLLTILSVGLIVVCTRRRK---QTQKSSTLLSMEQQFPMVSY-- 695
+K T IL +L LL +L + LI+ C ++++ + S+L ++ + +
Sbjct: 801 FSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEP 860
Query: 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEA 753
EL +AT+ F+ +N+IG S VY+G L ED +AVKV+NLK+ S K F E +
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKT 919
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
L ++HRNL+KI+ ++ KALV +M++G+LED + S + +L++++
Sbjct: 920 LSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG---SLLEKI 972
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
++ + +AS I+YLH PIVH DLKP+N+LLD D VAHVSDFG A+ L R T++
Sbjct: 973 DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTA 1032
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG--LTLHGF 931
S+ +GT+GY+APE+ V+ DV+SFGI+++E+ T +RPT D +TL
Sbjct: 1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQL 1092
Query: 932 VKMAL---PEKVMEIVDFALLLDPGNE--RAKIEECLTAVVRIGVLCSMESPSERIHMAD 986
V+ ++ + ++ ++D L G+ K EE + +++ + C+ P +R M +
Sbjct: 1093 VEKSIGNGRKGMVRVLDMEL----GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNE 1148
Query: 987 AVKNLCAAREKYKGRR 1002
+ +L R K R
Sbjct: 1149 ILTHLMKLRGKANSFR 1164
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 332/1007 (32%), Positives = 500/1007 (49%), Gaps = 152/1007 (15%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
LYL + + +GN+ + + L+ N L G IP+ LG L L VL L N +G I
Sbjct: 155 LYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVI 214
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNV---AENQLTGQLPPSIGNIS 197
P L + ++ + ++ +N LTG IP+ +G L+NL V EN LTG +PP IGN+
Sbjct: 215 PPELGNMESMTDLALSQNKLTGSIPSTLG----NLKNLMVLYLYENYLTGVIPPEIGNME 270
Query: 198 TLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRF 256
++ L + +NKL G IP SLG L++L LS+ +N +G +PP + NI S+ + L N+
Sbjct: 271 SMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKL 330
Query: 257 EGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL 316
G +P ++G NL L IL + +N LTG IP N +++ L L+ N +G + F +L
Sbjct: 331 TGSIPSSLG-NLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNL 389
Query: 317 P------------------------NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETL 352
++ L+L QN L +GS+ D N +KLE+L
Sbjct: 390 KNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKL-TGSVPDS-----FGNFTKLESL 443
Query: 353 GLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI---RNLANIYALGLEYNQLTG 409
L N G++P +AN S +T + + N +G P + R L NI L+YN L G
Sbjct: 444 YLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNI---SLDYNHLEG 500
Query: 410 TIPYTI------------------------GELINLQALDFSANNLHG------------ 433
IP ++ G +L +DFS N HG
Sbjct: 501 PIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKL 560
Query: 434 ------------IIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
IP I N++ L L L NNL G +P ++GN NL L ++ N+L+G
Sbjct: 561 GALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSG 620
Query: 482 TLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTS 541
+P + +T L SL DLSSN S IP + L +++SRN+F G IP LS T
Sbjct: 621 RVPAGLSFLTNLESL-DLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQ 678
Query: 542 LEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
L L + N G IPS L SL+S++ LDLS NNLSG IP E + L +++S N E
Sbjct: 679 LTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLE 738
Query: 602 GQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHN-TRPRKAKITILKVLIPVIVLLT 660
G +P F T +L EN LC + + L C +P+K ++ +L+P++ +L
Sbjct: 739 GPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLV 798
Query: 661 ILSV--GLIVVCTRRRK---------QTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSN 709
ILS+ C R+RK +T ++ ++ S++ +F Y ++ ++TNEF ++
Sbjct: 799 ILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKF---KYQDIIESTNEFDPTH 855
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI------KSFVAECEALKNIRHRNLI 763
LIG G + VYR NL + + +AVK ++ I + F+ E +AL IRHRN++
Sbjct: 856 LIGTGGYSKVYRANLQDTI--IAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVV 913
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
K+ CS + F L+Y+YM+ GSL L +ND+ L +R+N+ VA A+
Sbjct: 914 KLFGFCS---HRRHTF--LIYEYMEKGSLNKLL--ANDEEAKRLTWTKRINVVKGVAHAL 966
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
Y+HH PIVH D+ N+LLD+D A +SDFG AK L + SS+ + GT G
Sbjct: 967 SYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLL-----KTDSSNWSAVAGTYG 1021
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN------DGLTLHGFVKMALP 937
YVAPE+ V+ DVYSFG+L+LE+ G+ P + + + L+L
Sbjct: 1022 YVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISD---- 1077
Query: 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM 984
E+V+E R + E L +V + +LC +P R M
Sbjct: 1078 ERVLE------------PRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1137), Expect = e-123, Method: Compositional matrix adjust.
Identities = 333/1013 (32%), Positives = 514/1013 (50%), Gaps = 123/1013 (12%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L L N S+ G + +G +S L++++L +N L G IP L L L+ L L N+ +G I
Sbjct: 244 LNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEI 303
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQ 200
P + S L++ + N+L+G +P I LE L ++ QL+G++P + +L+
Sbjct: 304 PEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLK 363
Query: 201 QLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGR 259
QL + N L G IPE+L +L +L L + N G L P I N+++L+ + L N EG+
Sbjct: 364 QLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNI 319
LP I L KL++L + +N +G IPQ N ++L ++++ GNHF G++ L +
Sbjct: 424 LPKEISA-LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKEL 482
Query: 320 TRLNLGQNNLGSG---SIGD---LDFITLLTN------------CSKLETLGLNSNRFGG 361
L+L QN L G S+G+ L+ + L N LE L L +N G
Sbjct: 483 NLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG 542
Query: 362 SLPRSIANLSTITIIAMGLNQISGTI-----------------------PLEIRNLANIY 398
+LP S+ +L +T I + N+++GTI PLE+ N N+
Sbjct: 543 NLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLD 602
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP---------------------- 436
L L NQLTG IP+T+G++ L LD S+N L G IP
Sbjct: 603 RLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGP 662
Query: 437 --DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLS 494
+G LS L L L N ++P+ L NC L++L++ N L G++P +I + L+
Sbjct: 663 IPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALN 722
Query: 495 SLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLE-YLKMQDNSFR 553
+L+L N SGS+P +G L L +L +SRN +GEIP + L+ L + N+F
Sbjct: 723 -VLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFT 781
Query: 554 GSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNK 613
G IPS++ +L +E LDLS N L+G++P + D+ L YLN+S+N+ G++ K FS
Sbjct: 782 GDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRW 839
Query: 614 TRISLIENGKLCGGLDELHLPACHNTRPRKAKITILK---VLIPVIVLLTILSVGLIVVC 670
S + N LCG L C+ R + + V+I I LT + + ++V+
Sbjct: 840 PADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIA 895
Query: 671 T--RRR----KQTQKSSTLLS------MEQQFPM---------VSYAELNKATNEFSLSN 709
++R K+ ST + P+ + + ++ +AT+ S
Sbjct: 896 LFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEF 955
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITV 768
+IG G G VY+ L E+ VAVK I K S KSF E + L IRHR+L+K++
Sbjct: 956 MIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGY 1014
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ---RLNISIDVASAIEY 825
CSS K + L+Y+YM++GS+ DWL + ++ L+ RL I++ +A +EY
Sbjct: 1015 CSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEY 1071
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LHH C PPIVH D+K SNVLLD +M AH+ DFGLAK L + T S++ + GY+
Sbjct: 1072 LHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW-FACSYGYI 1130
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945
APEY + DVYS GI+L+E+ TG+ PT ++F + + +V E +E+
Sbjct: 1131 APEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV-----ETHLEVAG 1185
Query: 946 FAL--LLDPGNERAKI-----EECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
A L+DP + K E+ V+ I + C+ SP ER A +L
Sbjct: 1186 SARDKLIDP---KLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 335/1048 (31%), Positives = 525/1048 (50%), Gaps = 129/1048 (12%)
Query: 50 PMGITSSWNNS-INVCQWTGVTCGQRHPRVI-------------------------QLYL 83
P + S WN S + CQW +TC +++ +L +
Sbjct: 54 PPSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVI 113
Query: 84 RNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN 143
N ++ G +S +G+ S L I+L+SN+L GEIP+ LG+L L+ L L+ N +G IP
Sbjct: 114 SNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPE 173
Query: 144 LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN-QLTGQLPPSIGNISTLQQL 202
L C +L N + N L+ +P +G LE++ N +L+G++P IGN L+ L
Sbjct: 174 LGDCVSLKNLEIFDNYLSENLPLELGKI-STLESIRAGGNSELSGKIPEEIGNCRNLKVL 232
Query: 203 GVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLP 261
G+ K+ G +P SLGQL L LSV SG +P + N S L + L N G LP
Sbjct: 233 GLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLP 292
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITR 321
+G L L+ +++ QNNL G IP+ +L ++LS N+FSG + F +L N+
Sbjct: 293 KELG-KLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQE 351
Query: 322 LNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLN 381
L L NN+ +GSI ++L+NC+KL +++N+ G +P I L + I N
Sbjct: 352 LMLSSNNI-TGSIP-----SILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQN 405
Query: 382 QISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGN 441
++ G IP E+ N+ AL L N LTG++P + +L NL L +N + G+IP IGN
Sbjct: 406 KLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGN 465
Query: 442 LSTLNSLWL-------------GF-----------NNLQGNIPSSLGNCKNLMLLNVSKN 477
++L L L GF NNL G +P + NC+ L +LN+S N
Sbjct: 466 CTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNN 525
Query: 478 KLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
L G LP + +T L +LD+SSN ++G IP +G+L +L +L +S+N F+GEIP++L
Sbjct: 526 TLQGYLPLSLSSLTKLQ-VLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLG 584
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEV-LDLSCNNLSGQIPEYLE----------- 585
CT+L+ L + N+ G+IP L ++ +++ L+LS N+L G IPE +
Sbjct: 585 HCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDIS 644
Query: 586 ------DLSFLE------YLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGG------ 627
DLS L LN+S+N F G +P VF + N LC
Sbjct: 645 HNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCF 704
Query: 628 -LDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQKSSTLLSM 686
+ L + +I I +LI V +L +L V ++ + + S T ++
Sbjct: 705 VSNSSQLTTQRGVHSHRLRIAI-GLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENL 763
Query: 687 EQQFPMVSYAELNKATNEFSLS-----NLIGQGSFGFVYRGNLG-------EDLLPVAVK 734
+ + +LN T E L N+IG+G G VY+ + + L PV V
Sbjct: 764 -WTWQFTPFQKLN-FTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVP 821
Query: 735 VINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSL 792
+N K K G SF AE + L +IRH+N+++ + C + + + L+YDYM +GSL
Sbjct: 822 NLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWN-----KNTRLLMYDYMSNGSL 876
Query: 793 EDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852
L + + +L R I + A + YLHH C PPIVH D+K +N+L+ D
Sbjct: 877 GSLLHERSGVC--SLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEP 934
Query: 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
++ DFGLAK + D +S++ I G+ GY+APEYG ++ DVYS+G+++LE+
Sbjct: 935 YIGDFGLAKLVDDGDFARSSNT---IAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVL 991
Query: 913 TGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVL 972
TG++P DGL + +VK + ++++D L P +E +EE + + + +L
Sbjct: 992 TGKQPIDPTIPDGLHIVDWVKKI---RDIQVIDQGLQARPESE---VEE-MMQTLGVALL 1044
Query: 973 CSMESPSERIHMADA---VKNLCAAREK 997
C P +R M D + +C RE+
Sbjct: 1045 CINPIPEDRPTMKDVAAMLSEICQEREE 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 340/1040 (32%), Positives = 498/1040 (47%), Gaps = 123/1040 (11%)
Query: 27 SC-FALSNETDRV-ALLAIKSQL--QDPMGITSSW---NNSINVCQWTGVTCGQRHPRVI 79
SC FA+S + ALL KS Q SSW N S W GV C +I
Sbjct: 39 SCSFAVSATVEEANALLKWKSTFTNQTSSSKLSSWVNPNTSSFCTSWYGVACSLG--SII 96
Query: 80 QLYLRNQSV-------------------------GGFLSPYVGNLSFLRFINLASNNLHG 114
+L L N + G +SP G S L + +L+ N L G
Sbjct: 97 RLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVG 156
Query: 115 EIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK 174
EIP ELG LS L L L N +G+IPS + + + ++ N LTG IP+ G K
Sbjct: 157 EIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNL-TK 215
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
L NL + N L+G +P IGN+ L++L + N L G IP S G L+++ L++ EN S
Sbjct: 216 LVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLS 275
Query: 235 GMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNAS 293
G +PP I N+++L+ +SL TN+ G +P +G N+ L +L + N L GSIP
Sbjct: 276 GEIPPEIGNMTALDTLSLHTNKLTGPIPSTLG-NIKTLAVLHLYLNQLNGSIPPELGEME 334
Query: 294 NLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLG 353
+++ L +S N +G V F L + L L N L SG I + N ++L L
Sbjct: 335 SMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQL-SGPIP-----PGIANSTELTVLQ 388
Query: 354 LNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPY 413
L++N F G LP +I + + + N G +P +R+ ++ + + N +G I
Sbjct: 389 LDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISE 448
Query: 414 TIGELINLQALDFSANNLHG------------------------IIPDSIGNLSTLNSLW 449
G L +D S NN HG IP I N++ L+ L
Sbjct: 449 AFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLD 508
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
L N + G +P S+ N + L ++ N+L+G +P I +T L LDLSSN S IP
Sbjct: 509 LSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLE-YLDLSSNRFSSEIP 567
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
+ NL L +++SRN IP L+ + L+ L + N G I S SL+++E L
Sbjct: 568 PTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERL 627
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLD 629
DLS NNLSGQIP +D+ L ++++S+N+ +G +P F N + N LCG ++
Sbjct: 628 DLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVN 687
Query: 630 ELH-LPACHNTRPRKA---KITILKVLIPVIVLLTILSV-GLIVVCTRRR-KQTQKSSTL 683
L C T +K+ + I+ +L+P+I + ILSV I +C R+R KQ ++ +
Sbjct: 688 TTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDS 747
Query: 684 LSMEQQFPM------VSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN 737
S + + V Y E+ KAT EF LIG G G VY+ L ++ AVK +N
Sbjct: 748 ESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAIM--AVKKLN 805
Query: 738 LKQKGSI------KSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGS 791
SI + F+ E AL IRHRN++K+ CS + + F LVY+YM+ GS
Sbjct: 806 ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCS---HRRNTF--LVYEYMERGS 860
Query: 792 LEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 851
L L+ ND L+ +R+N+ VA A+ Y+HH P IVH D+ N+LL D
Sbjct: 861 LRKVLE--NDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYE 918
Query: 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEM 911
A +SDFG AK L + SS+ + GT GYVAPE V+ DVYSFG+L LE+
Sbjct: 919 AKISDFGTAKLL-----KPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEV 973
Query: 912 FTGRRP-------THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLT 964
G P + + + L+L LPE E I+E +
Sbjct: 974 IKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE----------------IKEEVL 1017
Query: 965 AVVRIGVLCSMESPSERIHM 984
++++ +LC P R M
Sbjct: 1018 EILKVALLCLHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 323/1002 (32%), Positives = 501/1002 (50%), Gaps = 120/1002 (11%)
Query: 80 QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGT 139
+L + ++ G L +G+ L+ ++L+SN L G+IP L +L L+ L+L+ N +G
Sbjct: 109 KLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGK 168
Query: 140 IPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNV----AENQLTGQLPPSIGN 195
IP ++S CS L + + N LTG IP +G KL L V +++GQ+P IG+
Sbjct: 169 IPPDISKCSKLKSLILFDNLLTGSIPTELG----KLSGLEVIRIGGNKEISGQIPSEIGD 224
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTN 254
S L LG+ E + G +P SLG+L+ L LS+ SG +P + N S L + L N
Sbjct: 225 CSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYEN 284
Query: 255 RFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFS 314
G +P IG L KL+ L + QN+L G IP+ N SNL +++LS N SG +
Sbjct: 285 SLSGSIPREIG-QLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG 343
Query: 315 SLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTIT 374
L + + N SGSI T ++NCS L L L+ N+ G +P + L+ +T
Sbjct: 344 RLSFLEEFMISDNKF-SGSIP-----TTISNCSSLVQLQLDKNQISGLIPSELGTLTKLT 397
Query: 375 IIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI 434
+ NQ+ G+IP + + ++ AL L N LTGTIP + L NL L +N+L G
Sbjct: 398 LFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGF 457
Query: 435 IPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLS 494
IP IGN S+L L LGFN + G IPS +G+ K + L+ S N+L G +P +I + L
Sbjct: 458 IPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQ 517
Query: 495 SLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG 554
++DLS+N + GS+P V +L L LD+S N+FSG+IP +L SL L + N F G
Sbjct: 518 -MIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSG 576
Query: 555 SIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEY---------------------- 592
SIP+SL +++LDL N LSG+IP L D+ LE
Sbjct: 577 SIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNK 636
Query: 593 --------------------------LNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCG 626
LN+SYN F G +P +F + L N KLC
Sbjct: 637 LSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCS 696
Query: 627 GLDELHLPACHNT--------------RPRKAKITILKVLIPVIVLLTILSVGLIVVCTR 672
+ +C T R RK ++T+ ++ +VL+ + G + V
Sbjct: 697 STQD----SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMIL---GAVAVIRA 749
Query: 673 RRKQTQKSSTLLSMEQQFPMVSYAELNKATNE----FSLSNLIGQGSFGFVYRGNLGEDL 728
RR + + L ++ + +LN + ++ N+IG+G G VYR ++
Sbjct: 750 RRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGE 809
Query: 729 LPVAVKVI---------NLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779
+ +AVK + + K K SF AE + L IRH+N+++ + C + +
Sbjct: 810 V-IAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWN-----RNT 863
Query: 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL 839
+ L+YDYM +GSL L + + +L+ R I + A + YLHH C PPIVH D+
Sbjct: 864 RLLMYDYMPNGSLGSLLHE---RRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDI 920
Query: 840 KPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG 899
K +N+L+ D +++DFGLAK + + I S++ + G+ GY+APEYG ++
Sbjct: 921 KANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNT---VAGSYGYIAPEYGYSMKITEKS 977
Query: 900 DVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKI 959
DVYS+G+++LE+ TG++P +G+ L +V+ +E++D L A+
Sbjct: 978 DVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN--RGSLEVLDSTLR---SRTEAEA 1032
Query: 960 EECLTAVVRIGVLCSMESPSERIHMADA---VKNLCAAREKY 998
+E + V+ +LC SP ER M D +K + RE+Y
Sbjct: 1033 DE-MMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEY 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1003 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.966 | 0.931 | 0.515 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.972 | 0.512 | 0.511 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.962 | 0.954 | 0.500 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.974 | 0.950 | 0.482 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.980 | 0.962 | 0.483 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.960 | 0.938 | 0.495 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.961 | 0.943 | 0.484 | 0.0 | |
| 224117950 | 1018 | predicted protein [Populus trichocarpa] | 0.980 | 0.965 | 0.488 | 0.0 | |
| 444737622 | 1032 | Putative LRR receptor-like serine/threon | 0.958 | 0.931 | 0.494 | 0.0 | |
| 449441592 | 1023 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.956 | 0.490 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2461), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/999 (51%), Positives = 687/999 (68%), Gaps = 30/999 (3%)
Query: 33 NETDRVALLAIKSQL-QDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGF 91
NETDR+ALLAIK+Q+ QDP+GIT+SWN+S++ C WTGVTCG RH RV L L + + G
Sbjct: 37 NETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGS 96
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
LSP +GNL+FL +NL NN HG+IP ELGRLSRL+ L L NSFSG IP+NLS CSNL+
Sbjct: 97 LSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLV 156
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
F + NNL G IP+++G Y K+ + + N LTG +P S+GN+++++ L N L G
Sbjct: 157 YFRLGFNNLIGRIPSWLGSYP-KVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEG 215
Query: 212 IIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPK 270
IP++LGQL+ L F+ + N FSG++P ++N+SSLE SL N+ G LP ++ F LP
Sbjct: 216 SIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPN 275
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L++L +G N+ TGS+P S SNASNL+ +++ ++F+GKV IDF +PN+ L L N LG
Sbjct: 276 LQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLG 335
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTIPL 389
G DL F+ L C L+ L L+ ++FGG LP SIANLST + + + NQ+SGTIP
Sbjct: 336 KGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPP 395
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
I NL N+ L L N TG+IP IG L L +D S N L G IP S+GN++ L SL
Sbjct: 396 GIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLH 455
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
L N+L G IPSS GN L L++S N L GT+P +++++ +L+ L+L+ N ++G +P
Sbjct: 456 LQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLP 515
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
V LKNL LD+S N+ SGEIP L SC +LE+L M+ N F+GSIP S ISL+ + L
Sbjct: 516 SEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDL 575
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLD 629
DLS NNLSGQIPE+L+ LS L LNLS+N+FEGQ+PTKGVF+N T S+ N KLCGG+
Sbjct: 576 DLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIP 634
Query: 630 ELHLPACHNTRPRKAKITI-LKVLIPVIV--LLTILSVGLIVVCTRRRKQTQKSSTLLSM 686
ELHLPAC T+P+ + LK++I ++ L +L + L+V+ RR + + S T S
Sbjct: 635 ELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASS 694
Query: 687 EQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS 746
+ VSY L KAT FS +NLIG G FG VY+G LG+D VAVKVI L Q+G++KS
Sbjct: 695 KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKS 754
Query: 747 FVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ--QSNDQVD 804
F AECEAL+NIRHRNL+K++T CSS+D++G+DFKALVY++M +GSLE+WL + D+++
Sbjct: 755 FKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEIN 814
Query: 805 GNLNLI---QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
L ++ QRLNI+IDVASA++YLHHHC PIVH DLKPSN+LLD+DM AHV DFGLA+
Sbjct: 815 DVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLAR 874
Query: 862 FLFDRP--IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
F+ + + SSSIG+KGT+GY APEYGMG VS GD YS+GILLLEMFTG+RPT
Sbjct: 875 FIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 934
Query: 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNE---------------RAKIEECLT 964
+MF+D L LH FVKMALPE++ +I+D L E R K+ ECL
Sbjct: 935 SMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLI 994
Query: 965 AVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKGRRV 1003
+++RIGV CS+ESP ER+ + +A+K L R+ G V
Sbjct: 995 SILRIGVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/1009 (51%), Positives = 690/1009 (68%), Gaps = 34/1009 (3%)
Query: 20 LFLLNPD----SCFALSNETDRVALLAIKSQL-QDPMGITSSWNNSINVCQWTGVTCGQR 74
+FL +P S NETDR+ALLAIK+Q+ QDP+GIT+SWN+S++ C WTGVTCG R
Sbjct: 51 IFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHR 110
Query: 75 HPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFN 134
H RV L L + + G LSP +GNL+FL +NL NN HG+IP ELGRLSRL+ L L N
Sbjct: 111 HQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNN 170
Query: 135 SFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIG 194
SFSG IP+NLS CSNL+ F + NNL G IP+++G Y K+ + + N LTG +P S+G
Sbjct: 171 SFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSY-PKVVRMQLHYNNLTGPVPDSLG 229
Query: 195 NISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLT 253
N+++++ L N L G IP++LGQL+ L F+ + N FSG++P ++N+SSLE SL
Sbjct: 230 NLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPY 289
Query: 254 NRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDF 313
N+ G LP ++ F LP L++L +G N+ TG +P S SNASNL+ +++ ++F+GKV IDF
Sbjct: 290 NKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDF 349
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST- 372
+PN+ L L N LG G DL F+ L C L+ L L+ ++FGG LP SIANLST
Sbjct: 350 GGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQ 409
Query: 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
+ + + NQ+SGTIP I NL N+ L L N TG+IP IG L L +D S N L
Sbjct: 410 LMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLS 469
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITT 492
G IP S+GN++ L SL L N+L G IPSS GN L L++S N L GT+P +++++ +
Sbjct: 470 GHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVS 529
Query: 493 LSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSF 552
L+ L+L+ N ++G +P V LKNL LD+S N+ SGEIP L SC +LE+L M+ N F
Sbjct: 530 LTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFF 589
Query: 553 RGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+GSIP S ISL+ + LDLS NNLSGQIPE+L+ LS L LNLS+N+FEGQ+PTKGVF+N
Sbjct: 590 KGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNN 648
Query: 613 KTRISLIENGKLCGGLDELHLPACHNTRPRKAKITI-LKVLIPVIV--LLTILSVGLIVV 669
T S+ N KLCGG+ ELHLPAC T+P+ + LK++I ++ L +L + L+V+
Sbjct: 649 ATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVI 708
Query: 670 CTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLL 729
RR + + S T S + VSY L KAT FS +NLIG G FG VY+G LG+D
Sbjct: 709 NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDET 768
Query: 730 PVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS 789
VAVKVI L Q+G++KSF AECEAL+NIRHRNL+K++T CSS+D++G+DFKALVY++M +
Sbjct: 769 VVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPN 828
Query: 790 GSLEDWLQ--QSNDQVDGNLNLI---QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNV 844
GSLE+WL + D+++ L ++ QRLNI+IDVASA++YLHHHC PIVH DLKPSN+
Sbjct: 829 GSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNI 888
Query: 845 LLDHDMVAHVSDFGLAKFLFDRP--IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVY 902
LLD+DM AHV DFGLA+F+ + + SSSIG+KGT+GY APEYGMG VS GD Y
Sbjct: 889 LLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTY 948
Query: 903 SFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNE------- 955
S+GILLLEMFTG+RPT +MF+D L LH FVKMALPE++ +I+D L E
Sbjct: 949 SYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAAD 1008
Query: 956 --------RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996
R K+ ECL +++RIGV CS+ESP ER+ + +A+K L R+
Sbjct: 1009 SSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRK 1057
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2358), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/985 (50%), Positives = 665/985 (67%), Gaps = 20/985 (2%)
Query: 33 NETDRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGFL 92
NETDR++LLA K+Q+ DP+ SSWN S + C+W+GV CG RH R+++L L++ + G L
Sbjct: 31 NETDRLSLLAFKAQITDPLDALSSWNASTHFCKWSGVICGHRHQRIVELNLQSSQLTGNL 90
Query: 93 SPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLIN 152
SP++GNLSFLR +NL N +IP ELGRL RL+ LVL N+FSG IP N+S CSNL+
Sbjct: 91 SPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLGNNTFSGEIPVNISSCSNLLV 150
Query: 153 FSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI 212
+ NNLTG+IPA +G KL + N L G +P S GN+S++Q +N L G
Sbjct: 151 LHLGSNNLTGKIPAQLGSLS-KLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGG 209
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPKL 271
IPESLG L+ L + +VAEN+ SG +P I NISSL +SL N+ G LP ++G NLP L
Sbjct: 210 IPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNL 269
Query: 272 KILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGS 331
L++ N+L G IP + SNAS + +++LS N+ +GK+ D +SLP++ +L + N+LG+
Sbjct: 270 AYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLGN 328
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTIPLE 390
G DL F+ L N + LE+LG+N N FGG LP ++N ST + I G NQI G+IP E
Sbjct: 329 GEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTE 388
Query: 391 IRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWL 450
I NL ++ L LE NQL G IP +IG+L NL AL + N + G IP S+GN+++L +
Sbjct: 389 IGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSF 448
Query: 451 GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL 510
NNLQG IP+SLGN L++L++S+N L+G +P ++L I++LS LL L N ++GS+P
Sbjct: 449 AQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPS 508
Query: 511 VVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLD 570
VG L NL L +S+NR SGEIP +L SC SLE L + N F G +P L SL+++++L
Sbjct: 509 EVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVP-DLSSLRALQMLL 567
Query: 571 LSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDE 630
LS NNLSGQIP++L+D LE L+LSYNDFEG+VP +GVF N +RIS+ N KLCGG+ +
Sbjct: 568 LSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQ 627
Query: 631 LHLPACHN---TRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQKSSTLLSME 687
L LP C + RP+ IL + IP L +L ++ +R+ K S S E
Sbjct: 628 LDLPKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTKDEPASGP--SWE 685
Query: 688 QQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF 747
F ++Y +L +AT+ FS SNL+G G+FG VYRG L D VAVKV+NL +KG+ KSF
Sbjct: 686 SSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSF 745
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN----DQV 803
+AEC AL NIRHRNL+K+IT CSS DF+G+DFKALVY++M +GSLE+WL +
Sbjct: 746 MAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPE 805
Query: 804 DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863
NL+L+QRLNI+IDVASA++YLH+HCQ P+VH DLKPSNVLL DM A V DFGLA+FL
Sbjct: 806 TRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFL 865
Query: 864 FDRPIQ--ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+ Q SSS+G+KGT+GY APEYGMG VS GDVYS+GILLLEMFTGRRPT M
Sbjct: 866 PEASNQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGM 925
Query: 922 FNDGLTLHGFVKMALPEKVMEIVDFALL----LDPGNERAKIEECLTAVVRIGVLCSMES 977
F DG LH + KM LP+ V+E VD L ++ ++ K+ EC+ +++++G+ CS E
Sbjct: 926 FKDGHNLHNYAKMVLPDNVLEFVDPTLREHEEMNHNDDSHKVMECMVSIIKVGLACSAEL 985
Query: 978 PSERIHMADAVKNLCAAREKYKGRR 1002
P ER+ +A+ V L RE GR+
Sbjct: 986 PGERMGIANVVVELHRIREMLDGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 901 bits (2328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/1013 (48%), Positives = 687/1013 (67%), Gaps = 36/1013 (3%)
Query: 14 FVWCVTLFLLNPDSCFALS---NETDRVALLAIKSQL-QDPMGITSSWNNSINVCQWTGV 69
+W + L ++ SC +LS NETDR++LLA K+ + DP+ I SSWN S++ C+W+G+
Sbjct: 11 LLWVLFLKMIQL-SCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGI 69
Query: 70 TCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVL 129
TCG RH RVI++ L + + G L+ ++GNLSFLR +NL +N+L IP E+GRL RL+ L
Sbjct: 70 TCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTL 129
Query: 130 VLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQL 189
+L NSFSG IP N+S+CSNL+ + RNNLTG++PA + KL+ N LTG++
Sbjct: 130 ILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAELKSLS-KLQMFEFEINYLTGEI 188
Query: 190 PPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQ 248
PS N+S+L+ + N +G IP S+GQL+ L S+ +NFSG++PP IFN+SSL
Sbjct: 189 SPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTI 248
Query: 249 ISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGK 308
+S+ N+ G LP ++G +LPKL++L + N +GSIP + SNASNLV L++S N+F+GK
Sbjct: 249 LSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGK 308
Query: 309 VGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIA 368
V + L N++ + + +NNLG+G DL F+ L N + LE L + N GG LP ++
Sbjct: 309 VP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLS 367
Query: 369 NLSTITI-IAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFS 427
N ST + +A G N+I G IP EI NL + ALG E N+LTG+IP ++G+L NL L +
Sbjct: 368 NFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLN 427
Query: 428 ANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQI 487
NN+ G IP S+GN+++L+++ L NNL+G+IPSSLGNC+ ++L+++S+N L+GT+P ++
Sbjct: 428 DNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKEL 487
Query: 488 LEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKM 547
+ I +LS LDLS N +GS+P+ VG L NL LD+S+N+ SGEIP +L SCT LE L +
Sbjct: 488 ISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYL 547
Query: 548 QDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTK 607
Q N+F+G+IP SL SL+ I L+LS NNL+GQIP + + LE L+LSYNDFEG+VP +
Sbjct: 548 QGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAE 607
Query: 608 GVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKIT-----ILKVLIPVIVLLTIL 662
GVF N + S+ N LCGG+ E++LP C + K K + I+ V +V + +L
Sbjct: 608 GVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVLLL 667
Query: 663 SVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG 722
+ L+ C + RK + S + S++ F VSY L KAT+ FS +NLIG GSFG VY+G
Sbjct: 668 TSALLFCCLKMRKNKEASGS--SLDIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKG 725
Query: 723 NLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782
L D +AVKV+NL+ KG+ +SF+ EC+AL N+RHRNL+K++T CSS DF+ +DFKAL
Sbjct: 726 ILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDFKAL 785
Query: 783 VYDYMQSGSLEDWLQQS----NDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838
VY+YM +GSLE+WL + DQ L+LI+RL+ISIDVASA++YLH+ CQ P+VH D
Sbjct: 786 VYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQCQVPVVHCD 845
Query: 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLT 898
LKPSN+LLD DM AHV DFGLA+FL P + SSSIGI+GTVGY APEYGMG +VS
Sbjct: 846 LKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSPSSSIGIRGTVGYAAPEYGMGSDVSTY 905
Query: 899 GDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLL--DPGNE- 955
GDVY++GILLLE+FTG++PT MF DGL LH KMA+P+++ D LL+ D G
Sbjct: 906 GDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRLALAADPFLLITEDEGTSA 965
Query: 956 -------------RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995
R K+ CL ++++IGV CS ESP +R+ ++D L R
Sbjct: 966 SATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDISDVANELVRIR 1018
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/1021 (48%), Positives = 690/1021 (67%), Gaps = 38/1021 (3%)
Query: 4 IFISIRCLGTFVWCVTLFLLNPDSCFALSNETDRVALLAIKSQL-QDPMGITSSWNNSIN 62
+F S C +FV+ ++L + +C +NETD +AL+ K+++ DP+GI SSWN++I+
Sbjct: 1 MFCSAFCFRSFVFLLSLISV---TCSDYTNETDLLALIQFKNKIVDDPLGIMSSWNSTIH 57
Query: 63 VCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGR 122
CQW GV+CG+RH RV L L++ + G +SP++GNLSFLR ++L +N+ EIP ++GR
Sbjct: 58 FCQWHGVSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGR 117
Query: 123 LSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAE 182
L L++ L NS SG IP ++S CSNLI+ + NNLTGEIP +G LKL+NL +
Sbjct: 118 LRSLQIFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGS-LLKLKNLTLEV 176
Query: 183 NQLTGQLPPSIGNISTLQQLGVGENK-LYGIIPESLGQLRDLNFLSVAENNFSGMLPP-I 240
N LTG +PPS+GN+S+L+ L + +NK L+G +P +LG+L++L L++ +N SG++PP I
Sbjct: 177 NGLTGTIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSI 236
Query: 241 FNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNL 300
FN+SSL + + N F G LP +IG +LP L+ + N TGSIP S SNASN+ +L +
Sbjct: 237 FNLSSLTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQV 296
Query: 301 SGNHFSGKVGIDFSSLPNITRLN---LGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
S N+ +G+V +L + RLN L N+LGSG DL F++ LTN + LE L + N
Sbjct: 297 SLNNLTGEV----PTLEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRN 352
Query: 358 RFGGSLPRSIANLST-ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIG 416
FGG LP+ I+NLST + +I++ N I G+IP I L N+ + N+++G IP +IG
Sbjct: 353 NFGGELPKQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIG 412
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSK 476
EL NL+ L NNL G IP S+GNL+ L +L+LG N+L+G+IPSSLGNCK L++L +
Sbjct: 413 ELQNLEGLVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCG 472
Query: 477 NKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTL 536
N L+G +PP + I +L + S N SGS+P+ +G L NL LD+S N SGEIP++L
Sbjct: 473 NNLSGDIPPGLFGIFSLLYIC-FSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSL 531
Query: 537 SSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596
C SLE L M N F GSIPS+L SL+ + + S NNLSG+IPE+ + + LE L+LS
Sbjct: 532 GGCISLEDLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLS 591
Query: 597 YNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITILKVLIPVI 656
YN+FEG +P +G+F N T +S+I N +LCGG EL LP C +P++ K+ + + +
Sbjct: 592 YNNFEGMIPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAIT 651
Query: 657 VLLTI-LSVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGS 715
VLL + L V + +C+ RRK ++ L SM + VSY L KATN FS SNL+G GS
Sbjct: 652 VLLALALVVTCLFLCSSRRK--RREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGS 709
Query: 716 FGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775
FG VY+G L ++ + +AVKV+NL ++G+ +SF+AECEAL+NIRHRNL+K++T CSSID+
Sbjct: 710 FGSVYKGMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYH 769
Query: 776 GDDFKALVYDYMQSGSLEDWLQ--QSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP 833
G+DFKA+VY++M +GSLEDWL + LNL+QRLNI+IDVA A+EYLHHHC+ P
Sbjct: 770 GNDFKAIVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMP 829
Query: 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFL----FDRPIQETSSSSIGIKGTVGYVAPEY 889
I H DLKPSNVLLD ++ HV DFGLAKFL D P E S+SIG++GT+GY PEY
Sbjct: 830 IAHCDLKPSNVLLDDELTGHVGDFGLAKFLSGASLDYPTNE--STSIGVRGTIGYAPPEY 887
Query: 890 GMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALL 949
G+GG VS GD YS+GILLLEMFTG+RPT MF +G LH FVK A+PE+V +I D LL
Sbjct: 888 GVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQITDPTLL 947
Query: 950 L-DPGNERAKIE----------ECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998
+P + K E ECL +++RIG+ CS+E P ER+ ++DAV L + R +
Sbjct: 948 QEEPTGDDDKHEISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQLHSVRNEL 1007
Query: 999 K 999
+
Sbjct: 1008 Q 1008
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/984 (49%), Positives = 668/984 (67%), Gaps = 21/984 (2%)
Query: 33 NETDRVALLAIKSQLQDPMGIT-SSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGF 91
NETD ALLA K+++QDP T SSWN+S++ C W G+TCG+RH RV + L +Q + G
Sbjct: 30 NETDYEALLAFKAKIQDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGT 89
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
LSPYVGN+SFLR I LA+N +HGEIP E+GRL RL+VL+L NS G IP+NLS CS+L
Sbjct: 90 LSPYVGNISFLREIRLANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLA 149
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
+ RN L GEIP +G+ KL L+ +N L G++P SIGN+++L+ L + N L G
Sbjct: 150 ELYIDRNKLGGEIPTELGFLS-KLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEG 208
Query: 212 IIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPK 270
IP+SLG+L+ L L + EN SG +PP ++N+S + L N F G LP N+G + P
Sbjct: 209 TIPDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPH 268
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L+ L + QN +G IP S +NAS L I++ + N +GK+ F L +++ L+ G NNLG
Sbjct: 269 LQWLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLG 328
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITI-IAMGLNQISGTIPL 389
+G ++ F+ LTNCS L+ + +N+NR GSLP ++ NLST + + N I G IP
Sbjct: 329 TGGDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPS 388
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
I NL N+ L ++ N TG IP + G L L+ +N L G IP S+GNLS L+ L+
Sbjct: 389 GIGNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLY 448
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
L N L+ IP+SLG CKNL+ L +S+ L G++P Q+ +++ L+LS N +GS+P
Sbjct: 449 LDDNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLP 508
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
+G+LK L +LD+S N SGEIPT+ CTSLE L M+DN F+GSIPSS SL+ I+ L
Sbjct: 509 STIGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFL 568
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLD 629
DLSCNNLSGQ+P +L + F+ LNLSYN+FEG+VP KGVF+N++ +S++ N KLCGG+
Sbjct: 569 DLSCNNLSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGIL 627
Query: 630 ELHLPACHNTRPRKAKITILKVLIPVIV---LLTILSVGLIVVCTRRRKQTQKSSTLLSM 686
ELHLP C N P+K K++ L+ L+ + + L+ ++V + C ++K+ + SS L +
Sbjct: 628 ELHLPECPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKRKEHSSDTL-L 686
Query: 687 EQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS 746
++ FP +SY L KAT+ FS +NLIG GSF VY+G + ED VA+KV+NL+++G+ KS
Sbjct: 687 KESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKS 746
Query: 747 FVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN 806
F ECEAL+NIRHRNL+KIIT CSSIDF+G++FKALVY+YM GSLE WL + + D
Sbjct: 747 FKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQ 806
Query: 807 L-------NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
NL++R+NI+IDVA+A++YLHHHC PI+H D+KPSN+LLD DM+ H+ DFGL
Sbjct: 807 QINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGL 866
Query: 860 AKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
A+ F P E SSS GIKGT GY APEYG G VS+ GDVYS+GILLLEM TG+RP
Sbjct: 867 ARIFQEFSEPSLE--SSSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEMMTGKRP 924
Query: 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNER-AKIEECLTAVVRIGVLCSME 976
F GL LH F KMALP+ V+EI D LL + E A +EECLT++V+IGV CSM+
Sbjct: 925 IDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSERHLENAASMEECLTSLVKIGVACSMD 984
Query: 977 SPSERIHMADAVKNLCAAREKYKG 1000
SP +R+ M+ V+ L R+ ++G
Sbjct: 985 SPRDRMDMSRVVRELLMVRDTFQG 1008
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 893 bits (2307), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/996 (48%), Positives = 674/996 (67%), Gaps = 32/996 (3%)
Query: 33 NETDRVALLAIKSQLQ-DPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGF 91
NETD+++LL K+Q+ DP+G SSWN S CQW+GVTCG+RH RV++L L + + G
Sbjct: 32 NETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHSYQLVGS 91
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
LSP++GNLSFLR +NLA+N+L IP ELGRL RL+ LVL N+F G IP+N+S C+NL
Sbjct: 92 LSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANISRCANLR 151
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
R NLTG++PA +G KL+ L + N G++P S GN+S + + N L G
Sbjct: 152 ILDFSRGNLTGKLPAELGLLS-KLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEG 210
Query: 212 IIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPK 270
IP GQL+ L LS+ NN SGM+PP IFN+SSL +S N+ G LP +G LP
Sbjct: 211 SIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPN 270
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L++ + N G IP +FSNASNL+ + N+F+GKV SS ++ L +G NNLG
Sbjct: 271 LQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP-PLSSSHDLQVLGVGDNNLG 329
Query: 331 SGSIGDLDFI-TLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTIP 388
G DL+F+ L N + LE L + N FGG LP ++N ST + + NQI G+IP
Sbjct: 330 KGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIP 389
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
+I NL N+ ALGLE NQLTG IP ++G+L L L + N + G+IP S+GN+++L +
Sbjct: 390 TQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRV 449
Query: 449 WLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSI 508
+ NNL+G+IP SLGN + L+ L +S+N L+G +P +++ I +LS L LS N ++GS+
Sbjct: 450 NMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSL 509
Query: 509 PLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEV 568
P+ + L NL LD+S+NRFSGEIP +L SC SLE L +++N +G IP +L SL++I+
Sbjct: 510 PIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQE 569
Query: 569 LDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGL 628
L+LS NNL+GQIPE+LED LE LNLS+NDFEG+VP +G F N + IS+ N KLCGG+
Sbjct: 570 LNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGI 629
Query: 629 DELHLPACHNTRPRKAK-----ITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQKSSTL 683
+L+L C ++ P +K I I+ + + ++ I+S L+ C R++K +S
Sbjct: 630 PQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISF-LLFYCFRKKKDKPAASQ- 687
Query: 684 LSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS 743
S+E FP V+Y +L AT+ FS +NLIG+GSFG V++G LG D + VAVKV+NL +KG+
Sbjct: 688 PSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGA 747
Query: 744 IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ--QSND 801
KSF+AECEALK+IRHRNL+K++T CSSIDF+G+DFKALVY++M +G+LE+WL Q++D
Sbjct: 748 SKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSD 807
Query: 802 QVDG--NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
+ +G L+L+ RLNI+I +ASA+ YLHH CQ PI+H DLKPSN+LLD +M AHV DFGL
Sbjct: 808 EANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGL 867
Query: 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
A+F + Q +SS+G+KGT+GY APEYG+GG VS GDVYS+GILLLEMFTG+RP
Sbjct: 868 ARFHSEASNQ---TSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVD 924
Query: 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALL-----LDPGNERA-------KIEECLTAVV 967
MF DGL LH + KMALP++++E+VD L+ ++ +E +I CL ++
Sbjct: 925 GMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTII 984
Query: 968 RIGVLCSMESPSERIHMADAVKNLCAAREKYKGRRV 1003
++GV CS+E P ER+ + D V L ++ G R+
Sbjct: 985 KMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRM 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117950|ref|XP_002317696.1| predicted protein [Populus trichocarpa] gi|222858369|gb|EEE95916.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2292), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/1015 (48%), Positives = 669/1015 (65%), Gaps = 32/1015 (3%)
Query: 9 RCLGTFVW-----CVTLFLLNPDSCFALSNETDRVALLAIKS-QLQDPMGITSSWNNSIN 62
R L +F++ C + NP + +NETDR ALLA+K L DP SSWN S++
Sbjct: 4 RLLNSFLFILCALCSINYFENPTAS-GFTNETDREALLAMKHLVLSDPFRALSSWNASLH 62
Query: 63 VCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGR 122
C W GV CG +H RVI L L + + GFLSP++GNL+FLR I+L+ NN HG IP E+G+
Sbjct: 63 FCTWHGVACGSKHQRVIALNLSSLQLAGFLSPHIGNLTFLRRIDLSKNNFHGTIPEEVGQ 122
Query: 123 LSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVA- 181
L RL+ L L NSF +P NLSHCSNL + NNLTG+IP+ +G L NL
Sbjct: 123 LFRLQYLSLSNNSFQDELPGNLSHCSNLRFLGMEGNNLTGKIPSELG----SLSNLRAPG 178
Query: 182 --ENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP 239
+N LTG LP S GN+S+L L + EN L G IP +L L +L ++ NN SGM+P
Sbjct: 179 LLKNHLTGSLPRSFGNLSSLVSLSLRENNLEGSIPIEFERLSRLAYLDLSFNNLSGMVPE 238
Query: 240 -IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVIL 298
++NISSL +++++N GRLPL++G LP L+ L +G N G +P S N+S L L
Sbjct: 239 ELYNISSLSTVAMVSNNLSGRLPLDLGLTLPNLQTLYLGLNRFLGPVPASIVNSSGLEYL 298
Query: 299 NLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNR 358
+L+ N FSG V + SL + LN G N +G + DL F+T LTNC+ L+ +GL +
Sbjct: 299 DLASNSFSGPVPKNLGSLRYLQILNFGFNKIGDKNNNDLTFLTSLTNCTDLKEIGLYKSN 358
Query: 359 FGGSLPRSIANLST-ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGE 417
GG LP SIANLST + + M N I+GTIP EI NL + AL L N LTG +P +IG+
Sbjct: 359 LGGLLPNSIANLSTNLYYLVMWGNYITGTIPTEIGNLKSSQALDLADNMLTGRLPESIGK 418
Query: 418 LINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477
L+ L+ N + G IP ++GN+S L L LG N L+G IP SL NC +L LL++S N
Sbjct: 419 LVMLKEFYVHLNKISGEIPSALGNISGLLKLDLGVNLLEGTIPVSLANCTSLNLLDISHN 478
Query: 478 KLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
L+G +P +I +++L+ L L SN +SG +P V N++NLIQLDISRN+ GEIP+TL
Sbjct: 479 HLSGFIPEKIFSLSSLTLGLLLGSNRLSGRLPSQVVNMRNLIQLDISRNKICGEIPSTLE 538
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSY 597
+C LE L M N RG+IPSS L+SI VLD+SCNNLSGQIPE+L DL FL LNLS+
Sbjct: 539 TCLMLETLNMSGNFLRGTIPSSFKKLRSIRVLDVSCNNLSGQIPEFLADLPFLSNLNLSF 598
Query: 598 NDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKA-KITILKVLIPVI 656
N+FEG+VP +G F N ++ S+ N KLCGG+ + LP C T+ K ++ V V
Sbjct: 599 NEFEGKVPAEGAFENASQFSIAGNNKLCGGIKAIQLPECPRTKQHKRFSKRVVIVASSVA 658
Query: 657 VLLTILSVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSF 716
V +T+L + V R+ +K + +ME++F +VSY +L +AT+ FS +N+IG G +
Sbjct: 659 VFITLLLACIFAVGYRKLSANRKPLSASTMEKKFQIVSYQDLARATDGFSSANMIGDGGY 718
Query: 717 GFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776
G VY+G LG D VA+KV+ +Q+G+ ++FVAECE L+ IRHRNL+KI+T CSSIDFKG
Sbjct: 719 GSVYKGILGPDGQTVAIKVLKPEQRGANRTFVAECETLRRIRHRNLVKIVTACSSIDFKG 778
Query: 777 DDFKALVYDYMQSGSLEDWLQQS--NDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPI 834
+DFKALV+D+M GSLE WL S Q L+L+QR+++ IDVASA++YLH+HC I
Sbjct: 779 NDFKALVFDFMPGGSLESWLHPSAVESQNSKRLSLLQRISMLIDVASALDYLHNHCDEQI 838
Query: 835 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ--ETSSSSIGIKGTVGYVAPEYGMG 892
VH DLKPSN+LLD+D+ AHV DFGLA+ L + TS+SS+G++GTVGYVAPEYGMG
Sbjct: 839 VHCDLKPSNILLDNDLTAHVGDFGLARILSAATGETPSTSTSSLGVRGTVGYVAPEYGMG 898
Query: 893 GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLD- 951
G VS++GDVYS+GILLLEMFTG+RPT +MF +LH F K ALP++V EI+D L +D
Sbjct: 899 GQVSISGDVYSYGILLLEMFTGKRPTDSMFTGNNSLHNFAKTALPDQVSEIIDPLLKIDT 958
Query: 952 ----------PGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996
P + R KIE CL ++++IGVLCS+E PSER+ +A+ + R+
Sbjct: 959 QQLAESSRNGPSSSRDKIEGCLISILQIGVLCSVELPSERMVIAEVLSEFNKIRK 1013
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|444737622|emb|CCM07279.1| Putative LRR receptor-like serine/threonine-protein kinase FLS2 [Musa balbisiana] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/985 (49%), Positives = 654/985 (66%), Gaps = 24/985 (2%)
Query: 36 DRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRHP-RVIQLYLRNQSVGGFLSP 94
DR+AL + KS + DP+G +SWN + +VC+W GV CG+RHP RV L L + + G + P
Sbjct: 36 DRLALESFKSMVSDPLGALASWNRTNHVCRWQGVRCGRRHPDRVTALRLLSSGLVGRIPP 95
Query: 95 YVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFS 154
+V NL+FL+ + L NN HG+IP ELGRLSRL+ L L N G IP+ L CSNL S
Sbjct: 96 HVANLTFLQVLRLRDNNFHGQIPPELGRLSRLQGLDLSLNYLEGPIPATLIRCSNLRQVS 155
Query: 155 VRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIP 214
VR N LTGEIP +G K+ N+A+N LTG +P S+GN+++L L + N L G IP
Sbjct: 156 VRSNLLTGEIPRDVGLLS-KMLVFNLAQNNLTGSIPSSLGNMTSLFALFLQSNTLEGSIP 214
Query: 215 ESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKI 273
ES+G L+ L L +A N SG +P ++N+SS+ S+ +N EG LP N+ LP L++
Sbjct: 215 ESIGNLKSLQLLQIAYNRLSGAIPSSLYNLSSMSIFSVGSNLLEGTLPANMFDTLPSLEM 274
Query: 274 LIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGS 333
L++ N+ G IP S SNAS + + LS N+F+G V +L + +NL N L +
Sbjct: 275 LLMNNNHFQGHIPASLSNASYMGDIELSVNYFTGTVPSHLENLRRLYFINLSDNQLEATD 334
Query: 334 IGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTIPLEIR 392
D +F+ LTNCS L L L +N FGG LP S+AN S+ + + + N ISGTIP I
Sbjct: 335 SSDWEFLASLTNCSLLHVLVLGTNNFGGMLPTSLANFSSSLNTMTLESNHISGTIPTGIG 394
Query: 393 NLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGF 452
NL N+ L L N LTG IP TIG L NL L S N L G IPDSIGNL+ LN ++L
Sbjct: 395 NLFNLTTLSLSDNHLTGLIPPTIGGLRNLHGLGLSGNRLTGQIPDSIGNLTELNLIYLQD 454
Query: 453 NNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVV 512
N+L G IP S+GNC+ + +++S NKL+G +P Q+ I++LS+ L+LS+NL++G++PL V
Sbjct: 455 NDLGGRIPESIGNCRRVEEMDLSHNKLSGQIPMQLYSISSLSTYLNLSNNLLNGTLPLQV 514
Query: 513 GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLS 572
GNL+NL L ++ N+ SG+IPTTL C SLEYL + DNSF+GSIP SL +L+ + LDLS
Sbjct: 515 GNLRNLGALVLAHNKLSGDIPTTLGQCQSLEYLYLHDNSFQGSIPQSLSNLRGLSELDLS 574
Query: 573 CNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELH 632
NN+SG IPE+L DL L++LNLSYND EG VP GVF N T S+I N KLCGG LH
Sbjct: 575 NNNISGNIPEFLADLLALQHLNLSYNDLEGNVPNDGVFRNITAFSVIGNNKLCGGNQGLH 634
Query: 633 LPACHNTRPRKAKITILKVLIPVI--VLLTILSVGLIVVCTRRRKQTQKSSTLLSMEQQF 690
LP CH RK K L+V+IPVI VL ++ + + V R + +K S +E+QF
Sbjct: 635 LPPCHIHSGRKHKSLALEVVIPVISVVLCAVILLIALAVLHRTKNLKKKKSFTNYIEEQF 694
Query: 691 PMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAE 750
+SY EL +AT+EFS SNLIG GSFG VY+G + D VAVKV+NL++ G+ +SF++E
Sbjct: 695 KRISYNELLRATDEFSASNLIGMGSFGSVYKGAMDADGTTVAVKVLNLERHGASQSFISE 754
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL--QQSNDQVDGNLN 808
CEAL+NIRHRNL+KI+T+C S+D +G+DFKALV +YM +GSLE+WL ++S L
Sbjct: 755 CEALRNIRHRNLVKILTICLSVDNRGNDFKALVLNYMSNGSLENWLHPKESEASTRRKLT 814
Query: 809 LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI 868
L QRL+I+IDV+SA++YLHHH PIVH DLKPSNVLLD +M AHV DFGLA+FL +
Sbjct: 815 LPQRLSIAIDVSSALDYLHHHGPMPIVHCDLKPSNVLLDQEMCAHVGDFGLARFLQGTML 874
Query: 869 QETSSSSI--GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL 926
+ +I GIKGT+GYVAPEY MGG VS GD+YS+GILLLEM TG+RPT MF DGL
Sbjct: 875 DTDRNRTISTGIKGTIGYVAPEYAMGGKVSTNGDIYSYGILLLEMLTGKRPTEDMFKDGL 934
Query: 927 TLHGFVKMALPEKVMEIVDFA---LLLDPGNE-----------RAKIEECLTAVVRIGVL 972
+LH +V+M E + ++D LL++ G + R ++++C + V +G+
Sbjct: 935 SLHKYVEMTPIEDLFMVLDPGLGLLLVENGQQGEQNVVYRDVDRLEVQKCFVSAVNVGLA 994
Query: 973 CSMESPSERIHMADAVKNLCAAREK 997
CS E+P ER+ M D +K L R+K
Sbjct: 995 CSKENPRERMQMGDVIKELSETRDK 1019
|
Source: Musa balbisiana Species: Musa balbisiana Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441592|ref|XP_004138566.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2275), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/1011 (49%), Positives = 658/1011 (65%), Gaps = 32/1011 (3%)
Query: 14 FVWCVTLFLLNPDSCFALSNETDRVALLAIKSQLQ-DPMGITSSWNNSINVCQWTGVTCG 72
FV C LF L S +NETDR+ALL+ KS++ DP+G+ SWN S++ C W GV C
Sbjct: 18 FVICFLLFNLPLPSAAIGANETDRLALLSFKSEITVDPLGLFISWNESVHFCNWAGVICN 77
Query: 73 QRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLD 132
+ RV +L L + G LSP +GNLSFL +NL +N+ GEIP E+G LSRL+ L
Sbjct: 78 PQR-RVTELNLPSYQFNGKLSPSIGNLSFLTTLNLPNNSFGGEIPQEIGSLSRLQELDFR 136
Query: 133 FNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPS 192
N F G IP +S+CS L + NNLTG +P +G KLE + N+L G++P +
Sbjct: 137 NNYFVGEIPITISNCSQLQYIGLLNNNLTGVLPMELGL-LTKLEVFQCSSNELFGEIPET 195
Query: 193 IGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISL 251
GN+S+L+ N +G IP S GQLR+L L + N SG +P I+NISS+ SL
Sbjct: 196 FGNLSSLRGFWGTLNNFHGNIPSSFGQLRNLTALVIGANKLSGTIPSSIYNISSMRIFSL 255
Query: 252 LTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGI 311
N+ EG LP N+GF P L+IL + N +G IP + SNAS L +S N FSGKV
Sbjct: 256 PVNQLEGGLPTNLGFIFPNLQILKIHTNQFSGPIPFTLSNASKLEEFVISNNMFSGKVP- 314
Query: 312 DFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLS 371
+S ++ + +NNLG G++ DL+F+ L NC+ L ++ ++ N FGG+LP I+N S
Sbjct: 315 SLASTRHLEVFGIDRNNLGYGNVDDLNFLFPLVNCTNLSSVVISDNNFGGALPEYISNFS 374
Query: 372 T-ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANN 430
T + II G NQI GTIP EI NL + ALGLE NQLTG+IP + G+L L L + N
Sbjct: 375 TKLRIIGFGRNQIHGTIPTEIGNLFQLEALGLETNQLTGSIPSSFGKLYKLNDLFLNMNK 434
Query: 431 LHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEI 490
L G IP S+GNLS L L NNL G IP SLG ++L++L +S+N+L+G +P ++L I
Sbjct: 435 LSGTIPKSLGNLSALGRCNLRLNNLTGAIPPSLGESQSLLMLALSQNQLSGAIPKELLSI 494
Query: 491 TTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550
++LS LDLS N ++GSIPL VG L NL L IS N +G IP+TLS+CTSLE L + N
Sbjct: 495 SSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLTGVIPSTLSACTSLEDLYLDGN 554
Query: 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVF 610
G IP SL SL+ IE LDLS NNLSG+IP YL++ L YLNLS+N+ EG+VPT+GVF
Sbjct: 555 FLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSYLNLSFNNLEGEVPTQGVF 614
Query: 611 SNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITI-LKVLIPVIVLLTILSVGLIVV 669
N T S++ N KLC G++EL+LP C PRK K+T LK++I V+ + L L+++
Sbjct: 615 KNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKIIISVV---SGLVGALLII 671
Query: 670 CT----RRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLG 725
C RK+ KS S++ + VSY +L KATNEFS NLIG G +G VY+G L
Sbjct: 672 CCLLFFWSRKKKNKSDLSPSLKASYFAVSYNDLLKATNEFSPDNLIGVGGYGSVYKGILS 731
Query: 726 EDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785
+D VAVKV NL+ +G+ KSF+AECEALKNIRHRNL++I++ CS +DF+G+DF ALV+D
Sbjct: 732 QDKSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILSACSGVDFQGNDFMALVFD 791
Query: 786 YMQSGSLEDWLQQ-SNDQVDGN---LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841
+M +GSLE WL N +G LN++QRL+I+IDVASA++YLH+ PI H DLKP
Sbjct: 792 FMVNGSLEKWLHPVDNLNQEGEKMYLNIMQRLDIAIDVASALDYLHNGSPMPIAHCDLKP 851
Query: 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQ--ETSSSSIGIKGTVGYVAPEYGMGGNVSLTG 899
SNVLLD DM AHV DFGLAKF+ + Q T S SIGI+GTVGY PEY MG +S G
Sbjct: 852 SNVLLDADMTAHVGDFGLAKFMAETSFQNRSTESESIGIRGTVGYAPPEYAMGSKISTYG 911
Query: 900 DVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFAL----------- 948
DVYS+GILLLEMFTG+ PT MF DGLTL+ +V ALPE+V EI D +
Sbjct: 912 DVYSYGILLLEMFTGKSPTDNMFKDGLTLNNYVLTALPERVQEIADPTMGIQELNGMGNN 971
Query: 949 -LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998
L+ N+ +I++CL ++ IGV CS + P++R++++D V LC ARE +
Sbjct: 972 NLMFEANQSLRIKDCLFSIFSIGVACSTQMPNQRMNISDVVSQLCLAREIF 1022
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1003 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.960 | 0.939 | 0.448 | 6.8e-214 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.959 | 0.952 | 0.437 | 1.3e-210 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.964 | 0.956 | 0.422 | 1.8e-206 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.968 | 0.962 | 0.422 | 1.4e-204 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.986 | 0.964 | 0.435 | 2.3e-204 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.948 | 0.922 | 0.436 | 2.3e-204 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.702 | 0.867 | 0.409 | 2.3e-135 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.854 | 0.874 | 0.342 | 6.5e-122 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.602 | 0.531 | 0.327 | 9.7e-118 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.894 | 0.764 | 0.329 | 9.1e-116 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2067 (732.7 bits), Expect = 6.8e-214, P = 6.8e-214
Identities = 444/990 (44%), Positives = 615/990 (62%)
Query: 31 LSNETDRVALLAIKSQLQDPMGIT-SSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVG 89
L+ ETD+ ALL KSQ+ + + SWN+S+ +C WTGV CG +H RV + L +
Sbjct: 35 LTEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLT 94
Query: 90 GFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSN 149
G +SP+VGNLSFLR +NLA N HG IP+E+G L RL+ L + N F G IP LS+CS+
Sbjct: 95 GVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSS 154
Query: 150 LINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKL 209
L + N+L +P G KL L++ N LTG+ P S+GN+++LQ L N++
Sbjct: 155 LSTLDLSSNHLEQGVPLEFGSL-SKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQI 213
Query: 210 YGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNL 268
G IP + +L+ + F +A N F+G+ PP I+N+SSL +S+ N F G L + G L
Sbjct: 214 EGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLL 273
Query: 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNN 328
P L+IL +G N+ TG+IP++ SN S+L L++ NH +GK+ + F L N+ L L N+
Sbjct: 274 PNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNS 333
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTI 387
LG+ S GDLDF+ LTNCS+L+ L + N+ GG LP IANLST +T +++G N ISG+I
Sbjct: 334 LGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSI 393
Query: 388 PLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447
P I NL ++ L L N LTG +P ++GEL L+ + +N L G IP S+GN+S L
Sbjct: 394 PHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTY 453
Query: 448 LWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXX 507
L+L N+ +G+IPSSLG+C L+ LN+ NKL G++P +
Sbjct: 454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVG-- 511
Query: 508 XPLV--VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXX 565
PL +G LK L+ LD+S N+ SG+IP TL++C SLE+L +Q NSF G
Sbjct: 512 -PLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGL 570
Query: 566 XEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLC 625
LDLS NNLSG IPEY+ + S L+ LNLS N+F+G VPT+GVF N + +S+ N LC
Sbjct: 571 -RFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629
Query: 626 GGLDELHLPACHNTRPRKAXXXXXXXX---XXXXXXXXXXSVGLIVVC-------TRRRK 675
GG+ L L C PR+ + ++ +C + R
Sbjct: 630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689
Query: 676 QTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKV 735
+ + ++ + +SY EL K T FS SNLIG G+FG V++G LG VA+KV
Sbjct: 690 NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749
Query: 736 INLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDW 795
+NL ++G+ KSF+AECEAL IRHRNL+K++T+CSS DF+G+DF+ALVY++M +G+L+ W
Sbjct: 750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809
Query: 796 LQQSNDQVDGN----LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 851
L + GN L L RLNI+IDVASA+ YLH +C PI H D+KPSN+LLD D+
Sbjct: 810 LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869
Query: 852 AHVSDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909
AHVSDFGLA+ L FDR SS G++GT+GY APEYGMGG+ S+ GDVYSFGI+LL
Sbjct: 870 AHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLL 929
Query: 910 EMFTGRRPTHTMFNDGLTLHGFVKMALPEK-VMEIVDFALLLDPGNERAKIEECLTAVVR 968
E+FTG+RPT+ +F DGLTLH F K AL ++ ++I D +L + + ECLT V R
Sbjct: 930 EIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFR 989
Query: 969 IGVLCSMESPSERIHMADAVKNLCAAREKY 998
+GV CS ESP RI MA+A+ L + RE +
Sbjct: 990 VGVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2036 (721.8 bits), Expect = 1.3e-210, P = 1.3e-210
Identities = 431/986 (43%), Positives = 610/986 (61%)
Query: 32 SNETDRVALLAIKSQL-QDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGG 90
++ETDR ALL KSQ+ +D + SSWN+S +C W GVTCG+++ RV L L +GG
Sbjct: 21 TDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGG 80
Query: 91 FLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNL 150
+SP +GNLSFL ++L N G IP E+G+LSRL+ L + N G IP L +CS L
Sbjct: 81 VISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRL 140
Query: 151 INFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLY 210
+N + N L G +P+ +G L LN+ N + G+LP S+GN++ L+QL + N L
Sbjct: 141 LNLRLDSNRLGGSVPSELGSL-TNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLE 199
Query: 211 GIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLP 269
G IP + QL + L + NNFSG+ PP ++N+SSL+ + + N F GRL ++G LP
Sbjct: 200 GEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLP 259
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
L +G N TGSIP + SN S L L ++ N+ +G + F ++PN+ L L N+L
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSL 318
Query: 330 GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTIP 388
GS S DL+F+T LTNC++LETLG+ NR GG LP SIANLS + + +G ISG+IP
Sbjct: 319 GSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIP 378
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
+I NL N+ L L+ N L+G +P ++G+L+NL+ L +N L G IP IGN++ L +L
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438
Query: 449 WLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXXX 508
L N +G +P+SLGNC +L+ L + NKL GT+P +
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSL- 497
Query: 509 PLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXEV 568
P +G L+NL L + N+ SG++P TL +C ++E L ++ N F G EV
Sbjct: 498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEV 557
Query: 569 LDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGL 628
DLS N+LSG IPEY S LEYLNLS+N+ EG+VP KG+F N T +S++ N LCGG+
Sbjct: 558 -DLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616
Query: 629 DELHLPAC----------HNTRPRKAXXXXXXXXXXXXXXXXXXSVGLIVVCTRRRKQTQ 678
L C H++R +K SV LI + R++ +
Sbjct: 617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMA-SVTLIWLRKRKKNKET 675
Query: 679 KSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL 738
+ T ++E +SY +L ATN FS SN++G GSFG VY+ L + VAVKV+N+
Sbjct: 676 NNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNM 735
Query: 739 KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
+++G++KSF+AECE+LK+IRHRNL+K++T CSSIDF+G++F+AL+Y++M +GSL+ WL
Sbjct: 736 QRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHP 795
Query: 799 SN-DQV---DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
+++ L L++RLNI+IDVAS ++YLH HC PI H DLKPSNVLLD D+ AHV
Sbjct: 796 EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHV 855
Query: 855 SDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
SDFGLA+ L FD SS G++GT+GY APEYG+GG S+ GDVYSFGILLLEMF
Sbjct: 856 SDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMF 915
Query: 913 TGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVL 972
TG+RPT+ +F TL+ + K ALPE++++IVD ++L + ECLT V +G+
Sbjct: 916 TGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLR 975
Query: 973 CSMESPSERIHMADAVKNLCAAREKY 998
C ESP R+ + VK L + RE++
Sbjct: 976 CCEESPMNRLATSIVVKELISIRERF 1001
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1997 (708.0 bits), Expect = 1.8e-206, P = 1.8e-206
Identities = 419/991 (42%), Positives = 611/991 (61%)
Query: 32 SNETDRVALLAIKSQLQD-PMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGG 90
++ETDR ALL KSQ+ + + SSWNNS +C W VTCG++H RV L L +GG
Sbjct: 21 TDETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGG 80
Query: 91 FLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNL 150
+SP +GN+SFL ++L+ N G IP E+G L RL+ L + FNS G IP+ LS+CS L
Sbjct: 81 IVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRL 140
Query: 151 INFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLY 210
+N + N L +P+ +G KL L++ N L G+LP S+GN+++L+ LG +N +
Sbjct: 141 LNLDLYSNPLRQGVPSELGSL-TKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIE 199
Query: 211 GIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLP 269
G +P+ L +L + L ++ N F G+ PP I+N+S+LE + L + F G L + G LP
Sbjct: 200 GEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLP 259
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
++ L +G+N+L G+IP + SN S L ++ N +G + +F +P++ L+L +N L
Sbjct: 260 NIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPL 319
Query: 330 GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGL--NQISGTI 387
GS + GDL+FI LTNC+ L+ L + R GG+LP SIAN+ST +I++ L N G+I
Sbjct: 320 GSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMST-ELISLNLIGNHFFGSI 378
Query: 388 PLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447
P +I NL + L L N LTG +P ++G+L+ L L +N + G IP IGNL+ L
Sbjct: 379 PQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEI 438
Query: 448 LWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXX 507
L+L N+ +G +P SLG C +++ L + NKL GT+P +
Sbjct: 439 LYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSL 498
Query: 508 XPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXE 567
P +G+L+NL++L + N+FSG +P TL +C ++E L +Q NSF G
Sbjct: 499 -PNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRGLMGVRR 557
Query: 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGG 627
V DLS N+LSG IPEY + S LEYLNLS N+F G+VP+KG F N T + + N LCGG
Sbjct: 558 V-DLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGG 616
Query: 628 LDELHLPACHNTRPRKAXXXXXXXXXXXXXXXXXXSVGLIVV------CT-RRRKQTQKS 680
+ +L L C P ++ L++V C R+R++ Q++
Sbjct: 617 IKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQT 676
Query: 681 STLL--SMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL 738
+ L+ +E +SY +L ATN FS SN++G GSFG V++ L + VAVKV+N+
Sbjct: 677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736
Query: 739 KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
+++G++KSF+AECE+LK+ RHRNL+K++T C+S DF+G++F+AL+Y+Y+ +GS++ WL
Sbjct: 737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796
Query: 799 SN-DQV---DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
+++ L L++RLNI IDVAS ++YLH HC PI H DLKPSNVLL+ D+ AHV
Sbjct: 797 EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHV 856
Query: 855 SDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
SDFGLA+ L FD+ SS G++GT+GY APEYGMGG S+ GDVYSFG+LLLEMF
Sbjct: 857 SDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMF 916
Query: 913 TGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVL 972
TG+RPT +F LTLH + K+ALPEKV EI D A+L + ECLT V+ +G+
Sbjct: 917 TGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAECLTLVLEVGLR 976
Query: 973 CSMESPSERIHMADAVKNLCAAREKY-KGRR 1002
C E P+ R+ ++ K L + RE++ K RR
Sbjct: 977 CCEEYPTNRLATSEVAKELISIRERFFKTRR 1007
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1979 (701.7 bits), Expect = 1.4e-204, P = 1.4e-204
Identities = 419/991 (42%), Positives = 603/991 (60%)
Query: 29 FALSNETDRVALLAIKSQLQDPM-GITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQS 87
+ ++E+DR ALL IKSQ+ + S+WNNS +C W V CG++H RV +L L
Sbjct: 18 YGFTDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQ 77
Query: 88 VGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHC 147
+GG +SP +GNLSFL +++L++N+ G IP E+G L RLK L + FN G IP++LS+C
Sbjct: 78 LGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNC 137
Query: 148 SNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGEN 207
S L+ + NNL +P+ +G KL L + N L G+ P I N+++L L +G N
Sbjct: 138 SRLLYLDLFSNNLGDGVPSELGSL-RKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYN 196
Query: 208 KLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGF 266
L G IP+ + L + L++ NNFSG+ PP F N+SSLE + LL N F G L + G
Sbjct: 197 HLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGN 256
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
LP + L + N LTG+IP + +N S L + + N +G + +F L N+ L L
Sbjct: 257 LLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELAN 316
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISG 385
N+LGS S GDL F+ LTNCS L L ++ NR GG+LP SI N+ST +T++ + N I G
Sbjct: 317 NSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYG 376
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+IP +I NL + +L L N LTG +P ++G L+ L L +N G IP IGNL+ L
Sbjct: 377 SIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQL 436
Query: 446 NSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXX 505
L+L N+ +G +P SLG+C +++ L + NKL GT+P +
Sbjct: 437 VKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSG 496
Query: 506 XXXPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXX 565
P +G L+NL++L + N SG +P TL C S+E + +Q+N F G
Sbjct: 497 SL-PNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGV 555
Query: 566 XEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLC 625
V DLS NNLSG I EY E+ S LEYLNLS N+FEG+VPT+G+F N T +S+ N LC
Sbjct: 556 KNV-DLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLC 614
Query: 626 GGLDELHLPACHNTRPRKAXXXXXXXXXXXXXXXXXXSVGLIVVCT-----RRRKQTQK- 679
G + EL L C P ++ L++ ++RK QK
Sbjct: 615 GSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKI 674
Query: 680 -SSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL 738
+S ++E +SY +L AT+ FS SN++G GSFG V++ L + VAVKV+N+
Sbjct: 675 NNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNM 734
Query: 739 KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
+++G++KSF+AECE+LK+IRHRNL+K++T C+SIDF+G++F+AL+Y++M +GSL+ WL
Sbjct: 735 QRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHP 794
Query: 799 SN-DQV---DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
+++ L L++RLNI+IDVAS ++YLH HC PI H DLKPSN+LLD D+ AHV
Sbjct: 795 EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHV 854
Query: 855 SDFGLAKFL--FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
SDFGLA+ L FD+ SS G++GT+GY APEYGMGG S+ GDVYSFG+L+LEMF
Sbjct: 855 SDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMF 914
Query: 913 TGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVL 972
TG+RPT+ +F TL+ + K ALPE+V++I D ++L + ECL ++ +G+
Sbjct: 915 TGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLECLKGILDVGLR 974
Query: 973 CSMESPSERIHMADAVKNLCAAREKY-KGRR 1002
C ESP R+ ++A K L + RE++ K RR
Sbjct: 975 CCEESPLNRLATSEAAKELISIRERFFKTRR 1005
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1977 (701.0 bits), Expect = 2.3e-204, P = 2.3e-204
Identities = 443/1018 (43%), Positives = 614/1018 (60%)
Query: 6 ISIRCLGTFVWCVTLFLLNPDSCFALSNET-DRVALLAIKSQLQDPMGIT-SSWNNSINV 63
IS+ L FV + LL P S + D +ALL+ KS L G + +SWN S +
Sbjct: 2 ISLPLL-LFVLLFSALLLCPSSSDDDGDAAGDELALLSFKSSLLYQGGQSLASWNTSGHG 60
Query: 64 --CQWTGVTCGQR---HP-RVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIP 117
C W GV CG+R HP RV++L LR+ ++ G +SP +GNLSFLR ++L N L GEIP
Sbjct: 61 QHCTWVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIP 120
Query: 118 NELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLEN 177
EL RLSRL++L L NS G+IP+ + C+ L + + N L G IP IG L N
Sbjct: 121 PELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSN 180
Query: 178 LNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGML 237
L + +N L+G++P ++GN+++LQ+ + N+L G IP SLGQL L +++ +NN SGM+
Sbjct: 181 LYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMI 240
Query: 238 P-PIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLV 296
P I+N+SSL S+ N+ G +P N L L+++ +G N G IP S +NAS+L
Sbjct: 241 PNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLT 300
Query: 297 ILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNS 356
++ + GN FSG + F L N+T L L +N + D FI+ LTNCSKL+TL L
Sbjct: 301 VIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGE 360
Query: 357 NRFGGSLPRSIANLST-ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTI 415
N GG LP S +NLST ++ +A+ LN+I+G+IP +I NL + L L N G++P ++
Sbjct: 361 NNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSL 420
Query: 416 GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVS 475
G L NL L NNL G IP +IGNL+ LN L LG N G IP +L N NL+ L +S
Sbjct: 421 GRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLS 480
Query: 476 KNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXXXPLVVGNLKNLIQLDISRNRFSGEIPTT 535
N L+G +P + P +G+LKNL++ NR SG+IP T
Sbjct: 481 TNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNT 540
Query: 536 LSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXEVLDLSCNNLSGQIPEYLEDLSFLEYLNL 595
L C L YL +Q+N G E LDLS NNLSGQIP L D++ L LNL
Sbjct: 541 LGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNL 600
Query: 596 SYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLP-ACHNTRPRKAXXXXXXXXXX 654
S+N F G+VPT G F+ + IS+ N KLCGG+ +LHLP C RK
Sbjct: 601 SFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSL 660
Query: 655 XXXXXXXXSVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQG 714
S+ L++ +R K+ S T SM+ P+VSY++L KAT+ F+ +NL+G G
Sbjct: 661 AAALAILSSLYLLITWHKRTKKGAPSRT--SMKGH-PLVSYSQLVKATDGFAPTNLLGSG 717
Query: 715 SFGFVYRGNLG-EDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSID 773
SFG VY+G L +D VAVKV+ L+ ++KSF AECEAL+N+RHRNL+KI+T+CSSID
Sbjct: 718 SFGSVYKGKLNIQD--HVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSID 775
Query: 774 FKGDDFKALVYDYMQSGSLEDWLQ-QSNDQVDG-NLNLIQRLNISIDVASAIEYLHHHCQ 831
+G+DFKA+VYD+M +GSLEDW+ ++NDQ D +LNL +R+ I +DVA A++YLH H
Sbjct: 776 NRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGP 835
Query: 832 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD-RPIQETSSSSIGIKGTVGYVAPEYG 890
P+VH D+K SNVLLD DMVAHV DFGLA+ L D + + S+SS+G GT+GY APEYG
Sbjct: 836 EPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYG 895
Query: 891 MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLL 950
+G S GD+YS+GIL+LE+ TG+RPT + F L L +V++ L +V ++VD L+L
Sbjct: 896 VGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLIL 955
Query: 951 DPGN--------ERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000
D N +I EC+ ++R+G+ CS E PS R D + L A ++ G
Sbjct: 956 DSENWLNSTNNSPCRRITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1977 (701.0 bits), Expect = 2.3e-204, P = 2.3e-204
Identities = 432/990 (43%), Positives = 597/990 (60%)
Query: 32 SNETDRVALLAIKSQLQD--PMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVG 89
SNETD ALL KSQ+ + + +SWN+S C W GVTCG+R RVI L L +
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86
Query: 90 GFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSN 149
G +SP +GNLSFLR +NLA N+ IP ++GRL RL+ L + +N G IPS+LS+CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 150 LINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKL 209
L + N+L +P+ +G KL L++++N LTG P S+GN+++LQ+L N++
Sbjct: 147 LSTVDLSSNHLGHGVPSELGSL-SKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQM 205
Query: 210 YGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNL 268
G IP+ + +L + F +A N+FSG PP ++NISSLE +SL N F G L + G+ L
Sbjct: 206 RGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNN 328
P L+ L++G N TG+IP++ +N S+L ++S N+ SG + + F L N+ L + N+
Sbjct: 266 PNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNS 325
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST-ITIIAMGLNQISGTI 387
LG+ S L+FI + NC++LE L + NR GG LP SIANLST +T + +G N ISGTI
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 388 PLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447
P +I NL ++ L LE N L+G +P + G+L+NLQ +D +N + G IP GN++ L
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 448 LWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXX 507
L L N+ G IP SLG C+ L+ L + N+L GT+P Q
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIP-QEILQIPSLAYIDLSNNFLTGH 504
Query: 508 XPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXE 567
P VG L+ L+ L S N+ SG++P + C S+E+L MQ NSF G
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKN 564
Query: 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGG 627
V D S NNLSG+IP YL L L LNLS N FEG+VPT GVF N T +S+ N +CGG
Sbjct: 565 V-DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623
Query: 628 LDELHLPACH-NTRPRKAXXXXXXXXXXXXXXXXXXSVGLIVV----C--TRRRKQTQKS 680
+ E+ L C PRK S+ LI++ C +R+K+ S
Sbjct: 624 VREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNAS 683
Query: 681 ------STLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVK 734
ST L M + VSY EL+ AT+ FS +NLIG G+FG V++G LG + VAVK
Sbjct: 684 DGNPSDSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741
Query: 735 VINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLED 794
V+NL + G+ KSF+AECE K IRHRNL+K+ITVCSS+D +G+DF+ALVY++M GSL+
Sbjct: 742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDM 801
Query: 795 WLQQSN-DQVDGN---LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 850
WLQ + ++V+ + L ++LNI+IDVASA+EYLH HC P+ H D+KPSN+LLD D+
Sbjct: 802 WLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDL 861
Query: 851 VAHVSDFGLAKFLF--DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
AHVSDFGLA+ L+ DR SS G++GT+GY APEYGMGG S+ GDVYSFGILL
Sbjct: 862 TAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILL 921
Query: 909 LEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVR 968
LEMF+G++PT F LH + K L G A I+E L V++
Sbjct: 922 LEMFSGKKPTDESFAGDYNLHSYTKSILSG----------CTSSGGSNA-IDEGLRLVLQ 970
Query: 969 IGVLCSMESPSERIHMADAVKNLCAAREKY 998
+G+ CS E P +R+ +AV+ L + R K+
Sbjct: 971 VGIKCSEEYPRDRMRTDEAVRELISIRSKF 1000
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 296/722 (40%), Positives = 419/722 (58%)
Query: 105 INLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEI 164
+ L S+NL G I LG LS L+ L L N SG IP LS S L + N+L+GEI
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 165 PAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLN 224
PA +G L L + N L+G +P S+G ++ L L + EN L G IP S GQLR L+
Sbjct: 143 PAALGNL-TSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLS 201
Query: 225 FLSVAENNFSGMLP-PIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTG 283
FLS+A NN SG +P PI+NISSL +++N+ G LP N NLP L+ + + N G
Sbjct: 202 FLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHG 261
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLL 343
IP S NASN+ I + N FSG V + + N+ RL L + + D F+T L
Sbjct: 262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321
Query: 344 TNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGL--NQISGTIPLEIRNLANIYALG 401
TNCS L+ + L +FGG LP S++NLS+ +++++ + N+ISG++P +I NL N+ L
Sbjct: 322 TNCSNLQEVELGGCKFGGVLPDSVSNLSS-SLVSLSIRDNKISGSLPRDIGNLVNLQYLS 380
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS 461
L N LTG++P + +L NL+ L N L G +P +IGNL+ L ++ + FN G IPS
Sbjct: 381 LANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPS 440
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXXXPLVVGNLKNLIQL 521
+LGN L +N+ N G +P + P +G LKN+++
Sbjct: 441 TLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEF 500
Query: 522 DISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXEVLDLSCNNLSGQIP 581
N+ SGE P+T+ C L++L +Q+N G + LDLS NNLSGQIP
Sbjct: 501 HADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIP 560
Query: 582 EYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACH-NTR 640
L D+ L LNLS+N F G+VPT GVF+N + I + N +CGG+ ELHLP C +R
Sbjct: 561 MSLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSR 620
Query: 641 PRKAXXXXXXXXXX--XXXXXXXXSVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAEL 698
+K + +++ C +RRK+ ++T SM Q PM++Y +L
Sbjct: 621 KKKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATT--SM-QGHPMITYKQL 677
Query: 699 NKATNEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIKSFVAECEAL 754
KAT+ FS S+L+G GSFG VY+G GE VAV+V+ L+ ++KSF AECE L
Sbjct: 678 VKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETL 737
Query: 755 KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ-QSNDQVDG-NLNLIQR 812
+N RHRNL+KI+T+CSSID +G+DFKA+VYD+M +GSLEDWL ++NDQ + +L L QR
Sbjct: 738 RNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQR 797
Query: 813 LN 814
++
Sbjct: 798 VS 799
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
Identities = 310/905 (34%), Positives = 466/905 (51%)
Query: 127 KVLVLDFNS--FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQ 184
+V+ LD + G I ++++ + L + RN G+IP IG L+ L+++EN
Sbjct: 67 QVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENL 126
Query: 185 LTGQLPPSIGNISTLQQLGVGENKLYGIIPESL---GQLRDLNFLSVAENNFSGMLPPIF 241
L G +P +G ++ L L +G N+L G IP L G L ++ ++ N+ +G +P +
Sbjct: 127 LHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNY 186
Query: 242 N--ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIP-QSFSNASNLVIL 298
+ + L + L +N+ G +P ++ N LK + + N L+G +P Q S L L
Sbjct: 187 HCHLKELRFLLLWSNKLTGTVPSSLS-NSTNLKWMDLESNMLSGELPSQVISKMPQLQFL 245
Query: 299 NLSGNHF---SGKVGID--FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS-KLETL 352
LS NHF + ++ F+SL N + +L + L S+G + + + + S L +
Sbjct: 246 YLSYNHFVSHNNNTNLEPFFASLANSS--DLQELELAGNSLGG-EITSSVRHLSVNLVQI 302
Query: 353 GLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIP 412
L+ NR GS+P I+NL +T++ + N +SG IP E+ L+ + + L N LTG IP
Sbjct: 303 HLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIP 362
Query: 413 YTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLL 472
+G++ L LD S NNL G IPDS GNLS L L L N+L G +P SLG C NL +L
Sbjct: 363 MELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEIL 422
Query: 473 NVSKNKLTGTLPPQXXXXXXXXXXXXXXXXXXXXX-XPLVVGNLKNLIQLDISRNRFSGE 531
++S N LTGT+P + PL + + ++ +D+S N SG+
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482
Query: 532 IPTTLSSCTSLEYLKMQDNSFRGXXXXXXXXXXXXEVLDLSCNNLSGQIPEYLEDLSFLE 591
IP L SC +LE+L + N F + LD+S N L+G IP + S L+
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542
Query: 592 YLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAXXXXXXX 651
+LN S+N G V KG FS T S + + LCG + + AC +
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLL 600
Query: 652 XXXXXXXXXXXSVGLIV-------VCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNE 704
L+ + +++ + + ++P +SY +L AT
Sbjct: 601 SLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGG 660
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK-SFVAECEALKNIRHRNLI 763
F+ S+LIG G FG VY+G L + VAVKV++ K SF EC+ LK RHRNLI
Sbjct: 661 FNASSLIGSGRFGHVYKGVLRNNT-KVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+IIT CS G F ALV M +GSLE L + NL+LIQ +NI DVA I
Sbjct: 720 RIITTCSK---PG--FNALVLPLMPNGSLERHLYPG-EYSSKNLDLIQLVNICSDVAEGI 773
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL--FDRPIQETSSSSIG---- 877
YLHH+ +VH DLKPSN+LLD +M A V+DFG+++ + + + S S G
Sbjct: 774 AYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDG 833
Query: 878 -IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936
+ G+VGY+APEYGMG S GDVYSFG+LLLE+ +GRRPT + N+G +LH F+K
Sbjct: 834 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHY 893
Query: 937 PEKVMEIVDFALLL-DPGNERAKIE----ECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
P+ + I++ AL P + K E E + ++ +G++C+ +PS R M D +
Sbjct: 894 PDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEM 953
Query: 992 CAARE 996
+E
Sbjct: 954 GRLKE 958
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 764 (274.0 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 207/633 (32%), Positives = 317/633 (50%)
Query: 18 VTLFLLNPDSCFALSNETDRVALLAIKSQLQDPMGITSSWNNSINV--CQWTGVTCGQRH 75
+ L + P +A ++ + AL A K L DP+G +SW+ S C W GV C H
Sbjct: 10 IFLVIYAPLVSYADESQAEIDALTAFKLNLHDPLGALTSWDPSTPAAPCDWRGVGC-TNH 68
Query: 76 PRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNS 135
RV ++ L + G +S + L LR ++L SN+ +G IP L +RL + L +NS
Sbjct: 69 -RVTEIRLPRLQLSGRISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNS 127
Query: 136 FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGN 195
SG +P + + ++L F+V N L+GEIP +G L+ L+++ N +GQ+P + N
Sbjct: 128 LSGKLPPAMRNLTSLEVFNVAGNRLSGEIP--VGLP-SSLQFLDISSNTFSGQIPSGLAN 184
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTN 254
++ LQ L + N+L G IP SLG L+ L +L + N G LP I N SSL +S N
Sbjct: 185 LTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASEN 244
Query: 255 RFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQS-FSNASNLVILNLSGNHFSGKVGIDF 313
G +P G LPKL++L + NN +G++P S F N S L I+ L N FS V +
Sbjct: 245 EIGGVIPAAYGA-LPKLEVLSLSNNNFSGTVPFSLFCNTS-LTIVQLGFNAFSDIVRPET 302
Query: 314 SS--LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLS 371
++ + L+L +N + SG F LTN L+ L ++ N F G +P I NL
Sbjct: 303 TANCRTGLQVLDLQENRI-SGR-----FPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLK 356
Query: 372 TITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNL 431
+ + + N ++G IP+EI+ ++ L E N L G IP +G + L+ L N+
Sbjct: 357 RLEELKLANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSF 416
Query: 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQXXXXX 491
G +P S+ NL L L LG NNL G+ P L +L L++S N+ +G +P
Sbjct: 417 SGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLS 476
Query: 492 XXXXXXXXXXXXXXXXXPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNS 551
P VGNL L LD+S+ SGE+P LS +++ + +Q N+
Sbjct: 477 NLSFLNLSGNGFSGEI-PASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNN 535
Query: 552 FRGXXXXXXXXXXXXEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFS 611
F G ++LS N+ SG+IP+ L L L+LS N G +P +
Sbjct: 536 FSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPE--IG 593
Query: 612 NKTRISLIE--NGKLCGGLDELHLPACHNTRPR 642
N + + ++E + +L G H+PA + PR
Sbjct: 594 NCSALEVLELRSNRLMG-----HIPADLSRLPR 621
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 308/935 (32%), Positives = 472/935 (50%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L L + G + +GN S L + L N L G+IP ELG L +L+ L + N + +I
Sbjct: 245 LVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSI 304
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQ 200
PS+L + L + + N+L G I IG+ LE L + N TG+ P SI N+ L
Sbjct: 305 PSSLFRLTQLTHLGLSENHLVGPISEEIGFLE-SLEVLTLHSNNFTGEFPQSITNLRNLT 363
Query: 201 QLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGR 259
L VG N + G +P LG L +L LS +N +G +P I N + L+ + L N+ G
Sbjct: 364 VLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGE 423
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNI 319
+P GF L + +G+N+ TG IP N SNL L+++ N+ +G + L +
Sbjct: 424 IPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKL 481
Query: 320 TRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMG 379
L + N+L +G I + N L L L+SN F G +PR ++NL+ + + M
Sbjct: 482 RILQVSYNSL-TGPIP-----REIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMY 535
Query: 380 LNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI 439
N + G IP E+ ++ + L L N+ +G IP +L +L L N +G IP S+
Sbjct: 536 SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595
Query: 440 GNLSTLNSLWLGFNNLQGNIPSSL-GNCKNLML-LNVSKNKLTGTLPPQXXXXXXXXXXX 497
+LS LN+ + N L G IP L + KN+ L LN S N LTGT+P +
Sbjct: 596 KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEID 655
Query: 498 XXXXXXXXXXXPLVVGNLKNLIQLDISRNRFSGEIPTTL-SSCTSLEYLKMQDNSFRGXX 556
P + KN+ LD S+N SG IP + + L + NSF G
Sbjct: 656 LSNNLFSGSI-PRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEI 714
Query: 557 XXXXXXXXXXEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRI 616
LDLS NNL+G+IPE L +LS L++L L+ N+ +G VP GVF N
Sbjct: 715 PQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINAS 774
Query: 617 SLIENGKLCGGLDELHLPACHNTRPRKAXXXXXXXXXXXXXXXXXXSVGLIVV----CTR 672
L+ N LCG L P + V L+V+ C +
Sbjct: 775 DLMGNTDLCGSKKPLK-PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKK 833
Query: 673 RRKQTQKSS--TLLSMEQQFPMVSYA--ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDL 728
+ K+ + SS +L ++ + + EL +AT+ F+ +N+IG S VY+G L ED
Sbjct: 834 KEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDG 892
Query: 729 LPVAVKVINLKQKG--SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDY 786
+AVKV+NLK+ S K F E + L ++HRNL+KI+ ++ KALV +
Sbjct: 893 TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPF 948
Query: 787 MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846
M++G+LED + S + +L++++++ + +AS I+YLH PIVH DLKP+N+LL
Sbjct: 949 MENGNLEDTIHGSAAPIG---SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILL 1005
Query: 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGI 906
D D VAHVSDFG A+ L R T++S+ +GT+GY+APE+ V+ DV+SFGI
Sbjct: 1006 DSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGI 1065
Query: 907 LLLEMFTGRRPTHTMFNDG--LTLHGFVKMALPEKVMEIVDFALLLDPGNE--RAKIEEC 962
+++E+ T +RPT D +TL V+ ++ +V L ++ G+ K EE
Sbjct: 1066 IMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR-VLDMELGDSIVSLKQEEA 1124
Query: 963 LTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997
+ +++ + C+ P +R M + + +L R K
Sbjct: 1125 IEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4524 | 0.9611 | 0.9544 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00050192 | hypothetical protein (1011 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1003 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-128 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-29 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-09 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 413 bits (1062), Expect = e-128
Identities = 280/910 (30%), Positives = 467/910 (51%), Gaps = 52/910 (5%)
Query: 20 LFLLNPDSCFALSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRHPRVI 79
LN F++ + + LL+ KS + DP+ S+WN+S +VC W G+TC RV+
Sbjct: 18 FLFLN----FSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITC-NNSSRVV 72
Query: 80 QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLS-RLKVLVLDFNSFSG 138
+ L +++ G +S + L +++ INL++N L G IP+++ S L+ L L N+F+G
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIST 198
+IP NL + N L+GEIP IG + L+ L++ N L G++P S+ N+++
Sbjct: 133 SIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLVGKIPNSLTNLTS 189
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLP-PIFNISSLEQISLLTNRFE 257
L+ L + N+L G IP LGQ++ L ++ + NN SG +P I ++SL + L+ N
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 258 GRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLP 317
G +P ++G NL L+ L + QN L+G IP S + L+ L+LS N SG++ L
Sbjct: 250 GPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIA 377
N+ L+L NN +G I LT+ +L+ L L SN+F G +P+++ + +T++
Sbjct: 309 NLEILHLFSNNF-TGKIP-----VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362
Query: 378 MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
+ N ++G IP + + N++ L L N L G IP ++G +L+ + N+ G +P
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLL 497
L + L + NNLQG I S + +L +L++++NK G LP L +L
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENL- 480
Query: 498 DLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP 557
DLS N SG++P +G+L L+QL +S N+ SGEIP LSSC L L + N G IP
Sbjct: 481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 558 SSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRIS 617
+S + + LDLS N LSG+IP+ L ++ L +N+S+N G +P+ G F +
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASA 600
Query: 618 LIENGKLCGGLDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQT 677
+ N LCGG LP C R + + + ++L +++ G + + R +
Sbjct: 601 VAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL 660
Query: 678 QKSSTLLSM-EQQF----PMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVA 732
++ E QF S +N + N+I +G G Y+G ++ +
Sbjct: 661 KRVENEDGTWELQFFDSKVSKSIT-INDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 733 VKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSL 792
VK IN S +A+ + ++H N++K+I +C S + L+++Y++ +L
Sbjct: 720 VKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNL 770
Query: 793 EDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852
+V NL+ +R I+I +A A+ +LH C P +V G+L P +++D
Sbjct: 771 S--------EVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912
H+ L L SS+ YVAPE +++ D+Y FG++L+E+
Sbjct: 823 HLR-LSLPGLLCTDTKCFISSA---------YVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 913 TGRRPTHTMF 922
TG+ P F
Sbjct: 873 TGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 6e-44
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK-SFVAECEALKNIRHRNLIKIITVC 769
+G+G FG VY + VA+K+I + S+ + E E LK + H N++K+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
++ LV +Y + GSL+D L+++ G L+ + L I + + +EYLH +
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSN 111
Query: 830 CQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
I+H DLKP N+LLD D ++DFGL+K + S I GT Y+APE
Sbjct: 112 ---GIIHRDLKPENILLDSDNGKVKLADFGLSKL-----LTSDKSLLKTIVGTPAYMAPE 163
Query: 889 YGMG-GNVSLTGDVYSFGILLLEM 911
+G G S D++S G++L E+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 3e-42
Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 30/270 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHRNLI 763
+ + +G+GSFG VY + VA+KVI K K + + E + LK ++H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
++ V F+ +D LV +Y + G L D L++ G L+ + + SA+
Sbjct: 61 RLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
EYLH IVH DLKP N+LLD D ++DFGLA+ L P ++ ++ GT
Sbjct: 111 EYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTT----FVGTPE 161
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK---------M 934
Y+APE +G D++S G++L E+ TG+ P K
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW 221
Query: 935 ALPEKVMEIVDFALLLDPGNERAKIEECLT 964
+ + +++ L+ DP +R EE L
Sbjct: 222 DISPEAKDLIRKLLVKDP-EKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 77/293 (26%), Positives = 140/293 (47%), Gaps = 48/293 (16%)
Query: 706 SLSNLIGQGSFGFVYRG----NLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHR 760
+L +G+G+FG VY+G G+ + VAVK + + I+ F+ E ++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++K++ VC+ ++ +V +YM+ G L +L+++ L+L L+ ++ +A
Sbjct: 62 NVVKLLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKN----RPKLSLSDLLSFALQIA 112
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+EYL +H DL N L+ ++V +SDFGL++ L+D + I+
Sbjct: 113 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR- 168
Query: 881 TVGYVAPE---YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936
++APE G + S DV+SFG+LL E+FT G +P G++
Sbjct: 169 ---WMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQP-----YPGMS--------- 208
Query: 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989
E+V+E L G + C + + + C E P +R ++ V+
Sbjct: 209 NEEVLE------YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 78/295 (26%), Positives = 140/295 (47%), Gaps = 47/295 (15%)
Query: 706 SLSNLIGQGSFGFVYRG----NLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHR 760
+L +G+G+FG VY+G + VAVK + + I+ F+ E ++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++K++ VC+ ++ +V +YM G L D+L+++ + L+L L+ ++ +A
Sbjct: 62 NIVKLLGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIA 113
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+EYL +H DL N L+ ++V +SDFGL++ L+D + + I+
Sbjct: 114 RGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR- 169
Query: 881 TVGYVAPE---YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936
++APE G + S DV+SFG+LL E+FT G P G++
Sbjct: 170 ---WMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEP-----YPGMS--------- 209
Query: 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+V+E L G K C + ++ + C E P +R ++ V+ L
Sbjct: 210 NAEVLE------YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 22/228 (9%)
Query: 709 NLIGQGSFGFVYRGNL---GEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHRNLIK 764
+G+G+FG VY+G L VAVK + + K F+ E +K + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV----DGNLNLIQRLNISIDVA 820
++ VC+ + + LV +YM+ G L D+L++S L+L L+ +I +A
Sbjct: 61 LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS-IGIK 879
+EYL VH DL N L+ D+V +SDFGL++ ++D + + I+
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGL 926
++APE G + DV+SFG+LL E+FT G P + N+ +
Sbjct: 173 ----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 79/266 (29%), Positives = 126/266 (47%), Gaps = 30/266 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK--SFVAECEALKNIRHRNL 762
+ L +G GSFG VY+ VAVK++ + + S K + E L+ + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++I F+ D LV +Y + G L D+L + G L+ + I++ +
Sbjct: 61 VRLIDA-----FEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRG 110
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+EYLH + I+H DLKP N+LLD + V ++DFGLAK + ++ GT
Sbjct: 111 LEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTT----FVGTP 162
Query: 883 GYVAPE-YGMGGNVSLTGDVYSFGILLLEMFTGRRP-THTMFNDGLTLHGFVKMALPEKV 940
Y+APE G DV+S G++L E+ TG+ P + D L L ++ L +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL---IRRILGPPL 219
Query: 941 MEIVDFALLLDPGNERAK--IEECLT 964
G+E AK I++CL
Sbjct: 220 EFDEPK---WSSGSEEAKDLIKKCLN 242
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 705 FSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRH 759
L +G+G+FG VY+G L VAVK + + + F+ E +K + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N+++++ VC+ +G+ +V +YM G L D+L++ L L L +++ +
Sbjct: 61 PNIVRLLGVCT----QGEPLY-IVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQI 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG-I 878
A +EYL VH DL N L+ ++V +SDFGL++ +++ I
Sbjct: 112 AKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
K ++APE G + DV+SFG+LL E+FT G +P
Sbjct: 169 K----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 76/221 (34%), Positives = 116/221 (52%), Gaps = 18/221 (8%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI 763
EF+L +G G FG V+ G L ++ + VA+K++ + F E +ALK +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ VCS G+ ++ + M+ GSL +L+ QV L + ++++ VA +
Sbjct: 66 SLFAVCSV----GEPV-YIITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGM 117
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
YL +H DL N+L+ D+V V+DFGLA+ + + + +S I K T
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWT-- 171
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE G S DV+SFGILL EMFT G+ P M N
Sbjct: 172 --APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHRN 761
E++ L+G+GSFG VY + +AVK + L +++ E L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN--LIQRLNISIDV 819
+++ + + + +Y+ GSL L++ G L +I++ + +
Sbjct: 61 IVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKY--TRQI 110
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
+ YLH + IVH D+K +N+L+D D V ++DFG AK L D ET + ++
Sbjct: 111 LEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD---IETGEGTGSVR 164
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT ++APE G D++S G ++EM TG+ P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 45/277 (16%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI 763
F + IG+G FG VY+ VA+KVI L+ K + + E + LK +H N++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN------ISI 817
K S K + + +V ++ GSL+D L+ + Q L +
Sbjct: 61 KYYG---SYLKKDELW--IVMEFCSGGSLKDLLK----------STNQTLTESQIAYVCK 105
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ +EYLH + I+H D+K +N+LL D + DFGL+ L + +
Sbjct: 106 ELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL------SDTKARNT 156
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR------RPTHTMFNDGLTLH-G 930
+ GT ++APE G D++S GI +E+ G+ P +F G
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---KIATNG 213
Query: 931 FVKMALPEKV-MEIVDF---ALLLDPGNERAKIEECL 963
+ PEK E DF L +P +R E+ L
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNP-EKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 78/217 (35%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
E L IG+G FG V G+ G+ VAVK + + ++F+AE + +RH N
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQK---VAVKCLKDDST-AAQAFLAEASVMTTLRHPN 61
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
L++++ V +G+ +V +YM GSL D+L+ V + L Q+L ++DV
Sbjct: 62 LVQLLGVV----LQGNPL-YIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFALDVCE 113
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+EYL + VH DL NVL+ D+VA VSDFGLAK E S K
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--------EASQGQDSGKLP 162
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
V + APE S DV+SFGILL E+++ GR P
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRN 761
L +G G FG V+ G VAVK LK S ++F+ E + +K +RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMG-TWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
L+++ VCS + + +V +YM GSL D+L+ L L Q ++++ +A
Sbjct: 63 LVQLYAVCS----EEEPI-YIVTEYMSKGSLLDFLK---SGEGKKLRLPQLVDMAAQIAE 114
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YL +H DL N+L+ ++V ++DFGLA+ + D + IK T
Sbjct: 115 GMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE G ++ DV+SFGILL E+ T GR P M N
Sbjct: 172 ----APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 74/216 (34%), Positives = 114/216 (52%), Gaps = 22/216 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRNLIKIITV 768
+G G FG V+ G L + PVAVK + + G++ K F+AE + +K +RH LI++ V
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
C+ ++ +V + M+ GSL ++LQ L L Q ++++ VAS + YL
Sbjct: 70 CTL-----EEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEA 121
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
+H DL NVL+ + + V+DFGLA+ + I E + G K + + APE
Sbjct: 122 Q---NYIHRDLAARNVLVGENNICKVADFGLAR-VIKEDIYE---AREGAKFPIKWTAPE 174
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ S+ DV+SFGILL E+ T GR P M N
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 85/219 (38%), Positives = 113/219 (51%), Gaps = 31/219 (14%)
Query: 704 EFSLSNLIGQGSFGFV----YRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH 759
E L IG+G FG V YRGN VAVK I K + ++F+AE + +RH
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCI--KNDATAQAFLAEASVMTQLRH 58
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
NL++++ V ++ KG + +V +YM GSL D+L+ V G L L S+DV
Sbjct: 59 SNLVQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A+EYL + VH DL NVL+ D VA VSDFGL K E SS+ K
Sbjct: 112 CEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGK 160
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
V + APE S DV+SFGILL E+++ GR P
Sbjct: 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 83/303 (27%), Positives = 120/303 (39%), Gaps = 58/303 (19%)
Query: 707 LSNLIGQGSFGFVY-------RGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIR 758
+G+G FG V N GE VAVK +N + F E E L+ +
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQ---VAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H N++K VC G L+ +Y+ SGSL D+LQ+ DQ +NL + L S
Sbjct: 65 HENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQ 117
Query: 819 VASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF------------D 865
+ ++YL +H DL N+L++ + + +SDFGLAK L +
Sbjct: 118 ICKGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924
PI + APE S DV+SFG+ L E+FT G
Sbjct: 174 SPIF--------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE- 218
Query: 925 GLTLHGFVKMALPEK-VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH 983
F++M + M + LL G + C V + LC P +R
Sbjct: 219 ------FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS 272
Query: 984 MAD 986
AD
Sbjct: 273 FAD 275
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 90/305 (29%), Positives = 140/305 (45%), Gaps = 63/305 (20%)
Query: 711 IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSI---KSFVAECEALKNIRHRNL 762
+G+G+FG V+ G D VAVK LK+ S K F E E L N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ---------QSNDQVDGNLNLIQRL 813
+K VC+ +GD +V++YM+ G L +L+ +S D G L L Q L
Sbjct: 71 VKFYGVCT----EGDPP-IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 814 NISIDVASAIEYL--HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
I++ +AS + YL H VH DL N L+ +D+V + DFG++ R + T
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTT 175
Query: 872 SSSSIGIKGT----VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGL 926
+G G + ++ PE M + DV+SFG++L E+FT G++P + + N
Sbjct: 176 DYYRVG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--- 230
Query: 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMAD 986
E+V+E + LL C + V I + C P +RI++ D
Sbjct: 231 -----------EEVIECITQGRLLQRP------RTCPSEVYDIMLGCWKRDPQQRINIKD 273
Query: 987 AVKNL 991
+ L
Sbjct: 274 IHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 77/223 (34%), Positives = 115/223 (51%), Gaps = 22/223 (9%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRH- 759
+ + +G+GSFG VY L D VA+KV+ K + ++ F+ E + L ++ H
Sbjct: 1 SYRILRKLGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++K+ F+ + LV +Y+ GSLED L++ + G L+ + L I +
Sbjct: 58 PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQI 110
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPI-QETSSSSIG 877
SA+EYLH I+H D+KP N+LLD D V + DFGLAK L D +
Sbjct: 111 LSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 878 IKGTVGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRP 917
GT GY+APE +G S + D++S GI L E+ TG P
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEAL-KNIR 758
++F +IG+GSF V E A+K+++ L ++ +K E E L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H +IK+ F+ ++ V +Y +G L ++++ G+L+ + +
Sbjct: 61 HPGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAE 110
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI------QETS 872
+ A+EYLH I+H DLKP N+LLD DM ++DFG AK L T+
Sbjct: 111 ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 873 SSSIGIK---------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923
S K GT YV+PE + D+++ G ++ +M TG+ P N
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-N 226
Query: 924 DGLTLHGFVKMAL------PEKVMEIVDFALLLDPGNER 956
+ LT +K+ P ++++ L+LDP +R
Sbjct: 227 EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDP-QDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 70/224 (31%), Positives = 113/224 (50%), Gaps = 25/224 (11%)
Query: 704 EFSLSNLIGQGSFGFVYRGN-LGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHR 760
E + +G G FG V+ G G+ VA+K+I +G++ F+ E + + + H
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKI--DVAIKMIR---EGAMSEDDFIEEAKVMMKLSHP 59
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
NL+++ VC+ + F +V +YM +G L ++L++ G L L++ DV
Sbjct: 60 NLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRER----KGKLGTEWLLDMCSDVC 110
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A+EYL + +H DL N L+ D V VSDFGLA+++ D + +SS G K
Sbjct: 111 EAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKF 163
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
V + PE S DV+SFG+L+ E+F+ G+ P N
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 86/283 (30%), Positives = 136/283 (48%), Gaps = 53/283 (18%)
Query: 704 EFSLSNLIGQGSFGFVYRGN-LGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ +L +IG+G FG V +G G+ VAVK N+K + ++F+ E + + H+NL
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNL 61
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++++ V I G +V + M G+L ++L+ + +++IQ L S+DVA
Sbjct: 62 VRLLGV---ILHNG---LYIVMELMSKGNLVNFLRTRGRAL---VSVIQLLQFSLDVAEG 112
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT- 881
+EYL +VH DL N+L+ D VA VSDFGLA+ S+G+ +
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-----------VGSMGVDNSK 158
Query: 882 --VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938
V + APE S DV+S+G+LL E+F+ GR P + KM+L E
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP-------------YPKMSLKE 205
Query: 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
V E V+ ++P E C V + C P +R
Sbjct: 206 -VKECVEKGYRMEPP------EGCPADVYVLMTSCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 26/228 (11%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRN 761
+ L +LIG+G+FG VY+G E VA+K I+L ++ ++KS + E + LKN++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++K I + D ++ +Y ++GSL +++ G V
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQ 110
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YLH + ++H D+K +N+L D V ++DFG+A L + S + GT
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL-----NDVSKDDASVVGT 162
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG------RRPTHTMFN 923
++APE S D++S G ++E+ TG P +F
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 27/226 (11%)
Query: 707 LSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLI 763
N IG G+FG VY NL L +AVK I ++ +IK E + L+ ++H NL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGEL-MAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 764 KIITVCSSIDFKGDDFKALVYDYM---QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
K ++ + VY +M G+LE+ L+ + ++I+ + +
Sbjct: 63 K----YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRIL---DEHVIRVYTLQL--L 109
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YLH H IVH D+KP+N+ LDH+ V + DFG A L + G
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAG 165
Query: 881 TVGYVAPEYGMGGNVSLTG---DVYSFGILLLEMFTGRRPTHTMFN 923
T Y+APE GG G D++S G ++LEM TG+RP + N
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 46/231 (19%)
Query: 711 IGQGSFGFVY--RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKI 765
+G+GSFG V R L A+KV+ + ++ ++ + E L I H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY--AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK- 57
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA----- 820
+ F+ ++ LV +Y G L L + S + A
Sbjct: 58 -LHYA---FQTEEKLYLVLEYAPGGELFSHLSK-------------EGRFSEERARFYAA 100
Query: 821 ---SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
A+EYLH I++ DLKP N+LLD D ++DFGLAK L + +
Sbjct: 101 EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC--- 154
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFN 923
GT Y+APE +G D +S G+LL EM TG+ P ++
Sbjct: 155 --GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 70/224 (31%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK----GSIKSFVAECEALKNIRHR 760
F L +IG+G+FG V + A+K +N KQK GS+++ + E L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNIS 816
L+ + S F+ ++ LV D + G L L Q S +QV + I
Sbjct: 61 FLVN---LWYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV--------KFWIC 107
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-KFLFDRPIQETSSSS 875
++ A+EYLH I+H D+KP N+LLD H++DF +A K D TS
Sbjct: 108 -EIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--- 160
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
GT GY+APE S+ D +S G+ E G+RP
Sbjct: 161 ----GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 26/226 (11%)
Query: 706 SLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRH 759
++ +IG G FG V RG L G+ + VA+K LK S K F+ E + H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDH 64
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N+I++ V + K ++ +YM++GSL+ +L+++ DG + Q + + +
Sbjct: 65 PNIIRLEGVVT----KSRPV-MIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGI 115
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD-RPIQETSSSSIGI 878
AS ++YL VH DL N+L++ ++V VSDFGL++ L D T I I
Sbjct: 116 ASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ T APE + DV+SFGI++ E+ + G RP M N
Sbjct: 173 RWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 68/216 (31%), Positives = 118/216 (54%), Gaps = 23/216 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRNLIKIITV 768
+GQG FG V+ G VA+K + + G++ ++F+ E + +K +RH L+++ V
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S ++ +V +YM GSL D+L+ ++ L L Q ++++ +AS + Y+
Sbjct: 70 VS------EEPIYIVTEYMSKGSLLDFLK---GEMGKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
+ VH DL+ +N+L+ ++V V+DFGLA+ + D ++ G K + + APE
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPE 173
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ G ++ DV+SFGILL E+ T GR P M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHRNLIKIITVC 769
+GQGS G VY+ A+K I++ K + E + L++ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH-- 827
+K + ++V +YM GSL D L++ + L I + + ++YLH
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAYI-----ARQILKGLDYLHTK 118
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
H I+H D+KPSN+L++ ++DFG++K L + ++ + GTV Y++P
Sbjct: 119 RH----IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFV---GTVTYMSP 169
Query: 888 EYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
E G + S D++S G+ LLE G+ P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 29/221 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--SIKSFVAECEALKNIRHR 760
+E +L IG G FG V+ G E VA+K I ++G S + F+ E + + + H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKR-KVAIKTI---REGAMSEEDFIEEAQVMMKLSHP 59
Query: 761 NLIKIITVC---SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
L+++ VC S I LV+++M+ G L D+L+ G + L + +
Sbjct: 60 KLVQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCL 107
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
DV + YL ++H DL N L+ + V VSDFG+ +F+ D + +SS G
Sbjct: 108 DVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD----DQYTSSTG 160
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
K V + +PE S DV+SFG+L+ E+F+ G+ P
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 38/226 (16%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVK------VINLKQKGSIKSFVAECEALKNIRHRNLI 763
IG+G+FG VY+G L + VAVK +LK+K F+ E E LK H N++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIV 55
Query: 764 KIITVCSSIDFKGDDFKALVY---DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
K+I VC K +Y + + GSL +L++ ++ L + + L +S+D A
Sbjct: 56 KLIGVCVQ--------KQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAA 103
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS--SIGI 878
+ +EYL +H DL N L+ + V +SDFG+++ + I S I I
Sbjct: 104 AGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPI 159
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
K T APE G + DV+S+GILL E F+ G P M N
Sbjct: 160 KWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 78/288 (27%), Positives = 140/288 (48%), Gaps = 42/288 (14%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNL 762
+ ++ + +G G +G VY G + L VAVK LK+ ++ F+ E +K I+H NL
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNL 64
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++++ VC+ + F ++ ++M G+L D+L++ N Q +N + L ++ ++SA
Sbjct: 65 VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSA 116
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+EYL +H DL N L+ + + V+DFGL++ + +T ++ G K +
Sbjct: 117 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPI 169
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ APE S+ DV++FG+LL E+ T +G M+ P ++
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YG---MS-PYPGID 210
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER-----IHMA 985
+ LL+ G + E C V + C +PS+R IH A
Sbjct: 211 LSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 69/228 (30%), Positives = 119/228 (52%), Gaps = 29/228 (12%)
Query: 707 LSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINL----KQKGSIKSFVAECEALKNIRH 759
+ +IG G FG V RG L G+ + VA+K + KQ+ + F++E + H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDH 64
Query: 760 RNLIK---IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
N+I ++T + ++ ++M++G+L+ +L+Q+ DG +IQ + +
Sbjct: 65 PNIIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQN----DGQFTVIQLVGML 112
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+A+ ++YL + VH DL N+L++ ++V VSDFGL++FL D T +SS+
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE-MFTGRRPTHTMFN 923
G K + + APE + DV+S+GI++ E M G RP M N
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 23/216 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRNLIKIITV 768
+G G FG V+ G + VAVK + + G++ +SF+ E + +K +RH L+++ V
Sbjct: 14 LGNGQFGEVWMGTWNGNT-KVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S ++ +V +YM GSL D+L+ + L L ++++ VA+ + Y+
Sbjct: 70 VS------EEPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYIE- 119
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
+ +H DL+ +N+L+ +V ++DFGLA+ + D + IK T APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ G ++ DV+SFGILL E+ T GR P M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 710 LIGQGSFGFVYRGNL---GEDLLPVAVKVINL----KQKGSIKSFVAECEALKNIRHRNL 762
+IG G FG V+RG L G + VA+K + KQ+ + F++E + H N+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMGQFSHHNI 68
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
I++ V + FK ++ +YM++G+L+ +L+ DG + Q + + +A+
Sbjct: 69 IRLEGVVTK--FKP---AMIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAG 119
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
++YL VH DL N+L++ ++ VSDFGL++ L D P E + ++ G K +
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--EGTYTTSGGKIPI 174
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941
+ APE + DV+SFGI++ E+ + G RP M N +VM
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------------HEVM 220
Query: 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ ++ L +C +AV ++ + C + + R D V L
Sbjct: 221 KAINDGFRL------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 78/303 (25%), Positives = 144/303 (47%), Gaps = 58/303 (19%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIK---SFVAECE 752
E LS + +G+G+FG VY+G L E L +V + LK+ K F E E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL-----------QQSND 801
+ +++H N++ ++ VC+ + ++++Y+ G L ++L + ++
Sbjct: 61 LMSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
V +L+ L+I+I +A+ +EYL HH VH DL N L+ + +SDFGL+
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTH 919
+ ++ S S+ V ++ PE + G + D++SFG++L E+F+ G +P +
Sbjct: 172 RDIYSADYYRVQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-Y 227
Query: 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALLLD-PGNERAKIEECLTAVVRIGVLCSMESP 978
F++ ++V+E++ LL P E+C V + + C E P
Sbjct: 228 YGFSN-------------QEVIEMIRSRQLLPCP-------EDCPARVYALMIECWNEIP 267
Query: 979 SER 981
+ R
Sbjct: 268 ARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 23/222 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS--FVAECEALKNIRHRNLIKIITV 768
+G G FG V G VA+K+I ++GS+ F+ E + + + H L+++ V
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
C+ +V +YM +G L ++L++ + Q L + DV + YL
Sbjct: 68 CTK-----QRPIYIVTEYMSNGCLLNYLREHGKR----FQPSQLLEMCKDVCEGMAYLES 118
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
+H DL N L+D VSDFGL++++ D + +SS+G K V + PE
Sbjct: 119 K---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPE 171
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLH 929
+ S DV++FG+L+ E+++ G+ P N
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 9e-22
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHRNLIKII 766
IG+GSFG VY D +K I+L + + E + LK + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN--------DQVDGNLNLIQRLNISID 818
F+ +V +Y G L +++ +Q+ L+ +
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI---------LDWFVQ 111
Query: 819 VASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ A++YLH I+H D+KP N+ L + + + DFG++K L T +
Sbjct: 112 LCLALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKT 162
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y++PE + D++S G +L E+ T + P
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 64/216 (29%), Positives = 117/216 (54%), Gaps = 23/216 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRNLIKIITV 768
+GQG FG V+ G VA+K + + G++ ++F+ E + +K +RH L+ + V
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S ++ +V ++M GSL D+L++ + + L L Q ++++ +A + Y+
Sbjct: 70 VS------EEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIE- 119
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
+ +H DL+ +N+L+ ++V ++DFGLA+ + D ++ G K + + APE
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED----NEYTARQGAKFPIKWTAPE 173
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ G ++ DV+SFGILL E+ T GR P M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 68/227 (29%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVK------VINLKQKGSIKSFVAECEALKN 756
++F +G GSFG V A+K ++ LKQ + + E L++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN---EKRILQS 57
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
IRH L+ + F+ D LV +Y+ G L L++S G +
Sbjct: 58 IRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYA 107
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
V A+EYLH IV+ DLKP N+LLD D ++DFG AK + R T +
Sbjct: 108 AQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYT--- 157
Query: 877 GIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y+APE YG D ++ GIL+ EM G P
Sbjct: 158 -LCGTPEYLAPEIILSKGYGK------AVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 70/229 (30%), Positives = 116/229 (50%), Gaps = 31/229 (13%)
Query: 706 SLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINL----KQKGSIKSFVAECEALKNIR 758
+ +IG G FG V G L G+ +PVA+K + KQ+ + F++E +
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFD 63
Query: 759 HRNLIK---IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
H N+I ++T + +V +YM++GSL+ +L++ DG +IQ + +
Sbjct: 64 HPNIIHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKH----DGQFTVIQLVGM 111
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+AS ++YL VH DL N+L++ ++V VSDFGL++ L D P E + ++
Sbjct: 112 LRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTT 166
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE-MFTGRRPTHTMFN 923
G K + + APE + DV+S+GI++ E M G RP M N
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 41/273 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVC 769
+G G FG V+ G VA+K +LKQ S ++F+AE +K ++H L+++ V
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
+ ++ +YM++GSL D+L+ L + + ++++ +A + ++
Sbjct: 71 TQEPI------YIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIE-- 119
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
+ +H DL+ +N+L+ + ++DFGLA+ + D + IK T APE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 890 GMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFAL 948
G ++ DV+SFGILL E+ T GR P M N PE +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------------PEVIQN------ 215
Query: 949 LLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
L+ G + + C + + LC E P ER
Sbjct: 216 -LERGYRMPRPDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 66/234 (28%), Positives = 114/234 (48%), Gaps = 37/234 (15%)
Query: 711 IGQGSFGFVYRGNLGE--DLLP------VAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+G+G+FG V+ L E +LLP VAVK + + + + F E E L ++H+++
Sbjct: 13 LGEGAFGKVF---LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ----------QSNDQVDGNLNLIQR 812
++ VC+ +G +V++YM+ G L +L+ D G L L Q
Sbjct: 70 VRFYGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
L I+ +AS + YL VH DL N L+ +V + DFG++ R I T
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTD 176
Query: 873 SSSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+G + + ++ PE + + D++SFG++L E+FT G++P + + N
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 711 IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIK 764
+GQGSFG VY G GE VA+K +N F+ E +K ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 765 IITVCSSIDFKGDDFKALV-YDYMQSGSLEDWLQQ---SNDQVDGN--LNLIQRLNISID 818
++ V S G LV + M G L+ +L+ + G L + + ++ +
Sbjct: 74 LLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+A + YL VH DL N ++ D+ + DFG+ R I ET G
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMT-----RDIYETDYYRKGG 179
Query: 879 KGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
KG V ++APE G + DV+SFG++L EM T
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGN---LGEDL-LPVAVKVINLKQ-KGSIKSFVAECEALKNIR 758
E ++G G+FG VY+G GE + +PVA+KV+ + + K + E + ++
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H ++++++ +C S L+ M G L D+++ D N+ LN +
Sbjct: 68 HPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQ 117
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+A + YL +VH DL NVL+ ++DFGLAK L + E + G
Sbjct: 118 IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---DVDEKEYHAEGG 171
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
K + ++A E + + DV+S+G+ + E+ T G +P
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 74/224 (33%), Positives = 114/224 (50%), Gaps = 35/224 (15%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVI--NLKQKGSIKSFVAECEALKNIRHRNLIKIIT 767
L+G+G+FG V++G L +D PVAVK +L Q+ IK F++E LK H N++K+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59
Query: 768 VCSSIDFKGDDFKALVYDYMQ---SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
VC+ + +Y M+ G +L++ D+ L Q + ++D A+ +
Sbjct: 60 VCTQ--------RQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMA 107
Query: 825 YLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS--SSIGIKGT 881
YL +C +H DL N L+ + V +SDFG+++ QE SS G+K
Sbjct: 108 YLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQI 156
Query: 882 -VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ + APE G S DV+S+GILL E F+ G P M N
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 80/304 (26%), Positives = 137/304 (45%), Gaps = 48/304 (15%)
Query: 707 LSNLIGQGSFGFVYRG---NLG--EDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
L +G+G+FG V+ NL +D + VAVK + + K F E E L N++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSND-----------QVDGNLNLI 810
++K VC GD +V++YM+ G L +L+ Q G L L
Sbjct: 69 IVKFYGVCGD----GDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
Q L+I+ +AS + YL VH DL N L+ +++ + DFG+++ ++
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLH 929
++ + ++ PE M + DV+SFG++L E+FT G++P F
Sbjct: 181 VGGHTM---LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLS---- 230
Query: 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989
+V+E + +L ER ++ C V I + C P +R+++ + K
Sbjct: 231 -------NTEVIECITQGRVL----ERPRV--CPKEVYDIMLGCWQREPQQRLNIKEIYK 277
Query: 990 NLCA 993
L A
Sbjct: 278 ILHA 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 36/287 (12%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLK--QKGSIKSFVAECEALKNIRH 759
L ++G+G FG V G L +D L VAVK + L I+ F++E +K+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 760 RNLIKIITVCSSIDFKGDDFKALV-YDYMQSGSLEDWLQQSN-DQVDGNLNLIQRLNISI 817
N++K+I VC K +V +M+ G L +L S + L L L +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
D+A +EYL + +H DL N +L DM V+DFGL+K ++ +
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-- 175
Query: 878 IKGTVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935
K V ++A E + V + DV++FG+ + E+ T G+ P + N
Sbjct: 176 -KMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----------- 222
Query: 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI 982
EI D+ L GN + E+CL + + C P +R
Sbjct: 223 ------EIYDY---LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIR 758
+++ L +IG G+ VY E VA+K I+L++ S+ E +A+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEK---VAIKRIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H N++K S F D LV Y+ GSL D ++ S + + +I + +
Sbjct: 58 HPNVVK--YYTS---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA--TVLKE 110
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
V +EYLH + Q +H D+K N+LL D ++DFG++ L D T
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDRTRKVRKTF 166
Query: 879 KGTVGYVAPE-------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF 922
GT ++APE Y D++SFGI +E+ TG P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFK------ADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 57/212 (26%), Positives = 111/212 (52%), Gaps = 26/212 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G VY+ + VA+K I ++ + G + + E + L+ +RH N++++ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 769 CSSIDFKGDDFKALVYDYMQ---SGSLEDWLQQ-SNDQVDGNLNLIQRLNISIDVASAIE 824
+S KG + +V++YM +G L+ + + Q+ +++L ++
Sbjct: 67 VTS-KGKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQIKC---YMKQL------LEGLQ 114
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH + I+H D+K SN+L+++D V ++DFGLA+ R + ++ I T+ Y
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWY 167
Query: 885 VAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
PE +G D++S G +L E+F G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS-FVAECEALKNIRHRNLIKIITVC 769
IG+G+FG V+ G L D PVAVK +K+ F+ E LK H N++++I VC
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 770 SSIDFKGDDFKALVYDYM---QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
+ K +Y M Q G +L+ + L + + + + + A+ +EYL
Sbjct: 63 TQ--------KQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYL 110
Query: 827 H-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT-VGY 884
HC +H DL N L+ V +SDFG+++ D +S+ G+K V +
Sbjct: 111 ESKHC----IHRDLAARNCLVTEKNVLKISDFGMSREEED----GVYASTGGMKQIPVKW 162
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE G S DV+SFGILL E F+ G P + N
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 40/231 (17%)
Query: 709 NLIGQGSFGFVYRGNL------GEDLLPVAVKVINLKQKGSI----KSFVAECEALKNIR 758
N +G G+FG VY G G + VAVK + +KG+ K F+ E + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN--LNLIQRLNIS 816
H N++K++ VC ++ + ++ + M+ G L +L+ + + G L L + L+I
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAKFLFDRPIQET 871
+DVA YL Q +H DL N L+ D D V + DFGLA+ ++
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY------- 162
Query: 872 SSSSIGIKGT----VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
S +G V ++APE + G + DV+SFG+L+ E+ T G++P
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 27/220 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHR 760
+E + +G G FG V+ G + VA+K IN +G++ + F+ E + + + H
Sbjct: 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHP 59
Query: 761 NLIKIITVCSSIDFKGDDFKAL--VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
L+++ VC+ K L V ++M++G L ++L+Q G L+ L++ D
Sbjct: 60 KLVQLYGVCTQQ-------KPLYIVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQD 108
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
V +EYL + +H DL N L+ V VSDFG+ +++ D + TSSS G
Sbjct: 109 VCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSS--GA 161
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
K V + PE S DV+SFG+L+ E+FT G+ P
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 38/272 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
+G G FG V+ G + VAVK + S+++F+ E +K ++H L+++ V +
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
++ ++ +YM GSL D+L+ G + L + ++ S +A + Y+
Sbjct: 72 K-----EEPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIE--- 120
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYG 890
+ +H DL+ +NVL+ ++ ++DFGLA+ + D ++ G K + + APE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAI 176
Query: 891 MGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALL 949
G+ ++ DV+SFGILL E+ T G+ P M N D
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------------------DVMSA 216
Query: 950 LDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
L G ++E C + I C E ER
Sbjct: 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+G+ G VY+ VA+K + L+++ + + + E +K+ +H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYY---D 82
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
S + + +V +YM GSL D + Q +N Q + +V +EYLH
Sbjct: 83 SYLVGDELW--VVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE-- 888
++H D+K N+LL D ++DFG A L + S + GT ++APE
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-----VVGTPYWMAPEVI 188
Query: 889 ----YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
YG V D++S GI+ +EM G P
Sbjct: 189 KRKDYGP--KV----DIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 19/213 (8%)
Query: 710 LIGQGSFGFVYRG---NLGEDLLPVAVKVI-NLKQKGSIKSFVAECEALKNIRHRNLIKI 765
+G GSFG V RG G ++PVAVK + + K + F+ E + ++ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
V + +V + GSL D L+ G+ + + ++ +A+ + Y
Sbjct: 62 YGVVLTHPLM------MVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRY 112
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
L +H DL N+LL D + DFGL + L ++ +K +
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN--EDHYVMEEHLKVPFAWC 167
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
APE S DV+ FG+ L EMFT G P
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 710 LIGQGSFGFV-------YRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+G+G+FG V + N GE VAVK + ++ F E E LK+++H N+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGE---VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+K VC S G LV +Y+ GSL D+LQ+ +++D + L + +
Sbjct: 68 VKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYLQKHRERLDH----RKLLLYASQICKG 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-FDRP---IQETSSSSIGI 878
+EYL VH DL N+L++ + + DFGL K L D+ ++E S I
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI-- 175
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT----GRRPTHTMFNDGLTLHGFVKM 934
+ APE S+ DV+SFG++L E+FT P F++M
Sbjct: 176 ----FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----------FMRM 221
Query: 935 ALPEKVMEIVDFAL--LLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
+K +++ + L LL C + I C PS+R
Sbjct: 222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 711 IGQGSFGFVYRG---NLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKI 765
+G+G++G VY+ GE VA+K I L + G + + E LK ++H N++K+
Sbjct: 7 LGEGTYGVVYKARDKKTGE---IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
+ V + + LV++Y L+ +L D+ G L+ +I + + Y
Sbjct: 64 LDVIHT-----ERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H H I+H DLKP N+L++ D V ++DFGLA+ F P++ + + T+ Y
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA-FGIPLRTYTHEVV----TLWYR 165
Query: 886 APEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
APE +G T D++S G + EM TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 711 IGQGSFGFVYRGNL---GEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIK 764
+G G+FG V +G + VAVK LKQ K F+ E + + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+I VC KG+ LV + G L +L++ + + ++ VA +
Sbjct: 61 LIGVC-----KGEPL-MLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMGMA 109
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YL VH DL NVLL + A +SDFG+++ L + ++ + + +
Sbjct: 110 YLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKW 164
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921
APE G S DV+S+G+ L E F+ G +P M
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 704 EFSLSNLIGQGSFGFVY--RGNLGEDLLPVAV----KVINLKQKGSIKSFVAECEALKNI 757
+ +G G+FG V+ R + E + V +VI LKQ+ + + E LK +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
H +I++ + D F ++ +Y+ G L +L+ S G + L +
Sbjct: 59 SHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNS-----GRFSNSTGLFYAS 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ A+EYLH IV+ DLKP N+LLD + ++DFG AK L DR +
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--------TWT 157
Query: 878 IKGTVGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y+APE G V D ++ GIL+ EM G P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
F + +G+GS+G VY+ E VA+KV+ ++ ++ + E LK +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYI 60
Query: 763 IKIITVCSSIDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
+K + G FK +V +Y +GS+ D ++ +N L + I
Sbjct: 61 VK---------YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQ 107
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+EYLH + +H D+K N+LL+ + A ++DFG++ L D ++ I
Sbjct: 108 TLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVI-- 160
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT ++APE + D++S GI +EM G+ P +
Sbjct: 161 -GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 30/290 (10%)
Query: 711 IGQGSFGFVY------RG-NLGEDLLPVAVKVINLKQKGS-IKSFVAECEALKNIRHRNL 762
+G+G FG V G N GE VAVK + + G+ I E E L+N+ H N+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+K +C+ G + L+ +++ SGSL+++L ++ +++ NL Q+L ++ +
Sbjct: 69 VKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPRNKNKI----NLKQQLKYAVQICKG 121
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
++YL VH DL NVL++ + + DFGL K + +E + + V
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDLDSPV 176
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK-VM 941
+ APE + + DV+SFG+ L E+ T ++ + F+KM P M
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT------YCDSESSPMTLFLKMIGPTHGQM 230
Query: 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ +L+ G + C V ++ C PS+R + ++
Sbjct: 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 44/281 (15%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNL---GEDL-LPVAVKVINLKQKGSIKSFVAECE---AL 754
E L+G G FG V++G G+ + +PVA+K I + + ++F + A+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAM 63
Query: 755 KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN 814
++ H +++++ +C + LV GSL D ++Q D +D LN
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQR----LLN 113
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+ +A + YL H +VH +L N+LL D + ++DFG+A L+ + S
Sbjct: 114 WCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934
K + ++A E + G + DV+S+G+ + EM + +G
Sbjct: 171 ---HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS---------------YG---- 208
Query: 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSM 975
A P M + LL+ G A+ + C V + V C M
Sbjct: 209 AEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWM 249
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
L +G G FG V+ + VAVK + S+++F+AE +K ++H L+K
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN-LNLIQRLNISIDVASAI 823
+ V + + ++ ++M GSL D+L+ +G+ L + ++ S +A +
Sbjct: 66 LHAVVTK------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGM 115
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
++ Q +H DL+ +N+L+ +V ++DFGLA+ + D + IK T
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-- 170
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE G+ ++ DV+SFGILL+E+ T GR P M N
Sbjct: 171 --APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 59/228 (25%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPV--AVKVINLKQKGS---IKSFVAECEALKNIRH 759
+LS+L+ +G+FG ++ G L ++ V V +K S + + E L + H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN---LNLIQRLNIS 816
+N++ I+ VC + ++Y YM G+L+ +LQQ N L+ Q ++++
Sbjct: 68 QNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF-----------D 865
I +A + YLH ++H D+ N ++D ++ ++D L++ LF +
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
RP++ + S+ V EY S DV+SFG+LL E+ T
Sbjct: 181 RPVKWMALESL--------VNKEY------SSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIIT 767
++G+G+FG V+ D V +K I ++Q K + EC+ LK + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY-- 825
+F D +V +Y G+L +++Q+ R N +D + + +
Sbjct: 67 -----NFLEDKALMIVMEYAPGGTLAEYIQK-------------RCNSLLDEDTILHFFV 108
Query: 826 -----LHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
LHH I+H DLK N+LLD H MV + DFG++K L + S + +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVV 162
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRR 916
GT Y++PE G + D+++ G +L E+ + +R
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 68/234 (29%), Positives = 116/234 (49%), Gaps = 29/234 (12%)
Query: 707 LSNLIGQGSFGFVYRG---NL--GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
L +G+G+FG V+ NL +D + VAVK + + K F E E L N++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQ-QSNDQV---DGN----LNLIQRL 813
++K VC +GD +V++YM+ G L +L+ D V +GN L Q L
Sbjct: 69 IVKFYGVC----VEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
+I+ +A+ + YL VH DL N L+ +++ + DFG++ R + T
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYSTDY 175
Query: 874 SSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924
+G + ++ PE M + DV+S G++L E+FT G++P + + N+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 710 LIGQGSFGFVYRG---NLGEDLLPVAVKVINL----------KQKGSIKSFVAECEALKN 756
LIG+G++G VY GE + AVK + L +QK +K+ +E E LK+
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMM---AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ H N+++ + +++ ++ +Y+ GS+ L+ G +
Sbjct: 65 LDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFT 114
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
V + YLH I+H DLK N+L+D D + +SDFG++K D + ++
Sbjct: 115 EQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD---IYDNDQNM 168
Query: 877 GIKGTVGYVAPE----YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
++G+V ++APE Y G S D++S G ++LEMF GRRP
Sbjct: 169 SMQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 711 IGQGSFGFVY---RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIK 764
I +G++G V+ + + G+ A+KVI + +K + + E + L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ S F+G LV +Y+ G L L+ G+L+ ++ A+E
Sbjct: 58 L--YYS---FQGKKNLYLVMEYLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALE 107
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR---PIQETSSSSIGIKGT 881
YLH + I+H DLKP N+L+D + ++DFGL+K R + + I GT
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
Y+APE +G S T D +S G +L E G P H
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 711 IGQGSFGFV--YRGNLGEDLLPVAVKVINLKQKGSIK---SFVAECEALKNIRHRNLIKI 765
+G+G FG V Y + D V V LK++ + + E LK + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
CS +G L+ +Y+ GSL D+L + LNL Q L + + + Y
Sbjct: 72 KGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEGMAY 122
Query: 826 LH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF-----LFDRPIQETSSSSIGI 878
LH H+ +H DL NVLLD+D + + DFGLAK + R ++E S
Sbjct: 123 LHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSP--- 173
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
V + A E S DV+SFG+ L E+ T
Sbjct: 174 ---VFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 20/210 (9%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G FG V + A K ++ LK++ + + E + L+ + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
V + F+ D LV M G L+ + + + + + + +E+LH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG---FPEARAIFYAAQIICGLEHLH 112
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
Q IV+ DLKP NVLLD +SD GLA + + G T GY+AP
Sbjct: 113 ---QRRIVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAG---TPGYMAP 163
Query: 888 EYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
E G + D ++ G L EM GR P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHRNLIKIITVC 769
+G G+ G V + +AVK I L+ +I K + E + L ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
+ GD + +YM GSL+ L +V G + I++ V + YLH
Sbjct: 69 YN---NGDISICM--EYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
+ I+H D+KPSN+L++ + DFG++ L + S + GT Y+APE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-------SLAKTFVGTSSYMAPER 170
Query: 890 GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G + S+ D++S G+ L+E+ TGR P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-16
Identities = 51/152 (33%), Positives = 80/152 (52%), Gaps = 9/152 (5%)
Query: 39 ALLAIKSQLQDPMGITSSWNNSINVCQ---WTGVTCG----QRHPRVIQLYLRNQSVGGF 91
AL +KS L P+ WN V Q W+G C + + L L NQ + GF
Sbjct: 376 ALQTLKSSLGLPLRF--GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
+ + L L+ INL+ N++ G IP LG ++ L+VL L +NSF+G+IP +L ++L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN 183
++ N+L+G +PA +G L + N +N
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 703 NEFSLSNLIGQGSFGFVY---RGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEAL 754
+ L+GQG+FG VY + G +L AVK + K + + E + L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGREL---AVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 755 KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN 814
KN++H +++ C D F +YM GS++D L+ G L
Sbjct: 59 KNLQHERIVQYYG-CLRDDETLSIF----MEYMPGGSVKDQLKAY-----GALTETVTRK 108
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+ + +EYLH + IVH D+K +N+L D + DFG +K L Q SS
Sbjct: 109 YTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICSS 160
Query: 875 SIGIK---GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G+K GT +++PE G DV+S G ++EM T + P
Sbjct: 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 55/160 (34%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 521 LDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI 580
L + G IP +S L+ + + NS RG+IP SL S+ S+EVLDLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 581 PEYLEDLSFLEYLNLSYNDFEGQVPTK--GVFSNKTRISLIENGKLCG--GLDELHLPAC 636
PE L L+ L LNL+ N G+VP G ++ + +N LCG G L AC
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-----LRAC 537
Query: 637 HNTRPRKAKITI-LKVLIPVIVLLTILSVGLIVVCTRRRK 675
AKI I V + + L V + +RR+
Sbjct: 538 GPHLSVGAKIGIAFGVSVAFLFL-----VICAMCWWKRRQ 572
|
Length = 623 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINL-----KQKGSIKSFVAECEALKNIRHRNLIK 764
L+G GSFG VY G +D AVK ++L + ++K E L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ +D + + + GSL L++ G+ + + +E
Sbjct: 67 YLGTERE-----EDNLYIFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLE 116
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH VH D+K +N+L+D + V ++DFG+AK + S + KG+ +
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV------VEFSFAKSFKGSPYW 167
Query: 885 VAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRP 917
+APE G L D++S G +LEM TG+ P
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 61/303 (20%)
Query: 711 IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSI---KSFVAECEALKNIRHRNL 762
IGQG+FG V++ E VAVK+ LK++ S F E + H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL-------QQSNDQVDGN--------- 806
+K++ VC+ G L+++YM G L ++L Q S +
Sbjct: 71 VKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 807 -LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
L+ ++L I+ VA+ + YL + VH DL N L+ +MV ++DFGL++ ++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 866 RPIQETSSS-SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ S + +I I+ ++ PE + DV+++G++L E+F+ G +P + M +
Sbjct: 183 ADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 924 DGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH 983
E+V+ V GN + + C + + LC + PS+R
Sbjct: 239 --------------EEVIYYV------RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPS 278
Query: 984 MAD 986
A
Sbjct: 279 FAS 281
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 36/88 (40%), Positives = 58/88 (65%)
Query: 397 IYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
I LGL+ L G IP I +L +LQ+++ S N++ G IP S+G++++L L L +N+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLP 484
G+IP SLG +L +LN++ N L+G +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 35/284 (12%)
Query: 706 SLSNLIGQGSFGFVYRGNLGED--LLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRN 761
+L +G+G FG V G L +D +L VAVK + + + ++ F++E +K H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 762 LIKIITVC-SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI--D 818
++++I VC +++ +G ++ +M+ G L +L S D L ++ + D
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+AS +EYL +H DL N +L+ +M V+DFGL+K +++ +
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--- 174
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937
K V ++A E + DV+SFG+ + E+ T G+ P + N
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------------- 221
Query: 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
EI D+ L GN + +CL + + C + +P +R
Sbjct: 222 ----EIYDY---LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 706 SLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKS-FVAECEALKNIRHRN 761
+L IG+G FG VY+G + + + VAVK S++ F+ E ++ H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++K+I V + ++ +V + G L +LQ + L+L + S +++
Sbjct: 69 IVKLIGVIT------ENPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLST 118
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
A+ YL VH D+ NVL+ + DFGL+++L D + S + IK
Sbjct: 119 ALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-- 173
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
++APE + DV+ FG+ + E+ G +P + N
Sbjct: 174 --WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-15
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 705 FSLSNLIGQGSFGFV---YRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRH 759
+ L IG G++G V G VA+K I+ I K + E + L+++RH
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGR---KVAIKKISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 760 RNLIKIITVCSSIDFKGDDFKAL--VYDYMQSGSLEDWLQQSNDQVDGNLNLI--QRLNI 815
N+I ++ + +DF + V + M++ L ++ D ++ Q L
Sbjct: 59 ENIIGLLDI--LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL-- 113
Query: 816 SIDVASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
++YLH + ++H DLKPSN+L++ + + DFGLA+ + ++
Sbjct: 114 -----RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 874 SSIGIKGTVGYV------APE-YGMGGNVSLTGDVYSFGILLLEMFTGR 915
+ YV APE + D++S G + E+ T +
Sbjct: 164 T--------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 43/242 (17%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVI----NLKQKGSIKSFVA 749
EL+ + + ++G G FG + RG L + LPVA+ + + KQ+ + F+A
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLA 55
Query: 750 ECEALKNIRHRNLIK---IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN 806
E L H N+++ +IT +++ +V +YM +G+L+ +L++ +G
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKH----EGQ 103
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866
L Q + + +AS ++YL + VH L VL++ D+V +S F R
Sbjct: 104 LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF--------R 152
Query: 867 PIQETSS----SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE-MFTGRRPTHTM 921
+QE S +++ K V + APE + S DV+SFGI++ E M G RP M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 922 FN 923
Sbjct: 213 SG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 45/225 (20%)
Query: 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK---SFVA--ECEALKNIRHRNLI 763
+G+G++ VY+ E VA+K I L ++ K +F A E + L+ ++H N+I
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI---DVA 820
++ V F LV+++M++ LE +I+ +I + D+
Sbjct: 66 GLLDV-----FGHKSNINLVFEFMET-DLE--------------KVIKDKSIVLTPADIK 105
Query: 821 S-------AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
S +EYLH + I+H DLKP+N+L+ D V ++DFGLA+ F P ++ +
Sbjct: 106 SYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTH 161
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
+ T Y APE G G D++S G + E+ R P
Sbjct: 162 QVV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 55/304 (18%)
Query: 706 SLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRH 759
+L +G G+FG VY G D + + V V L + S + F+ E + H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 760 RNLIKIITVCSSIDFKGDDFKALVY----DYMQSGSLEDWLQQSNDQVD--GNLNLIQRL 813
+N++++I V F+ L + M G L+ +L+++ + + +L + L
Sbjct: 69 QNIVRLIGVS---------FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLAKFLFDRPIQE 870
+ DVA +YL + +H D+ N LL VA ++DFG+A R I
Sbjct: 120 FCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA-----RDIYR 171
Query: 871 TSSSSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLT 927
S G + + ++ PE + G + DV+SFG+LL E+F+ G P N
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---- 227
Query: 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADA 987
++VME V LDP + C V RI C +P +R + A
Sbjct: 228 ----------QEVMEFVTGGGRLDPP------KGCPGPVYRIMTDCWQHTPEDRPNFATI 271
Query: 988 VKNL 991
++ +
Sbjct: 272 LERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 82/314 (26%), Positives = 133/314 (42%), Gaps = 68/314 (21%)
Query: 706 SLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGS---IKSFVAECEALKNI 757
+L +G+G+FG V + + VAVK+ LK + + V+E E +K I
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMI 72
Query: 758 -RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----VDGNLNLIQ 811
+H+N+I ++ VC+ +G + +V +Y G+L D+L+ D +
Sbjct: 73 GKHKNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 812 RL------NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
L + + VA +E+L +H DL NVL+ D V ++DFGLA
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLA----- 179
Query: 866 RPIQE------TSSSSIGIKGTVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFT-GRRP 917
R I T++ + +K ++APE + V DV+SFG+LL E+FT G P
Sbjct: 180 RDIHHIDYYRKTTNGRLPVK----WMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
Query: 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMES 977
+ V E+ LL G K + C + + C E
Sbjct: 235 YPGI-----------------PVEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEV 274
Query: 978 PSERIHMADAVKNL 991
PS+R V++L
Sbjct: 275 PSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 704 EFSLSN---LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHR 760
E+ + ++G+G++G VY + +A+K I + ++ E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N+++ + S + FK + + + GSL L+ + N I I
Sbjct: 66 NIVQYLGSDS----ENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI--L 118
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFD-RPIQETSSSSIGI 878
++YLH + IVH D+K NVL++ + V +SDFG +K L P ET
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET------F 169
Query: 879 KGTVGYVAPE---YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT+ Y+APE G G D++S G ++EM TG+ P +
Sbjct: 170 TGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVI--NLKQKGSIKSFVAECEALKNIRH 759
F+L ++G+G FG V L + VAVK++ ++ I+ F+ E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 760 RNLIKIITVCSSIDFKGD-DFKALVYDYMQSGSLEDWLQQSN-DQVDGNLNLIQRLNISI 817
N+IK+I V KG ++ +M+ G L +L S + L L + I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
D+AS +EYL +H DL N +L+ +M V+DFGL+K ++ +S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS-- 175
Query: 878 IKGTVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFT-GRRP 917
K V ++A E + NV T DV++FG+ + E+ T G+ P
Sbjct: 176 -KLPVKWLALE-SLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHRNLIKIITVC 769
+G+G++ VY+G VA+K I+L ++G+ + + E +K ++H N++++ V
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
+ ++ LV++YM L+ ++ + G L+ + + + I + H +
Sbjct: 68 HT-----ENKLMLVFEYMD-KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
++H DLKP N+L++ ++DFGLA+ F P+ S+ + T+ Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV----TLWYRAPDV 171
Query: 890 GMGGNVSLTG-DVYSFGILLLEMFTGR 915
+G T D++S G ++ EM TGR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 38/266 (14%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVK---VINLKQKGSIKSFVAECEALKNIRHRN 761
F + IG+G F VYR D +PVA+K + +L + + E + LK + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI---SID 818
+IK F D+ +V + +G L ++ Q LI + +
Sbjct: 64 VIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFKKQ----KRLIPEKTVWKYFVQ 114
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ SA+E++H ++H D+KP+NV + V + D GL +F + ++++ +
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSL 166
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---- 934
GT Y++PE + D++S G LL EM + P + D + L+ K
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQC 223
Query: 935 ---ALP-----EKVMEIVDFALLLDP 952
LP E++ ++V+ + DP
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 709 NLIGQGSFGFVYRGNLGED---LLPVAVKVIN-LKQKGSIKSFVAECEALKNIRHRNLIK 764
+IG+G FG VY G L + + AVK +N + ++ F+ E +K+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWL--QQSNDQVDGNLNLIQRLNISIDVASA 822
++ +C + +V YM+ G L +++ + N V +LI + VA
Sbjct: 61 LLGIC----LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK---DLI---GFGLQVAKG 110
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+EYL VH DL N +LD V+DFGLA+ ++D+ + + G K V
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT-GAKLPV 166
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
++A E + DV+SFG+LL E+ T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 51/230 (22%)
Query: 711 IGQGSFGFVY---RGNLGEDLLPVAVKVINL-----KQKGSIKSFVAECEALKNIRHRNL 762
IG+GSFG V R + G+ L K I+ K+K + V+E L+ ++H N+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKIL---VWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNI 61
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR---------- 812
++ D D +Y M+ D L Q LIQ+
Sbjct: 62 VRYY------DRIIDRSNQTLYIVMEYCEGGD-LAQ----------LIQKCKKERKYIEE 104
Query: 813 ---LNISIDVASAIEYLHH--HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867
I + A+ H+ ++H DLKP+N+ LD + + DFGLA +
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA-----KI 159
Query: 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ SS + GT Y++PE + D++S G L+ E+ P
Sbjct: 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL-KQKGSIK-SFVAECEALKNIRHRN 761
EF N IG+G++G VYR VA+K + + ++ I S + E L N+RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 762 LIKI--ITVCSSID--FKGDDFKALVYDYMQS--GSLEDWLQQ--SNDQVDGNLNLIQRL 813
++++ + V +D F LV +Y + SL D + S QV
Sbjct: 68 IVELKEVVVGKHLDSIF-------LVMEYCEQDLASLLDNMPTPFSESQVKC-------- 112
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
+ + + ++YLH + I+H DLK SN+LL ++DFGLA+ + P + +
Sbjct: 113 -LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTP 167
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
+ T+ Y APE +G T D+++ G +L E+ +
Sbjct: 168 KVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVK------VINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+G G FG V + A+K ++ Q+ I S E E L+ H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ + FK + ++ +Y G L L+ G + V A E
Sbjct: 58 L--YRT---FKDKKYIYMLMEYCLGGELWTILRDR-----GLFDEYTARFYIACVVLAFE 107
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH+ I++ DLKP N+LLD + + DFG AK L Q+T + GT Y
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWT----FCGTPEY 158
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
VAPE + + D +S GILL E+ TGR P
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 65/230 (28%), Positives = 110/230 (47%), Gaps = 31/230 (13%)
Query: 711 IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRHRNL 762
+GQGSFG VY GN GE VAVK +N + S++ F+ E +K ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL-----NLIQRLNISI 817
++++ V S KG +V + M G L+ +L+ + + N L + + ++
Sbjct: 72 VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++A + YL+ VH DL N ++ HD + DFG+ R I ET G
Sbjct: 127 EIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKG 178
Query: 878 IKG--TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924
KG V ++APE G + + D++SFG++L E+ + +P + N+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIRHRNLIKIITV 768
LIG+G++G VYRG VA+K+INL + E L +R I
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI---DVASAIEY 825
S KG ++ +Y + GS+ ++ I IS+ +V A++Y
Sbjct: 68 YGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGP---------IAEKYISVIIREVLVALKY 116
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
+H ++H D+K +N+L+ + + DFG+A L + SS GT ++
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL-----NQNSSKRSTFVGTPYWM 168
Query: 886 APEYGMGGNVSLT-GDVYSFGILLLEMFTGRRP 917
APE G T D++S GI + EM TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 71/297 (23%), Positives = 132/297 (44%), Gaps = 55/297 (18%)
Query: 711 IGQGSFGFVYRGNLGEDLLP-------VAVKVI-NLKQKGSIKSFVAECEALKNIRHRNL 762
+G+ +FG +Y+G+L LP VA+K + ++ F E + + H N+
Sbjct: 13 LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ---------SNDQ---VDGNLNLI 810
+ ++ V + + ++++Y+ G L ++L S+D+ V +L+
Sbjct: 70 VCLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
L+I+I +A+ +EYL H VH DL N+L+ + +SD GL++ ++
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLH 929
S+ + ++ PE M G S D++SFG++L E+F+ G +P + N
Sbjct: 182 VQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------ 232
Query: 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMAD 986
++V+E+V LL E+C + + C E PS R D
Sbjct: 233 --------QEVIEMVRKRQLLPCS------EDCPPRMYSLMTECWQEGPSRRPRFKD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 67/211 (31%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEAL-KNIRHRNLIKII 766
IG+GSFG V D AVKV+ K +K K +AE L KN++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
F+ D V DY+ G L LQ+ + + ++ASA+ YL
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFY-----AAEIASALGYL 112
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
H I++ DLKP N+LLD ++DFGL K I+ + ++S GT Y+A
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTST-FCGTPEYLA 164
Query: 887 PEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
PE T D + G +L EM G P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 35/244 (14%)
Query: 680 SSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK 739
SS+ S S +EL + N IG G+ G VY+ A+KVI
Sbjct: 58 SSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN 110
Query: 740 QKGSIKSFVA-ECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
+ +++ + E E L+++ H N++K C + + + L+ ++M GSLE
Sbjct: 111 HEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--TH 163
Query: 799 SNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858
D+ +++ + S I YLH IVH D+KPSN+L++ ++DFG
Sbjct: 164 IADEQ-------FLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPE-----YGMGGNVSLTGDVYSFGILLLEMFT 913
+++ L + +SS+ GT+ Y++PE G GD++S G+ +LE +
Sbjct: 214 VSRIL--AQTMDPCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 914 GRRP 917
GR P
Sbjct: 269 GRFP 272
|
Length = 353 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINL---------KQKGSIKSFVAECEALKNIRHR 760
LIG GSFG VY G +AVK + L +++ + + E LK ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N+++ + SS+D D + +Y+ GS+ L G N +
Sbjct: 67 NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQIL 116
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-FDRPIQETSSSSIGIK 879
+ YLH+ I+H D+K +N+L+D+ +SDFG++K L + +T+ + ++
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G+V ++APE + + D++S G L++EM TG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 9e-14
Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 54/283 (19%)
Query: 704 EFSLSNLIGQGSFGFVY---RGNLGEDLLPVAVKVINL----------KQKGSIKSFVAE 750
E+++ +G G+FG VY + N G++LL A+K IN+ ++ SI V+E
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLL--ALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 751 CEALK-NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNL 809
+K +RH N+++ F +D +V D ++ L + S +
Sbjct: 59 VTIIKEQLRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTE 112
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
+ NI + + A+ YLH + IVH DL P+N++L D ++DFGLAK Q
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-------Q 163
Query: 870 ETSSSSI-GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928
+ S + + GT+ Y PE DV++FG +L +M T + P ++ + L+L
Sbjct: 164 KQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS--TNMLSL 221
Query: 929 HGFVKMALPEKVMEIVDFALLLDPGNE-------RAKIEECLT 964
+IV+ + +P E I CLT
Sbjct: 222 -----------ATKIVE--AVYEPLPEGMYSEDVTDVITSCLT 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G VY+ VA+K I L+ +G K+ + E + LK + H N+IK++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
D LV+++M + L ++ + +LI+ + + + + H
Sbjct: 67 F----RHKGDL-YLVFEFMDT-DLYKLIKDRQRGLP--ESLIK--SYLYQLLQGLAFCHS 116
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
H I+H DLKP N+L++ + V ++DFGLA+ T T Y APE
Sbjct: 117 H---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAPE 168
Query: 889 --YGMGG---NVSLTGDVYSFGILLLEMFTGR 915
G G V D++S G + E+ + R
Sbjct: 169 LLLGDKGYSTPV----DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 710 LIGQGSFGFVYRGNL---GEDL-LPVAVKVI--NLKQKGSIKSFVAECEALKNIRHRNLI 763
++G G+FG VY+G GE++ +PVA+KV+ N K + K + E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVC 72
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+++ +C + + LV M G L D+++++ D++ G+ +L LN + +A +
Sbjct: 73 RLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRI-GSQDL---LNWCVQIAKGM 122
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
YL + +VH DL NVL+ ++DFGLA+ L I ET + G K +
Sbjct: 123 SYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEYHADGGKVPIK 176
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVME 942
++A E + + DV+S+G+ + E+ T G +P G +P+
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP----------YDGIPAREIPD---- 222
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
LL+ G + C V I V C M R + V
Sbjct: 223 ------LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
+G G+FG VY+ E L A K+I ++ + ++ F+ E + L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-- 70
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
+ ++ ++ ++ G+L+ + +++ L Q + + A+ +LH H
Sbjct: 71 ---YFYENKLWILIEFCDGGALDSIM----LELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGL-AKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
++H DLK N+LL D ++DFG+ AK +Q+ + GT ++APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDT----FIGTPYWMAPEV 174
Query: 890 GMGGNVSLT-----GDVYSFGILLLEMFTGRRPTHTM 921
D++S GI L+E+ P H +
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 84/339 (24%), Positives = 134/339 (39%), Gaps = 68/339 (20%)
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITR 321
+ N + N ++ N L + + + SSL +
Sbjct: 19 EVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLP-------SSLSRLLS 71
Query: 322 LNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLN 381
L+L + I LD L N L +L LN NR ++ + L+ +T + + N
Sbjct: 72 LDLLSPSG----ISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNN 126
Query: 382 QISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGN 441
I+ PL +N+ L L N++ +P + N
Sbjct: 127 NITDIPPLIGLLKSNLKELDLSDNKIE-------------------------SLPSPLRN 161
Query: 442 LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSS 501
L L +L L FN+L ++P L N NL L++S NK++ LPP+I ++ L L DLS+
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEEL-DLSN 218
Query: 502 NLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI 561
N I + + NLKNL L++S N+ +P S+
Sbjct: 219 NSII-ELLSSLSNLKNLSGLELSNNKLE-------------------------DLPESIG 252
Query: 562 SLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+L ++E LDLS N +S L L+ L L+LS N
Sbjct: 253 NLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSL 289
|
Length = 394 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 68/239 (28%), Positives = 116/239 (48%), Gaps = 44/239 (18%)
Query: 704 EFSLSNLI-----GQGSFGFVYRG-------NLGEDLLPVAVKVINLKQKGSIKSF---V 748
EF L+ G+G FG V R + + + VAVK+ LK + K +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65
Query: 749 AECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----NDQ 802
+E E +K I +H+N+I ++ VC+ +G + ++ +Y G+L ++L+ +
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 803 VDGN------LNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVS 855
D L+ ++ + VA +EYL C +H DL NVL+ D V ++
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIA 176
Query: 856 DFGLAKFLFDRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
DFGLA+ + D ++TS+ + +K ++APE + DV+SFGIL+ E+FT
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 28/214 (13%)
Query: 711 IGQGSFGFVY--RGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRHRNLIKI 765
I +G+FG VY + D A+KV+ ++ K + + AE + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYF--AIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESP 57
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
F+ D+ LV +Y+ G ++ G L +V +E
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK-----TLGGLPEDWAKQYIAEVVLGVED 112
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH Q I+H D+KP N+L+D ++DFGL++ + GT Y+
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---------KFVGTPDYL 160
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
APE +G D +S G ++ E G P H
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 705 FSLSNLIGQGSFGFVYRG-NLGEDLLPVAVK--VINLKQKGSIKSFVAECEALKNIR--- 758
+ IG+G++G VY+ +L VA+K + L ++G S + E LK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRF-VALKKVRVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ------SNDQVDGNLNLIQR 812
H N+++++ VC + LV++++ L +L + + + +L+++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI---KDLMRQ 115
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
L +++LH H IVH DLKP N+L+ D ++DFGLA+ ++ + TS
Sbjct: 116 L------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTS 165
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ T+ Y APE + + + D++S G + E+F RRP
Sbjct: 166 -----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIR 758
F + IG+G F VY+ D VA+K + + + K+ + E + LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H N+IK + S I+ ++ +V + +G L ++ Q + +
Sbjct: 61 HPNVIKYLA--SFIE---NNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQ 114
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ SA+E++H I+H D+KP+NV + V + D GL +F SS +
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAA 163
Query: 879 KGTVG---YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
VG Y++PE + D++S G LL EM + P
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 45/224 (20%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+G+FG VY+ + A+KV+ S K VA+ E I RN I V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 771 SID-----------FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI-D 818
+D F+ D LV DYM G L LQ+ +G + R I +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-----EGRFSE-DRAKFYIAE 104
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ A+E+LH + IV+ DLKP N+LLD + DFGL+K + ++
Sbjct: 105 LVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTF 156
Query: 879 KGTVGYVAPEY-----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G +V D +S G+L+ EM G P
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI---KSFVAECEALKNI-R 758
N+ ++IG+G+FG V + + +D L + + +K+ S + F E E L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN-----------DQVDGNL 807
H N+I ++ C + +G + L +Y G+L D+L++S + L
Sbjct: 67 HPNIINLLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 808 NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867
+ Q L+ + DVA ++YL Q +H DL N+L+ + VA ++DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 868 IQETSSSSIGIKGTVG-----YVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ +K T+G ++A E + DV+S+G+LL E+ +
Sbjct: 173 -----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRG---NLGEDL-LPVAVKVIN--LKQKGSIKSFVAECEALKNI 757
E ++G G+FG VY+G GE + +PVA+K++N K +++ F+ E + ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASM 66
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
H +L++++ VC S + LV M G L D++ + D + L LN +
Sbjct: 67 DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCV 116
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+A + YL + +VH DL NVL+ ++DFGLA+ L E ++ G
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG---DEKEYNADG 170
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
K + ++A E + DV+S+G+ + E+ T G +P
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G+ G V++ E VA+K + L++ G + E +AL+ +H ++K++ V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
G F LV +YM S L + L+ L Q + + + Y+H
Sbjct: 68 FP----HGSGF-VLVMEYMPS-DLSEVLRDEERP----LPEAQVKSYMRMLLKGVAYMH- 116
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
I+H DLKP+N+L+ D V ++DFGLA+ LF S + T Y APE
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQV---ATRWYRAPE 170
Query: 889 --YG---MGGNVSLTGDVYSFGILLLEMFTGR 915
YG V D+++ G + E+ G
Sbjct: 171 LLYGARKYDPGV----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 46/286 (16%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL---GEDL-LPVAVKVINLKQKGSIKS---FVAECEALKN 756
EF ++G G+FG VY+G GE + +PVA+K L++ S K+ + E + +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMAS 65
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ + ++ +++ +C + + L+ M G L D++++ D + LN
Sbjct: 66 VDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQ----YLLNWC 115
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ +A + YL +VH DL NVL+ ++DFGLAK L E +
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL---GADEKEYHAE 169
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935
G K + ++A E + + DV+S+G+ + E+ T G +P DG
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DG---------- 214
Query: 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
+P + + +L+ G + C V I V C M R
Sbjct: 215 IPAS-----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 255
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 79/325 (24%), Positives = 133/325 (40%), Gaps = 67/325 (20%)
Query: 707 LSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKGS---IKSFVAECEALKNIR 758
L +G+G FG V + VAVK+ LK+ S ++ ++E LK +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKM--LKENASSSELRDLLSEFNLLKQVN 61
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS--------------NDQVD 804
H ++IK+ CS D L+ +Y + GSL +L++S N
Sbjct: 62 HPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 805 GN-----LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
N L + ++ + ++ ++YL + +VH DL NVL+ +SDFGL
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 860 AKFLF-DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
++ ++ + + S I +K ++A E + DV+SFG+LL E+ T G P
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMES 977
G+ PE++ LL G + E C + + + C +
Sbjct: 230 Y-----PGIA---------PERLFN------LLKTGYRMERPENCSEEMYNLMLTCWKQE 269
Query: 978 PSERIHMADAVKNLCAAREKYKGRR 1002
P +R AD K L EK +
Sbjct: 270 PDKRPTFADISKEL----EKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 31/240 (12%)
Query: 701 ATNEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIK---SFVAECE 752
A + ++S +GQGSFG VY G E VA+K +N + S++ F+ E
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEAS 61
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL----- 807
+K ++++++ V S +G ++ + M G L+ +L+ +++ N
Sbjct: 62 VMKEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 808 NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867
+L + + ++ ++A + YL+ + VH DL N ++ D + DFG+ R
Sbjct: 117 SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RD 168
Query: 868 IQETSSSSIGIKG--TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924
I ET G KG V +++PE G + DV+SFG++L E+ T +P M N+
Sbjct: 169 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 41/237 (17%)
Query: 703 NEFSLSNLIGQGSFG------------FVYRGNLGEDLLPVAVKVINLK---QKGSIKSF 747
+ L +G+G FG F+ G D PV V V L+ K + F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQV 803
+ E + + +++ N+I+++ VC S DD ++ +YM++G L +L Q S
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 804 DGNLNLIQRLNI---SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
N+ + N+ ++ +AS ++YL VH DL N L+ + ++DFG++
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 861 KFLFDRPIQETSSSSIGIKG----TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ L+ S I+G + ++A E + G + DV++FG+ L EMFT
Sbjct: 177 RNLY-------SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 57/237 (24%), Positives = 112/237 (47%), Gaps = 34/237 (14%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS-FVAECE 752
E +LS + +G+ FG VY+G+L GE VA+K + K +G ++ F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL-----------QQSND 801
++H N++ ++ V + + ++++ Y L ++L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
V L ++I +A+ +E+L H +VH DL NVL+ + +SD GL +
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
++ + +S+ + +++PE M G S+ D++S+G++L E+F+ G +P
Sbjct: 173 EVYAADYYKLMGNSLL---PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 70/254 (27%), Positives = 99/254 (38%), Gaps = 66/254 (25%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRN 761
F L+G+G G V+ L A+KV++ K ++ +K + E E L + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
L + F+ + + LV DY G L LQ+ + +S +VA
Sbjct: 63 LPTLYA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----------LSEEVAR 106
Query: 822 --------AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAK---------- 861
A+EYLH IV+ DLKP N+LL H+ SDF L+K
Sbjct: 107 FYAAEVLLALEYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVS 161
Query: 862 --------------FLFDRPIQETSSSSIGIKGTVGYVAPE----YGMGGNVSLTGDVYS 903
+ +E S S GT Y+APE G G V D ++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWT 217
Query: 904 FGILLLEMFTGRRP 917
GILL EM G P
Sbjct: 218 LGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 39/274 (14%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRHR 760
F + IG+G F VYR D PVA+K + + + K+ V E + LK + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI---SI 817
N+IK + F D+ +V + +G L ++ Q LI + +
Sbjct: 63 NVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQ----KRLIPERTVWKYFV 113
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ SA+E++H ++H D+KP+NV + V + D GL +F ++++
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHS 165
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM--- 934
+ GT Y++PE + D++S G LL EM + P + D + L +
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLCQKIEQ 222
Query: 935 ----ALP-----EKVMEIVDFALLLDPGNERAKI 959
LP EK+ E+V + DP ++R I
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDP-DQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI---KSFVAECEALKNI-RH 759
+ ++IG+G+FG V R + +D L + + LK+ S + F E E L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQVDGNLN 808
N+I ++ C + +G + A+ +Y G+L D+L++S L
Sbjct: 63 PNIINLLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 809 LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI 868
Q L + DVA+ ++YL + +H DL NVL+ ++ + ++DFGL++
Sbjct: 118 SQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------- 167
Query: 869 QETSSSSIGIKGTVG-----YVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ +K T+G ++A E + DV+SFG+LL E+ +
Sbjct: 168 ----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G VY+ +A+K I L+Q+ G + + E LK ++H N++++ V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S + LV++Y+ L+ + S D N LI+ I I Y H
Sbjct: 70 VHS-----EKRLYLVFEYLDL-DLKKHMDSSPD-FAKNPRLIKTYLYQI--LRGIAYCHS 120
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVA-HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
H ++H DLKP N+L+D A ++DFGLA+ F P++ + + T+ Y AP
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV----TLWYRAP 172
Query: 888 EYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
E +G + S D++S G + EM +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 48/246 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
++F + +IG+G+FG V+ + A+KV+ + ++ I AE + L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
++K+ S F+ ++ LV +YM G L + L + D R I+ ++
Sbjct: 61 PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEE---TARFYIA-EL 110
Query: 820 ASAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAK---------FLFDR 866
A++ +H +H D+KP N+L+D D H+ +DFGL K + +
Sbjct: 111 VLALDSVHKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLND 163
Query: 867 PIQETSSSSIGIK---------------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEM 911
++ ++ GT Y+APE G L D +S G++L EM
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 912 FTGRRP 917
G P
Sbjct: 224 LYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 38/225 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
F+L IG+GSFG VY+ VA+KVI+L+ EA I ++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DI 46
Query: 763 IKIITVCSSID------FKG---DDFK-ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR 812
+ I S + G K ++ +Y GS D L+ G L+
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP------GKLDETYI 100
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
I +V +EYLH + I H D+K +N+LL + ++DFG++ L T
Sbjct: 101 AFILREVLLGLEYLH--EEGKI-HRDIKAANILLSEEGDVKLADFGVSGQL-----TSTM 152
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
S GT ++APE D++S GI +E+ G P
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 33/220 (15%)
Query: 710 LIGQGSFG--FVYRGNLGEDLLPV-AVKVI---NLKQKGSIKSFVAECEALKNIRHRNLI 763
++GQGSFG F+ R G D + A+KV+ LK + +++ + E + L + H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNISIDV 819
K+ F+ + L+ D+++ G L L + + + V L ++
Sbjct: 62 KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AEL 107
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A A+++LH I++ DLKP N+LLD + ++DFGL+K D E + S
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID---HEKKAYSFC-- 159
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
GTV Y+APE + + D +SFG+L+ EM TG P
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 710 LIGQGSFGFV---YRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA--LKNIRHRNLIK 764
L+GQG+FG V Y + G +L V+ + S + ECE LKN++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
I+ + + + + +YM GS++D L+ G L + + +
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMS 120
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG- 883
YLH + IVH D+K +N+L D + DFG +K L Q S GI+ G
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRSVTGT 172
Query: 884 --YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+++PE G DV+S G ++EM T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 52/236 (22%), Positives = 108/236 (45%), Gaps = 28/236 (11%)
Query: 705 FSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVIN-LKQKGSIKSFVAECEA 753
F SNL +G+G FG V+ V VK + K + F E +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG----NLNL 809
+ + H+N+++++ +C + + ++ +Y G L+ +L+ + + + L+
Sbjct: 62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
Q++ + +A +++L + VH DL N L+ VS L+K +++
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 870 ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924
+ ++ I ++ ++APE + S DV+SFG+L+ E+FT G P + + ++
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 37/230 (16%)
Query: 707 LSNLIGQGSFGFVYRGN-LGED------LLPVAVKVINLKQKGSIKSF---VAECEALKN 756
L +G+G FG V +G D + VAVK+ LK + K ++E E +K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKM 79
Query: 757 I-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN----------DQV-D 804
I +H+N+I ++ C+ D ++ +Y G+L ++L+ QV +
Sbjct: 80 IGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 805 GNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
L+ ++ + VA +EYL +H DL NVL+ D V ++DFGLA+ +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 865 DRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
++T++ + +K ++APE + DV+SFG+LL E+FT
Sbjct: 192 HIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 56/225 (24%), Positives = 111/225 (49%), Gaps = 24/225 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRH 759
+++ IGQG+FG V++ + VA+K + N K+ I + + E + L+ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKH 70
Query: 760 RNLIKIITVCSSIDFKGDDFKA---LVYDYMQ---SGSLEDWLQQSNDQVDGNLNLIQRL 813
N++ +I +C + + +K LV+++ + +G L SN V L+ I++
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL------SNKNVKFTLSEIKK- 123
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
+ + + + Y+H + I+H D+K +N+L+ D + ++DFGLA+ F +
Sbjct: 124 -VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPN 178
Query: 874 SSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRP 917
T+ Y PE +G + D++ G ++ EM+T R P
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 34/92 (36%), Positives = 58/92 (63%), Gaps = 2/92 (2%)
Query: 375 IIAMGLNQ--ISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
I +GL+ + G IP +I L ++ ++ L N + G IP ++G + +L+ LD S N+ +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLG 464
G IP+S+G L++L L L N+L G +P++LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-12
Identities = 80/274 (29%), Positives = 116/274 (42%), Gaps = 15/274 (5%)
Query: 250 SLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKV 309
SL N R ++ L L L + NN+T P SNL L+LS N +
Sbjct: 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SL 155
Query: 310 GIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIAN 369
+LPN+ L+L N+L D LL+N S L L L+ N+ LP I
Sbjct: 156 PSPLRNLPNLKNLDLSFNDL-------SDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIEL 207
Query: 370 LSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN 429
LS + + + N I + + NL N+ L L N+L +P +IG L NL+ LD S N
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN 265
Query: 430 NLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE 489
+ S+G+L+ L L L N+L +P L LL LT L
Sbjct: 266 QI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL--LNLLLTLKALELKLN 321
Query: 490 ITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDI 523
L++ + + S ++ +L NL LD
Sbjct: 322 SILLNNNILSNGETSSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGN-LGEDL----LPVAVKVINLKQKGSIKSF---VAECEAL 754
+L +G+G FG V +G D PV V V LK + K V+E E +
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM 71
Query: 755 KNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ--------SNDQV-- 803
K I +H+N+I ++ C+ + LV +Y G+L ++L+ S D
Sbjct: 72 KMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 804 -DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+ L ++ + VA +EYL +H DL NVL+ D V ++DFGLA+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 863 LFDRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ + ++T++ + +K ++APE + DV+SFG+LL E+FT
Sbjct: 184 VHNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVI-NLKQKGSIK-SFVAECEALKNIRHRNLIKII 766
+G G+FG V +G + + VAVK++ N ++K + E ++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL-NLIQRLNISIDVASAIEY 825
+C + + LV + + G L +LQ++ + N+ L+ + V+ ++Y
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVHQ------VSMGMKY 110
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-FDRPIQETSSSSIGIKGTVGY 884
L VH DL NVLL A +SDFGL+K L D + + K V +
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG---KWPVKW 164
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921
APE S DV+SFG+L+ E F+ G++P M
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G VY+ VA+K I L + +G + + E LK + H N++K++ V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 769 CSS-------IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ +F D K +M + L L LI+ + +
Sbjct: 68 IHTENKLYLVFEFLHQDLK----KFMDASPLSGI----------PLPLIK--SYLFQLLQ 111
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ + H H ++H DLKP N+L++ + ++DFGLA+ F P++ + + T
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV----T 163
Query: 882 VGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
+ Y APE +G T D++S G + EM T R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ S +E+LH I++ DLKP NVLLD+D +SD GLA L D S + G
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-----QSKTKGY 157
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT G++APE G + D ++ G+ L EM R P
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS------IKSFVAECEALKNIRHRNLI 763
++G+G++G V + VA+K K K S K+ + E + L+ +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ F+ LV++Y++ LE L+ S + + ++ + AI
Sbjct: 64 NLKEA-----FRRKGRLYLVFEYVERTLLEL-LEASPGGLP--PDAVRS--YIWQLLQAI 113
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
Y H H I+H D+KP N+L+ V + DFG A+ L RP + T
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRW 166
Query: 884 YVAPE-------YGMGGNVSLTGDVYSFGILLLEMFTGR 915
Y APE YG DV++ G ++ E+ G
Sbjct: 167 YRAPELLVGDTNYGKP------VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 704 EFSLSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
++ L IG G++G VY+ ++ L VA+KVI L+ + E LK RH N+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL-VAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+ + D +V +Y GSL+D Q + G L+ +Q + +
Sbjct: 63 VAYFG-----SYLRRDKLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKG 113
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ YLH + +H D+K +N+LL D ++DFG++ L T + GT
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSFIGTP 165
Query: 883 GYVAPEYGMGGNVSLTG------DVYSFGILLLEMFTGRRPTHTMFN 923
++APE V G D+++ GI +E+ + P MF+
Sbjct: 166 YWMAPEV---AAVERKGGYDGKCDIWALGITAIELAELQPP---MFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-12
Identities = 34/89 (38%), Positives = 52/89 (58%), Gaps = 1/89 (1%)
Query: 472 LNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGE 531
L + L G +P I ++ L S+ +LS N I G+IP +G++ +L LD+S N F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 532 IPTTLSSCTSLEYLKMQDNSFRGSIPSSL 560
IP +L TSL L + NS G +P++L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRH 759
AT+ +L L G+GS+ VY+G + VA+KVI++K ++G + + E LK ++H
Sbjct: 4 ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 760 RNLI---KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
N++ II ++ F V++YM + L Q Q G L+
Sbjct: 63 ANIVLLHDIIHTKETLTF--------VFEYMHTD-----LAQYMIQHPGGLHPYNVRLFM 109
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ + Y+H I+H DLKP N+L+ + ++DFGLA+ P Q SS +
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK-SIPSQTYSSEVV 165
Query: 877 GIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
T+ Y P+ +G + S D++ G + +EM G+
Sbjct: 166 ----TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 32/224 (14%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
F+ IG+GSFG V++G VA+K+I+L++ AE E +++I+ I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 765 IITVCSS---IDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+++ C S + G K ++ +Y+ GS D L+ G + Q +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLK 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ ++YLH + +H D+K +NVLL ++DFG+A L D I+ +
Sbjct: 109 EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT----- 160
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT ++APE D++S GI +E+ G P M
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVI--NLKQKGSIKSFVAECEALKNIRHRNLIKIIT 767
L+G+GS+G V + E VA+K + K K + E LK +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
V F+ LV++++ L+D L++ + +D + +++ + IE+ H
Sbjct: 68 V-----FRRKKRLYLVFEFVDHTVLDD-LEKYPNGLD--ESRVRK--YLFQILRGIEFCH 117
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
H I+H D+KP N+L+ V + DFG A+ L P E + + T Y AP
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAP-GEVYTDYV---ATRWYRAP 169
Query: 888 EYGMGG-NVSLTGDVYSFGILLLEMFTG 914
E +G D+++ G L+ EM TG
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+GS G V VAVK ++L+++ + E +++ +H N I+ + S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN---IVEMYS 83
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
S + D +V ++++ G+L D + + +N Q + + V A+ +LH
Sbjct: 84 S--YLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSFLHAQ- 134
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE-- 888
++H D+K ++LL D +SDFG F + + + GT ++APE
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFG-----FCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 889 ----YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
YG D++S GI+++EM G P FN+
Sbjct: 188 SRLPYGT------EVDIWSLGIMVIEMVDGEPP---YFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
F+ IG+GSFG VY+G VA+K+I+L++ AE E +++I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 765 IITVCSS---IDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+++ C S + G K ++ +Y+ GS D L+ G L I
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILR 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ ++YLH + +H D+K +NVLL ++DFG+A L D I+ +
Sbjct: 109 EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT----- 160
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT ++APE D++S GI +E+ G P
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHRN 761
+ + +G+G+ G V + L + A+K I + K + E E K+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 762 LIKIITVC-----SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++K SSI + +Y + GSL+ ++ + G + I+
Sbjct: 61 IVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYKKVKKR-GGRIGEKVLGKIA 111
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
V + YLH I+H D+KPSN+LL + DFG++ L +S +
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAG 161
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G S+T DV+S G+ LLE+ R P
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 61/234 (26%), Positives = 113/234 (48%), Gaps = 37/234 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGN-LGED------LLPVAVKVI--NLKQKGSIKSFVAECEA 753
++ +L +G+G FG V LG D + VAVK++ + +K + V+E E
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEM 73
Query: 754 LKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------ND 801
+K I +H+N+I ++ C+ D ++ +Y G+L ++L+
Sbjct: 74 MKMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 802 QVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
D + ++ + VA +EYL C +H DL NVL+ + V ++DFGLA
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA 184
Query: 861 KFLFDRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ + + ++T++ + +K ++APE + DV+SFG+L+ E+FT
Sbjct: 185 RDVNNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G VY+G + VA+K I L+ ++G + + E LK ++H N++ + V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQ--SNDQVDGNL---NLIQRLNISIDVASAI 823
+ L+++++ S L+ +L +D L L Q L I
Sbjct: 68 LMQ-----ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ-------GI 114
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
+ H ++H DLKP N+L+D+ V ++DFGLA+ F P++ + + T+
Sbjct: 115 LFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV----TLW 166
Query: 884 YVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
Y APE +G T D++S G + EM T ++P
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 22/215 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEAL-KNIRHRNLIKI 765
+IG+GSFG V + AVKV+ K +K K ++E L KN++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
F+ D V DY+ G L LQ+ ++ + ++ASA+ Y
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGY 111
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH IV+ DLKP N+LLD ++DFGL K I+ ++S GT Y+
Sbjct: 112 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST-FCGTPEYL 163
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920
APE T D + G +L EM G P ++
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEAL-KNIRHRNLIKI 765
+IG+GSFG V D AVKV+ K +K +AE L KN++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
F+ + V DY+ G L LQ+ ++ + +VASAI Y
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-----AAEVASAIGY 111
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH I++ DLKP N+LLD ++DFGL K + +ET+S+ GT Y+
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTST---FCGTPEYL 163
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920
APE T D + G +L EM G P ++
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 63/277 (22%), Positives = 124/277 (44%), Gaps = 43/277 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRHRNLIKIIT 767
IG G FG V G + P V V L+ S++ F+ E + ++++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 768 VCSS-IDFKGDDFKALVYDYMQSGSLEDWLQ--QSNDQVDGNLNLIQRLNISIDVASAIE 824
C+ + LV ++ G L+ +L+ + + + + +QR+ + ++A +
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLL 114
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS-IGIKGTVG 883
+LH + +H DL N LL D+ + D+GL+ + T + ++
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---- 167
Query: 884 YVAPEY--GMGGNV-----SLTGDVYSFGILLLEMFT-GRRP----------THTMFNDG 925
++APE + GN+ + +V+S G+ + E+F G +P T+T+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227
Query: 926 LTL-HGFVKMALPEKVMEIVDFALLLDPGNERAKIEE 961
L L +K+ L ++ E++ F L +R EE
Sbjct: 228 LKLPKPRLKLPLSDRWYEVMQFCWL--QPEQRPSAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 28/235 (11%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK 745
+E+ +VS + K F IGQG+ G VY VA+K +NL+Q+ +
Sbjct: 5 LEKLRTIVSVGDPKKKYTRF---EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE 61
Query: 746 SFVAECEALKNIRHRNLIKIIT---VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ 802
+ E ++ +H N++ + V + +V +Y+ GSL D + ++
Sbjct: 62 LIINEILVMRENKHPNIVNYLDSYLVGDEL--------WVVMEYLAGGSLTDVVTETCMD 113
Query: 803 VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+G + + R + A+E+LH + ++H D+K N+LL D ++DFG
Sbjct: 114 -EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ P Q S+ + GT ++APE D++S GI+ +EM G P
Sbjct: 165 I--TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 57/255 (22%)
Query: 698 LNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI 757
L T F L +IG+G++G VY+ + VA+K++++ + + E L+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 758 -RHRNLIKIITVCSSIDFKGDDFKA----------LVYDYMQSGSLEDWLQQSNDQVDGN 806
H N+ F G K LV + GS+ D V G
Sbjct: 60 SNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-------TDLVKGL 103
Query: 807 LNLIQRLN------ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFG 858
+RL I + + YLH + ++H D+K N+LL + A V DFG
Sbjct: 104 RKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFG 158
Query: 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPE-----YGMGGNVSLTGDVYSFGILLLEMFT 913
++ L D + ++ GT ++APE + DV+S GI +E+
Sbjct: 159 VSAQL-DSTLGRRNTFI----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213
Query: 914 GR------RPTHTMF 922
G+ P +F
Sbjct: 214 GKPPLCDMHPMRALF 228
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 27/65 (41%), Positives = 44/65 (67%)
Query: 174 KLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNF 233
L+++N++ N + G +PPS+G+I++L+ L + N G IPESLGQL L L++ N+
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 234 SGMLP 238
SG +P
Sbjct: 503 SGRVP 507
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+GSFG V++G VA+K+I+L++ AE E +++I+ I +++ C
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--ITVLSQCD 60
Query: 771 S---IDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
S + G K ++ +Y+ GS D L+ G L+ Q I ++ +
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGL 114
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
+YLH + +H D+K +NVLL ++DFG+A L D I+ GT
Sbjct: 115 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-----TFVGTPF 166
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
++APE D++S GI +E+ G P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI---KSFVAECEALKNI-RHRNLIK 764
++IG+G+FG V + + +D L + + +K+ S + F E E L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQVDGNLNLIQRL 813
++ C +G + A+ +Y G+L D+L++S + L+ Q L
Sbjct: 61 LLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
+ + DVA ++YL Q +H DL N+L+ + VA ++DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR-----------G 161
Query: 874 SSIGIKGTVG-----YVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ +K T+G ++A E + DV+S+G+LL E+ +
Sbjct: 162 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 707 LSNLIGQGSFGFVY---RGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA--LKNIRHRN 761
L L+G+G+FG VY + G +L V Q+ S + ECE LKN+RH
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+++ + K ++ +YM GS++D L+ + N+ +R I
Sbjct: 66 IVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTE---NVTRRYTRQI--LQ 117
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YLH + IVH D+K +N+L D + DFG +K IQ S GIK
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSV 169
Query: 882 VG---YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G +++PE G DV+S ++EM T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 37/253 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGN---LGED--LLPVAVKVINLKQKGSIK-SFVAECEALKN 756
N S +G G+FG V L + ++ VAVK++ S + + ++E + + +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 757 I-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+ H N++ ++ C+ G ++ +Y G L ++L++ + L L L+
Sbjct: 95 LGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF---LTLEDLLSF 146
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
S VA + +L +C +H DL NVLL H + + DFGLA R I + S
Sbjct: 147 SYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLA-----RDIM--NDS 195
Query: 875 SIGIKGT----VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDG---- 925
+ +KG V ++APE + DV+S+GILL E+F+ G P M D
Sbjct: 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 926 LTLHGFVKMALPE 938
L G+ +MA PE
Sbjct: 256 LIKEGY-RMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS-FVAECEALKNIRHRNLIKIITVC 769
+G G+ G V + L +A K+I+L+ K +I++ + E + L ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA- 71
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
F D ++ ++M GSL+ L+++ + L +SI V + YL
Sbjct: 72 ----FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK 122
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
Q I+H D+KPSN+L++ + DFG++ L D S + GT Y++PE
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPER 173
Query: 890 GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G + S+ D++S G+ L+E+ GR P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
+G G+FG VY+ E A KVI K + ++ ++ E E L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
F D ++ ++ G+++ + ++D L Q I + A++YLH
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAVDAIML----ELDRGLTEPQIQVICRQMLEALQYLH--- 127
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGL-AKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
I+H DLK NVLL D ++DFG+ AK + + +Q S GT ++APE
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV--KTLQRRDS----FIGTPYWMAPEV 181
Query: 890 GMGGNVSLT-----GDVYSFGILLLEMFTGRRPTHTM 921
M + T D++S GI L+EM P H +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 46/228 (20%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVK------VINLKQKGSIKSFVAECEALKNI 757
+F + +G GSFG V A+K ++ +KQ ++ E L +
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILMEL 75
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS----NDQVDGNLNLIQRL 813
H ++ ++ CS F+ ++ + +++ G L L+++ ND + +
Sbjct: 76 SHPFIVNMM--CS---FQDENRVYFLLEFVVGGELFTHLRKAGRFPND--------VAKF 122
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
++ A EYLH I++ DLKP N+LLD+ V+DFG AK + DR
Sbjct: 123 -YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------- 171
Query: 874 SSIGIKGTVGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ + GT Y+APE G G V D ++ G+LL E G P
Sbjct: 172 -TFTLCGTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 28/235 (11%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGN---LGEDLLPVAVKVINLKQKG 742
ME+ +VS + K +++ IGQG+ G V+ G++ VA+K INL+++
Sbjct: 5 MEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQE---VAIKQINLQKQP 58
Query: 743 SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ 802
+ + E +K +++ N++ + GD+ +V +Y+ GSL D + ++
Sbjct: 59 KKELIINEILVMKELKNPNIVNFLDSF----LVGDEL-FVVMEYLAGGSLTDVVTETC-- 111
Query: 803 VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
++ Q + + A+E+LH + ++H D+K NVLL D ++DFG
Sbjct: 112 ----MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ P Q S+ + GT ++APE D++S GI+ +EM G P
Sbjct: 165 I--TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS-FVAECEALKNIRHRN 761
++F + +G G+ G V++ + L +A K+I+L+ K +I++ + E + L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN---DQVDGNLNLIQRLNISID 818
++ F D ++ ++M GSL+ L+++ +Q+ G +SI
Sbjct: 65 IVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--------VSIA 111
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
V + YL + I+H D+KPSN+L++ + DFG++ L D S +
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSF 162
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE G + S+ D++S G+ L+EM GR P
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 1/91 (1%)
Query: 423 ALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGT 482
L L G IP+ I L L S+ L N+++GNIP SLG+ +L +L++S N G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 483 LPPQILEITTLSSLLDLSSNLISGSIPLVVG 513
+P + ++T+L +L+L+ N +SG +P +G
Sbjct: 482 IPESLGQLTSL-RILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G+FG VY+ + VA+K I N K I + E + LK ++H N++ +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 768 VCSSIDFKGDDFKALVY---DYMQ---SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ K + VY YM SG LE N V L Q + +
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSV--KLTESQIKCYMLQLLE 126
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
I YLH + I+H D+K +N+L+D+ + ++DFGLA+ P G +
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 882 VG------YVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
Y PE +G T D++ G + EMFT R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-11
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 50/240 (20%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN-----------IR 758
LIG+G G VY L D PV + + LK+ I+ ++E LK +
Sbjct: 9 LIGKGGMGEVY---LAYD--PVCSRRVALKK---IREDLSENPLLKKRFLREAKIAADLI 60
Query: 759 HRNLIKIITVCSSID--------FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLI 810
H ++ + ++CS D +G K+L+ Q SL L + ++
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT-------SVG 113
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL------- 863
L+I + + IEY+H ++H DLKP N+LL + D+G A F
Sbjct: 114 AFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 864 --FDRPIQETSSSSIGIKG----TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
D + SS+ I G T Y+APE +G S + D+Y+ G++L +M T P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 27/164 (16%)
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
I++ + A+EYLH + ++H D+KPSNVL++ + + DFG++ +L D S +
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD------SVA 159
Query: 875 SIGIKGTVGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRPT---HTMFNDGLT 927
G Y+APE + DV+S GI ++E+ TGR P T F
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--- 216
Query: 928 LHGFVKM---ALPEKVM--EIVDF---ALLLDPGNERAKIEECL 963
L V+ LP + E DF L + ER E L
Sbjct: 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNY-KERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN----IRHRNLIKI 765
++G+GSFG V L AVK LK+ + EC ++ + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
C+ F+ + V +++ G L +Q G +L + + ++ +++
Sbjct: 60 HLYCT---FQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH I++ DLK NV+LD D ++DFG+ K + + +S+ GT Y+
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFC--GTPDYI 163
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
APE G + + D +SFG+LL EM G+ P H
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 13/146 (8%)
Query: 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP 833
F+ + V +Y+ G L +Q S G + + + ++ +++LH
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG 893
I++ DLK NVLLD D ++DFG+ K + E +S+ GT Y+APE G
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFC--GTPDYIAPEILKGQ 171
Query: 894 NVSLTGDVYSFGILLLEMFTGRRPTH 919
+ + D +SFG+LL EM G+ P H
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 30/261 (11%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHR 760
+F + +L+G+G FG V R D+ A+KV+ + + V+ E ++I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIY--AMKVMKKSVLLA-QETVSFFEEERDILSI 57
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
+ I F+ D LV +Y G L L + DQ D ++ +A
Sbjct: 58 SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYLA 109
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ +H Q VH D+KP NVL+D ++DFG A L S + G
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPV---G 165
Query: 881 TVGYVAPEY------GMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFNDGLTLH 929
T Y+APE G + D +S G++ EM GR P + +N+ +
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225
Query: 930 GFVKMALPEKVMEIVDFALLL 950
F+K PE DF L+
Sbjct: 226 RFLK--FPEDPKVSSDFLDLI 244
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRN 761
+F + N IG+GSFG V++ D A+K I+L + + + E L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+I+ F +V +Y ++G L L+ + + + R I I +
Sbjct: 61 IIRYYE-----SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLG- 113
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ +LH I+H D+K N+ LD + D G+AK L D ++ + I GT
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-----NTNFANTIVGT 164
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y++PE + DV++ G++L E TG+ P
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIR---HRNLIKI 765
IG G++G VY+ VA+K + ++ + G S V E LK + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ---VDGNLNLIQRLNISIDVASA 822
+ VC++ + LV++++ L +L + + +L+++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+++LH +C IVH DLKP N+L+ ++DFGLA+ I + + T+
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTL 171
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y APE + + D++S G + EMF R+P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G++ V++G L E+L VA+K I L+ ++G+ + + E LKN++H N++ +
Sbjct: 13 LGEGTYATVFKGRSKLTENL--VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI-DVASAIEYL 826
+ + + LV++Y+ S L+Q D GNL + + I + + + Y
Sbjct: 71 IIHT-----ERCLTLVFEYLDSD-----LKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYC 119
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
H I+H DLKP N+L++ ++DFGLA+ P + S+ + T+ Y
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV----TLWYRP 171
Query: 887 PEYGMGGN-VSLTGDVYSFGILLLEMFTGR 915
P+ +G S D++ G +L EM TGR
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 705 FSLSNLIGQGSFG--FVYRGNLGED-----LLPVAVKVINLKQKGSIKSFVAECEALKNI 757
F L ++G G++G F+ R G D + V K +++ + + E + L++I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
R + V F+ D L+ DY+ G L L Q + + + S
Sbjct: 62 RQSPFL----VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY-----SG 112
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ A+E+LH + I++ D+K N+LLD + ++DFGL+K + ++ S
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS---- 165
Query: 878 IKGTVGYVAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRP 917
GT+ Y+AP+ GG+ G D +S G+L+ E+ TG P
Sbjct: 166 FCGTIEYMAPDIVRGGD---GGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLKQKGSIK-SFVAECEALKNIRHRNLIKIIT 767
+G G+FG V +G + + + VA+KV+ + + S++ + E E + + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
VC + LV + G L +L D++ + N+++ ++ V+ ++YL
Sbjct: 63 VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVS-NVVELMH---QVSMGMKYLE 112
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
VH DL NVLL + A +SDFGL+K L + S K + + AP
Sbjct: 113 ---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS--AGKWPLKWYAP 167
Query: 888 EYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921
E S DV+S+GI + E F+ G++P M
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/225 (24%), Positives = 108/225 (48%), Gaps = 21/225 (9%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI------KSFVAECEALKNI 757
E++ ++G+G++G VY G + L +AVK + L + + E + LK++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+H N+++ + C D+ ++ +++ GS+ L + G L +
Sbjct: 60 KHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTK 109
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI- 876
+ + YLH++C +VH D+K +NV+L + + + DFG A+ L + T S+ +
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+ GT ++APE D++S G + EM TG+ P +M
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+GS G V VAVK+++L+++ + E +++ +H+N++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
G++ L+ +++Q G+L D + Q+ LN Q + V A+ YLH
Sbjct: 88 ---LVGEELWVLM-EFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQ- 136
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGL-AKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
++H D+K ++LL D +SDFG A+ D P +++ + GT ++APE
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEV 188
Query: 890 GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
D++S GI+++EM G P
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 34/264 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+GS G V + VAVK ++L+++ + E +++ +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY- 86
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
GD+ +V ++++ G+L D + + +N Q + + V A+ LH
Sbjct: 87 ---LVGDEL-WVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQ- 135
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYG 890
++H D+K ++LL HD +SDFG F + + + GT ++APE
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFG-----FCAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 891 MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND-GLTLHGFVKMALPEKVMEI------ 943
D++S GI+++EM G P FN+ L ++ LP K+ +
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPKLKNLHKVSPS 245
Query: 944 ----VDFALLLDPGNERAKIEECL 963
+D L+ DP +RA E L
Sbjct: 246 LKGFLDRLLVRDPA-QRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLP---VAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKI 765
IG+G++G VY+ D L VA+K I L+ +G + + E LK + H N++++
Sbjct: 7 IGEGTYGVVYKA---RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
+ V S ++ LV++++ L+ ++ S LI+ + I Y
Sbjct: 64 LDVVHS-----ENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSYLYQL--LQGIAY 114
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H H ++H DLKP N+L+D + ++DFGLA+ F P++ + + T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVV----TLWYR 166
Query: 886 APEYGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
APE +G T D++S G + EM RRP
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 46/226 (20%)
Query: 711 IGQGSFGFVY--RGNLGEDLLPVAVKVINLKQKGSIKSF---VAECEALKNIRHRNLIKI 765
IG GSFG VY R ++ VA+K ++ K S + + + E L+ +RH N
Sbjct: 23 IGHGSFGAVYFARDVRTNEV--VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN---- 76
Query: 766 ITVCSSIDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI---D 818
+I++KG + LV +Y L ++D ++ + +Q + I+
Sbjct: 77 -----TIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHG 123
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ YLH H + +H D+K N+LL ++DFG A + ++S +
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFV-- 172
Query: 879 KGTVGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT ++APE + G DV+S GI +E+ + P M
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 37/100 (37%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++ +E LH Q IV+ DLKP N+LLD +SD GLA + P +T +
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRV- 162
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GTVGY+APE + + D ++ G LL EM G+ P
Sbjct: 163 --GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
+G G+FG VY+ E + A KVI+ K + ++ ++ E + L + H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 771 SIDFKGDDFKALVYDYMQSGSLED-WLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
F ++ ++ ++ G+++ L+ + + ++ + + A+ YLH
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-----ALNYLH-- 120
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
+ I+H DLK N+L D ++DFG++ R IQ S GT ++APE
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDS----FIGTPYWMAPEV 174
Query: 890 GMGGN-----VSLTGDVYSFGILLLEMFTGRRPTHTM 921
M DV+S GI L+EM P H +
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 707 LSNLIGQGSFGFVY---RGNLGEDLLPVAVKVINL-----KQKGSIKSFVAECEALKNIR 758
L L+GQG+FG VY + G +L AVK + + + + E + LKN+
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGREL---AVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H +I+ + + ++ ++M GS++D L+ + N+ ++ +
Sbjct: 63 HE---RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKY--TRQ 114
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ + YLH + IVH D+K +N+L D + DFG +K L Q S G+
Sbjct: 115 ILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGM 166
Query: 879 KGTVG---YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
K G +++PE G D++S G ++EM T + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRN 761
F + +G+GS+G VY+ D A+K ++L QK + V E L ++ H N
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-VNEIRILASVNHPN 60
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL---NLIQRLNISID 818
+I + +D G+ +V +Y G L + + + L I R I I
Sbjct: 61 IISYKE--AFLD--GNKL-CIVMEYAPFGDLSKAISKR--KKKRKLIPEQEIWR--IFIQ 111
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ ++ LH I+H DLK +N+LL + + + D G++K L + +
Sbjct: 112 LLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAKTQ 161
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G S D++S G LL EM T P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 63/234 (26%), Positives = 116/234 (49%), Gaps = 34/234 (14%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIR 758
++F + IG+G++G VY R +L VA+K + L +++G + + E + L+ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGEL--VALKKVRLDNEKEGFPITAIREIKILRQLN 64
Query: 759 HRNLIKIITVCS----SIDFKGDDFK-ALVYDYMQS---GSLEDWLQQSNDQVDGNLNLI 810
HRN++ + + + ++DFK D LV++YM G LE L ++ D + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE--DHIKSFM 122
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
++L + Y H + +H D+K SN+LL++ ++DFGLA+ +
Sbjct: 123 KQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRPTHTMFN 923
++ I T+ Y PE +G DV+S G +L E+FT ++P +F
Sbjct: 174 YTNKVI----TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP---IFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 27/226 (11%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEAL-KNIRHRNLIKI 765
+IG+GSFG V D AVKV+ K + K +AE L KN++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
F+ + V D++ G L LQ+ + R + ++ASA+ Y
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAA-EIASALGY 111
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH IV+ DLKP N+LLD ++DFGL K I ++ +++ GT Y+
Sbjct: 112 LH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTT-FCGTPEYL 163
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFNDGL 926
APE T D + G +L EM G P M+++ L
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 29/89 (32%), Positives = 52/89 (58%)
Query: 352 LGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTI 411
LGL++ G +P I+ L + I + N I G IP + ++ ++ L L YN G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 412 PYTIGELINLQALDFSANNLHGIIPDSIG 440
P ++G+L +L+ L+ + N+L G +P ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIIT-- 767
+IG+G FG VY + A+K ++ K+ IK E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 768 -----VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
VC + F D + D M G L L Q + + + ++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILG 109
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-KFLFDRPIQETSSSSIGIKGT 881
+E++H+ +V+ DLKP+N+LLD +SD GLA F +P +S+ GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GT 158
Query: 882 VGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRP 917
GY+APE G + D +S G +L ++ G P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 34/264 (12%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCS 770
IG+GS G V VAVK ++L+++ + E +++ H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
+ GD+ +V ++++ G+L D + + +N Q + + V A+ YLH+
Sbjct: 86 NSYLVGDEL-WVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQ- 137
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYG 890
++H D+K ++LL D +SDFG F + + + GT ++APE
Sbjct: 138 --GVIHRDIKSDSILLTSDGRIKLSDFG-----FCAQVSKEVPKRKSLVGTPYWMAPEVI 190
Query: 891 MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND-GLTLHGFVKMALPEKVMEI------ 943
D++S GI+++EM G P FN+ L ++ LP +V +
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDNLPPRVKDSHKVSSV 247
Query: 944 ----VDFALLLDPGNERAKIEECL 963
+D L+ +P ++RA +E L
Sbjct: 248 LRGFLDLMLVREP-SQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 40/275 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK---SFVAECEALKNIRHRNLIKIIT 767
IG G FG V + D V V LK S K F+ + + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 768 VC-SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV-DGNLNLIQRLNISIDVASAIEY 825
C +I + LV++Y + G L+ +L Q + L L+QR+ + ++A+ + +
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
+H H +H DL N L D+ V D+G+ + ET + ++
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC---VPLRWL 168
Query: 886 APEY---GMGGNVSLT----GDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK----- 933
APE GG ++ +V++ G+ L E+F ++ +D L+ +K
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228
Query: 934 -----MALP--EKVMEIVDFALLLDPGNERAKIEE 961
+ LP E+ E++ F L +RA EE
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWL--SPEKRATAEE 261
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 704 EFSLSNLIGQGSFG--FVYRGNLGEDLLPV-AVKVIN----LKQKGSIKSFVAECEALKN 756
F L ++G G++G F+ R G D + A+KV+ +++ +++ E L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+R + V F+ + L+ DY+ G + L Q ++ + + S
Sbjct: 61 VRQSPFL----VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY-----S 111
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLFDRPIQETSSSS 875
++ A+E+LH + IV+ D+K N+LLD + ++DFGL+K FL E +
Sbjct: 112 GEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL-----SEEKERT 163
Query: 876 IGIKGTVGYVAPEY--GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+APE G GG+ D +S GIL+ E+ TG P
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVIN----LKQKGSIKSFVAECEALKNIR 758
+F+ +G GSFG V ED PVA+K +KQK + +E + L I
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK-QVDHVFSERKILNYIN 89
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H + + FK + + LV +++ G +L++ N + ++ I +
Sbjct: 90 HPFCVNLYG-----SFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVL- 142
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
EYL IV+ DLKP N+LLD D ++DFG AK + +T + ++
Sbjct: 143 ---IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK------VVDTRTYTLC- 189
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938
GT Y+APE + D ++ GI + E+ G P + N+ L ++ +
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA--NEPLLIY--------Q 238
Query: 939 KVME-IVDFALLLD 951
K++E I+ F LD
Sbjct: 239 KILEGIIYFPKFLD 252
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN------IRHRNLI 763
++G+GSFG V+ L A+K LK+ + EC ++ H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ C+ F+ + V +Y+ G L +Q + +L + + ++ +
Sbjct: 60 HLY--CT---FQTKENLFFVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGL 109
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
++LH IV+ DLK N+LLD D ++DFG+ K + + + + + GT
Sbjct: 110 QFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC--GTPD 161
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
Y+APE +G + + D +SFG+LL EM G+ P H
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G V++ E VA+K + L +G S + E LK ++H+N++++ V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S D LV++Y L+ + N +D +++ + + + H
Sbjct: 68 LHS-----DKKLTLVFEYCDQ-DLKKYFDSCNGDID--PEIVKSFMFQL--LKGLAFCHS 117
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
H ++H DLKP N+L++ + ++DFGLA+ F P++ S+ + T+ Y P+
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV----TLWYRPPD 169
Query: 889 YGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
G + T D++S G + E+ RP
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-10
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK 745
+E+ +VS + K F IGQG+ G VY VA++ +NL+Q+ +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 746 SFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG 805
+ E ++ ++ N++ + GD+ +V +Y+ GSL D + ++ +G
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMD-EG 116
Query: 806 NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
+ + R + A+E+LH + ++H D+K N+LL D ++DFG +
Sbjct: 117 QIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-- 166
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
P Q S+ + GT ++APE D++S GI+ +EM G P
Sbjct: 167 TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ ++ +++LH I++ DLK NVLLD + ++DFG+ K TS+
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI-LGGVTTST-- 155
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
GT Y+APE D ++ G+LL EM G+ P
Sbjct: 156 --FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 6e-10
Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 704 EFSLSNLIGQGSFGFVYRGN---LGEDLLPVAVKVINLKQKGS---IKSFVAECEALKNI 757
E+ N I +G++G VYR GE VA+K + ++++ I S + E L +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGE---IVALKKLKMEKEKEGFPITS-LREINILLKL 61
Query: 758 RHRNLIKI--ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+H N++ + + V S++D + +V +Y+ E L+ + + + +
Sbjct: 62 QHPNIVTVKEVVVGSNLD---KIY--MVMEYV-----EHDLKSLMETMKQPFLQSEVKCL 111
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ + S + +LH + I+H DLK SN+LL++ + + DFGLA+ + P++ +
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLV 167
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
+ T+ Y APE +G T D++S G + E+ T +
Sbjct: 168 V----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 711 IGQGSFG--FVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA--ECEALKNIRHRNLIKII 766
+G+G+FG +YR ED V K +NL + + A E L ++H N+I
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
F D+ + +Y G+L D + + Q+ L + SA+ Y+
Sbjct: 66 N-----HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSAVSYI 117
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
H + I+H D+K N+ L + + DFG++K L E S + + GT Y++
Sbjct: 118 H---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS----EYSMAE-TVVGTPYYMS 169
Query: 887 PEYGMGGNVSLTGDVYSFGILLLEMFTGRR 916
PE G + D+++ G +L E+ T +R
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 703 NEFSLSNLIGQGSFGFVY---RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKN 756
+F + +GQG +G V+ + + GE VA+K + L + ++ + E + L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ----R 812
+ L+K++ F+ D++ L +Y+ G L NL ++ R
Sbjct: 58 TKSEWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLN--------NLGVLSEDHAR 104
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
+ ++ A++ LH + +H DLKP N L+D ++DFGL+K
Sbjct: 105 FYM-AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--------GIV 152
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ + + G+ Y+APE G T D +S G +L E G P
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-10
Identities = 76/286 (26%), Positives = 117/286 (40%), Gaps = 52/286 (18%)
Query: 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEA 753
A + ++ +S ++G G+ G V D P AVKV++++ + AE
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFK--------ALVYDYMQSGSLEDWLQQSNDQVDG 805
L N +++K C DF D + ALV DY +G L Q+ +
Sbjct: 85 LLNCDFFSIVK----CHE-DFAKKDPRNPENVLMIALVLDYANAGDLR---QEIKSRAKT 136
Query: 806 NLNLIQR----LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
N + L I + +A +HH ++H D+K +N+LL + + + DFG +K
Sbjct: 137 NRTFREHEAGLLFIQVLLA-----VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 862 FLFDRPIQETSSSSIG--IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
T S +G GT YVAPE S D++S G+LL E+ T +RP
Sbjct: 192 MY-----AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF- 245
Query: 920 TMFNDGLTLHGFVKMAL------------PEKVMEIVDFALLLDPG 953
DG + + L PE + EIV L DP
Sbjct: 246 ----DGENMEEVMHKTLAGRYDPLPPSISPE-MQEIVTALLSSDPK 286
|
Length = 496 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 11/101 (10%)
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI- 876
++ +E LH + V+ DLKP N+LLD +SD GLA ++ SI
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-------VKIPEGESIR 159
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G GTVGY+APE +L+ D + G L+ EM G+ P
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 44/139 (31%), Positives = 67/139 (48%), Gaps = 26/139 (18%)
Query: 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRL------NISIDVASAIEYLHHHCQPPIVHGD 838
++M GSL DQV L R+ ISI V + YL + I+H D
Sbjct: 79 EHMDGGSL--------DQV---LKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRD 125
Query: 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLT 898
+KPSN+L++ + DFG++ L D S + GT Y++PE G + ++
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSGQLID-------SMANSFVGTRSYMSPERLQGTHYTVQ 178
Query: 899 GDVYSFGILLLEMFTGRRP 917
D++S G+ L+EM GR P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKII 766
L+G+G+FG V A+K++ + K + + E LKN RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
F+ D V +Y+ G L + S ++V + + ++ SA++YL
Sbjct: 61 ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV---FSEDRTRFYGAEIVSALDYL 111
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK---GTVG 883
H IV+ DLK N++LD D ++DFGL K E + + +K GT
Sbjct: 112 H---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--------EGITDAATMKTFCGTPE 160
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL 926
Y+APE + D + G+++ EM GR P + ++ L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIIT-- 767
+IG+G FG VY + A+K ++ K+ IK E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALN---ERIMLSLVSTG 54
Query: 768 -----VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
VC S F D + + D M G L L Q + + + ++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILG 109
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-KFLFDRPIQETSSSSIGIKGT 881
+E++H+ +V+ DLKP+N+LLD +SD GLA F +P +S+ GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GT 158
Query: 882 VGYVAPE-YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GY+APE G + D +S G +L ++ G P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+GS+ VY+G L L VA+K I L+ +G+ + + E LK+++H N I+T
Sbjct: 13 LGEGSYATVYKGRSKLTGQL--VALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVT 67
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN-------LIQRLNISIDVA 820
+ I LV++Y+ + L+Q D G L+ L Q L
Sbjct: 68 LHDII--HTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQLLR------ 114
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ Y H ++H DLKP N+L+ ++DFGLA+ P + S+ +
Sbjct: 115 -GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV---- 165
Query: 881 TVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRR--PTHTMFNDGLTL 928
T+ Y P+ +G S + D++ G + EM TGR P T D L
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 22/232 (9%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK 745
+E+ +VS + K F IGQG+ G VY VA+K +NL+Q+ +
Sbjct: 5 LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE 61
Query: 746 SFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG 805
+ E ++ ++ N++ + GD+ +V +Y+ GSL D + ++ +G
Sbjct: 62 LIINEILVMRENKNPNIVNYLDSY----LVGDEL-WVVMEYLAGGSLTDVVTETCMD-EG 115
Query: 806 NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
+ + R + A+++LH + ++H D+K N+LL D ++DFG +
Sbjct: 116 QIAAVCR-----ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-- 165
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
P Q S+ + GT ++APE D++S GI+ +EM G P
Sbjct: 166 TPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKII 766
++G+GSFG V L E AVKV+ + Q ++ + E L R+ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN--DQVDGNLNLIQRLNISIDVASAIE 824
C F+ D V +++ G L +Q+S D+ + ++ SA+
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALM 110
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
+LH I++ DLK NVLLDH+ ++DFG+ K I ++S GT Y
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTST-FCGTPDY 162
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+APE + D ++ G+LL EM G P
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 24/196 (12%)
Query: 731 VAVKVI---NLKQKGSIKSFVAECEALKNIRHRNLIKIIT--VCSSIDFKGDDFKALVYD 785
VA+K++ +++ F E + H N++ ++ V++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA------PPGLLFAVFE 59
Query: 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845
Y+ +L + L DG L + + + V A+ H+ IVH DLKP N++
Sbjct: 60 YVPGRTLREVLAA-----DGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIM 111
Query: 846 L---DHDMVAHVSDFGLAKFLFD-RPIQETSSSSIG-IKGTVGYVAPEYGMGGNVSLTGD 900
+ A V DFG+ L R + + + GT Y APE G V+ D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 901 VYSFGILLLEMFTGRR 916
+Y++G++ LE TG+R
Sbjct: 172 LYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA--LKNIRHRN 761
+ ++G+GS+G V D +K +NL+ + AE EA L ++H N
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
I+ S + D +V + + G L L++ ++ L Q + + +A
Sbjct: 61 ---IVAYRESWE-GEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAM 113
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
A++YLH + I+H DLK NV L + V D G+A+ L ++ + +S+ I GT
Sbjct: 114 ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLI---GT 165
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
Y++PE + DV++ G + EM T
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHR 760
+F + +IG+G+FG V L A+K++N + ++ F E + L N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN--LIQRLNISID 818
+ + F+ ++ LV DY G L L + D++ ++ + + I+ID
Sbjct: 62 WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG-LAKFLFDRPIQETSSSSIG 877
++ LH+ VH D+KP N+L+D + ++DFG K + D +Q SS+
Sbjct: 117 ---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ----SSVA 163
Query: 878 IKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y++PE G D +S G+ + EM G P
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-------HRNLI 763
+G G+FG VY E VA+K K K S+ EC L+ ++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
K+ V F+ +D V++YM+ G+L Q D+ + +I + +
Sbjct: 62 KLKEV-----FRENDELYFVFEYME-GNL---YQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867
++H H H DLKP N+L+ V ++DFGLA+ + RP
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 711 IGQGSFGFVYRG---NLGEDL----LPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI 763
+GQG+F +++G +G+ V +KV++ + +SF + + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
VC GD+ +V +Y++ GSL+ +L+++ + + N+ +L ++ +A A+
Sbjct: 63 LNYGVCVC----GDE-SIMVQEYVKFGSLDTYLKKNKNLI----NISWKLEVAKQLAWAL 113
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
+L + HG++ NVLL + + K L D I T + +
Sbjct: 114 HFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLERIP 169
Query: 884 YVAPE-YGMGGNVSLTGDVYSFGILLLEMFTG 914
+V PE N+SL D +SFG L E+F+G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
S + NL L ++L N L I +EL L+ L L LD N+ + P SNL
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
+ N + +P+ + L+NL+++ N L+ LP + N+S L L + NK+
Sbjct: 144 ELDLSDNKIE-SLPSPLRNL-PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-S 199
Query: 212 IIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKL 271
+P + L L L ++ N+ +L + N+ +L + L N+ E LP +IG NL L
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIG-NLSNL 257
Query: 272 KILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
+ L + N + S S + +NL L+LSGN S
Sbjct: 258 ETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 28/225 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
++F + +IG+G+FG V + A+K++N + ++ F E L N
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--- 57
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
+ IT F+ +++ LV DY G L L + D++ ++ R I+ ++
Sbjct: 58 -GDCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYIA-EM 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG-LAKFLFDRPIQETSSSSIGI 878
AI +H Q VH D+KP NVLLD + ++DFG K D +Q SS+ +
Sbjct: 112 VLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ----SSVAV 164
Query: 879 KGTVGYVAPEY------GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE GM G D +S G+ + EM G P
Sbjct: 165 -GTPDYISPEILQAMEDGM-GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLLP---VAVK-VINLKQKGSIKS-----------FVA-- 749
+G+G++G V + D L VA+K V ++ + F
Sbjct: 13 KGAHLGEGTYGKVEKA---YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 750 ECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNL 809
E + + I+H N++ ++ V + DF LV D M S D + + ++ L
Sbjct: 70 ELKIMNEIKHENIMGLVDV-----YVEGDFINLVMDIMAS----DLKKVVDRKI--RLTE 118
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
Q I + + + + LH +H DL P+N+ ++ + ++DFGLA+ P
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 870 ETSSSSIGIKG---------TVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGR 915
+T S ++ T+ Y APE MG D++S G + E+ TG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+++ + A+ YL ++H D+KPSN+LLD + DFG++ L D S +
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD------SKA 170
Query: 875 SIGIKGTVGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
G Y+APE + DV+S GI L+E+ TG+ P
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 711 IGQGSFGFVYRG-NLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIR---HRNLIK 764
IG+G++G V++ +L VA+K + ++ ++G S + E L+++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------VDGNLNLIQRLNISI 817
+ VC+ + LV++++ L +L + + D L++ L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL---- 123
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++LH H +VH DLKP N+L+ ++DFGLA+ Q +S +
Sbjct: 124 ------DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV- 170
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T+ Y APE + + + D++S G + EMF R+P
Sbjct: 171 --VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN-------I 757
+ + IG+GSFG +Y D +K I+L K V E EA K +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLT-----KMPVKEKEASKKEVILLAKM 56
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+H N I+T +S G F +V +Y G D +++ N Q + Q L+ +
Sbjct: 57 KHPN---IVTFFASFQENGRLF--IVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFV 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSI 876
++ ++++H I+H D+K N+ L + MVA + DFG+A+ L D E + + +
Sbjct: 109 QISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCV 163
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE + D++S G +L E+ T + P
Sbjct: 164 ---GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 18/135 (13%)
Query: 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH--HHCQPPIVHGDLKPS 842
++M GSL+ ++ G + + I++ V + YL+ H I+H D+KPS
Sbjct: 83 EFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR----IMHRDIKPS 133
Query: 843 NVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVY 902
N+L++ + DFG++ L + I +T GT Y++PE GG ++ DV+
Sbjct: 134 NILVNSRGQIKLCDFGVSGELINS-IADT------FVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 903 SFGILLLEMFTGRRP 917
S GI ++E+ G+ P
Sbjct: 187 SLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 56/210 (26%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G++ V++G L E+L VA+K I L+ ++G+ + + E LK+++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI-DVASAIEYL 826
+ + D LV++Y L+ L+Q D GN+ + + I + + + Y
Sbjct: 72 IVHT-----DKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYC 120
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
H ++H DLKP N+L++ ++DFGLA+ P + S+ + T+ Y
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV----TLWYRP 172
Query: 887 PEYGMGGN-VSLTGDVYSFGILLLEMFTGR 915
P+ +G + S D++ G + EM +GR
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/209 (25%), Positives = 107/209 (51%), Gaps = 24/209 (11%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G++ VY+G L ++L VA+K I L+ ++G+ + + E LK+++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL--VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
+ + + LV++Y+ L+ +L D N I N+ + + + L+
Sbjct: 72 IIHT-----EKSLTLVFEYLDK-DLKQYL-------DDCGNSINMHNVKLFLFQLLRGLN 118
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
+ + ++H DLKP N+L++ ++DFGLA+ P + S+ + T+ Y P
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV----TLWYRPP 173
Query: 888 EYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
+ +G + S D++ G + EM TGR
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKII 766
L+G+G+FG V A+K++ + K + V E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI-SIDVASAIEY 825
F+ D V +Y G L + S ++V +R ++ SA+EY
Sbjct: 61 ----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTE----ERARFYGAEIVSALEY 110
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK---GTV 882
LH +V+ D+K N++LD D ++DFGL K E S +K GT
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTP 159
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y+APE + D + G+++ EM GR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK---SFVAECEALKNIRHRNLIKIIT 767
IG G FG V G + V V L+ + F+ E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 768 VC-SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
C SI + LV ++ G L+++L+ + V ++ +VAS + +L
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS-SIGIKGTVGYV 885
H Q +H DL N L D+ + D+GLA + T ++ ++ +
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 886 APEYG---MGGNVSLTGDVYSFGILLLEMFT-GRRP 917
G + + + +++S G+ + E+FT +P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHRNLIKIITV 768
+G G++G V VA+K + + + K E LK+++H N+I ++ V
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 769 CSSIDFKGDDFKA--LVYDYMQS--GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ D D F LV +M + G L + S D+ IQ L + ++
Sbjct: 83 FTP-DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-------IQFLVYQM--LKGLK 132
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
Y+H I+H DLKP N+ ++ D + DFGLA+ +T S G T Y
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVTRWY 181
Query: 885 VAPEYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
APE + + + T D++S G ++ EM TG+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIIT--- 767
IG+GSFG V + + A+K I +K I V+ E + R ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI---RKAHI---VSRSEVTHTLAERTVLAQVNCPF 54
Query: 768 -VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
V F+ + LV ++ G L LQ+ +G +L + + ++ A+E L
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENL 109
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
H + +++ DLKP N+LLD+ + DFGL K + GT Y+A
Sbjct: 110 H---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDKTNTFCGTPEYLA 161
Query: 887 PEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
PE +G + D ++ G+LL EM TG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
S +++ A+ YLH + I++ DLK NVLLD + ++D+G+ K RP TS+
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTST-- 155
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G + + D ++ G+L+ EM GR P
Sbjct: 156 --FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 8e-09
Identities = 24/41 (58%), Positives = 26/41 (63%), Gaps = 2/41 (4%)
Query: 33 NETDRVALLAIKSQLQ-DPMGITSSWN-NSINVCQWTGVTC 71
DR ALLA KS L DP G SSWN +S + C WTGVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
S +++ A+ +LH + I++ DLK NVLLD + ++D+G+ K RP TS+
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-- 155
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G + + D ++ G+L+ EM GR P
Sbjct: 156 --FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 26/242 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLP---VAVKVINLKQKGSIKSFVAECEALKNIRHR 760
E+ + LIG G FG VY D K+ NL+ + + V E NI
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68
Query: 761 NLIKIITVCSSIDFKG-------DDFK--ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ 811
+ I + +ID G FK + Y ++ LE ++ + + +
Sbjct: 69 DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNK 125
Query: 812 RL--NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF--DRP 867
+L NI D+ + +EY+H H I HGD+KP N+++D + ++ D+G+A +
Sbjct: 126 KLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182
Query: 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927
I+ + +GT+ Y + G V+ GD+ S G +L+ + P ++G
Sbjct: 183 IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242
Query: 928 LH 929
+H
Sbjct: 243 IH 244
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNI-RHRN 761
F L L+G G++G VY+G + A+KV+++ ++ IK E LK HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRN 64
Query: 762 LIKIITVCSSIDFKG-DDFKALVYDYMQSGSLEDWLQQSNDQVDGN-LNLIQRLNISIDV 819
+ + G DD LV ++ +GS+ D ++ + GN L I ++
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREI 120
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
+ +LH H ++H D+K NVLL + + DFG++ L DR + ++
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNT----FI 172
Query: 880 GTVGYVAPEY-----GMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT ++APE D++S GI +EM G P M
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKII 766
L+G+G+FG V A+K++ + K + + E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI-SIDVASAIEY 825
F+ D V +Y G L + S ++V R ++ SA++Y
Sbjct: 61 ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSE----DRARFYGAEIVSALDY 110
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
LH + +V+ DLK N++LD D ++DFGL K I++ ++ GT Y+
Sbjct: 111 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKT-FCGTPEYL 163
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
APE + D + G+++ EM GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIKIIT 767
+G+G FG V + A K ++ LK+K K + E E L+ + N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
+ + + K LV M G L+ + ++ L + + ++ S + I +LH
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLH 112
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD-RPIQETSSSSIGIKGTVGYVA 886
IV+ D+KP NVLLD +SD GLA L D + I + + GT GY+A
Sbjct: 113 ---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-------GTNGYMA 162
Query: 887 PEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
PE S D ++ G + EM GR P
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVC 769
+G+GS+ VY+G + VA+KVI L+++ G+ + + E LK ++H N++ + +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
+ + LV++Y+ + L Q D+ G L+ + + Y+H
Sbjct: 73 HT-----KETLTLVFEYVHTD-----LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-- 120
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY 889
Q I+H DLKP N+L+ ++DFGLA+ P S+ + T+ Y P+
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV----TLWYRPPDV 174
Query: 890 GMGGN-VSLTGDVYSFGILLLEMFTG 914
+G S D++ G + +EM G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 13/136 (9%)
Query: 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841
LV +Y+ G L +Q+ + + + ++ A+ +LH + I++ DLK
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFY-----AAEICIALNFLH---ERGIIYRDLKL 124
Query: 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDV 901
NVLLD D ++D+G+ K P TS+ GT Y+APE G + D
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGL-GPGDTTST----FCGTPNYIAPEILRGEEYGFSVDW 179
Query: 902 YSFGILLLEMFTGRRP 917
++ G+L+ EM GR P
Sbjct: 180 WALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 51/279 (18%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHRNLIKIITVC 769
+G G+ G VY+ +AVKVI L + K ++E E I+ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE------------ILYKC 56
Query: 770 SS---IDFKGDDFK----ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
S I F G F ++ ++M GSL D ++ + V G I++ V
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLGR--------IAVAVVKG 107
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ YL I+H D+KPSN+L++ + DFG++ Q +S + GT
Sbjct: 108 LTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-------QLVNSIAKTYVGTN 157
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
Y+APE G + DV+S GI +E+ GR P + + G + +P ++++
Sbjct: 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN----QGSL---MPLQLLQ 210
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
+ +D + + V C + P ER
Sbjct: 211 CI-----VDEDPPVLPVGQFSEKFVHFITQCMRKQPKER 244
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 711 IGQGSFGFVYR------GNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNL 762
IG+G++G VY+ G L VA+K L+ ++G + + E L+ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKL------VALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 763 I-KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN---LNLIQRLNISID 818
I +++ V + G LV++Y+ S L+ ++ SN + G I+ +
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMD-SNGRGPGRPLPAKTIKSFMYQLL 120
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSIG 877
A + H H ++H DLKP N+L+D + ++D GL + F P++ + +
Sbjct: 121 KGVA--HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV- 173
Query: 878 IKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTG 914
T+ Y APE +G + S D++S G + EM
Sbjct: 174 ---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 807 LNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
L+L L S VA +++L +C +H D+ NVLL VA + DFGLA
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLA----- 259
Query: 866 RPIQETSSSSIGIKGT----VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920
R I + S+ +KG V ++APE ++ DV+S+GILL E+F+ G+ P
Sbjct: 260 RDIM--NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 921 MFNDGLTLHGFVKMALPEKVMEIVDFALL 949
+ + F KM M DFA
Sbjct: 318 ILVN----SKFYKMVKRGYQMSRPDFAPP 342
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 705 FSLSNLIGQGSFG--FVYRGNLGEDLLPV-AVKVIN----LKQKGSIKSFVAECEALKNI 757
F L ++G G++G F+ R G D + A+KV+ +++ + + E + L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ-RLNIS 816
R + V F+ D L+ DY+ G L L Q + + R+ I+
Sbjct: 62 RRCPFL----VTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIA 112
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
++ A+++LH Q I++ D+K N+LLD + ++DFGL+K F +E + S
Sbjct: 113 -EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK-EFLAEEEERAYS-- 165
Query: 877 GIKGTVGYVAPEY---GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+APE G GG+ D +S G+L E+ TG P
Sbjct: 166 -FCGTIEYMAPEVIRGGSGGHDKAV-DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 60/237 (25%), Positives = 101/237 (42%), Gaps = 21/237 (8%)
Query: 693 VSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECE 752
+ + L F L ++G G++G VY+G + A+KV+++ + + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEIN 64
Query: 753 ALKNI-RHRNLIKIITVCSSIDFKG-DDFKALVYDYMQSGSLEDWLQQSNDQVDGN-LNL 809
LK HRN+ G DD LV ++ +GS+ D ++ + GN L
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK----GNALKE 120
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
I ++ + +LH H ++H D+K NVLL + + DFG++ L DR +
Sbjct: 121 DWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVG 176
Query: 870 ETSSSSIGIKGTVGYVAPEY-----GMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
++ GT ++APE D++S GI +EM G P M
Sbjct: 177 RRNT----FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 11/101 (10%)
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD-RPIQETSSSSI 876
++ +E LH IV+ DLKP N+LLD +SD GLA + + I+
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR------- 159
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G GTVGY+APE + + D + G L+ EM G+ P
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 61/234 (26%), Positives = 91/234 (38%), Gaps = 59/234 (25%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVI--NLKQKGSIKSFVAECEALKN 756
TN + +G G+FG V D L VA+K I K E + LK+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSA---RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 757 IRHRNLIKIITVCSS--------IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN 808
+RH N+I + + S + G D L + S LE
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEK-------------Q 108
Query: 809 LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI 868
IQ I ++Y+H +VH DLKPSN+L++ + + DFGLA+ I
Sbjct: 109 FIQYFLYQI--LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR------I 157
Query: 869 QETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-------DVYSFGILLLEMFTGR 915
Q+ + GYV+ Y + LT D++S G + EM G+
Sbjct: 158 QDPQMT--------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
A+E+LH I++ DLKP N+LLD ++DFGL K I E + + GT
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHT-FCGT 163
Query: 882 VGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ Y+APE G G V D +S G L+ +M TG P
Sbjct: 164 IEYMAPEILMRSGHGKAV----DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 30/235 (12%)
Query: 691 PMVSYAELNKATNEF--SLSNL--IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-- 744
P ELNK E NL +G G++G V + L VAVK ++ + I
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 745 KSFVAECEALKNIRHRNLIKIITVCS-SIDFKGDDFKALVYDYMQS--GSLEDWLQQSND 801
K E LK+++H N+I ++ V + + + + LV M + ++ + ++D
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
V + I R ++Y+H I+H DLKPSN+ ++ D + DFGLA+
Sbjct: 121 HVQFLIYQILR---------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
Query: 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
T G T Y APE + + + T D++S G ++ E+ TGR
Sbjct: 169 --------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 25/193 (12%)
Query: 735 VINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLED 794
VI Q+G E L+ I H ++I++ F + F L+ ++ L
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILPRYKT-DLYC 171
Query: 795 WLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
+L N+ + L I V AI+YLH + I+H D+K N+ ++H +
Sbjct: 172 YLAAKR-----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL 223
Query: 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG 914
DFG A F P+ ++ G GT+ APE D++S GI+L EM T
Sbjct: 224 GDFGAACF----PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 915 RRPTHTMFN-DGL 926
++F DGL
Sbjct: 280 H---DSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 775 KGDDFKALVYDY--MQSGSLEDWLQQ--SNDQVDGNLNLIQRLNISIDVASAIEYL-HHH 829
K D + YD GS + ++ S+D +G L + L+ + VA +E+L +
Sbjct: 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKN 257
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLFDRPIQETSSSSIGIKGTVGYVAPE 888
C VH DL NVLL + + DFGLA+ + D S+ + +K ++APE
Sbjct: 258 C----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPE 309
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947
+ DV+S+GILL E+F+ G P M D T + +K
Sbjct: 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYNKIK-------------- 354
Query: 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSER---IHMADAVKNL 991
G AK + V I V C P +R +H++D V++L
Sbjct: 355 ----SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 731 VAVKVINL-KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS 789
VAVKV+ + + F+ E + L + N+ +++ VC+ D ++ +YM++
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMEN 103
Query: 790 GSLEDWLQQSNDQVDGNLNLIQR-------LNISIDVASAIEYLHHHCQPPIVHGDLKPS 842
G L +LQ+ L + L ++ +AS + YL VH DL
Sbjct: 104 GDLNQFLQKHVA-ETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 843 NVLLDHDMVAHVSDFGLAKFLFDR-----------PIQETSSSSIGIKGTVGYVAPEYGM 891
N L+ + ++DFG+++ L+ PI+ + S+ +
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV--------------L 205
Query: 892 GGNVSLTGDVYSFGILLLEMFT-GRRPTH 919
G + DV++FG+ L E+ T R +
Sbjct: 206 LGKFTTKSDVWAFGVTLWEILTLCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 30/226 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
++F + +IG+G+FG V + A+K++N + ++ F E + L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
R + + F+ ++ LV DY G L L + D++ ++ R ++ ++
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLA-EM 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFG-LAKFLFDRPIQETSSSSI 876
AI+ +H Q VH D+KP NVLL D H+ +DFG + L D +Q S++
Sbjct: 112 VLAIDSVH---QLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQ----SNV 162
Query: 877 GIKGTVGYVAPEY--GMGGNVSLTG---DVYSFGILLLEMFTGRRP 917
+ GT Y++PE M G D +S G+ + EM G P
Sbjct: 163 AV-GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 711 IGQGSFGFV---YRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKI 765
IG G++G V G+ VA+K I K + E + L++ +H N+I I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKK---VAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 766 ITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLN--LIQRLNISIDVAS 821
+ G DFK +V D M+S L + + ++ L Q L
Sbjct: 70 RDILRP---PGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
++Y+H ++H DLKPSN+L++ D + DFG+A+ L P + + + T
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-AT 174
Query: 882 VGYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y APE + + D++S G + EM GRR
Sbjct: 175 RWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 33/84 (39%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG 893
IV+ DLKP N+LLD +SD GLA + P ET +G TVGY+APE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVRGRVG---TVGYMAPEVINNE 176
Query: 894 NVSLTGDVYSFGILLLEMFTGRRP 917
+ + D + G L+ EM G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 705 FSLSNL-----IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIR 758
F+ +L IG+G+FG V + +AVK I K + + + + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 759 HRNLIKIIT------------VCSSI-DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG 805
+ I+ +C + D D F VY+ ++S E+ L +
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------- 111
Query: 806 NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
I++ A+ YL + I+H D+KPSN+LLD + + DFG++ L D
Sbjct: 112 ---------IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160
Query: 866 RPIQETSSSSIGIKGTVGYVAPE-----YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
I +T + G Y+APE G +V DV+S GI L E+ TG+ P
Sbjct: 161 S-IAKTRDA-----GCRPYMAPERIDPSARDGYDVR--SDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF---VAECEALKNIRHRNLIKIIT 767
IG GSFG VY VAVK ++ K + + + + E + L+ ++H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE--- 824
+I++KG K ++ +E L ++D ++ + +Q + I+ A++
Sbjct: 83 ---TIEYKGCYLK----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH H ++H D+K N+LL ++DFG A SS + GT +
Sbjct: 136 YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA---------SKSSPANSFVGTPYW 183
Query: 885 VAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+APE + G DV+S GI +E+ + P M
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVC- 769
+G GS G V+ + VAVK I L S+K + E + ++ + H N++K+ V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 770 -SSIDFKGD-----DFKAL--VYDYMQSGSLEDWLQQ---SNDQVDGNLNLIQRLNISID 818
S D D + ++ V +YM++ L + L+Q S + L + Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHA--RLFMYQLLR---- 125
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++Y+H ++H DLKP+NV ++ D+V + DFGLA+ + D S G
Sbjct: 126 ---GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEG 178
Query: 878 IKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGR 915
+ T Y +P + N + D+++ G + EM TG+
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 6e-08
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 36/169 (21%)
Query: 759 HRNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
H N++K++ V K ++ K LV++YM++ +L+ + R NI
Sbjct: 66 HPNIVKLLNV-----IKAENDKDIYLVFEYMET----------------DLHAVIRANIL 104
Query: 817 IDV---------ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867
DV A++Y+H ++H DLKPSN+LL+ D ++DFGLA+ L +
Sbjct: 105 EDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
+ T Y APE +G G D++S G +L EM G+
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRN 761
+ + IG+G++G V + VA+K I+ Q ++ + E + L+ +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 762 LIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ--SNDQVDGNLNLIQRLNISI 817
+I I+ + F + F +V + M++ + Q SND + L I R
Sbjct: 65 IIGILDIIRPPSF--ESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++Y+H ++H DLKPSN+LL+ + + DFGLA R +
Sbjct: 118 ----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA-----RIADPEHDHTGF 165
Query: 878 IKGTVG---YVAPEYGMGGNVSLTG-------DVYSFGILLLEMFTGR 915
+ V Y APE + L D++S G +L EM + R
Sbjct: 166 LTEYVATRWYRAPE------IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 54/268 (20%)
Query: 704 EFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHR 760
+F L IG G++G VY+ N GE A+KVI L+ E +K+ +H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGE---LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ + D + ++ GSL+D V G L+ Q +S +
Sbjct: 67 NIVAYFG-----SYLRRDKLWICMEFCGGGSLQDIYH-----VTGPLSESQIAYVSRETL 116
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YLH + +H D+K +N+LL + ++DFG++ I T + G
Sbjct: 117 QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA-----QITATIAKRKSFIG 168
Query: 881 TVGYVAPEYGM----GGNVSLTGDVYSFGILLLEMFTGRRPT---HTM------------ 921
T ++APE GG L D+++ GI +E+ + P H M
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLC-DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ 227
Query: 922 ---FNDGL----TLHGFVKMAL---PEK 939
D + + H FVKMAL P+K
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMALTKNPKK 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKN--IRHR 760
+F+ ++G+GSFG V G D L A+K+ LK+ I+ EC ++ + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDEL-YAIKI--LKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
+ +T S F+ D V +Y+ G L +QQ G Q + + +++
Sbjct: 58 DKPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEIS 111
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLFDRPIQETSSSSIGIK 879
+ +LH + I++ DLK NV+LD + ++DFG+ K + D T
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT------FC 162
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + D +++G+LL EM G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 45/197 (22%), Positives = 92/197 (46%), Gaps = 28/197 (14%)
Query: 730 PVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDY 786
PV V V L++ K + F+ E + + ++ N+I+++ VC + D ++ +Y
Sbjct: 46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEY 100
Query: 787 MQSGSLEDWL---QQSNDQVDGNLNLIQR---LNISIDVASAIEYLHHHCQPPIVHGDLK 840
M++G L +L + ++ I + ++ +AS ++YL VH DL
Sbjct: 101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLA 157
Query: 841 PSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG----TVGYVAPEYGMGGNVS 896
N L+ + ++DFG+++ L+ S I+G + +++ E + G +
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFT 210
Query: 897 LTGDVYSFGILLLEMFT 913
DV++FG+ L E+ T
Sbjct: 211 TASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 31/88 (35%), Positives = 52/88 (59%), Gaps = 2/88 (2%)
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRL 260
LG+ L G IP + +LR L ++++ N+ G +PP +I+SLE + L N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 261 PLNIGFNLPKLKILIVGQNNLTGSIPQS 288
P ++G L L+IL + N+L+G +P +
Sbjct: 483 PESLG-QLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF---VAECEALKNIRHRNLIKIIT 767
IG GSFG VY VA+K ++ K S + + + E + L+ I+H N
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN------ 86
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE--- 824
SI++KG + ++ +E L ++D ++ + +Q + I+ A++
Sbjct: 87 ---SIEYKG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH H ++H D+K N+LL ++DFG A +S + GT +
Sbjct: 140 YLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI---------ASPANSFVGTPYW 187
Query: 885 VAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+APE + G DV+S GI +E+ + P M
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 41/198 (20%)
Query: 735 VINLKQKGSIKSFVAECEALKNIRHRNLIKI--------ITVCSSIDFKGDDFKALVYDY 786
V+ + QKG+ + E L+N+ H ++I++ IT + D +Y Y
Sbjct: 95 VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-----LYTY 146
Query: 787 MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846
+ L + Q L I + + YLH I+H D+K N+ +
Sbjct: 147 LTKR-------------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFI 190
Query: 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGI 906
+ + D G A+F P + +G+ GTV APE + D++S GI
Sbjct: 191 NDVDQVCIGDLGAAQFPVVAP------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGI 244
Query: 907 LLLEMFTGRRPTHTMFND 924
+L EM P T+F D
Sbjct: 245 VLFEMLA--YP-STIFED 259
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVC 769
+G+G++G VY+ + +A+K I L+ + + E + L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 770 SSIDFKGDDF-KALVY---DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
+DF G F + VY +YM +GSL+ ++++R I+ V +++
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKF 117
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
L I+H D+KP+NVL++ + + DFG++ L + + ++IG + Y+
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL----VASLAKTNIGCQ---SYM 168
Query: 886 APEY----GMGGNVSLT--GDVYSFGILLLEMFTGRRP 917
APE G N + T DV+S G+ +LEM GR P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 705 FSLSNLIGQGSFGFVYRGNL--GEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRH 759
+ + IG+G++G VY+ G+D A+K + G +S E L+ ++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI-SI- 817
N++ ++ V D L++DY + D Q I + S+
Sbjct: 62 ENVVSLVEVFLE---HADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 818 -DVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETS 872
+ + + YLH + ++H DLKP+N+L+ V + D GLA+ LF+ P++
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAPLK-PL 169
Query: 873 SSSIGIKGTVGYVAPEYGMG 892
+ + T+ Y APE +G
Sbjct: 170 ADLDPVVVTIWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 2/86 (2%)
Query: 182 ENQ-LTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLP-P 239
+NQ L G +P I + LQ + + N + G IP SLG + L L ++ N+F+G +P
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIG 265
+ ++SL ++L N GR+P +G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 39/115 (33%), Positives = 57/115 (49%), Gaps = 17/115 (14%)
Query: 813 LNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
L+ S VA + +L +C +H DL N+LL H + + DFGLA R I
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLA-----RDI--R 265
Query: 872 SSSSIGIKGT----VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921
+ S+ +KG V ++APE + DV+S+GILL E+F+ G P M
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 27/214 (12%)
Query: 710 LIGQGSFGFVY--RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHRNLIK 764
L+G+G+FG V R A+K++ + K + + E L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYY--AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI-SIDVASAI 823
+ F+ D V +Y G L + S ++V R ++ SA+
Sbjct: 60 L-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSE----DRARFYGAEIVSAL 108
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
YLH +V+ DLK N++LD D ++DFGL K I + ++ GT
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKT-FCGTPE 160
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y+APE + D + G+++ EM GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 710 LIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEAL-KNI-----RHRNL 762
++G+GSFG V L G D + A+KV LK+ ++ +C K I +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEV-YAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+ F+ D V +Y+ G L +Q+S + D + + +V A
Sbjct: 59 TAL---HCC--FQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRF----YAAEVTLA 108
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ +LH H +++ DLK N+LLD + ++DFG+ K + T+ GT
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-----FCGTP 160
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y+APE + D ++ G+L+ EM G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 40/234 (17%)
Query: 697 ELNKATNEF-----SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVA 749
ELNK E +LS +G G++G V + VA+K ++ + +I K
Sbjct: 5 ELNKTVWEVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 750 ECEALKNIRHRNLIKIITV----CSSIDFKGDDFKALVYDYMQSGSLEDWLQQ---SNDQ 802
E LK++ H N+I ++ V S DF D LV M + L + ++ S+D
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDF--QDV-YLVTHLMGA-DLNNIVKCQKLSDDH 119
Query: 803 VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+ + I R ++Y+H I+H DLKPSN+ ++ D + DFGLA+
Sbjct: 120 IQFLVYQILR---------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR- 166
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGR 915
T G T Y APE + + + T D++S G ++ E+ TG+
Sbjct: 167 -------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA--ECEALKNIRHRNLIKIITV 768
IG+GSFG ED +K IN+ + + + E L N++H N I+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---IVQY 64
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
S + G+ + +V DY + G D ++ N Q Q L+ + + A++++H
Sbjct: 65 QESFEENGNLY--IVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
I+H D+K N+ L D + DFG+A+ L E + + I GT Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCI---GTPYYLSPE 171
Query: 889 YGMGGNVSLTGDVYSFGILLLEMFT 913
+ D+++ G +L EM T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 23/153 (15%)
Query: 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS--------IDVASAIE 824
DFK DD L+ +Y G L ++Q L + L + A++
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQ---------RLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
+H ++H DLK +N+ L + + DFG +K D + +SS GT Y
Sbjct: 184 EVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS---FCGTPYY 237
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+APE S D++S G++L E+ T RP
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 40/248 (16%)
Query: 692 MVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAEC 751
M+ L T+ + + IG+G++G VY+ +D AVK+++ I E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEI 65
Query: 752 EALKNI-----RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN-----D 801
EA NI H N++K F G +KA D + G L L+ N +
Sbjct: 66 EAEYNILQSLPNHPNVVK---------FYGMFYKA---DKLVGGQLWLVLELCNGGSVTE 113
Query: 802 QVDGNLNLIQRLN---ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858
V G L QRL+ IS + A+ L H I+H D+K +N+LL + + DFG
Sbjct: 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEY-----GMGGNVSLTGDVYSFGILLLEMFT 913
++ L ++ +S GT ++APE + DV+S GI +E+
Sbjct: 174 VSAQLTSTRLRRNTSV-----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 914 GRRPTHTM 921
G P M
Sbjct: 229 GDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 35/207 (16%)
Query: 725 GEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783
G LL VAVK++ K + F+ E + L ++ N+I+++ VC +D ++
Sbjct: 44 GRPLL-VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMI 97
Query: 784 YDYMQSGSLEDWL---------QQSNDQV--DGNLNLIQR---LNISIDVASAIEYLHHH 829
+YM++G L +L + ND V L I L++++ +AS ++YL
Sbjct: 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--- 154
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG----TVGYV 885
VH DL N L+ ++ ++DFG+++ L+ + I+G + ++
Sbjct: 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY-------AGDYYRIQGRAVLPIRWM 207
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMF 912
A E + G + DV++FG+ L E+
Sbjct: 208 AWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 8e-07
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 35/190 (18%)
Query: 733 VKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSL 792
K+I K +I+ V + +K+ + N IK+ +++ L+ DY++ G L
Sbjct: 46 QKIIKAKNFNAIEPMVHQL--MKD--NPNFIKLYYSVTTLKGH-----VLIMDYIKDGDL 96
Query: 793 EDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV- 851
D L++ +G L+ + I + A+ LH H I+H D+K NVL D
Sbjct: 97 FDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR 148
Query: 852 AHVSDFGLAKFLFDRPIQETSSSSIGIK----GTVGYVAPEYGMGGNVSLTGDVYSFGIL 907
++ D+GL K IG GT+ Y +PE G N ++ D ++ G+L
Sbjct: 149 IYLCDYGLCK-------------IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVL 195
Query: 908 LLEMFTGRRP 917
E+ TG+ P
Sbjct: 196 TYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 44/219 (20%)
Query: 711 IGQGSFGFV---YRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKI 765
IG G+ G V + LG + VAVK ++ + + K E LK + H+N+I +
Sbjct: 29 IGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDW--LQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ V + SLE++ + + +D NL + + + + S +
Sbjct: 86 LNV-----------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 824 EY-----LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
Y + H I+H DLKPSN+++ D + DFGLA+ T+ ++ +
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TACTNFMM 179
Query: 879 KGTV---GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG 914
V Y APE +G D++S G ++ E+ G
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF---VAECEALKNIRHRNLIKIIT 767
IG GSFG VY + VA+K ++ K S + + + E L+ +RH N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN------ 76
Query: 768 VCSSIDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+I ++G + LV +Y L ++D ++ + +Q + I+ A+
Sbjct: 77 ---TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGAL 125
Query: 824 E---YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YLH H ++H D+K N+LL + + DFG A + + + G
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANXFVG 173
Query: 881 TVGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
T ++APE + G DV+S GI +E+ + P M
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+F+ ++G+GSFG V G D L A+K+ LK+ I+ EC + R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDEL-YAIKI--LKKDVVIQDDDVECTM---VEKRVL 54
Query: 763 I-----KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+T S F+ D V +Y+ G L +QQ G + +
Sbjct: 55 ALSGKPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFYAA 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
++A + +LH I++ DLK NV+LD + ++DFG+ K E +
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------ENMWDGVT 157
Query: 878 IK---GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
K GT Y+APE + D ++FG+LL EM G+ P
Sbjct: 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVK-VINLKQKGSIKSF-VAECEALKNIRHRNLIKIITV 768
IG+GS+G V++ E VA+K + + IK + E LK ++H NL+ +I V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH- 827
F+ LV++Y L + + + I A+ + H
Sbjct: 69 -----FRRKRKLHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK 118
Query: 828 HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAP 887
H+C +H D+KP N+L+ + DFG A+ L T + T Y AP
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-----TRWYRAP 169
Query: 888 EYGMGGNVSLTG-DVYSFGILLLEMFTG 914
E +G DV++ G + E+ TG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 50/219 (22%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHR 760
N+F + ++G+G++G V + E VA+K ++ ++ + E + L+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN----DQVDGNLNLIQRLNIS 816
N++++ F+ LV++Y++ LE + N ++V +
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI--------- 106
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ AI + H + IVH D+KP N+L+ H+ V + DFG A+ L + ++++
Sbjct: 107 YQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL----SEGSNANYT 159
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
T Y +PE +G D++S G +L E+ G+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 51/244 (20%)
Query: 697 ELNKATNEFSLS----NLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSI--KSF 747
E+NK E +G G++G V GE VA+K ++ + I K
Sbjct: 5 EVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRA 61
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ------S 799
E LK+++H N+I ++ V +S GD+F+ LV YMQ+ LQ+ S
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAV-SGDEFQDFYLVMPYMQTD-----LQKIMGHPLS 115
Query: 800 NDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
D+V + Q L ++Y+H I+H DLKP N+ ++ D + DFGL
Sbjct: 116 EDKV--QYLVYQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163
Query: 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPT 918
A+ + G T Y APE + + + T D++S G ++ EM TG+
Sbjct: 164 AR--------HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK--- 212
Query: 919 HTMF 922
T+F
Sbjct: 213 -TLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 697 ELNKATNE-FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALK 755
++N++ N+ + L N+IG GSFG VY + VA+K + Q K+ E +K
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMK 114
Query: 756 NIRHRNLIKIITVCSSIDFKGDD---FKALVYDYMQSGSLEDWLQQ--SNDQVDGNLNLI 810
N+ H N+I + + FK ++ F +V +++ ++ +++ N+ L L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNH---ALPLF 170
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQ 869
S + A+ Y+H I H DLKP N+L+D + + DFG AK L
Sbjct: 171 LVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL----- 222
Query: 870 ETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTG 914
S+ + Y APE +G N + D++S G ++ EM G
Sbjct: 223 -AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 10/128 (7%)
Query: 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLL 846
+S S + ++ ++ L L ++ S VA +E+L C +H DL N+LL
Sbjct: 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILL 206
Query: 847 DHDMVAHVSDFGLAKFLFDRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFG 905
+ V + DFGLA+ ++ P + + +K ++APE + DV+SFG
Sbjct: 207 SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFG 262
Query: 906 ILLLEMFT 913
+LL E+F+
Sbjct: 263 VLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 711 IGQGSFGFVYRGNL----GEDL------LPVAVKVINLKQKGSI-KSFVAECEALKNIRH 759
+GQG+F +Y+G L D+ + V +KV L +F + + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQLSH 60
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
++L+K+ VC D +V +Y++ G L+ +L + N++L +L+++ +
Sbjct: 61 KHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQL 110
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-------MVAHVSDFGLAKFLFDRPIQETS 872
ASA+ YL +VHG++ N+L+ +SD G+ + R +
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER 167
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLT--GDVYSFGILLLEMFTG 914
++APE G SLT D +SFG LLE+ +
Sbjct: 168 IP---------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+++ L +G G++G VY+ NL L AVK+I L+ E +K +H N
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGEL-AAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++ + + + +Y GSL+D V G L+ +Q + +
Sbjct: 68 IVAYFG-----SYLSREKLWICMEYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQ 117
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YLH + +H D+K +N+LL + ++DFG+A I T + GT
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGT 169
Query: 882 VGYVAPEYGM---GGNVSLTGDVYSFGILLLEM 911
++APE G + D+++ GI +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 697 ELNKATNEF--SLSNL--IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS--FVAE 750
ELNK E NL +G G++G V VAVK ++ + I + E
Sbjct: 5 ELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE 64
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKA--LVYDYMQS--GSLEDWLQQSNDQVDGN 806
LK+++H N+I ++ V + ++F LV + M + ++ + S++ V
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPAT-SIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQ-- 121
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866
LI +L ++Y+H I+H DLKPSNV ++ D + DFGLA+
Sbjct: 122 -FLIYQL------LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----- 166
Query: 867 PIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGR 915
+ G T Y APE + + + T D++S G ++ E+ G+
Sbjct: 167 ---QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 60/216 (27%), Positives = 84/216 (38%), Gaps = 44/216 (20%)
Query: 714 GSFGFVY----RGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKII--- 766
GS G V+ G+ E V VK + G K+ E + LK I HR +I +I
Sbjct: 103 GSEGEVFVCTKHGD--EQRKKVIVKAVT---GG--KTPGREIDILKTISHRAIINLIHAY 155
Query: 767 ----TVCSSI-DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
TVC + +K D F + D LE + IQR +
Sbjct: 156 RWKSTVCMVMPKYKCDLFTYV--DRSGPLPLEQAI------------TIQR-----RLLE 196
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
A+ YLH I+H D+K N+ LD A + DFG A L P + G GT
Sbjct: 197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP---DTPQCYGWSGT 250
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ +PE D++S G++L EM
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 50/179 (27%)
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
+K + H+N+I ++ V + ++F+ VY M+ L D NL Q +
Sbjct: 69 MKLVNHKNIIGLLNVFTP-QKSLEEFQD-VYLVME---LMD------------ANLCQVI 111
Query: 814 NISID----------VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863
+ +D + I++LH I+H DLKPSN+++ D + DFGLA+
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 166
Query: 864 FDRPIQETSSSSIGIKGTV---GYVAPE--YGMG--GNVSLTGDVYSFGILLLEMFTGR 915
T+ +S + V Y APE GMG NV D++S G ++ EM G
Sbjct: 167 -------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV----DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 40/227 (17%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+F+ ++G+GSFG V G D L A+K+ LK+ I+ EC + R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDEL-YAIKI--LKKDVIIQDDDVECTM---VEKRVL 54
Query: 763 I-----KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+T S F+ D V +Y+ G L +QQ G + +
Sbjct: 55 ALPGKPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAA 108
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLFDRPIQETSSSSI 876
++A + +LH I++ DLK NV+LD + ++DFG+ K +F T
Sbjct: 109 EIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----- 160
Query: 877 GIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE YG + D ++FG+LL EM G+ P
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK---FLFDRPIQETSSSS 875
V ++YLH + IV+ DLK N+LLD + ++DFGL K DR TS+
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TST-- 160
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT ++APE + + D + G+L+ EM G P
Sbjct: 161 --FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 750 ECEALKNIRHRNLIKIITVCSSIDFK---GDDFKALVYDYMQSGSLEDWLQQSNDQVDGN 806
E AL + H N++KI + S + +Y +M + DW D
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-DW-------KDRP 264
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866
L L Q I + A+EY+H ++H D+K N+ L+ D + DFG A F++
Sbjct: 265 L-LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEK 319
Query: 867 PIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ G GTV +PE G D++S G++LL+M +
Sbjct: 320 E---REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP-IQETSS 873
S VA +E+L C +H DL N+LL + V + DFGLA+ ++ P S
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ + +K ++APE + DV+SFG+LL E+F+
Sbjct: 236 ARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 6/193 (3%)
Query: 429 NNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
+N ++P S+ L +L+ L + + +L N L L+++ N+L + L
Sbjct: 56 SNTLLLLPSSLSRLLSLDLLSPSGISS-LDGSENLLNLLPLPSLDLNLNRLRSNISE--L 112
Query: 489 EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQ 548
T + LDL +N I+ PL+ NL +LD+S N+ +P+ L + +L+ L +
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171
Query: 549 DNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKG 608
N +P L +L ++ LDLS N +S +P +E LS LE L+LS N + +
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLS 229
Query: 609 VFSNKTRISLIEN 621
N + + L N
Sbjct: 230 NLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-06
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866
L L Q ++ + SAI+Y+H + I+H D+K NVL++ + DFG A F
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACF---- 309
Query: 867 PIQETSSSSI--GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910
+ + S+ GI GTV APE G + + D++S G+++ E
Sbjct: 310 -ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-06
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRHR 760
EF + I +G+FG VY G + AVKV+ ++ K + AE +AL +
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
++ + S + LV +Y+ G ++ L + G + + +VA
Sbjct: 65 FIVHLYYSLQSANNV-----YLVMEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVA 114
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI 868
A++YLH H I+H DLKP N+L+ ++ ++DFGL+K +R +
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP-IQETSS 873
S VA +E+L C +H DL N+LL + V + DFGLA+ ++ P
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+ + +K ++APE ++ DV+SFG+LL E+F+
Sbjct: 241 ARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 52/235 (22%)
Query: 712 GQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRNLIKIITVC 769
+ + L VAVK INL K +K E + ++H N++ +T
Sbjct: 11 EDLMIVHLAKHKPTNTL--VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS- 67
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH- 828
F D +V M GS ED L+ +G L I DV +A++Y+H
Sbjct: 68 ----FIVDSELYVVSPLMAYGSCEDLLK--THFPEGLPELAIAF-ILKDVLNALDYIHSK 120
Query: 829 HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA----------KFLFDRPIQETSSSSIGI 878
+H +K S++LL D +S + + + D P +
Sbjct: 121 GF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN----- 171
Query: 879 KGTVGYVAPEYGMGGNV---SLTG-----DVYSFGILLLEMFTGRRP---THTMF 922
+ +++PE V +L G D+YS GI E+ G P
Sbjct: 172 ---LPWLSPE------VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH--R 760
+F LI G++G VY E A+K IN KQ +++ + + ++I
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNL-IQRLNISIDV 819
N + CS F+ +V +Y++ G L+ G L + + R+ + V
Sbjct: 60 NPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETV 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF--------LFDRPIQET 871
A+EYLH++ IVH DLKP N+L+ ++DFGL+K L++ I++
Sbjct: 112 L-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 872 SSSSIG--IKGTVGYVAPEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ + + GT Y+APE G G V D ++ GI+L E G P
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-06
Identities = 55/247 (22%), Positives = 108/247 (43%), Gaps = 37/247 (14%)
Query: 703 NEFSLSNLIGQGSFGFVY---RGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH 759
NE+ + IG G FG V+ E A+ LK++ V E ++ ++H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKH 71
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
+N+++ I + K + ++ ++ +G L +Q+ ++ G + ++I+ +
Sbjct: 72 KNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQL 127
Query: 820 ASAIEYLHHHCQPP----IVHGDLKPSNVLLDHDM-----------------VAHVSDFG 858
A+ Y H+ P ++H DLKP N+ L + +A + DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSL--TGDVYSFGILLLEMFTGRR 916
L+K + I+ + S + GT Y +PE + S D+++ G ++ E+ +G+
Sbjct: 188 LSKNI---GIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 917 PTHTMFN 923
P H N
Sbjct: 242 PFHKANN 248
|
Length = 1021 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 25/138 (18%)
Query: 260 LPLNIGFN----LPKLKILIVGQNNLTGSIPQSFSNASNLVI--LNLSGNHFSGKVGIDF 313
LPL G+N +P+ Q+ +G+ Q S I L L G + D
Sbjct: 386 LPLRFGWNGDPCVPQ-------QHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI 438
Query: 314 SSLPNITRLNLGQNNLGSG---SIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANL 370
S L ++ +NL N++ S+G + + LE L L+ N F GS+P S+ L
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLG---------SITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 371 STITIIAMGLNQISGTIP 388
+++ I+ + N +SG +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 710 LIGQGSFGFVYRG-NLGEDLLPVAVKVINL------KQKGSIKSFVAECEALKNIRHRNL 762
+G G+F Y+ ++ L +AVK + +Q+ +++ E + + H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 763 IKII-TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
I+++ C F L ++M GS+ L + G +N + +
Sbjct: 66 IRMLGATCEDSHFN------LFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLR 114
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ YLH + I+H D+K +N+L+D + ++DFG A L +
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARL-AAKGTGAGEFQGQL 168
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ ++APE G + DV+S G +++EM T + P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLP---VAVKVINL-KQKGSIKSFVAECEALKNIRH 759
++++ ++G+GSFG R L + + A+K I L K +++ E L ++H
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N I+ S F+ D +V +Y G D +Q+ Q L + +
Sbjct: 58 PN---IVAFKES--FEADGHLYIVMEYCDGG---DLMQKIKLQRGKLFPEDTILQWFVQM 109
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
++++H + ++H D+K N+ L + + DFG A+ L + +
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----TSPGAYACTYV 161
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT YV PE + D++S G +L E+ T + P
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 10/109 (9%)
Query: 807 LNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK-FLF 864
L+ + + S VA+ +E+L +C VH DL NVL+ + + DFGLA+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
D S+ + +K ++APE + DV+SFGILL E+FT
Sbjct: 292 DSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 1e-05
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
LK L + N LT +F NL +L+LSGN+ + FS LP++ L+L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI---- 757
++ + + IG+G++G V++ ++ AVK+++ I E EA NI
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKAL 71
Query: 758 -RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN-- 814
H N++K + D K D LV + GS+ D V G L +R+
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-------TDLVKGFLKRGERMEEP 124
Query: 815 -ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
I+ + A+ L H +H D+K +N+LL + + DFG++ L ++ +S
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 874 SSIGIKGTVGYVAPEY-----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT ++APE + DV+S GI +E+ G P
Sbjct: 185 V-----GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 711 IGQGSFGFVYRGNL--GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITV 768
+G+G++G VY+ G+D A+K I + G S E L+ ++H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDW----LQQSNDQVDGNLNLIQRLNISI--DVASA 822
S D L++DY + + W +++ + L + + S+ +
Sbjct: 67 FLS---HSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
I YLH + ++H DLKP+N+L+ ++D G A+ LF+ P++ + +
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLD-PV 175
Query: 879 KGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931
T Y APE +G + + D+++ G + E+ T H D T + F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 46/224 (20%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKIITV 768
IG+G++G V E VA+K I + K + E + L+++ H N+I I +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 769 CSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ--------SNDQVDGNLNLIQRLNISID 818
+ F +VY+ M + L Q S+D L + R
Sbjct: 73 MPPPH--REAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR------ 119
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
++Y+H ++H DLKPSN+LL+ + + DFGLA+ T+S
Sbjct: 120 ---GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDF 164
Query: 879 KG----TVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
T Y APE + + T DV+S G + E+ GR+P
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 27/98 (27%), Positives = 41/98 (41%), Gaps = 9/98 (9%)
Query: 268 LPKLKILIVGQNNLTG----SIPQSFSNASNLVILNLSGNHFSGKVGID----FSSLPNI 319
LK L + N + ++ + NL +L+L+ N + + +SL ++
Sbjct: 164 NRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL 223
Query: 320 TRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
LNLG NNL L L N S L TL L+ N
Sbjct: 224 EVLNLGDNNLTDAGAAALASALLSPNIS-LLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 705 FSLSNLIGQGSFGFV---YRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRH 759
+ + +IG+GS+G V + GE VA+K IN + + E + L+ +RH
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKINDVFEHVSDATRILREIKLLRLLRH 58
Query: 760 RNLIKIITVC---SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN--LIQRLN 814
++++I + S +FK D + +V++ M+S L ++ ++D + L Q L
Sbjct: 59 PDIVEIKHIMLPPSRREFK-DIY--VVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF-DRPIQETSS 873
A++Y+H + H DLKP N+L + D + DFGLA+ F D P +
Sbjct: 115 -------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 874 SSIGIKGTVGYVAPEY--GMGGNVSLTGDVYSFGILLLEMFTGR 915
+ T Y APE + D++S G + E+ TG+
Sbjct: 165 DYV---ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 731 VAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQ 788
VA+K ++ + + K E +K + H+N+I ++ V +
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-----------------FTP 94
Query: 789 SGSLEDW--LQQSNDQVDGNLNLIQRLNISIDVASAIEY-----LHHHCQPPIVHGDLKP 841
SLE++ + + +D NL + ++ + + S + Y + H I+H DLKP
Sbjct: 95 QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 154
Query: 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV---GYVAPEYGMGGNVSLT 898
SN+++ D + DFGLA+ T+ +S + V Y APE +G
Sbjct: 155 SNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 899 GDVYSFGILLLEMFTGR 915
D++S G ++ EM G
Sbjct: 206 VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 26/227 (11%)
Query: 711 IGQGSFGFVYRGNL--GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITV 768
+G+G++G VY+ G+D A+K I + G S E L+ ++H N+I + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDW----LQQSNDQVDGNLNLIQRLNISI--DVASA 822
S D L++DY + + W +++ + L + + S+ +
Sbjct: 67 FLS---HADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
I YLH + ++H DLKP+N+L+ ++D G A+ LF+ P++ + +
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLD-PV 175
Query: 879 KGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
T Y APE +G + + D+++ G + E+ T H D
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-05
Identities = 24/89 (26%), Positives = 52/89 (58%), Gaps = 2/89 (2%)
Query: 348 KLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQL 407
L+++ L+ N G++P S+ +++++ ++ + N +G+IP + L ++ L L N L
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 408 TGTIPYTIG-ELINLQALDFSAN-NLHGI 434
+G +P +G L++ + +F+ N L GI
Sbjct: 503 SGRVPAALGGRLLHRASFNFTDNAGLCGI 531
|
Length = 623 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 45/215 (20%), Positives = 86/215 (40%), Gaps = 35/215 (16%)
Query: 718 FVYRGNLGEDLLPVAVKVINLKQKGS---IKSFVAECEALKNIRHRNLIKI----ITVCS 770
+Y+G V ++ KG I E + L+ I N++KI I +
Sbjct: 35 SIYKGIFNNK--EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC 830
+ +L+ +Y G L + L + D L+ +L+++ID + L+ +
Sbjct: 93 DLPRL-----SLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYG 890
P + +L + L+ + + GL K L P + + V Y
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----------VYFSYK 190
Query: 891 MGGNV----SLTGDVYSFGILLLEMFTGRRPTHTM 921
M ++ ++ D+YS G++L E+FTG+ P +
Sbjct: 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVK-VINLKQK-GSIKSFVAECEALKNIRHRNLIKIITV 768
IG G+FG V+ D VA+K + N+ Q S K E + L +H N++ + +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 769 CSSIDFKGDDFKAL--VYDYMQSGSLEDWL--QQ--SNDQVDGNLNLIQRLNISIDVASA 822
D F+ + V + MQS L + Q S+D V L I R
Sbjct: 68 LQPPHI--DPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILR---------G 115
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
++YLH I+H D+KP N+L++ + V + DFGLA+ ++E S + V
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR------VEEPDESKHMTQEVV 166
Query: 883 G--YVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
Y APE MG + D++S G + E+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 705 FSLSNLIGQGSFGFVY-----RGNLGEDLLPVA-VKVINLKQKGSIKSFVAECEALKNIR 758
+ L +G+GSFG VY + E L + + V L ++++ E + L +
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLD 60
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H ++K F D ++ +Y + L+ L++ L+ Q I
Sbjct: 61 HPAIVKFHA-----SFLERDAFCIITEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQ 114
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ + Y+H Q I+H DLK N+ L ++++ + DFG+++ L T+
Sbjct: 115 LLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-----F 165
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEM 911
GT Y++PE D++S G +L EM
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 541 SLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+L+ L + +N + L +++VLDLS NNL+ PE L L L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 711 IGQGSFGFV---YRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKI 765
IG G+ G V Y L + VA+K ++ + + K E +K + H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 766 ITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ V + ++F+ LV + M + +L +Q D + L Q L I
Sbjct: 82 LNVFTP-QKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQML-------CGI 132
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV- 882
++LH I+H DLKPSN+++ D + DFGLA+ T+ +S + V
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMMTPYVV 180
Query: 883 --GYVAPEYGMGGNVSLTGDVYSFGILLLEM------FTGR 915
Y APE +G D++S G ++ EM F GR
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 25/77 (32%), Positives = 44/77 (57%), Gaps = 2/77 (2%)
Query: 258 GRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLP 317
G +P +I L L+ + + N++ G+IP S + ++L +L+LS N F+G + L
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 318 NITRLNLGQNNLGSGSI 334
++ LNL N+L SG +
Sbjct: 491 SLRILNLNGNSL-SGRV 506
|
Length = 623 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 17/148 (11%)
Query: 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP 833
F+ D + +V +YM G L + + SN V + +V A++ +H
Sbjct: 112 FQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF----YTAEVVLALDAIHSM---G 162
Query: 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEY---- 889
+H D+KP N+LLD ++DFG + + ++ GT Y++PE
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV----GTPDYISPEVLKSQ 218
Query: 890 GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G G D +S G+ L EM G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/152 (19%), Positives = 62/152 (40%), Gaps = 26/152 (17%)
Query: 719 VYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI--KIITVCSSIDFKG 776
VY LG +K+ ++KG E L+ + + L K++ +
Sbjct: 14 VYL--LGTKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS-----GES 64
Query: 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVH 836
D + L+ ++++ +L++ ++ + I+ +A + LH + H
Sbjct: 65 DGWSYLLMEWIEGETLDEVSEEEKED------------IAEQLAELLAKLHQLPLLVLCH 112
Query: 837 GDLKPSNVLLDHDMVAHVSDFGLAKF---LFD 865
GDL P N+L+D + + D+ A + FD
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGPPAFD 144
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 33/129 (25%), Positives = 48/129 (37%), Gaps = 36/129 (27%)
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-------FDRPIQETSSS 874
AI+ +H +H D+KP N+LLD +SDFGL L F R + S
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 875 SIGIK--------------------------GTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
+ GT Y+APE + + D +S G+++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 909 LEMFTGRRP 917
EM G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 32/140 (22%), Positives = 55/140 (39%), Gaps = 41/140 (29%)
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL---------AKFL----- 863
++ AIE +H + +H D+KP N+L+D D ++DFGL +K+
Sbjct: 109 ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 864 -----FDRPIQETSSSSIGIK-------------------GTVGYVAPEYGMGGNVSLTG 899
+ + + +K GT Y+APE + +
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 900 DVYSFGILLLEMFTGRRPTH 919
D +S G++L EM G+ P
Sbjct: 226 DWWSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 35/126 (27%), Positives = 49/126 (38%), Gaps = 33/126 (26%)
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-------FDRPIQETSSS 874
AI+ +H Q +H D+KP N+LLD +SDFGL L F R + S
Sbjct: 113 AIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 875 SIGIK-----------------------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEM 911
+ GT Y+APE M + D +S G+++ EM
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 912 FTGRRP 917
G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 35/126 (27%), Positives = 50/126 (39%), Gaps = 33/126 (26%)
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-------FDRPIQETSSS 874
AI+ +H Q +H D+KP N+LLD +SDFGL L F R + + S
Sbjct: 113 AIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 875 SIGIK-----------------------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEM 911
+ GT Y+APE M + D +S G+++ EM
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 912 FTGRRP 917
G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 59/189 (31%), Positives = 85/189 (44%), Gaps = 10/189 (5%)
Query: 435 IPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKN--LMLLNVSKNKLTGTLPPQILEITT 492
+++ NL L SL L N L+ NI L L L N + + + +
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLK- 143
Query: 493 LSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSF 552
LDLS N I S+P + NL NL LD+S N S ++P LS+ ++L L + N
Sbjct: 144 ---ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 553 RGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+P + L ++E LDLS NN ++ L +L L L LS N E + G SN
Sbjct: 199 S-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
Query: 613 KTRISLIEN 621
+ L N
Sbjct: 257 LETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 18/51 (35%), Positives = 27/51 (52%), Gaps = 4/51 (7%)
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
R ++ +V + LH IVHGDL SN++L + + DFGL +F
Sbjct: 94 RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 54/243 (22%), Positives = 83/243 (34%), Gaps = 58/243 (23%)
Query: 417 ELINLQALDFSANNLHGI----IPDSIGNLSTLNSLWLGFNNLQGN------IPSSLGNC 466
+L+ LQ L N L + ++ +L L L N + L
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80
Query: 467 KNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSI-PLVVGNLK----NLI 519
L L++S N L + + SSL L L++N + L+ LK L
Sbjct: 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140
Query: 520 QLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNSFRGS-------------------- 555
+L + RNR G + L + L+ L + +N +
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 556 ------------IPSSLISLKSIEVLDLSCNNLSGQI-----PEYLEDLSFLEYLNLSYN 598
+ +L SLKS+EVL+L NNL+ L L L+LS N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
Query: 599 DFE 601
D
Sbjct: 261 DIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 33/156 (21%)
Query: 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI--------SIDVASAIEY 825
F+ D + +V +YM G L +NL+ ++ + +V A++
Sbjct: 112 FQDDKYLYMVMEYMPGGDL--------------VNLMSNYDVPEKWAKFYTAEVVLALDA 157
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
+H ++H D+KP N+LLD ++DFG + + + ++ GT Y+
Sbjct: 158 IHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV----GTPDYI 210
Query: 886 APEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+PE G G D +S G+ L EM G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
NL++LD S N L I + L L L L NNL P + +L L++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 19/60 (31%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 445 LNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLI 504
L SL L N L + NL +L++S N LT ++ P+ LDLS N +
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 517 NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNL 576
NL LD+S NR + +L+ L + N+ P + L S+ LDLS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 33/156 (21%)
Query: 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS--------IDVASAIEY 825
F+ D + +V +YM G L +NL+ +I +V A++
Sbjct: 112 FQDDKYLYMVMEYMPGGDL--------------VNLMSNYDIPEKWARFYTAEVVLALDA 157
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
+H +H D+KP N+LLD ++DFG D +++ GT Y+
Sbjct: 158 IHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAV---GTPDYI 210
Query: 886 APEY----GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+PE G G D +S G+ L EM G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
++Y+H ++H DLKP N+L++ D + DFGLA+ + P + + T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT-EYVAT 172
Query: 882 VGYVAPEYGMGGNVSLTG--DVYSFGILLLEMFTGRRP 917
Y APE M S T DV+S G +L E GR+P
Sbjct: 173 RWYRAPEI-MLSFQSYTKAIDVWSVGCILAE-LLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 9/62 (14%)
Query: 813 LNISIDVASA-IEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF---L 863
L I +A I++L + P +VHGD +P N+++D V D+ LA L
Sbjct: 173 LGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232
Query: 864 FD 865
D
Sbjct: 233 ED 234
|
Length = 321 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 49/221 (22%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 711 IGQGSFGFVYRGNLG------------EDLLPVAVKVINLKQKGSIKSFVAECEALKNIR 758
+G+G+ +Y G L E + V +KV++ + +F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H++++ + VC D +V ++++ G L+ ++ + +D L + ++
Sbjct: 63 HKHIVLLYGVCVR-----DVENIMVEEFVEFGPLDLFMHRKSDV----LTTPWKFKVAKQ 113
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ASA+ YL +VHG++ N+LL + + + G L D I T S
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLAREGID--GECGPFIKLSDPGIPITVLSRQEC 168
Query: 879 KGTVGYVAPE-YGMGGNVSLTGDVYSFGILLLEM-FTGRRP 917
+ ++APE N+S+ D +SFG L E+ + G P
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1003 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.2 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.87 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.86 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.39 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-116 Score=1124.87 Aligned_cols=921 Identities=30% Similarity=0.513 Sum_probs=777.5
Q ss_pred CCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCceeeEEeCCCCCcEEEEEeecCCCCcccCccccCCCCCcEEEcCCCC
Q 001858 32 SNETDRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNN 111 (1003)
Q Consensus 32 ~~~~~~~al~~~k~~~~d~~~~~~sW~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~L~~n~ 111 (1003)
..+.|++||++||+++.||.+.+++|+...+||.|+||+|++ .++|+.|+|++++++|.+++.+..+++|++|+|++|+
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 357899999999999999988899998778999999999986 4699999999999999999999999999999999999
Q ss_pred CCCCCchhhc-ccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccceEEccCcccccccC
Q 001858 112 LHGEIPNELG-RLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLP 190 (1003)
Q Consensus 112 ~~g~ip~~l~-~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip 190 (1003)
++|.+|..+. .+++|++|+|++|.++|.+|. +.+++|++|+|++|.+++.+|..++.+ ++|++|+|++|.+++.+|
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC-CCCCEEECccCcccccCC
Confidence 9999999876 999999999999999999986 568999999999999999999998775 899999999999999999
Q ss_pred CCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCC-cccCCchhHHhhcccccCCCCCcccccCcc
Q 001858 191 PSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLP 269 (1003)
Q Consensus 191 ~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~ 269 (1003)
..++++++|++|++++|++.+.+|..++++++|++|+|++|++++.+|. +.++++|++|++++|++.+.+|..+. +++
T Consensus 182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~ 260 (968)
T PLN00113 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLK 260 (968)
T ss_pred hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCC
Confidence 9999999999999999999999999999999999999999999987764 78899999999999999999998876 899
Q ss_pred ccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCC
Q 001858 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349 (1003)
Q Consensus 270 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L 349 (1003)
+|++|++++|++++.+|..+.++++|++|+|++|.+.+..|..+..+++|++|++++|.+.... +..+..+++|
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~l~~L 334 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTSLPRL 334 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhcCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999987532 2357789999
Q ss_pred cEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccc
Q 001858 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN 429 (1003)
Q Consensus 350 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 429 (1003)
+.|++++|++.+.+|..++.+.+|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n 414 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414 (968)
T ss_pred CEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCccccccc
Q 001858 430 NLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509 (1003)
Q Consensus 430 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p 509 (1003)
++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+. . ..++.|++++|++++.+|
T Consensus 415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~-~~L~~L~ls~n~l~~~~~ 492 (968)
T PLN00113 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-S-KRLENLDLSRNQFSGAVP 492 (968)
T ss_pred EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-c-ccceEEECcCCccCCccC
Confidence 99999999999999999999999999999999999999999999999999988887653 2 345678999999999999
Q ss_pred cccccccccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCc
Q 001858 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF 589 (1003)
Q Consensus 510 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 589 (1003)
..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..|..+++|+.|||++|++++.+|..+..+++
T Consensus 493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 572 (968)
T PLN00113 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572 (968)
T ss_pred hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceEecCCCcccccCCCCCccCCCcceeeccCCCccCCCCCCCCCCCCCCCCCccccceeEeehhHHHHHHHHhhh-eee
Q 001858 590 LEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVG-LIV 668 (1003)
Q Consensus 590 L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~~~~~~~~~~~~i~~~~~~~~~~l~~~-~~~ 668 (1003)
|++|++++|+++|.+|..++|..+....+.||+.+|++......++|...+.. ..+.+.+++++++++++++++ +++
T Consensus 573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (968)
T PLN00113 573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT--PSWWFYITCTLGAFLVLALVAFGFV 650 (968)
T ss_pred cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccccc--ceeeeehhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999997765556677543222 112222222222222222222 222
Q ss_pred EEEeeccccccccchhh--cccC-C--CcccHHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccc
Q 001858 669 VCTRRRKQTQKSSTLLS--MEQQ-F--PMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS 743 (1003)
Q Consensus 669 ~~~rrrk~~~~~~~~~~--~~~~-~--~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~ 743 (1003)
++++++....+...... .+.. . ..............|...+.||+|+||+||+|++..+++.||||.++.....
T Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~- 729 (968)
T PLN00113 651 FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI- 729 (968)
T ss_pred HHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-
Confidence 22222211111100000 0000 0 0001112223345677889999999999999999889999999998633221
Q ss_pred hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 001858 744 IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823 (1003)
Q Consensus 744 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 823 (1003)
..+|++.+++++||||++++++|. ++...++||||+++|+|.++++. ++|.++.+++.|+++|+
T Consensus 730 ---~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L 793 (968)
T PLN00113 730 ---PSSEIADMGKLQHPNIVKLIGLCR-----SEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKAL 793 (968)
T ss_pred ---cHHHHHHHhhCCCCCcceEEEEEE-----cCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHH
Confidence 235688999999999999999974 34567999999999999999953 78999999999999999
Q ss_pred HHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchh
Q 001858 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYS 903 (1003)
Q Consensus 824 ~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvws 903 (1003)
+|||..+.++|+||||||+||+++.++..++. ||.+..... .....||+.|+|||++.+..++.++||||
T Consensus 794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S 863 (968)
T PLN00113 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---------DTKCFISSAYVAPETRETKDITEKSDIYG 863 (968)
T ss_pred HHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---------CCCccccccccCcccccCCCCCcccchhh
Confidence 99997766799999999999999999888875 555533211 11235789999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh-HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC
Q 001858 904 FGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK-VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI 982 (1003)
Q Consensus 904 lG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 982 (1003)
|||++|||++|+.||............|.+...... ....+++.+.... ....+...++.+++.+||+.+|++||
T Consensus 864 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred HHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCc
Confidence 999999999999999654444444444444332221 2222332222111 11233456788999999999999999
Q ss_pred CHHHHHHHHHHHHhhh
Q 001858 983 HMADAVKNLCAAREKY 998 (1003)
Q Consensus 983 s~~ev~~~L~~~~~~~ 998 (1003)
+|+|+++.|+++.+..
T Consensus 940 t~~evl~~L~~~~~~~ 955 (968)
T PLN00113 940 CANDVLKTLESASRSS 955 (968)
T ss_pred CHHHHHHHHHHhhccc
Confidence 9999999999886643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-61 Score=613.92 Aligned_cols=516 Identities=35% Similarity=0.536 Sum_probs=482.2
Q ss_pred CCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCc-CCCCCceeecccccccCCCCccccccccccce
Q 001858 99 LSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLS-HCSNLINFSVRRNNLTGEIPAYIGYYWLKLEN 177 (1003)
Q Consensus 99 l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~-~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~ 177 (1003)
..+++.|||++|+++|.+|..+..+++|++|+|++|.++|.+|..+. .+++|++|+|++|+++|.+|... +++|++
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~---l~~L~~ 144 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGS---IPNLET 144 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccc---cCCCCE
Confidence 35799999999999999999999999999999999999999999876 99999999999999999999743 479999
Q ss_pred EEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCC-cccCCchhHHhhccccc
Q 001858 178 LNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRF 256 (1003)
Q Consensus 178 L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l 256 (1003)
|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|. +.++.+|+.|+++.|++
T Consensus 145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 99999999999999999999999999999999999999999999999999999999987664 77899999999999999
Q ss_pred CCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCC
Q 001858 257 EGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGD 336 (1003)
Q Consensus 257 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 336 (1003)
.+.+|..+. ++++|++|++++|++++.+|..|+++++|++|+|++|++++..|..+..+++|++|++++|.+....
T Consensus 225 ~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~--- 300 (968)
T PLN00113 225 SGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI--- 300 (968)
T ss_pred CCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC---
Confidence 999999887 8999999999999999999999999999999999999999999999999999999999999986532
Q ss_pred hhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccc
Q 001858 337 LDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIG 416 (1003)
Q Consensus 337 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 416 (1003)
+..+.++++|++|++++|.+.+..|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+.
T Consensus 301 ---p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 301 ---PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred ---ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 24567899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhcccccc
Q 001858 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL 496 (1003)
Q Consensus 417 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~ 496 (1003)
.+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+..+.++ +.
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~ 456 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QM 456 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cE
Confidence 99999999999999999999999999999999999999999999999999999999999999999998887776665 56
Q ss_pred ccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCcee
Q 001858 497 LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNL 576 (1003)
Q Consensus 497 l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 576 (1003)
+++++|.+.+.+|..+ ..++|+.||+++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++
T Consensus 457 L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 457 LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 7999999999998866 458999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcccccCCCccceEecCCCcccccCCCC-CccCCCcceeeccCCCccC
Q 001858 577 SGQIPEYLEDLSFLEYLNLSYNDFEGQVPTK-GVFSNKTRISLIENGKLCG 626 (1003)
Q Consensus 577 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 626 (1003)
++.+|..+..+++|+.|+|++|+++|.+|.. ..+..+..+.+.+|+..+.
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 9999999999999999999999999988863 3455677788888887653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=407.46 Aligned_cols=291 Identities=41% Similarity=0.635 Sum_probs=237.9
Q ss_pred CCCcccHHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeee
Q 001858 689 QFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITV 768 (1003)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 768 (1003)
....|+++++..+|++|+..+.||+|+||.||+|...+ ++.||||++........++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 45679999999999999999999999999999999974 48899998875443314569999999999999999999999
Q ss_pred eeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC
Q 001858 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848 (1003)
Q Consensus 769 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 848 (1003)
|.+. ++..++|||||++|+|.+++...... .++|.+|++||.++|+||+|||+.+.+.||||||||+|||+|+
T Consensus 140 C~e~----~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 140 CLEG----GEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred EecC----CceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 8542 22589999999999999999885422 7899999999999999999999999889999999999999999
Q ss_pred CCCeEEcccccccccccCCccccCcccccc-cccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCccc-CCcc
Q 001858 849 DMVAHVSDFGLAKFLFDRPIQETSSSSIGI-KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF-NDGL 926 (1003)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~-~~~~ 926 (1003)
++++||+|||+|+..... ....... .||.+|+|||+...+..+.|+||||||++++|+++|+.|.+... ..+.
T Consensus 213 ~~~aKlsDFGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred CCCEEccCccCcccCCcc-----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 999999999999654220 1111111 79999999999999999999999999999999999999887643 3344
Q ss_pred hhhHHHHhhCch-hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 927 TLHGFVKMALPE-KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 927 ~~~~~~~~~~~~-~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
.+..|....+.+ ++.+++|+.+.... .. ..+...++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~---~~-~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGE---YP-DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCC---CC-hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 466666554444 46677776654211 11 11556779999999999999999999999999965543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=380.02 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=215.4
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC-ceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD-FKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~ 781 (1003)
+.+..+.||+|..|+||+++|+.+++.+|+|++.... +...+++.+|++++++.+||+||+++|.+ ..+. ...
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceEE
Confidence 4556789999999999999999999999999996443 44468899999999999999999999995 3445 589
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++|+|++++.. .+.+++...-+++.+|++||.|||+ + +||||||||+|||+...|.+||||||.+
T Consensus 155 I~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence 99999999999999987 4679999999999999999999996 6 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
..+... ....++||..|||||.+.+..|+.++||||||++++|+.+|++||...... +..+
T Consensus 227 ~~lvnS-------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------------~~~~ 287 (364)
T KOG0581|consen 227 GILVNS-------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------------YLDI 287 (364)
T ss_pred HHhhhh-------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC------------CCCH
Confidence 876432 334588999999999999999999999999999999999999998764111 1223
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.++......|. +.+.. .+.+++..++-.|++.+|++||++.|+++|=.-
T Consensus 288 ~~Ll~~Iv~~ppP-~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 288 FELLCAIVDEPPP-RLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred HHHHHHHhcCCCC-CCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 4445544443332 22221 578889999999999999999999999987443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=404.81 Aligned_cols=476 Identities=29% Similarity=0.440 Sum_probs=327.1
Q ss_pred EEEEEeecCCCCcccCccccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeeccc
Q 001858 78 VIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157 (1003)
Q Consensus 78 v~~l~l~~~~~~g~~~~~l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~ 157 (1003)
...+.+.+|.+. .+.+.+.+|..|.+|++++|+++ +.|+++|++..++.|+.|+|+++ .+|++++.+.+|+.|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 345566666665 46677888888888888888888 78888888888888888888888 7888888888888888888
Q ss_pred ccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCC
Q 001858 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGML 237 (1003)
Q Consensus 158 N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 237 (1003)
|.+. ++|+.++.. ..|+.|+..+|+++ .+|+.++++.+|..|++.+|+++. .|+..-+++.|+.||...|-++..+
T Consensus 124 n~~~-el~~~i~~~-~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRL-LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLETLP 199 (565)
T ss_pred ccee-ecCchHHHH-hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhhcCC
Confidence 8887 777777765 57777888888877 677777778888888888888774 4444444777888888888777777
Q ss_pred CCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccc-cccccchhhhccCccccCccCcccCCC
Q 001858 238 PPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSF-SNASNLVILNLSGNHFSGKVGIDFSSL 316 (1003)
Q Consensus 238 ~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l 316 (1003)
|.++.+.+|+.|++..|++. .+| ++. .+..|++|+++.|+|. .+|... .+++++.+|||..|++. ..|+.+.-+
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 77777777777777777776 566 333 5666777777777776 444433 36667777777777766 445556666
Q ss_pred CcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccc--ccccccc--cccccc---C----
Q 001858 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLS--TITIIAM--GLNQIS---G---- 385 (1003)
Q Consensus 317 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L--~~n~l~---~---- 385 (1003)
.+|++||+++|.|+..+. .++++ +|+.|.+.+|.+..+-.+.+..-+ -|++|.- ..-.++ +
T Consensus 275 rsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 275 RSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred hhhhhhcccCCccccCCc-------ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 667777777776665543 35555 666666666666532111111111 1222211 000010 0
Q ss_pred ------cccccccCCCCccEEEcccccccccCCCccccccc---cceeccccccccccccccccCCCccce-eecccccc
Q 001858 386 ------TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELIN---LQALDFSANNLHGIIPDSIGNLSTLNS-LWLGFNNL 455 (1003)
Q Consensus 386 ------~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~N~l 455 (1003)
........+.+.+.|++++-+++ .+|+....... .+..+++.|++. .+|..+..+..+.+ +.+++|.+
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 00112233455666666666666 45554444333 566666666666 45655555544433 33444444
Q ss_pred cccCCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCcc
Q 001858 456 QGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTT 535 (1003)
Q Consensus 456 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 535 (1003)
+ .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln--------------------------~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~ 476 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN--------------------------DLPEEMGSLVRLQTLNLSFNRFR-MLPEC 476 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh--------------------------hcchhhhhhhhhheecccccccc-cchHH
Confidence 4 66666666666666666666665 45555777778999999999997 89999
Q ss_pred ccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecCCCcccccCC
Q 001858 536 LSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605 (1003)
Q Consensus 536 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 605 (1003)
+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.|. .+|+.+++|++|++|+++||+|. .++
T Consensus 477 ~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr 544 (565)
T KOG0472|consen 477 LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPR 544 (565)
T ss_pred HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCH
Confidence 988889999999999998777777999999999999999998 78889999999999999999998 444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=394.35 Aligned_cols=476 Identities=28% Similarity=0.382 Sum_probs=352.7
Q ss_pred CCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccceEEc
Q 001858 101 FLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNV 180 (1003)
Q Consensus 101 ~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L 180 (1003)
.|+.|++++|.+. .+-+.+.++..|++|++++|+++ ++|++++.+.+++.|+.++|+++
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls------------------- 104 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS------------------- 104 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-------------------
Confidence 4555666666665 45555666666666666666666 56666666666666666666555
Q ss_pred cCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCC
Q 001858 181 AENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRL 260 (1003)
Q Consensus 181 ~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~l 260 (1003)
.+|+.++.+.+|+.|++++|++. .+|++++.+..|+.|+..+|+++..++..+++.+|..+++.+|++. .+
T Consensus 105 -------~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~-~l 175 (565)
T KOG0472|consen 105 -------ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLK-AL 175 (565)
T ss_pred -------hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchh-hC
Confidence 55555666666666666666666 5666666666666666666666666666666666666777777666 44
Q ss_pred CcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhH
Q 001858 261 PLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFI 340 (1003)
Q Consensus 261 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 340 (1003)
|.+.- +++.|++|++.+|-++ .+|..++.+.+|+.|+|..|+|...+ .|.++..|++|+++.|+|+.++.
T Consensus 176 ~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpa------ 245 (565)
T KOG0472|consen 176 PENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPA------ 245 (565)
T ss_pred CHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHH------
Confidence 44443 3677777777777776 66777777777777777777777443 67777777778888777766543
Q ss_pred hhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCcccccc-
Q 001858 341 TLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELI- 419 (1003)
Q Consensus 341 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~- 419 (1003)
.....+++|.+|||.+|+++ ..|..++.+.+|..||+++|.|+ .+|..++++ .|+.|-+.+|.+..+-.+-+..-+
T Consensus 246 e~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~ 322 (565)
T KOG0472|consen 246 EHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQ 322 (565)
T ss_pred HHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHH
Confidence 24557788888888888887 67888888888888888888888 567788888 888888888888732222222111
Q ss_pred -ccceecc-------cccccc----cc-cc---ccccCCCccceeecccccccccCCccccCCCC---CCeeeccCcccc
Q 001858 420 -NLQALDF-------SANNLH----GI-IP---DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKN---LMLLNVSKNKLT 480 (1003)
Q Consensus 420 -~L~~L~L-------s~N~l~----~~-~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~ls~N~l~ 480 (1003)
-|++|.= +.-.=. .. .+ .....+.+.+.|+++.-+++ .+|.....-.. .+..+++.|++.
T Consensus 323 ~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~ 401 (565)
T KOG0472|consen 323 EVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC 401 (565)
T ss_pred HHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh
Confidence 1333321 111000 00 11 12234567899999999999 67765544333 788999999998
Q ss_pred CCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCccccCCccc
Q 001858 481 GTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSL 560 (1003)
Q Consensus 481 ~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 560 (1003)
++|..+..+..+.+.+.+++|.++ -+|..++.+++|..|+|++|-+. .+|.+++.+..|+.|+++.|+|. .+|..+
T Consensus 402 -elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~ 477 (565)
T KOG0472|consen 402 -ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECL 477 (565)
T ss_pred -hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHH
Confidence 999999999999999999999887 78888999999999999999997 89999999999999999999998 899999
Q ss_pred ccccCcCeeeccCceeccCCcccccCCCccceEecCCCcccccCCCCCccCCCcceeeccCCCc
Q 001858 561 ISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKL 624 (1003)
Q Consensus 561 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 624 (1003)
..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+...+|..+...+++.+-+.|||+-
T Consensus 478 y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 478 YELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 9999999999999999977777799999999999999999998888899999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=372.13 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=211.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc-------chHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-------SIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
.+.|.+.+.||.|+||.|-+|..+.+++.||||+++..... ......+|+++|++++|||||++.++ +
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence 45688899999999999999999999999999999744211 22345799999999999999999999 5
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC---CC
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MV 851 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~ 851 (1003)
..+++.|+||||++||+|.+++-. .+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 667788999999999999999987 45778888899999999999999999 99999999999999866 68
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCCCC---CccccchhHHHHHHHHHhCCCCCCcccCCcchh
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV---SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~ 928 (1003)
+||+|||+|+... ........+||+.|.|||++.++.+ ..++|+||+||++|-+++|.+||++...+..
T Consensus 318 lKItDFGlAK~~g------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-- 389 (475)
T KOG0615|consen 318 LKITDFGLAKVSG------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-- 389 (475)
T ss_pred EEecccchhhccc------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--
Confidence 9999999998763 3445566899999999999887643 3478999999999999999999987543311
Q ss_pred hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+.+.+ ........++.+.+..++...++.+++..||++||++.|+++|=+
T Consensus 390 -----------l~eQI---~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 390 -----------LKEQI---LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred -----------HHHHH---hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 12222 222233334556667788889999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.49 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=206.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|.+.+.||+|+||+||+|+++.++..||||.+... .....+.+..|++++++++|||||++++++ ..+++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence 46899999999999999999999999999999999755 455567889999999999999999999995 55778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC------CCeE
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD------MVAH 853 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~------~~~k 853 (1003)
.++|||||.||+|.+|+++ .+.+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEEEEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEE
Confidence 8999999999999999998 55899999999999999999999999 99999999999999865 4589
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchh-----
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL----- 928 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~----- 928 (1003)
|+|||+|+.+.++. .....+|++-|||||++..++|+.|+|+||+|+++|||++|+.||......+.-.
T Consensus 156 IADFGfAR~L~~~~------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 156 IADFGFARFLQPGS------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred ecccchhhhCCchh------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 99999999885433 2334789999999999999999999999999999999999999998644332211
Q ss_pred ---hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 001858 929 ---HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAV 988 (1003)
Q Consensus 929 ---~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 988 (1003)
....+........+..-..+..++..+..... .+....+..+|.+|+.+.++-
T Consensus 230 ~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~-------~~~~~~l~~~p~~~~~~~~~~ 285 (429)
T KOG0595|consen 230 NEIVPVLPAELSNPLRELLISLLQRNPKDRISFED-------FFDHPFLAANPQDRADAFELE 285 (429)
T ss_pred ccccCchhhhccCchhhhhhHHHhcCccccCchHH-------hhhhhhcccCcccccCccccc
Confidence 11111222333334444445554433333322 223344455677777665543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=384.84 Aligned_cols=262 Identities=31% Similarity=0.463 Sum_probs=212.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccc--hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+..+.+.+|+|+||+||+|.+.++. .||||++....... .+.|.+|+.++++++|||||+++|+|... ....+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~ 116 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLC 116 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceE
Confidence 3444566999999999999997442 29999997543222 56999999999999999999999998542 22679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-cEeccCCCCceEeCCCC-CeEEccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP-IVHGDLKPSNVLLDHDM-VAHVSDFGL 859 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dikp~Nill~~~~-~~kl~DfG~ 859 (1003)
+||||+++|+|.++++... .+.+++..+.+++.|||+||+|||++ + |||||+||+|||++.++ ++||+|||+
T Consensus 117 iVtEy~~~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred EEEEeCCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 9999999999999998852 56899999999999999999999999 7 99999999999999997 999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccC--CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM--GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||...... .
T Consensus 191 sr~~~~~~-----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~---------- 253 (362)
T KOG0192|consen 191 SREKVISK-----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--Q---------- 253 (362)
T ss_pred ceeecccc-----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--H----------
Confidence 98653321 2222367999999999999 669999999999999999999999999876431 0
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhhc
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 1000 (1003)
....++... .++.....+...+..++.+||+.+|+.||++.+++..|+.+...+..
T Consensus 254 -~~~~v~~~~------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 -VASAVVVGG------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -HHHHHHhcC------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 011111111 12222333778899999999999999999999999999998887654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=385.52 Aligned_cols=261 Identities=33% Similarity=0.522 Sum_probs=219.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
....+...+.||+|.||+||.|.+.++ ..||+|.++.. ....+.|.+|+++|++++|++||+++++|.. ++..
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~pi 276 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPI 276 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCce
Confidence 344566778999999999999999744 47999999744 4445889999999999999999999999853 3468
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
+||||||+.|+|.++++... +..+...+.+.++.|||+||+||+++ ++||||+.++||||+++..+||+|||+|
T Consensus 277 yIVtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred EEEEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999999999843 56789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+...+..+.... ...-+..|.|||++..+.++.|||||||||+||||+| |+.||..+.+. +
T Consensus 351 r~~~d~~Y~~~~----~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------e 412 (468)
T KOG0197|consen 351 RLIGDDEYTASE----GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------E 412 (468)
T ss_pred cccCCCceeecC----CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------------H
Confidence 965554433322 2334678999999999999999999999999999999 99998876542 3
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
+.+.+++. .|.+.++.|+..++++|..||..+|++|||++.+...++.+....
T Consensus 413 v~~~le~G------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 413 VLELLERG------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHhcc------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 33334433 334445668899999999999999999999999999998877643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.63 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=214.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC-Cc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD-DF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~~ 779 (1003)
.+|++.++||+|.||+||++.+..++..||.|.++... ....++...|+.+++.++|||||++++.- +.++ ..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchh
Confidence 46889999999999999999999999999999987443 34467899999999999999999998842 3334 44
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CcEeccCCCCceEeCCCCCeEEcccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQP-PIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
.++|||++++|+|.+.|+..+.+ +..+++..+|+++.|++.|++++|...+. -|+||||||.||+++.+|.+|++|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 89999999999999999987665 67899999999999999999999994322 28899999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+++++.... ......+|||.||+||.+.+..|+++|||||+||++|||+.-+.||.+.. + .
T Consensus 174 L~r~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~---------~ 234 (375)
T KOG0591|consen 174 LGRFLSSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----L---------L 234 (375)
T ss_pred hHhHhcchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----H---------H
Confidence 999885433 33345789999999999999999999999999999999999999997631 0 1
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+-|..+ +.++ -..+-++..+..++..|+.+||+.||+.-.++..+..
T Consensus 235 ~L~~KI~qg---d~~~--~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 235 SLCKKIEQG---DYPP--LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHcC---CCCC--CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122223322 2211 1124567889999999999999999997666666554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=381.13 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=214.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.+|...+.||+|+|+.||++++..+|..||+|++.+. +....+...+|+++.+.++|||||+++++ |++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 5799999999999999999999889999999999743 45556789999999999999999999999 788999
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
+|+|.|+|..++|..++++ .+.+++.+++.+.+||+.|+.|||++ +|+|||+|..|++++++.++||+|||+
T Consensus 93 VYivLELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred eEEEEEecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccce
Confidence 9999999999999999986 57899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|..+... .......+|||.|.|||++.....++.+||||+|||+|-|+.|++||+...
T Consensus 165 At~le~~-----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------------- 222 (592)
T KOG0575|consen 165 ATQLEYD-----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----------------- 222 (592)
T ss_pred eeeecCc-----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------
Confidence 9877432 223345789999999999999999999999999999999999999998632
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+..++....+. ..+.....+..+++.+.++++|++|||+.+|+.+
T Consensus 223 vkety~~Ik~~~Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 223 VKETYNKIKLNEY----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHHHhcCc----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2222222222211 1122445667888999999999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=395.61 Aligned_cols=266 Identities=28% Similarity=0.493 Sum_probs=222.6
Q ss_pred ccCCccCeeeeccceEEEEEEEC-----CCCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
.+.+..+.||+|+||+||+|+.. +....||||.++..... ..++|++|++.+..++|||||+++|+|. .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence 34556788999999999999874 34467999999866655 7889999999999999999999999985 3
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQV---------DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
++..++|+|||..|+|.+|+..+.+.. ..+++..+.+.||.|||.||+||-++ .+||||+..+|+||+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 667799999999999999998865432 23389999999999999999999999 899999999999999
Q ss_pred CCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcc
Q 001858 848 HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGL 926 (1003)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~ 926 (1003)
++..|||+|||+++.....++..... ...=+++|||||.+..++|+.+||||||||++||+++ |+.||.+..++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~---~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-- 712 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRG---NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-- 712 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccC---CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--
Confidence 99999999999999887666554322 1234689999999999999999999999999999999 99998775542
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~ 999 (1003)
++.+.+...-. .+.++.|+.+++.+|..||+.+|++||+++||-..|++..+.-+
T Consensus 713 ------------EVIe~i~~g~l------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 ------------EVIECIRAGQL------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ------------HHHHHHHcCCc------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 33333332222 23356788999999999999999999999999999988765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.90 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=210.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
+.|+...++|+|+||+||+++++.+|+.||||++....+ .-.+-.++|+++++.++|||+|.++++ |.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 468888999999999999999999999999999974433 224567899999999999999999999 5667889
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+||++. ++.+-++.+. ..++...+.++++|++.|+.|+|++ ++|||||||+|||++.+|.+|+||||+|
T Consensus 77 hLVFE~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred EEEeeecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhh
Confidence 999999998 6666666653 4578889999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh-HHHHhhCch
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH-GFVKMALPE 938 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~-~~~~~~~~~ 938 (1003)
+.+.. ....++-++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-++-+. ...-..+.+
T Consensus 149 R~L~~-----pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 149 RTLSA-----PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred HhhcC-----CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 98752 2233444678999999999887 6899999999999999999999988876432222111 111111223
Q ss_pred hHHHHHHhh------ccc---CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFA------LLL---DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~------l~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+-..+.... ... ++.+...........+.+++..|++.||++|++-+|++.|
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 333332211 111 1112222334455678899999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=349.81 Aligned_cols=202 Identities=33% Similarity=0.496 Sum_probs=183.1
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..++|++.++||+|+||+||.++.+++++.+|+|++++.. ..+.+...+|..++.+++||.||+++.. |++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 3578999999999999999999999999999999997543 3456788999999999999999999876 7889
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..|+|+||+.||.|..++++ ++.+++..++-++.+|+.||.|||+. +|||||+||+|||+|++|+++|+||
T Consensus 98 ~kLylVld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred CeEEEEEeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 999999999999999999998 57899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
|+++.... .......++||+.|||||++.+..|+.++|.||+|+++|||++|.+||..
T Consensus 170 gL~k~~~~-----~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 170 GLCKEDLK-----DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred ccchhccc-----CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 99985422 22333458999999999999999999999999999999999999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.26 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=217.7
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
....|++.++||.|..++||+|+....+..||||++..+... ..+.+.+|+..++.++||||++++.. |..+..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEecce
Confidence 356899999999999999999999999999999999866543 35889999999999999999999987 566788
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.|+||.||.+|++.+.++... ...+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 999999999999999999875 34599999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC--CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG--GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
+..+.+......... ..++||+.|||||++.. ..|+.|+||||||++..|+.+|..||..+++-.
T Consensus 173 sa~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------------ 239 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------------ 239 (516)
T ss_pred eeeecccCceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------------
Confidence 988776542222222 56789999999999544 468999999999999999999999998765321
Q ss_pred hhHHHHHHhhcccCC------CCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDP------GNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.-..++.+| .............|.+++..|++.||++|||+++++++
T Consensus 240 -----vLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 240 -----VLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -----HHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1112222222 11223334456689999999999999999999999975
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.45 Aligned_cols=375 Identities=24% Similarity=0.268 Sum_probs=295.5
Q ss_pred ceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCc
Q 001858 200 QQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQN 279 (1003)
Q Consensus 200 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N 279 (1003)
+.|++++|++....+..|.++++|+.+++..|.++. +|.... ...+|+.|+|.+|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~------------------------IP~f~~-~sghl~~L~L~~N 135 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR------------------------IPRFGH-ESGHLEKLDLRHN 135 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhhh------------------------cccccc-cccceeEEeeecc
Confidence 456666666666666666666666666666666552 222221 3345666777777
Q ss_pred ccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCC
Q 001858 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRF 359 (1003)
Q Consensus 280 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l 359 (1003)
.|+.+-.+.++.++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+.++.+. |.++.+|.+|.|+.|++
T Consensus 136 ~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~------F~~lnsL~tlkLsrNri 209 (873)
T KOG4194|consen 136 LISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGH------FDSLNSLLTLKLSRNRI 209 (873)
T ss_pred ccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccc------ccccchheeeecccCcc
Confidence 777666667777788888888888888777667777777888888888888877764 44666788888888888
Q ss_pred CCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccc
Q 001858 360 GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI 439 (1003)
Q Consensus 360 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 439 (1003)
+...+..|.++++|+.|+|..|+|.-.--..|.++++|+.|.|..|.|.......|..+.++++|+|+.|+++..-..++
T Consensus 210 ttLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~l 289 (873)
T KOG4194|consen 210 TTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWL 289 (873)
T ss_pred cccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccc
Confidence 87777778888888888888888875446678888888888888888887777788888888888888888887777788
Q ss_pred cCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCccccccccccccccccc
Q 001858 440 GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLI 519 (1003)
Q Consensus 440 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~ 519 (1003)
.+++.|+.|+||+|.|+..-++++..+++|++|+|++|+|+ .++++-+...+.++.|+|++|.++......|..+++|+
T Consensus 290 fgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~ 368 (873)
T KOG4194|consen 290 FGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH 368 (873)
T ss_pred cccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence 88888888888888888777888888888888888888888 67777666666677778888888877778899999999
Q ss_pred cccccccccccccCc---cccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecC
Q 001858 520 QLDISRNRFSGEIPT---TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596 (1003)
Q Consensus 520 ~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 596 (1003)
.|||++|.|+..|.+ .|.++++|+.|+|.+|+|......+|.++..|+.|||.+|.|..+-|++|..+ .|+.|-++
T Consensus 369 ~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 369 KLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred hhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 999999999977654 68889999999999999995555789999999999999999999999999999 89999998
Q ss_pred CCcccccCCCC
Q 001858 597 YNDFEGQVPTK 607 (1003)
Q Consensus 597 ~N~l~~~~p~~ 607 (1003)
.-.|-|.+-.+
T Consensus 448 SssflCDCql~ 458 (873)
T KOG4194|consen 448 SSSFLCDCQLK 458 (873)
T ss_pred ccceEEeccHH
Confidence 88887776554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.84 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=212.2
Q ss_pred HHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc
Q 001858 699 NKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 699 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 774 (1003)
++...+|.+++.||+|+|++||+|+...+++.||||++.+. .+...+....|-.+|.++ .||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 34567899999999999999999999999999999998633 334456777889999999 89999999977 7
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEE
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
.++...|+|+||+++|+|.++|++ .+.+++..++.++.+|+.|++|||++ |||||||||+|||+|.||++||
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEE
Confidence 888999999999999999999998 46899999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccCCcc------c--cCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcc
Q 001858 855 SDFGLAKFLFDRPIQ------E--TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL 926 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~------~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~ 926 (1003)
+|||.|+.+.+.... . .......++||..|.+||++..+..++++|+|+||||+|+|+.|++||.+... ..
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yl 294 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YL 294 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HH
Confidence 999999988754322 1 11122568999999999999999999999999999999999999999976321 00
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
. .+++++. ...-| +..++...+++.+.+..||++|++.++|.+|-
T Consensus 295 i------------FqkI~~l-~y~fp-------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 I------------FQKIQAL-DYEFP-------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred H------------HHHHHHh-cccCC-------CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0 1122221 11111 12234556667777788999999999998763
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=375.52 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=219.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCC---ceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDL---LPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
...+.++||.|.||+||+|+.+..+ ..||||.++... +..+.+|..|+.||.++.||||+++.|+. .....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence 3457889999999999999997555 569999998543 44567999999999999999999999994 55677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|.|||++|+|+.|++.+ ++.+.+.|...+.++||.|++||.+. ++||||+.++||||+.+..+|++|||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 89999999999999999986 46799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
++.+.+.. +......+-.-+.+|.|||++...+++.+|||||+|+++||.++ |..||.++.+.
T Consensus 778 SRvledd~--~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-------------- 841 (996)
T KOG0196|consen 778 SRVLEDDP--EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------------- 841 (996)
T ss_pred eeecccCC--CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------------
Confidence 99886544 11111112223579999999999999999999999999999888 99999987653
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
++...++... |.+.+.+|+..+.++|++||+.|-.+||.+++|+..|.++.++
T Consensus 842 dVIkaIe~gy------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 842 DVIKAIEQGY------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHhcc------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3333344333 3344567889999999999999999999999999999887653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=348.95 Aligned_cols=265 Identities=27% Similarity=0.402 Sum_probs=209.9
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|...+.||+|+||+||++.+..++...|||..........+.+.+|++++++++|||||+++|.... .....++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeE
Confidence 4568888999999999999999998899999999876544346779999999999999999999996322 1113688
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a 860 (1003)
++|||+++|+|.+++.+.. +.+++..+..+..||++|++|||++ |||||||||+|||++. ++.+||+|||++
T Consensus 93 i~mEy~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeeeccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999999999853 2799999999999999999999999 9999999999999999 799999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
..... ............||+.|||||++..+ ...+++||||+||++.||+||+.||.... +.
T Consensus 166 ~~~~~--~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~ 228 (313)
T KOG0198|consen 166 KKLES--KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EE 228 (313)
T ss_pred ccccc--ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------ch
Confidence 86643 12223334457899999999999854 44569999999999999999999987530 00
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
........ .... .+..++.++....+++.+|+..+|+.|||++++++|.....+
T Consensus 229 ~~~~~~ig-~~~~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIG-REDS--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHh-ccCC--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 01111111 1110 112223356677889999999999999999999998765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=321.31 Aligned_cols=268 Identities=23% Similarity=0.331 Sum_probs=210.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.+|...+++|+|.||.||+|++.++|+.||||.++... ++-.....+|++.++.++||||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 46888899999999999999999999999999997443 3335678899999999999999999999 6678888
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
.+|+|||+. +|...|+.. ...+...++..++.++++|++|||++ .|+|||+||.|+|++.+|.+||+|||+|
T Consensus 77 ~lVfEfm~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred EEEEEeccc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccch
Confidence 999999988 999999875 45789999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hC
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---AL 936 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~ 936 (1003)
+.+...... ....+.|.+|.|||.+.|. .|+..+||||.|||+.||+-|.+-|.+...- .++...+.. ..
T Consensus 149 r~f~~p~~~-----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~ 222 (318)
T KOG0659|consen 149 RFFGSPNRI-----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPT 222 (318)
T ss_pred hccCCCCcc-----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCC
Confidence 987643322 2223679999999998875 6899999999999999999988776653321 122111111 11
Q ss_pred chhH---H---HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKV---M---EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~---~---~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
++++ . +..+-.....+ ........+..+..+++..++..+|.+|.+++|++++
T Consensus 223 ~~~WP~~~~lpdY~~~~~~P~~-~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 223 PDQWPEMTSLPDYVKIQQFPKP-PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccCccccccccHHHHhcCCCC-ccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 1 11221111111 2222344556677899999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.06 Aligned_cols=273 Identities=24% Similarity=0.341 Sum_probs=212.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.+.|+.+++||+|.||.||+|++..+|+.||+|+++... ++......+||.++++++||||+++.+.... .....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~---~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS---KLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe---cCCce
Confidence 356778899999999999999999999999999998654 5667788999999999999999999998654 23568
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.|+|+|||++ +|.-++... .-.+++.++..++.|++.|++|+|++ ||+|||||.+|||+|.+|.+||+|||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 8999999999 898888763 45799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC--
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL-- 936 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~-- 936 (1003)
|+++.... ....+..+.|.+|.|||.+.|. .|+.++|+||.|||+.||+.|++.|.+...- .++...++..-
T Consensus 265 Ar~y~~~~----~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP 339 (560)
T KOG0600|consen 265 ARFYTPSG----SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSP 339 (560)
T ss_pred eeeccCCC----CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCC
Confidence 99875433 2234557789999999998875 7999999999999999999999998764321 12222221111
Q ss_pred chhHHHHHH---hhcccCCCC-c---hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVD---FALLLDPGN-E---RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~---~~l~~~~~~-~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.++.....+ ......... + ++.........++++..++..||++|.|+.+++++
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111000 000000011 1 12233455677888889999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.28 Aligned_cols=248 Identities=29% Similarity=0.467 Sum_probs=214.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..+ .+.+.+.+|++++++++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 578888999999999999999999999999999975543 446789999999999999999999998 6778899
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|.||+.| +|..+++. ++.++++++..++.+++.|+.|||+. +|.|||+||+||+++..|++|+||||+|
T Consensus 77 ~vVte~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred EEEehhhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhh
Confidence 999999988 99999998 67899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
+.+... ........||+.|||||...+++|+..+|.||+||++|||++|++||-. ..+
T Consensus 148 r~m~~~-----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----------------~si 205 (808)
T KOG0597|consen 148 RAMSTN-----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----------------RSI 205 (808)
T ss_pred hhcccC-----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----------------HHH
Confidence 977443 2333457899999999999999999999999999999999999999853 234
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.++++.....++ .-+ ......+..+....+..||..|.+..+++.|
T Consensus 206 ~~Lv~~I~~d~v-~~p---~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 206 TQLVKSILKDPV-KPP---STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHhcCCC-CCc---ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 444444433322 111 1456778888889999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.39 Aligned_cols=268 Identities=27% Similarity=0.425 Sum_probs=213.7
Q ss_pred HHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecc
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID 773 (1003)
Q Consensus 696 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 773 (1003)
.++....++..+.+.||+|+||+||+|+|.++ ||||++.... ++..+.|.+|+.++++-+|.||+-|.|||..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 45555677788999999999999999999865 9999998554 3356899999999999999999999999643
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
+.. .+|+.+++|.+|+.+++.. +..++..+...||.||++|+.|||.+ +|||||+|..||++.++++||
T Consensus 460 ---p~~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 460 ---PPL-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred ---Cce-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEE
Confidence 333 8999999999999999875 46799999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCC---CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~ 930 (1003)
|+|||++..-..- ..........|...|||||++..+ +|++.+||||||+|+|||++|..||.. .+.+..+..
T Consensus 529 IgDFGLatvk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm 604 (678)
T KOG0193|consen 529 IGDFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM 604 (678)
T ss_pred Eecccceeeeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE
Confidence 9999999643211 111122234578899999987653 689999999999999999999999983 322221110
Q ss_pred HHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 931 FVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
.-+.... .+.......+.+++.+++..||..++++||.+.+|+..|+++..+.
T Consensus 605 VGrG~l~---------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 605 VGRGYLM---------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ecccccC---------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0000000 0112233456788999999999999999999999999998887753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.01 Aligned_cols=272 Identities=20% Similarity=0.273 Sum_probs=212.0
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccch-HHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 778 (1003)
..++|.+.++||.|.||.||+|+...++..||||.++..-..+. -.=.+|++.+++++ ||||+++.+++ .+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi-----~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI-----RDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh-----hccC
Confidence 35689999999999999999999999999999999974433322 23368999999998 99999999984 3344
Q ss_pred -ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 779 -FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 779 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
..++|||||+. +|+++++.+ +..+++.+++.|+.||++||+|+|++ |+.|||+||+|||+.....+||+||
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 89999999976 999999885 56899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccC-CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchh--hHHHHh
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL--HGFVKM 934 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~--~~~~~~ 934 (1003)
|+||..... ..++.++.|.+|.|||++. .+.|+.+.||||+|||++|+.+-++-|.+...-++-+ .+....
T Consensus 155 GLARev~Sk------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 155 GLAREVRSK------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGT 228 (538)
T ss_pred ccccccccC------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCC
Confidence 999977543 2334467899999999865 5688999999999999999999998887643222211 111111
Q ss_pred hCc---hhHHHHHHhhcccCCCCc----hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 935 ALP---EKVMEIVDFALLLDPGNE----RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 935 ~~~---~~~~~~i~~~l~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
... .+-..+...+-..-|... ......+..+..+++.+|+.+||.+|||++|.+++-
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111 111223333322222222 222334677889999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.80 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=214.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
..|..-++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++-| ...+..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence 4577778999999999999999999999999999988888888899999999999999999999874 44578899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|||||+||+|.|.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..
T Consensus 348 VMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 99999999999999863 489999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
+.... ......+||+.|||||+.....|++++||||||++++||+-|.+||-... .++.
T Consensus 419 i~~~~-----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----------------PlrA 477 (550)
T KOG0578|consen 419 ISEEQ-----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----------------PLRA 477 (550)
T ss_pred ccccc-----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----------------hHHH
Confidence 64432 34456789999999999999999999999999999999999999985321 1122
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.--.... ..+....+.+...+.++..+|+..||++|++++|+++|
T Consensus 478 lyLIa~ng--~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 478 LYLIATNG--TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHhhcC--CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111112 22333445667889999999999999999999999986
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.35 Aligned_cols=375 Identities=21% Similarity=0.247 Sum_probs=288.8
Q ss_pred CCcccCccccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCcc
Q 001858 88 VGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAY 167 (1003)
Q Consensus 88 ~~g~~~~~l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~ 167 (1003)
+.|.+|+ .-+.||||+|.++..=+.+|.++.+|+.++|..|.++ .||...+...+|+.|+|.+|.|+ ++..+
T Consensus 72 l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se 143 (873)
T KOG4194|consen 72 LKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSE 143 (873)
T ss_pred cCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHH
Confidence 4555554 3467999999999667788999999999999999999 89998888888999999999998 45443
Q ss_pred ccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCccc-CCch
Q 001858 168 IGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN-ISSL 246 (1003)
Q Consensus 168 ~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L 246 (1003)
--..++.|+.||||.|.++..--+++..-.++++|+|++|+|+..--+.|..+.+|.+|.|+.|+++..++..|. ++.|
T Consensus 144 ~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L 223 (873)
T KOG4194|consen 144 ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKL 223 (873)
T ss_pred HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchh
Confidence 333458899999999999854446777778899999999999988788899999999999999999987776665 7788
Q ss_pred hHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCC
Q 001858 247 EQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326 (1003)
Q Consensus 247 ~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 326 (1003)
+.|+|..|++. .+-...|.++++|+.|.|..|.|...-...|..+.++++|+|+.|+++..-..++.+++.|+.|+|++
T Consensus 224 ~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~ 302 (873)
T KOG4194|consen 224 ESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSY 302 (873)
T ss_pred hhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccch
Confidence 88888888776 33333455777777777777777766666777777777777777777777777777777777777777
Q ss_pred CCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEccccc
Q 001858 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQ 406 (1003)
Q Consensus 327 N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 406 (1003)
|.|..+.+..|. -+++|++|+|++|+|+...+.+|..++.|++|+|++|.|...-..+|..+++|++|||++|.
T Consensus 303 NaI~rih~d~Ws------ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ 376 (873)
T KOG4194|consen 303 NAIQRIHIDSWS------FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNE 376 (873)
T ss_pred hhhheeecchhh------hcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCe
Confidence 777777666543 36777778888887777777777777777777777777776666777777777777777777
Q ss_pred ccccCCC---ccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCcc
Q 001858 407 LTGTIPY---TIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478 (1003)
Q Consensus 407 l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 478 (1003)
|...+.+ .|.++++|+.|+|.+|+|..+...+|.++.+|++|+|.+|.|...-|++|..+ .|++|-+..-.
T Consensus 377 ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 377 LSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred EEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 7765543 46667777777777777776666677777777777777777777777777777 77777665433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.24 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=207.1
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc----cc-cchHHHHHHHHHHHhcC-CCCceeEeeeeeeccc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK----QK-GSIKSFVAECEALKNIR-HRNLIKIITVCSSIDF 774 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 774 (1003)
..+.|.+.+.||+|+||.|+.|.+..++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 457899999999999999999999999999999987653 22 23456778999999998 99999999994
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-CCeE
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAH 853 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~k 853 (1003)
......++||||+.+|+|.+++.. .+.+.+.++..++.|++.|++|+|++ ||+||||||+||+++.+ +.+|
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEE
Confidence 456668999999999999999998 46788999999999999999999999 99999999999999999 9999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCC-CC-ccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VS-LTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++...
T Consensus 162 l~DFG~s~~~~-----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------- 228 (370)
T KOG0583|consen 162 LSDFGLSAISP-----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------- 228 (370)
T ss_pred EeccccccccC-----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------
Confidence 99999998763 1223334578999999999999977 76 789999999999999999999986211
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHH-HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEEC-LTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+...+.+....-|. .+ ...+..++.+|+..+|.+|+++.|+.++
T Consensus 229 ------~~l~~ki~~~~~~~p~-------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 229 ------PNLYRKIRKGEFKIPS-------YLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ------HHHHHHHhcCCccCCC-------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 1111112222222221 11 5567888999999999999999999955
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.95 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=213.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+-|++++-||.|+.|.|-.|++..+|+.+|||++.... ......+.+|+-+|+-+.||||++++++ +++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 356889999999999999999999999999999997552 2234678899999999999999999999 67889
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
++|+|.||+++|.|++++-. ++++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||
T Consensus 86 ~lylvlEyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred eEEEEEEecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence 99999999999999999988 67899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCC-ccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVS-LTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
+|....++.. -...+|++.|+|||++.|.+|+ .++||||.|||+|.+++|+.||++.
T Consensus 158 MAsLe~~gkl------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---------------- 215 (786)
T KOG0588|consen 158 MASLEVPGKL------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---------------- 215 (786)
T ss_pred eeecccCCcc------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc----------------
Confidence 9986544333 3346799999999999999885 7899999999999999999999841
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.++.+..+-... ...++...+.+..+++++|+..||++|.|++||.+|-.
T Consensus 216 -Nir~LLlKV~~G----~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 216 -NIRVLLLKVQRG----VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred -cHHHHHHHHHcC----cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 222222222211 12233455667888899999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=377.15 Aligned_cols=265 Identities=26% Similarity=0.469 Sum_probs=219.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCC-----ceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDL-----LPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
...+..+.||+|+||+||+|...... ..||||.+++. +.++..+|.+|..+|+.++||||++++|+|. .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l----~- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL----D- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec----C-
Confidence 34556788999999999999985432 34999988744 4566789999999999999999999999984 3
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEE
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQV--DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
....++++|||++|+|..||++.+... ...+...+...++.|||+|+.||+++ ++|||||.++|+|+++...+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 666799999999999999999975432 45689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHH
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+|||+|+.+.+..+...... ..-+.+|||||.+..+.++.|+|||||||++||+++ |..||....+.+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~---a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------- 913 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE---AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------- 913 (1025)
T ss_pred cccchhHhhhhchheeccCc---cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------
Confidence 99999998776665544433 223568999999999999999999999999999999 9999987543211
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
+..+.... |.+.+..|++.++++|.+||+.+|++||++..+++.+.++.+..
T Consensus 914 ------~~~~~~gg-------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 914 ------LLDVLEGG-------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ------HHHHHhCC-------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11122222 34445678899999999999999999999999999888876554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.04 Aligned_cols=279 Identities=22% Similarity=0.261 Sum_probs=221.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEec--cccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
....|...+.||+|+||.|+.|.++.+++.||||++. .......++..+|+++++.++|+||+.+.++........-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666799999999999999999999999999997 56666778999999999999999999999997664445567
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..|+|+|+|+. +|.+.++. +..+....+..+..|+++|++|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 100 DvYiV~elMet-DL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHhh-HHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 78999999966 99999987 34589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcc-hhhH------
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL-TLHG------ 930 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~-~~~~------ 930 (1003)
+|+..... ......+..+.|.+|.|||.+.. ..|+.+.||||.|||+.||++|+.-|.+...-++ ....
T Consensus 171 LAR~~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 171 LARYLDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred ceeecccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 99987543 23344456788999999998654 6899999999999999999999999876432211 1111
Q ss_pred ---HHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 931 ---FVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 931 ---~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.....-++.+...+...-...+.+-............++..+++..||.+|+|++|+++|-
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1111112233333443333333333344445667788999999999999999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.30 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=206.3
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..++|++.++||+|+||+||+|+-+.+|..+|+|++++.. ....+....|-.+|....+|.||+++.. |.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998553 4456788899999999999999999976 7889
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+++||||||++||++..+|.+ .+.+++..++.++.+++-||+-+|+. |+|||||||+|+|||..|++||+||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred CeeEEEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence 999999999999999999988 67899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCc------------------cccCc------------------------ccccccccccccCccccCCCCC
Q 001858 858 GLAKFLFDRPI------------------QETSS------------------------SSIGIKGTVGYVAPEYGMGGNV 895 (1003)
Q Consensus 858 G~a~~~~~~~~------------------~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~ 895 (1003)
|++.-+..... ..... .....+|||.|||||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99954422100 00000 0023679999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhc-ccCCCCchhhHHHHHHHHHHHHhhcc
Q 001858 896 SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFAL-LLDPGNERAKIEECLTAVVRIGVLCS 974 (1003)
Q Consensus 896 ~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~~~~~~~~~~~~~~~~l~~l~~~cl 974 (1003)
+..+|.||+|||+|||+.|.+||....+. +-...++.... ...|.+. .+..+..+++.+|+
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-------------~T~rkI~nwr~~l~fP~~~-----~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQ-------------ETYRKIVNWRETLKFPEEV-----DLSDEAKDLITRLL 427 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHHHhhhccCCCcC-----cccHHHHHHHHHHh
Confidence 99999999999999999999999875432 11222222111 1122111 22355677777888
Q ss_pred ccCCCCCCC---HHHHHHH
Q 001858 975 MESPSERIH---MADAVKN 990 (1003)
Q Consensus 975 ~~~p~~RPs---~~ev~~~ 990 (1003)
. ||++|.- ++||.+|
T Consensus 428 ~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred c-CHHHhcCcccHHHHhcC
Confidence 7 9999984 5666543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.11 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=210.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
...|+..+.||+|+||.||+|.+..+++.||+|++..+. +.+++++++|+.++..++++||.++++. +..+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccH
Confidence 346777899999999999999999999999999998554 4567899999999999999999999998 4557778
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
+++|||+.||++.+.++. ...+.+..+.-+.+++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 999999999999999987 34457888888999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
..+.... .....++||+.|||||++....|+.|+||||+|++.+||++|.+|+....+-..
T Consensus 159 ~ql~~~~-----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------- 219 (467)
T KOG0201|consen 159 GQLTNTV-----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------- 219 (467)
T ss_pred eeeechh-----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------
Confidence 7654322 222458899999999999988999999999999999999999999987644111
Q ss_pred HHHHHhhcccCCCCchhhH-HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKI-EECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+..-|...++.. ..+...+.+++..|++.+|+.||++.++++|
T Consensus 220 -------lflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 -------LFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -------EEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111111111111 1456778999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=350.69 Aligned_cols=268 Identities=24% Similarity=0.395 Sum_probs=207.3
Q ss_pred HhccCCccCeeeeccceEEEEEEEC-----CCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 773 (1003)
..++|++.++||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|+++++.+ +||||++++++|.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT--- 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence 3468999999999999999999852 345689999987432 23356789999999999 8999999999863
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCC---------------------------------------------------
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQ--------------------------------------------------- 802 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 802 (1003)
......++||||+++|+|.+++......
T Consensus 82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 3345678999999999999999764211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccc
Q 001858 803 ------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876 (1003)
Q Consensus 803 ------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 876 (1003)
+...+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~ 234 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 234 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch---hccc
Confidence 123578889999999999999999999 9999999999999999999999999999765322111 1112
Q ss_pred cccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCc
Q 001858 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNE 955 (1003)
Q Consensus 877 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~ 955 (1003)
...++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .....+......
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------------~~~~~~~~~~~~----- 296 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------------EFCQRLKDGTRM----- 296 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------------HHHHHHhcCCCC-----
Confidence 2346788999999999999999999999999999997 999987643211 111111111000
Q ss_pred hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 956 RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 956 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
.....+...+.+++.+||+.+|++||++.|+++.|+.+.++
T Consensus 297 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 297 -RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01122345688999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.46 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=205.8
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
.-.+-||.|+.|.||+|+.. ++.||||+++.-+ ..+++-+++++||||+.|.|+|.. ...++||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiME 192 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIME 192 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-----CceeEEeee
Confidence 34577999999999999996 5589999886322 347888999999999999999864 456699999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
||..|-|.+.++. +..+...-...|..+||.|+.|||.+ .|||||+|.-||||+.+..+||+|||.++...+
T Consensus 193 fCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 193 FCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred ccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999998 55788888899999999999999999 999999999999999999999999999987643
Q ss_pred CCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1003)
. .....++||..|||||++.+.+++.|+||||||||||||+||..||.+....... +.+
T Consensus 265 ~------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII--wGV------------- 323 (904)
T KOG4721|consen 265 K------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII--WGV------------- 323 (904)
T ss_pred h------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE--Eec-------------
Confidence 2 4455689999999999999999999999999999999999999999765432111 000
Q ss_pred hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 946 FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 946 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
....-..+.+..|++-|.-++++||+..|..||++.+++.|+..+...+
T Consensus 324 ----GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 324 ----GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred ----cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 0111223455677888999999999999999999999999998765543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.51 Aligned_cols=266 Identities=27% Similarity=0.360 Sum_probs=208.3
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--------------cchHHHHHHHHHHHhcCCCCceeE
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--------------GSIKSFVAECEALKNIRHRNLIKI 765 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~ 765 (1003)
+.-++|++.+.||+|.||.|-+|++..+++.||||++.+... ...+...+|+.++++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345899999999999999999999999999999999963321 113578899999999999999999
Q ss_pred eeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 766 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
+++.. ....+..|+|+||+..|.+.+.-.. ...+.+.++++++.++..||+|||.+ |||||||||+|+|
T Consensus 174 iEvLD---DP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL 242 (576)
T KOG0585|consen 174 IEVLD---DPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL 242 (576)
T ss_pred EEeec---CcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence 99853 4556789999999998877643221 22399999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCC----CCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN----VSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
++++|++||+|||.+..+..+........-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999999998664332222222333467999999999877632 357889999999999999999998642
Q ss_pred cCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 922 FNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
. ..+..++... +| -..+..++..+.+..++.+++..||+.|.+..||..|.+..+
T Consensus 323 ~-----------------~~~l~~KIvn-~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 323 F-----------------ELELFDKIVN-DP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred h-----------------HHHHHHHHhc-Cc-ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 1 2222222221 11 112222345677888999999999999999999998876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.23 Aligned_cols=265 Identities=26% Similarity=0.454 Sum_probs=221.9
Q ss_pred HHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 696 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
++++-...+....++||-|.||+||.|.|+...-.||||.++ ++....++|.+|+.+|+.++|||+|+++|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~---- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH---- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc----
Confidence 334444456677889999999999999999999999999998 445567899999999999999999999999854
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 855 (1003)
+...|||+|||.+|+|.||++++. +..++....+.+|.||+.|++||..+ .+||||+.++|+||+++..+|++
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEee
Confidence 456699999999999999999876 44677778899999999999999999 99999999999999999999999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHh
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
|||+++++....+.... +..-++.|.|||-+....++.|+|||+|||++||+.| |-.||.+.+-.
T Consensus 408 DFGLsRlMtgDTYTAHA----GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------- 473 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------- 473 (1157)
T ss_pred ccchhhhhcCCceeccc----CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------
Confidence 99999998665544432 2345788999999999999999999999999999999 88888764311
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
++..++++.. |....+.|+..++++|+.||+++|++||+++|+-+.++.+..
T Consensus 474 ----qVY~LLEkgy------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 474 ----QVYGLLEKGY------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ----HHHHHHhccc------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1223333333 233456788999999999999999999999999999887543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=311.86 Aligned_cols=200 Identities=29% Similarity=0.412 Sum_probs=181.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
-.+|+..+.||.|+||.|.+++.+.++..+|+|++++.. ....+...+|..+++.+.||.++++++. +.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 357888999999999999999999999999999997543 2345678899999999999999999987 56788
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||++||.|..++++ .+.+++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred eEEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 89999999999999999998 46799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCccc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF 922 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~ 922 (1003)
+|+...+. ....+||+.|+|||.+....++.++|.|||||++|||+.|..||....
T Consensus 190 FAK~v~~r--------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 190 FAKRVSGR--------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ceEEecCc--------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 99877443 234789999999999999999999999999999999999999997643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.40 Aligned_cols=282 Identities=26% Similarity=0.351 Sum_probs=214.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc--CCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI--RHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
..+..+.+.||+|.||+||+|.+. |+.||||++...++ +.+.+|.++++.+ +|+||..|++.-.. +...-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEE
Confidence 456788899999999999999997 55899999975444 5677888888876 99999999986322 1122345
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEeccCCCCceEeCCCCCeEE
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH-----CQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
.++|++|.+.|||+||+.++ .++.....+++..+|.||+|||.. .+|.|.|||||++||||..++.+.|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 78999999999999999863 588899999999999999999964 5789999999999999999999999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCCC----C--CccccchhHHHHHHHHHhCCCCCCcccCCcchh
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN----V--SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~ 928 (1003)
+|+|+|....... ..........+||.+|||||++...- + -..+||||||.|+||+.....--+-...-...+
T Consensus 358 ADLGLAv~h~~~t-~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 358 ADLGLAVRHDSDT-DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred eeceeeEEecccC-CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999998765432 22333444578999999999987642 1 235999999999999987432211111111111
Q ss_pred hHHHHhhCc-hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 929 HGFVKMALP-EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 929 ~~~~~~~~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
.++++...+ +++.+++...-.....+.++...++...+.++|+.||..+|+.|.|+--+.+.+.++.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222222 34555555444444445677778889999999999999999999999999999988764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.68 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=212.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
..+|++.+.||+|.||.|-+|.....|+.||||.+++.. +++.-.+.+|++||+.++||||++++.+ |++.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 357889999999999999999998899999999997543 4445578899999999999999999998 77888
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
...+||||..+|.|+||+.. .+.+++.+++.+++||..|+.|+|.+ +++|||+|.+|||+|+++++||+|||
T Consensus 127 KIvivMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred eEEEEEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 89999999999999999998 56899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCC-CccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
++-.+.+. ..-..++|++-|.+||...+.+| ++.+|-||+|+++|-++.|..||++.+-
T Consensus 199 LSNly~~~------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------------- 258 (668)
T KOG0611|consen 199 LSNLYADK------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------------- 258 (668)
T ss_pred hhhhhccc------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------------
Confidence 99876443 34456899999999999999888 4789999999999999999999987431
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
..+..-+.......|.. +....-++++++..+|++|.|+.+|..|-+
T Consensus 259 k~lvrQIs~GaYrEP~~--------PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 259 KRLVRQISRGAYREPET--------PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHHhhcccccCCCC--------CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 12333344444444422 234456788999999999999999987743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=346.97 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=210.8
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCc---e-EEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLL---P-VAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 773 (1003)
..++-.+.++||+|+||+||+|+....+. . ||||..+.. .....++|.+|+++++.++|||||+++|++
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa---- 230 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA---- 230 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 34555667999999999999999865322 3 899998842 355678999999999999999999999995
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
..+...++|||++.||+|.+++++.. +.++..+...++.+.|.||+|||+. +++||||.++|+|++.++.+|
T Consensus 231 -~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 231 -VLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred -cCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 44677899999999999999999853 3699999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~ 932 (1003)
|+|||+++.-.. +.... ....-+.+|+|||.+..+.+++++|||||||++||+++ |..||.++...
T Consensus 303 ISDFGLs~~~~~--~~~~~---~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------- 369 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--YVMKK---FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------- 369 (474)
T ss_pred eCccccccCCcc--eeecc---ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------
Confidence 999999975321 11111 01135689999999999999999999999999999999 89998875432
Q ss_pred HhhCchhHHHHH-HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 001858 933 KMALPEKVMEIV-DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 933 ~~~~~~~~~~~i-~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~ 999 (1003)
++...+ ........ ....+..+..++.+||..+|++||+|.++.+.++.+.+...
T Consensus 370 ------~v~~kI~~~~~r~~~------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 ------EVKAKIVKNGYRMPI------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------HHHHHHHhcCccCCC------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 222222 21211111 11345677888889999999999999999999999887655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.38 Aligned_cols=280 Identities=24% Similarity=0.290 Sum_probs=210.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc--CCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI--RHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
......+.+|+|+||.||+|... ++.||||++.... .+.|++|-+|++.. +|+||++|+++-...+.. ...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 34556789999999999999996 4799999997543 36788888888765 899999999984443322 5578
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCcEeccCCCCceEeCCCCCeEE
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH------CQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
++|+||.+.|+|.+|++.+ .++|....+++..+++||+|||+. .+|+|+|||||++||||..|+++.|
T Consensus 284 wLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 9999999999999999974 589999999999999999999976 3689999999999999999999999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCCC-C-----CccccchhHHHHHHHHHhCCCCCCcccCCc--c
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-V-----SLTGDVYSFGILLLEMFTGRRPTHTMFNDG--L 926 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDvwslG~il~ell~g~~P~~~~~~~~--~ 926 (1003)
+|||+|..+.+.. .......-+||.+|||||++.+.. + -.+.||||+|.|+|||++...-+.....++ .
T Consensus 358 aDFGLAl~~~p~~---~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 358 ADFGLALRLEPGK---PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred eccceeEEecCCC---CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 9999998886432 222233478999999999987752 1 235899999999999999766543222222 2
Q ss_pred hhhHHHHhhC-chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 927 TLHGFVKMAL-PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 927 ~~~~~~~~~~-~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
.+...+.... -+++++.+-+.-....-...+........+.+.+..||+.||+.|.|+.=+-+++.++..-
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 2222233222 2345544433222211112222234556788899999999999999999999988876543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.88 Aligned_cols=271 Identities=24% Similarity=0.321 Sum_probs=205.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
-.|+-.+++|.|+||.||+|...++++.||||+.-..... -.+|+++|+++.|||||++.-++......+.-+..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3567779999999999999999999999999987533221 236999999999999999998876644333456779
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-CCeEEccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAK 861 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG~a~ 861 (1003)
|||||+. +|.++++..... +..++...++-+.+|+++|++|||+. +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 100 VleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 9999988 999999864333 45788888999999999999999998 99999999999999976 899999999999
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
.+..+. ....+..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.. +..++...++..-.+.
T Consensus 175 ~L~~~e------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt- 246 (364)
T KOG0658|consen 175 VLVKGE------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPT- 246 (364)
T ss_pred eeccCC------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCC-
Confidence 875432 22446789999999998875 79999999999999999999999998743 3333333333221111
Q ss_pred HHHHHhhcc-----cCCCCchh-----hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALL-----LDPGNERA-----KIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~-----~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.+..+-. ..|.-... .......+..+++.++++++|.+|.++.|++.+
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111110 01111110 122345678899999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=310.71 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=207.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|++-+.||+|+|+.||++.+..+|+.+|+|++.... ....+.+.+|++|.+.++||||+++.+. +....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 467888999999999999999999999999999986332 3356889999999999999999999987 566788
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC---CCCeEEcc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSD 856 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~D 856 (1003)
.|+|+|+|+|++|..-|-.. ..+++..+-.+..||++|+.|+|.+ +|||||+||+|+++.. ...+|++|
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecc
Confidence 89999999999998777652 4678888999999999999999999 9999999999999953 44699999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
||+|..+.+ .....+++|||+|||||++...+|+..+|||+.||++|-++.|++||.+....
T Consensus 157 FGvAi~l~~------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------------ 218 (355)
T KOG0033|consen 157 FGLAIEVND------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------ 218 (355)
T ss_pred cceEEEeCC------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------------
Confidence 999987752 23344678999999999999999999999999999999999999999874321
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
++.++..+.+.....+.+....++..+++++|+..||++|.|+.|.++|=+
T Consensus 219 -----rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 219 -----RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred -----HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 122222222222222333444566778888999999999999999887643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=345.62 Aligned_cols=276 Identities=21% Similarity=0.264 Sum_probs=205.4
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.++||+|+||.||+|++..+++.||||+++.. .......+.+|++++++++||||+++++++......+....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999999999999998632 223345788999999999999999999987544334445689
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||++ ++|.+++.. ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 599999876 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCC--CCCCccccchhHHHHHHHHHhCCCCCCcccCCcch-h-hHHHHhhC-
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMG--GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT-L-HGFVKMAL- 936 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~-~-~~~~~~~~- 936 (1003)
........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... . ........
T Consensus 152 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 152 VAFNDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccCc--cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 54322111 111233568999999998765 67899999999999999999999999754321100 0 00000000
Q ss_pred -------chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 -------PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 -------~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.....+.........+.............+.+++.+|++.+|++||+++|++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111112222222222211111112234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=372.00 Aligned_cols=471 Identities=28% Similarity=0.362 Sum_probs=258.8
Q ss_pred cCccccCCCCCcEEEcCCCCCCCCCchh-hcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccc
Q 001858 92 LSPYVGNLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGY 170 (1003)
Q Consensus 92 ~~~~l~~l~~L~~L~L~~n~~~g~ip~~-l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~ 170 (1003)
||..+..=..|+.|+++.|-+- ..|-+ +.+..+|+.||||+|.++ ..|..|..+.+|+.|.+++|.+.
T Consensus 13 ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~--------- 81 (1081)
T KOG0618|consen 13 IPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR--------- 81 (1081)
T ss_pred cchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh---------
Confidence 4444443334555666665554 33322 233334666666666655 55555555555555555555554
Q ss_pred cccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHh
Q 001858 171 YWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQIS 250 (1003)
Q Consensus 171 ~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ 250 (1003)
..|.+++++.+|++|.|.+|++. ..|.++..+++|++|+++.|++...++.+..+..++.+.
T Consensus 82 -----------------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~ 143 (1081)
T KOG0618|consen 82 -----------------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELA 143 (1081)
T ss_pred -----------------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHh
Confidence 44555555555555555555555 455555555556666666665555555555555555555
Q ss_pred hcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCC
Q 001858 251 LLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330 (1003)
Q Consensus 251 l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 330 (1003)
.++|.....++ -..++.+++..|.+.+.++..+..++. .|||++|.+. ...+..+++|+.|....|++.
T Consensus 144 ~s~N~~~~~lg------~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls 212 (1081)
T KOG0618|consen 144 ASNNEKIQRLG------QTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLS 212 (1081)
T ss_pred hhcchhhhhhc------cccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccc
Confidence 55552111121 112555666666666555555555544 5666666655 223455556666666666665
Q ss_pred CCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEccccccccc
Q 001858 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGT 410 (1003)
Q Consensus 331 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 410 (1003)
.+... .++|+.|+.++|.++...+. ..-.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .
T Consensus 213 ~l~~~----------g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~ 278 (1081)
T KOG0618|consen 213 ELEIS----------GPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-A 278 (1081)
T ss_pred eEEec----------CcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-h
Confidence 54332 24566666666665521111 11235666666666666 33466666666666666666664 5
Q ss_pred CCCccccccccceeccccccccccccccccCCCccceeecccccccccCCc-cccCCCC-CCeeeccCccccCCCchhhh
Q 001858 411 IPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKN-LMLLNVSKNKLTGTLPPQIL 488 (1003)
Q Consensus 411 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~-L~~L~ls~N~l~~~~p~~~~ 488 (1003)
+|..+...++|+.|.+..|.+. -+|+...+++.|++|+|..|+|. ..|+ .+.-... |+.|+.+.|++. ..|..-.
T Consensus 279 lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e 355 (1081)
T KOG0618|consen 279 LPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEE 355 (1081)
T ss_pred hHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccc
Confidence 5666666666666666666665 45555555666666666666666 3333 2222222 555666666665 4443322
Q ss_pred hhccccccccCCCCccccccccccccccccccccccccccccccC-ccccCcccccEEEecCCCccccCCcccccccCcC
Q 001858 489 EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIP-TTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIE 567 (1003)
Q Consensus 489 ~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 567 (1003)
...+.++.|.+.+|.++...-..+.+.++|+.|+|++|+|. .+| ..+.++..|++|+||+|+++ .+|..+.+++.|+
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH 433 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence 33334445566666666555555666666666666666665 334 35556666666666666666 5666666666666
Q ss_pred eeeccCceeccCCcccccCCCccceEecCCCccccc-CCCCCccCCCcceeeccCCC
Q 001858 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQ-VPTKGVFSNKTRISLIENGK 623 (1003)
Q Consensus 568 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~n~~ 623 (1003)
+|...+|+|. ..| .+..++.|+.+|+|.|+|+.. +|.....+++..+.+.||.+
T Consensus 434 tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 6666666666 445 556666666666666666542 23222334555666666665
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.98 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=214.7
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
+.++|++++.||+|.||.||.|+.+.++-.||+|++.+.. .+..+++.+|+++-+.++||||.+++++ |.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 3468999999999999999999999999999999986443 3446789999999999999999999999 6788
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...|+++||..+|++...++..+ ...+++...+.+..|+|.|+.|+|.. +|+||||||+|+|++.++..|++||
T Consensus 95 ~riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 89999999999999999999654 55788999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|-+... ........+||..|.|||...+...+..+|+|++|++.||++.|..||.....
T Consensus 169 GwsV~~-------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------------- 227 (281)
T KOG0580|consen 169 GWSVHA-------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------------- 227 (281)
T ss_pred Cceeec-------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------------
Confidence 998643 23445568899999999999999999999999999999999999999976431
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.+...-+.+.-...| ........+++.+|+..+|.+|.+..|++.+-.
T Consensus 228 ~etYkrI~k~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 228 SETYKRIRKVDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHHHHccccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 112222232333333 223456778888999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.67 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=201.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+++++.++|++++++++++ .+++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3778899999999999999999899999999986432 22335678999999999999999999884 456678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999998886533 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ......||..|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 150 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------------- 209 (285)
T cd05631 150 VQIPEGE------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------------- 209 (285)
T ss_pred EEcCCCC------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--------------
Confidence 7653221 11235689999999999999999999999999999999999999975432110
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 990 (1003)
.+.+.......+. .........+.+++.+||+.+|++||+ ++|++++
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 210 REEVDRRVKEDQE---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHhhcccc---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111111111110 111223456788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.10 Aligned_cols=250 Identities=20% Similarity=0.309 Sum_probs=200.0
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccccccc---hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS---IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
..||+|++|.||+|.+ +++.||||+++...... .+.|.+|++++++++||||+++++++... ..+....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence 6799999999999998 47799999997544333 56788999999999999999999986431 123456789999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++.. .+.+++.....++.+++.|++|+|+.. +++||||||+||+++.++.+|++|||+++....
T Consensus 103 y~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 103 YCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred eCCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 9999999999986 346889999999999999999999732 788999999999999999999999999976532
Q ss_pred CCccccCcccccccccccccCccccCC--CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH-
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMG--GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME- 942 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 942 (1003)
.. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ++.+
T Consensus 176 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------------~~~~~ 233 (283)
T PHA02988 176 PP--------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------------EIYDL 233 (283)
T ss_pred cc--------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------------HHHHH
Confidence 21 12458899999999876 67899999999999999999999999754211 1111
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
++..... + .....++..+.+++.+||+.+|++||+++|+++.|+.++.
T Consensus 234 i~~~~~~--~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 234 IINKNNS--L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHhcCCC--C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111 1 0111345678899999999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=343.05 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=204.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++ .+.+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 46899999999999999999999899999999997442 23456788999999999999999999884 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 8999999999999999976 35688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus 148 a~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------------- 206 (333)
T cd05600 148 SKGIVT--------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------------- 206 (333)
T ss_pred Cccccc--------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------------
Confidence 975432 12235699999999999999999999999999999999999999975322110
Q ss_pred HHHHHHh-hcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 VMEIVDF-ALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~-~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+... .....|... .........+.+++.+|+..+|++||+++|++++
T Consensus 207 ~~~i~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 207 WENLKYWKETLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhccccccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011000 000111110 0002335667889999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=302.58 Aligned_cols=275 Identities=21% Similarity=0.276 Sum_probs=218.0
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++.+.+|+|+|+-||.++.-.+++.||+|++.....++.+..++|++..++++|||++++++++....-......
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999988999999999987777778899999999999999999999998755444456678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
|++++|+..|+|.+.++..... +..+++.++++|+.++++|+++||+. .++++||||||.||++++++.+++.|||.+
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 9999999999999999886543 45899999999999999999999998 335999999999999999999999999999
Q ss_pred cccccCCccc----cCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 861 KFLFDRPIQE----TSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 861 ~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+...-..... .-........|..|.|||.+. +...+.++||||+||++|+|+.|..||+.....+..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7653211000 001112234789999999764 346789999999999999999999999865443322211100
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
. .-..-|.. ...++.+.+++.+|++.||.+||++.+++.++..+
T Consensus 257 -----------n-~q~s~P~~-----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 -----------N-AQISIPNS-----SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------c-cccccCCC-----CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0 00011111 11467889999999999999999999999998765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=309.04 Aligned_cols=272 Identities=24% Similarity=0.304 Sum_probs=207.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|+..+.|++|+||.||+|+++.+++.||+|+++.+. .+-.-.-.+|+.++.+.+|||||.+-.+... .+-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 357888999999999999999999999999999998544 3334466899999999999999999988643 23456
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.|+||||++. +|..++.... .++...++.-+..|+++|++|||.+ .|+|||+||+|+|++..|.+||+|||+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 8999999998 9999998863 5789999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--- 935 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~--- 935 (1003)
|+.+... ....+..+.|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+...-+ ++...+...
T Consensus 224 AR~ygsp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtP 297 (419)
T KOG0663|consen 224 AREYGSP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTP 297 (419)
T ss_pred hhhhcCC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCC
Confidence 9987543 2334457789999999998875 68999999999999999999999887643221 111111110
Q ss_pred ---CchhHHH--HHH-hhcccCC-CCchhhHHH--HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 ---LPEKVME--IVD-FALLLDP-GNERAKIEE--CLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ---~~~~~~~--~i~-~~l~~~~-~~~~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+...+ .+. ......| .+-+..... ..+.-++++...+.+||.+|.|+.|.++|
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111 010 0000111 111111111 33566788889999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.96 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=214.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc-
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF- 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~- 779 (1003)
++|...+++|+|+||.++.++++.+++.|++|.+.... .......++|+.++++++|||||.+.+. |..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCce
Confidence 57899999999999999999999999999999997543 3344578999999999999999999998 455555
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||+|++||++.+.|.+.+ +..+++..+..++.|++.|+.|||+. .|+|||||+.||+++.++.+|+.|||+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 999999999999999999876 56899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|+.+.+.. .....++||+.||+||.+.+.+|+.|+|+||+||++|||++-+++|.....
T Consensus 153 aK~l~~~~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---------------- 211 (426)
T KOG0589|consen 153 AKILNPED-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---------------- 211 (426)
T ss_pred hhhcCCch-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch----------------
Confidence 99875432 233457899999999999999999999999999999999999999976432
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..++.+..... ..+.......++..++..|++.+|+.||++.+++.+
T Consensus 212 -~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 212 -SELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -HHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22222222221 112234456788999999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=334.75 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=201.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence 36889999999999999999999899999999986432 2234678899999999999999999987 456778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence 8999999999999999987 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
++...+. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 148 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------------~ 205 (291)
T cd05612 148 AKKLRDR--------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------------G 205 (291)
T ss_pred chhccCC--------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------H
Confidence 9765321 11346899999999999988999999999999999999999998653211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKNL 991 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~L 991 (1003)
..+.+......-+ ......+.+++.+|++.||.+||+ ++|+++|-
T Consensus 206 ~~~~i~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 206 IYEKILAGKLEFP-------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHHHHHhCCcCCC-------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1111111111111 112346788999999999999995 88888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.44 Aligned_cols=267 Identities=21% Similarity=0.357 Sum_probs=201.0
Q ss_pred hccCCccCeeeeccceEEEEEEECC----------------CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCcee
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE----------------DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIK 764 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 764 (1003)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .....+|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678999999999999999998642 34479999987543 223567999999999999999999
Q ss_pred EeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 001858 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ--------------VDGNLNLIQRLNISIDVASAIEYLHHHC 830 (1003)
Q Consensus 765 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 830 (1003)
+++++. +.+..++||||+++|+|.+++...... ....+++.+++.++.|++.|++|||+.
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 999853 456689999999999999999764211 123578889999999999999999999
Q ss_pred CCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHH
Q 001858 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910 (1003)
Q Consensus 831 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~e 910 (1003)
+|+||||||+||+++.++.+||+|||+++.+...... .......++..|+|||++.++.++.++|||||||++||
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 9999999999999999999999999999765432211 11122346789999999988899999999999999999
Q ss_pred HHh--CCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 001858 911 MFT--GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAV 988 (1003)
Q Consensus 911 ll~--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 988 (1003)
|++ +..||......+ .. +............. .......++..+.+++.+||+.+|++||++.||.
T Consensus 233 l~~~~~~~p~~~~~~~~--~~--------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 233 ILMLCKEQPYGELTDEQ--VI--------ENAGEFFRDQGRQV---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHccCCCCCCcCCHHH--HH--------HHHHHHhhhccccc---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 987 566776532211 00 00111111000000 0000112346788999999999999999999998
Q ss_pred HHHH
Q 001858 989 KNLC 992 (1003)
Q Consensus 989 ~~L~ 992 (1003)
+.|+
T Consensus 300 ~~l~ 303 (304)
T cd05096 300 AFLT 303 (304)
T ss_pred HHHh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.75 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=197.2
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 23346788999999999999999999884 45678899999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++.. .+.+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 76 YANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999999999986 45789999999999999999999999 999999999999999999999999999975321
Q ss_pred CCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1003)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... +.....+.
T Consensus 148 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------------~~~~~~~~ 208 (323)
T cd05571 148 D-----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------------EKLFELIL 208 (323)
T ss_pred C-----CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------------HHHHHHHH
Confidence 1 1122345699999999999999999999999999999999999999964221 01111111
Q ss_pred hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 946 FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 946 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
..... ........+.+++.+|++.+|++|| ++.|+++|
T Consensus 209 ---~~~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 ---MEEIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---cCCCC----CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11110 0112345678899999999999999 79998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.24 Aligned_cols=271 Identities=21% Similarity=0.290 Sum_probs=203.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 46899999999999999999999999999999987432 23356788999999999999999999884 456788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++++.+..+... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 999999998776655433 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh-HHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH-GFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~-~~~~~~~~~~ 939 (1003)
........ .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... .......+..
T Consensus 148 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07848 148 RNLSEGSN----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223 (287)
T ss_pred cccccccc----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence 86532211 112235689999999999988899999999999999999999999976432211000 0001111111
Q ss_pred HHHHHHhh--c--ccCCCC------chhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 VMEIVDFA--L--LLDPGN------ERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~--l--~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........ . ...+.. ...........+.+++.+|++.+|++||+++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11110000 0 000000 001112245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.89 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=202.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 357899999999999999999999999999999987432 23456789999999999999999999984 4567
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++|+|.+++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 88999999999999999987 35688999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+++...+.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus 164 ~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------------~ 221 (329)
T PTZ00263 164 FAKKVPDRT--------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------------F 221 (329)
T ss_pred CceEcCCCc--------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------------H
Confidence 997653221 135689999999999999999999999999999999999999864321 0
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 990 (1003)
...+.+......-| ......+.+++.+|++.+|++||+ ++|+++|
T Consensus 222 ~~~~~i~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 222 RIYEKILAGRLKFP-------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHhcCCcCCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111111111 112345778999999999999996 6888766
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.21 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=219.1
Q ss_pred CCccCeeeeccceEEEEEEECC----CCceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGE----DLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
....++||+|-||.||+|.+.. ....||||.-+.. ..+..+.|..|+.+++.++||||++++|+|. +..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQP 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------ccc
Confidence 3456789999999999998842 3346889988753 3445788999999999999999999999985 345
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|||.++.|.|..|++..+ ..++......++.||+.|++|||+. .+|||||..+||||....-+|++|||+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 699999999999999999864 5688889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
++.+.+..+...+. ..=++.|||||-+.-..++.++|||.|||++||++. |..||.+..+.+..
T Consensus 538 SR~~ed~~yYkaS~----~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------- 602 (974)
T KOG4257|consen 538 SRYLEDDAYYKASR----GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------- 602 (974)
T ss_pred hhhccccchhhccc----cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------
Confidence 99998776554432 234678999999999999999999999999999998 99999987665332
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
.....++|.+.++.|+..++.++-+||.++|.+||.+.|+...|..+.+
T Consensus 603 ---------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 ---------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2334556778888999999999999999999999999999999988776
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.76 Aligned_cols=268 Identities=22% Similarity=0.327 Sum_probs=207.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCEE
Confidence 4689999999999999999999999999999999975432 3346799999999999999999999985 345678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EEEeecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 999999999999999986 346889999999999999999999852 6999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-----
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA----- 935 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~----- 935 (1003)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+ +.......
T Consensus 152 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~ 222 (331)
T cd06649 152 GQLIDS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGE 222 (331)
T ss_pred cccccc-------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccc
Confidence 755321 1123468999999999999999999999999999999999999996532211 10000000
Q ss_pred -------------------------C-chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 936 -------------------------L-PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 936 -------------------------~-~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
. .....+..+......+.... ......++.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00011111111111111100 1123567899999999999999999999998
Q ss_pred HHH
Q 001858 990 NLC 992 (1003)
Q Consensus 990 ~L~ 992 (1003)
+-.
T Consensus 301 h~~ 303 (331)
T cd06649 301 HTF 303 (331)
T ss_pred ChH
Confidence 753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=316.23 Aligned_cols=279 Identities=23% Similarity=0.322 Sum_probs=208.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCC-ceeEeeeeeecc-cCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRN-LIKIITVCSSID-FKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~ 777 (1003)
...|...++||+|+||+||+|+.+.+|+.||+|+++...+ +......+|+.++++++|+| |+++.+++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777889999999999999999999999999985543 45678899999999999999 999999975432 2233
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++|+||++. +|.+++....... ..++...+..++.|++.|++|||++ +|+||||||+||+++++|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 478899999987 9999998865321 4577788999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|+|+...- ........++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+....++-...+--...
T Consensus 165 GlAra~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 165 GLARAFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred chHHHhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 99986531 12224456799999999999887 7899999999999999999999888775432211111110001
Q ss_pred c-h-hH---HHHHHhh--cccC--CCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 P-E-KV---MEIVDFA--LLLD--PGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~-~-~~---~~~i~~~--l~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
| + .+ ....+-. .... +..-............+++.+|++++|.+|.|++++++|
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 0 01 1111100 0000 000011111112367889999999999999999999987
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.23 Aligned_cols=385 Identities=25% Similarity=0.392 Sum_probs=235.0
Q ss_pred CCCCcEEEcCCCCCC-CCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccce
Q 001858 99 LSFLRFINLASNNLH-GEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLEN 177 (1003)
Q Consensus 99 l~~L~~L~L~~n~~~-g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~ 177 (1003)
|+..|-.|+++|.|+ +..|.....+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-.++..+ +.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~L-p~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDL-PRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccc-hhhHH
Confidence 455566677777776 356777777777777777777776 67777777777777666666665 222222221 44455
Q ss_pred EEccCcccc-cccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhccccc
Q 001858 178 LNVAENQLT-GQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRF 256 (1003)
Q Consensus 178 L~L~~n~l~-~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l 256 (1003)
+++..|++. .-||+.|-.|..|..||||+|+++ +.|..+..-+++-.|+||+|+|.
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie---------------------- 139 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE---------------------- 139 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc----------------------
Confidence 555555443 236666667777777777777777 66777776667777777777666
Q ss_pred CCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCC
Q 001858 257 EGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGD 336 (1003)
Q Consensus 257 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 336 (1003)
.||..++.+++.|-+|+|++|++. .+|..+..+..|+.|+|++|.+...--..+-
T Consensus 140 --tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLP---------------------- 194 (1255)
T KOG0444|consen 140 --TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLP---------------------- 194 (1255)
T ss_pred --cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCc----------------------
Confidence 566666667888888888888887 6677788888888888888877632222222
Q ss_pred hhhHhhhcCCCCCcEeeccCcCCC-CCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCcc
Q 001858 337 LDFITLLTNCSKLETLGLNSNRFG-GSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTI 415 (1003)
Q Consensus 337 ~~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 415 (1003)
.+++|++|.+++.+=+ ..+|.++..+.+|..+|++.|.+. ..|+++.++++|+.|+||+|+|+ .+.-..
T Consensus 195 --------smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~ 264 (1255)
T KOG0444|consen 195 --------SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTE 264 (1255)
T ss_pred --------cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccH
Confidence 2344455555543322 134555555555555555555554 44555555555555555555555 333333
Q ss_pred ccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhccccc
Q 001858 416 GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSS 495 (1003)
Q Consensus 416 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~ 495 (1003)
+... +|++|+||.|+++ .+|++++.+++|+.|.+.+|+++
T Consensus 265 ~~W~------------------------~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~--------------- 304 (1255)
T KOG0444|consen 265 GEWE------------------------NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT--------------- 304 (1255)
T ss_pred HHHh------------------------hhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc---------------
Confidence 3444 4455555555554 45555555555555555555554
Q ss_pred cccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCce
Q 001858 496 LLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNN 575 (1003)
Q Consensus 496 ~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 575 (1003)
+ .-+|..++.+.+|+.+..++|++. .+|+.++.+..|+.|.|++|++. .+|+++.-|+.|+.|||.+|.
T Consensus 305 --------F-eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 305 --------F-EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred --------c-cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 0 024445677777777777777776 77777777778888888888776 677788778888888888876
Q ss_pred eccCCcccccCCCccceEec
Q 001858 576 LSGQIPEYLEDLSFLEYLNL 595 (1003)
Q Consensus 576 l~~~~p~~l~~l~~L~~L~l 595 (1003)
=--.+|.--..-++|+.-++
T Consensus 374 nLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 374 NLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred CccCCCCcchhhhcceeeec
Confidence 44333322222244554444
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=330.06 Aligned_cols=274 Identities=20% Similarity=0.314 Sum_probs=202.8
Q ss_pred ccCCccCeeeeccceEEEEEEECC-CCceEEEEEecccc--ccchHHHHHHHHHHHhc---CCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGE-DLLPVAVKVINLKQ--KGSIKSFVAECEALKNI---RHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 776 (1003)
.+|++.+.||+|+||+||+|++.. +++.||+|+++... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 46789999987433 22345667788777766 6999999999986544455
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++||||++ ++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 677899999997 59999997643 34589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA- 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~- 935 (1003)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.......
T Consensus 154 fg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~ 226 (290)
T cd07862 154 FGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIG 226 (290)
T ss_pred ccceEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhC
Confidence 9999765322 11223568999999999988899999999999999999999999997643221 111111100
Q ss_pred --CchhHHHHH---HhhcccCCCCc-hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 --LPEKVMEIV---DFALLLDPGNE-RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 --~~~~~~~~i---~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+++..... .......+... ..........+.+++.+|++.+|++||++.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 011110000 00111111010 11112334567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.71 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=203.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (1003)
.-.+|.+.++||+|+||.|++|..+.+++.+|||++++. ..++.+..+.|.+|+... +||.+++++++ |..
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 346899999999999999999999999999999999855 356678889999999888 59999999998 788
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
.++.|.||||+.||++..+.+ .+.+++..+.-+|..|+.||.|||++ +|||||+|.+|||+|.+|++||+|
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecc
Confidence 999999999999999443333 46799999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
||+++.-.. .......++||+.|||||++.+..|+.++|.|||||++|||+.|..||.+..
T Consensus 512 FGlcKe~m~-----~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-------------- 572 (694)
T KOG0694|consen 512 FGLCKEGMG-----QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-------------- 572 (694)
T ss_pred cccccccCC-----CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--------------
Confidence 999975422 2233446899999999999999999999999999999999999999998643
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM 984 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 984 (1003)
-.++.+..+..++..-+ -++.+...|+++.+..+|++|.-+
T Consensus 573 ---Eee~FdsI~~d~~~yP~----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 573 ---EEEVFDSIVNDEVRYPR----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---HHHHHHHHhcCCCCCCC----cccHHHHHHHHHHhccCcccccCC
Confidence 22334444444332222 234566777888888888888855
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=338.39 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=204.4
Q ss_pred hccCCccCeeeeccceEEEEEEE-----CCCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 774 (1003)
.++|++.+.||+|+||.||+|++ ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 45799999999999999999975 3456689999987433 23456788999999999 899999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCC----------------------------------------------------
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQ---------------------------------------------------- 802 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 802 (1003)
.+.+..++||||+++|+|.++++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 4466789999999999999999764310
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 803 ------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 803 ------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
....+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 012578899999999999999999999 99999999999999999999999999997653
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+.
T Consensus 266 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------------~~~~~ 329 (375)
T cd05104 266 NDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------------KFYKM 329 (375)
T ss_pred Ccccc---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------------HHHHH
Confidence 32111 11112335678999999999999999999999999999998 888986543221 11122
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+....... .......++.+++.+||+.+|++||++.|+++.|++.
T Consensus 330 ~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRML------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccCC------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 22111110 0111245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=327.92 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=212.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccc-hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS-IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
....+.++||+|-||+|.++.... +..||||+++...... ..+|.+|+++|.+++||||++++|+|.. ++.++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence 456778999999999999999863 6899999998665443 5899999999999999999999999853 56679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+|||++|+|.+|+.++... ........+|+.||+.|++||.+. ++||||+.++|+|+|.++++||+|||+++
T Consensus 612 mI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence 999999999999999987432 245566778999999999999999 99999999999999999999999999999
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh--CCCCCCcccCCcchhhHHHHhhCchh
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT--GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~--g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
.+..+++.... ...+=+++|||||.+.-++++.++|||+||+++||+++ ...||+...++ +
T Consensus 686 ~lysg~yy~vq---gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------------~ 748 (807)
T KOG1094|consen 686 NLYSGDYYRVQ---GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------------Q 748 (807)
T ss_pred ccccCCceeee---cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--------------H
Confidence 77665544322 23455789999999999999999999999999999876 77888765432 1
Q ss_pred HHHHHHhhcc-cCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 940 VMEIVDFALL-LDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 940 ~~~~i~~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
..+....++. ..+......+..|+..+++++..||..+.++||+++++...|.+.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111111 111112233446778899999999999999999999999998764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.79 Aligned_cols=257 Identities=26% Similarity=0.344 Sum_probs=212.1
Q ss_pred HHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc--------chHHHHHHHHHHHhc-CCCCceeEeeee
Q 001858 699 NKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--------SIKSFVAECEALKNI-RHRNLIKIITVC 769 (1003)
Q Consensus 699 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~~~~ 769 (1003)
+.....|.-.+.+|.|..++|.++.++.+++.+|+|++...... ..+.-.+|+.|++++ .||+|+++.++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~- 91 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV- 91 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-
Confidence 34556788889999999999999999999999999999643221 134567799999998 79999999999
Q ss_pred eecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC
Q 001858 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 849 (1003)
Q Consensus 770 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 849 (1003)
++.+.+.++|+|.|+.|.|.|++.. .-.+++...++|+.|+.+|++|||.+ .|||||+||+|||++++
T Consensus 92 ----yes~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 92 ----YESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN 159 (411)
T ss_pred ----ccCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc
Confidence 5667888999999999999999987 56799999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccCCccccCcccccccccccccCccccCC------CCCCccccchhHHHHHHHHHhCCCCCCcccC
Q 001858 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG------GNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~ell~g~~P~~~~~~ 923 (1003)
.++||+|||+|+.+.++ ..-+..+||++|.|||.+.- ..|+..+|+||+||++|.++.|.+||....+
T Consensus 160 ~~i~isDFGFa~~l~~G------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPG------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred cceEEeccceeeccCCc------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 99999999999977543 23345789999999997643 3578889999999999999999999865210
Q ss_pred CcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 924 DGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.-..........+-+.+.+.+......+++.+|++.||++|.|++|+++|=
T Consensus 234 -----------------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 234 -----------------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred -----------------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 011111222344445566677778888999999999999999999999763
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=333.09 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=196.3
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999999999999999997432 33456778899999999999999999884 45677899999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 76 YANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred CCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999999876 34689999999999999999999999 999999999999999999999999999875322
Q ss_pred CCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1003)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+
T Consensus 148 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------------~~~~~~- 207 (323)
T cd05595 148 D-----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------RLFELI- 207 (323)
T ss_pred C-----CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------------HHHHHH-
Confidence 1 11122356999999999999999999999999999999999999998653211 111111
Q ss_pred hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 946 FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 946 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
...... ........+.+++.+|++.+|++|| ++.+++++
T Consensus 208 --~~~~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 208 --LMEEIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --hcCCCC----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111110 0112345678899999999999998 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=364.38 Aligned_cols=485 Identities=26% Similarity=0.361 Sum_probs=311.4
Q ss_pred cEEEEEeecCCCCcccCccccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecc
Q 001858 77 RVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156 (1003)
Q Consensus 77 ~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~ 156 (1003)
+++.|+++.|.+-.---+.+.+--+|+.|||++|.++ ..|..+..+.+|+.|+++.|.+. .+|.+++++++|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3667777766544321234444555999999999998 89999999999999999999999 899999999999999999
Q ss_pred cccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCC
Q 001858 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGM 236 (1003)
Q Consensus 157 ~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 236 (1003)
+|.+. .+|..+..+ .+|++|++++|++. .+|..+..++.+..+..++|.... .++... .+.+++..|.+.+.
T Consensus 100 ~n~l~-~lP~~~~~l-knl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISEL-KNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred cchhh-cCchhHHhh-hcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccc
Confidence 99887 777776654 67777777777776 677777777777777777772221 222222 66666666666655
Q ss_pred CCC-cccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCC
Q 001858 237 LPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315 (1003)
Q Consensus 237 ~~~-~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 315 (1003)
++. +.++.. .|+|..|.+. .+.. .++++|+.|....|++.... -..++|+.|+.++|.+....+. .-
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~-~~dl---s~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~ 239 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME-VLDL---SNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PV 239 (1081)
T ss_pred hhcchhhhhe--eeecccchhh-hhhh---hhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cc
Confidence 442 333333 4667777665 2222 24566677777777665221 1235666777777766632211 12
Q ss_pred CCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCC
Q 001858 316 LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA 395 (1003)
Q Consensus 316 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 395 (1003)
-.+|+++++++|++..++ .....|.+|+.++..+|+++ .+|..+...++|+.|.+..|.++ -+|.....++
T Consensus 240 p~nl~~~dis~n~l~~lp-------~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~ 310 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSNLP-------EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLK 310 (1081)
T ss_pred cccceeeecchhhhhcch-------HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccc
Confidence 235777777777776543 34556777777777777774 66777777777777777777776 4566666777
Q ss_pred CccEEEcccccccccCCC-ccccccc-cceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeee
Q 001858 396 NIYALGLEYNQLTGTIPY-TIGELIN-LQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLN 473 (1003)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 473 (1003)
.|+.|+|..|+|. ..|+ .+..+.. |..|+.+.|++.......=..++.|+.|++.+|.++...-..+.+.++|+.|+
T Consensus 311 sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh 389 (1081)
T KOG0618|consen 311 SLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH 389 (1081)
T ss_pred eeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence 7777777777776 3343 3333322 66677777777633222222456788888888888877777788888888888
Q ss_pred ccCccccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCcc
Q 001858 474 VSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553 (1003)
Q Consensus 474 ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 553 (1003)
|++|++. .+|+....-...++.|+||+|+++ .+|..+.++..|+.|...+|++. ..| ++..++.|+.+|++.|+|+
T Consensus 390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 8888887 788776554444455566666655 44455555556666666666655 445 5555566666666666655
Q ss_pred ccC-CcccccccCcCeeeccCceeccCCcccccCCCccceEecCCC
Q 001858 554 GSI-PSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598 (1003)
Q Consensus 554 ~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 598 (1003)
... |... .-++|++|||++|.-....-..|..+.++...+++-|
T Consensus 466 ~~~l~~~~-p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 466 EVTLPEAL-PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhhhhC-CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 322 2221 1255666666666432233344445555555555444
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=326.61 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=200.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence 57999999999999999999999999999999987443 23345788999999999999999999984 4566789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++ +|.+++... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 80 lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EEEeCCCc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 99999985 999998764 34578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hCc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---ALP 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~~ 937 (1003)
...... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ....... ..+
T Consensus 152 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 225 (288)
T cd07871 152 AKSVPT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTE 225 (288)
T ss_pred eccCCC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 542211 11223467999999998765 5688999999999999999999999976432211 1111100 001
Q ss_pred hhHHHHHHh---hcccCCCCch----hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDF---ALLLDPGNER----AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~---~l~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+...... .....+..+. ........+..+++.+|++.+|++|||++|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111110000 0000010000 0011223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=311.37 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=216.5
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
-|.+..+||+|+||.||+|.++++|+.+|||.+..+ .+.+++.+|+.++++.+.|++|++||.| -.....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEee
Confidence 477889999999999999999999999999998754 3458899999999999999999999985 345667999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
||||..|+..|.++.. +.++.+.++..++...+.|++|||.. .-+|||||+.|||+..+|.+|++|||.|..+
T Consensus 107 MEYCGAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 9999999999999875 46899999999999999999999999 8999999999999999999999999999654
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
.++......+.||+.|||||++..-.|+.++||||+|++..||..|++||.+..+-...
T Consensus 180 -----TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------- 238 (502)
T KOG0574|consen 180 -----TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------- 238 (502)
T ss_pred -----hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee----------------
Confidence 33445555688999999999999999999999999999999999999999875321110
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.++-..|.+....+++...++-++++.|+-..|++|-|+.++.+|-
T Consensus 239 --FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 239 --FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred --EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 1222344444556778889999999999999999999999998874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.40 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=199.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+|+++++.++||||+++++++ .++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47899999999999999999999999999999997432 23346788999999999999999999984 55778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred EEEEECCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccc
Confidence 8999999999999999976 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcccc---------------------------------CcccccccccccccCccccCCCCCCccccchhHHH
Q 001858 860 AKFLFDRPIQET---------------------------------SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGI 906 (1003)
Q Consensus 860 a~~~~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~ 906 (1003)
+..+........ .......+||+.|+|||++.+..++.++||||+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 975432110000 00111246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhc-ccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC--
Q 001858 907 LLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFAL-LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-- 983 (1003)
Q Consensus 907 il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-- 983 (1003)
++|||++|+.||......+ ....+..... ...|.. ......+.+++.+|+. +|.+|++
T Consensus 228 il~el~~G~~Pf~~~~~~~-------------~~~~i~~~~~~~~~~~~-----~~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQE-------------TYRKIINWKETLQFPDE-----VPLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred HHHHhhcCCCCCCCCCHHH-------------HHHHHHcCCCccCCCCC-----CCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 9999999999997532110 0111111000 001110 1123456677777886 8999997
Q ss_pred -HHHHHHH
Q 001858 984 -MADAVKN 990 (1003)
Q Consensus 984 -~~ev~~~ 990 (1003)
++|++++
T Consensus 289 ~~~~ll~h 296 (364)
T cd05599 289 GVNEIKSH 296 (364)
T ss_pred CHHHHhcC
Confidence 9988875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.25 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.7
Q ss_pred hccCCccCeeeeccceEEEEEEEC---CCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++.... .....|.+|+.++++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence 457899999999999999999875 3456899999875432 3346789999999999999999999985 346
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++||||+++|+|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCC
Confidence 6789999999999999999764 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|.+........ .......++..|+|||.+.+..++.++||||+||++||+++ |+.||......
T Consensus 152 g~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------------ 215 (266)
T cd05064 152 RRLQEDKSEAI----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------------ 215 (266)
T ss_pred cccccccccch----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------------
Confidence 98764322111 11112335678999999999999999999999999999775 99998754211
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+..+.+..... .+....++..+.+++.+||+.+|++||++.|+.+.|+.+
T Consensus 216 --~~~~~~~~~~~------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 --DVIKAVEDGFR------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --HHHHHHHCCCC------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111211111 111233556788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=332.43 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=196.9
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 33456788999999999999999999884 55678899999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++.. .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 76 y~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 76 YVNGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred CCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999876 34689999999999999999999999 999999999999999999999999999875322
Q ss_pred CCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1003)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+
T Consensus 148 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------------~~~~~~- 207 (328)
T cd05593 148 D-----AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------KLFELI- 207 (328)
T ss_pred c-----ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------------HHHHHh-
Confidence 1 11122356999999999999999999999999999999999999999653211 111111
Q ss_pred hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 946 FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 946 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
...... ........+.+++.+|++.+|++|| ++.|++++
T Consensus 208 --~~~~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 208 --LMEDIK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --ccCCcc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111110 0112345678899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=337.58 Aligned_cols=265 Identities=23% Similarity=0.400 Sum_probs=204.8
Q ss_pred HhccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 773 (1003)
..++|++.+.||+|+||.||+|++.. ++..||+|+++... ....+.+.+|+++++.+ +||||++++++|
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---- 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC---- 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence 34579999999999999999998643 33579999997433 23356788999999999 899999999985
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCC----------------------------------------------------
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSND---------------------------------------------------- 801 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------- 801 (1003)
......++||||+++|+|.++++....
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 446678999999999999999865321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCc
Q 001858 802 -------------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI 868 (1003)
Q Consensus 802 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~ 868 (1003)
.....+++.++++++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0123578899999999999999999999 999999999999999999999999999976532211
Q ss_pred cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 869 QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
........++..|+|||++.+..++.++||||+||++|||++ |+.||....... .....+...
T Consensus 268 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------------~~~~~~~~~ 331 (374)
T cd05106 268 ---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------------KFYKMVKRG 331 (374)
T ss_pred ---eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------------HHHHHHHcc
Confidence 111112335678999999998899999999999999999997 999987543211 111111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
..... ....+.++.+++.+||+.+|++||++.++++.|+++.
T Consensus 332 ~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQMSR------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCccC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11100 0112456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=339.07 Aligned_cols=206 Identities=24% Similarity=0.335 Sum_probs=176.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|++++++++||+|+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 46889999999999999999999999999999997432 23346788899999999999999999884 55678
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.+ .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 8999999999999999986 45789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccc------------------------------cCcccccccccccccCccccCCCCCCccccchhHHHHHH
Q 001858 860 AKFLFDRPIQE------------------------------TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909 (1003)
Q Consensus 860 a~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ 909 (1003)
++.+....... ........+||+.|+|||++.+..++.++||||+||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 97653211000 000012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCcc
Q 001858 910 EMFTGRRPTHTM 921 (1003)
Q Consensus 910 ell~g~~P~~~~ 921 (1003)
||++|+.||...
T Consensus 228 ell~G~~Pf~~~ 239 (363)
T cd05628 228 EMLIGYPPFCSE 239 (363)
T ss_pred HHHhCCCCCCCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=341.19 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=196.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5888999999999999999999999999999997432 23356789999999999999999999985 456788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++|+|.+++.. .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++++||+|||++
T Consensus 77 ~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred EEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 999999999999999986 34688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCcc------------------------------------------ccCcccccccccccccCccccCCCCCCcc
Q 001858 861 KFLFDRPIQ------------------------------------------ETSSSSIGIKGTVGYVAPEYGMGGNVSLT 898 (1003)
Q Consensus 861 ~~~~~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 898 (1003)
+.+...... ..........||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 643110000 00001123579999999999998889999
Q ss_pred ccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh-cccCCCCchhhHHHHHHHHHHHHhh--ccc
Q 001858 899 GDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA-LLLDPGNERAKIEECLTAVVRIGVL--CSM 975 (1003)
Q Consensus 899 sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~--cl~ 975 (1003)
+||||+||++|||++|+.||......+ .....+... ....|. ......++.+++.+ |+.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~-------------~~~~i~~~~~~~~~~~-----~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTE-------------TQLKVINWENTLHIPP-----QVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHH-------------HHHHHHccccccCCCC-----CCCCCHHHHHHHHHHccCc
Confidence 999999999999999999997532211 011111100 001110 01122344455554 667
Q ss_pred cCCCCCCCHHHHHHH
Q 001858 976 ESPSERIHMADAVKN 990 (1003)
Q Consensus 976 ~~p~~RPs~~ev~~~ 990 (1003)
++|..||+++|+++|
T Consensus 291 ~~~~~R~~~~~~l~h 305 (381)
T cd05626 291 EERLGRNGADDIKAH 305 (381)
T ss_pred ccccCCCCHHHHhcC
Confidence 777789999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=329.47 Aligned_cols=271 Identities=22% Similarity=0.324 Sum_probs=200.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+.||+|+||+||+|++..+++.||+|+++.... .....+.+|+++++.++||||+++++++ .++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 4689999999999999999999998999999999874432 2345678899999999999999999984 456778
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++ ++|.+++... .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred EEEEECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 99999996 5888888764 34688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh--Cc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--LP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~--~~ 937 (1003)
+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||................. ..
T Consensus 151 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (303)
T cd07869 151 RAKSVPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225 (303)
T ss_pred eeccCCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence 7542211 11223468999999998765 4578899999999999999999999976432211111111100 00
Q ss_pred hhHHHHHHh--------hcccCCCCchhhHH--HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDF--------ALLLDPGNERAKIE--ECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~--------~l~~~~~~~~~~~~--~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......... .....+........ .....+.+++.+|++.+|++|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000 00000100000000 122457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.43 Aligned_cols=260 Identities=26% Similarity=0.495 Sum_probs=207.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCC-----ceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDL-----LPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
++|++.+.||+|+||.||+|.+...+ ..||+|.++.... .....|.+|++++++++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 47889999999999999999986544 6799999874432 2346789999999999999999999985 34
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVD-----------GNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
....+++|||+++++|.+++........ ..+++.+++.++.|++.|++|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 5677999999999999999987533212 5688999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 001858 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924 (1003)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~ 924 (1003)
++.++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||+||++|||++ |..||.....
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~- 232 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN- 232 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 999999999999999765332211 11122346788999999988899999999999999999998 9999865321
Q ss_pred cchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 925 GLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+..+.+.... .......++.++.+++.+||+.+|++||+++||+++|++
T Consensus 233 -------------~~~~~~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -------------QEVIEMIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------------HHHHHHHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11222222111 111223456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=330.29 Aligned_cols=241 Identities=24% Similarity=0.317 Sum_probs=193.9
Q ss_pred eeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||.||+|++..+++.||+|+++.. .......+.+|++++++++||||+++++++ .+++..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 69999999999999989999999998643 233456788999999999999999999884 4567889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++|+|.+++.. .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 76 NGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999999976 34689999999999999999999999 99999999999999999999999999997542211
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.....
T Consensus 148 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----------------~~~~~~~ 205 (312)
T cd05585 148 -----DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------NEMYRKI 205 (312)
T ss_pred -----CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----------------HHHHHHH
Confidence 112235699999999999999999999999999999999999999975321 0111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC---HHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH---MADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~~ 990 (1003)
..... . ........+.+++.+|++.+|++||+ +.|++.|
T Consensus 206 ~~~~~-~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 206 LQEPL-R---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HcCCC-C---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11111 0 01123456788999999999999985 6677654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=332.80 Aligned_cols=267 Identities=23% Similarity=0.353 Sum_probs=205.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.++||+|+||.||+|.+..++..+|+|++.... ....+.+.+|+++++.++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 468999999999999999999999999999999987543 233467899999999999999999999953 46678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++|+|.+++.. .+.+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 999999999999999986 346889999999999999999999742 6999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-----
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA----- 935 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~----- 935 (1003)
....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||......+. .......
T Consensus 152 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 222 (333)
T cd06650 152 GQLIDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGCPVEGDP 222 (333)
T ss_pred hhhhhhc-------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcCcccCCc
Confidence 7553211 1234689999999999988899999999999999999999999975332111 0000000
Q ss_pred ------------------------CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 936 ------------------------LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 936 ------------------------~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.........+......+..... .....++.+++.+||+.+|++||+++|++++-
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 0000111111111111100000 01235688999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.56 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=200.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCC-ceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDL-LPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+++++.++||||+++++++ .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 457999999999999999999976554 689999986432 33456788999999999999999999985 456
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++||||+++|+|.+++.. .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 778999999999999999987 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 176 G~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------- 234 (340)
T PTZ00426 176 GFAKVVDTR--------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------------- 234 (340)
T ss_pred CCCeecCCC--------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------------
Confidence 999765321 12356999999999999888999999999999999999999999753211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
.....+......-| ......+.+++.+|++.+|++|+ +++|+.++
T Consensus 235 -~~~~~i~~~~~~~p-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 -LIYQKILEGIIYFP-------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -HHHHHHhcCCCCCC-------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111111111111 11234567889999999999995 89998876
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=343.36 Aligned_cols=269 Identities=21% Similarity=0.281 Sum_probs=213.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC-CCCceeEeee-eeecccCC-CC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITV-CSSIDFKG-DD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~ 778 (1003)
..++++.++|.+|||+.||.|.+.+.+..||+|++-..++.......+|+++|+.++ |+|||.+++. .....-.. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 356788899999999999999999887999999998777777889999999999996 9999999993 22211122 35
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
++++.||||.||.|-|++..+.. ..+.+.++++|+.++++|+++||.. +++|||||||-+|||++.+|..||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 67899999999999999987653 3499999999999999999999997 6789999999999999999999999999
Q ss_pred cccccccCCccccC----cccccccccccccCcccc---CCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 859 LAKFLFDRPIQETS----SSSIGIKGTVGYVAPEYG---MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
.|+-.......... ........|+.|.|||.+ .+..++.|+||||+||+||-++....||+....- .
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--a---- 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--A---- 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--e----
Confidence 99653322110000 011123468999999964 5678999999999999999999999999864211 0
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
++ +.....+....+...+..+++.|++++|++||++.+|+..+.++...
T Consensus 266 -----------Il------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -----------IL------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------EE------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 00 01111222345678899999999999999999999999999887643
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.79 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=206.9
Q ss_pred hccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 774 (1003)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++... ....+.+.+|+++++++ +||||++++++|.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~---- 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT---- 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence 4589999999999999999997543 34789999987432 22346788899999999 8999999999873
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCC---------------------------------------------------
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQV--------------------------------------------------- 803 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 803 (1003)
..+...++++||+++++|.+++.......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 34567789999999999999997532110
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccc
Q 001858 804 -----DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878 (1003)
Q Consensus 804 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 878 (1003)
...+++.++..++.||+.|++|||+. +|+||||||+||+++.++.++|+|||+++.+....... .....
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---~~~~~ 235 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGDA 235 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---hccCC
Confidence 13689999999999999999999999 99999999999999999999999999998763322111 11123
Q ss_pred cccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchh
Q 001858 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERA 957 (1003)
Q Consensus 879 ~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~ 957 (1003)
.++..|+|||++.+..++.++||||+||++|||++ |+.||......+ .....+.......
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------------~~~~~~~~~~~~~------ 296 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------------EFCRRLKEGTRMR------ 296 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------------HHHHHHhccCCCC------
Confidence 46778999999999999999999999999999998 999987532211 1111111111110
Q ss_pred hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 958 KIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 958 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
........+.+++.+||+.+|++||++.|++++|+.+.+
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011234578899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=338.95 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=204.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++++.++||||++++++ +.+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence 46899999999999999999999899999999997432 2445678999999999999999999987 455778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.+++... +.+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 89999999999999999873 5689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCc------------------------cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCC
Q 001858 860 AKFLFDRPI------------------------QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915 (1003)
Q Consensus 860 a~~~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~ 915 (1003)
+........ ...........||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 976543220 00011223356999999999999999999999999999999999999
Q ss_pred CCCCcccCCcchhhHHHHhhCchhHHHHHH--hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 001858 916 RPTHTMFNDGLTLHGFVKMALPEKVMEIVD--FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-MADAVKN 990 (1003)
Q Consensus 916 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~ 990 (1003)
.||...... +....+.. .... .|. ...+...+.+++.+|+. +|++||+ ++|++++
T Consensus 228 ~Pf~~~~~~-------------~~~~~i~~~~~~~~-~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQ-------------ETYNKIINWKESLR-FPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHH-------------HHHHHHhccCCccc-CCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 999753311 01111111 0111 111 11135567888889997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.34 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=208.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|++..+++.||||.++... ......+.+|+++++.++|||++++++++. +.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 57899999999999999999999899999999876322 233457899999999999999999999853 4567
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||+++++|.+++...... ...+++.+++.++.|++.|++|||++ +++|+||||+||+++.++.++++|||+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 79999999999999998754322 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+........ ......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||........ .
T Consensus 153 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~------------~ 215 (267)
T cd08228 153 GRFFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF------------S 215 (267)
T ss_pred ceeccchhH-----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH------------H
Confidence 976543211 11234588899999999888899999999999999999999999854321110 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
....+... ..+ ..........+.+++.+||+.+|++||+++++++.+++++
T Consensus 216 ~~~~~~~~--~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 LCQKIEQC--DYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHhcC--CCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11111110 111 1112234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.96 Aligned_cols=257 Identities=27% Similarity=0.481 Sum_probs=206.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|++++++++|||++++++++ ..+...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcE
Confidence 34688889999999999999999988999999998743 33457889999999999999999999985 3456779
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++..++.++.|+++|++|||+. +++||||||+||++++++.+|++|||.+.
T Consensus 79 lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 79 IITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEEeCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999997643 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
......... .....++..|+|||...+..++.++|||||||++|||++ |..||...... +.
T Consensus 153 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------------~~ 214 (263)
T cd05052 153 LMTGDTYTA----HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QV 214 (263)
T ss_pred ccccceeec----cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------------HH
Confidence 654322111 112234678999999988999999999999999999998 99998653211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
...+...... .....++..+.+++.+||+.+|++||++.|+.+.|+.+
T Consensus 215 ~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 YELLEKGYRM------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHCCCCC------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111111111 11122356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.25 Aligned_cols=381 Identities=26% Similarity=0.355 Sum_probs=332.2
Q ss_pred CCcEEEEEeecCCCC-cccCccccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCcee
Q 001858 75 HPRVIQLYLRNQSVG-GFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINF 153 (1003)
Q Consensus 75 ~~~v~~l~l~~~~~~-g~~~~~l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L 153 (1003)
.+-|..+|+++|+++ +..|.++..++.+++|.|...++. .+|.+++.|.+|++|.+++|++. .+-..++.|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 357889999999999 579999999999999999999999 99999999999999999999999 677889999999999
Q ss_pred ecccccccC-CCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcc-cccCCCCCCeEecCCc
Q 001858 154 SVRRNNLTG-EIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE-SLGQLRDLNFLSVAEN 231 (1003)
Q Consensus 154 ~l~~N~l~~-~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N 231 (1003)
++++|++.. -||..+..+ ..|+.||||+|+++ ..|..+..-+++-.|+||+|+|. .||. -+.+|+.|-+||||+|
T Consensus 84 ~~R~N~LKnsGiP~diF~l-~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRL-KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred hhhccccccCCCCchhccc-ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccc
Confidence 999999975 789999875 89999999999999 89999999999999999999999 5665 5789999999999999
Q ss_pred cCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccc-cCcCccccccccchhhhccCccccCccC
Q 001858 232 NFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLT-GSIPQSFSNASNLVILNLSGNHFSGKVG 310 (1003)
Q Consensus 232 ~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 310 (1003)
++..++|.+-.+..|++|.|++|.+.- ....-.-.+++|+.|++++.+-+ .-+|.++..+.+|..+|||.|.+. .+|
T Consensus 161 rLe~LPPQ~RRL~~LqtL~Ls~NPL~h-fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLEMLPPQIRRLSMLQTLKLSNNPLNH-FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhhhcCHHHHHHhhhhhhhcCCChhhH-HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 999999999999999999999998762 11111115778889999988765 458999999999999999999998 778
Q ss_pred cccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccC-cccc
Q 001858 311 IDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISG-TIPL 389 (1003)
Q Consensus 311 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~ 389 (1003)
..+-.+++|+.|+|++|+|+.+..+. ....+|++|+|+.|+++ .+|..++++++|+.|.+.+|+++- -+|.
T Consensus 239 ecly~l~~LrrLNLS~N~iteL~~~~-------~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKITELNMTE-------GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred HHHhhhhhhheeccCcCceeeeeccH-------HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 88999999999999999999876542 23468999999999999 899999999999999999999874 4788
Q ss_pred cccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCC
Q 001858 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL 469 (1003)
Q Consensus 390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 469 (1003)
.++++.+|+++..++|.+. ..|+.++.+..|+.|.|++|++- .+|+++.-++.|+.|||..|.=--..|..-..-++|
T Consensus 311 GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~l 388 (1255)
T KOG0444|consen 311 GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKL 388 (1255)
T ss_pred chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcc
Confidence 9999999999999999998 89999999999999999999987 689999999999999999987552333322222445
Q ss_pred Cee
Q 001858 470 MLL 472 (1003)
Q Consensus 470 ~~L 472 (1003)
+.-
T Consensus 389 efY 391 (1255)
T KOG0444|consen 389 EFY 391 (1255)
T ss_pred eee
Confidence 443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=346.81 Aligned_cols=263 Identities=23% Similarity=0.268 Sum_probs=207.7
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccC---
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK--- 775 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 775 (1003)
..++|++.+.||+|+||+||+|++..+++.||||++.... ......+.+|+..+..++|+|++++.+.+...+..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4579999999999999999999999899999999986442 33456788999999999999999988765432211
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 855 (1003)
.....++||||+++|+|.+++...... ...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 112367999999999999999764332 45789999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
|||+++.+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 186 DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------------ 250 (496)
T PTZ00283 186 DFGFSKMYAATVS---DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------------ 250 (496)
T ss_pred ecccCeecccccc---ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------------
Confidence 9999986543211 1122345799999999999999999999999999999999999999965321
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.+......... +....+...+.+++.+||+.+|++||++.+++++
T Consensus 251 -----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 -----EEVMHKTLAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----HHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111111111 1112345678899999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.87 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=201.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|++.++||+|+||+||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4788899999999999999998889999999986432 22235678899999999999999999884 456678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEeccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999887532 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .. +.+
T Consensus 150 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~---------~~~ 213 (285)
T cd05605 150 VEIPEGE------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR---------EEV 213 (285)
T ss_pred eecCCCC------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH---------HHH
Confidence 7653211 1123468999999999998899999999999999999999999997532110 00 011
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
...+. ..+. .........+.+++.+||+.+|++|| +++++.++
T Consensus 214 ~~~~~----~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 ERRVK----EDQE---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHhh----hccc---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11111 1111 11123456688999999999999999 88899776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.20 Aligned_cols=256 Identities=21% Similarity=0.246 Sum_probs=204.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCC-CceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGED-LLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+++++.++||||+++++++ ..++..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence 3488999999999999999998777 778999987655555556788899999999999999999985 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++|+|.+++...... ...+++.++..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999999999988753221 45688999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
.+.+... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus 218 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------------~ 277 (478)
T PTZ00267 218 QYSDSVS---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------------R 277 (478)
T ss_pred ecCCccc---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------------H
Confidence 6543211 1122345699999999999999999999999999999999999999864321 1
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+......... +....+...+.+++.+|++.+|++||++++++.+
T Consensus 278 ~~~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 278 EIMQQVLYGKYD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHhCCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111111111110 0111234568899999999999999999999754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=340.96 Aligned_cols=257 Identities=21% Similarity=0.263 Sum_probs=196.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999999999999986432 23356788999999999999999999884 55778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 8999999999999999976 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCc--------------------------------------cccCcccccccccccccCccccCCCCCCccccc
Q 001858 860 AKFLFDRPI--------------------------------------QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDV 901 (1003)
Q Consensus 860 a~~~~~~~~--------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv 901 (1003)
|..+..... ...........||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 853310000 000001123579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCC
Q 001858 902 YSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981 (1003)
Q Consensus 902 wslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 981 (1003)
||+||++|||++|+.||......+. ............ .+........+.+++.+|+ .+|++|
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~-------------~~~i~~~~~~~~----~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAET-------------QLKVINWETTLH----IPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHH-------------HHHHhccCcccc----CCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 9999999999999999975432110 011110000000 0000112334455555655 499999
Q ss_pred C---CHHHHHHH
Q 001858 982 I---HMADAVKN 990 (1003)
Q Consensus 982 P---s~~ev~~~ 990 (1003)
+ ++.|+++|
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=334.84 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=201.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|.+..+++.||+|... .+.+.+|++++++++||||+++++++ ..+...+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeE
Confidence 357999999999999999999999999999999753 24567899999999999999999985 3456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+|++. ++|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 160 lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 160 LILPRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EEEecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999996 589998876 34688999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCC------cchhhHHHHhh
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND------GLTLHGFVKMA 935 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~------~~~~~~~~~~~ 935 (1003)
...+.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||-..... ...+.......
T Consensus 231 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~ 306 (391)
T PHA03212 231 FPVDIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306 (391)
T ss_pred cccccc----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence 542211 11223457999999999999999999999999999999999999886432211 11111111100
Q ss_pred ------Cc----hhHHHHH---HhhcccCCCCc--hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 ------LP----EKVMEIV---DFALLLDPGNE--RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ------~~----~~~~~~i---~~~l~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+ ....... .......+..+ .....+....+..++.+|++.+|++|||++|++++
T Consensus 307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01 0111111 11111122211 11223445678899999999999999999999975
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=339.56 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=173.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5888999999999999999999999999999987432 23356788999999999999999999984 456788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++|+|.+++.+ .+.+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~E~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 999999999999999976 34688999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCc------------------------------------------cccCcccccccccccccCccccCCCCCCcc
Q 001858 861 KFLFDRPI------------------------------------------QETSSSSIGIKGTVGYVAPEYGMGGNVSLT 898 (1003)
Q Consensus 861 ~~~~~~~~------------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 898 (1003)
+.+..... ...........||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 53311000 000001123569999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCCCcc
Q 001858 899 GDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 899 sDvwslG~il~ell~g~~P~~~~ 921 (1003)
+||||+||++|||++|+.||...
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCC
Confidence 99999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=339.08 Aligned_cols=257 Identities=19% Similarity=0.241 Sum_probs=197.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++ .+..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 46889999999999999999999999999999986432 23356788999999999999999999984 55778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccc
Confidence 8999999999999999976 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccc--------cC----------------------------------cccccccccccccCccccCCCCCCc
Q 001858 860 AKFLFDRPIQE--------TS----------------------------------SSSIGIKGTVGYVAPEYGMGGNVSL 897 (1003)
Q Consensus 860 a~~~~~~~~~~--------~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 897 (1003)
++.+....... .. .......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 96432110000 00 0001246999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh-cccCCCCchhhHHHHHHHHHHHHhhcccc
Q 001858 898 TGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA-LLLDPGNERAKIEECLTAVVRIGVLCSME 976 (1003)
Q Consensus 898 ~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 976 (1003)
++||||+||++|||++|+.||......+ ......... ...-|. .......+.+++.+|+.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~-------------~~~~i~~~~~~~~~p~-----~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHE-------------TYRKIINWRETLYFPD-----DIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHH-------------HHHHHHccCCccCCCC-----CCCCCHHHHHHHHHHhc-
Confidence 9999999999999999999996532110 001111100 000011 01123456677778886
Q ss_pred CCCC---CCCHHHHHHHH
Q 001858 977 SPSE---RIHMADAVKNL 991 (1003)
Q Consensus 977 ~p~~---RPs~~ev~~~L 991 (1003)
+|.+ |+++.|++++-
T Consensus 289 ~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 289 NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred CHhhcCCCCCHHHHhcCC
Confidence 5555 56999998863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.36 Aligned_cols=273 Identities=23% Similarity=0.319 Sum_probs=202.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhc---CCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNI---RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|++.+.||+|+||+||+|++..+++.||+|.++... ......+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999999999999999987432 22234566788777766 699999999987654444456
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++ +|.+++.... ...+++.+++.++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 78999999985 8999887643 34589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~ 937 (1003)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+ ......... .+
T Consensus 154 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~ 226 (288)
T cd07863 154 LARIYSCQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 226 (288)
T ss_pred ccccccCcc------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCC
Confidence 997653221 1123468999999999988899999999999999999999999986543211 111111100 00
Q ss_pred --hhHHHHHH---hhcc-cCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 --EKVMEIVD---FALL-LDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 --~~~~~~i~---~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+..... .... ..+........+....+.+++.+|+++||++||++.|++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0000 00000111122345667899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.41 Aligned_cols=261 Identities=24% Similarity=0.393 Sum_probs=205.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCc----eEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..+|++.+.||+|+||.||+|++..++. .||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence 3569999999999999999999865554 48999987443 3345688999999999999999999998632
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
...++|+||+++|+|.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 2457999999999999999864 24588899999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 153 fG~a~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------------ 217 (316)
T cd05108 153 FGLAKLLGADEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------ 217 (316)
T ss_pred ccccccccCCCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 9999866432111 11112234678999999999999999999999999999998 9999865321
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
.+....+...... + ....+...+.+++.+||+.+|++||++.+++..+..+.+..
T Consensus 218 --~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 218 --SEISSILEKGERL-P-----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --HHHHHHHhCCCCC-C-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111222211111 1 11123456789999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=336.17 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=194.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.+|+..++||+|+||+||+|++..+++.||||++..... ...+.+.+|+++++.++|+||+++++++ ...+..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 456778999999999999999998999999999864432 2346789999999999999999999984 5567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++|+|.+. ....+..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 149 lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 149 VLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999998642 2346778889999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
.+.... .......||..|+|||++.. ...+.++|||||||++|||++|+.||......+
T Consensus 217 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----------- 280 (353)
T PLN00034 217 ILAQTM-----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----------- 280 (353)
T ss_pred eccccc-----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----------
Confidence 653211 11223568999999998743 234568999999999999999999997322111
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
....+.......+ ......+...+.+++.+||+.+|++||++.|+++|-
T Consensus 281 ---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 281 ---WASLMCAICMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---HHHHHHHHhccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1111111111111 111123456788999999999999999999999874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.42 Aligned_cols=256 Identities=19% Similarity=0.238 Sum_probs=201.1
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++ .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 3568999999999999999999999999999999996432 23345678899999999999999999884 557
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++|+|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence 788999999999999999875 2478888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC----CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
|++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 187 G~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------- 253 (370)
T cd05596 187 GTCMKMDANGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------- 253 (370)
T ss_pred cceeeccCCCc----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---------
Confidence 99976532211 111235699999999987653 4788999999999999999999999753210
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE--RIHMADAVKNL 991 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~L 991 (1003)
.....+.... .....+........+.+++.+|++.+|.+ ||++.|+++|-
T Consensus 254 ----~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 254 ----GTYSKIMDHK----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ----HHHHHHHcCC----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0111111110 00011111123456778889999988987 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=334.21 Aligned_cols=253 Identities=24% Similarity=0.288 Sum_probs=200.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 36889999999999999999999999999999997442 23456788999999999999999999884 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 89999999999999999874 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccC------CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM------GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+..+..... .......||+.|+|||++. +..++.++||||+||++|||++|+.||......
T Consensus 149 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------- 215 (330)
T cd05601 149 AARLTANKM----VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------- 215 (330)
T ss_pred CeECCCCCc----eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---------
Confidence 976533211 1122346899999999976 456788999999999999999999999653211
Q ss_pred hhCchhHHHHHHhhc-ccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 934 MALPEKVMEIVDFAL-LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.....+..... ...| ........+..++..|++ +|++||+++++++|
T Consensus 216 ----~~~~~i~~~~~~~~~~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 ----KTYNNIMNFQRFLKFP-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----HHHHHHHcCCCccCCC-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01111111100 0111 111234557788888997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.16 Aligned_cols=243 Identities=24% Similarity=0.323 Sum_probs=195.8
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997432 23356778899999999999999999884 45678899999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
|+++|+|.+++.. ...+++.+++.++.|++.|++|||+ . +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 76 YANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999999876 3468999999999999999999997 6 89999999999999999999999999987532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... +...+.+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------------~~~~~~i 208 (325)
T cd05594 148 KD-----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------------EKLFELI 208 (325)
T ss_pred CC-----CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------------HHHHHHH
Confidence 11 1112235699999999999999999999999999999999999999965321 1111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
......-| ......+.+++.+|++.+|++|+ +++++++|
T Consensus 209 ~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LMEEIRFP-------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hcCCCCCC-------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11111111 12345678899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.52 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=196.7
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCC-CceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHR-NLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 779 (1003)
+|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|+++++.+.|+ +|+++++++ .+.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 588899999999999999999999999999998743 233456788899999999765 577787773 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 8999999999999999976 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +
T Consensus 148 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------------~ 208 (324)
T cd05587 148 CKENIFG-----GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------------E 208 (324)
T ss_pred ceecCCC-----CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------------H
Confidence 8643211 11222356899999999999999999999999999999999999999753211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM-----ADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~ 990 (1003)
....+.......| ......+.+++.+|+..+|++|++. +++.++
T Consensus 209 ~~~~i~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 209 LFQSIMEHNVSYP-------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHcCCCCCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111111111 1234567889999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.04 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=194.3
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|+++.. .....+.+..|.++++.. +||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999999999999999999998743 234456778898888877 699999999984 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 Ey~~~g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999999999987 34689999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------------~~~~~i 208 (320)
T cd05590 148 FN-----GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------------DLFEAI 208 (320)
T ss_pred cC-----CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------------HHHHHH
Confidence 11 11122356999999999999999999999999999999999999999753211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM------ADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~ 990 (1003)
.......| ......+.+++.+|++.+|++||++ +++++|
T Consensus 209 ~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 209 LNDEVVYP-------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred hcCCCCCC-------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11111111 1134567889999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.13 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=208.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc---chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|+-.+.||+|+||.||-|++..+...||||.+....++ .+.++.+|++++++++|||++.+-||| -.+...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchH
Confidence 455668899999999999999999999999999755443 467899999999999999999999995 446667
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
|+|||||-| +-.|++.-+ ..++.+.++..|+.+.+.|++|||++ +.||||||+.|||+++.|.||++|||.|
T Consensus 102 WLVMEYClG-SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 102 WLVMEYCLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHhc-cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 999999966 888888876 46799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.+..+ ...++|||.|||||++. .+.|+-++||||+|++-.|+...++|.-.+
T Consensus 174 si~~P---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM---------------- 228 (948)
T KOG0577|consen 174 SIMAP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---------------- 228 (948)
T ss_pred hhcCc---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----------------
Confidence 86533 23588999999999864 578999999999999999999999996433
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
..+..+..-+....|.-. ..+....|.+++..|++.-|.+|||.+++++|-...+
T Consensus 229 NAMSALYHIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 229 NAMSALYHIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hHHHHHHHHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 122333333333333222 3456678999999999999999999999998765443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.54 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=194.8
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHH---HhcCCCCceeEeeeeeecccCCCC
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEAL---KNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ +.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 677899999999999999999999999999997432 23345667776655 466899999999984 4567
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++++|..++.. +.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence 88999999999999988864 4689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+++..... ........|++.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 147 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------------- 207 (324)
T cd05589 147 LCKEGMGF-----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------------- 207 (324)
T ss_pred CCccCCCC-----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------------
Confidence 98643221 11223457999999999999999999999999999999999999999753211
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
+....+.......| ..+...+.+++.+|++.+|++|| ++.+++++
T Consensus 208 ~~~~~i~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 EVFDSIVNDEVRYP-------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHhCCCCCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11111111111111 12345678899999999999999 56777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.58 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=209.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
...+|++.++||+|+||.||+|.+.. +..+|+|++..........+.+|+++++.++|||++++++++ .+....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 35678999999999999999999986 789999999866555567899999999999999999999985 445678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 99999999999999998643 45689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
....+.... .....++..|+|||...+..++.++||||+|+++|+|++ |+.||..... .+
T Consensus 152 ~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------------~~ 212 (261)
T cd05148 152 RLIKEDVYL-----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------------HE 212 (261)
T ss_pred hhcCCcccc-----ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------------HH
Confidence 765432211 112346778999999988889999999999999999998 8999865321 11
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
..+.+.... +.+....+...+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 213 ~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 213 VYDQITAGY------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHhCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111111111 1111123456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.06 Aligned_cols=257 Identities=19% Similarity=0.249 Sum_probs=198.5
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence 34578999999999999999999999999999999986422 22345688999999999999999999984 55
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
+...++||||+++|+|.+++.. ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence 7788999999999999999975 2478889999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCC----CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~ 932 (1003)
||+|........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 186 FG~a~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------- 253 (370)
T cd05621 186 FGTCMKMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------- 253 (370)
T ss_pred cccceecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------
Confidence 999986532211 111245699999999998654 3778999999999999999999999653210
Q ss_pred HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 001858 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE--RIHMADAVKNL 991 (1003)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~L 991 (1003)
.....+++...... .+........+.+++.+|+..++.+ |+++.|+++|-
T Consensus 254 -----~~~~~i~~~~~~~~----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 254 -----GTYSKIMDHKNSLN----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred -----HHHHHHHhCCcccC----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 01112221111111 1111123445667777778755443 88999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.60 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=191.1
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999997432 23345566677777655 899999999884 4567889999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~gg~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999999976 34689999999999999999999999 99999999999999999999999999997542
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+
T Consensus 148 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------------~~~~~i 208 (316)
T cd05592 148 NGE-----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------------ELFDSI 208 (316)
T ss_pred CCC-----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Confidence 211 1222356899999999999989999999999999999999999999753211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA-DAVK 989 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~ 989 (1003)
. ...+.. ...+...+.+++.+|++.+|++||++. ++.+
T Consensus 209 ~---~~~~~~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 209 L---NDRPHF----PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred H---cCCCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 111110 111245567889999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=349.45 Aligned_cols=269 Identities=23% Similarity=0.316 Sum_probs=206.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.++||+|+||.||+|++..+++.||+|+++.... ...++|.+|++++++++||||+++++++ .+++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 579999999999999999999998999999999874322 2346799999999999999999999985 34567
Q ss_pred eEEeeecccCCCHHHHHhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQ------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
.++||||+++|+|.+++...... .....++.+++.++.|+++|++|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999999753211 123456788899999999999999999 999999999999999999999
Q ss_pred EcccccccccccCCc-------------cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 854 VSDFGLAKFLFDRPI-------------QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
|+|||+++....... ...........||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521100 0001111235699999999999999999999999999999999999999975
Q ss_pred ccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHHHHHhh
Q 001858 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-HMADAVKNLCAAREK 997 (1003)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~~~~~ 997 (1003)
........ ......|.. .....+.+..+.+++.+|++.+|++|| +++++.+.|+...+.
T Consensus 234 ~~~~ki~~-----------------~~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 234 KKGRKISY-----------------RDVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred cchhhhhh-----------------hhhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 32211100 000011100 011123455678899999999999996 566777777766543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.93 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=202.9
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++|||++++++++. .+...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 357999999999999999999998899999999997555555567889999999999999999999853 456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.. .+.+++.++..++.|++.|++|||+. +|+|||++|+||+++.++.++++|||++.
T Consensus 83 iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999975 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
...... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||......+...
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------- 219 (267)
T cd06646 155 KITATI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------- 219 (267)
T ss_pred eecccc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----------
Confidence 653211 1122346889999999874 3457789999999999999999999985432211000
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
....... .+ ............+.+++.+||+.+|++||+++++++++
T Consensus 220 ---~~~~~~~--~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 ---LMSKSNF--QP-PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---eeecCCC--CC-CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000000 00 00111112345788999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.89 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=194.9
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|+||.||+|++..+++.||+|+++... ....+.+..|.++++.+ +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999899999999987432 33456678899998876 799999999984 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999976 34688999999999999999999999 99999999999999999999999999997532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+
T Consensus 148 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------------~~~~~i 208 (321)
T cd05591 148 LNG-----VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------------DLFESI 208 (321)
T ss_pred cCC-----ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------------HHHHHH
Confidence 211 1122356899999999999989999999999999999999999999753211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-------CHHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-------HMADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~~ 990 (1003)
.......| ..+...+.+++.+|++.+|++|| ++++++++
T Consensus 209 ~~~~~~~p-------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHDDVLYP-------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCCCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11111111 11235678899999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=319.16 Aligned_cols=265 Identities=25% Similarity=0.449 Sum_probs=208.6
Q ss_pred hccCCccCeeeeccceEEEEEEE-----CCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..+|.+.+.||+|+||.||++.. ..++..+|+|.+........+.+.+|++++++++|||++++++++ ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 35788999999999999999986 234567999998755555567899999999999999999999985 34
Q ss_pred CCceEEeeecccCCCHHHHHhhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSND--------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 848 (1003)
....++||||+++++|.+++..... .....+++.+++.++.|++.|++|||++ +++||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 5678999999999999999976432 1123589999999999999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcch
Q 001858 849 DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLT 927 (1003)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~ 927 (1003)
++.+|++|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--- 229 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--- 229 (288)
T ss_pred CCcEEeccCCccccccCCce---eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999976532211 111122345778999999998899999999999999999998 89998653211
Q ss_pred hhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
...+.+...... .. .......+.+++.+||+.+|.+||++.|+.+.|+.+.+.
T Consensus 230 -----------~~~~~i~~~~~~---~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 -----------EVIECITQGRVL---QR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -----------HHHHHHHcCCcC---CC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111111100 00 012245689999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.91 Aligned_cols=259 Identities=28% Similarity=0.348 Sum_probs=209.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+.|++.+.||+|.-|+||+++..+++..+|+|++.+.. .....+.+.|-+|++.+.||.+..++.. ++.+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence 356778899999999999999999999999999997554 3345677889999999999999999998 67788
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
+.++|||||+||+|....+++. ++.+++..++-++.+|+-||+|||-. |||+||+||+||||.++|++.++||.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 8999999999999999998865 67899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCC---------------------------------c------------------cccCcccccccccccccCc
Q 001858 859 LAKFLFDRP---------------------------------I------------------QETSSSSIGIKGTVGYVAP 887 (1003)
Q Consensus 859 ~a~~~~~~~---------------------------------~------------------~~~~~~~~~~~gt~~y~aP 887 (1003)
++......+ . .........++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 986442100 0 0011233457899999999
Q ss_pred cccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHH
Q 001858 888 EYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVV 967 (1003)
Q Consensus 888 E~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~ 967 (1003)
|++.|...+.++|.|+|||++|||+.|+.||.+..+.+ -...++.+-+. .+...+......
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------------Tl~NIv~~~l~------Fp~~~~vs~~ak 365 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------------TLRNIVGQPLK------FPEEPEVSSAAK 365 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------------hHHHHhcCCCc------CCCCCcchhHHH
Confidence 99999999999999999999999999999998754431 12222221111 111124456677
Q ss_pred HHHhhccccCCCCCCC----HHHHHHH
Q 001858 968 RIGVLCSMESPSERIH----MADAVKN 990 (1003)
Q Consensus 968 ~l~~~cl~~~p~~RPs----~~ev~~~ 990 (1003)
+++++.+..||++|.. ++||.+|
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcC
Confidence 8888888888888887 7777665
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.25 Aligned_cols=258 Identities=29% Similarity=0.471 Sum_probs=205.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCC---CceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.++|++.+.||+|+||+||+|.+... ...||||.++... ....+.|.+|+.++++++||||+++++++ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence 35789999999999999999998643 4579999987443 33356789999999999999999999984 446
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++||||+++++|.+++... .+.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence 6789999999999999999764 24789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|+++........ .......++..|+|||...+..++.++||||+|+++|||++ |..||......
T Consensus 151 g~~~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------------ 215 (266)
T cd05033 151 GLSRRLEDSEAT---YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------------ 215 (266)
T ss_pred chhhcccccccc---eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------------
Confidence 999876421111 11112335678999999998899999999999999999998 99998653211
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
...+.+...... + ....+...+.+++.+||+.+|++||++.|++++|.++
T Consensus 216 --~~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 --DVIKAVEDGYRL-P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --HHHHHHHcCCCC-C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111111 1 1123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.35 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=205.4
Q ss_pred eeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccC
Q 001858 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS 789 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 789 (1003)
++|+|.||+||.|++..+...+|||-+........+-+..|+...+.++|.|||+++|.+ ..+++.-+.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999999877777778899999999999999999999985 456778899999999
Q ss_pred CCHHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC-CCCCeEEcccccccccccC
Q 001858 790 GSLEDWLQQSNDQVDGNL--NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDR 866 (1003)
Q Consensus 790 gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a~~~~~~ 866 (1003)
|+|.++++..- +++ .+..+--+.+||++|+.|||+. .|||||||-+|||+. -.|.+||+|||.++.+..
T Consensus 657 GSLSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg- 728 (1226)
T KOG4279|consen 657 GSLSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG- 728 (1226)
T ss_pred CcHHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-
Confidence 99999998742 344 7777888999999999999999 999999999999996 578999999999987633
Q ss_pred CccccCcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 867 PIQETSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.......+.||..|||||++..+ .|+.++|||||||++.||.||++||........ ...
T Consensus 729 ----inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMF 789 (1226)
T KOG4279|consen 729 ----INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMF 789 (1226)
T ss_pred ----CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhh
Confidence 22233457899999999999876 478899999999999999999999976543211 111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+..+.+ ..++.+++...+...++.+|..++|.+||+++++++.
T Consensus 790 kVGmyK---vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 790 KVGMYK---VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhccee---cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 111111 2234566777888899999999999999999999863
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=314.53 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=204.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++ .+.+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence 467899999999999999999975 55679999876432 3357899999999999999999999884 4566789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 78 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred EEEecCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccce
Confidence 9999999999999997643 45688899999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ......++..|+|||+..++.++.++||||+||++|+|++ |+.||...... ..
T Consensus 152 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------------~~ 213 (261)
T cd05072 152 VIEDNEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------------DV 213 (261)
T ss_pred ecCCCcee----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------------HH
Confidence 65432211 1112346778999999988889999999999999999998 99998653211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
...+...... + ....+..++.+++.+|+..+|++||+++++.+.|+.
T Consensus 214 ~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 214 MSALQRGYRM-P-----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHcCCCC-C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111111 1 111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=327.48 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred cCCccCeeeeccceEEEEEEEC---CCCceEEEEEecccc----ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQ----KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (1003)
+|++.+.||+|+||.||+|+.. .+++.||+|++.... ....+.+.+|+++++.+ +||+|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 4888999999999999999874 467899999986432 23345788899999999 59999999987 45
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 855 (1003)
.++..++||||+++|+|.+++.. ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEe
Confidence 56778999999999999999976 34689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
|||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||........
T Consensus 148 DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------- 215 (332)
T cd05614 148 DFGLSKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-------- 215 (332)
T ss_pred eCcCCccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--------
Confidence 9999976432211 112235699999999998765 478899999999999999999999964322111
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
...+.......++.. .......+.+++.+|++.+|++|| ++++++++
T Consensus 216 -----~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 216 -----QSEVSRRILKCDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----HHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011111111122211 112345678899999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.14 Aligned_cols=251 Identities=33% Similarity=0.575 Sum_probs=193.5
Q ss_pred ccCeeeeccceEEEEEEEC----CCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 707 LSNLIGQGSFGFVYRGNLG----EDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 707 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+.+.||+|+||.||+|.+. ..+..|+||+++.... ...+.|.+|++.+++++||||++++|++. ..+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence 4578999999999999997 3457899999964333 23689999999999999999999999974 344589
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++|+|.+++.... ...+++.+++.++.|+++|++|||+. +++|+||+++||+++.++.+||+|||++.
T Consensus 78 lv~e~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSR 151 (259)
T ss_dssp EEEE--TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999852 35789999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ .......+...|+|||.+.+..++.++||||||+++|||++ |+.||..... .++
T Consensus 152 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------------~~~ 214 (259)
T PF07714_consen 152 PISEKSKY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------------EEI 214 (259)
T ss_dssp ETTTSSSE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------------HHH
T ss_pred cccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccc--------------ccc
Confidence 66222111 11222446789999999988889999999999999999999 7888765421 111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.+.+....... ....++..+.+++.+||+.+|++||++.++++.|
T Consensus 215 ~~~~~~~~~~~------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKLKQGQRLP------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHTTEETT------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccccce------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12222221111 1123456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=326.54 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=208.7
Q ss_pred cCCccCeeeeccceEEEEEEECCC---CceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+....++||+|.||.|++|.|... -..||||.++..... ...+|.+|+.+|.+++|||++++||+.. + ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl-----~-qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL-----D-QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec-----c-ch
Confidence 345568899999999999999643 356999999855544 6789999999999999999999999953 2 45
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
..+|||.++.|+|.+.+++.. ...+.......++.|||.|+.||.++ +.||||+..+|+++-....+||+|||+
T Consensus 185 ~mMV~ELaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence 579999999999999999832 56788888999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.+-+....... .......-...|+|||.+...+++.++|||+|||++|||++ |..||-+... .
T Consensus 259 mRaLg~ned~Y--vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~ 322 (1039)
T KOG0199|consen 259 MRALGENEDMY--VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------I 322 (1039)
T ss_pred eeccCCCCcce--EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------H
Confidence 99875433221 11112335678999999999999999999999999999999 8899876422 1
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+.+| ..++.+..+.|.+++++++..||..+|++||++.+|.+.+-.
T Consensus 323 qIL~~iD------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 323 QILKNID------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHhcc------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 2223333 123344456788999999999999999999999999866544
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.97 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=196.6
Q ss_pred eeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||+||+|.+..+++.||+|.+..... ...+.+..|+++++.++||||+++.+++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 6999999999999999999999999864322 2335678899999999999999999874 4567789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++|+|.+++...... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 76 ~~g~L~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 76 NGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred CCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence 999999888653221 45789999999999999999999999 99999999999999999999999999997653322
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 152 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------------~~~~~~~~~ 213 (280)
T cd05608 152 -----SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------------ENKELKQRI 213 (280)
T ss_pred -----ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------------hHHHHHHhh
Confidence 11223568999999999999999999999999999999999999997532210 001111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
. ..+. .........+.+++.+|++.+|++|| +++|++++
T Consensus 214 ~-~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 L-NDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred c-ccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1 1110 11123456788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.26 Aligned_cols=251 Identities=30% Similarity=0.472 Sum_probs=199.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
++|++.+.||+|+||.||+|.++ ++..+|+|.+... ....+.+.+|++++++++||||+++++++ ..++..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence 56888999999999999999886 4567999988633 33356889999999999999999999985 34567899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++|+|.+++... .+.+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++.
T Consensus 77 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccc
Confidence 99999999999999753 24588999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
....... ......++..|+|||...+..++.++||||+|+++|||++ |+.||...... +...
T Consensus 150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------------~~~~ 212 (256)
T cd05114 150 VLDDEYT----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------------EVVE 212 (256)
T ss_pred cCCCcee----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------------HHHH
Confidence 5332211 1112345678999999988889999999999999999999 89998653211 0111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.+........+ ......+.+++.+||+.+|++||+++|+++.|
T Consensus 213 ~i~~~~~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 213 MISRGFRLYRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11111111111 11235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=324.28 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|.+++... +||+|+++++++ .+++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 23445677788888765 899999999984 4567889999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999999976 35688999999999999999999999 99999999999999999999999999986432
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------------~~~~~~~ 208 (316)
T cd05620 148 FG-----DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------------DELFESI 208 (316)
T ss_pred cC-----CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------------HHHHHHH
Confidence 11 1122345689999999999999999999999999999999999999965321 1111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA-DAVK 989 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~ 989 (1003)
.. ..+.... ....++.+++.+|++.+|++||++. ++.+
T Consensus 209 ~~---~~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 209 RV---DTPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred Hh---CCCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11 1111101 1245677899999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=333.23 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=206.9
Q ss_pred HhccCCccCeeeeccceEEEEEEECCC-----CceEEEEEeccccc-cchHHHHHHHHHHHhcC-CCCceeEeeeeeecc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGED-----LLPVAVKVINLKQK-GSIKSFVAECEALKNIR-HRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 773 (1003)
..++|++.++||+|+||.||+|++... +..||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence 456899999999999999999987432 34699999974432 33567999999999996 99999999995
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCC---------------------------------------------------
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQ--------------------------------------------------- 802 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 802 (1003)
.+....++||||+++|+|.+++......
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 3456789999999999999998764210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCC
Q 001858 803 ----------------------------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPS 842 (1003)
Q Consensus 803 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 842 (1003)
....+++.++..++.|++.|++|||+. +|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence 013478888999999999999999999 9999999999
Q ss_pred ceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcc
Q 001858 843 NVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921 (1003)
Q Consensus 843 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~ 921 (1003)
||+++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred hEEEeCCCEEEEEeCCcceecccccc---ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999976532211 111122456788999999988899999999999999999997 99998754
Q ss_pred cCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 922 FNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
..+. .....+..... ......+...+.+++.+||+.+|++||++.++.+.|+++.+
T Consensus 344 ~~~~-------------~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 344 IVDS-------------TFYNKIKSGYR------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred chhH-------------HHHHHHhcCCC------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2211 11111111110 11112345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=324.61 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=193.7
Q ss_pred CeeeeccceEEEEEEEC---CCCceEEEEEecccc----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 709 NLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQ----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+++++.++||||+++++++ ..++..+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 68999999999999873 467899999987432 22345678899999999999999999884 4466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.. .+.+.+..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 77 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 77 LILEYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEeCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 99999999999999976 45678889999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....
T Consensus 149 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------------~~~~ 210 (323)
T cd05584 149 ESIHEG-----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------------KTID 210 (323)
T ss_pred ecccCC-----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------------HHHH
Confidence 532211 1122356899999999999888999999999999999999999999753210 0111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
....... .-| ......+.+++.+|++.+|++|| +++++.++
T Consensus 211 ~~~~~~~-~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 211 KILKGKL-NLP-------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcCCC-CCC-------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111111 111 12345678999999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.20 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=203.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCc----eEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|++.+.||+|+||+||+|.+..+++ .||+|.+.... .....++..|+..++++.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 578889999999999999999976665 47777775332 223467788888999999999999999852 2
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++++||+++|+|.+++... .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCC
Confidence 3467899999999999999764 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|+++...+... ........++..|+|||+..++.++.++|||||||++|||++ |+.||.+...
T Consensus 154 g~~~~~~~~~~---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------- 217 (279)
T cd05111 154 GVADLLYPDDK---KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------------- 217 (279)
T ss_pred ccceeccCCCc---ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------------
Confidence 99986543221 111223457789999999988899999999999999999998 9999865421
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
....+.+........ ...+...+..++.+||+.+|++||++.|+.+.|..+.+.
T Consensus 218 -~~~~~~~~~~~~~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 218 -HEVPDLLEKGERLAQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred -HHHHHHHHCCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 112222222211111 011234567889999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=323.54 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=192.2
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|+++... ....+.+..|..+++.. +||||+++++++ .+++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 23445677788888765 899999999984 4566789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ey~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999999976 34688999999999999999999999 99999999999999999999999999987432
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+
T Consensus 148 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------------~~~~~i 208 (316)
T cd05619 148 LGD-----AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------------ELFQSI 208 (316)
T ss_pred CCC-----CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Confidence 111 1122356899999999999989999999999999999999999999753211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH-HHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA-DAVK 989 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~ 989 (1003)
.. ..+... ......+.+++.+|++.+|++||++. ++.+
T Consensus 209 ~~---~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 209 RM---DNPCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred Hh---CCCCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 111100 11345677889999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.55 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=196.5
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|+||.||+|++..+++.||+|+++... ....+.+.+|..+++.+ +||||+++++++ ......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 47999999999999999999999999997432 23346688899999998 799999999984 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999876 35789999999999999999999999 99999999999999999999999999986421
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+.... ...+...+.+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-----~~~~~~~~~~ 217 (329)
T cd05588 148 RP-----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ-----NTEDYLFQVI 217 (329)
T ss_pred cC-----CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccc-----cchHHHHHHH
Confidence 11 1122235799999999999999999999999999999999999999974322110000 0001111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH------MADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~~~ 990 (1003)
......-| ..+...+.+++.+|++.+|++||+ ++|+++|
T Consensus 218 ~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 218 LEKQIRIP-------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HcCCCCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111111 123456788999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.19 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=204.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|++|.||+|.+..+++.||+|.+... .....+.+.+|+++++.++|||++++++++ ..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 477889999999999999999999999999998643 234467889999999999999999999984 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.
T Consensus 76 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEeCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccce
Confidence 9999999999999998743 35789999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......|++.|+|||+..+..++.++|+||+|+++|||++|+.||...... ..
T Consensus 150 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~- 209 (256)
T cd08529 150 LLSDNT-----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------------AL- 209 (256)
T ss_pred eccCcc-----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------------HH-
Confidence 654321 1122346889999999999988999999999999999999999998653210 00
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......... ......+...+.+++.+||+.+|++||++.+++++
T Consensus 210 --~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 210 --ILKIIRGVF---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHHHcCCC---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111111 11111345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.35 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=195.3
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 4799999999999999999999999999743 223345678899888877 899999999984 4567889999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 E~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999876 35689999999999999999999999 99999999999999999999999999997532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||........... .......+.+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~-----~~~~~~~~~i 217 (329)
T cd05618 148 RP-----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----NTEDYLFQVI 217 (329)
T ss_pred CC-----CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc-----ccHHHHHHHH
Confidence 11 1112235789999999999999999999999999999999999999964322111000 0000111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC------HHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH------MADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~~~ 990 (1003)
......-| ......+.+++.+|++.+|++||+ ++++++|
T Consensus 218 ~~~~~~~p-------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 218 LEKQIRIP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred hcCCCCCC-------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11111111 123456778999999999999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.15 Aligned_cols=265 Identities=28% Similarity=0.493 Sum_probs=209.3
Q ss_pred hccCCccCeeeeccceEEEEEEECC-----CCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|.++.......+.+.+|++++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----cc
Confidence 3568888999999999999998642 4456999998755555557899999999999999999999985 34
Q ss_pred CCceEEeeecccCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSND-----------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
....++||||+++++|.+++..+.. ...+.+++.+++.++.|++.|++|||++ +|+||||||+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 155 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCL 155 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEE
Confidence 5678999999999999999976532 1234689999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 001858 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924 (1003)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~ 924 (1003)
++.++.++++|||++......... .......++..|+|||+..+..++.++||||+||++|||++ |+.||......
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred EccCCcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999765332211 11123446788999999998999999999999999999999 99998653211
Q ss_pred cchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 925 GLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
...+.+....... ....++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 233 --------------~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 --------------EVIECITQGRVLE------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --------------HHHHHHhCCCCCC------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111110 0112345788999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.50 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=196.4
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+..|.+++... +|++|+++++++ .+.+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4788999999999999999999999999999987432 23345677788888877 589999998884 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCC
Confidence 8999999999999999976 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 148 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------------~ 208 (323)
T cd05616 148 CKENMWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------------E 208 (323)
T ss_pred ceecCCCC-----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------------H
Confidence 97532111 1122356899999999999999999999999999999999999999753211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM-----ADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~ 990 (1003)
....+......-| ......+.+++.+|++.+|++|++. .++.++
T Consensus 209 ~~~~i~~~~~~~p-------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 209 LFQSIMEHNVAYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHhCCCCCC-------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111111111111 1234567889999999999999974 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=325.18 Aligned_cols=238 Identities=29% Similarity=0.317 Sum_probs=188.1
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHH-HHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECE-ALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|++.... ....+.+..|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999987432 223345555555 56788999999999884 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.++++. .+.+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 76 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 76 DYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred cCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999999976 45688999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------------~~~~ 205 (323)
T cd05575 148 EH-----SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----------------AEMY 205 (323)
T ss_pred cC-----CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----------------HHHH
Confidence 21 1122235689999999999999999999999999999999999999965321 1111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA 985 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 985 (1003)
+.......... ......+.+++.+|++.+|++||++.
T Consensus 206 ~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 206 DNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111111111 11245678899999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.74 Aligned_cols=273 Identities=21% Similarity=0.212 Sum_probs=202.8
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-cCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999999989999999998643 2334567889999999999999999999864322 1223
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++ ++.+.+.. .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 457999999976 67776643 478888999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh--
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-- 935 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-- 935 (1003)
|+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+ .+.......
T Consensus 168 g~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~ 240 (359)
T cd07876 168 GLARTACTN------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGT 240 (359)
T ss_pred CCccccccC------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 999754221 11223568999999999999999999999999999999999999997643211 111111110
Q ss_pred Cchh----HHHHHHhhcccCCCCchhh----------------HHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 936 LPEK----VMEIVDFALLLDPGNERAK----------------IEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 936 ~~~~----~~~~i~~~l~~~~~~~~~~----------------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.... ....+.......+...... .......+.+++.+|++.+|++|||++|+++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 1111111111111100000 011235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.64 Aligned_cols=271 Identities=25% Similarity=0.360 Sum_probs=205.9
Q ss_pred ccCCccCeeeeccceEEEEEEE----CCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+|++.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 5788999999999999999984 45678999999876655556789999999999999999999997642 3345
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++|+||+++++|.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence 689999999999999999764 24589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--- 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~--- 935 (1003)
+++........ ........++..|+|||+..+..++.++||||+||++|||++|..|+...... ........
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (284)
T cd05081 154 LTKVLPQDKEY--YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQG 228 (284)
T ss_pred ccccccCCCcc--eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccccccc
Confidence 99866432111 00111122445699999998888999999999999999999988775432211 00000000
Q ss_pred --CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 936 --LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 936 --~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
....+.+.+.... +.+....+...+.+++.+||+++|++|||+.|+++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNG------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCC------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111111111 1111123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=331.71 Aligned_cols=262 Identities=18% Similarity=0.243 Sum_probs=201.2
Q ss_pred HHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeee
Q 001858 695 YAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSS 771 (1003)
Q Consensus 695 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 771 (1003)
..+.....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 3344455689999999999999999999999999999999986422 23345678899999999999999999884
Q ss_pred cccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCC
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 851 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 851 (1003)
.++...++||||+++|+|.+++.. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence 456788999999999999999975 2478889999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCC----CCCccccchhHHHHHHHHHhCCCCCCcccCCcch
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~ 927 (1003)
+||+|||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus 181 ikL~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--- 253 (371)
T cd05622 181 LKLADFGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--- 253 (371)
T ss_pred EEEEeCCceeEcCcCCc----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---
Confidence 99999999986533211 112235699999999998654 3788999999999999999999999753210
Q ss_pred hhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHHH
Q 001858 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE--RIHMADAVKNL 991 (1003)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~L 991 (1003)
.....+.. .......+........+..++.+|+..++.+ ||+++|+.++.
T Consensus 254 ----------~~~~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 ----------GTYSKIMN----HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----------HHHHHHHc----CCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00111111 1000001111223455677888888744433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=323.38 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=195.5
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|+++... ......+..|.++++.+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999899999999997432 33456778899999888 799999999984 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999999876 34689999999999999999999999 99999999999999999999999999986432
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+
T Consensus 148 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------------~~~~~i 208 (318)
T cd05570 148 LGG-----VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------------ELFQSI 208 (318)
T ss_pred cCC-----CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------------HHHHHH
Confidence 111 1122356899999999999999999999999999999999999999653211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH-----HHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM-----ADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~~ 990 (1003)
.......| ..+...+.+++.+|++.+|++||++ .+++++
T Consensus 209 ~~~~~~~~-------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDEVRYP-------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCCCCCC-------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11110111 1234567899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=317.80 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=203.9
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCC-C
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKG-D 777 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 777 (1003)
.+.+.|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++++ +|||++++++++......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999999899999999987443 3346788999999998 7999999999975433221 3
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 56789999999999999998643 34688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~ 932 (1003)
|++...... ........|+..|+|||++. +..++.++||||+||++|||++|+.||........
T Consensus 156 g~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------ 224 (272)
T cd06637 156 GVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 224 (272)
T ss_pred CCceecccc-----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------
Confidence 999754321 11223456899999999876 34578899999999999999999999864321100
Q ss_pred HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...... .+ .+......+...+.+++.+||..+|++||++.|++++
T Consensus 225 --------~~~~~~----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 225 --------LFLIPR----NP-APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------HHHHhc----CC-CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 00 0011111234568899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=335.90 Aligned_cols=273 Identities=23% Similarity=0.309 Sum_probs=198.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc---CCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF---KGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 778 (1003)
..+|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999899999999885321 334579999999999999999887643322 2223
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-CeEEccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDF 857 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df 857 (1003)
+.++||||+++ ++.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 56799999985 788877653222 45789999999999999999999999 999999999999999665 7999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA- 935 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~- 935 (1003)
|+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||.+....+ .+.......
T Consensus 216 Gla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLG 288 (440)
T ss_pred ccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 9998653221 12235689999999987664 68999999999999999999999997643221 111111110
Q ss_pred -CchhHHHHHHhhcc--cCCCCchh-----hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 -LPEKVMEIVDFALL--LDPGNERA-----KIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 -~~~~~~~~i~~~l~--~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+.......... .-|..... .....+.++.+++.+|++.+|++||++.|+++|
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 01110000000000 00000000 011234578899999999999999999999975
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=317.44 Aligned_cols=260 Identities=30% Similarity=0.507 Sum_probs=205.5
Q ss_pred hccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.++..... ..+.+.+|++++++++|||++++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence 3568889999999999999998743 3578999998754433 457899999999999999999999985 3
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSND---------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 846 (1003)
.....++||||+++++|.+++..... .....+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 45778999999999999999987532 1234688999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCc
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDG 925 (1003)
Q Consensus 847 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~ 925 (1003)
+.++.+|++|||.++........ .......+++.|+|||++.+..++.++||||+||++|||++ |+.||......
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~- 231 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE- 231 (280)
T ss_pred cCCCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999754322111 11122346788999999999999999999999999999998 99998653221
Q ss_pred chhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
...+.+.......+ .......+.+++.+||+.+|++||++.|+++.|+
T Consensus 232 -------------~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 -------------EVIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------------HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111221111111 1123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.79 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=203.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCc---eEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+|++.+.||+|+||.||+|.+..+++ .||+|+++.. .....+.|..|+.+++.++||||+++++++ .++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 458889999999999999999876554 5999998744 233457899999999999999999999984 4566
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++++|.+++... .+.+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence 789999999999999999764 34689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
++....................+..|+|||+..+..++.++||||+||++|||++ |..||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------------- 218 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------- 218 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------------
Confidence 9976543221111111111112457999999998999999999999999999887 99998653211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
...+.+..... .+...+++..+.+++.+||+.+|++||++++++..|+++
T Consensus 219 -~~~~~i~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 -DVINAIEQDYR------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHHHHHHcCCc------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111111 111123456688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.83 Aligned_cols=271 Identities=25% Similarity=0.313 Sum_probs=204.9
Q ss_pred CCccCeeeeccceEEEEEEE----CCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 705 FSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
|++.+.||+|+||+||++.. ..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 38889999999999988653 34677899999875432 345678899999999999999999998643 33456
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.+++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred EEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccc
Confidence 7899999999999999975 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH-hhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK-MALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~-~~~~~ 938 (1003)
++......... .......++..|+|||...+..++.++||||+|+++|||++|+.||......-........ .....
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05080 154 AKAVPEGHEYY--RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231 (283)
T ss_pred ccccCCcchhh--ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence 98654322110 1111223567799999998888999999999999999999999998654321111100000 00011
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
...+.++.... .+....++..+.+++.+||+++|++||+++++++.|+++.
T Consensus 232 ~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 12222221111 1111234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.07 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=202.5
Q ss_pred CCccCeeeeccceEEEEEEECCCCc--eEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCCCc
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLL--PVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGDDF 779 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 779 (1003)
|.+.+.||+|+||.||+|.+..++. .||+|.++.. .....+.+.+|+++++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999876654 6999988643 23345788999999999999999999998743221 12335
Q ss_pred eEEeeecccCCCHHHHHhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSND-QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
.++++||+++|+|.+++...+. .....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998854322 1134589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
+++.+....... ......+++.|+|||+..+..++.++||||+||++|||++ |+.||......
T Consensus 158 ~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------------- 221 (272)
T cd05075 158 LSKKIYNGDYYR---QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------------- 221 (272)
T ss_pred cccccCccccee---cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence 998664322111 1122346778999999999999999999999999999999 88898653211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+..+.+...... .....+...+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 222 -~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 -EIYDYLRQGNRL------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111111000 01112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.70 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=208.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+++.+|+++++.++|||++++++++ .+++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 46888999999999999999998899999999876432 22346888999999999999999999985 34667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.+++|||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchh
Confidence 89999999999999998753322 45689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+....... .......|+..|+|||+..+..++.++||||+|+++|+|++|..||.....+..
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------------- 214 (267)
T cd08229 153 GRFFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------- 214 (267)
T ss_pred hhccccCC-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-------------
Confidence 87653321 111234688999999999888899999999999999999999999864322100
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
+..+......... .........+.+++.+||+.+|++||++.+|++.++++.
T Consensus 215 --~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 215 --SLCKKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --HHhhhhhcCCCCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111111111100 011234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.18 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=204.6
Q ss_pred CCccCeeeeccceEEEEEEECCC---CceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCCC
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGDD 778 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 778 (1003)
|.+.+.||+|+||.||+|....+ +..||+|.++... ......+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998643 4789999987433 2334678999999999999999999998654332 2334
Q ss_pred ceEEeeecccCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQ-VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
..++|+||+++|+|.+++...... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 578999999999999998664321 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|+++.......... .....++..|+|||++.+..++.++||||+||++|||++ |..||......
T Consensus 158 g~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------------ 222 (273)
T cd05035 158 GLSKKIYSGDYYRQ---GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------------ 222 (273)
T ss_pred cceeeccccccccc---cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99986643321111 112235678999999988889999999999999999999 88888653221
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+..+.+... .. ......+...+.+++.+||+.+|++||++.|++++|+.+
T Consensus 223 --~~~~~~~~~---~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 --EIYDYLRHG---NR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHHHHcC---CC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111 11 011123456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=321.01 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=213.3
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc---chHHHHHHHHHHHhcC-CCCceeEeeeeeecccCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---SIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 776 (1003)
....|++.+.||+|.||.||+++.+.+|+.+|+|++.+.... ..+...+|+++++.+. |||||.+.++ +++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence 356799999999999999999999999999999999755432 4568999999999998 9999999999 566
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC----CCe
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MVA 852 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~~ 852 (1003)
....++|||+++||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+... +.+
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 77899999999999999999874 399999999999999999999999 99999999999999643 479
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~ 932 (1003)
|++|||+|....+ .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.......
T Consensus 179 k~~DFGla~~~~~------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~----- 247 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF----- 247 (382)
T ss_pred EEeeCCCceEccC------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-----
Confidence 9999999987643 22334578999999999999999999999999999999999999999875432111
Q ss_pred HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
. .....++.-..+.++.......+++..++..+|.+|++++++++|-
T Consensus 248 --------~----~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 248 --------L----AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred --------H----HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 1 1222222333444556677788899999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.90 Aligned_cols=247 Identities=25% Similarity=0.294 Sum_probs=193.5
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||+||+++...+++.||+|.+.... ....+.+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999986322 22234566799999999999999999884 4567889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 76 ~g~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 76 NGGDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred CCCCHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 9999999886543 34588999999999999999999999 99999999999999999999999999997653221
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ..+.....
T Consensus 150 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------------~~~~~~~~ 210 (277)
T cd05607 150 ------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------------KEELKRRT 210 (277)
T ss_pred ------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------------HHHHHHHh
Confidence 11234689999999999988899999999999999999999999865321100 01111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....... .......++.+++.+|++.+|++||+++|++++
T Consensus 211 ~~~~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 211 LEDEVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred hcccccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1111100 011234567899999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.89 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=209.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++|++++++++++ ..++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 57899999999999999999999899999999886322 23356899999999999999999999985 34567
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.+++...... ...+++.+++.++.+++.|++|||+. +|+||||+|+||+++.++.++++|||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccce
Confidence 89999999999999999764322 45689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+....... .......++..|+|||...+..++.++||||+||++|+|++|+.||...... .
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----------- 213 (267)
T cd08224 153 GRFFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---L----------- 213 (267)
T ss_pred eeeccCCC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---H-----------
Confidence 87653321 1112345888999999998888999999999999999999999998543211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
.+..+......... ...+.....+.+++.+||+.+|++||++.++++.++.++
T Consensus 214 -~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 214 -YSLCKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -HHHHhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111111100000 001234557889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.45 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=205.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCc--eEEEEEeccc-cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLL--PVAVKVINLK-QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 778 (1003)
++|++.+.||+|+||.||+|....++. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++ ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 578999999999999999999876654 4788887632 233456789999999999 799999999985 3456
Q ss_pred ceEEeeecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
..++|+||+++++|.+++...... ....+++.+++.++.|++.|++|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 789999999999999999764321 123588999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcc
Q 001858 848 HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGL 926 (1003)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~ 926 (1003)
.++.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 154 ~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-- 225 (297)
T cd05089 154 ENLASKIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-- 225 (297)
T ss_pred CCCeEEECCcCCCccccce------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 9999999999998632110 01111223567999999988889999999999999999997 99998654211
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhhc
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 1000 (1003)
+..+.+...... .....+...+.+++.+||+.+|.+||+++++++.|+.+.+++++
T Consensus 226 ------------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 226 ------------ELYEKLPQGYRM------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------------HHHHHHhcCCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111111 01122346788999999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=316.91 Aligned_cols=260 Identities=24% Similarity=0.435 Sum_probs=202.3
Q ss_pred HhccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
..++|++.+.||+|+||.||+|.+.+ ++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 46789999999999999999998742 34679999986432 22345788999999999999999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQ-----VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 849 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 849 (1003)
......++||||+++++|.+++...... .....++.++..++.|++.|++|||+. +++||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 4456789999999999999999764321 123467889999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchh
Q 001858 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTL 928 (1003)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~ 928 (1003)
+.++++|||+++.......... .....++..|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----- 227 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRK---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----- 227 (277)
T ss_pred CCEEECCCCCccccCCcceeec---CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 9999999999976533221111 112345788999999998899999999999999999999 7888865321
Q ss_pred hHHHHhhCchhHHHHH-HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIV-DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i-~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+...+.+ .......+ ..+...+.+++.+|++.+|++||++.|+++.++
T Consensus 228 ---------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 ---------EQVLRFVMEGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---------HHHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111 11111111 123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.60 Aligned_cols=267 Identities=21% Similarity=0.341 Sum_probs=203.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCC----------------ceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCcee
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDL----------------LPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIK 764 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 764 (1003)
..+|++.+.||+|+||.||+|.+...+ ..||+|++.... ....+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 467999999999999999999876433 458999987443 234578899999999999999999
Q ss_pred EeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecc
Q 001858 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV------DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838 (1003)
Q Consensus 765 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 838 (1003)
+++++. .++..++|+||+++++|.+++....... ...+++..++.++.|++.|++|||+. +|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999853 4567899999999999999998754222 23689999999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh--CCC
Q 001858 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT--GRR 916 (1003)
Q Consensus 839 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~--g~~ 916 (1003)
|||+||+++.++.++++|||+++........ .......++..|+|||+..+..++.++|||||||++|||++ |..
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 9999999999999999999999765332211 11123446788999999888889999999999999999998 667
Q ss_pred CCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 917 PTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
||......+ .+................+....++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 233 p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 233 PYEHLTDQQ-------------VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCcChHH-------------HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 775432110 011111100000000001111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.89 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=200.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+|++.+.||+|+||+||+|.+.+ +..||+|.+... ....+.|.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence 468889999999999999998864 456999988733 333567999999999999999999999863 3556799
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++|+|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++.
T Consensus 77 v~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999997642 3689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..+.... ......++..|+|||...+..++.++|||||||++|||++ |+.||...... ...
T Consensus 150 ~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------------~~~ 211 (256)
T cd05113 150 VLDDEYT----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------------ETV 211 (256)
T ss_pred cCCCcee----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHH
Confidence 5433211 1112346678999999988889999999999999999998 99998653211 111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+.+...... + . .......+.+++.+||+.+|++||++.++++.++
T Consensus 212 ~~~~~~~~~-~--~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 EKVSQGLRL-Y--R---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHhcCCCC-C--C---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111111110 0 0 0112467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.22 Aligned_cols=255 Identities=31% Similarity=0.493 Sum_probs=203.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||.||+|++..+ ..||+|+++... ...+.+.+|++++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 46799999999999999999998755 469999987432 23467899999999999999999998742 34568
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++|+|.+++.... ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++|+|||.++
T Consensus 77 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred EEEEcCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 9999999999999998643 34678999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
.+...... ......++..|+|||+..+..++.++||||+||++|||++ |+.||...... ..
T Consensus 151 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------------~~ 212 (262)
T cd05071 151 LIEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------------EV 212 (262)
T ss_pred eccccccc----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------------HH
Confidence 65432211 1112346778999999988899999999999999999999 88888653211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
.+.+.... + .+...++...+.+++.+|++.+|++||+++++.+.|+..
T Consensus 213 ~~~~~~~~---~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 213 LDQVERGY---R---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHhcCC---C---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111110 0 111223456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.79 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-----cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-----GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
++|++.+.||+|++|.||+|.+..++++||+|.+..... ...+.+.+|++++++++||||+++++++ .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 568999999999999999999988899999999864321 2245788999999999999999999985 456
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++|+||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+||
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 688999999999999999986 34688899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|.++....... .........|+..|+|||+..+..++.++||||+|+++|||++|+.||......
T Consensus 149 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------- 213 (263)
T cd06625 149 GASKRLQTICS--SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------------- 213 (263)
T ss_pred ccceecccccc--ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------------
Confidence 99976532211 111112345788999999999988999999999999999999999998643211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........ .. ........+...+.+++.+||..+|.+||++.|++++
T Consensus 214 ~~~~~~~~---~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 AAIFKIAT---QP---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHhc---cC---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00011110 00 0111122345667889999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.61 Aligned_cols=267 Identities=24% Similarity=0.354 Sum_probs=205.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|+||.||+|.+..++..||+|.++.... ....++.+|++++++++||||+++++++ .+++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence 368899999999999999999998999999999874422 2345688999999999999999999985 4567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.++++.. +.+++..+..++.|+++|++|||+.. +++||||||+||+++.++.+|++|||++.
T Consensus 76 lv~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred EEeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 999999999999999863 46889999999999999999999732 89999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC-----
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL----- 936 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~----- 936 (1003)
..... ......|+..|+|||+..+..++.++||||+|+++|||++|+.||....... .........
T Consensus 149 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 219 (308)
T cd06615 149 QLIDS-------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEA 219 (308)
T ss_pred ccccc-------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccc
Confidence 54221 1123568899999999888889999999999999999999999986432111 111110000
Q ss_pred ----------------chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 937 ----------------PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 937 ----------------~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+....+..+......+.. .+ .......+.+++.+|++.+|++||+++|++++-.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK-LP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cCCcccccCCCCCccchhhHHHHHHHHhcCCCcc-Cc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 001111122111111111 00 0123456889999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=337.75 Aligned_cols=271 Identities=21% Similarity=0.261 Sum_probs=196.7
Q ss_pred HHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCC------CceeEeeeeee
Q 001858 698 LNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHR------NLIKIITVCSS 771 (1003)
Q Consensus 698 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~ 771 (1003)
+....++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|++++++++|. +++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~- 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ- 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE-
Confidence 3345688999999999999999999999889999999996332 2234566788887777554 5788888753
Q ss_pred cccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCC
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDM 850 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~ 850 (1003)
.+....++|||++ +++|.+++.+ .+.+++.++..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 202 ---~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 202 ---NETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred ---cCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 2345688999988 6689999876 3568999999999999999999997 5 899999999999998765
Q ss_pred ----------------CeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhC
Q 001858 851 ----------------VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG 914 (1003)
Q Consensus 851 ----------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g 914 (1003)
.+||+|||.+.... .......||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 49999999885321 112246799999999999999999999999999999999999
Q ss_pred CCCCCcccCCcch-hhHHHHhhCchhH---------HHHHHhhcccCCCCchhh---------HH--HHHHHHHHHHhhc
Q 001858 915 RRPTHTMFNDGLT-LHGFVKMALPEKV---------MEIVDFALLLDPGNERAK---------IE--ECLTAVVRIGVLC 973 (1003)
Q Consensus 915 ~~P~~~~~~~~~~-~~~~~~~~~~~~~---------~~~i~~~l~~~~~~~~~~---------~~--~~~~~l~~l~~~c 973 (1003)
+.||......+.. ........++..+ .++........+...... .. .....+.+++.+|
T Consensus 342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 9999764321110 0000001111111 111111111111000000 00 1124577999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 001858 974 SMESPSERIHMADAVKN 990 (1003)
Q Consensus 974 l~~~p~~RPs~~ev~~~ 990 (1003)
++.||++||+++|+++|
T Consensus 422 L~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTH 438 (467)
T ss_pred CCcChhhCCCHHHHhcC
Confidence 99999999999999985
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.14 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=192.7
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+|+..+.||+|+||+||+|.+..+++.||+|+++.. .....+.+..|.++++.+. |++|+++.++ +.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 467789999999999999999999999999998743 2334567888999998885 5777788877 345667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccc
Confidence 8999999999999999976 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 148 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------------~ 208 (323)
T cd05615 148 CKEHMVDG-----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------------E 208 (323)
T ss_pred ccccCCCC-----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------------H
Confidence 97532211 1122356899999999999989999999999999999999999999753211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM 984 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 984 (1003)
..+.+.......| ......+.+++.+|++.+|++|++.
T Consensus 209 ~~~~i~~~~~~~p-------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 209 LFQSIMEHNVSYP-------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHhCCCCCC-------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111111111111 1234567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=330.72 Aligned_cols=206 Identities=25% Similarity=0.349 Sum_probs=175.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|++++..++||+|+++++. +.+++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 36888999999999999999999999999999997432 3345678889999999999999999988 455778
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.+ .+.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred EEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence 8999999999999999976 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccc------------------------------cCcccccccccccccCccccCCCCCCccccchhHHHHHH
Q 001858 860 AKFLFDRPIQE------------------------------TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909 (1003)
Q Consensus 860 a~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ 909 (1003)
+.......... ........+||+.|+|||++.+..++.++||||+||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 87543211000 000012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCcc
Q 001858 910 EMFTGRRPTHTM 921 (1003)
Q Consensus 910 ell~g~~P~~~~ 921 (1003)
||++|+.||...
T Consensus 228 el~tG~~Pf~~~ 239 (360)
T cd05627 228 EMLIGYPPFCSE 239 (360)
T ss_pred ecccCCCCCCCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.65 Aligned_cols=255 Identities=32% Similarity=0.493 Sum_probs=203.9
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++|||++++++++ ...+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 467899999999999999999976 45689999987433 3357789999999999999999999985 4456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 78 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeeecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 9999999999999997643 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ .......+..|+|||+..+..++.++||||+|+++|||++ |+.||..... ...
T Consensus 152 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~ 213 (261)
T cd05068 152 VIKEDIYE----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------------AEV 213 (261)
T ss_pred EccCCccc----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------------HHH
Confidence 76432111 1111223568999999998899999999999999999999 9999865321 111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
...+...... +....+...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 214 ~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 LQQVDQGYRM------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHcCCCC------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112211111 1112335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.89 Aligned_cols=270 Identities=20% Similarity=0.257 Sum_probs=210.0
Q ss_pred cHHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 694 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
.++.+..+.++|++.+.||+|+||.||+|.+..+++.+|+|+++... .....+.+|+.+++++ +|||++++++++...
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556667889999999999999999999999899999999886432 2236788899999999 699999999987654
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
...++...++||||+++++|.+++...... ...+++..++.++.|+++|+.|||+. +++||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 445667889999999999999998753222 45688999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcch
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~ 927 (1003)
|++|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||.......
T Consensus 164 kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-- 236 (286)
T cd06638 164 KLVDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-- 236 (286)
T ss_pred EEccCCceeecccCC-----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--
Confidence 999999997653221 11123468999999998753 457889999999999999999999986532110
Q ss_pred hhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
....... ...+ ...........+..++.+||+.+|++||++.|++++.
T Consensus 237 -----------~~~~~~~---~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 -----------ALFKIPR---NPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----------HHhhccc---cCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000000 0000 0001111234688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.69 Aligned_cols=251 Identities=18% Similarity=0.244 Sum_probs=202.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+|++.+.||+|+||.||++.+..+++.||+|.++.. .....+.+.+|+.+++.++|||++++++++ .+++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 478889999999999999999989999999998643 233457788999999999999999999984 45678899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.... ...+++..++.++.|++.|++|||++ +|+|+||||+||+++.++.++++|||.+..
T Consensus 76 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEeeCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCccee
Confidence 999999999999987643 34678999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
..... .......|++.|+|||+..+..++.++|+||+|+++|+|++|+.||...... ....
T Consensus 150 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------------~~~~ 210 (255)
T cd08219 150 LTSPG-----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------------NLIL 210 (255)
T ss_pred ecccc-----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------------HHHH
Confidence 53221 1122356889999999998888999999999999999999999998642210 0111
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+. .... .+....+...+.+++.+||+.+|++||++.|++..
T Consensus 211 ~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVC---QGSY---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHh---cCCC---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 1111 01112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.62 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=199.9
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+++++.++|++++++.+++ ..++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 667789999999999999999999999999986432 22345678899999999999999998874 4567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEeccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcce
Confidence 9999999999999887533 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... ......|+..|+|||++.+..++.++|+||+||++|||++|+.||...... ...
T Consensus 151 ~~~~~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--------------~~~ 210 (285)
T cd05632 151 KIPEGE------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--------------VKR 210 (285)
T ss_pred ecCCCC------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--------------HHH
Confidence 543211 112346899999999999889999999999999999999999999753211 001
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 990 (1003)
+.+........ ..........+.+++..|++.+|++||+ +.+++++
T Consensus 211 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 211 EEVDRRVLETE---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHhhhccc---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11111111110 0111223456788999999999999999 7787775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.78 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=204.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++. .+...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEE
Confidence 358999999999999999999998889999999998665555678899999999999999999999853 456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 94 lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 99999999999999864 3478899999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......|++.|+|||...+..++.++|||||||++|+|++|+.||......+. .
T Consensus 165 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------------~- 225 (296)
T cd06654 165 QITPEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------------L- 225 (296)
T ss_pred hccccc-----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------------H-
Confidence 543221 111234688999999999888899999999999999999999999965322100 0
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........+ .....+.....+.+++.+||..+|++||++.|++++
T Consensus 226 --~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 226 --YLIATNGTP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --HHHhcCCCC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000000100 011112344567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.70 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=202.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCce--EEEEEeccc-cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLP--VAVKVINLK-QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 777 (1003)
.++|++.+.||+|+||.||+|.+..++.. +|+|.++.. .....+.+.+|++++.++ +||||+++++++ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 45788999999999999999998776654 577766532 223346788999999999 899999999985 446
Q ss_pred CceEEeeecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 846 (1003)
+..++||||+++++|.+++...... ....+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 6789999999999999999865321 123688999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCc
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDG 925 (1003)
Q Consensus 847 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~ 925 (1003)
+.++.+||+|||++...... .......++..|+|||+..+..++.++||||+||++|||++ |..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 230 (303)
T ss_pred cCCCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-
Confidence 99999999999998632110 01111234678999999888889999999999999999998 99998643221
Q ss_pred chhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
+..+.+...... .........+.+++.+||+.+|++||+++++++.+..+...
T Consensus 231 -------------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 -------------ELYEKLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -------------HHHHHHhcCCcC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111000 01112345678999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.55 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=206.7
Q ss_pred HhccCCccCeeeeccceEEEEEEECCC-----CceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGED-----LLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 773 (1003)
..++|++.+.||+|+||.||+|.+... ...+|+|.+.... ......+.+|+++++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 456789999999999999999998643 3689999987432 23346788999999999 899999999985
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCC
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSND-----------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPS 842 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 842 (1003)
..++..+++|||+++|+|.++++.... ...+.+++.+++.++.|++.|++|||+. +|+||||||+
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 445678999999999999999976421 2245789999999999999999999999 9999999999
Q ss_pred ceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcc
Q 001858 843 NVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921 (1003)
Q Consensus 843 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~ 921 (1003)
||+++.++.+|++|||.++.+....... ......++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYR---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred eEEEcCCCeEEeCcccccccccccccee---ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999999998664322111 1111235678999999988899999999999999999998 99998653
Q ss_pred cCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 922 FNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
... +..+.+...... .....+...+.+++.+||+++|++|||+.|+++.|+++.
T Consensus 239 ~~~--------------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVE--------------ELFKLLKEGYRM------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHH--------------HHHHHHHcCCcC------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 211 111111111111 111123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.45 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=202.2
Q ss_pred ccCCccCeeeeccceEEEEEEEC----CCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLG----EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|++.+.||+|+||.||+|.+. .+++.||+|.+.... ......+.+|++++++++||||+++++++ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence 46788899999999999999852 355789999987433 23346789999999999999999999984 445
Q ss_pred CceEEeeecccCCCHHHHHhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQ------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
...++||||+++++|.+++...... ....+++.++..++.|++.|++|||++ +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 6789999999999999999643210 023578899999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 001858 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924 (1003)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~ 924 (1003)
++.++.+|++|||+++........ .......++..|+|||++.+..++.++||||+||++|||++ |..||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~- 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN- 232 (283)
T ss_pred EcCCCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 999999999999999765432211 11122345778999999988889999999999999999998 9889864321
Q ss_pred cchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 925 GLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
..+.+.+...... +..+.+...+.+++.+||+.+|++||++.++.++|.+
T Consensus 233 -------------~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 -------------QEVIEMVRKRQLL------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------------HHHHHHHHcCCcC------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1112222211111 1112234568889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.06 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=202.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++ ...+..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence 35788889999999999999999989999999998765555556788999999999999999999984 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++.. .+.+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 99999999999999976 35689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
...... .......|+..|+|||++. ...++.++||||+||++|+|++|+.||........
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------------ 217 (267)
T cd06645 155 QITATI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------------ 217 (267)
T ss_pred EccCcc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------------
Confidence 653221 1122356899999999874 45688899999999999999999999864322110
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......... .+.. ......+...+.+++.+|++.+|++||++++++++
T Consensus 218 -~~~~~~~~~--~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 218 -LFLMTKSNF--QPPK-LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -HHhhhccCC--CCCc-ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000000 0000 00001123467889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.48 Aligned_cols=266 Identities=23% Similarity=0.394 Sum_probs=204.1
Q ss_pred hccCCccCeeeeccceEEEEEEEC-----CCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 774 (1003)
.++|++.+.||+|+||+||+|.+. .+++.||||+++... ......+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee----
Confidence 467999999999999999999853 356789999997433 22346788999999999 6899999999863
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCC----------------------------------------------------
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQ---------------------------------------------------- 802 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 802 (1003)
..+...++||||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 2345678999999999999999753210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccC
Q 001858 803 ----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872 (1003)
Q Consensus 803 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 872 (1003)
....+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 012468888999999999999999999 9999999999999999999999999999765322111
Q ss_pred cccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccC
Q 001858 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLD 951 (1003)
Q Consensus 873 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 951 (1003)
.......++..|+|||+..+..++.++||||+|+++|||++ |..||...... +.....+.......
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~ 302 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------------EEFCRRLKEGTRMR 302 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------------HHHHHHHhccCCCC
Confidence 11112345678999999988899999999999999999997 99998653221 11111111111110
Q ss_pred CCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 952 PGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 952 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
........+.+++.+||+.+|++||++.|++++|+.+.+
T Consensus 303 ------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 ------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001123468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=327.02 Aligned_cols=274 Identities=22% Similarity=0.243 Sum_probs=202.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.++||+|+||.||+|.+..+++.||+|++... .....+++.+|+++++.++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998643 223456788999999999999999999986543322223689
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+. ++|.+++.. ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 488888865 35689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hCc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---ALP 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~~ 937 (1003)
...... ........+++.|+|||++.+. .++.++||||+||++|||++|+.||......+ ........ ...
T Consensus 152 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~ 226 (372)
T cd07853 152 VEEPDE----SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSL 226 (372)
T ss_pred ecccCc----cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCH
Confidence 653221 1112234578999999998774 47899999999999999999999997643221 11111100 000
Q ss_pred hhHHH---HHHhhcccCCCCchh------hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 938 EKVME---IVDFALLLDPGNERA------KIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 938 ~~~~~---~i~~~l~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+.+.. .....+...+..... ...+....+.+++.+|++.+|++||++.|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 11110 011111111111000 0112245678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.01 Aligned_cols=249 Identities=30% Similarity=0.430 Sum_probs=197.0
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
+.||+|+||.||+|++..+++.||+|...... ......+.+|++++++++||||+++++++ ......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 46999999999999998899999999876432 23346799999999999999999999985 3456789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++....+..
T Consensus 76 ~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 76 QGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred cCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 999999999753 34588999999999999999999999 99999999999999999999999999997543221
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDF 946 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 946 (1003)
.. .......++..|+|||.+.++.++.++||||+|+++|||++ |..||..... ......+..
T Consensus 149 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------------~~~~~~~~~ 211 (252)
T cd05084 149 YA---STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------------QQTREAIEQ 211 (252)
T ss_pred cc---ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------------HHHHHHHHc
Confidence 11 11111224567999999998899999999999999999998 8888864321 111222221
Q ss_pred hcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 947 ALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 947 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.... .....++..+.+++.+|++.+|++||++.|+.+.|.
T Consensus 212 ~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRL------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCC------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111 111233557889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.84 Aligned_cols=261 Identities=27% Similarity=0.419 Sum_probs=203.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
..++|.+.+.||+|+||.||+|.+.. ++..||+|...... ......|.+|+.++++++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS----- 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 35679999999999999999999976 67789999886443 23346789999999999999999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC--
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQ--VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-- 850 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-- 850 (1003)
.+....++||||+++++|.+++...+.. ....+++.++.+++.||+.|++|||+. +++||||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 3355678999999999999999875422 123689999999999999999999999 999999999999998754
Q ss_pred -CeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchh
Q 001858 851 -VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTL 928 (1003)
Q Consensus 851 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~ 928 (1003)
.+|++|||+++......... .......+..|+|||++.+..++.++||||+||++|||++ |+.||......
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---- 228 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---- 228 (277)
T ss_pred cceEeccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 59999999998663322111 1112234568999999998999999999999999999997 99998753221
Q ss_pred hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
...+.+....... ....++..+.+++.+|++.+|++||++.+++++|.
T Consensus 229 ----------~~~~~~~~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ----------EVMEFVTGGGRLD------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111121111111 11223457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=328.20 Aligned_cols=272 Identities=21% Similarity=0.211 Sum_probs=202.4
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-cCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999998889999999987432 233567889999999999999999999864322 1233
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++ ++.+.+.. .+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 457999999976 77777653 478889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM--- 934 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~--- 934 (1003)
|+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+. .......
T Consensus 164 g~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 236 (355)
T cd07874 164 GLARTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGT 236 (355)
T ss_pred cccccCCCcc------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 9997543221 12235689999999999998999999999999999999999999975422111 1110000
Q ss_pred h-------CchhHHHHHHhhcccC----C----C----CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 935 A-------LPEKVMEIVDFALLLD----P----G----NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~-------~~~~~~~~i~~~l~~~----~----~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. ..+.....++...... + . ............+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0011111111100000 0 0 0000011123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.26 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=206.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCc----eEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..+|++.++||+|+||+||+|++..++. .||+|+++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------ 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc------
Confidence 4578899999999999999999876665 489999864432 33567889999999999999999999863
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++++||+++|+|.+++... .+.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECC
Confidence 23457999999999999999764 34689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
||+++........ .......++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 153 fG~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------ 217 (279)
T cd05109 153 FGLARLLDIDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------------ 217 (279)
T ss_pred CCceeecccccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 9999866322111 11112235678999999988899999999999999999998 8999865321
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
......+...... + ....+...+.+++.+||+.+|++||++.|+++.++.+.+..
T Consensus 218 --~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 218 --REIPDLLEKGERL-P-----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --HHHHHHHHCCCcC-C-----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1112222221111 1 11123556889999999999999999999999998887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.23 Aligned_cols=270 Identities=20% Similarity=0.298 Sum_probs=201.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence 57899999999999999999999899999999987443 23345678999999999999999999985 3466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++ +|.+++... ...+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred EEEeCCCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccce
Confidence 99999986 888888764 34578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hCc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---ALP 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~~ 937 (1003)
...... .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ....... ..+
T Consensus 153 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~ 226 (309)
T cd07872 153 AKSVPT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTE 226 (309)
T ss_pred ecCCCc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Confidence 542211 11122457899999998765 4678999999999999999999999976432211 1111100 000
Q ss_pred hhHHHHHHh---hcccCCC----CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 938 EKVMEIVDF---ALLLDPG----NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 938 ~~~~~~i~~---~l~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+.+...... .....+. ............+.+++.+|++.+|.+|||++|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 101000000 0000010 00111123445678999999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=308.33 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=205.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
++|++.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++|||++++++++ ......++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 5789999999999999999999888899999999866555678899999999999999999999984 45667899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
+|||+++++|.+++... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||.+..
T Consensus 78 ~~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEeCCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999999998764 24688999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCC---CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
..... .......++..|+|||...+. .++.++||||+||++|||++|+.||....... .
T Consensus 151 ~~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------------~ 212 (262)
T cd06613 151 LTATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------------A 212 (262)
T ss_pred hhhhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------------H
Confidence 53211 111234688899999998776 78899999999999999999999986532110 0
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... +... ...+ ............+.+++.+||+.+|++||++++++.+
T Consensus 213 ~~~-~~~~-~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 213 LFL-ISKS-NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHH-HHhc-cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 1100 0011 1111122345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.62 Aligned_cols=251 Identities=31% Similarity=0.488 Sum_probs=198.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+|++.+.||+|+||.||+|.+. ++..+|+|++... ......+.+|+++++.++||||+++++++ ...+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEE
Confidence 45888999999999999999886 4568999998633 22346788999999999999999999984 44567899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.... +.+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 77 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999997642 3689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..+..... .....++..|+|||...+..++.++||||+|+++|||++ |+.||...... +..
T Consensus 150 ~~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~~ 211 (256)
T cd05059 150 VLDDQYTS----SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------------EVV 211 (256)
T ss_pred cccccccc----cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------------HHH
Confidence 53322111 111224568999999998899999999999999999999 89998653211 111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+.+..... + ... ..++.++.+++.+||..+|++||++.|+++.|
T Consensus 212 ~~~~~~~~--~-~~~---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ESVSAGYR--L-YRP---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHcCCc--C-CCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111110 0 001 12356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.10 Aligned_cols=238 Identities=29% Similarity=0.320 Sum_probs=188.1
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHH-HHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECE-ALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986432 223345556655 46778999999999884 4567889999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 76 DFVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999999876 45789999999999999999999999 99999999999999999999999999987432
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +......
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------------~~~~~~~ 209 (325)
T cd05604 148 AQ-----SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------------EMYDNIL 209 (325)
T ss_pred CC-----CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-------------HHHHHHH
Confidence 11 11223456999999999999999999999999999999999999999653211 0011111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA 985 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 985 (1003)
.......+ .....+.+++.+|+..+|++||++.
T Consensus 210 ~~~~~~~~--------~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 210 HKPLVLRP--------GASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cCCccCCC--------CCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11111111 1234567889999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.89 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=200.1
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccccccc--hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.+.||+|+||+||+|++..+++.||+|++....... .....+|+.++++++||||+++++++. .....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 678899999999999999999999999999998554332 223456999999999999999999953 4777899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.. .+.+++.+++.++.|+++|++|||+. +|+|+||||+||+++.++.++|+|||.+..
T Consensus 76 v~~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEETTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999999984 45789999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccC-CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGM-GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
... .........++..|+|||+.. +..++.++||||+|+++|+|++|+.||...... .... ...
T Consensus 148 ~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~--------~~~ 212 (260)
T PF00069_consen 148 LSE-----NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLE--------IIE 212 (260)
T ss_dssp STS-----TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHH--------HHH
T ss_pred ccc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhh--------hhh
Confidence 411 112223456899999999988 788999999999999999999999998764110 0000 001
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........... .........+.+++.+|++.+|++||++.+++++
T Consensus 213 ~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 213 KILKRPLPSSS----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHTHHHHHT----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hcccccccccc----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110000000 0000112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.52 Aligned_cols=269 Identities=21% Similarity=0.268 Sum_probs=209.1
Q ss_pred cHHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 694 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
...++..+.++|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34555567889999999999999999999999899999999986432 2346778899999999 899999999998654
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
+....+..++|+||+++++|.++++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 444456789999999999999998753221 45689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCCC-----CCCccccchhHHHHHHHHHhCCCCCCcccCCcch
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~ 927 (1003)
|++|||++........ ......|+..|+|||.+... .++.++||||+||++|||++|+.||......
T Consensus 168 kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--- 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--- 239 (291)
T ss_pred EEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---
Confidence 9999999976532211 11234588999999987543 3678999999999999999999998754211
Q ss_pred hhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....+... .+.......+.....+.+++.+||+.+|++||++.|++++
T Consensus 240 ----------~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 ----------KTLFKIPR-----NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----------HHHHHHhc-----CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00111100 0001111112334568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.63 Aligned_cols=267 Identities=20% Similarity=0.352 Sum_probs=201.4
Q ss_pred hccCCccCeeeeccceEEEEEEECC----------------CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCcee
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE----------------DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIK 764 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 764 (1003)
.++|++.++||+|+||.||+|.+.. +...||+|+++... .....++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986432 34569999987443 233568999999999999999999
Q ss_pred EeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecc
Q 001858 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV------DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838 (1003)
Q Consensus 765 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 838 (1003)
+++++ ...+..++||||+++++|.+++....... ...+++.+++.++.|++.|++|||+. +++|||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 84 LLAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 99985 34566799999999999999998754221 23578889999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh--CCC
Q 001858 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT--GRR 916 (1003)
Q Consensus 839 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~--g~~ 916 (1003)
|||+||+++.++.++++|||+++.+...... .......++..|+|||...++.++.++||||+||++|||++ |..
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999765332211 11112335678999999888889999999999999999998 778
Q ss_pred CCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 917 PTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
||......+. +. ............. ..+....+...+.+++.+||+.+|++||++.||.+.|+
T Consensus 233 p~~~~~~~~~-----~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 233 PYSQLSDEQV-----IE-----NTGEFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CccccChHHH-----HH-----HHHHHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8764322110 00 0111111000000 00111123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.75 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=195.0
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++ .+....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 23456788999999888 699999999984 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999999876 34689999999999999999999999 99999999999999999999999999997432
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ..+.....+
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-------~~~~~~~~~ 215 (327)
T cd05617 148 GP-----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-------TEDYLFQVI 215 (327)
T ss_pred CC-----CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-------cHHHHHHHH
Confidence 11 111223569999999999999999999999999999999999999996533211100 001111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH------HHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM------ADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~~ 990 (1003)
.......| ......+.+++.+|++.+|++|+++ .++.+|
T Consensus 216 ~~~~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 216 LEKPIRIP-------RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhCCCCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11111111 1223557789999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.65 Aligned_cols=241 Identities=29% Similarity=0.333 Sum_probs=188.6
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHH-HHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECE-ALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 47999999999999999899999999987432 222334444544 56778999999999884 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+.+.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 76 DYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999999999976 34678889999999999999999999 99999999999999999999999999997532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +......
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~i~ 209 (325)
T cd05602 148 EH-----NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------------EMYDNIL 209 (325)
T ss_pred cC-----CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------------HHHHHHH
Confidence 21 11223456999999999999999999999999999999999999999753211 0011111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAV 988 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 988 (1003)
....... ......+.+++.+|++.+|.+||++.+.+
T Consensus 210 ~~~~~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 210 NKPLQLK--------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred hCCcCCC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1111111 12345678889999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=314.19 Aligned_cols=262 Identities=25% Similarity=0.432 Sum_probs=204.9
Q ss_pred cCCccCeeeeccceEEEEEEECC-----CCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
+|++.+.||+|+||.||+|+... ....+|+|.+..... ...+++.+|+.+++.++||||+++++.+. .+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47888999999999999998743 235688998864432 23567899999999999999999999853 45
Q ss_pred CceEEeeecccCCCHHHHHhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQ-------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 838 (1003)
+..++|+||+.+++|.+++...... ....+++.+++.++.|++.|++|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 6679999999999999998764211 124588999999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCC
Q 001858 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917 (1003)
Q Consensus 839 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P 917 (1003)
|||+||++++++.+||+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++ |+.|
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999765332211 11122345778999999888889999999999999999998 9999
Q ss_pred CCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
|.... ++++.+.+........ ...+...+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 230 ~~~~~--------------~~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 230 YPGIA--------------PERLFNLLKTGYRMER------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCC--------------HHHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 86532 1222233332221111 12234578899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.80 Aligned_cols=238 Identities=29% Similarity=0.304 Sum_probs=186.7
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHH-HHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECE-ALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999986432 222345555654 57888999999999884 4567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. ...+++.++..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 76 DYVNGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99999999998876 35688999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 148 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~~~~ 205 (321)
T cd05603 148 EP-----EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----------------SQMY 205 (321)
T ss_pred CC-----CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----------------HHHH
Confidence 21 1122335689999999999988999999999999999999999999965321 0111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA 985 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 985 (1003)
+..... +... .......+.+++.+|++.+|++||++.
T Consensus 206 ~~i~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 206 DNILHK-PLQL---PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHhcC-CCCC---CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111 1000 011234677889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.80 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=204.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCc---eEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.++|+..+.||+|+||.||+|+...++. .+|+|.++... ....+.+.+|++++++++|||++++.+++ .+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 4578888999999999999999865543 79999987442 33456789999999999999999999985 445
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++||||+++++|.+++... .+.+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence 6789999999999999999763 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|++.......... ........+..|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus 152 g~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------------- 216 (268)
T cd05063 152 GLSRVLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------------- 216 (268)
T ss_pred ccceecccccccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------------
Confidence 9997654321111 11111223567999999988889999999999999999998 9999864321
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
......+.... . .+....+...+.+++.+||+.+|++||++.++++.|+++
T Consensus 217 -~~~~~~i~~~~-~-----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 -HEVMKAINDGF-R-----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -HHHHHHHhcCC-C-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112222111 1 111223456788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.80 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=200.5
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++|||++++++++. .+...++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 3678899999999999999999889999999987555555678999999999999999999999853 45678999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+||+++++|.+++... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 81 IEFCAGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999988653 34689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.... .......++..|+|||++. +..++.++||||+||++|||++|+.||......+
T Consensus 154 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------------- 215 (282)
T cd06643 154 TRTI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------------- 215 (282)
T ss_pred cccc-----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-------------
Confidence 3211 1122356899999999874 3457789999999999999999999986532110
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....... ...+ .......+...+.+++.+||+.+|++||++++++++
T Consensus 216 ~~~~~~~---~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 216 VLLKIAK---SEPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHhh---cCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011100 0001 001111234578899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.13 Aligned_cols=271 Identities=21% Similarity=0.261 Sum_probs=200.7
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CC
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KG 776 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 776 (1003)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999999899999999986432 2234567889999999999999999988643221 22
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++++|++ +++|.++++. ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 34568999988 6799888763 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ .........
T Consensus 162 fg~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 232 (343)
T cd07878 162 FGLARQADDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVV 232 (343)
T ss_pred CccceecCCC--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999764321 123568999999999876 568899999999999999999999996532211 111111000
Q ss_pred --Cchh---------HHHHHHhhcccCCCCc-hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 --LPEK---------VMEIVDFALLLDPGNE-RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 --~~~~---------~~~~i~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.. ...... .+...+... ..........+.+++.+|++.+|++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 011111 010011000 00011123456789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.26 Aligned_cols=199 Identities=27% Similarity=0.378 Sum_probs=173.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC-C-----CCceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-H-----RNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~ 775 (1003)
..+|++.+.||+|+||.|.+|.+.++++.||||+++.. .....+...|+.++..++ | -|+|+++++ |.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~ 258 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FY 258 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cc
Confidence 34899999999999999999999999999999999843 344566778999999996 4 489999998 67
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC--CeE
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--VAH 853 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--~~k 853 (1003)
..++.|+|+|.++. +|+++++.+. ...++...++.++.||+.||.+||+. +|||+|+||+|||+.+-+ .+|
T Consensus 259 fr~HlciVfELL~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 259 FRNHLCIVFELLST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccceeeeehhhhh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence 78999999999976 9999999876 44699999999999999999999999 999999999999997544 799
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
|+|||.|++.....+ ..+-+..|.|||++.|.+|+.+.||||||||++||++|.+-|.+.
T Consensus 332 VIDFGSSc~~~q~vy--------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY--------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EEecccccccCCcce--------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999999987644332 244577899999999999999999999999999999998877664
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.46 Aligned_cols=249 Identities=33% Similarity=0.432 Sum_probs=200.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+|++.+.||+|+||.||+|... +..||+|..+.. ...+.+.+|+.++++++|+|++++++++ +..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence 57889999999999999999875 668999998633 3356899999999999999999999875 334566799
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++++|.++++... ...+++..++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||++..
T Consensus 78 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred EEECCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 999999999999998643 33588999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..... ....++..|+|||+..+..++.++||||+||++|||++ |+.||..... ....
T Consensus 152 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------------~~~~ 209 (256)
T cd05082 152 ASSTQ--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------------KDVV 209 (256)
T ss_pred ccccC--------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------------HHHH
Confidence 43211 12335678999999988899999999999999999998 9999864311 1111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
..+...... .....++..+.+++.+|++.+|++||+++++++.|+.
T Consensus 210 ~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 210 PRVEKGYKM------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHhcCCCC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111111111 1112345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=306.96 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=196.7
Q ss_pred eeeeccceEEEEEEE--CCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 710 LIGQGSFGFVYRGNL--GEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999975 45678899999864432 23567899999999999999999999852 345689999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++++|.+++.. ...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+|++|||++.....
T Consensus 76 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 76 LAELGPLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999999999976 34688999999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
..... .......++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+.+
T Consensus 148 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~~~~i 211 (257)
T cd05116 148 DENYY--KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------------EVTQMI 211 (257)
T ss_pred CCCee--eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHH
Confidence 22110 11112234678999999888889999999999999999998 99998753211 112222
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
....... ....++..+.+++.+||+++|++||++++|++.|+..
T Consensus 212 ~~~~~~~------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 212 ESGERME------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HCCCCCC------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2221111 1123456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.67 Aligned_cols=260 Identities=25% Similarity=0.450 Sum_probs=203.6
Q ss_pred hccCCccCeeeeccceEEEEEEEC-----CCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..+|++.++||+|+||.||+|... .++..+|+|.+........+.+.+|++++++++||||+++++++ .+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TE 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ec
Confidence 356788899999999999999752 34668999998765555567899999999999999999999985 34
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQ----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 846 (1003)
.+..+++|||+++++|.+++...... ....+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence 56679999999999999999875321 113588999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCc
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDG 925 (1003)
Q Consensus 847 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~ 925 (1003)
++++.+||+|||+++........ .......+++.|+|||+..+..++.++|||||||++|||++ |+.||......
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 231 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT- 231 (280)
T ss_pred cCCCCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-
Confidence 99999999999999755322111 11122345788999999998999999999999999999998 89998643211
Q ss_pred chhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+....+... .+.. ....++..+.+++.+||+.+|++||+++|+.+.|+
T Consensus 232 -------------~~~~~~~~~---~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 -------------EAIECITQG---RELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------HHHHHHHcC---ccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 1100 11123456889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=306.34 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=201.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||+++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence 357899999999999999999876 556799999874333 3467999999999999999999998742 34468
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++++|||.+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence 9999999999999997643 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
.+...... ......++..|+|||+..+..++.++||||||+++|||++ |+.||...... +.
T Consensus 151 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------------~~ 212 (260)
T cd05070 151 LIEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------------EV 212 (260)
T ss_pred eccCcccc----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------------HH
Confidence 65332211 1112335678999999988889999999999999999999 88998653211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+.... + .+........+.+++.+|+.++|++||+++++.+.|+.
T Consensus 213 ~~~~~~~~---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQVERGY---R---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcCC---C---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111 1 11112335678899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.48 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=210.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECC----CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGE----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
..++|++.+.||+|+||.||+|.+.. .+..||+|++.... ....+.+.+|+.++++++|||++++++++. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~ 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----E 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----c
Confidence 35689999999999999999999875 35789999886432 233567889999999999999999999863 3
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQ---VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
++...++++||+++++|.+++...... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 356779999999999999999875432 125689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHH
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~ 931 (1003)
|++|||+++.+.+...... .....++..|+|||++.+..++.++||||+||++||+++ |+.||.....
T Consensus 157 kl~d~g~~~~~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------- 225 (280)
T cd05043 157 KITDNALSRDLFPMDYHCL---GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------- 225 (280)
T ss_pred EECCCCCcccccCCceEEe---CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------
Confidence 9999999986543321111 112345778999999988889999999999999999999 9999865321
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
.++...+..... + .....++..+.+++.+||+.+|++||++.|+++.|+.+.++
T Consensus 226 ------~~~~~~~~~~~~--~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 226 ------FEMAAYLKDGYR--L----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------HHHHHHHHcCCC--C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111111111111 0 01112345688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.88 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=201.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc---------chHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---------SIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|++++++++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 478889999999999999999888899999988643322 135788999999999999999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEE
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
.+.+..++|+||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEe
Confidence 345678999999999999999976 34688899999999999999999999 9999999999999999999999
Q ss_pred cccccccccccCCcccc-CcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 855 SDFGLAKFLFDRPIQET-SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+|||.++.......... ........|+..|+|||.+.+..++.++||||+||++|+|++|+.||......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------- 218 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------- 218 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------
Confidence 99999987643211111 11112345889999999998888999999999999999999999999753211
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........ ...+ .........+.+++.+||+++|.+||++.|++++
T Consensus 219 ----~~~~~~~~---~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 219 ----QAIFKIGE---NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHHHHHhc---cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 01111111 1111 1112235677889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.83 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=204.2
Q ss_pred hccCCccCeeeeccceEEEEEEEC-----CCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 774 (1003)
.++|++.+.||+|+||.||+|.+. .++..||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 457999999999999999999862 345679999987443 23346789999999999 799999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEE
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl 854 (1003)
...+..++||||+.+|+|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence 34567899999999999999997643 23489999999999999999999999 9999999999999999999999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHH
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+|||+++....... ........++..|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 183 ~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------- 250 (302)
T cd05055 183 CDFGLARDIMNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------- 250 (302)
T ss_pred CCCcccccccCCCc---eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---------
Confidence 99999976532211 011112346788999999999999999999999999999998 99998654321
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+...+.++....... .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 251 ----~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 ----SKFYKLIKEGYRMAQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111122221111110 011235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.35 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=204.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|.+..++..||+|+++.......+.+.+|++++++++|||++++++++ ..+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence 45799999999999999999999888999999999766555667899999999999999999999985 4466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++... ...+++.+++.++.|++.|++|||+. +|+|+||+|+||+++.++.++|+|||.+.
T Consensus 79 lv~e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred EEeeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence 999999999999999764 34689999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
...... .......|+..|+|||.+. +..++.++||||+|+++|||++|+.||.......
T Consensus 152 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----------- 215 (280)
T cd06611 152 KNKSTL-----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----------- 215 (280)
T ss_pred hhcccc-----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----------
Confidence 543211 1122356899999999864 3456789999999999999999999987542110
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..... ....+ ........+...+.+++.+||+.+|++||++.+++++
T Consensus 216 --~~~~~----~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 216 --VLLKI----LKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --HHHHH----hcCCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01111 11100 0111112334567889999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=325.11 Aligned_cols=272 Identities=21% Similarity=0.198 Sum_probs=202.9
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-cCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999989999999998743 2334567889999999999999999998864322 2334
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++ ++.+.+.. .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 567999999976 78887753 477889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh--
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-- 935 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-- 935 (1003)
|+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+. ........
T Consensus 171 G~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~ 243 (364)
T cd07875 171 GLARTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGT 243 (364)
T ss_pred CCccccCCCC------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 9997643221 12235689999999999999999999999999999999999999976432111 11111100
Q ss_pred CchhHHH----HHHhhcccCCCCch----------------hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEKVME----IVDFALLLDPGNER----------------AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~----~i~~~l~~~~~~~~----------------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+... .+.......|.... .........+.+++.+|++.||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111 11111111110000 0001123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=313.50 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=201.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+.|++.++||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++|||++++++++ ..+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF-----YWDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE-----EeCCeEEE
Confidence 5799999999999999999999989999999999866666677899999999999999999999985 34567899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.+. ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 87 v~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EEecCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999888653 34689999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.... ........++..|+|||++. ...++.++||||+||++|||++|+.||......
T Consensus 160 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------- 221 (292)
T cd06644 160 NVKT-----LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------------- 221 (292)
T ss_pred cccc-----ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------------
Confidence 4221 11122345888999999874 345678999999999999999999998653210
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+.......+ ........+...+.+++.+||+.+|++||+++|++++
T Consensus 222 ----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 222 ----RVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ----HHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00011111111 0011112334567889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.61 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=208.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ ......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence 357888999999999999999999889999999886443 33357899999999999999999999985 345778
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++++|.+++.. .+.+++..+..++.+++.|+.|||+.. +++||||+|+||+++.++.++|+|||++
T Consensus 79 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred EEEEecCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999999999876 346899999999999999999999732 8999999999999999999999999998
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... .....|+..|+|||++.+..++.++||||+||++|+|++|+.||......+.. ...+..+
T Consensus 152 ~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~~ 218 (284)
T cd06620 152 GELINSI-------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMGI 218 (284)
T ss_pred cchhhhc-------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhHH
Confidence 6542211 11346899999999998888999999999999999999999999764332110 0111122
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+.......+.. ....+....+.+++.+|++++|++||++.|++++..-
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 219 LDLLQQIVQEPPPR--LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHHHHHhhccCCC--CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 22333322221111 1112245678899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.41 Aligned_cols=239 Identities=26% Similarity=0.322 Sum_probs=190.7
Q ss_pred CeeeeccceEEEEEEE---CCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 709 NLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
+.||+|+||.||++++ ..+++.||+|+++... ......+.+|++++++++||||+++++++ .+++..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 6799999999999886 3567899999997433 22345678899999999999999999984 456788999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|||+++|+|.+++.+ ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 77 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 77 LDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 999999999999976 34689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
.... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .....
T Consensus 149 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------------~~~~~ 209 (318)
T cd05582 149 IDHE-----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------------ETMTM 209 (318)
T ss_pred CCCC-----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------------HHHHH
Confidence 3221 1122356899999999998888999999999999999999999999753211 11111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMAD 986 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 986 (1003)
+......-| ......+.+++.+|++.+|++||++.+
T Consensus 210 i~~~~~~~p-------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 210 ILKAKLGMP-------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHcCCCCCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111111111 123456788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.56 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=199.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCC--------------CceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEe
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED--------------LLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKII 766 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 766 (1003)
.++|++.+.||+|+||.||+|.+.+. ...||+|+++... ......|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 36899999999999999999987532 2358999987442 22345789999999999999999999
Q ss_pred eeeeecccCCCCceEEeeecccCCCHHHHHhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 001858 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL 839 (1003)
Q Consensus 767 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 839 (1003)
+++ ......++||||+++++|.+++...... ....+++.+++.++.|++.|++|||+. +++||||
T Consensus 84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 985 4466789999999999999999653211 012478899999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh--CCCC
Q 001858 840 KPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT--GRRP 917 (1003)
Q Consensus 840 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~--g~~P 917 (1003)
||+||+++.++.+|++|||++......... .......++..|+|||+..++.++.++|||||||++|||++ |..|
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999765332211 11122345778999999988899999999999999999998 5667
Q ss_pred CCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
|......+ ... ...+.......... .......+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 ~~~~~~~~-~~~---------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 233 YSLLSDEQ-VIE---------NTGEFFRNQGRQIY---LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CcccChHH-HHH---------HHHHhhhhcccccc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 65432110 000 00000010000000 0001113457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=315.81 Aligned_cols=267 Identities=25% Similarity=0.411 Sum_probs=207.4
Q ss_pred hccCCccCeeeeccceEEEEEEECC-------CCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-------DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
.++|.+.+.||+|+||.||+|++.. +...||+|.++... ......+.+|+++++++ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 4679999999999999999998743 23469999997542 23356788899999999 7999999999863
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCC
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 841 (1003)
..+..++||||+++|+|.+++...... ....+++.++..++.|++.|++|||+. +++||||||
T Consensus 95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 456789999999999999999875321 134689999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCc
Q 001858 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920 (1003)
Q Consensus 842 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~ 920 (1003)
+||+++.++.+|++|||.++......... ......++..|+|||++.+..++.++||||+||++|||++ |+.||..
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK---KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh---ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999997653211110 1111224568999999988889999999999999999998 8888854
Q ss_pred ccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 001858 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~ 999 (1003)
... +++.+.+..... ......+..++.+++.+|+..+|++||++.|+++.|.++.+...
T Consensus 246 ~~~--------------~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 246 VPV--------------EELFKLLKEGHR------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred CCH--------------HHHHHHHHcCCC------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 221 112222221111 11122345678889999999999999999999999999877644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=323.98 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=205.7
Q ss_pred HHhccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccc-ccchHHHHHHHHHHHhcC-CCCceeEeeeeeec
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIR-HRNLIKIITVCSSI 772 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 772 (1003)
...++|.+.+.||+|+||.||+|++.+ .++.||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~-- 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT-- 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--
Confidence 345678899999999999999999643 45689999997443 223457899999999997 999999999863
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCC--------------------------------------------------
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------------------------------------------------- 802 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------- 802 (1003)
..+..++|+||+++|+|.++++..+..
T Consensus 112 ---~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 112 ---KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ---cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 356789999999999999999764310
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 001858 803 -------------------------------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL 839 (1003)
Q Consensus 803 -------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 839 (1003)
....+++.++..++.|++.|++|||+. +|+||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence 012467788899999999999999998 9999999
Q ss_pred CCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCC
Q 001858 840 KPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPT 918 (1003)
Q Consensus 840 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~ 918 (1003)
||+||+++.++.+|++|||+++........ .......++..|+|||.+.+..++.++||||+||++|||++ |+.||
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999765322110 11122357889999999988889999999999999999998 88998
Q ss_pred CcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 919 HTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
......+ ...+.+...... .....+...+.+++.+||..+|++||+++|+++.|+.+.
T Consensus 343 ~~~~~~~-------------~~~~~~~~~~~~------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMNE-------------QFYNAIKRGYRM------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCchH-------------HHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 6543211 111222211111 011123467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=319.70 Aligned_cols=202 Identities=27% Similarity=0.359 Sum_probs=172.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.+++.++|+||+++++++ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4789999999999999999999999999999998642 233456788999999999999999999984 45678
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.+. ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 89999999999999999763 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
+..+..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 149 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 149 CLRLLADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeecCCCCC----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 976533211 11122468999999999863 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=313.27 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=200.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|+..+.||+|+||+||+|.+..+++.||+|.+..... ...+.+.+|+.++++++|++++++++.+ ..++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 36778899999999999999999999999999864322 2234677899999999999999999885 445678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 99999999999999986543 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ . +..
T Consensus 150 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~--------~~~ 213 (285)
T cd05630 150 VHVPEGQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--R--------EEV 213 (285)
T ss_pred eecCCCc------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--H--------HHH
Confidence 7543221 11234689999999999999999999999999999999999999975432100 0 001
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 990 (1003)
....+..... ........+.+++.+|++.+|++||+ ++|+.++
T Consensus 214 ~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 214 ERLVKEVQEE-------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred Hhhhhhhhhh-------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1111100000 01123456788999999999999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=314.25 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=201.9
Q ss_pred ccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
.+|++.+.||+|+||.||+|.+.. .++.||+|+++..... ..+.+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 457788999999999999998753 3578999999744332 246788999999999999999999985 44
Q ss_pred CCceEEeeecccCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSND-----------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
....++++||+++++|.+++..... .....+++..++.++.|++.|++|+|+. +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 5667999999999999999864321 1123588899999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 001858 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFND 924 (1003)
Q Consensus 846 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~ 924 (1003)
+++++.+||+|||+++........ .......+++.|+|||++.++.++.++||||+||++|||++ |..||.....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 232 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 232 (283)
T ss_pred ecCCCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 999999999999998765332211 11122346789999999988889999999999999999998 8888765321
Q ss_pred cchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 925 GLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 925 ~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+..+.+... .. .+....++..+.+++.+||+.+|++||+++||++.|+.
T Consensus 233 -------------~~~~~~i~~~---~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -------------QDVIEMIRNR---QV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------------HHHHHHHHcC---Cc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 11 11122355678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=307.53 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=195.2
Q ss_pred CeeeeccceEEEEEEECC---CCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGE---DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|.+.. ....||+|.+.... ....+.+.+|+.+++.++|||++++++++. ..++..++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence 468999999999998643 34679999885332 334578889999999999999999999763 2345678999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+.+|+|.+++.... ....+..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 77 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 77 PYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred ecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999997642 3467788899999999999999999 99999999999999999999999999997654
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhC-CCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG-RRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
+...... .......++..|+|||+..+..++.++|||||||++|||++| ..||..... ......
T Consensus 150 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------------~~~~~~ 214 (262)
T cd05058 150 DKEYYSV-HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------------FDITVY 214 (262)
T ss_pred CCcceee-cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------------HHHHHH
Confidence 3221111 111233467789999999888999999999999999999995 555543211 011111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
+ ....+ ....+..+..+.+++.+||+++|++||++.|+++.++++..
T Consensus 215 ~---~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 L---LQGRR---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred H---hcCCC---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1 11111 01111234578899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=308.86 Aligned_cols=259 Identities=28% Similarity=0.470 Sum_probs=203.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCC---ceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDL---LPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.++... ....+.+.+|+.++++++||||+++++++ .++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 357889999999999999999885433 479999886432 23356889999999999999999999985 446
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++||||+++++|.+++... .+.+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++||
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 6789999999999999999764 24689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|++..+...... ........++..|+|||++.+..++.++||||+|+++||+++ |+.||......
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------------ 216 (267)
T cd05066 151 GLSRVLEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------------ 216 (267)
T ss_pred Ccccccccccce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------------
Confidence 999866432211 111111234568999999998899999999999999999887 99998653221
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+....+..... .+....++..+.+++.+|++.+|++||++.++++.|.++
T Consensus 217 --~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 --DVIKAIEEGYR------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --HHHHHHhCCCc------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111111110 011122345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.15 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=198.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|||++++++++. .++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence 36788899999999999999999899999999986442 233467889999999999999999999854 356778
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|..+ ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 76 lv~e~~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 76 ICTEFMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEEecCCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999999999654 2467888999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..... ......||..|+|||++.+..++.++||||+|+++|+|++|+.||.......... .+....
T Consensus 144 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~ 209 (279)
T cd06619 144 QLVNS-------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLL 209 (279)
T ss_pred ecccc-------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHH
Confidence 55322 1123568999999999999899999999999999999999999997543221111 001111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..+ ....+... ........+.+++.+|++.+|++||+++|++++-
T Consensus 210 ~~~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 210 QCI---VDEDPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHH---hccCCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111 11111110 0111235678999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=313.13 Aligned_cols=266 Identities=25% Similarity=0.419 Sum_probs=206.5
Q ss_pred HhccCCccCeeeeccceEEEEEEEC-------CCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeee
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLG-------EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSS 771 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 771 (1003)
...+|.+.+.||+|+||.||+|++. .++..||+|...... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 3567899999999999999999752 234579999986432 33456789999999999 899999999985
Q ss_pred cccCCCCceEEeeecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLK 840 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 840 (1003)
......++||||+++|+|.+++...... ....+++.++..++.|++.|++|||+. +|+|||||
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 3456779999999999999999875321 124678899999999999999999999 99999999
Q ss_pred CCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 001858 841 PSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTH 919 (1003)
Q Consensus 841 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~ 919 (1003)
|+||+++.++.+|++|||.++......... ......+++.|+|||+..+..++.++||||+|+++|||++ |..||.
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYK---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccc---cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999998653322111 1112345678999999988889999999999999999998 788875
Q ss_pred cccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
.... .++.+.+.... . ......+...+.+++.+||+.+|++||++.|+++.|+++..-
T Consensus 242 ~~~~--------------~~~~~~~~~~~---~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 242 GIPV--------------EELFKLLKEGH---R---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred cCCH--------------HHHHHHHHcCC---c---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 4321 11111111111 0 011123456788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.96 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=204.3
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc--chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+.+-|.+.+.||+|.|+.|-+|++.-+|..||||++.+.+-+ ....+.+|++-|+.++|||||++|++ .....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence 456799999999999999999999999999999999865433 34578899999999999999999998 56678
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC-CCCCeEEccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDF 857 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~Df 857 (1003)
..|+|+|.-++|+|+|||-++ +..+.+.-+.+++.||+.|+.|+|.. .+||||+||+||.+- .-|-+|++||
T Consensus 91 KlyLiLELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred eEEEEEEecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence 899999999999999999887 45689999999999999999999999 899999999998876 4689999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCC-ccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVS-LTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|++-.+.++. .-...+|+..|-|||.+.|..|+ +++||||+|||+|-+++|+.||+.....+
T Consensus 164 GFSNkf~PG~------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------- 226 (864)
T KOG4717|consen 164 GFSNKFQPGK------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------- 226 (864)
T ss_pred cccccCCCcc------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------
Confidence 9997665433 23346899999999999999987 67999999999999999999998643221
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.-+++.. ...+.....+..+++..|+..||.+|.+.+||+.+
T Consensus 227 --TLTmImDCK--------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 --TLTMIMDCK--------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --hhhhhhccc--------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111111111 12223445566677777777777777777777653
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=342.22 Aligned_cols=261 Identities=21% Similarity=0.313 Sum_probs=202.5
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
...++|++.+.||+|+||+||+|.+..++..||+|++.... ......|..|+.+++.++||||+++++++.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence 34578999999999999999999999999999999987432 2335678999999999999999999998532 334
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCcEeccCCCCceEeCCC----
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQ----PPIVHGDLKPSNVLLDHD---- 849 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dikp~Nill~~~---- 849 (1003)
...++||||+++|+|.++|...... .+.+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 5789999999999999999864322 3579999999999999999999998521 259999999999999642
Q ss_pred -------------CCeEEcccccccccccCCccccCcccccccccccccCccccCC--CCCCccccchhHHHHHHHHHhC
Q 001858 850 -------------MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG--GNVSLTGDVYSFGILLLEMFTG 914 (1003)
Q Consensus 850 -------------~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~ell~g 914 (1003)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 358999999997653221 1123568999999998854 4588999999999999999999
Q ss_pred CCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 915 RRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.||...... . .+...+.. .+... .......+.+++..||+.+|.+||++.|++.+
T Consensus 240 k~PF~~~~~~----~---------qli~~lk~----~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 240 KTPFHKANNF----S---------QLISELKR----GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCcCCcH----H---------HHHHHHhc----CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999643211 0 11111111 11100 11224568899999999999999999999854
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=309.86 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=204.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCC-----CceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED-----LLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+++++.++||||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 46789999999999999999998643 4789999986443 23345788999999999999999999985 4
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQ-----VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 850 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 850 (1003)
.....++||||+++|+|.+++...... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 457789999999999999999764322 123578899999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhh
Q 001858 851 VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLH 929 (1003)
Q Consensus 851 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~ 929 (1003)
.+||+|||+++........ .......++..|+|||...++.++.++||||+||++||+++ |+.||......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 228 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----- 228 (277)
T ss_pred CEEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----
Confidence 9999999999765432211 11122346789999999988889999999999999999998 99998643211
Q ss_pred HHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
...+.+...... .....+...+.+++.+||+.+|++||++.|+++.|+
T Consensus 229 ---------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 ---------EVLKFVIDGGHL------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------HHHHHHhcCCCC------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111111000 111123567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=325.34 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=210.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCC----ceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDL----LPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+.+..++||.|+||+||+|.+-..+ .+||||++... .....+++.+|+.+|.+++|||+++++++|...
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 3456789999999999999996554 47999988633 344568899999999999999999999998542
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
...+|++||+.|+|.|+++.++ +.+.....+.|..|||+||.|||++ ++|||||.++||||..-..+||+|||
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 2689999999999999999974 5688889999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
+|+........ .......-.+.|||=|.+....++.++|||||||++||++| |..|+..+..
T Consensus 844 la~ll~~d~~e---y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------------- 906 (1177)
T KOG1025|consen 844 LAKLLAPDEKE---YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------------- 906 (1177)
T ss_pred hhhccCccccc---ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------------
Confidence 99877543211 11112234678999999999999999999999999999999 9999887543
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
+++.+.++.. +|.+.++-+..+++.++.+||..|+..||+++++...+.+.-+
T Consensus 907 ~eI~dlle~g------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 907 EEIPDLLEKG------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHhhHHHhcc------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 2333333322 2334445677889999999999999999999999999877544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=307.50 Aligned_cols=254 Identities=27% Similarity=0.475 Sum_probs=203.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|||++++++++ ..+..+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence 467899999999999999999875 56789999987433 3457899999999999999999999874 234679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 77 IITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence 9999999999999987643 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ......++..|+|||++.+..++.++||||+|+++|||++ |+.||...... ..
T Consensus 151 ~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~ 212 (260)
T cd05067 151 LIEDNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------------EV 212 (260)
T ss_pred ecCCCCcc----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------------HH
Confidence 65422211 1112346778999999988889999999999999999999 99999753311 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+..... .+.......++.+++.+|+..+|++||+++++.+.|+.
T Consensus 213 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 213 IQNLERGYR------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHcCCC------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111110 01112234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.78 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=197.5
Q ss_pred CeeeeccceEEEEEEECCCC---ceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDL---LPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|+||.||+|++...+ ..||+|.++.... ...+.+.+|+++++++.|||++++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999875544 7899999874443 24567899999999999999999999752 34568999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++++|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++...
T Consensus 75 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 75 ELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred EeCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceee
Confidence 999999999999873 3689999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
..... ........++..|+|||...+..++.++|||||||++|||++ |+.||...... +....
T Consensus 147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------------~~~~~ 210 (257)
T cd05060 147 AGSDY--YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------------EVIAM 210 (257)
T ss_pred cCCcc--cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------------HHHHH
Confidence 32211 111111224568999999998899999999999999999998 99998654211 11111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
+... .+. +....+...+.+++.+||+++|++||++.++.+.|++..
T Consensus 211 ~~~~---~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 211 LESG---ERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHcC---CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111 110 111223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=314.13 Aligned_cols=252 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++ ..++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 46899999999999999999999889999999999765555567889999999999999999999985 4466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.
T Consensus 93 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999864 3578899999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......+++.|+|||...+..++.++||||+||++|+|++|+.||..........
T Consensus 164 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------------- 225 (297)
T cd06656 164 QITPEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------------- 225 (297)
T ss_pred EccCCc-----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-------------
Confidence 643221 11123458889999999988889999999999999999999999996532211000
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.......+ ...........+.+++.+||+.+|++||+++|++++
T Consensus 226 ---~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 226 ---LIATNGTP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---eeccCCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 011122334567789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.83 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=202.1
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|||++++.+.+. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4888999999999999999998889999999986432 234567899999999999999999988642 2344678
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.... ...+++.+++.++.+++.|++|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 77 lv~e~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred EEecccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999999998643 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||...... . ...
T Consensus 151 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~--------~~~ 212 (257)
T cd08223 151 VLENQC-----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----S--------LVY 212 (257)
T ss_pred EecccC-----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----H--------HHH
Confidence 653221 1222356889999999999999999999999999999999999998643211 0 001
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.... ..... ........+.+++.+|++.+|++||++.|++++
T Consensus 213 ~~~~-~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 RIIE-GKLPP------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHh-cCCCC------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111 11101 112344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.12 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=205.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|+..+.||+|+||.||.++...+++.+++|.+.... ....+.+.+|++++++++|+||+++++++ .+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 5888999999999999999999999999999986432 34456789999999999999999999995 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+.
T Consensus 76 ~~~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceE
Confidence 9999999999999998643 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
....... ......|++.|+|||...+..++.++||||+|+++|||++|+.||...... +...
T Consensus 150 ~~~~~~~-----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------~~~~ 211 (256)
T cd08221 150 ILGSEYS-----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------------NLVV 211 (256)
T ss_pred Ecccccc-----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------------HHHH
Confidence 6533221 122356899999999998888899999999999999999999998642211 1111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.... .... +........+.+++.+||..+|++||++.|++++.
T Consensus 212 ~~~~----~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 KIVQ----GNYT---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHc----CCCC---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111 1111 11133456688999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.73 Aligned_cols=274 Identities=23% Similarity=0.362 Sum_probs=204.5
Q ss_pred ccCCccCeeeeccceEEEEEEE----CCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..|++.+.||+|+||.||.|+. ..++..||+|.++... ....+.+.+|+++++.++|||++++.+++.. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3578889999999999999985 3467889999987443 3335689999999999999999999998643 224
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++++|.+++.+. ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++++||
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence 5679999999999999999763 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC-
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL- 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~- 936 (1003)
|+++.+...... ........++..|+|||+..+..++.++||||+||++|||++++.|+...... .........
T Consensus 154 g~~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~ 228 (284)
T cd05079 154 GLTKAIETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHG 228 (284)
T ss_pred ccccccccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccc
Confidence 999866432211 11112345677899999998888999999999999999999988764321110 000000000
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
.......+...... .+.+....+...+.+++.+|++.+|++||++.|+++.++++
T Consensus 229 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 229 QMTVTRLVRVLEEG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccHHHHHHHHHcC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00011111111100 01111123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=306.14 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=195.6
Q ss_pred eeeeccceEEEEEEEC--CCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeec
Q 001858 710 LIGQGSFGFVYRGNLG--EDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDY 786 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 786 (1003)
.||+|+||.||+|.+. +.+..||+|+...... ...+.+.+|++++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 4899999999999875 3455799999875433 23467899999999999999999999853 3456899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccC
Q 001858 787 MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866 (1003)
Q Consensus 787 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~ 866 (1003)
+++++|.+++... ...+++.++++++.|++.|++|||++ +++||||||+||+++.++.+|++|||++......
T Consensus 76 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 76 ASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred CCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999753 34689999999999999999999999 9999999999999999999999999999755322
Q ss_pred CccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHH
Q 001858 867 PIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVD 945 (1003)
Q Consensus 867 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 945 (1003)
.... .......++..|+|||...+..++.++|||||||++||+++ |+.||...... .....+.
T Consensus 149 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~~~ 212 (257)
T cd05115 149 DSYY--KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------------EVMSFIE 212 (257)
T ss_pred ccce--eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHHHHHH
Confidence 1111 11111234678999999888889999999999999999996 99998754321 1122222
Q ss_pred hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 946 FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 946 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
...... ....+..++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 213 ~~~~~~------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLD------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 211111 1122356788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.79 Aligned_cols=266 Identities=22% Similarity=0.311 Sum_probs=207.3
Q ss_pred cHHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 694 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
+..++..+.+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|||++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555567789999999999999999999999899999999986443 3346788899999998 799999999986432
Q ss_pred cc-CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCC
Q 001858 773 DF-KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 851 (1003)
Q Consensus 773 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~ 851 (1003)
.. ......+++|||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 11 23567899999999999999998644 34578889999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcc
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL 926 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~ 926 (1003)
++|+|||++....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||.......
T Consensus 160 ~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~- 233 (282)
T cd06636 160 VKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR- 233 (282)
T ss_pred EEEeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-
Confidence 9999999987542211 1122356899999999875 3467889999999999999999999986532110
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.... +... . ........+...+.+++.+||+.+|++||++.|++++
T Consensus 234 ------------~~~~-~~~~--~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 234 ------------ALFL-IPRN--P---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ------------hhhh-HhhC--C---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000 0100 0 0111112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.09 Aligned_cols=268 Identities=25% Similarity=0.423 Sum_probs=207.1
Q ss_pred hccCCccCeeeeccceEEEEEEEC-------CCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLG-------EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
.++|.+.++||+|+||.||+|++. .....||+|+++... ......+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC--- 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence 467889999999999999999863 234579999987432 23356788999999999 699999999985
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCC
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 841 (1003)
.+.+..++||||+++|+|.+++...... ....+++.++..++.|++.|++|||++ +++||||||
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 3456789999999999999999774321 134689999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCc
Q 001858 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920 (1003)
Q Consensus 842 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~ 920 (1003)
+||+++.++.+|++|||.++.......... .....++..|+|||++.+..++.++||||+||++|||++ |+.||..
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKK---TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccc---cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999976543221111 111224567999999988899999999999999999999 8888865
Q ss_pred ccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhhc
Q 001858 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 1000 (1003)
... .+..+.+..... ......+..++.+++.+|++.+|++||++.|+++.|.++.....+
T Consensus 240 ~~~--------------~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 240 IPV--------------EELFKLLREGHR------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred CCH--------------HHHHHHHHcCCC------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 321 111111111110 011123345778899999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.81 Aligned_cols=253 Identities=32% Similarity=0.544 Sum_probs=203.1
Q ss_pred CeeeeccceEEEEEEECCC---CceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|.+... +..||+|+++..... ..+.+.+|++.++.++|+|++++++++ ......++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVC-----TEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeee-----cCCCceEEEE
Confidence 4799999999999999865 889999999755433 367899999999999999999999985 3467789999
Q ss_pred ecccCCCHHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQ----VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
||+++++|.++++..... ....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999874211 125789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
........ ........++..|+|||...+..++.++||||+|+++|||++ |..||..... .+
T Consensus 153 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------~~ 215 (262)
T cd00192 153 RDVYDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------------EE 215 (262)
T ss_pred cccccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------------HH
Confidence 87643321 111223457889999999988889999999999999999999 6999876421 11
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
..+.+... .+......++.++.+++.+|++.+|++||++.|++++|+
T Consensus 216 ~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 216 VLEYLRKG------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHcC------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111111 111112233567889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=319.62 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=200.8
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEecc----ccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL----KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+...+||+|+|-+||+|.+..+|..||--.++. .++...++|..|+.+++.++||||++++..... .......
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d---~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD---TDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec---CCCceee
Confidence 456789999999999999999999888544432 234446899999999999999999999988543 2235678
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC-CCCCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a 860 (1003)
+|+|.|..|+|..|++++ +.++...++.|++||++||.|||++ .|+|+|||||-+||+|+ ..|.|||+|.|+|
T Consensus 120 ~iTEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeeecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence 999999999999999995 5788899999999999999999998 78999999999999997 4689999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
+..... ....++|||.|||||... ..|+..+||||||++++||+|+.+||....+..+.+........|..+
T Consensus 194 tl~r~s-------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl 265 (632)
T KOG0584|consen 194 TLLRKS-------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL 265 (632)
T ss_pred HHhhcc-------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence 876332 223478999999999755 889999999999999999999999998765543333333222223222
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+- ...+.+++.+|+.. .++||++.|++.+
T Consensus 266 ~kV~------------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 SKVK------------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hccC------------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2211 23577899999998 8999999999874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.61 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=203.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++.+....+|.|..|.||+++...++...|||.+.... ..+.+++...++++..-+ .|.||+.+|| |..+..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy-----Fi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY-----FITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE-----EeeCchH
Confidence 34556678999999999999999999999999997554 344677777888776664 8999999999 4556777
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
+++||.|.. .+..+++.. .+++++.-+-++...+..|+.||.+++ +|+|||+||+|||+|+.|++|+||||++
T Consensus 167 ~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 899999965 666666654 456899888899999999999999886 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCC---CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.++.+... .....|.+.|||||.+... .|+.++||||||+.++|+.||++||.....+
T Consensus 240 GrlvdSkA------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------------- 300 (391)
T KOG0983|consen 240 GRLVDSKA------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------------- 300 (391)
T ss_pred ceeecccc------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------------
Confidence 87755332 2234689999999998654 6889999999999999999999999874322
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.++..+.+...| +..+........+.+++..|++.|+.+||...++++|
T Consensus 301 ---Fe~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 301 ---FEVLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---HHHHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122233333334 3333334477889999999999999999999999875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.13 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=197.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 47899999999999999999999889999999886432 1234578899999999999999999998532 234
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++++||+++++|.+++.. .+.+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.+||+||
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 567899999999999999976 34588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|+++....... .........++..|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------------- 215 (266)
T cd06651 151 GASKRLQTICM--SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------------- 215 (266)
T ss_pred CCccccccccc--cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------------
Confidence 99976532111 111122345889999999999888999999999999999999999998753211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+....... ....+ .........+..++ .||..+|++||+++|+++|
T Consensus 216 ~~~~~~~~--~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 216 AAIFKIAT--QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHhc--CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01111100 00111 11112233445555 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.86 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=200.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
++|++.+.||+|+||.||+|.+... ..||+|.+.... ...+.+.+|++++++++|||++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 5688999999999999999998654 469999876432 33467899999999999999999998742 345689
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||.++.
T Consensus 78 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred EEEcCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 999999999999997643 34588999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
....... ......++..|+|||+..+..++.++||||+|+++|||++ |+.||...... +..
T Consensus 152 ~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~~ 213 (260)
T cd05069 152 IEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------------EVL 213 (260)
T ss_pred ccCCccc----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHH
Confidence 5332211 1112346778999999988899999999999999999999 89998753211 111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
+.+..... + +.....+..+.+++.+||..+|++||+++++.+.|++
T Consensus 214 ~~~~~~~~--~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVERGYR--M----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHcCCC--C----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111110 0 1112345678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=305.71 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=204.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .+.+.+|++++++++|||++++++++ ..+...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEE
Confidence 3679999999999999999999998889999999875433 67899999999999999999999985 4457789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+++||+++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||++.
T Consensus 75 l~~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 75 IVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEEecCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 999999999999999763 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.........
T Consensus 148 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------------- 208 (256)
T cd06612 148 QLTDTM-----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------------- 208 (256)
T ss_pred hcccCc-----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--------------
Confidence 653321 1122345788999999998889999999999999999999999998753221100
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+.. ...............+.+++.+||+.+|++||++.|++++
T Consensus 209 ~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 209 FMIPN----KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcc----CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 00000 0001111122344678899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.32 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=199.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|++|+||+|++..+++.||+|.++... ....+.+.+|+.++++++|||++++++++ .++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 4788899999999999999999899999999986432 23346788999999999999999999985 4567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||++ ++|.+++..... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccccee
Confidence 9999997 589998876432 35689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh--Cch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--LPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~--~~~ 938 (1003)
...... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||......+.... ..... ..+
T Consensus 150 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (285)
T cd07861 150 AFGIPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTE 223 (285)
T ss_pred ecCCCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCCh
Confidence 543211 111223578899999987654 568899999999999999999999975432111100 00000 000
Q ss_pred h----HHHH--HHhhccc-CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 K----VMEI--VDFALLL-DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~----~~~~--i~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. .... ....... ..............++.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000 0000000 0000001111234667899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=312.05 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=204.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+++++.++|||++++++++ ......++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 4689999999999999999999889999999999766555667889999999999999999999985 44667899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 94 v~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 94 VMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 9999999999999864 3578999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
..... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||......+ ....
T Consensus 165 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------------~~~~ 226 (296)
T cd06655 165 ITPEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------------ALYL 226 (296)
T ss_pred ccccc-----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHH
Confidence 53221 11123458899999999988889999999999999999999999986532210 0000
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+... ..+ .......+...+.+++.+||..+|++||++.+++.+
T Consensus 227 -~~~~--~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 227 -IATN--GTP--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -HHhc--CCc--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1100 000 011112344567889999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=318.74 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=195.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|..++..++|++|+++++++ .+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4789999999999999999999999999999998642 223345688899999999999999999984 45678
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 89999999999999999864 24688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
+........ .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||......
T Consensus 149 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---------- 214 (331)
T cd05624 149 CLKMNQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------- 214 (331)
T ss_pred eeeccCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----------
Confidence 976533211 11123569999999998765 46788999999999999999999999643211
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE--RIHMADAVKN 990 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~ 990 (1003)
+............ ............+.+++.+|+...+++ |++++++.++
T Consensus 215 ---~~~~~i~~~~~~~---~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ---ETYGKIMNHEERF---QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---HHHHHHHcCCCcc---cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0011111100000 001111223455667777777755443 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=308.17 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=199.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+++++.++|+||+++++++ ..++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 80 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFF 80 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEE
Confidence 455566667899999999999999888899999998765555567899999999999999999999985 445778
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEEccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNL--NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDF 857 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Df 857 (1003)
++|+||+++++|.+++.... ..+ ++.++..++.|++.|++|||+. +|+||||||+||+++. ++.++|+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence 99999999999999998642 234 7888899999999999999999 9999999999999986 679999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCC--CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN--VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
|.+....... .......|+..|+|||+..+.. ++.++||||+|+++|+|++|+.||..........
T Consensus 154 g~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------- 221 (268)
T cd06624 154 GTSKRLAGIN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------- 221 (268)
T ss_pred hhheecccCC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-------
Confidence 9997653211 1112245889999999976643 7889999999999999999999986432110000
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.. .......+ .........+.+++.+||+.+|++||++.|++++
T Consensus 222 -----~~--~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 -----FK--VGMFKIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----hh--hhhhccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 00000111 1112344568899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=317.40 Aligned_cols=256 Identities=22% Similarity=0.259 Sum_probs=194.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.++||+|+||+||++++..+++.||+|++... .......+.+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 4688999999999999999999999999999998632 223345688899999999999999999884 45678
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++|+|.+++.+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 89999999999999999864 24688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
+........ .......||+.|+|||++. ...++.++||||+||++|||++|+.||......
T Consensus 149 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---------- 214 (332)
T cd05623 149 CLKLMEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------- 214 (332)
T ss_pred heecccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----------
Confidence 975432211 1112346999999999876 346788999999999999999999999653211
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhcccc--CCCCCCCHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSME--SPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~ 990 (1003)
+....+....... ........+...+.+++.+|+.. ++..|+++.|+++|
T Consensus 215 ---~~~~~i~~~~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ---ETYGKIMNHKERF---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---HHHHHHhCCCccc---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011111100000 00111122344566677776644 44447899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.04 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=196.4
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEec--cccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 777 (1003)
....|++.++||+||.+.||++...+. +.||+|++. ..+.+....|.+|+..+.++ .|.+||++++| ..++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTD 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccC
Confidence 456899999999999999999998644 567777664 33455678899999999999 59999999999 5668
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
++.|+||||=+. +|..++++.. ...+...++.+..|++.|+.++|.+ ||||.|+||.|+|+ -.|.+||+||
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDF 503 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDF 503 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeee
Confidence 999999998654 9999999854 2344347889999999999999999 99999999999999 5789999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC-----------CCCccccchhHHHHHHHHHhCCCCCCcccCCcc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-----------NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL 926 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~ 926 (1003)
|+|..+.... ++-....-+||+.||+||++... ++++++||||+|||+|+|+.|+.||+...+..
T Consensus 504 GIA~aI~~DT---TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~- 579 (677)
T KOG0596|consen 504 GIANAIQPDT---TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI- 579 (677)
T ss_pred chhcccCccc---cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-
Confidence 9998765432 23333456899999999987543 35688999999999999999999997643210
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+..+.++.-.. +.+...+ ..++..+|..|+..||.+||+..|++++
T Consensus 580 -----------aKl~aI~~P~~~I----efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -----------AKLHAITDPNHEI----EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----------HHHHhhcCCCccc----cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1112222211111 1111111 1228899999999999999999999975
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.96 Aligned_cols=274 Identities=27% Similarity=0.399 Sum_probs=208.3
Q ss_pred ccCCccCeeeeccceEEEEEEECC----CCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGE----DLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|++.+.||+|+||.||+|++.. +++.||+|+++..... ..+.|.+|+++++.+.|||++++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 467788999999999999999753 4788999999755443 46789999999999999999999998632 335
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++||
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence 67899999999999999998642 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh-hC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM-AL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~-~~ 936 (1003)
|.+......... ........++..|+|||...+..++.++||||+|+++|||++|+.|+................ ..
T Consensus 154 g~~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 154 GLAKVLPEDKDY--YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred ccccccccCCcc--eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 999876422111 111112335667999999988899999999999999999999999976533221110000000 00
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
...+.+.+.... +.+....+..++.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGE------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCC------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111112222111 1111223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.40 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=203.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||++....+++.||+|.+... .....+.+.+|++++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 488899999999999999999989999999998643 233456889999999999999999999984 5567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 76 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 9999999999999997643 33578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......|++.|+|||+..+..++.++||||+||++|+|++|+.||..... .
T Consensus 150 ~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------------~ 207 (256)
T cd08218 150 VLNSTV-----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------------K 207 (256)
T ss_pred ecCcch-----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----------------H
Confidence 653221 111234588899999999988899999999999999999999999864211 1
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+........ ..........+.+++.+||+.+|++||++.|++++
T Consensus 208 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 208 NLVLKIIRGSY---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHhcCCC---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111111 11122345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.05 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=209.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+.|.++..||.|+||.||+|..+.++...|.|++........++|+-|++|+....||+||++++.| ..++..++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEE
Confidence 4577788999999999999999988888899999888888889999999999999999999999874 44677899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
..|||.||..+..+-.- +..+.+.++..+++|++.|+.|||++ .|||||+|+.|||++.+|.++++|||.+..
T Consensus 107 liEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999999887653 56799999999999999999999999 999999999999999999999999999854
Q ss_pred cccCCccccCcccccccccccccCcccc-----CCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYG-----MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.. .+......+.||+.|||||+. +..+|+.++||||||+++.||..+.+|.+...
T Consensus 180 n~-----~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------------- 239 (1187)
T KOG0579|consen 180 NK-----STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------------- 239 (1187)
T ss_pred ch-----hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---------------
Confidence 31 222233458899999999975 45689999999999999999999999966431
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...++-+....+|. ....+......|.++..+|+..+|..||+++++++|
T Consensus 240 --pMRVllKiaKSePP-TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 240 --PMRVLLKIAKSEPP-TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --hHHHHHHHhhcCCC-cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11222222223332 122234456788999999999999999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.92 Aligned_cols=203 Identities=24% Similarity=0.330 Sum_probs=163.8
Q ss_pred cCeeeeccceEEEEEEEC--CCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 708 SNLIGQGSFGFVYRGNLG--EDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
.++||+|+||+||+|++. .+++.||+|.+.... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999975 366889999986432 23567899999999999999999988642 33556789999
Q ss_pred cccCCCHHHHHhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe----CCCCCeEEccc
Q 001858 786 YMQSGSLEDWLQQSNDQ----VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 857 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Df 857 (1003)
|+++ +|.+++...... ....+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9965 898888654321 123589999999999999999999999 99999999999999 45678999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
|+++....... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLK--PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCc--cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99986543211 11122345789999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.24 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=204.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCC---CceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
..+|.+.+.||+|+||.||+|.+... ...||||...... ....+.+.+|++++++++|||++++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------E 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------C
Confidence 35688899999999999999987543 3569999887544 334568999999999999999999999853 2
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence 34689999999999999997642 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|+++......... .....++..|+|||.+....++.++||||+|+++|||++ |+.||......+.
T Consensus 152 g~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---------- 217 (270)
T cd05056 152 GLSRYLEDESYYK----ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---------- 217 (270)
T ss_pred ceeeeccccccee----cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------
Confidence 9997654322111 112335678999999888889999999999999999996 9999875432110
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
...+..... ....+.++..+.+++.+|+.++|++||++.++++.|++++..
T Consensus 218 ----~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 ----IGRIENGER------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----HHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011111110 011123456788999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=311.21 Aligned_cols=269 Identities=21% Similarity=0.322 Sum_probs=198.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++|||+++++++ +.+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence 4788899999999999999999999999999986432 2234567889999999999999999998 45677889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++ +|.+++... .+.+++.+++.++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 76 lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 76 LVFEYCDQ-DLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred EEEecCCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999975 888887653 34689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC--ch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL--PE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~--~~ 938 (1003)
...... .......++..|+|||++.+. .++.++||||+||++|||++|+.|+.........+........ ++
T Consensus 148 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07839 148 AFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222 (284)
T ss_pred ccCCCC-----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 543211 111234578899999987765 4689999999999999999999986433222111111111000 00
Q ss_pred h-HHHHH---HhhcccCCCCc---hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 K-VMEIV---DFALLLDPGNE---RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~-~~~~i---~~~l~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. +.... +.......... ..........+.+++.+|++.+|++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 00000 00000000000 01112245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=318.55 Aligned_cols=265 Identities=19% Similarity=0.249 Sum_probs=194.3
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
...+|++.+.||+|+||.||+|++..+++.||+|+... .....|+.++++++||||+++++++. .....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCee
Confidence 34579999999999999999999998899999997542 22356999999999999999999853 45667
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+|++. ++|.+++... ...+++.+++.++.||+.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred EEEEEccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 99999995 5899888763 35689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCC-CCcccCCcchh--------hHH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-THTMFNDGLTL--------HGF 931 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P-~~~~~~~~~~~--------~~~ 931 (1003)
+..... .......||..|+|||++.+..++.++||||+||++|||+++..| |.......... ...
T Consensus 205 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 205 QFPVVA------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred cccccC------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 753211 112235689999999999999999999999999999999985554 44322211100 000
Q ss_pred HHh------hCc-----hhHHHHHHh-hcccCCCCchhhH--HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 932 VKM------ALP-----EKVMEIVDF-ALLLDPGNERAKI--EECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ~~~------~~~-----~~~~~~i~~-~l~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... ..+ ......++. .....+..+.... .........++.+|++.+|++|||+.|+++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 000 000111110 0011111111111 1223445678999999999999999999976
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.32 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=202.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECC-----CCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
..++|++.++||+|+||.||+|.++. .+..||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 46789999999999999999997642 345799998864332 2235688899999999999999999985
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQ-----VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 849 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 849 (1003)
.+....++||||+++|+|.+++...... ......+..+..++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 3456779999999999999999764321 123456788899999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchh
Q 001858 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTL 928 (1003)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~ 928 (1003)
+.++++|||+++.......... .....++..|+|||.+.++.++.++||||+||++|||++ |..||......
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---- 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---- 228 (288)
T ss_pred CcEEECcCCccccccccccccc---cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999976533221111 112345778999999998899999999999999999999 78888643211
Q ss_pred hHHHHhhCchhHHHHH-HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIV-DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i-~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
+..+.+ +...... .+.+...+.+++.+|++.+|++||++.|+++.++..
T Consensus 229 ----------~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 ----------QVLKFVMDGGYLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ----------HHHHHHHcCCCCCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111 1111111 112345789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.86 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=203.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..|+..+.||.|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++|||++++++++ .++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEE
Confidence 45778899999999999999998889999999987443 34457899999999999999999999985 4466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.. +.+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.
T Consensus 79 lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 79 IIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccce
Confidence 99999999999999864 3578899999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......++..|+|||++.+..++.++||||+||++|||++|+.||....... ..
T Consensus 150 ~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~ 210 (277)
T cd06640 150 QLTDTQ-----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------------VL 210 (277)
T ss_pred eccCCc-----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------------Hh
Confidence 653321 11223457889999999988889999999999999999999999987543210 00
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+. ...+ ......+...+.+++.+||+.+|++||+++|++++
T Consensus 211 ~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 FLIP---KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhh---cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1111 0111 11223456678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.98 Aligned_cols=250 Identities=33% Similarity=0.481 Sum_probs=203.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+|++++++++ .+....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence 467899999999999999999875 67899999975544 467899999999999999999999985 3467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 77 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccc
Confidence 9999999999999998643 23689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ...++..|+|||++.++.++.++||||+|+++|||++ |+.||...... ..
T Consensus 151 ~~~~~~~--------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------------~~ 208 (256)
T cd05039 151 EASQGQD--------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DV 208 (256)
T ss_pred ccccccc--------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------------HH
Confidence 6522111 1234678999999988889999999999999999997 99998643211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+...... ......+..+.+++.+|+..+|++||++.|+++.|+.
T Consensus 209 ~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 209 VPHVEKGYRM------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhcCCCC------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111111110 1112235678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.44 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=198.9
Q ss_pred CeeeeccceEEEEEEECC-CC--ceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGE-DL--LPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|++|.||+|.+.. .+ ..||+|.++.... ...+.+.+|++++++++||||+++++++ .+ ...++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV-----LT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEE-----cC-CeEEEEE
Confidence 468999999999999865 33 3699999986555 5567899999999999999999999985 23 6779999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++..+.
T Consensus 75 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred EecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence 99999999999987431 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
..... ........++..|+|||++.+..++.++||||+||++|||++ |+.||...... +..+.
T Consensus 149 ~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~~~~ 212 (257)
T cd05040 149 QNEDH--YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------------QILKK 212 (257)
T ss_pred ccccc--eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHH
Confidence 32211 111113457789999999988899999999999999999998 99998643211 11111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+.... .........+..+.+++.+|++.+|++||+++|+++.|.
T Consensus 213 ~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 213 IDKEG-----ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHhcC-----CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11100 001111234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.82 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=195.7
Q ss_pred CeeeeccceEEEEEEECCCCc--eEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLL--PVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|++.+++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++. ..+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 468999999999999987765 46888876332 33456788999999999 8999999999853 456679999
Q ss_pred ecccCCCHHHHHhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 785 DYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
||+++|+|.+++...... ....+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999764321 123578999999999999999999998 999999999999999999999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~ 932 (1003)
++|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 153 l~dfgl~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------- 218 (270)
T cd05047 153 IADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 218 (270)
T ss_pred ECCCCCccccchh------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------
Confidence 9999998532110 11111234667999999988889999999999999999997 99998653211
Q ss_pred HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
.....+...... .....+...+.+++.+||+.+|.+||++.|+++.|..+.
T Consensus 219 ------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ------ELYEKLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------HHHHHHhCCCCC------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111111100 111123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=311.13 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=201.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|++++++++||||+++++++ ..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence 3688999999999999999999989999999988743 233356889999999999999999999984 4467889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++..... ...+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+|++|||++.
T Consensus 76 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999999999999876321 346899999999999999999999632 89999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCC------CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN------VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
.+.... .....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||......
T Consensus 152 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------- 213 (286)
T cd06622 152 NLVASL-------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----------- 213 (286)
T ss_pred cccCCc-------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----------
Confidence 553211 12245788999999875543 478999999999999999999998643211
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.....+.......+.. ....+...+..++.+|++.+|++||++++++.+-
T Consensus 214 ---~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 214 ---NIFAQLSAIVDGDPPT---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred ---hHHHHHHHHhhcCCCC---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 1111111111111111 1223566788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=325.57 Aligned_cols=267 Identities=22% Similarity=0.242 Sum_probs=198.8
Q ss_pred hccCCccCeeeeccceEEEEEEECC--CCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
..+|++.+.||+|+||.||+|...+ .++.||+|.+... +.+.+|++++++++||||+++++++ .....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence 4579999999999999999998643 4578999987532 3456899999999999999999884 44667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|||++. ++|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.++|+|||+
T Consensus 161 ~~lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred EEEEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence 899999996 589998854 45789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCc--chhhHHHHhh--
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG--LTLHGFVKMA-- 935 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~--~~~~~~~~~~-- 935 (1003)
++....... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ..+....+..
T Consensus 232 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 232 ACKLDAHPD---TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred ccccCcccc---cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 976543221 112224679999999999999999999999999999999999999997643321 1111111100
Q ss_pred ----Cch----hHHHHHHhhc-ccCCCCchhh---HHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 ----LPE----KVMEIVDFAL-LLDPGNERAK---IEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ----~~~----~~~~~i~~~l-~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+. .......... ...+....+. .......+..++.+|+..+|++||++.|++.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0111111110 0111000000 01123467788999999999999999999986
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.17 Aligned_cols=256 Identities=30% Similarity=0.519 Sum_probs=203.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++.++||+|+||.||+|.+. +++.||||.+.... ...+++.+|++++++++|||++++++++ ......
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence 3468999999999999999999986 45779999987433 3457899999999999999999999984 445678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+++++|.+++.... ...+++.++..++.+++.|++|||+. +++|+||||+||+++.++.+|++|||.+
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred EEEEeccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 99999999999999997643 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
......... ......++..|+|||...+..++.++||||+|+++|||++ |+.||...... .
T Consensus 151 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------------~ 212 (261)
T cd05034 151 RLIEDDEYT----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------------E 212 (261)
T ss_pred eeccchhhh----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------------H
Confidence 765432111 1112334678999999998889999999999999999998 99998653211 1
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
..+.+...... + .....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 213 ~~~~~~~~~~~-~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 213 VLEQVERGYRM-P-----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcCCCC-C-----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11111111100 0 011224568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=304.35 Aligned_cols=257 Identities=20% Similarity=0.307 Sum_probs=190.1
Q ss_pred CeeeeccceEEEEEEECC--CCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||.||+|.+.. ++..+|+|.++.... .....+.+|+.++++++||||+++++++ .+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 368999999999998643 456799998864432 2345788999999999999999999985 34566799999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++...........++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccC
Confidence 99999999999875433234567788889999999999999999 999999999999999999999999999975432
Q ss_pred CCccccCcccccccccccccCccccCCC-------CCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGG-------NVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.... .......++..|+|||+..+. .++.++||||+|+++|||++ |+.||......+.
T Consensus 153 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----------- 218 (269)
T cd05087 153 EDYY---VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV----------- 218 (269)
T ss_pred ccee---ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-----------
Confidence 2111 111234578899999987542 35789999999999999996 9999965432111
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
....+.......+.. .........+.+++..|| .+|++||+++||++.|+
T Consensus 219 --~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 --LTYTVREQQLKLPKP--RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --HHHHhhcccCCCCCC--ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000111111111100 000112345778889999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.60 Aligned_cols=272 Identities=19% Similarity=0.205 Sum_probs=198.0
Q ss_pred ccCeeeec--cceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 707 LSNLIGQG--SFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 707 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+.++||+| +|++||+++++.+++.||+|+++... ....+.+.+|+++++.++||||+++++++. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 46789999 68899999999999999999997543 233456788999999999999999999853 4567899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++|+|.+++..+. ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++++||+.+..
T Consensus 77 v~e~~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred EEeccCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 999999999999997643 34589999999999999999999999 999999999999999999999999987654
Q ss_pred cccCCc--cccCcccccccccccccCccccCC--CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 863 LFDRPI--QETSSSSIGIKGTVGYVAPEYGMG--GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 863 ~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
...... ...........++..|+|||++.+ ..++.++||||+||++|||++|+.||.......... .......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~ 229 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPC 229 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccc
Confidence 322111 001111122356788999999876 458899999999999999999999997643221111 111111100
Q ss_pred h-------HHHHHHhh--------c----c---cCC----CCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 K-------VMEIVDFA--------L----L---LDP----GNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~-------~~~~i~~~--------l----~---~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. ..+..... . . ..+ ....+........+.+++.+|++.+|++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00000000 0 0 000 00011122345678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.67 Aligned_cols=269 Identities=21% Similarity=0.309 Sum_probs=201.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++||||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 57899999999999999999999889999999987443 33345778999999999999999999984 4567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++ +|.+++... ...+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred EEEecccc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999974 999988764 34688999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH---hhCc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK---MALP 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~---~~~~ 937 (1003)
...... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. ...... ....
T Consensus 153 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~ 226 (301)
T cd07873 153 AKSIPT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTE 226 (301)
T ss_pred ccCCCC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCh
Confidence 542211 111223578899999987654 578899999999999999999999975432211 110000 0011
Q ss_pred hhHHHHHHhhcc---cCCCCc----hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALL---LDPGNE----RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~---~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+......... ..+... ......+...+.+++.+|++.+|.+|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111110000 001000 01112234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.38 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=206.1
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc-CCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF-KGDD 778 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~ 778 (1003)
++++|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+++++++ .||||+++++++..... ....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46899999999999999999999988889999999874433 346789999999999 79999999999755332 3456
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++++|.++++..... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 689999999999999998764321 35789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
++....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||.......
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------- 225 (275)
T cd06608 159 VSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------- 225 (275)
T ss_pred cceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------
Confidence 997653221 11223458899999998653 346788999999999999999999986432110
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....... .+.............+.+++.+|+..+|++||++.|++++
T Consensus 226 -----~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 -----ALFKIPR-----NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----HHHHhhc-----cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111110 1111111122345678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=322.87 Aligned_cols=267 Identities=22% Similarity=0.248 Sum_probs=197.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++||||+++++++. .++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence 457999999999999999999999999999999642 234678999999999999999999853 356779
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|||++. ++|.+++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 237 lv~e~~~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEccC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999995 6999988753 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCC-c-----chhhHHHHhh
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND-G-----LTLHGFVKMA 935 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~-~-----~~~~~~~~~~ 935 (1003)
....... ........||..|+|||++.+..++.++|||||||++|||++|..|+-..... . ..+...+...
T Consensus 309 ~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 309 FARGSWS---TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred ecccccc---cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 6533211 11122356999999999999999999999999999999999988764322111 0 0111111100
Q ss_pred ------Cc----hhHHHHHHhhc--ccCCCCchhhH---HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 ------LP----EKVMEIVDFAL--LLDPGNERAKI---EECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ------~~----~~~~~~i~~~l--~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+ ..+........ ...+....... ......+.+++.+|++.||++|||++|++++
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00111010000 00111111111 1223467889999999999999999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.74 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=203.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|||++++.+++ .++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF-----LKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEE-----EECCeEE
Confidence 36888999999999999999999899999999987543 34456789999999999999999999985 3457889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++... .+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++
T Consensus 76 ~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred EEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccce
Confidence 999999999999999752 688999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ...
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------------~~~ 207 (274)
T cd06609 147 QLTSTM-----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------------RVL 207 (274)
T ss_pred eecccc-----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------------HHH
Confidence 764321 1122356888999999999888999999999999999999999998653211 111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+..... +.... ......+.+++.+|+..+|++||++++++++
T Consensus 208 ~~~~~~~~--~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 208 FLIPKNNP--PSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhhcCC--CCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111111 10000 0134567889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.78 Aligned_cols=276 Identities=20% Similarity=0.264 Sum_probs=206.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986432 3345678899999999999999999998766555556678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+||+++ ++.+++.. ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 999999975 88888754 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH---hhC
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK---MAL 936 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~---~~~ 936 (1003)
......... ........|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ....... ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPS 230 (336)
T ss_pred eeccccccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence 765332211 112233568999999998654 568899999999999999999999996532111 0100000 001
Q ss_pred chhHHHHHHhh----cccCCCCch----hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFA----LLLDPGNER----AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~----l~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
++.+....... ....+.... .........+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111110 000010111 0112235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.03 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=188.9
Q ss_pred CeeeeccceEEEEEEECC--CCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||+||+|.... ....+|+|.+..... .....|.+|++.++.++||||+++++.+ ......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 368999999999997532 345788888764332 2345788999999999999999999985 34567899999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++...........++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence 99999999999876543334567888899999999999999999 999999999999999999999999999865432
Q ss_pred CCccccCcccccccccccccCccccC-------CCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGM-------GGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
..... ......++..|+|||+.. ...++.++||||+||++|||++ |..||......+
T Consensus 153 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------------ 217 (269)
T cd05042 153 EDYYI---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------------ 217 (269)
T ss_pred chhee---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------------
Confidence 21111 112234677899999864 3456789999999999999999 788886532110
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.....+.......+ ...........+..++..|| .+|++||+++||.+.+
T Consensus 218 -~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 218 -VLKQVVREQDIKLP--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -HHHHHhhccCccCC--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 01111111111111 11111234456677888898 4999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=304.28 Aligned_cols=260 Identities=27% Similarity=0.382 Sum_probs=206.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+ ..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 46899999999999999999998889999999986433 23567899999999999999999999874 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+|++++++|.++++.... ...+++..++.++.|++.|++|||+. +++||||+|+||++++++.++++|||++.
T Consensus 76 iv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 99999999999999986432 24689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
.+....... ........|+..|+|||++... .++.++||||+||++|||++|+.||........ .
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------------~ 216 (267)
T cd06610 151 SLADGGDRT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-------------L 216 (267)
T ss_pred HhccCcccc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-------------H
Confidence 765432111 0122335689999999998776 788999999999999999999999975432110 1
Q ss_pred HHHHHhhcccCCCCchh--hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERA--KIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+... ..+..... ........+.+++.+|+..+|++||+++|++++
T Consensus 217 ~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 217 MLTLQ----NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHhc----CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111 11111111 112445678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.45 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=198.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 57899999999999999999999899999999886322 1234678899999999999999999997532 223
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++++|.+++.. ...+++..+.+++.|++.|++|||+. +++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcC
Confidence 567899999999999999986 34578889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|+++........ ........|+..|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------- 215 (265)
T cd06652 151 GASKRLQTICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------------- 215 (265)
T ss_pred cccccccccccc--ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------------
Confidence 999765321111 11122345889999999998888999999999999999999999998643111
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........... ...........+..++.+|+. +|++||+++|++++
T Consensus 216 ---~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 ---AAIFKIATQPT---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---HHHHHHhcCCC---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111011100 111122334566777888884 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.55 Aligned_cols=266 Identities=23% Similarity=0.273 Sum_probs=204.8
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++++.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 367888999999999999999988899999999874433 345678999999999999999999998643 2345679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++..... ....+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 78 lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 99999999999998865332 145688999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .....++..|+|||...+..++.++||||+||++|+|++|+.||.......... .+..
T Consensus 154 ~~~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------~~~~ 217 (287)
T cd06621 154 ELVNSL-------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---------IELL 217 (287)
T ss_pred cccccc-------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh---------HHHH
Confidence 543211 112457889999999998899999999999999999999999997542210110 0111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..+.....................+.+++.+||+.+|++||++.|++++-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred HHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11111000000000010012345688999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.32 Aligned_cols=242 Identities=26% Similarity=0.317 Sum_probs=187.5
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhc---CCCCceeEeeeeeecccCCCCceEEee
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNI---RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
||+|+||+||+|++..+++.||+|++.... ......+..|..++... +||+|+++++++ .+....++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 699999999999999999999999986432 22334556677777665 699999999884 5567789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++|+|.+++.. .+.+++.+++.++.||++|++|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 76 e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 76 DYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred cCCCCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999999999976 45689999999999999999999999 99999999999999999999999999997532
Q ss_pred cCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
... .......||..|+|||++.+. .++.++||||+||++|||++|+.||..... .+....
T Consensus 148 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------------~~~~~~ 208 (330)
T cd05586 148 TDN-----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------------QQMYRN 208 (330)
T ss_pred CCC-----CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------------HHHHHH
Confidence 211 112245699999999998764 478999999999999999999999865321 111111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC----CHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI----HMADAVKN 990 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP----s~~ev~~~ 990 (1003)
+......-+. ......+.+++.+|++.+|.+|| ++.|+++|
T Consensus 209 i~~~~~~~~~------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 209 IAFGKVRFPK------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHcCCCCCCC------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1111111110 11345667889999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=301.55 Aligned_cols=240 Identities=20% Similarity=0.385 Sum_probs=187.1
Q ss_pred CeeeeccceEEEEEEECCC------------CceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 709 NLIGQGSFGFVYRGNLGED------------LLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
+.||+|+||.||+|+.... ...||+|.+..........|.+|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 4689999999999986422 2358999887655555678899999999999999999999863 3
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCC-----
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV----- 851 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~----- 851 (1003)
+...++||||+++|+|..++... ...+++.++++++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~ 148 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG 148 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCC
Confidence 55678999999999999988753 34689999999999999999999999 9999999999999987664
Q ss_pred --eEEcccccccccccCCccccCcccccccccccccCccccC-CCCCCccccchhHHHHHHHHH-hCCCCCCcccCCcch
Q 001858 852 --AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-GGNVSLTGDVYSFGILLLEMF-TGRRPTHTMFNDGLT 927 (1003)
Q Consensus 852 --~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ell-~g~~P~~~~~~~~~~ 927 (1003)
++++|||++...... ....++..|+|||.+. +..++.++||||+||++|||+ .|+.||......
T Consensus 149 ~~~~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--- 216 (262)
T cd05077 149 PFIKLSDPGIPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--- 216 (262)
T ss_pred ceeEeCCCCCCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---
Confidence 899999998654211 1245788999999876 466889999999999999998 488887543211
Q ss_pred hhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 928 LHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 928 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+........... .. .....+.+++.+||+.+|++||++.++++++
T Consensus 217 -----------~~~~~~~~~~~~----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 -----------EKERFYEGQCML----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----------HHHHHHhcCccC----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 011111111100 01 1134678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.40 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=204.8
Q ss_pred hccCCccCeeeeccceEEEEEEECC-------CCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-------DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
..+|++.+.||+|+||.||+|.+.. ....||+|+++... ....+.+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence 3578999999999999999998642 22368999887432 23357889999999999 899999999985
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCC
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSND-----------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 841 (1003)
..++..++++||+++|+|.+++..... .....+++.++..++.|++.|++|||+. +++||||||
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 345678999999999999999986432 1134588999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCc
Q 001858 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920 (1003)
Q Consensus 842 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~ 920 (1003)
+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||+|+++|||++ |..||..
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999765332111 11111234568999999999999999999999999999998 8888865
Q ss_pred ccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHh
Q 001858 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~ 996 (1003)
... ++....+...... .....+...+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 240 ~~~--------------~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 240 IPV--------------EELFKLLKEGHRM------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCH--------------HHHHHHHHcCCCC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 321 1111111111111 1112334578899999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.42 Aligned_cols=261 Identities=24% Similarity=0.402 Sum_probs=205.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCc----eEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..+|++.+.||+|+||+||+|.+..++. .||+|....... .....+.+|++++++++|||++++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3678899999999999999999866554 589998864432 335678899999999999999999998642
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
...++|+||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 5678999999999999999864 23589999999999999999999998 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
||.++........ .......++..|+|||......++.++|+||+|+++||+++ |+.||.....
T Consensus 153 fg~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------ 217 (279)
T cd05057 153 FGLAKLLDVDEKE---YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------------ 217 (279)
T ss_pred CcccccccCcccc---eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------------
Confidence 9999865422111 11111224578999999888889999999999999999998 9999865321
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
+++...+...... +.. ..+...+..++.+||..+|++||++.++++.|..+.+..
T Consensus 218 --~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 218 --VEIPDLLEKGERL-PQP-----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred --HHHHHHHhCCCCC-CCC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 1122222211111 100 112345788899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.54 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=202.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++|||++++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 46889999999999999999999889999999986432 22345688999999999999999999985 446678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++++++..++.. ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 76 ~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 76 HLVFEYCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred EEEEeccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999888887654 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh--HHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH--GFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~--~~~~~~~~ 937 (1003)
........ ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....+.... .......+
T Consensus 148 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07847 148 RILTGPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222 (286)
T ss_pred eecCCCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 86533211 1123457889999998766 4578899999999999999999999976433211110 00000011
Q ss_pred hhHHHHHH------hhcccCCCCch---hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVD------FALLLDPGNER---AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~------~~l~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+..+ ......+.... .........+.+++.+||+++|++||++.|++.+
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 223 -RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred -HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 1111100 00011111110 1112335678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.44 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=204.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|||++++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4788899999999999999999899999999986432 2335678899999999999999999987532 3355678
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
++|||+++++|.+++...... ...+++.+++.++.|++.|++||| +. +++|+||+|+||+++.++.+|++|
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEec
Confidence 999999999999999875322 457899999999999999999999 66 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
||++........ ......|+..|+|||+..+..++.++||||+|+++|+|++|+.||.....
T Consensus 154 ~g~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------- 215 (265)
T cd08217 154 FGLAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------------- 215 (265)
T ss_pred ccccccccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------------
Confidence 999986543221 12234689999999999988899999999999999999999999875321
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+...+.+..... +.........+.+++.+|++.+|++||++.+|+++
T Consensus 216 -~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 -LQLASKIKEGKF------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -HHHHHHHhcCCC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111111111111 11112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.63 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCc----eEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 3568888999999999999999876665 478888764332 223478899999999999999999998632
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
...++++||+++|+|.+++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~D 152 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD 152 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcc
Confidence 2357899999999999999764 23588999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
||+++........ .......++..|+|||...+..++.++|||||||++|||++ |+.||.....
T Consensus 153 fg~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------------ 217 (303)
T cd05110 153 FGLARLLEGDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------------ 217 (303)
T ss_pred ccccccccCcccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 9999865432111 11112345778999999988899999999999999999997 9999865321
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhh
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~ 998 (1003)
....+.+...... + ....+...+..++.+||..+|++||+++++++.++++.+..
T Consensus 218 --~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 218 --REIPDLLEKGERL-P-----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --HHHHHHHHCCCCC-C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1112222211111 1 01123456788999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.42 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=201.1
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++ ..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4667788999999999999998888999999987443 33456789999999999999999999984 45677899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++++|.+++.. ..+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++..
T Consensus 80 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 80 IMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccc
Confidence 9999999999999864 3578999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
..... .......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...
T Consensus 151 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~ 211 (277)
T cd06642 151 LTDTQ-----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------------VLF 211 (277)
T ss_pred ccCcc-----hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------------HHh
Confidence 53321 11223457889999999998889999999999999999999999986432211 000
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.+.... .+ .........+.+++.+||+.+|++||++.|++++-
T Consensus 212 ~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 212 LIPKNS--PP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred hhhcCC--CC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 011000 01 11122345688999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.45 Aligned_cols=247 Identities=29% Similarity=0.445 Sum_probs=194.7
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
++||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|||++++++++. ..+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 46899999999999865 678899999874432 22457889999999999999999999863 355679999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++... ...+++.+++.++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++.......
T Consensus 75 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 75 PGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 999999998753 23578999999999999999999999 99999999999999999999999999997543221
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDF 946 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 946 (1003)
... .....++..|+|||+..+..++.++||||+|+++|++++ |..||...... .....+..
T Consensus 148 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------------~~~~~~~~ 209 (250)
T cd05085 148 YSS----SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------------QAREQVEK 209 (250)
T ss_pred ccc----CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------------HHHHHHHc
Confidence 111 111234678999999988889999999999999999998 99998653211 11111111
Q ss_pred hcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 947 ALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 947 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.... .....+...+.+++.+|++.+|++||++.|+++.|.
T Consensus 210 ~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRM------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111 111123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.65 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=202.2
Q ss_pred hccCCccCeeeeccceEEEEEEECC-----CCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++.... ...+.+.+|++++++++|||++++++++ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 4679999999999999999998743 567899999874432 2346789999999999999999999985 3
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEecc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSND-----------------QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 838 (1003)
.+...++|+||+++|+|.+++..... .....+++.+++.++.|++.|++|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 45667999999999999999975421 1123578899999999999999999999 999999
Q ss_pred CCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCC
Q 001858 839 LKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917 (1003)
Q Consensus 839 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P 917 (1003)
|||+||+++.++.++++|||++.......... ......++..|+|||...+..++.++||||+||++|||++ |..|
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK---ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcccc---ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999987553221111 1112234678999999988899999999999999999998 8888
Q ss_pred CCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
|...... +....+...... ...+.+...+.+++.+|++.+|++||++.|+++.|+
T Consensus 233 ~~~~~~~--------------~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 233 YYGMAHE--------------EVIYYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCHH--------------HHHHHHhcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 7543211 111111111110 011223567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=301.19 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=202.7
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc--chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|.+.+.||+|+||.||+|.+..+++.||+|.++..... ..+.+.+|++++++++|+||+++++++ .+.+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 588889999999999999999888999999998755443 567899999999999999999999984 4567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++.. ...+++..++.++.+++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.
T Consensus 76 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 76 IFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccccc
Confidence 99999999999999986 34578899999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCC---CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN---VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
......... ........++..|+|||++.+.. .+.++||||+|+++|||++|+.||........
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~------------ 214 (264)
T cd06626 148 KLKNNTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------------ 214 (264)
T ss_pred ccCCCCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH------------
Confidence 764432111 11012345788999999988766 88999999999999999999999975321100
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.......... ...+........+.+++.+|++.+|++||++.|++.+
T Consensus 215 ---~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 215 ---IMFHVGAGHK--PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---HHHHHhcCCC--CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000011 1111112234567789999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.41 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=202.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc------cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK------GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
+|+..+.||+|+||.||+|....+++.||+|+++.... ...+.+.+|++++++++|||++++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 47888999999999999999988999999999874331 1246789999999999999999999984 456
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-CeEEcc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSD 856 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~D 856 (1003)
+..++|+||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++|+||+|+||+++.++ .+||+|
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence 778999999999999999986 34688999999999999999999999 999999999999998776 599999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
||.+..+..... ..........|+..|+|||...+..++.++||||+|+++|+|++|+.||.........
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------- 217 (268)
T cd06630 148 FGAAARLAAKGT-GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--------- 217 (268)
T ss_pred cccccccccccc-cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---------
Confidence 999976643211 1111222356889999999998888999999999999999999999998643211100
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+........ .....+.....+.+++.+|++.+|++||++.|++++
T Consensus 218 -----~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 218 -----ALIFKIASATT--APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----HHHHHHhccCC--CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00100000000 011122345678889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.49 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=205.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++ ..+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence 36788899999999999999999899999999987543 33456789999999999999999999985 3457889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
+|+||+++++|.+++.... ..+++..+.+++.|++.|++|+|+ . +++|+||||+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred EEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999998742 578899999999999999999999 7 9999999999999999999999999998
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ....++..|+|||...+..++.++||||+|+++|+|++|+.||....... +..
T Consensus 149 ~~~~~~~~-------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------------~~~ 209 (265)
T cd06605 149 GQLVNSLA-------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP------------DGI 209 (265)
T ss_pred hhhHHHHh-------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------------ccH
Confidence 75532110 11568889999999999999999999999999999999999987543211 111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.++......+.... .......+.+++.+||..+|++||++.|++.+
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 210 FELLQYIVNEPPPRLP--SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHhcCCCCCCC--hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 2222222222111111 11145678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.94 Aligned_cols=269 Identities=22% Similarity=0.298 Sum_probs=199.1
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|+..+.||+|++|.||+|++..+++.||||.++... ....+.+.+|++++++++||||+++++++ .+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4788999999999999999999899999999987433 22346789999999999999999999984 4567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+. ++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++.
T Consensus 76 ~v~e~~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred EEeeccc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 9999996 58999887643 35689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCC-CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cch-
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LPE- 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~- 938 (1003)
...... .......++..|+|||...+.. ++.++||||+|+++|||++|+.||......+. ........ .+.
T Consensus 149 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~ 222 (284)
T cd07860 149 AFGVPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDE 222 (284)
T ss_pred hcccCc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 553211 1112234688999999876644 58889999999999999999999865322111 11111100 000
Q ss_pred hH----HHHH---HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KV----MEIV---DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~----~~~i---~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.. .... .....................+.+++.+|++.+|++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 0000 0000000000001111234567789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=299.66 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=201.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 4788899999999999999999899999999987442 33457899999999999999999999874 4567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-CCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG~a 860 (1003)
+||||+++++|.+++.... ...+++..++.++.+++.|++|||++ +++|+||+|+||+++.+ +.+|++|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 9999999999999998743 34589999999999999999999999 99999999999999865 46899999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ......|+..|+|||...+..++.++||||+|+++|+|++|+.||...... ...
T Consensus 150 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------------~~~ 210 (256)
T cd08220 150 KILSSKS------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------------ALV 210 (256)
T ss_pred eecCCCc------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------------HHH
Confidence 8653321 112245888999999998888999999999999999999999998653211 111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......... +........+.+++.+||+.+|++||++.|++++
T Consensus 211 ~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 211 LKIMSGTFA-------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHhcCCC-------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111110 0111235568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=299.81 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=201.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||.||+|.+. .+..+|+|.+... ....+.+.+|++++++++|+|++++.+++. . ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence 467899999999999999999865 4557999988643 234578899999999999999999998852 2 5679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+++++|.+++.... ....++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred EEEEeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCccee
Confidence 9999999999999998643 34678899999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ......++..|+|||++.++.++.++|+||+||++|++++ |+.||...... ..
T Consensus 151 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------------~~ 212 (260)
T cd05073 151 VIEDNEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------------EV 212 (260)
T ss_pred eccCCCcc----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------------HH
Confidence 65432211 1112345678999999988889999999999999999999 99998653211 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
.+.+...... +........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 213 ~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 IRALERGYRM------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHhCCCCC------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111111110 1112334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.67 Aligned_cols=269 Identities=24% Similarity=0.327 Sum_probs=201.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++ .++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 368889999999999999999988899999999864332 2346788999999999999999999984 557788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+||++++++.++... ...+++.+++.++.|+++|++|||+. +++|||++|+||++++++.++++|||++
T Consensus 76 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred EEEEecCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999989887764 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH--hhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK--MALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~--~~~~ 937 (1003)
....... .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||......+ ....... ....
T Consensus 148 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~ 221 (286)
T cd07846 148 RTLAAPG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLI 221 (286)
T ss_pred eeccCCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCc
Confidence 7653321 11223457899999998765 457789999999999999999999986432211 0000000 0011
Q ss_pred hhHHHHH------HhhcccCCC---CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIV------DFALLLDPG---NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i------~~~l~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+...... ......... ............+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 1111111 111111000 0011112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=299.00 Aligned_cols=251 Identities=30% Similarity=0.523 Sum_probs=199.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+... ......|.+|++++++++||+++++++++ ......+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceE
Confidence 346888899999999999999886 4668999988633 23346789999999999999999999984 4456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++... .+.+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 76 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEEcCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 999999999999999764 24578999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ......++.+|+|||...++.++.++||||+|+++|||++ |+.||...... ..
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------------~~ 210 (256)
T cd05112 149 FVLDDQYT----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------------EV 210 (256)
T ss_pred ecccCccc----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------------HH
Confidence 65332111 1112335678999999988889999999999999999998 99998653211 11
Q ss_pred HHHHHhhccc-CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 941 MEIVDFALLL-DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 941 ~~~i~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.+.+...... .+. .....+.+++.+||+.+|++||++.|++++|
T Consensus 211 ~~~~~~~~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 211 VETINAGFRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHhCCCCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111111111 111 1245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.16 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=200.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+.|.....||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++|||++++++.+ ...+..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEE
Confidence 3444457799999999999999888999999998765555567899999999999999999999884 44677899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.. +.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 97 v~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 97 VMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999998854 3578999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
..... .......|+..|+|||...+..++.++||||+|+++|||++|+.||...... ....
T Consensus 168 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------------~~~~ 228 (292)
T cd06658 168 VSKEV-----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------------QAMR 228 (292)
T ss_pred ccccc-----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHH
Confidence 43211 1112356889999999998888999999999999999999999998643210 0001
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+........ .........+..++.+|+..+|++||+++|++++
T Consensus 229 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 229 RIRDNLPPRV----KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHhcCCCcc----ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111110 1111234467788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=300.19 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=199.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc------cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK------GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
+|++.+.||+|+||+||+|... +++.+|+|.++.... ...+.+.+|++++++++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 5888999999999999999874 678899998864321 2235688999999999999999999985 345
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..++|+||+++++|.+++.+ ...+++..++.++.|++.|++|||+. +|+|+||+|+||+++.++.++++||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccc
Confidence 788999999999999999976 34678999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCcc-ccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQ-ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|++......... ..........|+..|+|||+..+..++.++||||+||++|+|++|+.||........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---------- 216 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---------- 216 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH----------
Confidence 999765321111 111122235689999999999988899999999999999999999999965321100
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... +.......+. ........+.+++.+||+.+|++||++.|++++
T Consensus 217 ---~~~-~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 217 ---MFY-IGAHRGLMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---HHH-hhhccCCCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 0000000010 111234567889999999999999999999764
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=310.11 Aligned_cols=258 Identities=28% Similarity=0.322 Sum_probs=204.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc---chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||+||+|.+..+++.||+|.+...... ..+.+.+|+++++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 3688899999999999999999988999999999754322 456789999999999999999999884 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+.+++|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 899999999999999997643 35789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccc------------------------cCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCC
Q 001858 860 AKFLFDRPIQE------------------------TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915 (1003)
Q Consensus 860 a~~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~ 915 (1003)
+.......... .........||..|+|||+..+..++.++||||+|+++|+|++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 87543211100 001112346889999999999888999999999999999999999
Q ss_pred CCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC----HHHHHHH
Q 001858 916 RPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH----MADAVKN 990 (1003)
Q Consensus 916 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~~ 990 (1003)
.||...... ....+....... .+........+.+++.+|+..+|++||+ ++|++.+
T Consensus 230 ~pf~~~~~~-------------~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRD-------------ETFSNILKKEVT------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchH-------------HHHHHHhcCCcc------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 999754321 011111111110 1111114567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.61 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=202.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+.|+.-++||+|+||+||-++...+|+.||.|.+.+. .........+|-.++.+++.+.||.+--. |+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 35688889999999999999999999999999988633 23334567889999999999999887655 67889
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++|+..|.||+|.-+|.... .+.+++..+.-+|.+|+-||++||+. +||+||+||+|||+|+.|+++|+|.|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred ceEEEEEeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 9999999999999999998865 45799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|..+.++. .....+||.+|||||++.++.|+...|.||+||++|||+.|+.||..... .
T Consensus 333 LAvei~~g~------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------------K 392 (591)
T KOG0986|consen 333 LAVEIPEGK------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------------K 392 (591)
T ss_pred eEEecCCCC------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------------h
Confidence 998875432 22345899999999999999999999999999999999999999864321 1
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI 982 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 982 (1003)
.-.+-++++...++.... +..+++..++.+.-+..+|++|.
T Consensus 393 vk~eEvdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 393 VKREEVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred hhHHHHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhc
Confidence 122345556555553333 33445556666677788888886
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=282.13 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=215.2
Q ss_pred HhccCCcc-CeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCC
Q 001858 701 ATNEFSLS-NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+++|++. ++||-|-.|.|-.+.++.+++++|+|++... ....+|++..-.. .|||||.++++|.. .+.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN-SYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh-hccCce
Confidence 45667664 5799999999999999999999999998633 4456788876665 69999999999754 467788
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC---CCCeEEc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVS 855 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~ 855 (1003)
...+|||.|+||.|...|+.++ ...+++.++..|..||..|+.|||+. .|.||||||+|+|.+. +..+|++
T Consensus 133 cLLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 8899999999999999999876 55799999999999999999999999 9999999999999974 5579999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
|||+|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-.... ..
T Consensus 207 DfGFAK~t~~------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----------~a 270 (400)
T KOG0604|consen 207 DFGFAKETQE------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----------LA 270 (400)
T ss_pred ccccccccCC------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----------cc
Confidence 9999985422 2333446789999999999999999999999999999999999999865332 24
Q ss_pred CchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+++.++.-|......-|.+ .+.+.+++..++++..+..+|++|.|+.|+..+=
T Consensus 271 ispgMk~rI~~gqy~FP~p---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEP---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred CChhHHhHhhccCccCCCh---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 5666777677666665544 3455666777888899999999999999998763
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.00 Aligned_cols=253 Identities=29% Similarity=0.475 Sum_probs=197.4
Q ss_pred CeeeeccceEEEEEEECCCC------ceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 709 NLIGQGSFGFVYRGNLGEDL------LPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|+++++.++||||+++++++ ...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence 46899999999999986433 679999886433 23467899999999999999999999985 3456789
Q ss_pred EeeecccCCCHHHHHhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-----CeEE
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQ--VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHV 854 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl 854 (1003)
+||||+++++|.+++...... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 999999999999999764321 234578999999999999999999998 999999999999999877 8999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHH
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~ 933 (1003)
+|||++.......... ......++..|+|||++.++.++.++|||||||++|||++ |+.||......
T Consensus 153 ~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------- 220 (269)
T cd05044 153 GDFGLARDIYKSDYYR---KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------- 220 (269)
T ss_pred CCcccccccccccccc---cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---------
Confidence 9999997654322111 1112345788999999999999999999999999999998 99998643211
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+....+.... +.......+..+.+++.+||..+|++||++.++.+.|.
T Consensus 221 -----~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 221 -----EVLQHVTAGG------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----HHHHHHhcCC------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111110 11111234567889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.41 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=200.1
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+++++.++|||++++++++ .++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4778899999999999999998889999999986543 22456789999999999999999999985 4456
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++|+||+++++|.+++.. .+.+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 78999999999999999976 34588999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCC-CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
.+....... ......|+..|+|||...... ++.++|+||+|+++|+|++|+.||......
T Consensus 148 ~~~~~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------------- 208 (258)
T cd06632 148 MAKQVVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------------- 208 (258)
T ss_pred cceeccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------------
Confidence 997653221 122356889999999987766 899999999999999999999998653210
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........ .... ..........+.+++.+||+.+|++||++.+++++
T Consensus 209 ~~~~~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 209 AAVFKIGR---SKEL---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHh---cccC---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00011110 0000 01112234567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.64 Aligned_cols=239 Identities=23% Similarity=0.372 Sum_probs=185.9
Q ss_pred eeeeccceEEEEEEECC------------------------CCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeE
Q 001858 710 LIGQGSFGFVYRGNLGE------------------------DLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKI 765 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 765 (1003)
.||+|+||.||+|.... ....||+|++..........|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998532 124589999875544445678899999999999999999
Q ss_pred eeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceE
Q 001858 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845 (1003)
Q Consensus 766 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nil 845 (1003)
+++|. .+...++||||+++|+|.+++... .+.+++..+..++.|+++|++|||+. +|+||||||+||+
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nil 149 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNIL 149 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEE
Confidence 99964 355679999999999999998753 34688999999999999999999999 9999999999999
Q ss_pred eCCCC-------CeEEcccccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHH-hCCC
Q 001858 846 LDHDM-------VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMF-TGRR 916 (1003)
Q Consensus 846 l~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell-~g~~ 916 (1003)
++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 220 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV 220 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 97643 4899999988643211 11346788999998765 56889999999999999995 6999
Q ss_pred CCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 917 PTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 917 P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
||......+ .......... .+. .....+.+++.+||+.+|++||+++++++.|
T Consensus 221 p~~~~~~~~--------------~~~~~~~~~~-~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 221 PLKERTPSE--------------KERFYEKKHR-LPE-------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CccccChHH--------------HHHHHHhccC-CCC-------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 986532211 1111111111 111 1124578899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=307.57 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=163.3
Q ss_pred cCeeeeccceEEEEEEECC--CCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 708 SNLIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
..+||+|+||+||+|+... ++..||+|.++... ....+.+|++++++++||||+++++++.. ..+...++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3689999999999999753 56789999886432 23567899999999999999999998643 34567799999
Q ss_pred cccCCCHHHHHhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe----CCCCCeEEccc
Q 001858 786 YMQSGSLEDWLQQSND----QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDF 857 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill----~~~~~~kl~Df 857 (1003)
|+++ +|.+++..... .....+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 88888764321 1123588999999999999999999999 99999999999999 56679999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
|+++........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999866432211 1122235689999999988764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=304.59 Aligned_cols=259 Identities=22% Similarity=0.383 Sum_probs=202.5
Q ss_pred ccCCccCeeeeccceEEEEEEECC-----CCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
++|++.+.||+|+||+||+|+.+. +.+.||+|........ ..+.+.+|++++++++|||++++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 578899999999999999999753 3467999988654433 457899999999999999999999985 44
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQV----DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
....++||||+++|+|.++++...... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 567799999999999999998754221 12689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHH
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~ 931 (1003)
+++|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||......
T Consensus 157 ~l~~~~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------- 225 (275)
T cd05046 157 KVSLLSLSKDVYNSE----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------- 225 (275)
T ss_pred EEcccccccccCccc----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------
Confidence 999999987543221 112223456788999999888888999999999999999999 78888643211
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.....+.......+ ....++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 226 -------~~~~~~~~~~~~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 -------EVLNRLQAGKLELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------HHHHHHHcCCcCCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111110000000 11223467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=306.24 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=204.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++|||++++++++ ......+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCcEE
Confidence 36899999999999999999999888899999998765555567889999999999999999999985 3456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++|||++|+||+++.++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999999975 3478889999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
....... ......|++.|+|||.+.+..++.++||||+|+++|++++|+.||......+....
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------------ 226 (293)
T cd06647 164 QITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------------ 226 (293)
T ss_pred ccccccc-----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------------
Confidence 5533221 11234688999999999888899999999999999999999999975432111000
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. ...+.............+.+++.+||..+|++||++.+++.+
T Consensus 227 -~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 227 -I-----ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -h-----hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000001111122334567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.37 Aligned_cols=268 Identities=22% Similarity=0.288 Sum_probs=199.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc-----chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-----SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|++.+.||+|+||.||+|.+..+++.||||.++..... ....+..|++++++++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 478889999999999999999988999999999744322 245677899999999999999999985 3467
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+ +++|.+++.... ..+++.+++.++.|+++|++|||+. +|+|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccce
Confidence 789999999 889999997632 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-C
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-L 936 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~ 936 (1003)
+++...... .......++..|+|||.+.+ ..++.++||||+||++|||++|..||......+ ......... .
T Consensus 148 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~ 221 (298)
T cd07841 148 LARSFGSPN-----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGT 221 (298)
T ss_pred eeeeccCCC-----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCC
Confidence 997653321 11122346788999998755 457889999999999999999987776533211 111110000 0
Q ss_pred --chhHHHH---HHhh--cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 --PEKVMEI---VDFA--LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 --~~~~~~~---i~~~--l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....... .... ....+.............+.+++.+||+.+|++||+++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 0000 0000001111122345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=305.17 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCC---CceEEEEEeccccccch-----------HHHHHHHHHHHhcCCCCceeEee
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLKQKGSI-----------KSFVAECEALKNIRHRNLIKIIT 767 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 767 (1003)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999999877 66778887543322111 11223344556678999999998
Q ss_pred eeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 768 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
++.... ....+.++++|+... ++.+.++.. ...++..+..++.|++.|++|||+. +|+||||||+||+++
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeeEec-CCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 754321 112345778887754 777777652 2357888899999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccccCCccc--cCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCc
Q 001858 848 HDMVAHVSDFGLAKFLFDRPIQE--TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG 925 (1003)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~ 925 (1003)
.++.++|+|||+|+.+....... .........||+.|+|||+..+..++.++||||+||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 99999999999998764321111 1112223469999999999999999999999999999999999999998653221
Q ss_pred chhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
...... ..+.+.+..... .....+...+.+++..|++.+|++||+++++.+.+
T Consensus 241 ~~~~~~--------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAA--------KCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHh--------HHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100 011111111100 01122356788999999999999999999998865
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=297.59 Aligned_cols=252 Identities=32% Similarity=0.597 Sum_probs=200.8
Q ss_pred CCccCeeeeccceEEEEEEECCCC----ceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDL----LPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+++.+.||+|+||.||+|++...+ ..||+|+++..... ..+.+.+|+++++.++|+|++++++++ .+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence 356789999999999999998765 88999999755433 567899999999999999999999985 34567
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.+++|||+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~ 149 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGL 149 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCC
Confidence 899999999999999998743 12289999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+............ ...++..|+|||...+..++.++||||+|+++|+|++ |+.||..... .
T Consensus 150 ~~~~~~~~~~~~~----~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------------~ 211 (258)
T smart00219 150 SRDLYDDDYYKKK----GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------------E 211 (258)
T ss_pred ceecccccccccc----cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------------H
Confidence 9876443211111 1236789999999988889999999999999999998 7888764211 1
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
...+.+...... ........++.+++.+|++.+|++||++.|+++.|
T Consensus 212 ~~~~~~~~~~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 212 EVLEYLKKGYRL------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHhcCCCC------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111112111111 11112456788999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.43 Aligned_cols=279 Identities=21% Similarity=0.234 Sum_probs=207.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|++.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++||||+++.+++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 468999999999999999999999999999999987432 234567888999999999999999998764322 34567
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+. ++|.+++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 899999996 589998875 34589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH--hhC
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK--MAL 936 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~--~~~ 936 (1003)
+......... .........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...... ...
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~ 231 (334)
T cd07855 154 ARGLSSSPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSP 231 (334)
T ss_pred ceeecccCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCC
Confidence 9765332211 1111223468899999998765 4688999999999999999999999976432111 100000 011
Q ss_pred chh---------HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 937 PEK---------VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 937 ~~~---------~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+.. ..+..+..-...+..-..........+.+++.+|++.+|++||++++++.+-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 111 11111111001110001111234677899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=306.38 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=198.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+ ..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 36888999999999999999999999999999987443 23346788999999999999999999884 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.++++. .+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred EEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence 8999999999999999976 34689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcc----------ccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh
Q 001858 860 AKFLFDRPIQ----------ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH 929 (1003)
Q Consensus 860 a~~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~ 929 (1003)
++........ ..........|+..|+|||.+.+..++.++|+||+||++|||++|+.||.+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----- 222 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----- 222 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 8642111000 0000111245788999999998888999999999999999999999998643211
Q ss_pred HHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 930 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
++...+.......+... ......+.+++.+||+.+|++||++.++.+
T Consensus 223 ---------~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 223 ---------ELFGQVISDDIEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFE 269 (305)
T ss_pred ---------HHHHHHHhcccCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence 11111111111111111 123556889999999999999998544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=305.37 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=202.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++|||++++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 5888999999999999999998889999999987543 33457899999999999999999999985 4467789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+ +++|.+++.... ..+++.+++.++.|+++|++|||+. +++|+||||+||+++.++.++++|||.+.
T Consensus 76 ~v~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred EEeccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 999999 999999987642 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC---c
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL---P 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~---~ 937 (1003)
....... .......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ..........- +
T Consensus 148 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~ 222 (286)
T cd07832 148 LFSEEEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNE 222 (286)
T ss_pred cccCCCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCCh
Confidence 6543221 112234689999999987654 4688999999999999999998887653221 11111111000 0
Q ss_pred hhHHHH---HHhhcccCCCCch----hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEI---VDFALLLDPGNER----AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~---i~~~l~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....+. .+......+.... ....+....+.+++.+|++.+|++||+++++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 0000000000000 1112334778899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.14 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=197.1
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
++||+|+||.||+|.+.. ++.||+|.++..... ..+.+.+|++++++++||||+++++++ .+....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 479999999999999987 889999998754433 456899999999999999999999985 4566789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++... ...+++..+..++.+++.|++|||++ +++||||||+||+++.++.+|++|||.+.......
T Consensus 75 ~~~~l~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 75 PGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999999763 23578999999999999999999999 99999999999999999999999999997553221
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHHHHHHh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDF 946 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 946 (1003)
.. .......++..|+|||.+.++.++.++|+||+|+++|||++ |..||...... .....+..
T Consensus 148 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------------~~~~~~~~ 210 (251)
T cd05041 148 YT---VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------------QTRERIES 210 (251)
T ss_pred ce---eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------------HHHHHHhc
Confidence 11 11111234667999999988899999999999999999999 88888654221 11111211
Q ss_pred hcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 947 ALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 947 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.... ......+..+.+++.+|+..+|++||++.|+++.|.
T Consensus 211 ~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRM------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCC------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1111 111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.34 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=206.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++++ ......+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence 368889999999999999999998999999999875543 4467899999999999999999999985 4457889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
+|+||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999863 568999999999999999999999 8 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
......... .....++..|+|||...+..++.++||||||+++|+|++|+.||...... ..
T Consensus 148 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------------~~ 208 (264)
T cd06623 148 KVLENTLDQ-----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--------------SF 208 (264)
T ss_pred eecccCCCc-----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--------------CH
Confidence 765332211 12345788999999999888999999999999999999999998764320 01
Q ss_pred HHHHHhhcccCCCCchhhHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEE-CLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+.+........ ...... ....+.+++.+|++++|++||++.|++++
T Consensus 209 ~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FELMQAICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111111111 001111 45678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=338.56 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=206.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
-+|.....||.|.||.||-|....+|...|+|-++... ....+.+.+|..++..++|||+|+++|+ ..+++..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHREKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHHHH
Confidence 46777889999999999999999999999999886433 3345678899999999999999999998 5567788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++.||||++|+|.+.++. ++-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence 999999999999999987 34566777777889999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCC---CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN---VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
..+.... ......-....||+.|||||++.+.. -..++||||+|||+.||+||+.||+..++.
T Consensus 1382 ~ki~~~~-~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------------- 1447 (1509)
T KOG4645|consen 1382 VKIKNNA-QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------------- 1447 (1509)
T ss_pred eEecCch-hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------------
Confidence 8876542 22233344678999999999987754 457899999999999999999999876543
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.-..+.+.-..| +.++....+=.+++..|+..||..|-++.|++++
T Consensus 1448 --~aIMy~V~~gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 --WAIMYHVAAGHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --hHHHhHHhccCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2222222222222 2223355666788889999999999988888765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=312.20 Aligned_cols=278 Identities=21% Similarity=0.243 Sum_probs=207.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|.+.+.||+|+||+||+|++..+++.||||.++.. .....+.+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999999999999999998643 2333567788999999999999999999865433333356
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||+. ++|.+++.. .+.+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 899999996 589998876 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH------
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV------ 932 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~------ 932 (1003)
+....... .......++..|+|||.+.. ..++.++||||+||++|+|++|+.||....... ......
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 228 (337)
T cd07858 155 ARTTSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSP 228 (337)
T ss_pred ccccCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCC
Confidence 97653221 11223457889999998765 468899999999999999999999996542111 000000
Q ss_pred -----HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHH
Q 001858 933 -----KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAA 994 (1003)
Q Consensus 933 -----~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~~ 994 (1003)
.........+.++..-.............+...+.+++.+|++.+|++||+++|++++ ++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0001111122221111110001111223456778899999999999999999999987 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=305.66 Aligned_cols=278 Identities=21% Similarity=0.280 Sum_probs=202.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|..+... ......+.+|+.+++.++ ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999999899999999986443 223467889999999995 699999999875543333445
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEEcccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG 858 (1003)
.++||||+++ ++.+++..........+++.+++.++.||+.|++|||+. +|+||||+|+||+++. ++.+|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 899988765433245689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-C
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-L 936 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~ 936 (1003)
++..+.... .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||........... ..... .
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGT 230 (295)
T ss_pred cceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCC
Confidence 997553211 11122356888999998765 4578999999999999999999999875432111100 00000 0
Q ss_pred ch-----hHHHHHHhhccc--CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PE-----KVMEIVDFALLL--DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~-----~~~~~i~~~l~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+. ............ .+.......+.....+.+++.+|++++|++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000000000000 0000011112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=304.90 Aligned_cols=270 Identities=22% Similarity=0.340 Sum_probs=198.0
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
++|++.+.||+|++|+||+|.+..+++.||+|.+..... .....+.+|+++++.++||||+++++++ .+++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 678999999999999999999988899999999874432 2235677899999999999999999984 4567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++ +|.+++.... ..+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.+|++|||+++
T Consensus 80 lv~e~~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EEEecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 99999985 9999987642 4688999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---Cc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---LP 937 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~---~~ 937 (1003)
...... .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||................. .+
T Consensus 152 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07844 152 AKSVPS-----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226 (291)
T ss_pred ccCCCC-----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence 532111 11112346889999998765 4578899999999999999999999975432111111111000 00
Q ss_pred hhHHHHHHh---h--cc--cCCCCchhhHHHH--HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDF---A--LL--LDPGNERAKIEEC--LTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~---~--l~--~~~~~~~~~~~~~--~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+........ . .. ..+.......... .....+++.+|++.+|++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000 0 00 0000000000011 1566789999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.25 Aligned_cols=240 Identities=24% Similarity=0.404 Sum_probs=187.1
Q ss_pred CeeeeccceEEEEEEECCCC-------ceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 709 NLIGQGSFGFVYRGNLGEDL-------LPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+.||+|+||.||+|.+...+ ..||+|..........+.+.+|+.+++.++|||++++++++. .+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 46899999999999986543 348888886554455578899999999999999999999853 345679
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCC--------eE
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--------AH 853 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--------~k 853 (1003)
+||||+++|+|.++++... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++. ++
T Consensus 76 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred EEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEE
Confidence 9999999999999998642 3688999999999999999999999 9999999999999987765 69
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCC-CCCCcccCCcchhhHH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGR-RPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~-~P~~~~~~~~~~~~~~ 931 (1003)
++|||.+...... ....++..|+|||++.+. .++.++||||+|+++|||++|. .||......
T Consensus 149 l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------- 212 (258)
T cd05078 149 LSDPGISITVLPK---------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------- 212 (258)
T ss_pred ecccccccccCCc---------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------
Confidence 9999988654221 124578899999998764 5789999999999999999985 555432111
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.......... .-|. ....++.+++.+||+.+|++||+++++++.|
T Consensus 213 -------~~~~~~~~~~-~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 213 -------KKLQFYEDRH-QLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -------HHHHHHHccc-cCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111111110 0110 1134678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=303.72 Aligned_cols=246 Identities=26% Similarity=0.313 Sum_probs=200.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 46889999999999999999999899999999986432 23356788999999999999999999984 45677
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred EEEEEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 8999999999999999987 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+...... .....|++.|+|||.+.+...+.++||||+|+++|+|++|+.||..... ..
T Consensus 148 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~ 205 (290)
T cd05580 148 AKRVKGR--------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------------IQ 205 (290)
T ss_pred ccccCCC--------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------------HH
Confidence 9765332 2234688999999999888889999999999999999999999865321 01
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
..+.+. ...+ .........+.+++.+||..+|.+|| +++|++++
T Consensus 206 ~~~~~~---~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 206 IYEKIL---EGKV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHh---cCCc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 1111 00111245678899999999999999 77887764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=302.02 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=196.1
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHH-HHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEA-LKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+..|+.. ++..+|||++++++++ ..+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCcE
Confidence 468899999999999999999999999999999874432 223455666665 5666899999999985 346678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++ |+|.+++...... ...+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||.+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999997 5899888764322 357899999999999999999999853 7999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCC----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
....... ......|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||.......
T Consensus 152 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------- 214 (283)
T cd06617 152 GYLVDSV------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----------- 214 (283)
T ss_pred ccccccc------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----------
Confidence 7653211 1122457889999998765 446889999999999999999999986432110
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+.....+.......+ ...++..+.+++.+|+..+|++||++.+++++-
T Consensus 215 -~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 215 -QQLKQVVEEPSPQLP------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred -HHHHHHHhcCCCCCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111111111111111 112346788999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=300.47 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc----------cchHHHHHHHHHHHhcCCCCceeEeeeeeecc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK----------GSIKSFVAECEALKNIRHRNLIKIITVCSSID 773 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 773 (1003)
+|.+.+.||+|+||.||+|....+++.||+|.++.... ...+.+.+|+++++.++|||++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 47788999999999999999988899999998753211 0134678899999999999999999985
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
......++||||+++++|.+++... +.+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICK 148 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEE
Confidence 4466789999999999999999873 5688999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCCCC--CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN--VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
++|||+++...... .........|+..|+|||...... ++.++||||+|+++||+++|..||......
T Consensus 149 l~d~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------- 218 (272)
T cd06629 149 ISDFGISKKSDDIY---DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------- 218 (272)
T ss_pred Eeeccccccccccc---cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-------
Confidence 99999997543211 111122345889999999877654 789999999999999999999998642211
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+...+...... .+........++...+.+++.+|+.++|++||+++|++++
T Consensus 219 ------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 ------AAMFKLGNKRS--APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ------HHHHHhhcccc--CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111111000 0000011112345678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=305.66 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
++++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++|+||+++.+++ .+++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence 4578999999999999999999998889999999987443 23345778999999999999999999985 44667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||++ +++.+++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 899999996 6888777553 24577888999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LP 937 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~ 937 (1003)
++...... .......++..|+|||++.+. .++.++||||+||++|||++|+.||.........+....... .+
T Consensus 150 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07870 150 ARAKSIPS-----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP 224 (291)
T ss_pred ccccCCCC-----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence 97542211 111234578999999998764 578899999999999999999999975433211111111100 01
Q ss_pred hh-HHHHHH-------hhcccCCCCchhhH---HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EK-VMEIVD-------FALLLDPGNERAKI---EECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~-~~~~i~-------~~l~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.. ...... ......+....... ......+.+++.+|+..+|++|||+.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 000000 00000000000000 0113467788999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=282.66 Aligned_cols=210 Identities=24% Similarity=0.327 Sum_probs=178.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCC----ceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDL----LPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 775 (1003)
-..|+....||+|.||.||+|...+++ +.+|||.++.++ .+-.....+|+..+++++|||++.+..++. .
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----S 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----c
Confidence 357899999999999999999765443 379999997553 344567889999999999999999998853 3
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC----CC
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD----MV 851 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~----~~ 851 (1003)
.+..+++++||.+. +|...|+-++......++...+..++.||+.|+.|||++ =|+|||+||.|||+..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 37889999999999 999999998877677899999999999999999999999 69999999999999877 89
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
+||+|+|+++.+.+.-.. -.....++.|.+|.|||.+.|. .|+++.||||.|||+.||++-++-|.+.
T Consensus 175 VKIaDlGlaR~~~~plkp--l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKP--LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eEeecccHHHHhhccccc--cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999988653211 2223346789999999998875 6899999999999999999998888654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.20 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=199.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.|+....||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++|||++++++++ ..++..++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv 96 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVL 96 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEE
Confidence 344456899999999999999888999999999765555567889999999999999999999984 446778999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+||+++++|.+++.. ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 97 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 97 MEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999998754 3578999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
.... .......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 168 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------------~~~~~ 228 (297)
T cd06659 168 SKDV-----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------------QAMKR 228 (297)
T ss_pred cccc-----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHH
Confidence 3211 1122356899999999998888999999999999999999999998643211 00011
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+..... ............+.+++.+|++.+|++||+++|++++
T Consensus 229 ~~~~~~----~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 229 LRDSPP----PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HhccCC----CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111100 0011111234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=299.71 Aligned_cols=238 Identities=24% Similarity=0.446 Sum_probs=188.6
Q ss_pred CeeeeccceEEEEEEECCCC----------ceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 709 NLIGQGSFGFVYRGNLGEDL----------LPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+.||+|+||.||+|.+..++ ..|++|++...... ...|.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46899999999999997665 35888887644333 6789999999999999999999998632 4
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-------C
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-------V 851 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-------~ 851 (1003)
..++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCcee
Confidence 4589999999999999998742 2688999999999999999999999 999999999999999887 7
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHh-CCCCCCcccCCcchh
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTL 928 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~ 928 (1003)
+|++|||++..... .....++..|+|||++.+. .++.++||||+|+++|||++ |..||......
T Consensus 147 ~kl~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---- 213 (259)
T cd05037 147 IKLSDPGIPITVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---- 213 (259)
T ss_pred EEeCCCCccccccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----
Confidence 99999999976432 1123467789999998776 78899999999999999999 57777553211
Q ss_pred hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+...... .....+... ...+.+++.+||..+|++||++.|+++.|
T Consensus 214 ----------~~~~~~~-~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 214 ----------EKERFYQ-DQHRLPMPD-------CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----------hHHHHHh-cCCCCCCCC-------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0001111 000111110 15788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.39 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=199.4
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+++++.++|||++++++++ .+++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 677899999999999999998899999999987443 23346788999999999999999999985 45678899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||++ ++|.+++.... ...+++.+++.++.|+++|++|||+. +++||||+|+||+++.++.++++|||.+..
T Consensus 76 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred EEeccC-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 999995 59999987643 24689999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cch-h
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LPE-K 939 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~-~ 939 (1003)
..... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........ ........ .+. .
T Consensus 149 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 222 (283)
T cd07835 149 FGVPV-----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDED 222 (283)
T ss_pred cCCCc-----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChH
Confidence 43211 111223468899999987664 568899999999999999999999875422111 11111100 000 0
Q ss_pred H-------HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 940 V-------MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~-------~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
. .+.........+.............+.+++.+|++++|++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00000000000111111122334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=301.84 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=200.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.+++.++|||++++++++ ...+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence 355567999999999999999888999999998755555566789999999999999999999984 346678999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+||+++++|.+++.. +.+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+...
T Consensus 95 ~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 95 MEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 999999999999875 3578899999999999999999999 9999999999999999999999999988654
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
.... .......|+..|+|||...+..++.++||||+|+++|||++|+.||..... ......
T Consensus 166 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------------~~~~~~ 226 (285)
T cd06648 166 SKEV-----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------------LQAMKR 226 (285)
T ss_pred ccCC-----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------------HHHHHH
Confidence 3211 112234689999999999888899999999999999999999999864211 001111
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.... .+.. .........+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~--~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 227 IRDNL--PPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHhcC--CCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11110 0110 1111234578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=297.39 Aligned_cols=247 Identities=32% Similarity=0.486 Sum_probs=197.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+|++.+.||+|+||.||+|.. +++.||+|..+.. ...+.+.+|+.++++++|||++++++++. .+..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVIL------HNGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEc------CCCcEE
Confidence 5688999999999999999975 5678999998643 23467899999999999999999999853 233689
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++++|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+..
T Consensus 76 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcccee
Confidence 999999999999998643 34688999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..... .....+..|+|||.+.++.++.++||||+||++|||++ |+.||..... ....
T Consensus 150 ~~~~~--------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------------~~~~ 207 (254)
T cd05083 150 GSMGV--------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------------KEVK 207 (254)
T ss_pred ccccC--------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------------HHHH
Confidence 42211 11234578999999988899999999999999999998 9999865321 1112
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
+.+.......+ ...++..+.+++.+||+.+|++||+++++++.|+.
T Consensus 208 ~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 ECVEKGYRMEP------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHhCCCCCCC------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 22222221111 12335677899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=307.41 Aligned_cols=278 Identities=20% Similarity=0.264 Sum_probs=203.2
Q ss_pred cCCccCeeeeccceEEEEEEECC--CCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|++.++||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 47888999999999999999987 78999999998633 4445678899999999999999999999643 2236
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC----CCCeEE
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH----DMVAHV 854 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~----~~~~kl 854 (1003)
..++||||+++ ++.+++..........+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+|+
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEE
Confidence 78999999975 788888765444345789999999999999999999999 9999999999999999 899999
Q ss_pred cccccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcch------
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT------ 927 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~------ 927 (1003)
+|||++......... ........++..|+|||++.+. .++.++||||+||++|+|++|+.||.........
T Consensus 154 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 154 GDLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred CCCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 999999865432211 1112235678999999987664 5789999999999999999999999765433200
Q ss_pred --hhHHHHhhC---ch---------hHHHHHHhhcccCCC-Cchhh-HH---HHHHHHHHHHhhccccCCCCCCCHHHHH
Q 001858 928 --LHGFVKMAL---PE---------KVMEIVDFALLLDPG-NERAK-IE---ECLTAVVRIGVLCSMESPSERIHMADAV 988 (1003)
Q Consensus 928 --~~~~~~~~~---~~---------~~~~~i~~~l~~~~~-~~~~~-~~---~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 988 (1003)
....+...- +. +.....+........ ..... .+ .....+.+++.+|++++|++||++.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000000000 00 000000000000000 00000 00 2335688999999999999999999998
Q ss_pred HH
Q 001858 989 KN 990 (1003)
Q Consensus 989 ~~ 990 (1003)
++
T Consensus 312 ~~ 313 (316)
T cd07842 312 EH 313 (316)
T ss_pred cC
Confidence 65
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.97 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=200.6
Q ss_pred CCccCeeeeccceEEEEEEEC---CCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC-CC
Q 001858 705 FSLSNLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG-DD 778 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 778 (1003)
|++.+.||+|+||+||+|.+. .+++.||||++.... ....+++.+|++++++++|||++++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 356889999987432 234567889999999999999999999864422111 12
Q ss_pred ceEEeeecccCCCHHHHHhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQ-VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
..++++||+++|+|.+++...... ....+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 357899999999999988643211 123578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
|.++......... ......++..|++||...+..++.++||||+||++|||++ |+.||......
T Consensus 158 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------------ 222 (273)
T cd05074 158 GLSKKIYSGDYYR---QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------------ 222 (273)
T ss_pred cccccccCCccee---cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------------
Confidence 9998653322111 1112345678999999988889999999999999999999 88888653221
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
.....+...-... ........+.+++.+|++.+|++||++.|+.+.|+++
T Consensus 223 --~~~~~~~~~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 --EIYNYLIKGNRLK------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111100000 0012346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=300.24 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=199.9
Q ss_pred cCCccCeeeeccceEEEEEEECC-CCceEEEEEecccc----------ccchHHHHHHHHHHHh-cCCCCceeEeeeeee
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGE-DLLPVAVKVINLKQ----------KGSIKSFVAECEALKN-IRHRNLIKIITVCSS 771 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 771 (1003)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++|||++++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 47888999999999999999987 67889999886322 2234567788888875 6999999999985
Q ss_pred cccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCC
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDM 850 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~ 850 (1003)
.+++..++||||+++++|.+++...... ...+++.+++.++.|++.|+.|||+ . +++|+||+|+||+++.++
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCC
Confidence 4567889999999999999998653222 4568999999999999999999996 5 899999999999999999
Q ss_pred CeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhH
Q 001858 851 VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930 (1003)
Q Consensus 851 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~ 930 (1003)
.+|++|||.+....... ......|+..|+|||...+..++.++||||+|+++|||++|+.||......
T Consensus 152 ~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------ 219 (269)
T cd08528 152 KVTITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------ 219 (269)
T ss_pred cEEEecccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------
Confidence 99999999997653321 122356889999999999888999999999999999999999998642110
Q ss_pred HHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 931 FVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 931 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
........... . +.. .......+.+++.+||+.+|++||++.|+.++++
T Consensus 220 -------~~~~~~~~~~~-~-~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 -------SLATKIVEAVY-E-PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------HHHHHHhhccC-C-cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00111111111 1 100 1123456888999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.64 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=199.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcC---CCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIR---HRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++ |||++++++++ .++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 4778899999999999999998899999999987542 334567889999999996 99999999985 34667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++++|.++++. +.+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.++++|||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred EEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 8999999999999999864 2688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+....... .......|+..|+|||...++ .++.++||||+|+++|+|++|+.||........
T Consensus 148 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------------ 210 (277)
T cd06917 148 AALLNQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------------ 210 (277)
T ss_pred eeecCCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------------
Confidence 98764322 112234688999999987654 468899999999999999999999975322100
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+.. ..+... ........+.+++.+||+.+|++||++.|++++
T Consensus 211 --~~~~~~---~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 --MMLIPK---SKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --hhcccc---CCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000000 001000 001134578899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=295.60 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=185.8
Q ss_pred CeeeeccceEEEEEEECCC--CceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGED--LLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.||+|+||+||+|..... ...+++|.++... ....+.+.+|+.+++.++||||+++++++. +....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 3699999999999976432 3456677765433 234578999999999999999999999853 4567799999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
|+++|+|.+++++.... ....++..++.++.|+++|++|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence 99999999999874322 34567778889999999999999999 999999999999999999999999999864322
Q ss_pred CCccccCcccccccccccccCccccCC-------CCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCc
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMG-------GNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
... ........++..|+|||+... ..++.++|||||||++|||++ |..||......
T Consensus 152 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------- 215 (268)
T cd05086 152 EDY---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------------- 215 (268)
T ss_pred chh---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 111 111123567889999998743 245788999999999999997 56677543211
Q ss_pred hhHHHHHHhhcc--cCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 938 EKVMEIVDFALL--LDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 938 ~~~~~~i~~~l~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+.....+..... .+|... ......+.+++..|| .+|++||+++|+++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 216 EVLNHVIKDQQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHhhcccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 011111111110 111111 113456777888999 57999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=298.91 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=202.5
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
+|++.++||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||++++++ +.++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence 4788999999999999999999889999999997433 2346789999999999999999999987 4567788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+||+++++|.+++... ..+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 9999999999999999863 4688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... ......|+..|+|||...+..++.++|+||+|+++|+|++|+.||...... .. ...
T Consensus 148 ~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~---------~~~ 210 (258)
T cd05578 148 TKVTPDT------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IR---------DQI 210 (258)
T ss_pred cccCCCc------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HH---------HHH
Confidence 7653321 122355888999999998888999999999999999999999998764321 00 111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH--HHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM--ADAVK 989 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~~ 989 (1003)
...... . ...........+.+++.+||+.+|.+||++ +|+.+
T Consensus 211 ~~~~~~---~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 211 RAKQET---A----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHhcc---c----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 111111 0 111112334678899999999999999999 76654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.36 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=200.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+-|++.+.||+|+||.||+|.+..+++.||+|+..... ....+.+.+|++++++++|||++++++++ .++...+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence 34778899999999999999998889999999986433 23456788999999999999999999985 4466789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++++|.+++.. ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999999864 3578999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......++..|+|||...+..++.++||||+||++|+|++|..||...... ...
T Consensus 150 ~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------------~~~ 210 (277)
T cd06641 150 QLTDTQ-----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------------KVL 210 (277)
T ss_pred ecccch-----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------------HHH
Confidence 653321 1112345788999999998888999999999999999999999998643211 011
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+... ..+ .....+...+.+++.+||+.+|++||++++++++
T Consensus 211 ~~~~~~--~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 FLIPKN--NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHhcC--CCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111100 001 1112234567889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=302.99 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=195.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|...+.||+|+||+||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++ ..+...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence 4566788999999999999999999999999987443 234567889999999996 99999999985 3456778
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+.. ++.++...........+++..+..++.|++.|++|||+.. +++||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 99999865 6655443211111357899999999999999999999732 89999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCC---CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
...... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------------- 215 (288)
T cd06616 157 QLVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--------------- 215 (288)
T ss_pred HhccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------------
Confidence 653221 11223578899999998776 688999999999999999999999865320
Q ss_pred hHHHHHHhhccc-CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLL-DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+.+...... .+.........+...+.+++.+||+.+|++||+++|++++
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 216 -VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111111 1111111112345678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.03 Aligned_cols=201 Identities=28% Similarity=0.423 Sum_probs=178.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.+.|.+.+.||+|.|+.|.+|++..++..||||.+++..- ...+.+.+|+++++.++|||||+++.+ .+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecce
Confidence 5679999999999999999999999999999999985542 223558899999999999999999998 556788
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.|+||||+.+|.+++++.++ +...+..+..++.|+.+|++|||++ .|||||+|++||+++.+.++||+|||+
T Consensus 130 lylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccc
Confidence 89999999999999999984 4566688999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCC-CccccchhHHHHHHHHHhCCCCCCcc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
+..+... .....++|++.|+|||++.+.++ ++++|+||+|+++|.|++|..||++.
T Consensus 202 S~~~~~~------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 202 STFFDYG------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ceeeccc------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 9887533 33345789999999999998876 58899999999999999999999863
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.04 Aligned_cols=257 Identities=24% Similarity=0.316 Sum_probs=206.8
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
...+.|+..+.+|+|++|.||+|.+..++..||+|+++.... ..+.+.+|++.++.++|+|++++++++. ....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence 346678899999999999999999998889999999975444 4578899999999999999999999853 4577
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence 899999999999999998742 3789999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+....... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... .
T Consensus 163 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------------~ 224 (286)
T cd06614 163 AAQLTKEK-----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------------A 224 (286)
T ss_pred hhhhccch-----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------------H
Confidence 87553221 11123457889999999988889999999999999999999999986432110 0
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
........ + ........+...+.+++.+|++.+|.+||++.+++++-.
T Consensus 225 ~~~~~~~~----~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 225 LFLITTKG----I-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred HHHHHhcC----C-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 11111111 1 111112224567889999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=302.83 Aligned_cols=271 Identities=23% Similarity=0.336 Sum_probs=201.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++|+||+++++++. .++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 36889999999999999999999889999999987432 334578899999999999999999999853 46678
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++++.+..+... ...+++.+++.++.|++.|++|||+. +++|||++|+||+++.++.+||+|||++
T Consensus 76 ~iv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 76 YLVFEYVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 999999998777665544 34589999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh-HHHHhhCch
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH-GFVKMALPE 938 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~-~~~~~~~~~ 938 (1003)
........ .......++..|+|||+..+. .++.++||||+|+++|+|++|+.||......+.... .......+.
T Consensus 148 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07833 148 RALRARPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223 (288)
T ss_pred cccCCCcc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 76543221 122235678899999998888 788999999999999999999999875322110000 000000111
Q ss_pred hHHHHHHhh--c----ccCCCCchh----hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFA--L----LLDPGNERA----KIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~--l----~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......... . ...+..... ....+...+.+++.+||..+|++||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 111100000 0 000000000 011235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=307.56 Aligned_cols=272 Identities=21% Similarity=0.218 Sum_probs=203.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-cCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999999999999998632 2333467788999999999999999999864322 2333
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++ +|.+.+.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 567999999965 88888864 278889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh--h
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM--A 935 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~--~ 935 (1003)
|+++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||......+ .+...... .
T Consensus 163 g~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 235 (353)
T cd07850 163 GLARTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGT 235 (353)
T ss_pred ccceeCCCCC------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 9997653321 1123457899999999999999999999999999999999999997543211 11111100 0
Q ss_pred CchhHHHHHH----hhcccCCCCch-----------------hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEKVMEIVD----FALLLDPGNER-----------------AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~----~~l~~~~~~~~-----------------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+++..+... ......+..+. .........+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111 11111110000 0011234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=307.63 Aligned_cols=276 Identities=21% Similarity=0.315 Sum_probs=203.1
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 356789999999999999999999888999999988532 223345677899999999 99999999998643 234
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+++ +|.+++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred ceEEEEeccccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence 567999999975 99998875 2678889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh--
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM-- 934 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~-- 934 (1003)
|.+...................|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+. .......
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~ 230 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIG 230 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Confidence 99986643321111112233568999999998755 4578899999999999999999999965432211 1111110
Q ss_pred hCch-hH--------HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 935 ALPE-KV--------MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~~~~-~~--------~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+. .+ ....+....................+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000 00 11111000011101111112245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=277.93 Aligned_cols=272 Identities=21% Similarity=0.313 Sum_probs=206.2
Q ss_pred HHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecc
Q 001858 695 YAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 695 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 773 (1003)
+.+..+-++ +.||+|+|+.|--+....++..||||++.+.....+.+..+|++++... .|+||+++++|
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----- 144 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----- 144 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence 445544443 6799999999999999999999999999877666788999999999999 59999999999
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC---
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM--- 850 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~--- 850 (1003)
|+++...|+|||.|.||+|..+|++ ...+++.++.++..+|+.|+.|||.+ ||.|||+||+|||-....
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcC
Confidence 7888899999999999999999998 45799999999999999999999999 999999999999997544
Q ss_pred CeEEcccccccccccC-Cc-cccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhCCCCCCcccC
Q 001858 851 VAHVSDFGLAKFLFDR-PI-QETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 851 ~~kl~DfG~a~~~~~~-~~-~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~P~~~~~~ 923 (1003)
.+|||||.+..-+.-. +. ......-...+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.-.
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 5899999988543211 11 11222233567999999999743 23688999999999999999999999988765
Q ss_pred CcchhhHHHHhhC----chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 924 DGLTLHGFVKMAL----PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 924 ~~~~~~~~~~~~~----~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+-.+. +... .+.+.+-|...-..-|... +...+.+..+++...+..++.+|.++.+++.+
T Consensus 297 ~dCGWd---rGe~Cr~CQ~~LFesIQEGkYeFPdkd---WahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 297 ADCGWD---RGEVCRVCQNKLFESIQEGKYEFPDKD---WAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CcCCcc---CCCccHHHHHHHHHHHhccCCcCChhh---hHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 433222 2221 1223333333333333222 22333444455555566788888888887763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=299.80 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=197.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
..|++.+.||+|+||+||+|++..+++.||+|.+..... ...+++.+|+++++.++|||++++.+++. +++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence 568889999999999999999988899999999864332 23457889999999999999999999964 4566
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||++ |++.+++... ...+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||+
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCc
Confidence 799999997 4888877653 24589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
+...... ....++..|+|||++. ...++.++||||||+++|||++|+.||........
T Consensus 162 ~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---------- 222 (307)
T cd06607 162 ASLVSPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------- 222 (307)
T ss_pred ceecCCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----------
Confidence 8754221 1245788999999874 45688899999999999999999999865321100
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
.... .....+.. ....+...+..++.+||+.+|++||++.+++.+..
T Consensus 223 ---~~~~---~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 223 ---LYHI---AQNDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---HHHH---hcCCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0000 00011110 11234567889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=294.83 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=200.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 777 (1003)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 47899999999999999999999899999999875321 2335688999999999999999999998532 224
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++|+||+++++|.+++.. .+.+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcc
Confidence 567899999999999999976 34578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
|+++...... ..........|+..|+|||...+..++.++|+||+||++|+|++|+.||.....
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------- 214 (264)
T cd06653 151 GASKRIQTIC--MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------------- 214 (264)
T ss_pred cccccccccc--ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------------
Confidence 9997653211 111112235689999999999888899999999999999999999999864311
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.....+...... +........+.+.+++.+|++ +|.+||++.++++|
T Consensus 215 --~~~~~~~~~~~~---~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 215 --MAAIFKIATQPT---KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --HHHHHHHHcCCC---CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111111111111 111123345678889999999 57999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=291.84 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=204.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
+|++.+.||+|++|.||+|.+..+++.+++|++........+.+.+|++++++++||+++++++++ ..+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence 478889999999999999999888999999999765555668899999999999999999999985 445778999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+||+++++|.+++.... ..+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+...
T Consensus 76 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999998742 4689999999999999999999998 9999999999999999999999999999765
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
..... .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... .....
T Consensus 149 ~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~~ 208 (253)
T cd05122 149 SDTKA------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------------KALFK 208 (253)
T ss_pred ccccc------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------------HHHHH
Confidence 43221 22356889999999998888999999999999999999999998653211 00001
Q ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... ... ........+...+.+++.+|++.+|++||++.|++++
T Consensus 209 ~~~---~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 209 IAT---NGP-PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHh---cCC-CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 100 0111111124568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.63 Aligned_cols=271 Identities=22% Similarity=0.273 Sum_probs=199.9
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++.. .+....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 578899999999999999999998899999999974432 223467789999999999999999998643 223788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++|+||+++ +|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+|++|||++
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~ 153 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLA 153 (293)
T ss_pred EEEehhcCc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCce
Confidence 999999975 9999987642 3689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hC
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---AL 936 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~ 936 (1003)
....... .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......+. ....... ..
T Consensus 154 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~ 227 (293)
T cd07843 154 REYGSPL-----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPT 227 (293)
T ss_pred eeccCCc-----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCc
Confidence 7654321 111224578899999987664 468899999999999999999999975432111 0000000 00
Q ss_pred chhHHHHHH------hhccc-CCCCchhhHHH--HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 937 PEKVMEIVD------FALLL-DPGNERAKIEE--CLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~------~~l~~-~~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+..+..... ..... .+......... ....+.+++.+|++.+|++||++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 00000 00000001111 25667899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=300.89 Aligned_cols=278 Identities=20% Similarity=0.303 Sum_probs=200.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc---CC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF---KG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 776 (1003)
.++|++.++||+|+||.||+|++..+++.||||.+.... ......+.+|++++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999999999999999886432 2223466789999999999999999998765322 12
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++||||+.+ ++.+++... ...+++.+++.++.|++.|++|||++ +++|+||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 3456999999975 888888653 24689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcc-hhhHHHHh
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL-TLHGFVKM 934 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~-~~~~~~~~ 934 (1003)
||.+..+....... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||........ ........
T Consensus 163 fg~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 163 FGLARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred CCCcccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99998664322111 1112234578899999987664 468899999999999999999999865322110 00000000
Q ss_pred hCchhHH------HHHHhhcccCCCCchhhHH------HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 935 ALPEKVM------EIVDFALLLDPGNERAKIE------ECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~~~~~~~------~~i~~~l~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+++.. +..+.. ..+........ .....+.+++.+|++.+|++||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKM--ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhc--cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1111100 000000 00111100000 012456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.12 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=201.7
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
+|++.++||+|++|.||+|++..+++.||||.++.... ...+.+.+|++++++++|||++++++++ .+.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEEE
Confidence 48889999999999999999998999999999875432 3356778899999999999999999985 44567899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+++ +|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 76 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred EEecCCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 9999985 89998876432 34689999999999999999999999 999999999999999999999999999975
Q ss_pred cccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---Cch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---LPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~---~~~ 938 (1003)
..... .......++..|+|||++.+. .++.++||||+||++|+|++|+.||......+... ...... ...
T Consensus 150 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (284)
T cd07836 150 FGIPV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL-KIFRIMGTPTES 223 (284)
T ss_pred hcCCc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCChh
Confidence 43211 111224578899999987664 56889999999999999999999997643321111 111110 011
Q ss_pred hHHHHHHhh-ccc-CCCCc----hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFA-LLL-DPGNE----RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~-l~~-~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+....... ... .+... ....+.....+.+++.+|++.+|++||+++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111111000 000 00000 11112335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=294.26 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=200.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+++++.++|+|++++++++ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 4788899999999999999999999999999986432 23446788999999999999999999984 4567789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-CeEEcccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~a 860 (1003)
+|+||+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccc
Confidence 9999999999999997643 33578999999999999999999999 999999999999999886 4699999999
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhH
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....+.. .......|++.|+|||+..+..++.++||||+|+++|||++|+.||...... . ..
T Consensus 150 ~~~~~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~--------~~ 211 (257)
T cd08225 150 RQLNDSM-----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----Q--------LV 211 (257)
T ss_pred hhccCCc-----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H--------HH
Confidence 7653321 1112245889999999988888999999999999999999999998643211 1 11
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.......... ........+.+++.+|+..+|++||++.|++++
T Consensus 212 ~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQGYFAP-------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhcccCCC-------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111110 011224568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=292.40 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=204.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+++++.++|||++++.+.+ ......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence 57888999999999999999998899999999975433 4567889999999999999999999984 3457889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++...... ...+++.++..++.++++|++|||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~ 151 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISK 151 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcccee
Confidence 999999999999999875321 36789999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
...... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||......
T Consensus 152 ~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------- 209 (258)
T cd08215 152 VLSSTV-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------- 209 (258)
T ss_pred ecccCc-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----------------
Confidence 653321 1122346889999999988888999999999999999999999998653211
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+............. .......+.+++.+|+..+|++||++.|++++
T Consensus 210 ~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 210 ELALKILKGQYPPI---PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111111111 11335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=294.86 Aligned_cols=272 Identities=22% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhc---CCCCceeEeeeeeecccCCCCc
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNI---RHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+.+++++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999988899999999974322 2234667788877766 5999999999976544433445
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.+++|||+.+ +|.+++.... ...+++.+++.++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 8999887643 23689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~~ 938 (1003)
+..+.... ......++..|+|||++.+..++.++|+||+||++|||++|+.||......+ ....+.... .+.
T Consensus 154 ~~~~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 226 (287)
T cd07838 154 ARIYSFEM------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPS 226 (287)
T ss_pred ceeccCCc------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCC
Confidence 97653221 1122347889999999999999999999999999999999999987533211 111111100 000
Q ss_pred hHHHH-----HHhhcccC-CCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEI-----VDFALLLD-PGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~-----i~~~l~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..... ........ +........+....+.+++.+||+.+|++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000 00000000 001112223445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=293.62 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=194.5
Q ss_pred HHHHHHhccCCccCee--eeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 696 AELNKATNEFSLSNLI--GQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 696 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
.+.....++|++.+.+ |+|+||.||++....+++.+|+|.+........ |+.....+ +|||++++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~--- 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV--- 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE---
Confidence 4444556778887777 999999999999999999999999864322211 22222223 799999999985
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-C
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-V 851 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~ 851 (1003)
..++..++||||+++++|.+++... ..+++.+++.++.|+++|++|||+. +++||||||+||+++.++ .
T Consensus 79 --~~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 79 --TTLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred --ecCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence 3456789999999999999999863 3789999999999999999999999 999999999999999988 9
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
++++|||++...... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||............+
T Consensus 149 ~~l~dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T PHA03390 149 IYLCDYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219 (267)
T ss_pred EEEecCccceecCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence 999999998754321 12458899999999998899999999999999999999999997543322111111
Q ss_pred HHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-MADAVKN 990 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~ 990 (1003)
. .. .... ..........+.+++.+|++++|.+||+ ++|++++
T Consensus 220 ---------~---~~-~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 220 ---------L---KR-QQKK----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------H---Hh-hccc----CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 1 11 1110 1111234567889999999999999996 5988864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.57 Aligned_cols=272 Identities=19% Similarity=0.254 Sum_probs=196.4
Q ss_pred Ceeeec--cceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQG--SFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
..||+| +||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..++..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456666 99999999999899999999987433 23357789999999999999999999995 4466789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+.++++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+....
T Consensus 79 e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 79 PFMAYGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred ecccCCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 9999999999998753 23588999999999999999999999 99999999999999999999999998764432
Q ss_pred cCCcccc--CcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-----
Q 001858 865 DRPIQET--SSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA----- 935 (1003)
Q Consensus 865 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~----- 935 (1003)
....... ........++..|+|||++.+. .++.++||||+||++|||++|+.||.................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 2111110 0111112356779999998764 478899999999999999999999976532211111100000
Q ss_pred ---CchhHHHH--------------HHh-h---cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 936 ---LPEKVMEI--------------VDF-A---LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 936 ---~~~~~~~~--------------i~~-~---l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.+...... ... . .......+.+....+...+.+++.+||+.+|++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00000000 000 0 00000011222345667889999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=306.02 Aligned_cols=280 Identities=20% Similarity=0.218 Sum_probs=208.6
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998889999999987543 34457899999999999999999999986543322334789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+++ +|.+++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++.++++|||++.
T Consensus 81 lv~e~~~~-~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELMET-DLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchhh-hHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 99999985 89998876 34789999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh------
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM------ 934 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~------ 934 (1003)
........ ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+. .......
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~ 228 (330)
T cd07834 152 GVDPDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSE 228 (330)
T ss_pred eecccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCCh
Confidence 76443210 0112234578899999998887 789999999999999999999999976532111 0000000
Q ss_pred -----hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHH
Q 001858 935 -----ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAAR 995 (1003)
Q Consensus 935 -----~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~~~ 995 (1003)
.......+.+...-...+.............+.+++.+||+.+|++||++++++++ ++..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00111111111100000000111122345678899999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=299.25 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=197.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|++|+||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 468899999999999999999998999999999864332 3346788999999999999999999985 456788
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEEccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGL 859 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~ 859 (1003)
++||||+++ ++.+++.... ....++..++.++.||+.|++|||++ +++||||+|+||+++. ++.+|++|||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 77 YLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred EEEEecccc-cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccc
Confidence 999999964 8888886533 23467888999999999999999999 9999999999999985 55799999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc-
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP- 937 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~- 937 (1003)
+....... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||......+...........+
T Consensus 150 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 150 ARAFGIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred ccccCCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 97543211 111223578899999987664 57889999999999999999999997543211111000000000
Q ss_pred hhH-------HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 938 EKV-------MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~-------~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.. .+.........+.............+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000000000000011112234567899999999999999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=295.87 Aligned_cols=244 Identities=21% Similarity=0.267 Sum_probs=187.8
Q ss_pred eeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHh---cCCCCceeEeeeeeecccCCCCceEEe
Q 001858 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKN---IRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.||+|+||.||+|.+..+++.||+|.+..... .....+.+|..+++. .+||+++++++++ ..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 48999999999999998899999998864321 122334455544443 3799999998884 445678999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|||+++++|.+++.. .+.+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++...
T Consensus 76 ~e~~~~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 76 LDLMNGGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999999999976 35689999999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
.... .....|+..|+|||...+ ..++.++||||+||++|||++|+.||......... ....
T Consensus 148 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----------~~~~ 209 (279)
T cd05633 148 SKKK-------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EIDR 209 (279)
T ss_pred cccC-------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----------HHHH
Confidence 3211 122468999999998764 56789999999999999999999999754322110 1111
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKNL 991 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~L 991 (1003)
.. .... ....+.....+.+++.+|++.+|++|| +++|+++|-
T Consensus 210 ~~---~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 210 MT---LTVN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred Hh---hcCC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 10 0011 111223456788899999999999999 699998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=320.22 Aligned_cols=277 Identities=19% Similarity=0.206 Sum_probs=191.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCC-ceEEEEEe--------------c---cccccchHHHHHHHHHHHhcCCCCc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDL-LPVAVKVI--------------N---LKQKGSIKSFVAECEALKNIRHRNL 762 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni 762 (1003)
..++|++.++||+|+||+||+|..+... ..+++|.+ . .........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999998764322 12222211 0 0111234568899999999999999
Q ss_pred eeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCC
Q 001858 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPS 842 (1003)
Q Consensus 763 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 842 (1003)
+++++++ ...+..++|+|++.+ ++.+++..............++..++.|++.||+|||++ +|+||||||+
T Consensus 226 v~l~~~~-----~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~ 296 (501)
T PHA03210 226 LKIEEIL-----RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296 (501)
T ss_pred CcEeEEE-----EECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 9999995 345677999999865 888887654333333445677889999999999999999 9999999999
Q ss_pred ceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCC-CCcc
Q 001858 843 NVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-THTM 921 (1003)
Q Consensus 843 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P-~~~~ 921 (1003)
|||++.++.+||+|||+++.+.... ........||..|+|||++.+..++.++||||+||++|||++|+.+ +...
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 9999999999999999998664321 1112235799999999999999999999999999999999998764 4322
Q ss_pred cCC-cchhhHHHH------hhCch---hHHHHHHhhccc-CCCCchhhHH--HHHHHHHHHHhhccccCCCCCCCHHHHH
Q 001858 922 FND-GLTLHGFVK------MALPE---KVMEIVDFALLL-DPGNERAKIE--ECLTAVVRIGVLCSMESPSERIHMADAV 988 (1003)
Q Consensus 922 ~~~-~~~~~~~~~------~~~~~---~~~~~i~~~l~~-~~~~~~~~~~--~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 988 (1003)
... ...+..... ...++ ...+.++..... .+........ .....+..++.+|++.||.+||++.|++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 111 111111111 01111 122222211111 1100001111 1234567778899999999999999998
Q ss_pred HH
Q 001858 989 KN 990 (1003)
Q Consensus 989 ~~ 990 (1003)
++
T Consensus 453 ~h 454 (501)
T PHA03210 453 AL 454 (501)
T ss_pred hC
Confidence 75
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=292.53 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=202.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 47889999999999999999988899999999975543 4567899999999999999999999985 3456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+++||+++++|.+++... ..+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+.
T Consensus 76 ~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred EEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccce
Confidence 999999999999999863 5789999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
....... ......++..|+|||...+..++.++||||+|+++|+|++|+.||...... . ...
T Consensus 148 ~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~---------~~~ 209 (254)
T cd06627 148 KLNDVSK-----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----A---------ALF 209 (254)
T ss_pred ecCCCcc-----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----H---------HHH
Confidence 6643221 122346889999999988888899999999999999999999998643210 0 000
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... ....+ .........+.+++.+|++.+|++||++.|++.+
T Consensus 210 ~~~---~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 210 RIV---QDDHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHh---ccCCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 111 00111 1112234677899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=290.65 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=205.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|++++++++|||++++++++... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47788999999999999999998899999999875542 4467899999999999999999999985321 126789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 78 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred EEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 999999999999999873 3789999999999999999999998 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
........ .......++..|+|||...+...+.++||||+|+++|+|++|+.||...... . ....
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---------~~~~ 214 (260)
T cd06606 150 RLGDIETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---M---------AALY 214 (260)
T ss_pred eccccccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H---------HHHH
Confidence 76433210 1122356889999999998888999999999999999999999998764310 0 0000
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.... ..............+.+++.+|++.+|++||++.|++++
T Consensus 215 ~~~~------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 KIGS------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred hccc------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1000 001111222335678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=298.89 Aligned_cols=273 Identities=26% Similarity=0.316 Sum_probs=200.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|++++++++|+|++++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4679999999999999999999998999999999874432 223456789999999999999999998532 22356
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++||||+++ +|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred EEEEEecCCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccce
Confidence 7999999975 899988764 25689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cc
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LP 937 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~ 937 (1003)
+....... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ......... .+
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~ 228 (309)
T cd07845 155 ARTYGLPA-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTP 228 (309)
T ss_pred eeecCCcc-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence 98654321 11122345788999998765 457899999999999999999999997543211 111100000 00
Q ss_pred -hhHHHHHHh-----hccc--CCCC-chhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 938 -EKVMEIVDF-----ALLL--DPGN-ERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 938 -~~~~~~i~~-----~l~~--~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
.......+. .... .+.. ...........+.+++.+|++.||++||++.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000000 0000 0000 0001112355678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=296.51 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=200.3
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++|||++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 677899999999999999999889999999998553 33456788999999999999999999986431 1367899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++ +|.+++... ...+++.+++.++.|+++|++|||+. +++|+||+|+||++++++.+|++|||.+..
T Consensus 78 v~e~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred Eeccccc-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceee
Confidence 9999985 899888753 24689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---Cch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---LPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~---~~~ 938 (1003)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......... .+.
T Consensus 150 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~ 224 (287)
T cd07840 150 YTKRNS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDE 224 (287)
T ss_pred ccCCCc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchh
Confidence 643221 11122356888999997665 457899999999999999999999987543211 111111100 000
Q ss_pred hHHHH----HHhhcccCCCCc---hhhHHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEI----VDFALLLDPGNE---RAKIEE-CLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~----i~~~l~~~~~~~---~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..... ............ ...... +...+.+++.+|++.+|++||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 000000000000 011112 25678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=298.91 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=196.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.|+..+.||+|+||.||+|++..++..||+|.+..... ...+.+.+|++++++++|||++++++++ .++...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCeE
Confidence 47778899999999999999988899999999864322 2345788999999999999999999985 345677
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||+.+ ++.+.+... ...+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++++|||++
T Consensus 101 ~lv~e~~~g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred EEEEeCCCC-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999975 888877653 34689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
..... .....|+..|+|||++. ++.++.++||||+||++|||++|+.||......
T Consensus 173 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------- 230 (317)
T cd06635 173 SIASP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------- 230 (317)
T ss_pred cccCC---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------------
Confidence 65422 11245888999999873 456889999999999999999999998653211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
........... + ..........+.+++.+|++.+|.+||++.+++++...
T Consensus 231 ~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 231 SALYHIAQNES---P---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHHHHhccC---C---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00111111111 1 01112334567899999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=291.48 Aligned_cols=251 Identities=23% Similarity=0.268 Sum_probs=204.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|++.++||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+++++.++||||+++.+++ .+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence 4788899999999999999999899999999987432 33456788999999999999999999884 4567889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~ 151 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK 151 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchh
Confidence 999999999999999774322 45689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
..... ......++..|+|||...+..++.++|+||+|+++|||++|+.||...... +..
T Consensus 152 ~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------------~~~ 210 (256)
T cd08530 152 VLKKN-------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------------DLR 210 (256)
T ss_pred hhccC-------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHH
Confidence 66432 111245788999999999989999999999999999999999998653211 111
Q ss_pred HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+. .... .+........+.+++.+|++.+|++||++.|++++
T Consensus 211 ~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQ---RGKY---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHh---cCCC---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111 1111 11122445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=281.59 Aligned_cols=273 Identities=23% Similarity=0.336 Sum_probs=220.8
Q ss_pred HHHHHhccCCccCeeeeccceEEEEEEECCCC-----ceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeee
Q 001858 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDL-----LPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCS 770 (1003)
Q Consensus 697 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 770 (1003)
++.....+++....+-+|.||+||.|.+.+.. +.|-+|.++.. ++-....+..|.-.+....|||+..+.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444456777788999999999999876432 34666666522 2334567889999999999999999999974
Q ss_pred ecccCCCCceEEeeecccCCCHHHHHhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 771 SIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ---VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 771 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
++....++++.++.-|+|..|++.++.. ....+...+...++.|++.|++|||++ +|||.||.++|+++|
T Consensus 358 ----e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 358 ----EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred ----eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 4667789999999999999999965422 234577888899999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcc
Q 001858 848 HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGL 926 (1003)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~ 926 (1003)
+.-++|++|=.+++.+.+.++..-+.. .-.+..||+||.+....|+.++||||||+++|||+| |+.|+...++
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDn---EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--- 504 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDN---ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--- 504 (563)
T ss_pred hheeEEeccchhccccCcccccccCCC---CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---
Confidence 999999999999999988766543332 235678999999999999999999999999999999 9999876542
Q ss_pred hhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhhhh
Q 001858 927 TLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 927 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~~~ 999 (1003)
.++...++.. .|...+-+|+++++.+|..||...|++||++++++..|.+++.+..
T Consensus 505 -----------fEm~~ylkdG------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 505 -----------FEMEHYLKDG------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred -----------HHHHHHHhcc------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 3344433322 2334445788999999999999999999999999999999987764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=298.61 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=197.5
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
..+||+|+||.||+|....+++.||||.+..........+.+|+.+++.++|+|++++++++ ...+..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence 36799999999999999989999999998755555567899999999999999999999985 4467889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 100 EGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 99999998754 3578999999999999999999999 99999999999999999999999999987543211
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
.......|+..|+|||...+..++.++|+||+|+++|+|++|+.||...... .....+...
T Consensus 171 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------------~~~~~~~~~ 231 (292)
T cd06657 171 -----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------KAMKMIRDN 231 (292)
T ss_pred -----ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHhh
Confidence 1122356889999999988888999999999999999999999998642211 011111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
... ...........+.+++.+|++.+|.+||++.+++++
T Consensus 232 ~~~----~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 232 LPP----KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCc----ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 110 001111234557788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=293.71 Aligned_cols=266 Identities=18% Similarity=0.267 Sum_probs=196.3
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.++||+|+||.||+|.+..+++.||+|+++... ........+|+.+++++. |||++++++++.. ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 677899999999999999999899999999987432 222334567888899885 9999999998643 12367899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++ ++.+++... ...+++.+++.++.|++.|++|||+. +++||||+|+||+++. +.+||+|||+++.
T Consensus 78 v~e~~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 78 VFELMDM-NLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EEecCCc-cHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccc
Confidence 9999975 888888763 24689999999999999999999999 9999999999999999 9999999999976
Q ss_pred cccCCccccCcccccccccccccCccccC-CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---Cch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGM-GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---LPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~---~~~ 938 (1003)
..... ......++..|+|||+.. ++.++.++||||+||++|||++|+.||......+ ........ .++
T Consensus 149 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~ 220 (282)
T cd07831 149 IYSKP------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDA 220 (282)
T ss_pred cccCC------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCH
Confidence 53321 111245788999999754 4567889999999999999999999997543211 11111111 111
Q ss_pred hHHHHHHhhcccC---CCC----chhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLD---PGN----ERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~---~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+........... +.. -.......+..+.+++.+|++++|++||+++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 1111111100000 000 011122446789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=291.46 Aligned_cols=244 Identities=27% Similarity=0.346 Sum_probs=195.6
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||.|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++ .++...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 689999999999999889999999986432 23456799999999999999999999984 4567789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++.+. ..+++.++..++.|+++|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 76 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 76 LGGELWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred CCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 999999999873 4588999999999999999999998 99999999999999999999999999997653321
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
......|+..|+|||...+..++.++|+||+|+++|+|++|+.||.....+.. +......+..
T Consensus 148 ------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~~ 210 (262)
T cd05572 148 ------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----------EIYNDILKGN 210 (262)
T ss_pred ------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----------HHHHHHhccC
Confidence 11234678899999998888899999999999999999999999976432100 0111111100
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 990 (1003)
. ...........+.+++.+||+.+|++||+ ++|++++
T Consensus 211 ~------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 211 G------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred C------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 0 01111122567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=305.96 Aligned_cols=276 Identities=21% Similarity=0.270 Sum_probs=200.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecc--------
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSID-------- 773 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 773 (1003)
..+|++.+.||+|+||+||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999999999999999987666666678899999999999999999988754321
Q ss_pred -cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCC
Q 001858 774 -FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMV 851 (1003)
Q Consensus 774 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~ 851 (1003)
..+....++|+||+++ +|.+++.. ..+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 1122457899999974 89888863 3588999999999999999999999 9999999999999984 567
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhH
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~ 930 (1003)
+|++|||.++....... .........++..|+|||.+.. ..++.++||||+||++|||++|+.||......+.. ..
T Consensus 154 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~ 230 (342)
T cd07854 154 LKIGDFGLARIVDPHYS--HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QL 230 (342)
T ss_pred EEECCcccceecCCccc--cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence 89999999976532111 1111122357889999997654 56788999999999999999999999754321110 00
Q ss_pred HHHh-hC--chhHHHH---HHhhcc-cCCCCc---hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 931 FVKM-AL--PEKVMEI---VDFALL-LDPGNE---RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 931 ~~~~-~~--~~~~~~~---i~~~l~-~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.... .. +.+.... ...... .....+ ..........+.+++.+|++.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00 0000000 000000 000001 11112344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=295.88 Aligned_cols=246 Identities=24% Similarity=0.298 Sum_probs=193.6
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||+||+|.+..+++.||+|.+.... ....+.+.+|+++++.++|||++++++++ ...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999899999999986432 22345678899999999999999999884 4567789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 76 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~- 148 (277)
T cd05577 76 NGGDLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG- 148 (277)
T ss_pred CCCcHHHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-
Confidence 9999999998643 24689999999999999999999999 9999999999999999999999999999765321
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
.......++..|+|||+..+..++.++||||+|+++|+|++|+.||........ . +.+.. .
T Consensus 149 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~---------~~~~~----~ 209 (277)
T cd05577 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K---------EELKR----R 209 (277)
T ss_pred -----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H---------HHHHh----c
Confidence 111234578899999999888899999999999999999999999965432100 0 01111 1
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
....+. .........+.+++.+||+.+|++|| ++.+++.+
T Consensus 210 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 210 TLEMAV---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccc---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 111110 11112355678999999999999999 77777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=301.08 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=200.9
Q ss_pred HHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCC
Q 001858 699 NKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 699 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 776 (1003)
..++++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++|||++++.+++. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~ 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----SP 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----cC
Confidence 34678899999999999999999999999999999987532 2233567889999999999999999999853 23
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++|+||+. ++|.++++. ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++++|
T Consensus 82 ~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 82 LEDIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred CCcEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCc
Confidence 456789999984 589888864 3578888899999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH--
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK-- 933 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~-- 933 (1003)
||.+...... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ ......
T Consensus 152 fg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~ 222 (328)
T cd07856 152 FGLARIQDPQ--------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLL 222 (328)
T ss_pred cccccccCCC--------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 9999753211 122457889999998765 5688999999999999999999999965432110 000000
Q ss_pred hhCchhHH---------HHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 934 MALPEKVM---------EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 ~~~~~~~~---------~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...++++. +.+.......+.............+.+++.+|++.+|++||++++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111 1111111111111111112234678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=302.99 Aligned_cols=275 Identities=22% Similarity=0.256 Sum_probs=200.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 778 (1003)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999998889999999986432 2234568899999999999999999998654321 2234
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++|+||+.. ++.++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 56899999965 7776642 3588999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh--h
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM--A 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~--~ 935 (1003)
+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........ .
T Consensus 163 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~ 233 (342)
T cd07879 163 LARHADA--------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGV 233 (342)
T ss_pred CCcCCCC--------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCC
Confidence 9875421 1123467889999998776 468899999999999999999999997532111 11110000 0
Q ss_pred CchhHHHHHH--------hhcccCCCCc-hhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HHHHHh
Q 001858 936 LPEKVMEIVD--------FALLLDPGNE-RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAARE 996 (1003)
Q Consensus 936 ~~~~~~~~i~--------~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~~~~ 996 (1003)
..+...+... ......+... ..........+.+++.+|++.+|++||+++|++++ ++..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0011111000 0000000000 01111234567899999999999999999999976 555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=278.25 Aligned_cols=202 Identities=27% Similarity=0.385 Sum_probs=178.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.++|+..++||+|.||.|.+++.+.+++.+|+|+++++- ..+...-..|-++++..+||.+..+--. |...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 467889999999999999999999999999999998543 3445667789999999999998876543 77888
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..+.||||+.||.|.-++++ ...+++...+-+..+|..|+.|||++ +||+||+|.+|.++|.+|++||+|||
T Consensus 242 rlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred eEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 99999999999999999987 45788888888999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
+++.-. ........++||+.|.|||++....|+.++|.|.+||++|||++|+.||-..
T Consensus 314 LCKE~I-----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 314 LCKEEI-----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cchhcc-----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 997431 2233445689999999999999999999999999999999999999999654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=296.63 Aligned_cols=278 Identities=21% Similarity=0.297 Sum_probs=202.2
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecc----
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID---- 773 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 773 (1003)
...++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999999889999999987443 233457788999999999999999999875422
Q ss_pred -cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 774 -FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 774 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
..+....++|+||+++ ++.+++... ...+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 1234478999999986 777777653 34689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+...
T Consensus 156 kl~dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~ 230 (302)
T cd07864 156 KLADFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELI 230 (302)
T ss_pred EeCcccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Confidence 9999999976543221 11122346788999998765 35688999999999999999999998643211 001000
Q ss_pred HH---hhCchhHHHHHHhhc----ccCCC---CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 932 VK---MALPEKVMEIVDFAL----LLDPG---NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ~~---~~~~~~~~~~i~~~l----~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.. ...+.....+..... ..... ..+......+..+.+++.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000000000000000 00000 0011112245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=318.57 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=192.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc-cccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-------
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSID------- 773 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 773 (1003)
..+|+..+.||+||||.||+++.+-+|+.||||++... +......+.+|++.+++++|||||+++....+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45788889999999999999999999999999999754 3344567889999999999999999984221000
Q ss_pred ------------------------------------------------------------------------------cC
Q 001858 774 ------------------------------------------------------------------------------FK 775 (1003)
Q Consensus 774 ------------------------------------------------------------------------------~~ 775 (1003)
..
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00
Q ss_pred ---------------------CC--------CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001858 776 ---------------------GD--------DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826 (1003)
Q Consensus 776 ---------------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 826 (1003)
.+ ...|+-||||+..++.++++.... .-.....|+++++|++|++|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~----~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF----NSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc----chhhHHHHHHHHHHHHHHHHH
Confidence 00 236788999999888888876421 114677899999999999999
Q ss_pred HhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc------c---C----CccccCcccccccccccccCccccCCC
Q 001858 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF------D---R----PIQETSSSSIGIKGTVGYVAPEYGMGG 893 (1003)
Q Consensus 827 H~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~------~---~----~~~~~~~~~~~~~gt~~y~aPE~~~~~ 893 (1003)
|+. |||||||||.||++++++.|||+|||+|+... + . .........+..+||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998722 0 0 011122244567899999999998765
Q ss_pred ---CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHH
Q 001858 894 ---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIG 970 (1003)
Q Consensus 894 ---~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~ 970 (1003)
.|+.|+|+||+|||++||+. ||.+....-. .+..+.+.. -|.+ .....+....-.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~------------iL~~LR~g~---iP~~-~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS------------ILTNLRKGS---IPEP-ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH------------HHHhcccCC---CCCC-cccccccchHHHHHH
Confidence 49999999999999999996 5654221000 011111111 1111 111112233346889
Q ss_pred hhccccCCCCCCCHHHHHH
Q 001858 971 VLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 971 ~~cl~~~p~~RPs~~ev~~ 989 (1003)
+++++.||++|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=321.50 Aligned_cols=265 Identities=28% Similarity=0.468 Sum_probs=210.9
Q ss_pred hccCCccCeeeeccceEEEEEEECC-------CCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeec
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGE-------DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 772 (1003)
.++..+.+.+|+|+||.|++|.... ....||||.++... ..+.+.+..|+++++.+ +||||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 3445667799999999999998631 14579999987433 34568899999999999 69999999999854
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCC
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSN---------DQVDG--NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 841 (1003)
++..++|+||+..|+|.++++..+ ..... .+...+.+.++.|||.|++||++. ++||||+.+
T Consensus 374 ----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 374 ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred ----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 677899999999999999999877 11111 389999999999999999999999 999999999
Q ss_pred CceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCc
Q 001858 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920 (1003)
Q Consensus 842 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~ 920 (1003)
+|||++.+..+||+|||+|+...+........... . =+..|||||.+....|+.++||||||+++|||++ |..||.+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~-~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAG-T-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCC-c-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999998765443332111100 0 2456999999999999999999999999999999 9999865
Q ss_pred ccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
... .+++.+.+. .+.+...++.|..+++.+|+.||+.+|++||++.|+++.+....
T Consensus 525 ~~~-------------~~~l~~~l~------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPP-------------TEELLEFLK------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCc-------------HHHHHHHHh------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 321 122222222 22333445567889999999999999999999999999998853
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=290.65 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=187.7
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHH-HhcCCCCceeEeeeeeecccCCCCceEEee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEAL-KNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.||+|+||.||+|.+..+++.||+|+++.... .....+..|..++ ...+|||++++++++ ..++..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 579999999999999988899999999864332 1223445555544 445899999999985 4466789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 864 (1003)
||+++++|.++++. .+.+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++....
T Consensus 77 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999999976 34688999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
. .....|+..|+|||...+..++.++||||+|+++|||++|..||...... ...+.+
T Consensus 149 ~---------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~ 205 (260)
T cd05611 149 E---------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------------AVFDNI 205 (260)
T ss_pred c---------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------------HHHHHH
Confidence 1 12345888999999988888899999999999999999999998643211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH---HHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM---ADAVKN 990 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~---~ev~~~ 990 (1003)
... ...........+...+.+++.+|++.+|++||++ +|++.+
T Consensus 206 ~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 206 LSR---RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred Hhc---ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 111 1000111112345678999999999999999966 455544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=293.62 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=203.0
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.+.||+|++|.||+|.+..+++.+|+|.++.... .....+.+|++++++++|||++++++++ ..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 6678899999999999999988899999999874432 2456788999999999999999999984 45678899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++ ++.+++... ...+++.+++.++.|++.|++|||+. +|+|+||+|+||+++.++.++++|||.+..
T Consensus 76 v~e~~~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred EEeccCC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 9999976 898888764 24689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hCch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---ALPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~~~ 938 (1003)
..... .......++..|+|||...+. .++.++|+||+|+++|+|++|+.||......+. ....... ..+.
T Consensus 148 ~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (283)
T cd05118 148 FGSPV-----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPE 221 (283)
T ss_pred cCCCc-----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchH
Confidence 64322 111224578899999998776 788999999999999999999999865432111 0000000 0001
Q ss_pred hHHHHH---Hhhc----ccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIV---DFAL----LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i---~~~l----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...... .... ...........+.....+.+++.+||+++|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 001100 1110 011111122234466789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=299.86 Aligned_cols=274 Identities=20% Similarity=0.254 Sum_probs=199.4
Q ss_pred cCCccCeeeeccceEEEEEEECCC--CceEEEEEecccc--ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGED--LLPVAVKVINLKQ--KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|++.+.||+|+||.||+|++..+ +..||+|.+.... ....+.+.+|+++++++ .||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 8899999986432 22356788999999999 599999999875432 12345
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++++||++ ++|.+++.. ...+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 6788999986 589999875 35689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh--h
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM--A 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~--~ 935 (1003)
.++........ .........||..|+|||+..+ ..++.++|+||+||++|+|++|+.||....... ........ .
T Consensus 151 ~a~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 228 (332)
T cd07857 151 LARGFSENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGT 228 (332)
T ss_pred Cceeccccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCC
Confidence 99865432211 1111223568999999998765 468899999999999999999999987533211 11110000 0
Q ss_pred Cchh-HH--------HHHHhhcccCCCCch-hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEK-VM--------EIVDFALLLDPGNER-AKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~-~~--------~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+++ .. ..... ....+.... .........+.+++.+|++.+|++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0011 11 11110 111111111 1111234578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.38 Aligned_cols=265 Identities=21% Similarity=0.233 Sum_probs=191.5
Q ss_pred cceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCH
Q 001858 715 SFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSL 792 (1003)
Q Consensus 715 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 792 (1003)
++|.||.++...+++.||+|+++.. .....+.+.+|+++++.++||||+++++++ .+.+..+++|||+++|+|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence 4456666666668899999998754 334567899999999999999999999984 456778999999999999
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCcc--c
Q 001858 793 EDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ--E 870 (1003)
Q Consensus 793 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 870 (1003)
.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.+......... .
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99998753 34588999999999999999999999 9999999999999999999999999998765432211 1
Q ss_pred cCcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHH----HHH
Q 001858 871 TSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM----EIV 944 (1003)
Q Consensus 871 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----~~i 944 (1003)
.........++..|+|||++... .++.++||||+||++|||++|+.||........... ......+.... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCccccccCchhhh
Confidence 11112234578899999998663 578899999999999999999999976432211111 11100000000 000
Q ss_pred Hhhcc------cCC----CCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 945 DFALL------LDP----GNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 945 ~~~l~------~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..... ..+ ............++.+++.+||+.+|++||++++++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00000 000 000111223456788999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-34 Score=277.41 Aligned_cols=253 Identities=25% Similarity=0.289 Sum_probs=197.1
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEeee
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
...||.|+||+|++-.++.+|+..|||+++.... .+.+++..|.+...+- +.||||+++|.+ |. ++..+++||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~----F~-EGdcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL----FS-EGDCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh----hc-CCceeeeHH
Confidence 4679999999999999999999999999985443 5567899998866555 799999999985 33 556689999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 865 (1003)
.|+- |+..+.+.--.-....+++.-.-+|..-...|+.||.+.. .|||||+||+|||++..|.+|+||||++..+.+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9976 8777654432222457888888888889999999998875 899999999999999999999999999976643
Q ss_pred CCccccCcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHH
Q 001858 866 RPIQETSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 866 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
+ ......+|...|||||.+... .|+.+|||||+|+++||+.||+.||....+ +.+-
T Consensus 221 S------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------------vfeq 278 (361)
T KOG1006|consen 221 S------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------------VFEQ 278 (361)
T ss_pred H------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------------HHHH
Confidence 2 222235688999999998653 488999999999999999999999875321 2222
Q ss_pred HHhhcccCCCCchhhH--HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 944 VDFALLLDPGNERAKI--EECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 944 i~~~l~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+..-...+|..-.... -+....+.+++.-|+..+-++||...++.++
T Consensus 279 l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3333334443222111 1356678999999999999999999998763
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=303.07 Aligned_cols=211 Identities=31% Similarity=0.418 Sum_probs=178.4
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhcCCCCceeEeeeeeecc-cCCCCce
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGDDFK 780 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 780 (1003)
..|...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|++++++++|||||+++++-.... ....+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34667789999999999999999999999999997543 344678899999999999999999999732211 1113456
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC--CCC--CeEEcc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDM--VAHVSD 856 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~D 856 (1003)
.+|||||.+|+|...+++... ...+++.+.+.+..+++.|+.|||++ +|+||||||.||++- ++| ..||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 899999999999999988654 45799999999999999999999999 999999999999994 444 369999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCC
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~ 924 (1003)
||+|+.+.+.. ....++||..|.+||.... +.|+..+|.|||||++|+.+||..||......
T Consensus 168 fG~Arel~d~s------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 168 FGAARELDDNS------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccccCCCCC------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99999875533 4456889999999999884 78899999999999999999999999876544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=299.76 Aligned_cols=271 Identities=21% Similarity=0.235 Sum_probs=200.4
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 777 (1003)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999899999999986332 2234578899999999999999999998643211 112
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++||||+ +++|.+++.. ..+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.++++||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 3468999999 6699988864 3588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh--
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM-- 934 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~-- 934 (1003)
|++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||....... ........
T Consensus 163 g~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~ 233 (343)
T cd07880 163 GLARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTG 233 (343)
T ss_pred ccccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 999754221 123457889999998776 457889999999999999999999997543211 11111110
Q ss_pred hCchh---------HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 935 ALPEK---------VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~~~~~---------~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..+.. ............+.......+.+...+.+++.+|+..+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111 111111111111111111112345568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=298.45 Aligned_cols=277 Identities=22% Similarity=0.251 Sum_probs=203.2
Q ss_pred HHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecc
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID 773 (1003)
Q Consensus 696 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 773 (1003)
.++...+++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344556789999999999999999999998899999999986432 223467888999999999999999999865322
Q ss_pred -cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 774 -FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 774 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
+......+++++++ +++|.++++. ..+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 22334567888887 6799888764 3588999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHH
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~ 931 (1003)
||+|||+++.... ......++..|+|||...+ ..++.++||||+||++|||++|+.||....... .....
T Consensus 160 kl~dfg~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~ 230 (345)
T cd07877 160 KILDFGLARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLI 230 (345)
T ss_pred EEecccccccccc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 9999999975422 1123467889999998766 467889999999999999999999986532211 11111
Q ss_pred HHh----------hCchhHHHHHHhhcccCCCCchh-hHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 932 VKM----------ALPEKVMEIVDFALLLDPGNERA-KIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 932 ~~~----------~~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
... .++..........+...+..... ........+.+++.+|++.+|.+||++.+++++=
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 110 01111011111111111111100 0011245678999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=296.35 Aligned_cols=280 Identities=22% Similarity=0.303 Sum_probs=200.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc--cchHHHHHHHHHHHhcCCCCceeEeeeeeeccc---CC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDF---KG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 776 (1003)
.++|++.++||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999998999999999864332 223567889999999999999999987543221 22
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++|+||+++ ++.+.+... ...+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.++++|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 4467899999976 777777643 34689999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCcccc------CcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhh
Q 001858 857 FGLAKFLFDRPIQET------SSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH 929 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~ 929 (1003)
||+++.......... ........+++.|+|||...+. .++.++||||+||++|||++|+.||........ ..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~ 237 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LH 237 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HH
Confidence 999976543221111 1111234578899999987654 578999999999999999999999875332111 11
Q ss_pred HHHHh---hCchhHHHHHH-------hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 930 GFVKM---ALPEKVMEIVD-------FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 930 ~~~~~---~~~~~~~~~i~-------~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..... ..+..+..... ......+.............+.+++.+|++.+|++||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 10000 00000000000 000000100011112233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=289.69 Aligned_cols=196 Identities=27% Similarity=0.430 Sum_probs=170.7
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeee
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
.++||.|.||+||-|+++.+|+.||||++.+.. ......+.+|+.|++.++||.||.+... ++..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 478999999999999999999999999997432 2334788999999999999999999988 567888999999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC---CCeEEcccccccc
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVSDFGLAKF 862 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~DfG~a~~ 862 (1003)
.+.| +..+.|-... .+.+++....-+..||+.|+.|||.+ +|+|+|+||+|||+... -++||||||+|++
T Consensus 644 Kl~G-DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred hhcc-hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9966 6656554433 67899999999999999999999999 99999999999999653 3799999999998
Q ss_pred cccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
+... ...+.++||+.|.|||++..+.|...-|+||.|||+|--++|..||...
T Consensus 717 IgEk------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 717 IGEK------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred cchh------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 7543 3445689999999999999999999999999999999999999999753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.61 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=203.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCC
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 778 (1003)
++|.+.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++ ||||++++++ +.+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence 46889999999999999999999899999999987432 233467889999999998 9999999988 45677
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+++++|.+++.+ .+.+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 88999999999999999987 34799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCcccc---------------CcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccC
Q 001858 859 LAKFLFDRPIQET---------------SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 859 ~a~~~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~ 923 (1003)
++........... ........++..|+|||...+..++.++||||+|++++++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9986643221100 1222345678999999998888899999999999999999999999875321
Q ss_pred CcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH----HHHHHH
Q 001858 924 DGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM----ADAVKN 990 (1003)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~~ 990 (1003)
. ........ ..... .......+.+++.+|++.+|++||++ +|++++
T Consensus 228 ~-------------~~~~~~~~-~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 Y-------------LTFQKILK-LEYSF-------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H-------------HHHHHHHh-cCCCC-------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 00111111 11111 11225568899999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=299.49 Aligned_cols=274 Identities=20% Similarity=0.274 Sum_probs=197.9
Q ss_pred ccCC-ccCeeeeccceEEEEEEECCCCceEEEEEeccccccc--------------hHHHHHHHHHHHhcCCCCceeEee
Q 001858 703 NEFS-LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--------------IKSFVAECEALKNIRHRNLIKIIT 767 (1003)
Q Consensus 703 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 767 (1003)
++|. +.+.||+|+||+||+|.+..+++.||+|+++...... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999999899999999986432211 125788999999999999999999
Q ss_pred eeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 768 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
++ ..++..++||||++ |+|.+++.. ...+++..+..++.|++.|++|||+. +++||||+|+||+++
T Consensus 88 ~~-----~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~ 153 (335)
T PTZ00024 88 VY-----VEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFIN 153 (335)
T ss_pred EE-----ecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEEC
Confidence 85 45667899999997 599999875 34689999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccccCCcc---------ccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCC
Q 001858 848 HDMVAHVSDFGLAKFLFDRPIQ---------ETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRP 917 (1003)
Q Consensus 848 ~~~~~kl~DfG~a~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P 917 (1003)
.++.++++|||.+......... ..........++..|+|||.+.+. .++.++||||+||++|||++|+.|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999765421110 011111223468899999998764 468899999999999999999999
Q ss_pred CCcccCCcchhhHHHHhh---CchhHHHHHH-----hhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 918 THTMFNDGLTLHGFVKMA---LPEKVMEIVD-----FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~---~~~~~~~~i~-----~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
|......+. +....... ....+..... ......+.............+.+++.+|++.+|++||+++|++.
T Consensus 234 ~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 975432211 11000000 0000000000 00000000001111223466889999999999999999999997
Q ss_pred HH
Q 001858 990 NL 991 (1003)
Q Consensus 990 ~L 991 (1003)
+-
T Consensus 313 ~~ 314 (335)
T PTZ00024 313 HE 314 (335)
T ss_pred Cc
Confidence 53
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=289.13 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=186.7
Q ss_pred eeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHH---HHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEA---LKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.||+|+||.||+|.+..+++.||+|.+..... .....+..|..+ ++...||+++++.+++ .+.+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 48999999999999988899999999864321 112234444443 4445799999999884 456778999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|||+.+++|.+++.. .+.+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 76 LDLMNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 999999999999875 35699999999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
.... .....|+..|+|||...++ .++.++||||+|+++|||++|+.||......... ....
T Consensus 148 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----------~~~~ 209 (278)
T cd05606 148 SKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EIDR 209 (278)
T ss_pred CccC-------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----------HHHH
Confidence 3211 1124689999999998754 6889999999999999999999999764321110 0111
Q ss_pred HHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 943 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
... ...+ .........+.+++.+|+..+|++|| ++.|++++
T Consensus 210 ~~~---~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 210 MTL---TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred Hhh---ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 110 1111 01112346788889999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=300.90 Aligned_cols=271 Identities=21% Similarity=0.259 Sum_probs=200.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGD 777 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 777 (1003)
..++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+.+|+.++++++|||++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467899999999999999999999989999999998643 22234667889999999999999999887432211 222
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...++|+||+ +++|.+++.. ..+++.+++.++.|+++|++|||+. +|+||||||+||+++.++.++|+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 3479999999 5699999874 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH---
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK--- 933 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~--- 933 (1003)
|++...... .....++..|+|||...+ ..++.++||||+||++|||++|+.||......+ .+.....
T Consensus 163 g~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~ 233 (343)
T cd07851 163 GLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVG 233 (343)
T ss_pred ccccccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcC
Confidence 999754221 123457889999998765 367889999999999999999999997543211 0110000
Q ss_pred --------hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 934 --------MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 --------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....+.....+.....................+.+++.+|++.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000111111111111111101011111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=288.45 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=193.4
Q ss_pred eeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++|||++++++. +..+...++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence 6899999999999998899999999864433 345678999999999999999999887 35577789999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++.+. +.+++..++.++.|+++|++|||+. +++||||+|+||+++.++.++++|||++.......
T Consensus 76 ~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 76 PGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 999999999873 4689999999999999999999999 99999999999999999999999999987543221
Q ss_pred cc---ccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHH
Q 001858 868 IQ---ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944 (1003)
Q Consensus 868 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i 944 (1003)
.. ..........++..|+|||...+...+.++||||+|+++|++++|+.||...... .....+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------------~~~~~~ 213 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------------EIFQNI 213 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Confidence 10 0011222355788999999998888999999999999999999999998653211 111111
Q ss_pred HhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 945 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
.. ... ..+........+.+++.+|++.+|++||++.++.+
T Consensus 214 ~~---~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 214 LN---GKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred hc---CCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 11 100 00111112567889999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=292.89 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=196.7
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+.|+..+.||+|+||.||+|++..++..||+|.+... .....+++.+|+++++.++|+|++++.+++. ....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCe
Confidence 4577788999999999999999888999999998632 2233457889999999999999999999853 4567
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
.++|+||+. |++.+.+... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||+
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence 799999997 5888877653 34588999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhC
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~ 936 (1003)
+...... ....|+..|+|||.+. ...++.++||||+||++|+|++|+.||......+
T Consensus 162 ~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------- 221 (308)
T cd06634 162 ASIMAPA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------- 221 (308)
T ss_pred ceeecCc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----------
Confidence 8754221 1245788999999864 3567889999999999999999999986532110
Q ss_pred chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHH
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 937 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~ 994 (1003)
....... ...+... .......+.+++.+||+.+|++||++.+++++-...
T Consensus 222 --~~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 222 --ALYHIAQ---NESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred --HHHHHhh---cCCCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0011111 0111100 112345678999999999999999999999875533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=291.75 Aligned_cols=245 Identities=26% Similarity=0.343 Sum_probs=193.0
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
|...+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++|||++++++++ .+....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCEEE
Confidence 6667889999999999999988999999999864332 2345788999999999999999999985 3456789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||+. |++.+++... ...+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 98 lv~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEecCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9999996 4888887653 34689999999999999999999999 99999999999999999999999999886
Q ss_pred ccccCCccccCcccccccccccccCccccC---CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGM---GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.... .....|+..|+|||++. +..++.++||||+||++|||++|+.||.......
T Consensus 170 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------------- 227 (313)
T cd06633 170 KSSP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------------- 227 (313)
T ss_pred ccCC---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------------
Confidence 4211 11346889999999874 4568889999999999999999999986532110
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
....... ...+... .......+.+++.+|++.+|.+||++.+++++
T Consensus 228 ~~~~~~~---~~~~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 228 ALYHIAQ---NDSPTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHh---cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 1111111 11223457889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=288.03 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=196.8
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
+|.+.++||+|+||.||+|++...+..+++|+.+... ......+..|+.+++.++|||++++++++ .+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence 5888999999999999999998776667777765321 22334677899999999999999999884 4566
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++|+||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++|+|++|+||+++. +.++++|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence 789999999999999999764322 45789999999999999999999999 9999999999999975 579999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.+....... .......|+..|+|||...+..++.++|+||+|+++|+|++|..||.....
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------------- 210 (260)
T cd08222 151 VSRLLMGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------------- 210 (260)
T ss_pred ceeecCCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------
Confidence 997653321 112234578899999998888889999999999999999999999854210
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
............ ......+...+.+++.+||+.+|++||++.|++++
T Consensus 211 --~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 211 --LSVVLRIVEGPT---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HHHHHHHHcCCC---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 001111111111 11122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=291.86 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=195.0
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ....+.+..|+.++.+. .||||+++++++ .++..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecCCe
Confidence 467889999999999999999999889999999997443 23345667788777777 499999999985 34667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
.++||||+++ ++.+++... ...+++.++..++.|++.|++|||+ . +|+||||+|+||+++.++.+||+|||
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELMST-CLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeeccCc-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccc
Confidence 8999999865 788777653 3478999999999999999999997 5 89999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCC----CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN----VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
++..+..... .....++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||.......
T Consensus 161 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------- 225 (296)
T cd06618 161 ISGRLVDSKA------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--------- 225 (296)
T ss_pred cchhccCCCc------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---------
Confidence 9976533211 11234788999999987554 7889999999999999999999986432110
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
+.......... + ..+....+..++.+++.+||+.+|++||++.+++++-
T Consensus 226 ---~~~~~~~~~~~---~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 226 ---EVLTKILQEEP---P--SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---HHHHHHhcCCC---C--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00111111110 0 0001112345688999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=286.61 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=197.4
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.+.||+|++|+||+|+...+++.||||.+..... .......+|+..+++++ |||++++++++ .+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence 6778999999999999999988889999999864432 22334567999999998 99999999984 44778899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||||+ +|+|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 76 v~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred EEecC-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 99999 779999987743 34689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccC-CCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH---hhCch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGM-GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK---MALPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~---~~~~~ 938 (1003)
..... ......++..|+|||+.. +..++.++|+||||+++|||++|+.||......+. ...... ....+
T Consensus 149 ~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (283)
T cd07830 149 IRSRP------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQ 221 (283)
T ss_pred ccCCC------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChh
Confidence 53321 112345788999999874 45578999999999999999999999865432111 110000 00011
Q ss_pred hHHHHH------HhhcccCC-CCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIV------DFALLLDP-GNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i------~~~l~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
...+.. ........ .......+.....+.+++++||+.+|++||+++|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 010000 00000000 00011111224678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=284.23 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=199.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--c-----cchHHHHHHHHHHHhcCCCCceeEeeeeeeccc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--K-----GSIKSFVAECEALKNIRHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 774 (1003)
.++|-+.+.||+|+|++||+|.+-...+.||||+-.... . ...+...+|.+|.+.+.||.||++++++.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---- 537 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---- 537 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----
Confidence 356888899999999999999999888999999875321 1 12456788999999999999999999974
Q ss_pred CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC---CCCC
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMV 851 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~ 851 (1003)
.+.+..+-|+||++|.+|+-|++. ...+++.+++.|++||+.|+.||.+. .++|||-|+||.|||+- ..|.
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eccccceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence 356677899999999999999998 45789999999999999999999997 67899999999999995 3578
Q ss_pred eEEcccccccccccCCccccCc--ccccccccccccCccccCCC----CCCccccchhHHHHHHHHHhCCCCCCcccCCc
Q 001858 852 AHVSDFGLAKFLFDRPIQETSS--SSIGIKGTVGYVAPEYGMGG----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG 925 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~ 925 (1003)
+||+|||+++++.+..+..... -.....||.+|++||.+--+ +++.|+||||+|||+|+.+.|+.||.......
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 9999999999987655432211 12346799999999976533 57889999999999999999999998643221
Q ss_pred chhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
..+. + ..+-++........ +....+...++++|+.+--++|....++..
T Consensus 692 dILq--------e---NTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQ--------E---NTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHh--------h---hchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1110 0 00111111111111 122344566777888888888877777654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=288.63 Aligned_cols=267 Identities=25% Similarity=0.349 Sum_probs=200.6
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|++++++++|||++++++++ .+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 567789999999999999999889999999997553 33456788999999999999999999984 44578899
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
|+||+++ +|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||.+..
T Consensus 76 v~e~~~~-~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 76 VFEYCDM-DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred EecCcCc-CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999985 9999998742 4689999999999999999999999 999999999999999999999999999976
Q ss_pred cccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh---hCch
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---ALPE 938 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~---~~~~ 938 (1003)
...... ......++..|+|||.+.+. .++.++||||+||++|||++|+.||......+. ....... ..+.
T Consensus 148 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (282)
T cd07829 148 FGIPLR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEE 221 (282)
T ss_pred cCCCcc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHH
Confidence 532211 11223467789999998776 789999999999999999999999865432111 0000000 0001
Q ss_pred hHHHHHHh-----hcccC-CCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDF-----ALLLD-PGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~-----~l~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+....+. ..... ..............+.+++.+|+..+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 11111000 00000 000011122235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=298.54 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=223.1
Q ss_pred HHHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecc
Q 001858 695 YAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 695 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 773 (1003)
++.+...++-|++.+.||+|.+|.||+++...+++.+|+|+.....+. .+++..|+++++.. .|||++.++|++...+
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 344445567899999999999999999999999999999998755443 36677899999998 7999999999998877
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeE
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~k 853 (1003)
-..++..++|||||.+||..|+++.-. +..+.|..+..|++.++.|+.|||.. .++|||||-.|||++.++.+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 788899999999999999999999866 67899999999999999999999999 999999999999999999999
Q ss_pred EcccccccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchh
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928 (1003)
Q Consensus 854 l~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~ 928 (1003)
++|||.+..+.. +.......+||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.++.+-
T Consensus 164 LvDFGvSaQlds-----T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---- 234 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-----TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---- 234 (953)
T ss_pred Eeeeeeeeeeec-----ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----
Confidence 999999976532 2333445789999999998754 35678899999999999999999998876431
Q ss_pred hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 929 HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..++. +..+|.+....++....+|.+++..|+..+.++||++.++++|
T Consensus 235 ------------raLF~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ------------RALFL--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------------hhhcc--CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 2234444445566778899999999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-33 Score=269.33 Aligned_cols=282 Identities=21% Similarity=0.318 Sum_probs=208.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecc--ccccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc---CC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF---KG 776 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 776 (1003)
.+.|+...+||+|.||+||+|+.+.+++.||+|++-. +.++......+|++++..++|+|++.++++|....- .+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3567777899999999999999999999999987643 345556778899999999999999999999976432 23
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
....++||++++. +|.-.+... ...++..++.+++.++..|+.|+|+. .|+|||+||.|+|++.+|.+||+|
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 4457999999998 898888764 35688999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcc-hhhHHH--
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL-TLHGFV-- 932 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~-~~~~~~-- 932 (1003)
||+++.+..+... ....+...+.|.+|.+||.+.|. .++++.|||+.|||+.||++|.+-+++...... .+....
T Consensus 168 FGlar~fs~~~n~-~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 168 FGLARAFSTSKNV-VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred cccccceeccccc-CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999876543322 22234456679999999988774 689999999999999999999988876433211 110000
Q ss_pred ---HhhCchhHHHHHHhhcccC--CCCchhhHHHHHH------HHHHHHhhccccCCCCCCCHHHHHHHHH
Q 001858 933 ---KMALPEKVMEIVDFALLLD--PGNERAKIEECLT------AVVRIGVLCSMESPSERIHMADAVKNLC 992 (1003)
Q Consensus 933 ---~~~~~~~~~~~i~~~l~~~--~~~~~~~~~~~~~------~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 992 (1003)
+...|.-..--.-..+... |.......++... ...+++.+.+..||.+|+.+.+++.|-.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 0011111000011111111 1111122222222 5667888889999999999999987753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=288.52 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=194.9
Q ss_pred cCCccCeeeeccceEEEEEEEC---CCCceEEEEEecccc----ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQ----KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (1003)
+|++.+.||+|+||.||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||+++++++. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 4778899999999999999864 356789999986432 22346788999999999 69999999987 44
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 855 (1003)
.+...++||||+++++|.+++.. ...+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence 56778999999999999999876 34688999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCCC--CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN--VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
|||+++....... .......|+..|+|||...+.. .+.++||||+|+++|||++|+.||...... ...
T Consensus 148 dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~----- 217 (288)
T cd05583 148 DFGLSKEFLAEEE----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQ----- 217 (288)
T ss_pred ECccccccccccc----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chH-----
Confidence 9999876533211 1112345889999999987665 688999999999999999999998642111 000
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
... ........+.. .......+.+++.+||+.+|++|||++++.+.+
T Consensus 218 ----~~~---~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 218 ----SEI---SRRILKSKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred ----HHH---HHHHHccCCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 111 11111111111 112345678899999999999999987775544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.38 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=195.0
Q ss_pred cCCccCeeeeccceEEEEEEEC---CCCceEEEEEecccc----ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLG---EDLLPVAVKVINLKQ----KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (1003)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|+++++++ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 367899999986432 22346788899999999 599999998874 4
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 855 (1003)
.+...++|+||+++++|.+++.. ...+++..+..++.|+++|++|||+. +++||||+|+||+++.++.+||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEe
Confidence 56678999999999999999986 34678899999999999999999999 99999999999999999999999
Q ss_pred ccccccccccCCccccCcccccccccccccCccccCCC--CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHH
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~ 933 (1003)
|||++......... ......|+..|+|||...+. .++.++||||+|+++|+|++|+.||...... .
T Consensus 148 dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~------- 215 (290)
T cd05613 148 DFGLSKEFHEDEVE----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-N------- 215 (290)
T ss_pred eCccceeccccccc----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-c-------
Confidence 99999765332111 11234588999999997753 4678899999999999999999998632111 0
Q ss_pred hhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 990 (1003)
...+..+......+. ....+...+..++.+|++.+|++|| ++.++..+
T Consensus 216 -----~~~~~~~~~~~~~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 216 -----SQAEISRRILKSEPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----cHHHHHHHhhccCCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011111111111111 1112345678999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.87 Aligned_cols=201 Identities=24% Similarity=0.410 Sum_probs=172.3
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
+|...++||+|.||+||+|+..++.+.||+|..+..+ ++......+|+-+++.++|.|||+++++ .+.+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 4666789999999999999999999999999987543 4456788999999999999999999998 56678889
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+|+||++. +|..+.... .+.++...++.++.|+++|+.++|++ .+.|||+||+|.++..+|..|++|||+++
T Consensus 78 lvfe~cdq-dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred EeHHHhhH-HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhh
Confidence 99999976 888888764 57899999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCccccCcccccccccccccCccccCCCC-CCccccchhHHHHHHHHHh-CCCCCCccc
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFT-GRRPTHTMF 922 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~ell~-g~~P~~~~~ 922 (1003)
-+.-. .......+.|.+|.+|+++.+.+ |+...|+||.||++.|+.. |++-|.+.+
T Consensus 150 afgip-----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 150 AFGIP-----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred hcCCc-----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 76322 11222345799999999998864 7888999999999999998 666566543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=311.76 Aligned_cols=208 Identities=26% Similarity=0.360 Sum_probs=179.9
Q ss_pred HHHHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeec
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSI 772 (1003)
Q Consensus 696 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 772 (1003)
.++.-..++|++.++||+|+||+|..++++.+++.||+|++.+. .......|..|-.+|.--+.+=|+++.-.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---- 143 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---- 143 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence 33444567899999999999999999999999999999999753 34556788889999988888888887654
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
|.++.+.|+|||||+||+|-.++.+. +++++..++-++..|+-||.-+|+. |+|||||||+|||+|..|++
T Consensus 144 -FQD~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 144 -FQDERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred -hcCccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence 78999999999999999999999984 3799999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccccCCccccCcccccccccccccCccccCC-----CCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 853 HVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-----GNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 853 kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
|++|||.+-.+...+ .......+|||-|.+||++.. +.|++.+|.||+||++|||+.|..||-.
T Consensus 215 kLADFGsClkm~~dG----~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADG----TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred eeccchhHHhcCCCC----cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999999997765322 122234689999999998653 5789999999999999999999999853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=316.42 Aligned_cols=148 Identities=30% Similarity=0.472 Sum_probs=131.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.++|.+.++||+|+||+||+|.+..+++.||||+++... ....+.+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 357999999999999999999999899999999987432 22346788999999999999999999874 4466
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..++||||+.+++|.+++.. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 78999999999999999976 34688899999999999999999999 99999999999999999999999999
Q ss_pred cccc
Q 001858 859 LAKF 862 (1003)
Q Consensus 859 ~a~~ 862 (1003)
+++.
T Consensus 150 ls~~ 153 (669)
T cd05610 150 LSKV 153 (669)
T ss_pred CCcc
Confidence 9863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.45 Aligned_cols=240 Identities=28% Similarity=0.348 Sum_probs=192.7
Q ss_pred eeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecc
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYM 787 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 787 (1003)
||+|+||.||++.+..+++.||+|+++.... .....+..|++++++++|||++++++. +..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence 6899999999999988899999999874432 245688999999999999999999987 45677889999999
Q ss_pred cCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCC
Q 001858 788 QSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP 867 (1003)
Q Consensus 788 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~ 867 (1003)
++++|.+++... ..+++.++..++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 76 PGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 999999999873 4689999999999999999999998 99999999999999999999999999997653321
Q ss_pred ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 868 IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 868 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
.......++..|+|||...+...+.++|+||+|+++|++++|+.||...... +.......
T Consensus 148 -----~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-------------~~~~~~~~-- 207 (250)
T cd05123 148 -----SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-------------EIYEKILK-- 207 (250)
T ss_pred -----CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------HHHHHHhc--
Confidence 1122356888999999998888899999999999999999999998653210 00111111
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCH---HHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM---ADAVK 989 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~---~ev~~ 989 (1003)
... .........+.+++.+|+..+|++||++ +++.+
T Consensus 208 --~~~----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 208 --DPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred --CCC----CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 100 1111124567889999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=290.04 Aligned_cols=243 Identities=23% Similarity=0.246 Sum_probs=197.5
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.+.+|.+...+|+|+|+.|-.+.+..+++..++|++.... .+-.+|+.++... .|||++++.++ +.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCce
Confidence 3567888888999999999999999999999999997552 2234577776666 79999999999 567888
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEe-CCCCCeEEcccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill-~~~~~~kl~DfG 858 (1003)
.++|||.+.++-+.+.+...+ ... .++.+|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eeeeehhccccHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 899999999999988887632 233 67788999999999999999 99999999999999 689999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.++...+. ....+-|..|.|||++....+++++|+||+|++||+|++|+.||..-+.+
T Consensus 462 ~a~~~~~~--------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------- 519 (612)
T KOG0603|consen 462 FWSELERS--------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------- 519 (612)
T ss_pred hhhhCchh--------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------------
Confidence 99865432 22345688999999999999999999999999999999999999875543
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..+..++...+ ..+..+....+++.+|++.+|.+||++.++..+=
T Consensus 520 ---~ei~~~i~~~~-----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 520 ---IEIHTRIQMPK-----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ---HHHHHhhcCCc-----cccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 11111221111 1144567788899999999999999999998653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=249.28 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=172.4
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 778 (1003)
..+.......||+|+||.|-+-++..+|+..|+|.+...- .+..++..+|+.+..+- .+|.+|.++|. +....
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhccc
Confidence 3344555678999999999999999999999999997443 34457788888876555 79999999997 45577
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..+++||.|+. ||..+.++--.. ++.+++...-+||..+.+|+.|||++. .++|||+||+|||++.+|++|+||||
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 78999999977 888876654332 678999999999999999999999986 89999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCC----CCCCccccchhHHHHHHHHHhCCCCCCcccC
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~il~ell~g~~P~~~~~~ 923 (1003)
.+.++.++- ......|...|||||.+.. ..|+.++||||+|++++||.++++||+....
T Consensus 195 IsG~L~dSi------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 195 ISGYLVDSI------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cceeehhhh------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 998775432 1122458889999998654 3688999999999999999999999986544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=273.22 Aligned_cols=220 Identities=20% Similarity=0.140 Sum_probs=175.2
Q ss_pred ccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHH
Q 001858 714 GSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLE 793 (1003)
Q Consensus 714 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 793 (1003)
|.+|.||+|++..+++.||+|+++... .+.+|...+....|||++++++++ .+....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999997542 233455555566799999999984 4567889999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCc
Q 001858 794 DWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873 (1003)
Q Consensus 794 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 873 (1003)
+++.+. ..+++.++..++.|+++|++|+|+. +|+||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------- 138 (237)
T cd05576 74 SHISKF-----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------- 138 (237)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-------
Confidence 999763 3589999999999999999999999 9999999999999999999999999988654321
Q ss_pred ccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCC
Q 001858 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPG 953 (1003)
Q Consensus 874 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~ 953 (1003)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+....... ......
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~~--- 195 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTTL--- 195 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------cccccc---
Confidence 112345778999999888889999999999999999999998865321100 000000
Q ss_pred CchhhHHHHHHHHHHHHhhccccCCCCCCCH
Q 001858 954 NERAKIEECLTAVVRIGVLCSMESPSERIHM 984 (1003)
Q Consensus 954 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 984 (1003)
.........+.+++.+|++.+|++||++
T Consensus 196 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 196 ---NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ---CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0011234567889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=267.19 Aligned_cols=205 Identities=26% Similarity=0.367 Sum_probs=176.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 777 (1003)
..+|....+||+|+||.|-+|..+++.+.+|||++++. .+++.+.-+.|-+++..- +-|.++++..+ +..-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 45788899999999999999999999999999999743 234445556677777766 56788888776 6677
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
+..|.||||+.||+|--.|++ -+.+.+..+.-+|.+||-|+-+||++ ||++||+|.+||++|.+|++||+||
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred hheeeEEEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 888999999999999999988 56788889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCC
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~ 924 (1003)
|+++.-. ........++||+.|+|||.+...+|+.++|.||+||++|||+.|+.||++.+.+
T Consensus 495 GmcKEni-----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 495 GMCKENI-----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred ccccccc-----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9997421 1223344689999999999999999999999999999999999999999886543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=296.23 Aligned_cols=276 Identities=19% Similarity=0.172 Sum_probs=172.6
Q ss_pred HhccCCccCeeeeccceEEEEEEECCC----CceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeee-cccC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGED----LLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSS-IDFK 775 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 775 (1003)
..++|++.++||+|+||.||+|++..+ +..||+|++..... .+.+..| .++...+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999888 88999998763322 1222211 1222222233222221111 1114
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCC
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQV---------------DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLK 840 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 840 (1003)
.+...++|+||+++++|.+++....... ........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 5667899999999999999997542100 01122345668999999999999999 99999999
Q ss_pred CCceEeCC-CCCeEEcccccccccccCCccccCcccccccccccccCccccCCC----------------------CCCc
Q 001858 841 PSNVLLDH-DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG----------------------NVSL 897 (1003)
Q Consensus 841 p~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ 897 (1003)
|+|||++. ++.+||+|||+|+.+.... ........+|+.|+|||.+... .++.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999986 5799999999997653221 1112235789999999964322 1334
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh-Cc-hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccc
Q 001858 898 TGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-LP-EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSM 975 (1003)
Q Consensus 898 ~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~-~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~ 975 (1003)
++||||+||++|||+++..|++... ..+....... .+ ..+...+......+-...............+++.+|++
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 5699999999999999777644210 0010000000 00 01111111100000000000001112234589999999
Q ss_pred cCCCCCCCHHHHHHH
Q 001858 976 ESPSERIHMADAVKN 990 (1003)
Q Consensus 976 ~~p~~RPs~~ev~~~ 990 (1003)
.||++|||++|+++|
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=267.46 Aligned_cols=268 Identities=24% Similarity=0.300 Sum_probs=201.9
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC-CC-----CceeEeeeeeecccC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HR-----NLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~ 775 (1003)
+++|.+...+|+|.||.|-++.+..++..||+|+++.... ..+...-|+++++++. +. -++++.+| |.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 7899999999999999999999999999999999974332 2355667999999993 32 24555555 45
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-------
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH------- 848 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~------- 848 (1003)
-.++.++|+|.+ |-|++|++..+. ..+++..+++.++.|++++++|||+. +++|-|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 577889999998 449999998865 45799999999999999999999999 9999999999999942
Q ss_pred -------------CCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCC
Q 001858 849 -------------DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915 (1003)
Q Consensus 849 -------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~ 915 (1003)
+..+|++|||.|++.... ....+.|..|.|||++.+-.++.++||||+||||+|+.+|.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 235899999999764221 13467899999999999999999999999999999999999
Q ss_pred CCCCcccCCcc-hhhHHHHhhCchhHHHHH------Hhh-cc--------------cCCCCch---hhHHHHHHHHHHHH
Q 001858 916 RPTHTMFNDGL-TLHGFVKMALPEKVMEIV------DFA-LL--------------LDPGNER---AKIEECLTAVVRIG 970 (1003)
Q Consensus 916 ~P~~~~~~~~~-~~~~~~~~~~~~~~~~~i------~~~-l~--------------~~~~~~~---~~~~~~~~~l~~l~ 970 (1003)
.-|.+-++.+. ...+.+-..+|..+..-. ..+ +. ..+.+.. .........+.+++
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 99887654331 122222223333322111 111 00 0010000 01123456799999
Q ss_pred hhccccCCCCCCCHHHHHHH
Q 001858 971 VLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 971 ~~cl~~~p~~RPs~~ev~~~ 990 (1003)
++++..||++|+|+.|++.|
T Consensus 387 ~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHccCccccccHHHHhcC
Confidence 99999999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=241.44 Aligned_cols=266 Identities=19% Similarity=0.294 Sum_probs=198.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+++|+|.|++||.|....++++++||+++.... +.+.+|+.+++.++ ||||++++++... ......
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~D---p~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCc
Confidence 4689999999999999999999988889999999985544 67789999999996 9999999998643 345567
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-CCeEEccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGL 859 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~DfG~ 859 (1003)
.+|+||+++.+...... .++..++..++.+++.|+.|+|+. ||+|||+||.|+++|.. ..++++|+|+
T Consensus 111 aLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred hhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence 89999999988777654 477788999999999999999999 99999999999999965 5799999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCC-CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
|.++.++... .-.+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-.......++....+..-.+
T Consensus 180 AEFYHp~~eY------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 180 AEFYHPGKEY------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred HhhcCCCcee------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 9987554211 12345677889998765 4678899999999999999999999754333323333332222222
Q ss_pred hHHHHHHhh-cccCCC---------Cchhh-------HHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFA-LLLDPG---------NERAK-------IEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~-l~~~~~---------~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
++...+.+. +..+|. ..++. ..-..++..+++.+.+.+|..+|||++|...|
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 222222211 111111 00000 00122556777788888999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.01 Aligned_cols=240 Identities=28% Similarity=0.384 Sum_probs=193.0
Q ss_pred cceEEEEEEECCCCceEEEEEeccccccc-hHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHH
Q 001858 715 SFGFVYRGNLGEDLLPVAVKVINLKQKGS-IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLE 793 (1003)
Q Consensus 715 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 793 (1003)
+||.||+|++.++++.+|+|++....... .+.+.+|++.+++++|+|++++++++. .....++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999999889999999997655444 689999999999999999999999853 346789999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCc
Q 001858 794 DWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873 (1003)
Q Consensus 794 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 873 (1003)
+++.... .+++.+++.++.+++++++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------ 141 (244)
T smart00220 76 DLLKKRG-----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------ 141 (244)
T ss_pred HHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc------
Confidence 9998632 388999999999999999999999 99999999999999999999999999998654321
Q ss_pred ccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCC
Q 001858 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPG 953 (1003)
Q Consensus 874 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~ 953 (1003)
......++..|+|||...+..++.++||||+|+++|+|++|..||...... ....+.... ...
T Consensus 142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------------~~~~~~~~~---~~~- 204 (244)
T smart00220 142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------------LELFKKIGK---PKP- 204 (244)
T ss_pred ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------------HHHHHHHhc---cCC-
Confidence 222356788999999998888999999999999999999999998653111 111111111 111
Q ss_pred CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 954 NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 954 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
........+...+.+++.+|+..+|++||++.+++++
T Consensus 205 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 205 PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 1111111145678899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=271.42 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=200.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.+++++..||.|+||.|=++..+.....+|+|++++. +....+....|-.+|...+.|.||++|.. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 3455667899999999999998876666888888643 34455678889999999999999999987 678899
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
+|+.||-|-||.++..+++ ++.++...+.-++.-+++|++|||++ +||+||+||+|.+++.+|-+|+.|||+
T Consensus 495 vYmLmEaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hhhhHHhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence 9999999999999999998 56788889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchh
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|+.+.. ......++||+.|.|||.+.++..+.++|.||+|+++||+++|.+||++..+-..+ ..
T Consensus 567 AKki~~------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY----------n~ 630 (732)
T KOG0614|consen 567 AKKIGS------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY----------NL 630 (732)
T ss_pred HHHhcc------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH----------HH
Confidence 987743 33445689999999999999999999999999999999999999999875321000 00
Q ss_pred HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHHHH
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKNLC 992 (1003)
Q Consensus 940 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~L~ 992 (1003)
+..-++..- .+.........++++....+|.+|.- +.||.+|.+
T Consensus 631 ILkGid~i~---------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 631 ILKGIDKIE---------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHhhhhhhh---------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 111111111 11122334456666666778888874 667766643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=280.40 Aligned_cols=275 Identities=18% Similarity=0.192 Sum_probs=183.3
Q ss_pred HhccCCccCeeeeccceEEEEEEEC----------------CCCceEEEEEeccccccchHH--------------HHHH
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLG----------------EDLLPVAVKVINLKQKGSIKS--------------FVAE 750 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 750 (1003)
..++|++.++||+|+||+||+|... ..++.||||.+........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3678999999999999999999752 234679999987543332233 3446
Q ss_pred HHHHHhcCCCCc-----eeEeeeeeecc---cCCCCceEEeeecccCCCHHHHHhhcCCC-------------------C
Q 001858 751 CEALKNIRHRNL-----IKIITVCSSID---FKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------------------V 803 (1003)
Q Consensus 751 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~ 803 (1003)
+.++.+++|.++ ++++++|.... ...++..++||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 67777764321 12245679999999999999999753211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCccccccccccc
Q 001858 804 DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883 (1003)
Q Consensus 804 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~ 883 (1003)
...+++..++.++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++..+..... .......+|+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~ 375 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPR 375 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcc
Confidence 12356788899999999999999999 999999999999999999999999999976532211 11111235789
Q ss_pred ccCccccCCCCC--------------------C--ccccchhHHHHHHHHHhCCC-CCCcccCCcchhhHHHHhhCchhH
Q 001858 884 YVAPEYGMGGNV--------------------S--LTGDVYSFGILLLEMFTGRR-PTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 884 y~aPE~~~~~~~--------------------~--~~sDvwslG~il~ell~g~~-P~~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
|+|||.+..... + .+.||||+||++|||++|.. ||............ .....
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~~~~ 450 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YDNDL 450 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----ccchH
Confidence 999998754321 1 24699999999999999876 66532111110000 00111
Q ss_pred HHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCC---CCCCCHHHHHHH
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESP---SERIHMADAVKN 990 (1003)
Q Consensus 941 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~~ 990 (1003)
..+.. ..... ..............+++.+++..+| .+|+|++|+++|
T Consensus 451 ~~~r~-~~~~~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 451 NRWRM-YKGQK--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHHh-hcccC--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11100 00000 0111122334566777778887655 789999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=250.72 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=177.3
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc---cccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 777 (1003)
-++|++.++||+|+|+.|..++++.+.+.||+|+++++ +++.+...+.|-.+...- +||.+|.+..+ |..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence 46899999999999999999999999999999999844 344556667777777766 79999999887 6778
Q ss_pred CceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccc
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 857 (1003)
...+.|.||++||+|--++++ ..+++++.++-+..+|.-|+.|||++ ||++||+|.+|+|+|.+|++|++||
T Consensus 324 srlffvieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred ceEEEEEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence 889999999999999888877 45799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcc
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921 (1003)
Q Consensus 858 G~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~ 921 (1003)
|+++.-- ........++||+.|.|||.+.+..|++.+|.|++|++++||+.|+.||+-.
T Consensus 396 gmcke~l-----~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 396 GMCKEGL-----GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred chhhcCC-----CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9997421 1223334589999999999999999999999999999999999999999753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=268.28 Aligned_cols=212 Identities=24% Similarity=0.333 Sum_probs=179.2
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
.-|..++.||-|+||+|.+++..++...||+|.+++.+ .........|-.|+..-..+=||+++-- |.+++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 34677889999999999999999899999999997553 3345667889999999999999999865 788999
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
+|+||||++||++-.++-+ .+-+.+.-++-++.++..|+++.|.. |+|||||||+|||||.+|++||+|||+
T Consensus 704 LYFVMdYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred eEEEEeccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence 9999999999999998877 46788888899999999999999999 999999999999999999999999999
Q ss_pred ccccc---cCCccccCc----------------------------------ccccccccccccCccccCCCCCCccccch
Q 001858 860 AKFLF---DRPIQETSS----------------------------------SSIGIKGTVGYVAPEYGMGGNVSLTGDVY 902 (1003)
Q Consensus 860 a~~~~---~~~~~~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvw 902 (1003)
++-+. +..+..... .....+||+.|+|||++....++..+|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 96442 111111000 00225699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCcccCCcch
Q 001858 903 SFGILLLEMFTGRRPTHTMFNDGLT 927 (1003)
Q Consensus 903 slG~il~ell~g~~P~~~~~~~~~~ 927 (1003)
|.|||||||+.|+.||......+.+
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcce
Confidence 9999999999999999887665443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=282.69 Aligned_cols=247 Identities=26% Similarity=0.330 Sum_probs=185.7
Q ss_pred ccCeeeeccce-EEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCceEEee
Q 001858 707 LSNLIGQGSFG-FVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 707 ~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
-.+++|.|+.| .||+|... ++.||||.+-.. ......+|+..++.- .|||||++++. ..++.+.|++.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal 582 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL 582 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence 34568999987 68999985 669999987522 234667899999988 69999999987 67788999999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC---C--CCeEEccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---D--MVAHVSDFGL 859 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~--~~~kl~DfG~ 859 (1003)
|.|.- +|.|+++..... .......+.+.+..|++.|++|||+. +|||||+||+||||+. + ..++|+|||+
T Consensus 583 ELC~~-sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred hHhhh-hHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99965 999999985111 11112145678899999999999998 9999999999999976 3 4689999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh-CCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
++.+......- .......||.+|+|||.+....-+.++|+||+||++|+.++ |.+||++....+..+
T Consensus 658 sKkl~~~~sS~--~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---------- 725 (903)
T KOG1027|consen 658 SKKLAGGKSSF--SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---------- 725 (903)
T ss_pred ccccCCCcchh--hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh----------
Confidence 99886543221 22345679999999999999988899999999999999999 599998643221111
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
..-........+. +++ ...+++.+++.++|..||++.+|+.|
T Consensus 726 --l~~~~~L~~L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 726 --LTGNYTLVHLEPL------PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --hcCccceeeeccC------chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0000001111111 111 56678889999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=266.99 Aligned_cols=198 Identities=26% Similarity=0.391 Sum_probs=171.6
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc--------ccchHHHHHHHHHHHhcC---CCCceeEeeeee
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--------KGSIKSFVAECEALKNIR---HRNLIKIITVCS 770 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 770 (1003)
..+|...+++|+|+||.|+.|.++.+...|+||.+.++. +...-....|++||..++ |+||+|++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-- 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-- 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence 456899999999999999999999999999999986432 111123556999999997 9999999999
Q ss_pred ecccCCCCceEEeeeccc-CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC
Q 001858 771 SIDFKGDDFKALVYDYMQ-SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 849 (1003)
Q Consensus 771 ~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~ 849 (1003)
|++++++|++||... +.+|.++|.. ++.+++.++..|+.||+.|+++||+. +|||||||-+|+.++.+
T Consensus 638 ---FEddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 638 ---FEDDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN 706 (772)
T ss_pred ---eecCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence 788999999999875 4489999987 56799999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCC-ccccchhHHHHHHHHHhCCCCCC
Q 001858 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVS-LTGDVYSFGILLLEMFTGRRPTH 919 (1003)
Q Consensus 850 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~il~ell~g~~P~~ 919 (1003)
|-+|++|||.|.+...++ ...++||..|+|||++.|.+|- ..-|||++|+++|.++...-||-
T Consensus 707 g~~klidfgsaa~~ksgp-------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP-------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCC-------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999997654333 3347899999999999998874 56899999999999999888863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=247.14 Aligned_cols=276 Identities=21% Similarity=0.236 Sum_probs=195.5
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
.+-.+.||.|+||.||.+++..+++.||.|++... .-...+++-+|++++..++|.|+...+++..-....--.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468999999999999999999999999988632 2334578889999999999999999887643211111134578
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
++|.|.. +|...|-. ...++...+.-+.+||++|++|||+. +|.||||||.|.+++.+-.+||||||+++.
T Consensus 135 ~TELmQS-DLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHh-hhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 9999976 88888866 45788888889999999999999999 999999999999999999999999999987
Q ss_pred cccCCccccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCc-chhhHHHHhhC-chh
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG-LTLHGFVKMAL-PEK 939 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~-~~~~~~~~~~~-~~~ 939 (1003)
..... .......+.|..|.|||.+.|. .|+.+.||||.||++.|++..+.-|....+-+ .++....-... .+.
T Consensus 206 ee~d~----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 206 WDQRD----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred cchhh----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 64321 2223334578899999998885 68999999999999999999888886532211 11111111111 111
Q ss_pred HHHHHH----hhcc---cCCCCch----hhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHH
Q 001858 940 VMEIVD----FALL---LDPGNER----AKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 940 ~~~~i~----~~l~---~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 993 (1003)
++..-+ .++. ..|+... .....--.+-..+.+.++..+|++|.+.++.+.++..
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 221111 1111 1111100 0001112234566677889999999999998877543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=249.40 Aligned_cols=138 Identities=24% Similarity=0.385 Sum_probs=118.9
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC--------CCCceeEeeeeeecc
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR--------HRNLIKIITVCSSID 773 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 773 (1003)
.++|.+.++||-|.|++||+|.+.+..+.||+|+.+. .....+..+.|++++++++ ...||++++.+...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs- 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS- 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-
Confidence 4789999999999999999999999999999999873 2333466788999999983 24799999987543
Q ss_pred cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD 847 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 847 (1003)
-..+.++++|+|++ |.+|..+|..+. .+.++...+++|++||+.||.|||+.| ||||-||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 35578899999999 559999999876 457899999999999999999999998 999999999999993
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=270.33 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=209.5
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|+....+|.|.||.||+|+++.+++..|+|+++.+.....+-.++|+-+++..+||||+.++|- +...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCcE
Confidence 4689999999999999999999999999999999998888888889999999999999999999987 45577789
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|||+.+|+|.|..+. .+.+.+.++..++++..+|++|||+. +-+|||||-.||++++.|.+|++|||.+.
T Consensus 89 icMEycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred EEEEecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence 99999999999998766 57899999999999999999999999 89999999999999999999999999996
Q ss_pred ccccCCccccCcccccccccccccCcccc---CCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYG---MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.+ ..+-.....+.||+.|||||+. ..+.|...+|||+.|+...|+-.-+.|.-+. .|.
T Consensus 161 qi-----tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--------------hpm 221 (829)
T KOG0576|consen 161 QI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--------------HPM 221 (829)
T ss_pred hh-----hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--------------chH
Confidence 54 4455556678999999999974 4567889999999999999999887773221 112
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+...+..+.....|. ..........|.++++.|+..+|.+||+++.+++|
T Consensus 222 r~l~LmTkS~~qpp~--lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPT--LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHhhccCCCCCc--ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 222222222222221 11112234567888899999999999999987763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=231.87 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=168.2
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCCCCce
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.+.|.+.+.+|+|.||.+-+++++++++.+++|.+.... ...++|.+|...--.+ .|.||+.-+++. |+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 467899999999999999999999999999999987443 3457888887654445 589999888764 6777888
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeC--CCCCeEEcccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFG 858 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~DfG 858 (1003)
..++||++.|+|.+-+.. ..+.+....+++.|+++|+.|+|++ .+||||||.+|||+- +..++|+||||
T Consensus 98 vF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 999999999999988764 3578888999999999999999999 999999999999994 34489999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCC-----CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-----NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~ 932 (1003)
..+..+.. -...--+..|.|||..... ...+.+|+|.||+++|.+++|+.||+.....+..+..|.
T Consensus 169 ~t~k~g~t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 169 LTRKVGTT--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred cccccCce--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 98754221 1112245679999975432 356789999999999999999999986655555554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-26 Score=235.02 Aligned_cols=212 Identities=32% Similarity=0.531 Sum_probs=182.8
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccC
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS 789 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 789 (1003)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++ ......++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence 68999999999999888899999999755432 357899999999999999999999985 334678999999999
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEEcccccccccccCCc
Q 001858 790 GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAKFLFDRPI 868 (1003)
Q Consensus 790 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 868 (1003)
++|.+++.... ..+++.+++.++.+++++++|||+. +++|+||+|.||+++. ++.++++|||.+........
T Consensus 76 ~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 76 GSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99999998642 4688999999999999999999999 9999999999999999 89999999999976533221
Q ss_pred cccCcccccccccccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhh
Q 001858 869 QETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFA 947 (1003)
Q Consensus 869 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 947 (1003)
......+...|++||..... ..+.++|+|++|+++++|
T Consensus 149 -----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------ 187 (215)
T cd00180 149 -----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187 (215)
T ss_pred -----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence 12234578899999998877 788999999999999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 948 LLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 948 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=244.67 Aligned_cols=273 Identities=25% Similarity=0.326 Sum_probs=202.3
Q ss_pred HHhccCCccCeeeeccceEEEEEEECC---CCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccC
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGE---DLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 775 (1003)
...+.|..+++||+|.|++||+|++.. .++.||+|.+...+.. .+..+|++++.++ .+.||+++.++ +.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~-----~r 105 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGC-----FR 105 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhh-----hc
Confidence 345678999999999999999999876 6788999999755443 6788999999999 58999999998 67
Q ss_pred CCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-CCCeEE
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMVAHV 854 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl 854 (1003)
.++.+.+|+||++.....++... ++..++..+++.+..||+|+|.. |||||||||+|++.+. .+.-.|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceE
Confidence 78899999999999999998764 66888999999999999999999 9999999999999984 567899
Q ss_pred cccccccccccCC------------c-c--------------------------ccCcccccccccccccCccccCCC-C
Q 001858 855 SDFGLAKFLFDRP------------I-Q--------------------------ETSSSSIGIKGTVGYVAPEYGMGG-N 894 (1003)
Q Consensus 855 ~DfG~a~~~~~~~------------~-~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~-~ 894 (1003)
.|||+|....... . . ..........||++|.|||++... .
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999997321100 0 0 000111235699999999998764 6
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHH---------------------HHH-------h
Q 001858 895 VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME---------------------IVD-------F 946 (1003)
Q Consensus 895 ~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~i~-------~ 946 (1003)
.++++||||.|+|++-++++++||-....+-..+.+.+...-+..+.. ... .
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 789999999999999999999998654443222222111111111100 000 1
Q ss_pred hcccCCC---CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 947 ALLLDPG---NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 947 ~l~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
.+..... .+....+..+...+++..+|+..+|.+|.+++|.++|
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 1111111 1122223334478899999999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=248.42 Aligned_cols=273 Identities=21% Similarity=0.302 Sum_probs=207.2
Q ss_pred HHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC------CCCceeEeeeeeec
Q 001858 699 NKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR------HRNLIKIITVCSSI 772 (1003)
Q Consensus 699 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 772 (1003)
..-..+|.+....|+|-|++|.+|.+...+..||||++... +...+.=+.|++++++++ --|+++++..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~---- 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH---- 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence 34567899999999999999999999988899999999843 334466678999999994 3466777665
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-C
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-V 851 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~ 851 (1003)
|....++|+|||.+.- +|.+++++.+. .-.+...++..++.|+.-||..|-.. +|+|+||||.||||.+.. .
T Consensus 503 -F~hknHLClVFE~Lsl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 503 -FKHKNHLCLVFEPLSL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred -hhhcceeEEEehhhhc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 6778899999999855 99999999765 34588899999999999999999998 999999999999998764 6
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcc-hhhH
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL-TLHG 930 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~-~~~~ 930 (1003)
+||||||.|....+.... .+..+..|.|||.+.|-.|+...|+||.||+|||+.||+.-|.+..+..+ .+.-
T Consensus 576 LKLCDfGSA~~~~eneit-------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT-------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred eeeccCcccccccccccc-------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 799999999876543322 24456789999999999999999999999999999999999987554321 1111
Q ss_pred HHHhhCchhHHH---H------------------------HHhhcccCCCC-----------chhhHHHHHHHHHHHHhh
Q 001858 931 FVKMALPEKVME---I------------------------VDFALLLDPGN-----------ERAKIEECLTAVVRIGVL 972 (1003)
Q Consensus 931 ~~~~~~~~~~~~---~------------------------i~~~l~~~~~~-----------~~~~~~~~~~~l~~l~~~ 972 (1003)
-++..+|..+.. + +..+....|.. ...........+..+..+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 112222222111 0 00111111100 111223456778899999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 001858 973 CSMESPSERIHMADAVKN 990 (1003)
Q Consensus 973 cl~~~p~~RPs~~ev~~~ 990 (1003)
|+..||++|.+..++++|
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999999876
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-28 Score=249.64 Aligned_cols=407 Identities=20% Similarity=0.230 Sum_probs=231.2
Q ss_pred CCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCC-ccCCCCCCC-c
Q 001858 163 EIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAE-NNFSGMLPP-I 240 (1003)
Q Consensus 163 ~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~-~ 240 (1003)
+||..+. ..-..++|..|+|+..-|..|+.+++|+.|||++|.|+.+-|++|..+.+|..|-+.+ |+|+.++.. +
T Consensus 60 eVP~~LP---~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F 136 (498)
T KOG4237|consen 60 EVPANLP---PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF 136 (498)
T ss_pred cCcccCC---CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence 6666554 3567889999999966667889999999999999999999999999999988877666 888877665 3
Q ss_pred ccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCccc
Q 001858 241 FNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNIT 320 (1003)
Q Consensus 241 ~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 320 (1003)
.++.+|+.|.+.-|++. .++...++.+++|..|.+.+|.+..+--.+|..+.+++.+.+..|.+.. ..+++.+.
T Consensus 137 ~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla 210 (498)
T KOG4237|consen 137 GGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLA 210 (498)
T ss_pred hhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhh
Confidence 45777777777777777 6777777777777777777777773333377777777777777776320 01111111
Q ss_pred EEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCccccccc-ccccccccccccccCc-ccccccCCCCcc
Q 001858 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANL-STITIIAMGLNQISGT-IPLEIRNLANIY 398 (1003)
Q Consensus 321 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~-~p~~~~~l~~L~ 398 (1003)
.- +.-| +..++......-..+.++++...-+..|... ..+..=..+.+..-++ ....|..+++|+
T Consensus 211 ~~-~a~~------------~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~ 277 (498)
T KOG4237|consen 211 DD-LAMN------------PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR 277 (498)
T ss_pred hH-Hhhc------------hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence 00 0000 1112222233333333444433222222211 1111111111111112 223455666666
Q ss_pred EEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCcc
Q 001858 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478 (1003)
Q Consensus 399 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 478 (1003)
.|+|++|+|+++-+.+|.++..++.|.|..|+|..+....|.++..|+.|+|.+|+|+..-|.+|..+.+|.+|+|-.|.
T Consensus 278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence 66666666665555666666666666666666655555555666666666666666665555666666666666665555
Q ss_pred ccCCC-chhhhhh--------------ccccccccCCCCcccc---cccccc---------ccccccccc-ccccccccc
Q 001858 479 LTGTL-PPQILEI--------------TTLSSLLDLSSNLISG---SIPLVV---------GNLKNLIQL-DISRNRFSG 530 (1003)
Q Consensus 479 l~~~~-p~~~~~~--------------~~l~~~l~L~~N~l~~---~~p~~~---------~~l~~L~~L-~Ls~N~l~~ 530 (1003)
+...- -.++.++ +....-+.++++.+.. ..|++. ..++-+... .-|++.++
T Consensus 358 ~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk- 436 (498)
T KOG4237|consen 358 FNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK- 436 (498)
T ss_pred ccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-
Confidence 53110 0111111 0011112222222110 011111 112223222 23333333
Q ss_pred ccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecCCC
Q 001858 531 EIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598 (1003)
Q Consensus 531 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 598 (1003)
.+|..+. ..-.+|++.+|.++ .+|.+ .+.+| .+|+|+|+|+..-...|.+++.|.+|-+++|
T Consensus 437 ~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 437 LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 5555443 24467888888888 67766 66777 8888888888666677888888888888776
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=233.27 Aligned_cols=267 Identities=22% Similarity=0.226 Sum_probs=197.1
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEecc--ccccchHHHHHHHHHHHhcCCCCceeEeeeeeeccc-CCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 778 (1003)
..+|.-.+.+|.|+- .|-.|.+.-.+++||+|.... ......++..+|...+..+.|+|+++++.++.-... ....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457777888999998 888899988899999998752 234456788899999999999999999998643221 2234
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..|+|||+|.. +|.+.+.. .++-..+..+..|++.|++|+|+. +|+|||+||+||++..+..+||.|||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 56899999976 99999874 356677889999999999999999 99999999999999999999999999
Q ss_pred cccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh---
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--- 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~--- 935 (1003)
+|+..... -.....+.|..|.|||++.+..+...+||||.||++.||++|+.-|.+. ..+.+|.+..
T Consensus 164 ~ar~e~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 164 LARTEDTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQL 233 (369)
T ss_pred hhcccCcc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHh
Confidence 99754221 2334567899999999999988999999999999999999999887642 2222222211
Q ss_pred ----------CchhHHHHHHhh----------cccCCC--CchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 ----------LPEKVMEIVDFA----------LLLDPG--NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ----------~~~~~~~~i~~~----------l~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
+.+-....+... ...+.. ...+...-.......++.+++..+|++|.+++++++|
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111111100 000000 0000000112345677889999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=233.58 Aligned_cols=200 Identities=33% Similarity=0.503 Sum_probs=172.3
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccccc-chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEe
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
|++.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++ ......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEEE
Confidence 56778999999999999999988899999999865544 568899999999999999999999985 345678999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+||+++++|.+++..... .+++.+++.++.+++.+++|+|+. +++|+|++|+||+++.++.++++|||.+...
T Consensus 76 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred EeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 999999999999987431 178999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCccccCcccccccccccccCcccc-CCCCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYG-MGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
.... ........++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 149 ~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDL----AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcc----cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4332 0112234578889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=210.76 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=200.5
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCceE
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
-.|+++++||+|.||++|.|+.--++++||||.-...++ ..++..|++..+.+. .+.|..++-|. .++.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeec-----cccchhh
Confidence 479999999999999999999988999999998764443 378889999999994 68998888763 4456668
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-----CeEEcc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHVSD 856 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-----~~kl~D 856 (1003)
+|+|.+ |-||.|+..-+ ++.++...+..+|.|++.-++|+|++ ..|+|||||+|+||+..+ .+.++|
T Consensus 101 LVidLL-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhh-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 999998 66999998876 56899999999999999999999999 999999999999997543 589999
Q ss_pred cccccccccCCcccc--CcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 857 FGLAKFLFDRPIQET--SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 857 fG~a~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
||+|+.+.+...... ........||.+||+-....+.+.+.+.|+-|+|.++.+.+.|..||++...+....
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~------ 246 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE------ 246 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH------
Confidence 999998876543321 223345679999999999999999999999999999999999999999876542211
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
..+.+-+. ....+...-.+..+.+|..-++-.-..+-.+-|..+-+..-+..+.
T Consensus 247 ----kYeKIGe~---Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 247 ----KYEKIGET---KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ----HHHHhccc---cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 01111110 1111112222334445555555555566677777665555444443
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=268.23 Aligned_cols=364 Identities=19% Similarity=0.226 Sum_probs=239.3
Q ss_pred CCcEEEEEeecCCCCc-cc-CccccCCCCCcEEEcCCCC------CCCCCchhhcccc-cCcEEEecccccccccCccCc
Q 001858 75 HPRVIQLYLRNQSVGG-FL-SPYVGNLSFLRFINLASNN------LHGEIPNELGRLS-RLKVLVLDFNSFSGTIPSNLS 145 (1003)
Q Consensus 75 ~~~v~~l~l~~~~~~g-~~-~~~l~~l~~L~~L~L~~n~------~~g~ip~~l~~l~-~L~~L~Ls~n~l~g~ip~~l~ 145 (1003)
+.+|..+.|.-..+.. .+ +.++.++++|++|.+..+. +...+|..+..++ +|+.|++.++.+. .+|..+
T Consensus 531 ~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f- 608 (1153)
T PLN03210 531 TKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF- 608 (1153)
T ss_pred cceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-
Confidence 3456666554333321 12 2357889999999997653 3446788887764 6999999999987 889888
Q ss_pred CCCCCceeecccccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCe
Q 001858 146 HCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNF 225 (1003)
Q Consensus 146 ~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 225 (1003)
...+|+.|++++|++. .+|..+.. +++|+.|+|+++...+.+|. ++.+++|++|+|++|.....+|..+.++++|+.
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~-l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~ 685 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHS-LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLED 685 (1153)
T ss_pred CccCCcEEECcCcccc-cccccccc-CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence 5789999999999987 67776654 47899999998765557774 888999999999988766788989999999999
Q ss_pred EecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccc
Q 001858 226 LSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF 305 (1003)
Q Consensus 226 L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 305 (1003)
|++++|..-+.+|...++++|+.|++++|...+.+|.. .++|++|++++|.++ .+|..+ .+++|+.|++.++..
T Consensus 686 L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~ 759 (1153)
T PLN03210 686 LDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS 759 (1153)
T ss_pred EeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence 99988754434444335556666666655444344421 234555555555554 334333 344444444443322
Q ss_pred cCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccC
Q 001858 306 SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISG 385 (1003)
Q Consensus 306 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 385 (1003)
.... . .+.... ......+++|+.|+|++|...+.+|..++++++|+.|++++|..-+
T Consensus 760 ~~l~-~----------------~~~~l~------~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~ 816 (1153)
T PLN03210 760 EKLW-E----------------RVQPLT------PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE 816 (1153)
T ss_pred hhcc-c----------------cccccc------hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC
Confidence 1100 0 000000 0011234677888888877766777778888888888887775444
Q ss_pred cccccccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccc-cccccCCcccc
Q 001858 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFN-NLQGNIPSSLG 464 (1003)
Q Consensus 386 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~ 464 (1003)
.+|..+ ++++|+.|++++|.....+|.. .++|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+.
T Consensus 817 ~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~ 890 (1153)
T PLN03210 817 TLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNIS 890 (1153)
T ss_pred eeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccc
Confidence 566555 6777888888876544444443 346777788888777 56777777788888888773 444 5666777
Q ss_pred CCCCCCeeeccCcc
Q 001858 465 NCKNLMLLNVSKNK 478 (1003)
Q Consensus 465 ~l~~L~~L~ls~N~ 478 (1003)
.+++|+.+++++|.
T Consensus 891 ~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 891 KLKHLETVDFSDCG 904 (1153)
T ss_pred cccCCCeeecCCCc
Confidence 77777777777764
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=266.49 Aligned_cols=312 Identities=21% Similarity=0.211 Sum_probs=177.5
Q ss_pred CcCCCCCceeeccccc------ccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccc
Q 001858 144 LSHCSNLINFSVRRNN------LTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217 (1003)
Q Consensus 144 l~~l~~L~~L~l~~N~------l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l 217 (1003)
+..+.+|+.|.+..+. +...+|..+..+..+|+.|++.++.++ .+|..+ .+.+|++|++++|++. .+|+.+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 4455666666554442 223445544444445666666666665 566655 3566667777776666 456666
Q ss_pred cCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchh
Q 001858 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVI 297 (1003)
Q Consensus 218 ~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 297 (1003)
..+++|+.|+|++|..-..+|.+..+++|+.|++++|.....+|..+. ++++|+.|++++|...+.+|..+ ++++|+.
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~-~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQ-YLNKLEDLDMSRCENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhh-ccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence 666677777776655444455555566666666666555456666654 67777777777765444566554 5677777
Q ss_pred hhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCC-------CCCccccccc
Q 001858 298 LNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFG-------GSLPRSIANL 370 (1003)
Q Consensus 298 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l 370 (1003)
|++++|...+..|. ..++|++|++++|.+..++.. ..+++|++|++.++... ...+..+...
T Consensus 709 L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~lP~~--------~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 709 LNLSGCSRLKSFPD---ISTNISWLDLDETAIEEFPSN--------LRLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred EeCCCCCCcccccc---ccCCcCeeecCCCcccccccc--------ccccccccccccccchhhccccccccchhhhhcc
Confidence 77777654433332 235677777777776654421 13556666666653321 1111222233
Q ss_pred ccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeec
Q 001858 371 STITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWL 450 (1003)
Q Consensus 371 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 450 (1003)
++|+.|++++|.....+|..++++++|+.|++++|..-+.+|..+ .+++|+.|++++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 456666666665555566666666666666666554333455444 4556666666665433333332 245566666
Q ss_pred ccccccccCCccccCCCCCCeeeccC
Q 001858 451 GFNNLQGNIPSSLGNCKNLMLLNVSK 476 (1003)
Q Consensus 451 ~~N~l~~~~p~~~~~l~~L~~L~ls~ 476 (1003)
++|.++ .+|..+..+++|+.|++++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCC
Confidence 666665 4555566666666666655
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=210.12 Aligned_cols=170 Identities=21% Similarity=0.238 Sum_probs=131.8
Q ss_pred CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCcc
Q 001858 790 GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869 (1003)
Q Consensus 790 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 869 (1003)
|+|.++++.. +..+++.+++.++.|++.|++|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc--
Confidence 6899999864 34699999999999999999999998 5 999999999999999 99997653211
Q ss_pred ccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcc
Q 001858 870 ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALL 949 (1003)
Q Consensus 870 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 949 (1003)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......+.....
T Consensus 64 --------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------------~~~~~~~~~~~~~ 123 (176)
T smart00750 64 --------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------------SAILEILLNGMPA 123 (176)
T ss_pred --------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------------cHHHHHHHHHhcc
Confidence 25889999999999999999999999999999999999998653221 1122223332222
Q ss_pred cCCCCchhhHHHHHH--HHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 950 LDPGNERAKIEECLT--AVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 950 ~~~~~~~~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
..+.. +........ .+.+++.+||+.+|++||++.|+++++.....+
T Consensus 124 ~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 124 DDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred CCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 22211 112223333 689999999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=248.05 Aligned_cols=312 Identities=23% Similarity=0.347 Sum_probs=191.5
Q ss_pred CCHhHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCceee----------------EEeCCCCCcEEEEEeecCCCCcc
Q 001858 32 SNETDRVALLAIKSQLQDPMGITSS----WNNSINVCQWTG----------------VTCGQRHPRVIQLYLRNQSVGGF 91 (1003)
Q Consensus 32 ~~~~~~~al~~~k~~~~d~~~~~~s----W~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~~~~g~ 91 (1003)
..++|.+++++..+.+.-|. .+++ |++.+++|.=.. |.|.. +.|+.+..-+......
T Consensus 60 ~~~~~~~~~~~~~~~l~~p~-~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 60 ASPEEIKSKFECLRMLAFPA-YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQASS 136 (754)
T ss_pred CCHHHHHHHHHHHHHhcCCc-hhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccccccccc
Confidence 55789999999999997663 4566 999999995444 77743 4666665443211110
Q ss_pred c--------------------Cc--------c-----ccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEeccccccc
Q 001858 92 L--------------------SP--------Y-----VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSG 138 (1003)
Q Consensus 92 ~--------------------~~--------~-----l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g 138 (1003)
- ++ . -+-..+...|+|++++++ .+|..+. ..|+.|+|++|+|+
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt- 212 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK- 212 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-
Confidence 0 00 0 012245677888888777 6777664 46788888888887
Q ss_pred ccCccCcCCCCCceeecccccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCccccc
Q 001858 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLG 218 (1003)
Q Consensus 139 ~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~ 218 (1003)
.+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+|+ .+|+.+.
T Consensus 213 sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~ 282 (754)
T PRK15370 213 SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP 282 (754)
T ss_pred cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC
Confidence 5776654 47888888888877 6676543 46778888888877 6676654 46778888888777 4666554
Q ss_pred CCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhh
Q 001858 219 QLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVIL 298 (1003)
Q Consensus 219 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 298 (1003)
.+|+.|++++|++++.++.+. ++|+.|++++|+++ .+|..+. ++|++|++++|.+++ +|..+.
T Consensus 283 --~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~-------- 345 (754)
T PRK15370 283 --EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP---PGLKTLEAGENALTS-LPASLP-------- 345 (754)
T ss_pred --CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc---ccceeccccCCcccc-CChhhc--------
Confidence 467778888877776543322 35666666666665 3443332 345555555555542 333221
Q ss_pred hccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCccccccccccccccc
Q 001858 299 NLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378 (1003)
Q Consensus 299 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 378 (1003)
++|+.|++++|+|+.++.. + .++|++|+|++|+++ .+|..+. ..|+.|++
T Consensus 346 ------------------~sL~~L~Ls~N~L~~LP~~-------l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdL 395 (754)
T PRK15370 346 ------------------PELQVLDVSKNQITVLPET-------L--PPTITTLDVSRNALT-NLPENLP--AALQIMQA 395 (754)
T ss_pred ------------------CcccEEECCCCCCCcCChh-------h--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhh
Confidence 3555555555555543211 1 146677777777766 3444433 25666777
Q ss_pred ccccccCcccc----cccCCCCccEEEccccccc
Q 001858 379 GLNQISGTIPL----EIRNLANIYALGLEYNQLT 408 (1003)
Q Consensus 379 ~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~ 408 (1003)
++|+++ .+|. .++.++++..|++.+|.+.
T Consensus 396 s~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 396 SRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred ccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 777666 3333 3344566677777777665
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=247.54 Aligned_cols=267 Identities=25% Similarity=0.305 Sum_probs=157.5
Q ss_pred CCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccceEE
Q 001858 100 SFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLN 179 (1003)
Q Consensus 100 ~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~ 179 (1003)
..-..|||++|+++ .+|+.+.. +|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|... .+|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~lp----~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVLP----PGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCcc----cccceee
Confidence 34566777777777 67777653 6777777777777 46653 467777777777777 556432 4677777
Q ss_pred ccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCC
Q 001858 180 VAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGR 259 (1003)
Q Consensus 180 L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 259 (1003)
|++|.++ .+|... ++|+.|++++|+++ .+|.. +++|++|+|++|++++.++. ..+|+.|++++|+++ .
T Consensus 269 Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~l---p~~L~~L~Ls~N~L~-~ 336 (788)
T PRK15387 269 IFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPAL---PSELCKLWAYNNQLT-S 336 (788)
T ss_pred ccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCC---cccccccccccCccc-c
Confidence 7777776 455432 45667777777776 34542 35677777777777654321 123445555555554 2
Q ss_pred CCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhh
Q 001858 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDF 339 (1003)
Q Consensus 260 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 339 (1003)
+|.. ..+|++|+|++|+|++ +|.. .++|+.|++++|+|+.++.
T Consensus 337 LP~l----p~~Lq~LdLS~N~Ls~-LP~l---------------------------p~~L~~L~Ls~N~L~~LP~----- 379 (788)
T PRK15387 337 LPTL----PSGLQELSVSDNQLAS-LPTL---------------------------PSELYKLWAYNNRLTSLPA----- 379 (788)
T ss_pred cccc----ccccceEecCCCccCC-CCCC---------------------------CcccceehhhccccccCcc-----
Confidence 3321 1244455555555442 2321 1234444555555443221
Q ss_pred HhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCcccccc
Q 001858 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELI 419 (1003)
Q Consensus 340 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 419 (1003)
...+|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+.+++
T Consensus 380 -----l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~ 445 (788)
T PRK15387 380 -----LPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLS 445 (788)
T ss_pred -----cccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhcc
Confidence 01345555666665553 3322 2355666666666663 3432 235677788888887 6777788888
Q ss_pred ccceeccccccccccccccccC
Q 001858 420 NLQALDFSANNLHGIIPDSIGN 441 (1003)
Q Consensus 420 ~L~~L~Ls~N~l~~~~~~~~~~ 441 (1003)
+|+.|+|++|+|++..+..+..
T Consensus 446 ~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 446 SETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred CCCeEECCCCCCCchHHHHHHH
Confidence 8888888888888776665533
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=245.28 Aligned_cols=269 Identities=28% Similarity=0.308 Sum_probs=159.3
Q ss_pred ccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceee
Q 001858 124 SRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLG 203 (1003)
Q Consensus 124 ~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~ 203 (1003)
..-..|+|+.|.|+ .+|+.+. ++|+.|++++|+++ .+|.. .++|++|+|++|+++ .+|.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLT-SLPVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccC-cccCc---ccccceee
Confidence 34556777777777 6777665 36777777777776 45542 245666666666666 34532 24555566
Q ss_pred eeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCccccc
Q 001858 204 VGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTG 283 (1003)
Q Consensus 204 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~ 283 (1003)
+++|.++ .+|..+ .+|+.|++++|+++. +|. ..++|++|+|++|+|++
T Consensus 269 Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~------------------------LP~----~p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 269 IFSNPLT-HLPALP---SGLCKLWIFGNQLTS------------------------LPV----LPPGLQELSVSDNQLAS 316 (788)
T ss_pred ccCCchh-hhhhch---hhcCEEECcCCcccc------------------------ccc----cccccceeECCCCcccc
Confidence 6666555 333322 334455555555442 221 12456666666666653
Q ss_pred CcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCC
Q 001858 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSL 363 (1003)
Q Consensus 284 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 363 (1003)
+|... .+|+.|++++|+|++++. ...+|++|+|++|+|+.+
T Consensus 317 -Lp~lp---~~L~~L~Ls~N~L~~LP~----lp~~Lq~LdLS~N~Ls~L------------------------------- 357 (788)
T PRK15387 317 -LPALP---SELCKLWAYNNQLTSLPT----LPSGLQELSVSDNQLASL------------------------------- 357 (788)
T ss_pred -CCCCc---ccccccccccCccccccc----cccccceEecCCCccCCC-------------------------------
Confidence 33321 245555666666553221 112455555555554433
Q ss_pred cccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccccCCC
Q 001858 364 PRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLS 443 (1003)
Q Consensus 364 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 443 (1003)
|.. ..+|+.|++++|+|+. +|.. ..+|+.|++++|+|++ +|... ++|+.|++++|+|++ +|.. ..
T Consensus 358 P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l---~~ 422 (788)
T PRK15387 358 PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPML---PS 422 (788)
T ss_pred CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcc---hh
Confidence 221 1234445555555553 3332 2467788888888873 55432 568888889888884 5543 34
Q ss_pred ccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhc
Q 001858 444 TLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEIT 491 (1003)
Q Consensus 444 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~ 491 (1003)
+|+.|++++|+|+ .+|..+.++++|+.|+|++|+|++..|..+..+.
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 6788999999998 7888899999999999999999987777664443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=221.04 Aligned_cols=267 Identities=21% Similarity=0.237 Sum_probs=198.0
Q ss_pred cCCccCeeeeccceEEEEEEECCCC-ceEEEEEeccccccchHHHHHHHHHHHhcCC----CCceeEeeeeeecccCCCC
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDL-LPVAVKVINLKQKGSIKSFVAECEALKNIRH----RNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 778 (1003)
+|.+.++||+|+||.||.|.+..++ ..+|+|............+..|..++..+.. +++.++++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 8999999999999999999997664 6789998875544333378889999998863 68888887732 3567
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-----CCeE
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-----MVAH 853 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-----~~~k 853 (1003)
+.++||+.+ |.+|.++..... .+.++...+.+++.|++.+|+++|+. |++||||||.|+.++.. ..+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEE
Confidence 789999988 669999887654 46899999999999999999999999 99999999999999865 4699
Q ss_pred Eccccccc--ccccCCc---cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchh
Q 001858 854 VSDFGLAK--FLFDRPI---QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928 (1003)
Q Consensus 854 l~DfG~a~--~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~ 928 (1003)
+.|||+|+ .+..... .........+.||.+|++++++.+...+++.|+||++.++.|+..|..||.........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~- 246 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK- 246 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-
Confidence 99999998 3322221 11111134567999999999999999999999999999999999999999665432110
Q ss_pred hHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHHhh
Q 001858 929 HGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 929 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~~ 997 (1003)
.............. ........+.++...+-..+..++|....+.+.++.....
T Consensus 247 ---------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 247 ---------SKFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ---------HHHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 01111111111110 0011123455555555567899999999999887766554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=261.47 Aligned_cols=205 Identities=17% Similarity=0.231 Sum_probs=139.6
Q ss_pred hcCC-CCceeEeeeeeecc--cCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 001858 756 NIRH-RNLIKIITVCSSID--FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQP 832 (1003)
Q Consensus 756 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 832 (1003)
.++| +||+++++++.... ..+.+..+.++||++ ++|.+++... ...+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~--- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQ--- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 4455 57777777653221 122345677889884 5999999753 34689999999999999999999999
Q ss_pred CcEeccCCCCceEeCC-------------------CCCeEEcccccccccccCCc---c--------ccCcccccccccc
Q 001858 833 PIVHGDLKPSNVLLDH-------------------DMVAHVSDFGLAKFLFDRPI---Q--------ETSSSSIGIKGTV 882 (1003)
Q Consensus 833 ~ivH~Dikp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~---~--------~~~~~~~~~~gt~ 882 (1003)
+|+||||||+|||++. ++.+|++|||+++....... . ..........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 44566666666654211000 0 0000111245899
Q ss_pred cccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHH
Q 001858 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEEC 962 (1003)
Q Consensus 883 ~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~ 962 (1003)
.|||||++.+..++.++|||||||++|||++|..|+..... .......... +.. ....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------------~~~~~~~~~~---~~~----~~~~ 237 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------------TMSSLRHRVL---PPQ----ILLN 237 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------------HHHHHHHhhc---Chh----hhhc
Confidence 99999999999999999999999999999998887542110 0001111000 100 0011
Q ss_pred HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 963 LTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 963 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......++.+|++++|.+||++.|++++
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 2334577789999999999999999875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=196.83 Aligned_cols=209 Identities=25% Similarity=0.333 Sum_probs=173.7
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCC-CCceeEeeeeeecccCCCCc
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH-RNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 779 (1003)
..+.|+++++||.|+||.+|.|..-.+|..||||+-+.. ....++..|.++.+.++| ..|..+..| ..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 357899999999999999999999999999999997533 333678889999999975 555555555 345667
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC---CCeEEcc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD---MVAHVSD 856 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~---~~~kl~D 856 (1003)
-.+|||.. |.+|.+...-+ ...++..+++..|-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|
T Consensus 86 nvlVMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ceeeeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 79999998 66999999876 45789999999999999999999999 99999999999999744 4689999
Q ss_pred cccccccccCCccc--cCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCC
Q 001858 857 FGLAKFLFDRPIQE--TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924 (1003)
Q Consensus 857 fG~a~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~ 924 (1003)
||+|+.+.+..... .........||.+|++-.+..+...+.+.|+-|+|.++.+.-.|..||++....
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 99998876543221 222334567999999999999999999999999999999999999999987543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-24 Score=225.41 Aligned_cols=326 Identities=19% Similarity=0.189 Sum_probs=229.7
Q ss_pred eccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeec
Q 001858 275 IVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354 (1003)
Q Consensus 275 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 354 (1003)
+.++-.++ .+|..+- ..-+.++|..|+|+.+++.+|+.+++|++|+|++|+|+.+..+ +|..+++|.+|-+
T Consensus 52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~------AF~GL~~l~~Lvl 122 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPD------AFKGLASLLSLVL 122 (498)
T ss_pred EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChH------hhhhhHhhhHHHh
Confidence 33444444 4555442 4567788899999988888899999999999999888876544 4556667666555
Q ss_pred cC-cCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccccccc
Q 001858 355 NS-NRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHG 433 (1003)
Q Consensus 355 ~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 433 (1003)
-+ |+|+......|+++..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+--.+|..+.+++.+.+..|.+-.
T Consensus 123 yg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic 202 (498)
T KOG4237|consen 123 YGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC 202 (498)
T ss_pred hcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc
Confidence 55 88887667778888888888888888887777888888888888888888874333477778888888887777431
Q ss_pred cccccccCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhc--cccccccCCCCccccccccc
Q 001858 434 IIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEIT--TLSSLLDLSSNLISGSIPLV 511 (1003)
Q Consensus 434 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~--~l~~~l~L~~N~l~~~~p~~ 511 (1003)
.++++.+... +. ..|..++...-..-..+.++++. .+++.-+... ++.+.+....+....-....
T Consensus 203 -----dCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~c 269 (498)
T KOG4237|consen 203 -----DCNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKC 269 (498)
T ss_pred -----ccccchhhhH-Hh------hchhhcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHH
Confidence 1223322221 11 22333444444555556666665 3333322221 22222222333333333456
Q ss_pred cccccccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccc
Q 001858 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLE 591 (1003)
Q Consensus 512 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 591 (1003)
|..+++|+.|+|++|++++.-+.+|.++..+++|+|..|+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 89999999999999999988889999999999999999999876677889999999999999999999999999999999
Q ss_pred eEecCCCcccccCCCCCccCCCcceeeccCC
Q 001858 592 YLNLSYNDFEGQVPTKGVFSNKTRISLIENG 622 (1003)
Q Consensus 592 ~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 622 (1003)
+|+|-.|+|.|.+-....-..++.-+..|||
T Consensus 350 ~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~ 380 (498)
T KOG4237|consen 350 TLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP 380 (498)
T ss_pred eeehccCcccCccchHHHHHHHhhCCCCCCC
Confidence 9999999999877653322333333345554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=219.34 Aligned_cols=170 Identities=22% Similarity=0.183 Sum_probs=131.0
Q ss_pred HHhccCCccCeeeeccceEEEEEEECC-CCceEEEEEeccc-----cccchHHHHHHHHHHHhcCCCCcee-Eeeeeeec
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGE-DLLPVAVKVINLK-----QKGSIKSFVAECEALKNIRHRNLIK-IITVCSSI 772 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 772 (1003)
...++|++.+.||+|+||+||+|.+.. +++.||||++... .....+.|.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345789999999999999999999876 6777899987532 1223567999999999999999985 4332
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC-CCCceEeCCCCC
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDMV 851 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~ 851 (1003)
+..++||||++|++|... .. .+ ...++.++++|++|||+. ||+|||| ||+||+++.++.
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~~-----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-RP-----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-Cc-----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence 235999999999999632 11 11 146788999999999999 9999999 999999999999
Q ss_pred eEEcccccccccccCCcccc---CcccccccccccccCccccCCC
Q 001858 852 AHVSDFGLAKFLFDRPIQET---SSSSIGIKGTVGYVAPEYGMGG 893 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~ 893 (1003)
+||+|||+|+.+........ ...-....+++.|+|||++...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999987754321111 0111356688999999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-22 Score=235.63 Aligned_cols=262 Identities=19% Similarity=0.338 Sum_probs=200.6
Q ss_pred CCceeeEEeCCCCCcEEEEEeecCCCCcccCccccCCCCCcEEEcCCCCCCCCCchhhcccccCcEEEecccccccccCc
Q 001858 63 VCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPS 142 (1003)
Q Consensus 63 ~c~w~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~ 142 (1003)
-+.|+-..|-. ..++.|++.+.+++. +|..+. ++|+.|+|++|+++ .+|..+. .+|++|+|++|+|+ .+|.
T Consensus 167 ~a~~r~~~Cl~--~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~ 237 (754)
T PRK15370 167 EAVQRMRDCLK--NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPA 237 (754)
T ss_pred HHHHHHHhhcc--cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCCh
Confidence 34566566754 367889999998884 676664 58999999999999 7898775 59999999999999 7888
Q ss_pred cCcCCCCCceeecccccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCC
Q 001858 143 NLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRD 222 (1003)
Q Consensus 143 ~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 222 (1003)
.+. .+|+.|+|++|+++ .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|+|+ .+|..+. .+
T Consensus 238 ~l~--~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~s 305 (754)
T PRK15370 238 TLP--DTIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SG 305 (754)
T ss_pred hhh--ccccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hh
Confidence 765 48999999999998 8898764 58999999999999 6888775 58999999999999 4676554 47
Q ss_pred CCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccC
Q 001858 223 LNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSG 302 (1003)
Q Consensus 223 L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 302 (1003)
|+.|++++|+++..++.+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++
T Consensus 306 L~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 306 ITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTITTLDVSR 376 (754)
T ss_pred HHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCcCEEECCC
Confidence 9999999999997655443 68999999999998 5887664 79999999999998 5676553 5788888888
Q ss_pred ccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCC
Q 001858 303 NHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFG 360 (1003)
Q Consensus 303 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 360 (1003)
|+|+..++. +. ..|+.|++++|+|..++.. ++..+..++++..|++.+|.+.
T Consensus 377 N~Lt~LP~~-l~--~sL~~LdLs~N~L~~LP~s---l~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 377 NALTNLPEN-LP--AALQIMQASRNNLVRLPES---LPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CcCCCCCHh-HH--HHHHHHhhccCCcccCchh---HHHHhhcCCCccEEEeeCCCcc
Confidence 888754332 21 2566777777776654321 1222333455555666555554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=197.83 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=189.0
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccc--ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEE
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
..+..+|.+...|+.|+|+++++ .+++|++...+ ....++|..|.-.++.+.||||..+++.|.. +....+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceE
Confidence 34556789999999999999865 57778876443 2234689999999999999999999999854 355689
Q ss_pred eeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEc--ccccc
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS--DFGLA 860 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~--DfG~a 860 (1003)
+..||+.|+|+..++... .-.++..|+.+++.++++|++|||+.. |-|.---+.++.+++|++.+++|+ |--++
T Consensus 265 isq~mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eeeeccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceee
Confidence 999999999999998865 446788899999999999999999983 334445688999999999988774 43322
Q ss_pred cccccCCccccCcccccccccccccCccccCCCCCC---ccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCc
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVS---LTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~ 937 (1003)
. ...+..-.+.||+||.++.++.+ .++|+|||++++||+.|...||.+..+-+...
T Consensus 341 f------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------- 399 (448)
T KOG0195|consen 341 F------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------- 399 (448)
T ss_pred e------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------
Confidence 1 11123346889999998877654 46899999999999999999998764422211
Q ss_pred hhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 938 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
+-.+.. -|...++.....+.+++.-|+..||.+||.+..|+--|++..
T Consensus 400 -------kialeg---lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 -------KIALEG---LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------hhhhcc---ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111111 112222345667889999999999999999999998887653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=226.78 Aligned_cols=257 Identities=20% Similarity=0.225 Sum_probs=190.1
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEeccc--ccc----chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKG----SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
...+++|.|++|.|+.+.........+.|..... ... ....+..|+.+-..++|||++..+..+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 3457899999998888887666555566544311 111 12236667778888999999887766432 222
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
..-+|||+++ +|..++.. .+.+...++..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred chhhhhcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence 3344999999 99999986 34688889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCccccCcccccccccccccCccccCCCCCCcc-ccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCch
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+..+.-. ...........+|+..|+|||+..+..|++. .||||.|+++..|.+|+.||......+..+...
T Consensus 467 ~~vf~~~-~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------- 538 (601)
T KOG0590|consen 467 ASVFRYP-WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------- 538 (601)
T ss_pred ceeeccC-cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------
Confidence 9765332 2222244556789999999999999999875 899999999999999999997655443332000
Q ss_pred hHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 939 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
..................++.....++.++++++|.+|.++++|++
T Consensus 539 -----~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 -----NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -----ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000001111123334455677788899999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-19 Score=200.63 Aligned_cols=263 Identities=30% Similarity=0.444 Sum_probs=195.4
Q ss_pred CCccCeeeeccceEEEEEEECCCCceEEEEEecccccc---chHHHHHHHHHHHhcCCC-CceeEeeeeeecccCCCCce
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---SIKSFVAECEALKNIRHR-NLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 705 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 780 (1003)
|.+.+.+|.|+||.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 677889999999999999997 67999998754433 367899999999999988 799999985 334447
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC-CeEEccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 859 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~DfG~ 859 (1003)
+++++++.++++.+++...... ..+.......+..|++.+++|+|+. +++|||+||+||+++..+ .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 9999999999999877763211 3688999999999999999999999 999999999999999988 799999999
Q ss_pred ccccccCCccccC-cccccccccccccCccccCC---CCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhh
Q 001858 860 AKFLFDRPIQETS-SSSIGIKGTVGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 860 a~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~ 935 (1003)
++........... .......|+..|+|||...+ ..+....|+||+|++++++++|..||...... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----------~ 218 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----------S 218 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----------c
Confidence 9855432211111 12345679999999999887 57888999999999999999999996654321 0
Q ss_pred CchhHHHHHHhhccc--CCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 001858 936 LPEKVMEIVDFALLL--DPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~~~l~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 990 (1003)
......+.+...... .+.............+.+++..|+..+|..|.++.+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 001111111111111 0000000001223456778888888899999998887765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=184.21 Aligned_cols=176 Identities=15% Similarity=0.184 Sum_probs=134.0
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchH---H------HHHHHHHHHhcCCCCceeEeeeeee
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK---S------FVAECEALKNIRHRNLIKIITVCSS 771 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~ 771 (1003)
..++|+..+++|.|+||.||++.. ++..+|+|+++.......+ . +.+|++.+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 468999999999999999999766 3568999999754433322 2 6899999999999999999887543
Q ss_pred ccc---CCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC
Q 001858 772 IDF---KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848 (1003)
Q Consensus 772 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~ 848 (1003)
... .-....++||||++|.+|.++.. +++ ....+++.+++.+|+. |++|||++|+||+++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 221 12346799999999999988732 222 2456999999999999 9999999999999999
Q ss_pred CCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHH
Q 001858 849 DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912 (1003)
Q Consensus 849 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell 912 (1003)
+| ++++|||......... . ...+.....+..++|+|++|+++....
T Consensus 171 ~g-i~liDfg~~~~~~e~~-----a------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRK-----A------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchh-----h------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 88 9999999886442110 0 011334455667899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=181.04 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=108.4
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEecccccc--c-------hHH-----------------HHHHHHHHHhcCCCC
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--S-------IKS-----------------FVAECEALKNIRHRN 761 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~n 761 (1003)
...||+|+||.||+|.+. +|+.||||+++..... . ... ..+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999743211 0 112 234999999998877
Q ss_pred ceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCcEeccCC
Q 001858 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLK 840 (1003)
Q Consensus 762 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dik 840 (1003)
+.....+. . ...++||||++++++...... .+.+++.++..++.|++.+++|+ |+. +|+|||||
T Consensus 81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlk 145 (190)
T cd05147 81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLS 145 (190)
T ss_pred CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 64433321 1 122799999999877655332 34688899999999999999999 688 99999999
Q ss_pred CCceEeCCCCCeEEccccccccc
Q 001858 841 PSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 841 p~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|+||+++ ++.++++|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 578999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=190.37 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=149.6
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccc---ccchHHHHHHHHHHHhcC----------CCCceeEeeee
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVAECEALKNIR----------HRNLIKIITVC 769 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~ 769 (1003)
..+...+.||.|+++.||.+++.++++++|+|++.... ....+.+.+|.-....+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 45566789999999999999999999999999986443 233566777765544432 22333333332
Q ss_pred eecc-------cCCCC-----ceEEeeecccCCCHHHHHhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 001858 770 SSID-------FKGDD-----FKALVYDYMQSGSLEDWLQQ---SNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPI 834 (1003)
Q Consensus 770 ~~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 834 (1003)
.... -.+.. ..+++|+-+.+ +|.+++.. .... ........+..+..|+++.+++||+. |+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 2110 00011 23567887754 88887653 2211 22344555566779999999999999 99
Q ss_pred EeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCC--------CCCCccccchhHHH
Q 001858 835 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG--------GNVSLTGDVYSFGI 906 (1003)
Q Consensus 835 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~ 906 (1003)
+|+||+|+|++++.+|.++++||+......... .....+..|.|||.... -.++.+.|.|++|+
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE--------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCcee--------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999998886543211 11234578999997533 24688899999999
Q ss_pred HHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCC
Q 001858 907 LLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981 (1003)
Q Consensus 907 il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 981 (1003)
++|.|+||+.||............ + ... .+.++.+..++...++++|++|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~~-----------------f-~~C-------~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEWD-----------------F-SRC-------RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGGG-----------------G-TTS-------S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccccccc-----------------c-hhc-------CCcCHHHHHHHHHHccCCcccC
Confidence 999999999999865332111100 0 000 0335567777788888888877
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=174.33 Aligned_cols=139 Identities=21% Similarity=0.171 Sum_probs=109.9
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccccc--------------------------hHHHHHHHHHHHhcCCCC
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--------------------------IKSFVAECEALKNIRHRN 761 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 761 (1003)
...||+|++|.||+|.+. +|+.||||+++...... ...+..|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999987542110 123467899999999998
Q ss_pred ceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccCC
Q 001858 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLK 840 (1003)
Q Consensus 762 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dik 840 (1003)
+.....+.. . ..++||||++++++...... ...++..+...++.|++.++.++|+ . ||+|||||
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlk 145 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLS 145 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 754444321 1 23899999998865443222 2356788899999999999999999 8 99999999
Q ss_pred CCceEeCCCCCeEEccccccccc
Q 001858 841 PSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 841 p~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|+||+++ ++.++++|||++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999998 899999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.6e-21 Score=173.93 Aligned_cols=166 Identities=31% Similarity=0.500 Sum_probs=119.1
Q ss_pred ccCCCCccEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCC
Q 001858 391 IRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLM 470 (1003)
Q Consensus 391 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 470 (1003)
+.++.+.+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 345566666777777776 56666677777777777777776 56666777777777777777776 6677777777777
Q ss_pred eeeccCccccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCC
Q 001858 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550 (1003)
Q Consensus 471 ~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 550 (1003)
.|||++|++.. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|
T Consensus 106 vldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence 77777766651 134555667777888888888886 77888888888888888888
Q ss_pred CccccCCcccccccCcCeeeccCceeccCCcccccC
Q 001858 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLED 586 (1003)
Q Consensus 551 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 586 (1003)
.+- .+|.+++.++.|++|.+.+|+++ .+|+.+++
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 887 67888888888888888888887 45544444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-20 Score=208.58 Aligned_cols=286 Identities=22% Similarity=0.280 Sum_probs=152.8
Q ss_pred eeeccCcccc-cCcCccccccccchhhhccCccccCc----cCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCC
Q 001858 273 ILIVGQNNLT-GSIPQSFSNASNLVILNLSGNHFSGK----VGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347 (1003)
Q Consensus 273 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 347 (1003)
.|+|..+.++ ......+..+.+|++|+++++.++.. ++..+...++|++|+++++.+...+.+.......+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566666666 33344455566677777777766432 222344455566666666555421111111223344455
Q ss_pred CCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccc----cCCCccccc-cccc
Q 001858 348 KLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG----TIPYTIGEL-INLQ 422 (1003)
Q Consensus 348 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l-~~L~ 422 (1003)
+|+.|++++|.+.+..+..+..+.+ . ++|++|++++|++++ .+...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCce
Confidence 5555555555554333333333222 1 225555555555542 122223334 5556
Q ss_pred eecccccccccc----ccccccCCCccceeecccccccc----cCCccccCCCCCCeeeccCccccCCCchhhhhhcccc
Q 001858 423 ALDFSANNLHGI----IPDSIGNLSTLNSLWLGFNNLQG----NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLS 494 (1003)
Q Consensus 423 ~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~ 494 (1003)
.|++++|.+++. ++..+..+++|++|++++|.+++ .++..+..+++|+.|++++|.+++.-..
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------- 211 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------- 211 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH---------
Confidence 666666665522 22334455566666666666653 2233344556677777777766521111
Q ss_pred ccccCCCCccccccccccccccccccccccccccccccCcccc-----CcccccEEEecCCCccc----cCCcccccccC
Q 001858 495 SLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS-----SCTSLEYLKMQDNSFRG----SIPSSLISLKS 565 (1003)
Q Consensus 495 ~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~ 565 (1003)
.++..+..+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++
T Consensus 212 ------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~ 279 (319)
T cd00116 212 ------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES 279 (319)
T ss_pred ------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCC
Confidence 1122245566777788877777653222222 23678888888888762 23445556677
Q ss_pred cCeeeccCceeccC----CcccccCC-CccceEecCCCcc
Q 001858 566 IEVLDLSCNNLSGQ----IPEYLEDL-SFLEYLNLSYNDF 600 (1003)
Q Consensus 566 L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~l~~N~l 600 (1003)
|+.+|+++|.++.. ....+... +.|+.+++.+|+|
T Consensus 280 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 280 LLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 88888888888744 44455555 6788888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-20 Score=171.08 Aligned_cols=180 Identities=28% Similarity=0.445 Sum_probs=157.6
Q ss_pred cccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhcccc
Q 001858 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLS 494 (1003)
Q Consensus 415 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~ 494 (1003)
+.++.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. .
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~------------ 93 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-I------------ 93 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-c------------
Confidence 446778899999999998 77888999999999999999999 88999999999999999999987 3
Q ss_pred ccccCCCCcccccccccccccccccccccccccccc-ccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccC
Q 001858 495 SLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSC 573 (1003)
Q Consensus 495 ~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 573 (1003)
.|..|+.++.|+.|||.+|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+
T Consensus 94 -------------lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 94 -------------LPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred -------------CccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 45558888999999999999964 48999999999999999999998 8899999999999999999
Q ss_pred ceeccCCcccccCCCccceEecCCCcccccCCCCCccC---CCcceeeccCCCc
Q 001858 574 NNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFS---NKTRISLIENGKL 624 (1003)
Q Consensus 574 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~---~~~~~~~~~n~~~ 624 (1003)
|.+- ..|..++.++.|+.|.+.+|+++-.+|..+.+. +........|||.
T Consensus 160 ndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 160 NDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred Cchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9998 689999999999999999999998888766554 3344567889985
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-20 Score=203.91 Aligned_cols=286 Identities=23% Similarity=0.306 Sum_probs=179.0
Q ss_pred HHhhcccccCCCCCcccccCccccceeeccCcccccC----cCccccccccchhhhccCccccC------ccCcccCCCC
Q 001858 248 QISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGS----IPQSFSNASNLVILNLSGNHFSG------KVGIDFSSLP 317 (1003)
Q Consensus 248 ~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~ 317 (1003)
+|+|..+.+++.--..++..++.|++|++++|.+++. ++..+...++|++|++++|.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4778888887443344445778899999999999643 56667788889999999998873 2334567789
Q ss_pred cccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCC-CC
Q 001858 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNL-AN 396 (1003)
Q Consensus 318 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~ 396 (1003)
+|++|++++|.+...... .+...... ++|++|++++|++++..... +...+..+ ++
T Consensus 82 ~L~~L~l~~~~~~~~~~~--~~~~l~~~-~~L~~L~ls~~~~~~~~~~~--------------------l~~~l~~~~~~ 138 (319)
T cd00116 82 GLQELDLSDNALGPDGCG--VLESLLRS-SSLQELKLNNNGLGDRGLRL--------------------LAKGLKDLPPA 138 (319)
T ss_pred ceeEEEccCCCCChhHHH--HHHHHhcc-CcccEEEeeCCccchHHHHH--------------------HHHHHHhCCCC
Confidence 999999999998752211 11122222 55999999999887421111 11122233 45
Q ss_pred ccEEEcccccccc----cCCCccccccccceecccccccccc----ccccccCCCccceeeccccccccc----CCcccc
Q 001858 397 IYALGLEYNQLTG----TIPYTIGELINLQALDFSANNLHGI----IPDSIGNLSTLNSLWLGFNNLQGN----IPSSLG 464 (1003)
Q Consensus 397 L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~ 464 (1003)
|++|++++|.+++ .++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+.
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~ 218 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLA 218 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhc
Confidence 5555555555542 1223344455666666666666532 223344456777777777776532 334566
Q ss_pred CCCCCCeeeccCccccCCCchhhhhhccccccccCCCCcccccccccccccccccccccccccccc----ccCccccCcc
Q 001858 465 NCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG----EIPTTLSSCT 540 (1003)
Q Consensus 465 ~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~ 540 (1003)
.+++|++|++++|++++.....+... . ....+.|+.|++++|.++. .++..+..++
T Consensus 219 ~~~~L~~L~ls~n~l~~~~~~~l~~~-----------------~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~ 278 (319)
T cd00116 219 SLKSLEVLNLGDNNLTDAGAAALASA-----------------L---LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE 278 (319)
T ss_pred ccCCCCEEecCCCcCchHHHHHHHHH-----------------H---hccCCCceEEEccCCCCCcHHHHHHHHHHhcCC
Confidence 77888888888888773211111110 0 1124578888888888762 2344566667
Q ss_pred cccEEEecCCCcccc----CCcccccc-cCcCeeeccCcee
Q 001858 541 SLEYLKMQDNSFRGS----IPSSLISL-KSIEVLDLSCNNL 576 (1003)
Q Consensus 541 ~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l 576 (1003)
+|+++++++|.++.. +...+... +.|+.|++.+|++
T Consensus 279 ~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 279 SLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 888888888888744 34444444 6788888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-19 Score=205.13 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=174.9
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-ccchHHHH---HHHHHHHhcCCCCceeEeeeeeecccCCCCc
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFV---AECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 779 (1003)
+|...+.+|.+.|=.|.+|++.+ | .|+||++-+.+ ....+.|. .|++ ...++|||++++.-+ ...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence 67778899999999999999973 4 48999986544 22333444 4444 555689999998766 445666
Q ss_pred eEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccc
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 859 (1003)
-|+|-+|+.+ +|+|.+.. ++.+...+.+.|+.|++.|+..+|+. ||+|||||.+|||++.=.-+.|+||..
T Consensus 96 AylvRqyvkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHHhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 7899999977 99999987 56788888999999999999999999 999999999999999999999999965
Q ss_pred ccccccCCccccCcccccc----cccccccCccccCCC----------C-CCccccchhHHHHHHHHHh-CCCCCCcccC
Q 001858 860 AKFLFDRPIQETSSSSIGI----KGTVGYVAPEYGMGG----------N-VSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~il~ell~-g~~P~~~~~~ 923 (1003)
-+...-.. +.......+ ..-..|.|||.+... . .+++-||||+||+++|+++ |++||.-.
T Consensus 167 FKPtYLPe--DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 167 FKPTYLPE--DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred cCCccCCC--CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 43221000 000111111 122469999976441 1 4677899999999999999 78888531
Q ss_pred CcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 924 DGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
++..|.... ........+. ++ ...+..++..|++.||++|.++++.++.-
T Consensus 243 ---QL~aYr~~~-~~~~e~~Le~------------Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 243 ---QLLAYRSGN-ADDPEQLLEK------------IE--DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ---HHHhHhccC-ccCHHHHHHh------------Cc--CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 111111100 0111111111 11 12467788889999999999999998863
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-18 Score=204.19 Aligned_cols=152 Identities=32% Similarity=0.544 Sum_probs=131.0
Q ss_pred CCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCC----ceeeEEeCC--CC--CcEEEEEeecCCCCcccCccccCCCCCc
Q 001858 32 SNETDRVALLAIKSQLQDPMGITSSWNNSINVC----QWTGVTCGQ--RH--PRVIQLYLRNQSVGGFLSPYVGNLSFLR 103 (1003)
Q Consensus 32 ~~~~~~~al~~~k~~~~d~~~~~~sW~~~~~~c----~w~gv~c~~--~~--~~v~~l~l~~~~~~g~~~~~l~~l~~L~ 103 (1003)
+.+.|.+||++||+++.+|.. .+|+++ .|| .|.||.|+. .. .+|+.|+|+++++.|.+|+.+++|++|+
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 457899999999999987653 589763 332 799999953 22 3699999999999999999999999999
Q ss_pred EEEcCCCCCCCCCchhhcccccCcEEEecccccccccCccCcCCCCCceeecccccccCCCCccccccccccceEEccCc
Q 001858 104 FINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN 183 (1003)
Q Consensus 104 ~L~L~~n~~~g~ip~~l~~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n 183 (1003)
.|+|++|+++|.+|..++.+++|++|+|++|+++|.+|+.++++++|++|+|++|+++|.+|..++....++..+++++|
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N 525 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999888765456667777766
Q ss_pred ccc
Q 001858 184 QLT 186 (1003)
Q Consensus 184 ~l~ 186 (1003)
...
T Consensus 526 ~~l 528 (623)
T PLN03150 526 AGL 528 (623)
T ss_pred ccc
Confidence 543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=167.07 Aligned_cols=189 Identities=15% Similarity=0.066 Sum_probs=136.0
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEecccccc----chHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCce
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG----SIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.+...|+.|+||+||.+.. .+.+++.+.+.....- ....+.+|+++++++. |+++.+++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3567899999999997766 4567777766532221 1235889999999995 58899998761 24
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC-CCCceEeCCCCCeEEccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL-KPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~Nill~~~~~~kl~DfG~ 859 (1003)
+++|||++|.+|.+.... + ...++.|++++++++|++ ||+|||| ||+||+++.++.++|+|||+
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred EEEEeeecCccHHhhhhh------h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 899999999998754321 1 134678999999999999 9999999 79999999999999999999
Q ss_pred ccccccCCcc----cc---Cc-ccccccccccccCccccCCC-CCC-ccccchhHHHHHHHHHhCCCCCCc
Q 001858 860 AKFLFDRPIQ----ET---SS-SSIGIKGTVGYVAPEYGMGG-NVS-LTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 860 a~~~~~~~~~----~~---~~-~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
|........- .. .. .......++.|++|+...-- ..+ .+.+.++-|+-+|.++|++.|+..
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 9854332210 00 00 00012256777777753221 233 567899999999999999988654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.2e-18 Score=200.47 Aligned_cols=200 Identities=23% Similarity=0.287 Sum_probs=155.2
Q ss_pred HHhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCcee-EeeeeeecccCCCC
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK-IITVCSSIDFKGDD 778 (1003)
Q Consensus 700 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~ 778 (1003)
.....|.|.+.+|+|+||.||+|...+ ++.||+|+-+.... -+|.--.+++.+++ +-+.. +..++..+-+ .+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~--~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLK-PQMLPSIMHISSAHVF--QN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhc-hhhhcchHHHHHHHcc--CC
Confidence 345678899999999999999999986 99999999764332 22222334455555 22211 2222222222 34
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC-------CCC
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-------DMV 851 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-------~~~ 851 (1003)
.-++|+||.+.|+|.+++.. .+..+|.-++.++.|++..+++||.. +||||||||+|+++.. ...
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 44899999999999999984 56788999999999999999999999 9999999999999952 346
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCC
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P 917 (1003)
++|+|||.+..+.-- .........++|-.+-.+|...|..++..+|-|.++-+++.|+.|++-
T Consensus 840 l~lIDfG~siDm~lf---p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLF---PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEc---CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 899999999876432 222344567889999999999999999999999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=165.55 Aligned_cols=139 Identities=19% Similarity=0.252 Sum_probs=107.0
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-----CCCCceeEeeeeeecccCCCCce
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-----RHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+++++.+ .||||++++|++... .+.+..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence 3457899999999995 6556554 69988765555567899999999999 579999999996441 122343
Q ss_pred E-Eeeec--ccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCcEeccCCCCceEeCC----CCCe
Q 001858 781 A-LVYDY--MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI-EYLHHHCQPPIVHGDLKPSNVLLDH----DMVA 852 (1003)
Q Consensus 781 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dikp~Nill~~----~~~~ 852 (1003)
+ +|+|| +.+++|.+++++. .+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 4 78999 5579999999752 24444 35577777777 999999 9999999999999974 3479
Q ss_pred EEcccccc
Q 001858 853 HVSDFGLA 860 (1003)
Q Consensus 853 kl~DfG~a 860 (1003)
+|+||+.+
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.5e-17 Score=170.87 Aligned_cols=203 Identities=22% Similarity=0.234 Sum_probs=138.2
Q ss_pred CCCCceeEeeeeeec----------------------ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHH
Q 001858 758 RHRNLIKIITVCSSI----------------------DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815 (1003)
Q Consensus 758 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 815 (1003)
+|||||++.+++... ...+....|+||..++. +|.+++... ..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 599999998876431 02235668999999976 999999863 4556677788
Q ss_pred HHHHHHHHHHHHhcCCCCcEeccCCCCceEeC--CCC--CeEEcccccccccccCCcc-ccCcccccccccccccCcccc
Q 001858 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDM--VAHVSDFGLAKFLFDRPIQ-ETSSSSIGIKGTVGYVAPEYG 890 (1003)
Q Consensus 816 ~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~--~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~ 890 (1003)
+.|+++|+.|||.+ ||.|||+|++|||+. +|+ .+.++|||++---...... +..+.....-|...-||||+.
T Consensus 347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 99999999999999 999999999999994 343 5788999998432221111 112222234477889999986
Q ss_pred CCCC-----C-CccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCchhhHHHHHH
Q 001858 891 MGGN-----V-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLT 964 (1003)
Q Consensus 891 ~~~~-----~-~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~ 964 (1003)
...+ . -.|+|.|+.|.+.||+++..-||-....-..+...|-+. +-++..+.++.
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-------------------qLPalp~~vpp 484 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-------------------QLPALPSRVPP 484 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-------------------hCCCCcccCCh
Confidence 5432 1 247999999999999999999986521111111111111 11222334455
Q ss_pred HHHHHHhhccccCCCCCCCHHHHHH
Q 001858 965 AVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 965 ~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
.+.+++...++.+|++|+++.=...
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHh
Confidence 6777788888888888887654433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=183.18 Aligned_cols=217 Identities=26% Similarity=0.384 Sum_probs=162.5
Q ss_pred HHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001858 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP 833 (1003)
Q Consensus 754 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 833 (1003)
++.+.|.|+.+++|.+.. +...+.|.+|+..|+|.|.+... .-.+++.....+.++++.|++|+|.. +
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s---~ 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS---P 68 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC---c
Confidence 356789999999999743 37779999999999999999874 45789999999999999999999998 5
Q ss_pred c-EeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCC-------CCccccchhHH
Q 001858 834 I-VHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-------VSLTGDVYSFG 905 (1003)
Q Consensus 834 i-vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslG 905 (1003)
| .|+.+++.|+++|....+|++|||+.....+. ..........-..-|.|||.+.+.. .+.++||||+|
T Consensus 69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ 145 (484)
T KOG1023|consen 69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG 145 (484)
T ss_pred ceeeeeeccccceeeeeEEEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence 5 89999999999999999999999999766431 1111111122456799999877641 46679999999
Q ss_pred HHHHHHHhCCCCCCcccCCcchhhHHHHhhCchhHHHHHHhhcccCCCCch--hhHHHHHHHHHHHHhhccccCCCCCCC
Q 001858 906 ILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNER--AKIEECLTAVVRIGVLCSMESPSERIH 983 (1003)
Q Consensus 906 ~il~ell~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs 983 (1003)
++++|+++.+.||+........ +++...+... ..+..++ ....+....+..++.+||..+|++||+
T Consensus 146 ii~~ei~~r~~~~~~~~~~~~~----------~eii~~~~~~--~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 146 IIMYEILFRSGPFDLRNLVEDP----------DEIILRVKKG--GSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred HHHHHHHhccCccccccccCCh----------HHHHHHHHhc--CCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 9999999999999764322111 1111112221 1111121 112245567899999999999999999
Q ss_pred HHHHHHHHHHHHhh
Q 001858 984 MADAVKNLCAAREK 997 (1003)
Q Consensus 984 ~~ev~~~L~~~~~~ 997 (1003)
+++|-..++.+...
T Consensus 214 ~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 214 IEQIRSKLLTINKG 227 (484)
T ss_pred HHHHHhhhhhhccc
Confidence 99999988877664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-18 Score=189.69 Aligned_cols=187 Identities=28% Similarity=0.328 Sum_probs=154.9
Q ss_pred eeeeccceEEEEEEE---CCCCceEEEEEecccccc--chHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCCCceEEe
Q 001858 710 LIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKG--SIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKALV 783 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 783 (1003)
.+|+|+||.|++++- ...+..+|+|+.+..... .......|..++..++ ||.++++... +..+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 368999999997543 345677999988643321 1225566888888886 9999998766 5667888999
Q ss_pred eecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 784 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+++..+|.+...+.. ...+.+.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||.++..
T Consensus 76 ld~~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred hhhcccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHh
Confidence 999999999988877 45677888888889999999999999 9999999999999999999999999999876
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
-+... .+||..|||||+.. ....++|.||+|++.+||++|..||..
T Consensus 148 v~~~~---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 148 VKEKI---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred Hhhhh---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 43221 17999999999987 567789999999999999999999976
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=167.57 Aligned_cols=144 Identities=19% Similarity=0.143 Sum_probs=112.8
Q ss_pred hccCCccCeeeeccceEEEEEE-ECCCCceEEEEEecccccc------------------------chHHHHHHHHHHHh
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGN-LGEDLLPVAVKVINLKQKG------------------------SIKSFVAECEALKN 756 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 756 (1003)
..-|++.+.||+|+||.||+|. +..+++.||+|+++..... ....+..|++.+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999999 6668999999998743210 01235789999999
Q ss_pred cCCC--CceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-
Q 001858 757 IRHR--NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP- 833 (1003)
Q Consensus 757 l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~- 833 (1003)
+.+. .+.+++++ ...++||||++++++...... .......++..++.|++.+++++|+. +
T Consensus 107 L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~ 169 (237)
T smart00090 107 LYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKE---GE 169 (237)
T ss_pred HHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence 9753 34444443 123799999999888765432 23455667789999999999999999 8
Q ss_pred cEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 834 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|+||||||+||+++ ++.++++|||.+...
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998743
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=173.48 Aligned_cols=129 Identities=29% Similarity=0.488 Sum_probs=109.4
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~D 856 (1003)
..+.++.|++++..+|.+++...+. ....++.....++.|++.|++| + +.+|+|+||.||+...+..+||.|
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 3467899999999999999986443 3456778889999999999999 5 899999999999999999999999
Q ss_pred cccccccccCC-ccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHh
Q 001858 857 FGLAKFLFDRP-IQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913 (1003)
Q Consensus 857 fG~a~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~ 913 (1003)
||+........ ............||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99998765432 1112334445679999999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=155.88 Aligned_cols=134 Identities=23% Similarity=0.349 Sum_probs=109.6
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccccc--------chHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCce
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG--------SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 780 (1003)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|++++..++|+++.....++. +....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 5799999999999988 4567999986532211 1246788999999999998876665532 24456
Q ss_pred EEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
++||||++|++|.+++.... . ++..++.+++.+++++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 89999999999999986521 1 7789999999999999999 999999999999999 889999999988
Q ss_pred cc
Q 001858 861 KF 862 (1003)
Q Consensus 861 ~~ 862 (1003)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 63
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=153.87 Aligned_cols=142 Identities=27% Similarity=0.220 Sum_probs=110.2
Q ss_pred HHHHhccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc----------------------chHHHHHHHHHHH
Q 001858 698 LNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG----------------------SIKSFVAECEALK 755 (1003)
Q Consensus 698 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 755 (1003)
+......|.+.+.||+|+||.||+|... +++.||||+++..... ....+..|+.++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333445888999999999999999885 7899999987633210 0123677888999
Q ss_pred hcCCCC--ceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001858 756 NIRHRN--LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP 833 (1003)
Q Consensus 756 ~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 833 (1003)
.+.|++ +.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+. +
T Consensus 89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~---g 145 (198)
T cd05144 89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH---G 145 (198)
T ss_pred HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC---C
Confidence 998774 4444432 234899999999998765421 23467889999999999998 9
Q ss_pred cEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 834 IVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 834 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
|+||||||+||++++++.++++|||.+...
T Consensus 146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 146 IIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=177.15 Aligned_cols=138 Identities=25% Similarity=0.316 Sum_probs=109.2
Q ss_pred HhccCCccCeeeeccceEEEEEEECCCCceEEEEEeccc--cc------cchHHHHHHHHHHHhcCCCCceeEeeeeeec
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QK------GSIKSFVAECEALKNIRHRNLIKIITVCSSI 772 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 772 (1003)
....|...+.||+|+||+||+|.+... .+++|+.... .. ...+++.+|+++++.++|++++....++.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-- 406 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-- 406 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE--
Confidence 344566789999999999999988644 3444432211 11 12356889999999999999988766642
Q ss_pred ccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCe
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA 852 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 852 (1003)
.....++||||+++++|.+++. ....++.+++++++|||+. +++|||+||+||++ .++.+
T Consensus 407 ---~~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 407 ---DPEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred ---eCCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence 2345689999999999999885 2467899999999999999 99999999999999 67899
Q ss_pred EEcccccccc
Q 001858 853 HVSDFGLAKF 862 (1003)
Q Consensus 853 kl~DfG~a~~ 862 (1003)
+++|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-15 Score=175.58 Aligned_cols=172 Identities=29% Similarity=0.411 Sum_probs=126.4
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|..++.|..|+||.||.++++.+.+++|+|+-+ +.- +++ ||..+.+. .+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----------ilR-----nilt~a~n-----------pf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----------ILR-----NILTFAGN-----------PF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----------hhh-----ccccccCC-----------cc
Confidence 467888999999999999999999999999995432 110 111 12222211 12
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
.| |+-.+.++.. ++++. +++.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++
T Consensus 134 vv------gDc~tllk~~-----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 134 VV------GDCATLLKNI-----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ee------chhhhhcccC-----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 33 4555555442 23332 237899999999 99999999999999999999999999997
Q ss_pred ccccCCc----------cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccC
Q 001858 862 FLFDRPI----------QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 862 ~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~ 923 (1003)
....... .........++||+.|.|||++.-..|+..+|.|++|+|+||.+.|+.||.+...
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 5421100 0111122346899999999999999999999999999999999999999987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-14 Score=150.15 Aligned_cols=130 Identities=26% Similarity=0.391 Sum_probs=102.6
Q ss_pred eeeeccceEEEEEEECCCCceEEEEEeccccc--------cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceE
Q 001858 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--------GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 710 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 781 (1003)
.||+|+||.||+|.+ ++..|++|+...... ....++.+|+++++.++|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 379999999999996 456899998653211 11356788999999998876554443321 234458
Q ss_pred EeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
+||||++|++|.+++.... . .++.+++.+++++|+. +++|||++|+||+++ ++.++++|||++.
T Consensus 74 lv~e~~~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred EEEEEECCccHHHHHhhcH-----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 9999999999999876521 1 7889999999999999 999999999999999 8899999999886
Q ss_pred c
Q 001858 862 F 862 (1003)
Q Consensus 862 ~ 862 (1003)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 4
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=172.26 Aligned_cols=152 Identities=33% Similarity=0.505 Sum_probs=116.5
Q ss_pred ccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecC
Q 001858 517 NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596 (1003)
Q Consensus 517 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 596 (1003)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|||++|+++|.+|+.+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCC--CccCCCcceeeccCCCccCCCCCCCCCCCCCCCCCccccceeEeehhHHHHHHHHhhheeeEEEeec
Q 001858 597 YNDFEGQVPTK--GVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRR 674 (1003)
Q Consensus 597 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~~c~~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~rrr 674 (1003)
+|+++|.+|.. ..+.....+.+.+|+++|+.+. .+.|.... ....++.++++++++++++++..+++++||+
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~~~~---~~~~~i~~~~~~~~~~l~~~~~~~~~~~~r~ 572 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACGPHL---SVGAKIGIAFGVSVAFLFLVICAMCWWKRRQ 572 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCcccC---CCceEEEEEhHHHHHHHHHHHHHhhheeehh
Confidence 99999999863 2233455778999999998653 35675322 2223444444444433333333333444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-15 Score=165.77 Aligned_cols=190 Identities=30% Similarity=0.442 Sum_probs=108.6
Q ss_pred cEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCc
Q 001858 398 YALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477 (1003)
Q Consensus 398 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 477 (1003)
...||+.|++. ++|..+..+..|+.+.|+.|.+. .+|..++++..|.+|||+.|+++ ..|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 34455555555 55555555555555556555555 45555555555666666666655 5555555554 555666666
Q ss_pred cccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCccccCC
Q 001858 478 KLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP 557 (1003)
Q Consensus 478 ~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 557 (1003)
+++ .+|+.+. +...+..+|.+.|++. .+|..++++.+|+.|.+..|++. .+|.++.. -.|..||++.|+++ .||
T Consensus 154 kl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 154 KLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred ccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecc
Confidence 665 4454443 2222222333444433 34444666677777777777776 56666663 34777777777776 677
Q ss_pred cccccccCcCeeeccCceeccCCcccccCCCc---cceEecCCC
Q 001858 558 SSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF---LEYLNLSYN 598 (1003)
Q Consensus 558 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~l~~N 598 (1003)
-.|.+|+.|++|-|.+|.|. ..|..++..-+ .++|+..-.
T Consensus 228 v~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 77777777777777777776 45554443322 345554444
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.4e-14 Score=141.75 Aligned_cols=135 Identities=26% Similarity=0.285 Sum_probs=97.2
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccccc--hHH----------------------HHHHHHHHHhcCCC--C
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKS----------------------FVAECEALKNIRHR--N 761 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 761 (1003)
.+.||+|+||+||+|.+. +++.||||+++...... ... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999987 78899999986432111 111 13456666666443 2
Q ss_pred ceeEeeeeeecccCCCCceEEeeecccCCCHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCcEeccC
Q 001858 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLED-WLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDL 839 (1003)
Q Consensus 762 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Di 839 (1003)
+.+.+++ ...++||||++++.+.. .+.... . ..++..++.+++.++.++|. . +|+|||+
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~------~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl 141 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR------L-LEDPEELYDQILELMRKLYREA---GLVHGDL 141 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh------h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCC
Confidence 4444443 12489999999954321 111110 0 15678899999999999999 7 9999999
Q ss_pred CCCceEeCCCCCeEEccccccccc
Q 001858 840 KPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 840 kp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
||+||+++ ++.++++|||.+...
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred ChhhEEEE-CCcEEEEECcccccc
Confidence 99999999 999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-15 Score=163.22 Aligned_cols=215 Identities=31% Similarity=0.435 Sum_probs=150.7
Q ss_pred EEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEE
Q 001858 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYAL 400 (1003)
Q Consensus 321 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 400 (1003)
.|.|++-+++.++.+... ..+.--...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..+.++..|+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~-----~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l 126 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAAS-----YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFL 126 (722)
T ss_pred ccccccchhhcCCCcccc-----ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHh
Confidence 466777777776666432 34455566777777777 56777777777777777777776 566666677777777
Q ss_pred EcccccccccCCCccccccccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCCeeeccCcccc
Q 001858 401 GLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLT 480 (1003)
Q Consensus 401 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 480 (1003)
+|+.|+++ ..|..++.++ |+.|-+++|+++ .+|+.++.+..|..|+.+.|.+. .+|..++++.+|+.|++..|++.
T Consensus 127 ~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 127 DLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred hhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 77777766 5565555553 666666667666 56666666666666666666666 56666666666666666666666
Q ss_pred CCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCCCccccCCccc
Q 001858 481 GTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSL 560 (1003)
Q Consensus 481 ~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 560 (1003)
.+|++ +..| .|..||+|.|+++ .+|-.|.+++.|++|-|.+|.++ ..|..+
T Consensus 203 -~lp~E-------------------------l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 203 -DLPEE-------------------------LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred -hCCHH-------------------------HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 45544 4433 3889999999998 89999999999999999999998 667665
Q ss_pred ccc---cCcCeeeccCce
Q 001858 561 ISL---KSIEVLDLSCNN 575 (1003)
Q Consensus 561 ~~l---~~L~~L~Ls~N~ 575 (1003)
... .-.++|+..-++
T Consensus 254 C~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 254 CEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred Hhccceeeeeeecchhcc
Confidence 433 335677777775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=133.69 Aligned_cols=135 Identities=19% Similarity=0.290 Sum_probs=111.1
Q ss_pred ccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCC--CCceeEeeeeeecccCCCCceEEee
Q 001858 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH--RNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 707 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
+.+.+|+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| ..+.+++++. ...+..++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 45789999999999999864 6799999864433 4678999999999976 5888888773 3346789999
Q ss_pred ecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccc
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 862 (1003)
||++++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 73 e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99998766543 4456677899999999999997445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.1e-15 Score=174.63 Aligned_cols=258 Identities=24% Similarity=0.272 Sum_probs=188.7
Q ss_pred hccCCccCeeeeccceEEEEEEECCC-CceEEEEEecccc--ccchHHHHHHHHHHHhcC-CCCceeEeeeeeecccCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED-LLPVAVKVINLKQ--KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 777 (1003)
...|.+.+.||+|+|+.|-.+....+ ...+|+|.+.... .........|..+-+.+. |+|++++++. ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 45688888999999999998887543 3456777665433 223445556788888886 9999999998 5567
Q ss_pred CceEEeeecccCCCHHHHHh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCcEeccCCCCceEeCCCC-CeEE
Q 001858 778 DFKALVYDYMQSGSLEDWLQ-QSNDQVDGNLNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM-VAHV 854 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~-~~kl 854 (1003)
+..+++.+|.+++++.+.+. .. ....+...+-.++.|+..++.|+| +. ++.|||+||+|.+++..+ ..++
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred cccccccCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence 77899999999999999883 32 114555566778999999999999 77 999999999999999999 9999
Q ss_pred cccccccccccCCccccCcccccccc-cccccCccccCCC-CCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHH
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKG-TVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932 (1003)
Q Consensus 855 ~DfG~a~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~ 932 (1003)
+|||+|..+... ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........+..|.
T Consensus 167 ~df~~At~~~~~--~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~ 244 (601)
T KOG0590|consen 167 ADFGLATAYRNK--NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK 244 (601)
T ss_pred CCchhhcccccc--CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence 999999876541 112223334567 9999999998874 556789999999999999999999877554443332222
Q ss_pred HhhCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 001858 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 933 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 989 (1003)
.... ... ............++..+++..+|+.|.+.+++..
T Consensus 245 ~~~~----------~~~------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 SNKG----------RFT------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc----------ccc------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 2110 000 1112223344566777788888999998888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.8e-13 Score=139.79 Aligned_cols=139 Identities=17% Similarity=0.124 Sum_probs=105.0
Q ss_pred cCeee-eccceEEEEEEECCCCceEEEEEecccc-------------ccchHHHHHHHHHHHhcCCCCc--eeEeeeeee
Q 001858 708 SNLIG-QGSFGFVYRGNLGEDLLPVAVKVINLKQ-------------KGSIKSFVAECEALKNIRHRNL--IKIITVCSS 771 (1003)
Q Consensus 708 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 771 (1003)
...|| .|+.|+||.+... +..+++|.+.... ......+.+|++++..++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35788 8999999999885 5679999885311 1223568889999999988775 667766322
Q ss_pred cccCCCCceEEeeecccC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC
Q 001858 772 IDFKGDDFKALVYDYMQS-GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 850 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~ 850 (1003)
. .......++|||++++ .+|.+++... .+++. .+.+++.+++++|+. ||+||||||+|||++.++
T Consensus 114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 114 R-HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred e-cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 1 1111123599999997 6999988642 34443 356899999999999 999999999999999999
Q ss_pred CeEEcccccccc
Q 001858 851 VAHVSDFGLAKF 862 (1003)
Q Consensus 851 ~~kl~DfG~a~~ 862 (1003)
.++++|||.++.
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-13 Score=136.30 Aligned_cols=210 Identities=20% Similarity=0.290 Sum_probs=147.8
Q ss_pred HhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 001858 755 KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPI 834 (1003)
Q Consensus 755 ~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 834 (1003)
-.+.|.|++++..|.....+.+.....++.|||..|++.+++++.+.. ...+....-.+|+-||..||.|||+. .|.|
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 344699999999998777777778889999999999999999987654 45677888889999999999999996 7899
Q ss_pred EeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhC
Q 001858 835 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG 914 (1003)
Q Consensus 835 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g 914 (1003)
+|+++.-+-|++..+|-+|+.--.-.... ...............+-++|.|||.-.....+-++|||+||+...||..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h-~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccc-hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999998888521111100 00000011111123467899999997777788899999999999999987
Q ss_pred CCCCCcccCCcchhhHHHHhhCchh-HHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 001858 915 RRPTHTMFNDGLTLHGFVKMALPEK-VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 915 ~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 991 (1003)
..--...... ...++ ....+- . ..++ .=...+.+|+..+|..||+|.+++.|.
T Consensus 279 Eiq~tnseS~----------~~~ee~ia~~i~-~-len~------------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESK----------VEVEENIANVII-G-LENG------------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcce----------eehhhhhhhhee-e-ccCc------------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 6542211110 00111 111111 0 0111 012456799999999999999998764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.9e-13 Score=152.08 Aligned_cols=198 Identities=31% Similarity=0.472 Sum_probs=101.6
Q ss_pred EEEecccccccccCccCcCCCCCceeecccccccCCCCcccccccc-ccceEEccCcccccccCCCCCCCCCcceeeeec
Q 001858 128 VLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWL-KLENLNVAENQLTGQLPPSIGNISTLQQLGVGE 206 (1003)
Q Consensus 128 ~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~-~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~ 206 (1003)
.|+++.|.+. .-+..+..++.++.|++.+|.++ .||...+.. . +|+.|++++|++. .+|..++++++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~-~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLL-KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccc-hhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5666666664 23334445556666666666665 555444331 1 4555555555555 4444455555555555555
Q ss_pred cccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCcC
Q 001858 207 NKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIP 286 (1003)
Q Consensus 207 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p 286 (1003)
|++. .+|...+.+++|+.|++++|+++. +|..+. ....|++|.+++|.+. ..+
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~------------------------l~~~~~-~~~~L~~l~~~~N~~~-~~~ 225 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISD------------------------LPPEIE-LLSALEELDLSNNSII-ELL 225 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCcccc------------------------Cchhhh-hhhhhhhhhhcCCcce-ecc
Confidence 5555 344333344455555555555543 333321 2233555555555332 344
Q ss_pred ccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcc
Q 001858 287 QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR 365 (1003)
Q Consensus 287 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 365 (1003)
..+.+++++..|.+++|++... +..+..+++++.|++++|.+++++. +..+.+|+.|++++|.+....|.
T Consensus 226 ~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~--------~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 226 SSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSISS--------LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhhhhcccccccccCCceeeec-cchhccccccceecccccccccccc--------ccccCccCEEeccCccccccchh
Confidence 5556666666666666665532 3344555555666666665554331 33455566666666665544333
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.5e-13 Score=151.33 Aligned_cols=182 Identities=38% Similarity=0.571 Sum_probs=113.9
Q ss_pred cCCCCccEEEcccccccccCCCcccccc-ccceeccccccccccccccccCCCccceeecccccccccCCccccCCCCCC
Q 001858 392 RNLANIYALGLEYNQLTGTIPYTIGELI-NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLM 470 (1003)
Q Consensus 392 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 470 (1003)
..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+..++|+
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 34456666666666666 5555555553 7777777777776 44556677777777777777777 5666555677777
Q ss_pred eeeccCccccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCC
Q 001858 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550 (1003)
Q Consensus 471 ~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 550 (1003)
.|++++|+++ .+|... .....|++|++++|.+. .++..+..+.++..|.+.+|
T Consensus 190 ~L~ls~N~i~-~l~~~~-------------------------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 190 NLDLSGNKIS-DLPPEI-------------------------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred heeccCCccc-cCchhh-------------------------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 7777777777 455432 23334666666666443 45555666666666666666
Q ss_pred CccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecCCCcccccCCC
Q 001858 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPT 606 (1003)
Q Consensus 551 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 606 (1003)
++. .++..++.+++++.|++++|+++...+ +..+.+++.|++++|.+....|.
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred eee-eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 665 335556666666666666666663322 66666666666666666655443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=6e-11 Score=135.58 Aligned_cols=141 Identities=20% Similarity=0.239 Sum_probs=99.9
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccccc----------------------------------------hHHH
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS----------------------------------------IKSF 747 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 747 (1003)
.+.||.|++|.||+|+.. +|+.||||+.+...... .-+|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 468999999999999986 68899999986331100 0135
Q ss_pred HHHHHHHHhc----CCCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH-H
Q 001858 748 VAECEALKNI----RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS-A 822 (1003)
Q Consensus 748 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~ 822 (1003)
.+|++.+.++ +|.+-+.+-.++.. .....++||||++|++|.++...... .. .+.+++.+++. .
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSF 269 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHH
Confidence 5566666665 23333333333321 12345899999999999988754211 11 23456666666 4
Q ss_pred HHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 823 l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+..+|.. |++|+|++|.||+++.++.++++|||++..+
T Consensus 270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 6788988 9999999999999999999999999999765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.8e-12 Score=141.40 Aligned_cols=203 Identities=26% Similarity=0.335 Sum_probs=160.7
Q ss_pred cCCccCeeee--ccceEEEEEEE--CCCCceEEEEEec--cccccchHHHHHHHHHHHhc-CCCCceeEeeeeeecccCC
Q 001858 704 EFSLSNLIGQ--GSFGFVYRGNL--GEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 704 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (1003)
.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+ ........+=.+|+...+++ .|++.++.... +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 3456678999 99999999998 7788899999844 23223334445677777777 59999985555 677
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCcEeccCCCCceEeCCC-CC
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS----AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MV 851 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~ 851 (1003)
.+..++-+|++. .++.++.... ...++....+.+..+..+ |+.++|+. .++|-|+||.||+...+ ..
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 888899999986 4777776553 345788888899999999 99999999 99999999999999999 88
Q ss_pred eEEcccccccccccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCCCCc
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920 (1003)
Q Consensus 852 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~ 920 (1003)
.+++|||+...+.+..............|...|++||. ..+.++.++|+|++|.++.+..++..+...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccC
Confidence 99999999998877654333333333368889999997 556788999999999999999998776543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-11 Score=131.91 Aligned_cols=172 Identities=19% Similarity=0.228 Sum_probs=131.6
Q ss_pred EEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcC
Q 001858 721 RGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN 800 (1003)
Q Consensus 721 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 800 (1003)
.|..+.++.+|.|+..+...........+-++.++.++||+|+++++. ++.++..|+|+|.+. .|..++++-
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~l- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKEL- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHHh-
Confidence 466777888999999886655445667788899999999999999987 566778999999983 688888762
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccccccccCCccccCcccccccc
Q 001858 801 DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880 (1003)
Q Consensus 801 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~g 880 (1003)
.......-+.||+.||.|||..+ +++|++|.-..|+|++.|..||++|.++........ ......-
T Consensus 102 -------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----~~~~~~~ 167 (690)
T KOG1243|consen 102 -------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----PAKSLYL 167 (690)
T ss_pred -------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----ccccchh
Confidence 25566778899999999999765 899999999999999999999999998865422111 1111122
Q ss_pred cccccCccccCCCCCCccccchhHHHHHHHHHhCCC
Q 001858 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRR 916 (1003)
Q Consensus 881 t~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~ 916 (1003)
-..|..|+.+.... -..|.|.|||+++|++.|..
T Consensus 168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 23466666543332 34699999999999999943
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-10 Score=130.94 Aligned_cols=145 Identities=17% Similarity=0.162 Sum_probs=94.3
Q ss_pred ccCCccCeeeeccceEEEEEEECCCCceEEEEEecccccc----------------------------------ch----
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG----------------------------------SI---- 744 (1003)
Q Consensus 703 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~---- 744 (1003)
.+|+. +.+|.|++|.||+|+.+.+|+.||||+.++.-.. ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7999999999999999877999999999743110 00
Q ss_pred --HHHHHHHHHHHhcC----CCCceeEeeeeeecccCCCCceEEeeecccCCCHHHHH--hhcCCCCCCCCCHHHHHHHH
Q 001858 745 --KSFVAECEALKNIR----HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL--QQSNDQVDGNLNLIQRLNIS 816 (1003)
Q Consensus 745 --~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~ 816 (1003)
-+|.+|+..+.+++ +...+.+-.++.+ -....++||||++|+.+.++- ..... ....+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHH
Confidence 12445555555542 4444443333211 123458999999999998753 22110 00112222223333
Q ss_pred HHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC----CeEEccccccccc
Q 001858 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----VAHVSDFGLAKFL 863 (1003)
Q Consensus 817 ~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~DfG~a~~~ 863 (1003)
.| +... |++|+|++|.||+++.++ .+++.|||++..+
T Consensus 274 ~Q-------if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 274 TQ-------VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 33 3445 999999999999999888 9999999999765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.7e-10 Score=119.51 Aligned_cols=279 Identities=15% Similarity=0.128 Sum_probs=175.3
Q ss_pred CccCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhc-CCCCceeEeeeeeeccc--CCCCceEE
Q 001858 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDF--KGDDFKAL 782 (1003)
Q Consensus 706 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~--~~~~~~~l 782 (1003)
...+.||+|+.+.+|-.-.-.+ .+.|++.........+ .+..+... .||-+-.-+.+-...-+ .......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4567899999999996543322 4567776444332222 22233333 56644321221111001 11222456
Q ss_pred eeecccCC-CHHHHHhhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccccc
Q 001858 783 VYDYMQSG-SLEDWLQQS-NDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 783 v~e~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 860 (1003)
.|..+.+. ...+++... +.+.-....|...+++++.++.+.+.||+. |.+-+|+.++|+||++++.+.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 77777664 233333321 223345789999999999999999999999 9999999999999999999999875433
Q ss_pred cccccCCccccCcccccccccccccCccccC-----CCCCCccccchhHHHHHHHHHhC-CCCCCcccCCcchhhHHHHh
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTG-RRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g-~~P~~~~~~~~~~~~~~~~~ 934 (1003)
.. ..........+|...|.+||... +...+...|-|.+|+++++++.| ++||++..........+ +.
T Consensus 165 qi------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~-E~ 237 (637)
T COG4248 165 QI------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL-ET 237 (637)
T ss_pred ee------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc-hh
Confidence 22 12233344567899999999754 33456779999999999999985 99998864321110000 00
Q ss_pred hC-chhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccC--CCCCCCHHHHHHHHHHHHhhhhc
Q 001858 935 AL-PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMES--PSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 935 ~~-~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--p~~RPs~~ev~~~L~~~~~~~~~ 1000 (1003)
.+ .......-+...-..|.++.+..+....++.-+..+|.... +.-||+++.++..|.++.+++..
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00 00000111122223344455566667777888888888764 56799999999999999988754
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.6e-13 Score=137.12 Aligned_cols=95 Identities=21% Similarity=0.385 Sum_probs=51.1
Q ss_pred ccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCC----CcccccccccccccccccccccCcc
Q 001858 312 DFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS----LPRSIANLSTITIIAMGLNQISGTI 387 (1003)
Q Consensus 312 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~ 387 (1003)
.|...+.|+.+.++.|.|..-.. ......+..|++|+.|||++|-++.. +...+..+++|++|++++|.++...
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~--~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G 257 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG 257 (382)
T ss_pred HHHhccccceEEEecccccCchh--HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence 35555667777777776654332 23345666777777777777777632 2333444455555555555555433
Q ss_pred cccc-----cCCCCccEEEccccccc
Q 001858 388 PLEI-----RNLANIYALGLEYNQLT 408 (1003)
Q Consensus 388 p~~~-----~~l~~L~~L~L~~N~l~ 408 (1003)
..+| ...++|++|.|.+|.|+
T Consensus 258 a~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 258 AIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HHHHHHHHhccCCCCceeccCcchhH
Confidence 3322 12344444444444444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.3e-12 Score=127.56 Aligned_cols=132 Identities=29% Similarity=0.292 Sum_probs=99.3
Q ss_pred CccceeecccccccccCCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCcccccccccccccccccccc
Q 001858 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLD 522 (1003)
Q Consensus 443 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~ 522 (1003)
..|+++||++|.|+ .+.++..-++.++.|++|+|.|+ . +. .+..+++|+.||
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~-------------------------v~-nLa~L~~L~~LD 335 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-T-------------------------VQ-NLAELPQLQLLD 335 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-e-------------------------eh-hhhhcccceEee
Confidence 45667777777776 56666666677777777777765 1 11 156678899999
Q ss_pred ccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCC-cccccCCCccceEecCCCccc
Q 001858 523 ISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI-PEYLEDLSFLEYLNLSYNDFE 601 (1003)
Q Consensus 523 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~ 601 (1003)
||+|.++ .+-.+=.++.+.+.|.|+.|.|.. -..+.++-+|..||+++|+|.... ...++++|-|+.+.|.+|++.
T Consensus 336 LS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 336 LSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred cccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9999997 666676778889999999999873 245778888999999999997533 256889999999999999998
Q ss_pred ccCC
Q 001858 602 GQVP 605 (1003)
Q Consensus 602 ~~~p 605 (1003)
+.+.
T Consensus 413 ~~vd 416 (490)
T KOG1259|consen 413 GSVD 416 (490)
T ss_pred ccch
Confidence 7543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-10 Score=112.58 Aligned_cols=137 Identities=21% Similarity=0.206 Sum_probs=99.2
Q ss_pred cCeeeeccceEEEEEEECC------CCceEEEEEecccc------------c----------cchHHHH----HHHHHHH
Q 001858 708 SNLIGQGSFGFVYRGNLGE------DLLPVAVKVINLKQ------------K----------GSIKSFV----AECEALK 755 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~ 755 (1003)
...||.|..+.||.|.... .+..+|||+.+... + ...+.+. +|++.++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 35789999985210 0 0122333 7999999
Q ss_pred hcC--CCCceeEeeeeeecccCCCCceEEeeecccCCCHHH-HHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCC
Q 001858 756 NIR--HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLED-WLQQSNDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQ 831 (1003)
Q Consensus 756 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~ 831 (1003)
++. .-++.+++++ ...++||||+.++.+.. .++. ..++..+...+..+++.++..+ |+.
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 984 3566677764 12389999998754322 2221 2344556677889999999999 788
Q ss_pred CCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 832 PPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 832 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
++||||+++.||+++ ++.+.++|||.|...
T Consensus 145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999999996 578999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.2e-12 Score=133.38 Aligned_cols=194 Identities=21% Similarity=0.227 Sum_probs=105.0
Q ss_pred ccCCCCCCeEecCCccCCCCCCC---cccCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccC-cCcccccc
Q 001858 217 LGQLRDLNFLSVAENNFSGMLPP---IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGS-IPQSFSNA 292 (1003)
Q Consensus 217 l~~l~~L~~L~L~~N~l~~~~~~---~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l 292 (1003)
...|++++.|||+.|-+....+. ...+++|+.|.|+.|++.-......-..++.|+.|.|+.|.++.. +...+..+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 33444444444444444332211 123444444444444443222222222567888888888888722 22344567
Q ss_pred ccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCccccccccc
Q 001858 293 SNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST 372 (1003)
Q Consensus 293 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 372 (1003)
++|+.|+|+.|....+......-+..|+.|+|++|++-+.+.+ .....++.|+.|+++.+.+...--...
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~-----~~~~~l~~L~~Lnls~tgi~si~~~d~----- 291 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQG-----YKVGTLPGLNQLNLSSTGIASIAEPDV----- 291 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccc-----cccccccchhhhhccccCcchhcCCCc-----
Confidence 7888888888864444444455666777777777777654432 234556666666666666653211000
Q ss_pred ccccccccccccCcccccccCCCCccEEEcccccccc-cCCCccccccccceeccccccccc
Q 001858 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG-TIPYTIGELINLQALDFSANNLHG 433 (1003)
Q Consensus 373 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~ 433 (1003)
..-+-...+++|++|+++.|++.. ..-..+..+.+|+.|....|.|+.
T Consensus 292 -------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 292 -------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred -------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 000112456677777777777752 111244556677777877887763
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=131.59 Aligned_cols=167 Identities=22% Similarity=0.289 Sum_probs=100.4
Q ss_pred CCCCCcceeeeeccccCCCCc--ccccCCCCCCeEecCCccCCCCCCC--cccCCchhHHhhcccccCCCCCcccccCcc
Q 001858 194 GNISTLQQLGVGENKLYGIIP--ESLGQLRDLNFLSVAENNFSGMLPP--IFNISSLEQISLLTNRFEGRLPLNIGFNLP 269 (1003)
Q Consensus 194 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~ 269 (1003)
..|++++.|||++|-+..-.| .-...|++|+.|+|+.|++...... ...++.|+.|.|+.|.++-.=-..+...+|
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 344445555555544442211 2234445555555555554433222 123445555555555554221122333678
Q ss_pred ccceeeccCcccccCcCccccccccchhhhccCccccCcc-CcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCC
Q 001858 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKV-GIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSK 348 (1003)
Q Consensus 270 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~ 348 (1003)
+|+.|+|..|.....-.....-+..|+.|||++|++-... ....+.++.|+.|+++.+.|.++...+.+........++
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK 302 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence 8888888888533344445566788899999999876443 234578889999999999988877665554555667788
Q ss_pred CcEeeccCcCCC
Q 001858 349 LETLGLNSNRFG 360 (1003)
Q Consensus 349 L~~L~L~~N~l~ 360 (1003)
|++|++..|++.
T Consensus 303 L~~L~i~~N~I~ 314 (505)
T KOG3207|consen 303 LEYLNISENNIR 314 (505)
T ss_pred ceeeecccCccc
Confidence 888888888885
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.7e-10 Score=115.38 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=95.6
Q ss_pred cCeeeeccceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCce-eEeeeeeecccCCCCceEEeeec
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI-KIITVCSSIDFKGDDFKALVYDY 786 (1003)
Q Consensus 708 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~ 786 (1003)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+.+++ +++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 357899999999999875 66899999764332 234567899999998654443 455432 1234799999
Q ss_pred ccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCcEeccCCCCceEeCCCCCeEEccccccc
Q 001858 787 MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 787 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 861 (1003)
++|.++.+. . .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~-~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTE-D------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCccccc-c------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999877543 0 011345678999999999982 12359999999999998 6789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.5e-12 Score=130.41 Aligned_cols=140 Identities=24% Similarity=0.333 Sum_probs=104.0
Q ss_pred CCCccceeeccccccccc----CCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCcccccccccccccc
Q 001858 441 NLSTLNSLWLGFNNLQGN----IPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLK 516 (1003)
Q Consensus 441 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~ 516 (1003)
.-+.|+.+..++|++... +...|...+.|+.+.+++|.|. |+..- .+-..|..++
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~---~eG~~------------------al~eal~~~~ 213 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIR---PEGVT------------------ALAEALEHCP 213 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEeccccc---CchhH------------------HHHHHHHhCC
Confidence 346788888888888732 3345677788999999999876 33320 1233477889
Q ss_pred ccccccccccccccc----cCccccCcccccEEEecCCCccccCCcccc-----cccCcCeeeccCceecc----CCccc
Q 001858 517 NLIQLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNSFRGSIPSSLI-----SLKSIEVLDLSCNNLSG----QIPEY 583 (1003)
Q Consensus 517 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~ 583 (1003)
+|+.|||.+|-|+.. +...+..++.|+.|++++|.++..-..+|. ..++|++|+|.+|.|+. .+...
T Consensus 214 ~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~ 293 (382)
T KOG1909|consen 214 HLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAAC 293 (382)
T ss_pred cceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHH
Confidence 999999999999743 445778889999999999999854433332 26899999999999974 23345
Q ss_pred ccCCCccceEecCCCccc
Q 001858 584 LEDLSFLEYLNLSYNDFE 601 (1003)
Q Consensus 584 l~~l~~L~~L~l~~N~l~ 601 (1003)
+...+.|..|+|++|.+.
T Consensus 294 ~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 294 MAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HhcchhhHHhcCCccccc
Confidence 567899999999999994
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.9e-11 Score=85.92 Aligned_cols=39 Identities=56% Similarity=1.058 Sum_probs=31.2
Q ss_pred HhHHHHHHHHHHhcC-CCCCCCCCCCCC--CCCCceeeEEeC
Q 001858 34 ETDRVALLAIKSQLQ-DPMGITSSWNNS--INVCQWTGVTCG 72 (1003)
Q Consensus 34 ~~~~~al~~~k~~~~-d~~~~~~sW~~~--~~~c~w~gv~c~ 72 (1003)
++|++||++||+++. ||.+.+++|+.+ .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999997 677899999876 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-11 Score=121.71 Aligned_cols=134 Identities=28% Similarity=0.348 Sum_probs=73.2
Q ss_pred cccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccc
Q 001858 288 SFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI 367 (1003)
Q Consensus 288 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~ 367 (1003)
.......|++||||+|.|+. +.....-+|.++.|++++|.|..+. . +
T Consensus 279 ~~dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v~--------n------------------------L 325 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTVQ--------N------------------------L 325 (490)
T ss_pred ecchHhhhhhccccccchhh-hhhhhhhccceeEEeccccceeeeh--------h------------------------h
Confidence 33344556666666666652 2233444455555555555544321 2 4
Q ss_pred cccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccccccccc-cccccCCCccc
Q 001858 368 ANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGII-PDSIGNLSTLN 446 (1003)
Q Consensus 368 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~ 446 (1003)
+.+++|+.|||++|.++ .+..+-.++.+.+.|.|++|.|. .-..+.++-+|..||+++|+|.... -..+++++.|+
T Consensus 326 a~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE 402 (490)
T KOG1259|consen 326 AELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLE 402 (490)
T ss_pred hhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHH
Confidence 44444444444444444 22333345556666666666664 2234556667777777777776331 23567777777
Q ss_pred eeecccccccc
Q 001858 447 SLWLGFNNLQG 457 (1003)
Q Consensus 447 ~L~L~~N~l~~ 457 (1003)
.+.|.+|.+.+
T Consensus 403 ~l~L~~NPl~~ 413 (490)
T KOG1259|consen 403 TLRLTGNPLAG 413 (490)
T ss_pred HHhhcCCCccc
Confidence 77777777774
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-11 Score=139.48 Aligned_cols=82 Identities=28% Similarity=0.288 Sum_probs=46.4
Q ss_pred cccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceecc---CCccc-ccCCCccceE
Q 001858 518 LIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSG---QIPEY-LEDLSFLEYL 593 (1003)
Q Consensus 518 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~-l~~l~~L~~L 593 (1003)
|+.+++++|.+. .++..+..+..+..|++.+|++... ..+.....+..+.++.|++.. ..... ....+.+..+
T Consensus 234 L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 667777777775 4445566666666667776666532 224445555666666666542 11111 3445556666
Q ss_pred ecCCCcccc
Q 001858 594 NLSYNDFEG 602 (1003)
Q Consensus 594 ~l~~N~l~~ 602 (1003)
.+.+|+...
T Consensus 311 ~~~~~~~~~ 319 (414)
T KOG0531|consen 311 TLELNPIRK 319 (414)
T ss_pred ccccCcccc
Confidence 666666554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.3e-11 Score=138.24 Aligned_cols=246 Identities=27% Similarity=0.292 Sum_probs=115.5
Q ss_pred ccccceeeccCcccccCcCccccccccchhhhccCccccCccCcccCCCCcccEEecCCCCCCCCCCCChhhHhhhcCCC
Q 001858 268 LPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347 (1003)
Q Consensus 268 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 347 (1003)
+..++.+.++.|.|.. +-..+..+++|+.|++.+|+|..+... +..+++|++|++++|.|+.+. .+..++
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i~--------~l~~l~ 140 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKLE--------GLSTLT 140 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc-hhhhhcchheecccccccccc--------chhhcc
Confidence 3444555555555552 223355556666666666666544321 445566666666666665432 233444
Q ss_pred CCcEeeccCcCCCCCCcccccccccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccc
Q 001858 348 KLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFS 427 (1003)
Q Consensus 348 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 427 (1003)
.|+.|++++|.|.. ...+..+..|+.+++++|++...-+. . ...+.+++.+++.
T Consensus 141 ~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~-----------------------~-~~~~~~l~~l~l~ 194 (414)
T KOG0531|consen 141 LLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEND-----------------------E-LSELISLEELDLG 194 (414)
T ss_pred chhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhh-----------------------h-hhhccchHHHhcc
Confidence 55666666665552 12222244444444444444422220 1 2344445555555
Q ss_pred cccccccccccccCCCccceeecccccccccCCccccCCC--CCCeeeccCccccCCCchhhhhhccccccccCCCCccc
Q 001858 428 ANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCK--NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLIS 505 (1003)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~ 505 (1003)
+|.+... ..+..+..+..+++..|.++..-+ +..+. .|+.+++++|++. .++
T Consensus 195 ~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~--------------------- 248 (414)
T KOG0531|consen 195 GNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSP--------------------- 248 (414)
T ss_pred CCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-ccc---------------------
Confidence 5554421 223333334444555555442111 11111 2555555555554 111
Q ss_pred cccccccccccccccccccccccccccCccccCcccccEEEecCCCcccc---CCcc-cccccCcCeeeccCceeccCCc
Q 001858 506 GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS---IPSS-LISLKSIEVLDLSCNNLSGQIP 581 (1003)
Q Consensus 506 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p 581 (1003)
..+..+.++..|++++|++... ..+.....+..+.+..|++... .... ....+.++.+.+..|.+....+
T Consensus 249 ----~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 249 ----EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ----ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 1133445555666666655422 2234445555555666655421 1111 4455667777777777765444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-10 Score=113.64 Aligned_cols=79 Identities=29% Similarity=0.333 Sum_probs=22.1
Q ss_pred ccccccccccccccccccCccc-cCcccccEEEecCCCccccC-CcccccccCcCeeeccCceeccCCc---ccccCCCc
Q 001858 515 LKNLIQLDISRNRFSGEIPTTL-SSCTSLEYLKMQDNSFRGSI-PSSLISLKSIEVLDLSCNNLSGQIP---EYLEDLSF 589 (1003)
Q Consensus 515 l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~ 589 (1003)
++.|+.|++++|+|+ .+++.+ ..+++|++|+|++|+|...- -..+..+++|+.|+|.+|+++...- ..+..+|+
T Consensus 63 L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~ 141 (175)
T PF14580_consen 63 LPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPS 141 (175)
T ss_dssp -TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT
T ss_pred hhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcCh
Confidence 344444444444444 222222 23444444444444443211 1233444555555555555542210 12344555
Q ss_pred cceEe
Q 001858 590 LEYLN 594 (1003)
Q Consensus 590 L~~L~ 594 (1003)
|+.||
T Consensus 142 Lk~LD 146 (175)
T PF14580_consen 142 LKVLD 146 (175)
T ss_dssp -SEET
T ss_pred hheeC
Confidence 55544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-10 Score=109.55 Aligned_cols=106 Identities=26% Similarity=0.349 Sum_probs=23.2
Q ss_pred cccchhhhccCccccCccCcccC-CCCcccEEecCCCCCCCCCCCChhhHhhhcCCCCCcEeeccCcCCCCCCcccc-cc
Q 001858 292 ASNLVILNLSGNHFSGKVGIDFS-SLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-AN 369 (1003)
Q Consensus 292 l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~ 369 (1003)
..++++|+|++|.|+.+. .++ .+.+|+.|+|++|.|+.++ .+..+++|++|++++|+|+.. .+.+ ..
T Consensus 18 ~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~--------~l~~L~~L~~L~L~~N~I~~i-~~~l~~~ 86 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLE--------GLPGLPRLKTLDLSNNRISSI-SEGLDKN 86 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--------T----TT--EEE--SS---S--CHHHHHH
T ss_pred cccccccccccccccccc--chhhhhcCCCEEECCCCCCcccc--------CccChhhhhhcccCCCCCCcc-ccchHHh
Confidence 334455555555554332 122 3444555555555554432 233445555555555555532 2222 23
Q ss_pred cccccccccccccccCc-ccccccCCCCccEEEccccccc
Q 001858 370 LSTITIIAMGLNQISGT-IPLEIRNLANIYALGLEYNQLT 408 (1003)
Q Consensus 370 l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 408 (1003)
+++|+.|++++|+|... .-..++.+++|+.|+|.+|.++
T Consensus 87 lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 87 LPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 44444444444444321 1123444555555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.3e-10 Score=138.18 Aligned_cols=86 Identities=22% Similarity=0.379 Sum_probs=40.1
Q ss_pred CcCCCCCceeecccccccCCCCccccccccccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCC
Q 001858 144 LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDL 223 (1003)
Q Consensus 144 l~~l~~L~~L~l~~N~l~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 223 (1003)
|..++.|++|||++|.--+++|..|+.+ -+|++|+|++..++ .+|..+++|..|.+|++..+.-...+|..+..+.+|
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~L-i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~L 644 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGEL-VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSL 644 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhh-hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccc
Confidence 3344444444444444434444444433 34444444444444 445555555555555555444333334444445555
Q ss_pred CeEecCCc
Q 001858 224 NFLSVAEN 231 (1003)
Q Consensus 224 ~~L~L~~N 231 (1003)
++|.+..-
T Consensus 645 r~L~l~~s 652 (889)
T KOG4658|consen 645 RVLRLPRS 652 (889)
T ss_pred cEEEeecc
Confidence 55554433
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=97.68 Aligned_cols=128 Identities=30% Similarity=0.395 Sum_probs=95.0
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccc--------ccchHHHHHHHHHHHhcCCCC--ceeEeeeeeecccCCCC
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--------KGSIKSFVAECEALKNIRHRN--LIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~ 778 (1003)
..+++|+-+.+|.+.+. +.++++|.-..+. .-...+-.+|++++.+++--. +..++++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 46789999999999774 3346666532211 112346778999999885333 3344443 345
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
...++|||++|..|.+.+... ...++..+=.-+.-||.. ||+|+|+.++||+++.++ +.++|||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence 558999999999999999763 245667777888899999 999999999999997665 9999999
Q ss_pred ccc
Q 001858 859 LAK 861 (1003)
Q Consensus 859 ~a~ 861 (1003)
++.
T Consensus 137 Lg~ 139 (204)
T COG3642 137 LGE 139 (204)
T ss_pred ccc
Confidence 996
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.6e-09 Score=121.36 Aligned_cols=251 Identities=17% Similarity=0.117 Sum_probs=166.9
Q ss_pred HhccCCccCeeeeccceEEEEEEEC-CCCceEEEEEeccccccchH--HHHHHHHHHHhc-CCCCceeEeeeeeecccCC
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLG-EDLLPVAVKVINLKQKGSIK--SFVAECEALKNI-RHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 701 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 776 (1003)
...+|..+..||.|.|+.||..... .++..|++|........... .-..|+.+...+ .|.+++++... +..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~ 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc
Confidence 3457888899999999999998765 57788999987643322222 223455555555 47777765544 344
Q ss_pred CCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCC-CCeEEc
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVS 855 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~-~~~kl~ 855 (1003)
.+..++=-||+++++....+.. ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cccccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 5556788999999988776633 34567777889999999999999998 99999999999999886 788999
Q ss_pred ccccccccccCCccccCcccccccccccc-cCccccCCCCCCccccchhHHHHHHHHHhCCCCCCcccCCcchhhHHHHh
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGY-VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 856 DfG~a~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P~~~~~~~~~~~~~~~~~ 934 (1003)
|||++..+.-. .....-++..| .+|+......+..++|+||||.-+.|.+++..--... .. +
T Consensus 410 ~~~~~t~~~~~-------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~---~------ 472 (524)
T KOG0601|consen 410 DFGCWTRLAFS-------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ---S------ 472 (524)
T ss_pred cccccccccee-------cccccccccccccchhhccccccccccccccccccccccccCcccCccc-cc---c------
Confidence 99999642110 00111123334 3566666677889999999999999999876532110 00 0
Q ss_pred hCchhHHHHHHhhcccCCCCchhhHHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHHHHH
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995 (1003)
Q Consensus 935 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~ 995 (1003)
.. +...... ........+..+...+..+++..||.+.+...+.+..+
T Consensus 473 ------~~-i~~~~~p-------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ------LT-IRSGDTP-------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------ee-eeccccc-------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00 0000000 00111134455555667788888998888876655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.5e-10 Score=129.92 Aligned_cols=208 Identities=23% Similarity=0.283 Sum_probs=148.8
Q ss_pred hccCCccCeeeeccceEEEEEEECCCCceEEEEEeccccc---cchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
.+.+.+.+.+-.|+++.++.+.-..++...++|+...... ...+....+-.+.-..++|-++...-- +....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCCC
Confidence 3566777889999999999988877776666665542211 112222222222222345655544322 34566
Q ss_pred ceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEcccc
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG 858 (1003)
..+++++|..+++|...++.. +..+....+.....+.++.+|||.. .+.|+|++|.|.+...+++.+++|||
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 778999999999999998874 3455555566777889999999998 79999999999999999999999998
Q ss_pred cccccccC----------------C-----c-----cccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHH
Q 001858 859 LAKFLFDR----------------P-----I-----QETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMF 912 (1003)
Q Consensus 859 ~a~~~~~~----------------~-----~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell 912 (1003)
.......- . . ...........||+.|.+||...+......+|.|+.|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 44322100 0 0 00001123466999999999999999999999999999999999
Q ss_pred hCCCCCCccc
Q 001858 913 TGRRPTHTMF 922 (1003)
Q Consensus 913 ~g~~P~~~~~ 922 (1003)
+|..||....
T Consensus 1030 ~g~pp~na~t 1039 (1205)
T KOG0606|consen 1030 TGIPPFNAET 1039 (1205)
T ss_pred cCCCCCCCcc
Confidence 9999997654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-09 Score=133.31 Aligned_cols=320 Identities=19% Similarity=0.225 Sum_probs=177.6
Q ss_pred ccccCcEEEecccccccccCccCcCCCCCceeecccccc-cCCCCccccccccccceEEccCcccccccCCCCCCCCCcc
Q 001858 122 RLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNL-TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQ 200 (1003)
Q Consensus 122 ~l~~L~~L~Ls~n~l~g~ip~~l~~l~~L~~L~l~~N~l-~~~ip~~~~~~~~~L~~L~L~~n~l~~~ip~~i~~l~~L~ 200 (1003)
+....+...+-+|.+. .++.+..+ ++|.+|-+..|.. ...++..+...++.|++|||++|.=-+.+|++|++|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3467777888888877 56666543 3788888888862 3377777666679999999999877779999999999999
Q ss_pred eeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCccc-CCchhHHhhcccccCCCCCcccccCccccceeeccCc
Q 001858 201 QLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN-ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQN 279 (1003)
Q Consensus 201 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N 279 (1003)
+|++++..+. .+|..+++|++|.+|++..+.-...++.+.. +++|+.|.+..-...
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~---------------------- 655 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALS---------------------- 655 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccc----------------------
Confidence 9999999999 8999999999999999998876555555443 666666665543311
Q ss_pred ccccCcCccccccccchhhhccCccccCccCcccCCCCccc----EEecCCCCCCCCCCCChhhHhhhcCCCCCcEeecc
Q 001858 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNIT----RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLN 355 (1003)
Q Consensus 280 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~ 355 (1003)
.+...-..+.++.+|+.+....... .....+..+++|. .+.+..+.... ....+..+.+|+.|.+.
T Consensus 656 -~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~~-------~~~~~~~l~~L~~L~i~ 725 (889)
T KOG4658|consen 656 -NDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKRT-------LISSLGSLGNLEELSIL 725 (889)
T ss_pred -cchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccce-------eecccccccCcceEEEE
Confidence 1111111222333333333322111 0001112222222 11111111110 11223345555555555
Q ss_pred CcCCCCCCcccccc------cccccccccccccccCcccccccCCCCccEEEcccccccccCCCccccccccceeccccc
Q 001858 356 SNRFGGSLPRSIAN------LSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN 429 (1003)
Q Consensus 356 ~N~l~~~~p~~~~~------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 429 (1003)
++.+.......... ++++..+...++..- ..+.+..-.++|+.|++..+...+.+......+..++.+-+..+
T Consensus 726 ~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~ 804 (889)
T KOG4658|consen 726 DCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFN 804 (889)
T ss_pred cCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccc
Confidence 55554222222111 111111111111111 12222334577888888877776666666666666666666667
Q ss_pred ccccc-ccccccCCCccceeecccccccccCC---ccccCCCCCCeeeccCc
Q 001858 430 NLHGI-IPDSIGNLSTLNSLWLGFNNLQGNIP---SSLGNCKNLMLLNVSKN 477 (1003)
Q Consensus 430 ~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~ls~N 477 (1003)
.+.+. .-...+.++++..+.+.+=.+....- ...+.+|.+..+.+.++
T Consensus 805 ~~~~l~~~~~l~~l~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~~~~~i~~~ 856 (889)
T KOG4658|consen 805 KLEGLRMLCSLGGLPQLYWLPLSFLKLEELIVEECPKLGKLPLLSTLTIVGC 856 (889)
T ss_pred ccccceeeecCCCCceeEecccCccchhheehhcCcccccCccccccceecc
Confidence 66655 34445555555555555433331111 12345666666666664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.6e-08 Score=106.08 Aligned_cols=145 Identities=21% Similarity=0.258 Sum_probs=107.5
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEeccccc-cchHHHHHHHHHHHhcCC--CCceeEeeeeeecccCCCCceEEeee
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRH--RNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.++.|..+.||++...+ ++.+++|+...... .....+.+|+++++.+++ ..+.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 578999999999998853 57899999764332 234678899999999965 34566777643211 1235689999
Q ss_pred cccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC----------------------------------- 830 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 830 (1003)
|++|.++.+.+.. ..++..+...++.++++++++||+..
T Consensus 81 ~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 81 RVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 9999887765421 24666777788888888888888521
Q ss_pred ------------------CCCcEeccCCCCceEeCC--CCCeEEcccccccc
Q 001858 831 ------------------QPPIVHGDLKPSNVLLDH--DMVAHVSDFGLAKF 862 (1003)
Q Consensus 831 ------------------~~~ivH~Dikp~Nill~~--~~~~kl~DfG~a~~ 862 (1003)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=94.73 Aligned_cols=142 Identities=23% Similarity=0.278 Sum_probs=100.7
Q ss_pred ccCeeeeccceEEEEEEECCCCceEEEEEecccc--------ccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCC
Q 001858 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--------KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 707 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 778 (1003)
....+-+|+.+.|+++.+. |+.+.||.-..+. .-..++..+|++.+.+++--.|.-..-+ +.+..
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 4578999999999999986 5566777532111 1124677889999998853233222111 12233
Q ss_pred ceEEeeecccC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCC---CeEE
Q 001858 779 FKALVYDYMQS-GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM---VAHV 854 (1003)
Q Consensus 779 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~---~~kl 854 (1003)
.-.++|||++| .++.+++...... ..........+..|-+.+.-||.. +|+|+|+..+||++..++ .+.+
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEE
Confidence 44799999987 4789998875432 222233367888999999999999 999999999999997655 4589
Q ss_pred ccccccc
Q 001858 855 SDFGLAK 861 (1003)
Q Consensus 855 ~DfG~a~ 861 (1003)
+|||++.
T Consensus 158 Idfgls~ 164 (229)
T KOG3087|consen 158 IDFGLSS 164 (229)
T ss_pred Eeecchh
Confidence 9999985
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.4e-07 Score=103.29 Aligned_cols=177 Identities=21% Similarity=0.224 Sum_probs=133.1
Q ss_pred cceEEEEEEECCCCceEEEEEeccccccchHHHHHHHHHHHhcCCCCceeEeeeeeecccCCCCceEEeeecccC-CCHH
Q 001858 715 SFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS-GSLE 793 (1003)
Q Consensus 715 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 793 (1003)
.-.+.|++....+|..|+.|+++.........-..-+++++++.|+|+|++.+++....| ++...++|++|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 346899999999999999999954433332223356788999999999999998764444 36677899999987 4788
Q ss_pred HHHhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCCeEEccccccccc
Q 001858 794 DWLQQSNDQ----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863 (1003)
Q Consensus 794 ~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~ 863 (1003)
+........ .+...++...|.++.|+..||.++|+. |..-+-+.|++|+++.+.+++|+.-|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 766543322 244678999999999999999999999 9999999999999999888998877666443
Q ss_pred ccCCccccCcccccccccccccCccccCCCCCCccccchhHHHHHHHHHhCCCC
Q 001858 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917 (1003)
Q Consensus 864 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~P 917 (1003)
...+ . |.+.+ -.+-|.=.+|.+++.+.||..-
T Consensus 444 ~~d~-----------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDP-----------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCC-----------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 2211 0 11111 1245888899999999999654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.6e-09 Score=83.93 Aligned_cols=60 Identities=38% Similarity=0.589 Sum_probs=34.9
Q ss_pred cccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceEecCCCcc
Q 001858 541 SLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600 (1003)
Q Consensus 541 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 600 (1003)
+|++|++++|+|+...+..|..+++|++|++++|+|+...|+.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455566666666544444555566666666666666555555666666666666666653
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.7e-08 Score=98.29 Aligned_cols=134 Identities=26% Similarity=0.210 Sum_probs=100.2
Q ss_pred cCCccCeeeeccceEEEEEEECCCCceEEEEEecccc-----------------c-----cchHHHHHHHHHHHhcCCC-
Q 001858 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----------------K-----GSIKSFVAECEALKNIRHR- 760 (1003)
Q Consensus 704 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~- 760 (1003)
=+.++.+||.|.-+.||.|... .+.++|||.-+... . -......+|.++|.++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999987 67789999753110 0 0134567899999999654
Q ss_pred -CceeEeeeeeecccCCCCceEEeeecccCCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccC
Q 001858 761 -NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL 839 (1003)
Q Consensus 761 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 839 (1003)
.+.+.+++ +...+|||+++|-.|...- ++......++..|++-+.-+-+. ||||||+
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 77777765 3448999999996665421 12334455666777777666677 9999999
Q ss_pred CCCceEeCCCCCeEEcccccc
Q 001858 840 KPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 840 kp~Nill~~~~~~kl~DfG~a 860 (1003)
++-||+++++|.+.++||--+
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred chheEEEecCCCEEEEeCccc
Confidence 999999999999999999544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-08 Score=81.48 Aligned_cols=59 Identities=44% Similarity=0.561 Sum_probs=30.4
Q ss_pred CccEEEcccccccccCCCccccccccceeccccccccccccccccCCCccceeeccccc
Q 001858 396 NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454 (1003)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 454 (1003)
+|++|++++|+++...+..|..+++|++|++++|+++.+.|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444455555555555555555554444455555555555555554
|
... |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-09 Score=96.56 Aligned_cols=91 Identities=20% Similarity=0.311 Sum_probs=66.9
Q ss_pred cccccccccccccccccccCccccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCcccccCCCccceE
Q 001858 514 NLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYL 593 (1003)
Q Consensus 514 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 593 (1003)
..+.++.|+|++|+|+ .+|.++..++.|+.|+++.|.+. ..|..+..|.+|..||..+|.+. .+|-.+-.-+.....
T Consensus 75 kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~ 151 (177)
T KOG4579|consen 75 KFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALI 151 (177)
T ss_pred ccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHH
Confidence 3446778888888887 77888888888888888888887 67777888888888888888887 444334333444555
Q ss_pred ecCCCcccccCCCC
Q 001858 594 NLSYNDFEGQVPTK 607 (1003)
Q Consensus 594 ~l~~N~l~~~~p~~ 607 (1003)
++.+++|.+..+.+
T Consensus 152 ~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 152 KLGNEPLGDETKKK 165 (177)
T ss_pred HhcCCcccccCccc
Confidence 66777787766654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.4e-07 Score=96.36 Aligned_cols=145 Identities=15% Similarity=0.066 Sum_probs=99.9
Q ss_pred CeeeeccceEEEEEEECCCCceEEEEEecccccc-----------chHHHHHHHHHHHhcC--CCCceeEeeeeeecccC
Q 001858 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-----------SIKSFVAECEALKNIR--HRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 709 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 775 (1003)
+.+-+.....|+++... |+.|.||........ ....+.+|.+.+.++. .-.+.+++++.......
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 45555555567777664 568999976422210 1124788999888883 22333444443221111
Q ss_pred CCCceEEeeecccCC-CHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCC------
Q 001858 776 GDDFKALVYDYMQSG-SLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH------ 848 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~------ 848 (1003)
....-++|+|++++. +|.+++.... ....+......++.+++..++-||.. ||+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence 123457999999986 8999986422 12345667788999999999999999 9999999999999975
Q ss_pred -CCCeEEccccccc
Q 001858 849 -DMVAHVSDFGLAK 861 (1003)
Q Consensus 849 -~~~~kl~DfG~a~ 861 (1003)
++.+.++||+.++
T Consensus 180 ~~~~~~LIDl~r~~ 193 (268)
T PRK15123 180 EDLKLSVIDLHRAQ 193 (268)
T ss_pred CCceEEEEECCccc
Confidence 4689999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=94.10 Aligned_cols=124 Identities=25% Similarity=0.230 Sum_probs=81.2
Q ss_pred EEEEEEECCCCceEEEEEeccccc----------------------c----chHHHHHHHHHHHhcCCC--CceeEeeee
Q 001858 718 FVYRGNLGEDLLPVAVKVINLKQK----------------------G----SIKSFVAECEALKNIRHR--NLIKIITVC 769 (1003)
Q Consensus 718 ~Vy~~~~~~~~~~vavK~~~~~~~----------------------~----~~~~~~~E~~~l~~l~h~--niv~~~~~~ 769 (1003)
.||.|... ++..+|+|+.+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999885 567999999752100 0 023567899999999654 566777652
Q ss_pred eecccCCCCceEEeeeccc--CCCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCcEeccCCCCceEe
Q 001858 770 SSIDFKGDDFKALVYDYMQ--SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY-LHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 770 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dikp~Nill 846 (1003)
...+||||++ |..+..+.... +...+...++.+++..+.. +|+. ||+|||+.+.||++
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv 140 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILV 140 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEE
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEe
Confidence 2279999999 65555443321 1123456677888886666 4677 99999999999999
Q ss_pred CCCCCeEEcccccccc
Q 001858 847 DHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 847 ~~~~~~kl~DfG~a~~ 862 (1003)
+++ .+.++|||.+..
T Consensus 141 ~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ETT-CEEE--GTTEEE
T ss_pred ecc-eEEEEecCccee
Confidence 877 999999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.4e-10 Score=123.38 Aligned_cols=89 Identities=33% Similarity=0.376 Sum_probs=65.2
Q ss_pred ccccccccccccccccccccccCc-cccCcccccEEEecCCCccccCCcccccccCcCeeeccCceeccCCc-ccccCCC
Q 001858 511 VVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIP-EYLEDLS 588 (1003)
Q Consensus 511 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~ 588 (1003)
.+..++.|++|||++|.+. .+|. ...++. |+.|++++|.++.. ..+.+|++|+.||+++|-|.+.-- ..+..|.
T Consensus 204 ~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs 279 (1096)
T KOG1859|consen 204 NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLS 279 (1096)
T ss_pred HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHH
Confidence 3667788888888888887 5554 344444 88888888888732 357788888888888888875322 3456677
Q ss_pred ccceEecCCCccccc
Q 001858 589 FLEYLNLSYNDFEGQ 603 (1003)
Q Consensus 589 ~L~~L~l~~N~l~~~ 603 (1003)
.|..|+|.||++.+.
T Consensus 280 ~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 280 SLIVLWLEGNPLCCA 294 (1096)
T ss_pred HHHHHhhcCCccccC
Confidence 888888899888763
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.7e-09 Score=119.78 Aligned_cols=128 Identities=26% Similarity=0.301 Sum_probs=85.5
Q ss_pred cccceEEccCcccccccCCCCCCCCCcceeeeeccccCCCCcccccCCCCCCeEecCCccCCCCCCCcccCCchhHHhhc
Q 001858 173 LKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLL 252 (1003)
Q Consensus 173 ~~L~~L~L~~n~l~~~ip~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~ 252 (1003)
.+|...+.++|.++ .+-.++.-++.|+.|+|++|+++.. +.+..|++|++|||+.|.+..++- +.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~-l~----------- 228 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQ-LS----------- 228 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccc-cc-----------
Confidence 57888999999988 6777888889999999999999854 478889999999999998874321 10
Q ss_pred ccccCCCCCcccccCccccceeeccCcccccCcCccccccccchhhhccCccccCccCcc-cCCCCcccEEecCCCCCC
Q 001858 253 TNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNITRLNLGQNNLG 330 (1003)
Q Consensus 253 ~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~ 330 (1003)
-..+ +|..|.+++|.++.. ..+.++++|+.||+++|-|.+--.-. +..|..|+.|+|.+|.+-
T Consensus 229 ------------~~gc-~L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 229 ------------MVGC-KLQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ------------hhhh-hheeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 0011 256666666666532 24566666677777777665432111 244455666666666553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9e-09 Score=92.35 Aligned_cols=113 Identities=19% Similarity=0.291 Sum_probs=75.7
Q ss_pred eeeccCccccCCCchhhhhhccccccccCCCCccccccccccccccccccccccccccccccCccccCcccccEEEecCC
Q 001858 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550 (1003)
Q Consensus 471 ~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 550 (1003)
..+|++|.+. .+|+.+....+..+.++|++|+|+ .+|.++..++.|+.|+++.|.+. ..|..+..+.+|..|+..+|
T Consensus 57 ~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~n 133 (177)
T KOG4579|consen 57 KISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPEN 133 (177)
T ss_pred EEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCC
Confidence 3344444444 444444444444444455555554 45556888889999999999998 77888888999999999999
Q ss_pred CccccCCcccccccCcCeeeccCceeccCCcccccCC
Q 001858 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL 587 (1003)
Q Consensus 551 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 587 (1003)
.+. .+|-.+..-...-..++.++.+.+.-+..++.+
T Consensus 134 a~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 134 ARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred ccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 997 677664443444555678888887666554443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.4e-06 Score=83.03 Aligned_cols=143 Identities=17% Similarity=0.130 Sum_probs=103.6
Q ss_pred eeeccceEEEEEEECCCCceEEEEEecccc------ccchHHHHHHHHHHHhcC--CCCceeEeeeeeecccCCCCceEE
Q 001858 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQ------KGSIKSFVAECEALKNIR--HRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 711 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 782 (1003)
-|+||.+.|+.....+. .+=+|.-...- +--...|.+|...++.+. .-.+.++. ++........-.-++
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36689999999877544 57777754111 223578999999999984 33355555 333222223344579
Q ss_pred eeecccC-CCHHHHHhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCcEeccCCCCceEeCCCCC--eEEccccc
Q 001858 783 VYDYMQS-GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV--AHVSDFGL 859 (1003)
Q Consensus 783 v~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~--~kl~DfG~ 859 (1003)
|+|.+++ .+|.+++.... ..+.+..+...+..+++.+++-||.. |+.|+|+.+.||+++.++. ++++||.-
T Consensus 103 VTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 9997764 48999986532 23457777889999999999999999 9999999999999987676 99999976
Q ss_pred ccc
Q 001858 860 AKF 862 (1003)
Q Consensus 860 a~~ 862 (1003)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-07 Score=96.22 Aligned_cols=57 Identities=23% Similarity=0.328 Sum_probs=27.6
Q ss_pred cCCchhHHhhcccccCCCCCcccccCccccceeeccCcccccCc-CccccccccchhhhccCcccc
Q 001858 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSI-PQSFSNASNLVILNLSGNHFS 306 (1003)
Q Consensus 242 ~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 306 (1003)
..+.++.+.+..|++.. .+|++..+.+..|.+...- .+.+..++.+-.|+|+.|+|.
T Consensus 180 ~~~c~~~~w~~~~~l~r--------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~id 237 (418)
T KOG2982|consen 180 QLPCLEQLWLNKNKLSR--------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNID 237 (418)
T ss_pred cCCcHHHHHHHHHhHHh--------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccc
Confidence 34455666666666542 3355555666666554221 123333444444444444443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.39 E-value=8.4e-08 Score=97.28 Aligned_cols=209 Identities=21% Similarity=0.235 Sum_probs=129.5
Q ss_pred cccccccccccccCccc-ccc-cCCCCccEEEcccccccc--cCCCccccccccceeccccccccccccccccCCCccce
Q 001858 372 TITIIAMGLNQISGTIP-LEI-RNLANIYALGLEYNQLTG--TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447 (1003)
Q Consensus 372 ~L~~L~L~~n~l~~~~p-~~~-~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 447 (1003)
.++.|.+.++.|..+.- ..| ...+.++++||.+|+|+. .+...+.++|.|++|+|+.|++...+...=..+.+|+.
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 34444444554432211 112 234567777777777762 33344556777777777777776433222145667788
Q ss_pred eeccccccc-ccCCccccCCCCCCeeeccCccccCCCchhhhhhccccccccCCCCcccccccc--cccccccccccccc
Q 001858 448 LWLGFNNLQ-GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL--VVGNLKNLIQLDIS 524 (1003)
Q Consensus 448 L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~N~l~~~~p~--~~~~l~~L~~L~Ls 524 (1003)
|-|.+..+. ......+..++.+++|.+|.|.+. .+++..|-+....|. .+..++.+..++++
T Consensus 126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~ 190 (418)
T KOG2982|consen 126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLN 190 (418)
T ss_pred EEEcCCCCChhhhhhhhhcchhhhhhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHHHHH
Confidence 877777765 233445667777888888888654 123444443322211 13345566777777
Q ss_pred ccccccccCccccCcccccEEEecCCCccccC-CcccccccCcCeeeccCceeccCC-cccccCCCccceEecCCCcccc
Q 001858 525 RNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI-PSSLISLKSIEVLDLSCNNLSGQI-PEYLEDLSFLEYLNLSYNDFEG 602 (1003)
Q Consensus 525 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~ 602 (1003)
-|++... ++++..+-+..|.+...- -..+..++.+..|+|+.|+|..-. -+.+..++.|..|.+++|++..
T Consensus 191 ~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 191 KNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred HHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 7887643 346777788888776432 245566788889999999987532 2678889999999999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1003 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-47 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-26 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-47 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-26 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-23 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 8e-05 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 8e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-04 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 7e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 499 bits (1288), Expect = e-164
Identities = 168/571 (29%), Positives = 270/571 (47%), Gaps = 24/571 (4%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L + + + + P++G+ S L+ ++++ N L G+ + + LK+L + N F G I
Sbjct: 205 LDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQ 200
P +L S+ N TGEIP ++ L L+++ N G +PP G+ S L+
Sbjct: 264 PP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 201 QLGVGENKLYGIIP-ESLGQLRDLNFLSVAENNFSGMLPP-IFNIS-SLEQISLLTNRFE 257
L + N G +P ++L ++R L L ++ N FSG LP + N+S SL + L +N F
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 258 GRLPLNIGFN-LPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL 316
G + N+ N L+ L + N TG IP + SN S LV L+LS N+ SG + SL
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITII 376
+ L L N L G I L LETL L+ N G +P ++N + + I
Sbjct: 442 SKLRDLKLWLNML-EGEI-----PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 377 AMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP 436
++ N+++G IP I L N+ L L N +G IP +G+ +L LD + N +G IP
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 437 DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN--KLTGTLPPQILEITTLS 494
++ S + N + G + N + + N + G Q+ ++T +
Sbjct: 556 AAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 495 SLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG 554
+++S + G N +++ LD+S N SG IP + S L L + N G
Sbjct: 612 PC-NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670
Query: 555 SIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKT 614
SIP + L+ + +LDLS N L G+IP+ + L+ L ++LS N+ G +P G F
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730
Query: 615 RISLIENGKLCGGLDELHLPACHNTRPRKAK 645
+ N LCG LP C +
Sbjct: 731 PAKFLNNPGLCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-154
Identities = 168/589 (28%), Positives = 280/589 (47%), Gaps = 33/589 (5%)
Query: 30 ALSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRHPRVIQLYLRN---Q 86
+ S + L++ K L D + W+++ N C + GVTC V + L +
Sbjct: 7 SQSLYREIHQLISFKDVLPDK-NLLPDWSSNKNPCTFDGVTCRDDK--VTSIDLSSKPLN 63
Query: 87 SVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPS--NL 144
+S + +L+ L + L++++++G + + L L L NS SG + + +L
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 145 SHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI---GNISTLQQ 201
CS L +V N L G LE L+++ N ++G L+
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLP 261
L + NK+ G + + + +L FL V+ NNFS +P + + S+L+ + + N+ G
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFS 240
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNIT 320
I +LK+L + N G IP +L L+L+ N F+G++ + +T
Sbjct: 241 RAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR-SIANLSTITIIAMG 379
L+L N+ G++ +CS LE+L L+SN F G LP ++ + + ++ +
Sbjct: 298 GLDLSGNHF-YGAV-----PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 380 LNQISGTIPLEIRNL-ANIYALGLEYNQLTGTIPYTIGE--LINLQALDFSANNLHGIIP 436
N+ SG +P + NL A++ L L N +G I + + LQ L N G IP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 437 DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL 496
++ N S L SL L FN L G IPSSLG+ L L + N L G +P +++ + TL +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET- 470
Query: 497 LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
L L N ++G IP + N NL + +S NR +GEIP + +L LK+ +NSF G+I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 557 PSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605
P+ L +S+ LDL+ N +G IP + S ++ N G+
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRY 575
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-25
Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 4/156 (2%)
Query: 77 RVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSF 136
+ G S + LS N+ S G + L + +N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 137 SGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK-LENLNVAENQLTGQLPPSIGN 195
SG IP + L ++ N+++G IP +G L+ L L+++ N+L G++P ++
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD--LRGLNILDLSSNKLDGRIPQAMSA 702
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAEN 231
++ L ++ + N L G IPE GQ N
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNN 737
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 305 bits (785), Expect = 3e-96
Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 13/307 (4%)
Query: 337 LDFITLLTNCSKL----ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT--IPLE 390
L L N + L T + + G L + + + + + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS 71
Query: 391 IRNLANIYALGL-EYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
+ NL + L + N L G IP I +L L L + N+ G IPD + + TL +L
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
+N L G +P S+ + NL+ + N+++G +P + L + + +S N ++G IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
NL NL +D+SRN G+ S + + + + NS + + K++ L
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLD 629
DL N + G +P+ L L FL LN+S+N+ G++P G + N LCG
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-- 307
Query: 630 ELHLPAC 636
LPAC
Sbjct: 308 --PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 1e-69
Identities = 78/348 (22%), Positives = 136/348 (39%), Gaps = 67/348 (19%)
Query: 31 LSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQ--WTGVTCGQRH--PRVIQLYLRNQ 86
L N D+ ALL IK L +P SSW + + C W GV C RV L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 87 SVGG--FLSPYVGNLSF-------------------------LRFINLASNNLHGEIPNE 119
++ + + NL + L ++ + N+ G IP+
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 120 LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLN 179
L ++ L L +N+ SGT+P ++S NL+ + N ++G IP G + ++
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 180 VAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP 239
++ N+LTG++PP+ N++ L + + N L G G ++ + +A+N+ + L
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILN 299
+ +L + L N + G++PQ + L LN
Sbjct: 240 VGLSKNLNGLDL-------------------------RNNRIYGTLPQGLTQLKFLHSLN 274
Query: 300 LSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347
+S N+ G++ +L N GS L C+
Sbjct: 275 VSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP--------LPACT 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = 3e-96
Identities = 99/609 (16%), Positives = 196/609 (32%), Gaps = 88/609 (14%)
Query: 36 DRVALLAIKSQLQDP--------MGITSSWNNSINVCQWT---GVTCGQRHPRVIQLYLR 84
D +AL I L ++WN + + W GV+
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN------------ 78
Query: 85 NQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSG----TI 140
+ + ++L G +P+ +G+L+ L+VL L +
Sbjct: 79 -------------SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGY-YWLKLENLNVAENQLTGQLPPSIGNISTL 199
P +S + R + Y + L + + + S
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 200 QQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGR 259
Q+G N + + +++ +L L + + F + E + +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENIC----EAWENENSEYAQQYKT 240
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGI-------- 311
L NL L + V +P + ++N++ N +
Sbjct: 241 EDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 312 DFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLS 371
D I + +G NNL + + T L KL L N+ G LP + +
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 372 TITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIP--YTIGELINLQALDFSAN 429
+ + + NQI+ + L +N+L IP + + + A+DFS N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN 412
Query: 430 NLHGI-------IPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG- 481
+ + + + ++S+ L N + L +N+ N LT
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 482 ---TLPPQILEITTLSSL--LDLSSNLISGSIP-LVVGNLKNLIQLDISRNRFSGEIPTT 535
+L + L +DL N ++ L L+ +D+S N FS PT
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531
Query: 536 LSSCTSLEYLKMQD------NSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF 589
+ ++L+ +++ N P + S+ L + N++ + E +
Sbjct: 532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPN 588
Query: 590 LEYLNLSYN 598
+ L++ N
Sbjct: 589 ISVLDIKDN 597
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 3e-82
Identities = 96/524 (18%), Positives = 166/524 (31%), Gaps = 82/524 (15%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+ S L + S+ I + + N+ + + + + L F +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
+ E EN N Q N+ L + V +P L
Sbjct: 216 SPFVAENICEA------WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
L ++ ++VA N + +L + ++I+ +G
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK----------------IQIIYIG 313
Query: 278 QNNL-TGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGD 336
NNL T + S L +L N GK+ F S + LNL N +
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPAN- 371
Query: 337 LDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLAN 396
++E L N+ +P + ++++
Sbjct: 372 -----FCGFTEQVENLSFAHNKL-KYIPNI----------------------FDAKSVSV 403
Query: 397 IYALGLEYNQLTG-------TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
+ A+ YN++ + T + IN+ +++ S N + + S L+S+
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463
Query: 450 LGFNNLQG-------NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLS 500
L N L + + N L +++ NKLT L TTL L +DLS
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDF-RATTLPYLVGIDLS 521
Query: 501 SNLISGSIPLVVGNLKNLIQLDI------SRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG 554
N S P N L I NR E P ++ C SL L++ N R
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579
Query: 555 SIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+ + +I VLD+ N Y+ L Y+
Sbjct: 580 KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-72
Identities = 73/493 (14%), Positives = 150/493 (30%), Gaps = 45/493 (9%)
Query: 77 RVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSF 136
+I+ + + + I SNN+ + + RL++L+ + + F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPF 218
Query: 137 SGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNI 196
N L ++ V +LP + +
Sbjct: 219 VAENICEAWENENSEY-----AQQYKTEDLKWDN-LKDLTDVEVYNCPNLTKLPTFLKAL 272
Query: 197 STLQQLGVGENKLYGI--------IPESLGQLRDLNFLSVAENNFSGMLPP--IFNISSL 246
+Q + V N+ + + + NN + + L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 247 EQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
+ L N+ EG G + KL L + N +T + L+ + N
Sbjct: 333 GMLECLYNQLEG-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390
Query: 307 GKV-GIDFSSLPNITRLNLGQNNLGSGSIGDLDFI-TLLTNCSKLETLGLNSNRFGGSLP 364
D S+ ++ ++ N +GS + D + + ++ L++N+
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 365 RSIANLSTITIIAMGLNQISG-------TIPLEIRNLANIYALGLEYNQLTGTIP-YTIG 416
+ S ++ I + N ++ +N + ++ L +N+LT +
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRAT 510
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTL------NSLWLGFNNLQGNIPSSLGNCKNLM 470
L L +D S N+ P N STL N N P + C +L
Sbjct: 511 TLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569
Query: 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG 530
L + N + + +I +S L D+ N V + ++
Sbjct: 570 QLQIGSNDIR-KVNEKIT--PNISVL-DIKDNPNISIDLSYVCPYIEAGMYMLFYDK--- 622
Query: 531 EIPTTLSSCTSLE 543
+ C +L+
Sbjct: 623 --TQDIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-65
Identities = 69/452 (15%), Positives = 139/452 (30%), Gaps = 67/452 (14%)
Query: 177 NLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGM 236
N N + Q S+ + + L + G +P+++GQL +L L++ +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 237 LPP-----IFNISSLEQISLLTNRFEGRLPLNIGF-NLPKLKILIVGQNNLTGSIPQSFS 290
I S EQ + ++ + L + + SI +S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 291 NASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLE 350
+ N+ + + ++ +KL
Sbjct: 181 ITLKDTQIGQLSNNIT--------FVSK--------------AVM---------RLTKLR 209
Query: 351 TLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGT 410
+ ++ F Q T L+ NL ++ + +
Sbjct: 210 QFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264
Query: 411 IPYTIGELINLQALDFSANNLHGI--------IPDSIGNLSTLNSLWLGFNNLQ-GNIPS 461
+P + L +Q ++ + N + +++G+NNL+ + +
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLI 519
SL K L +L N+L G LP + L L+L+ N I+ G + +
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP----AFGSEIKLASLNLAYNQITEIPANFCGFTEQVE 380
Query: 520 QLDISRNRFSGEIPTTLS--SCTSLEYLKMQDNSFRG-------SIPSSLISLKSIEVLD 570
L + N+ IP S + + + N + + ++ ++
Sbjct: 381 NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439
Query: 571 LSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEG 602
LS N +S E S L +NL N
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-59
Identities = 56/379 (14%), Positives = 117/379 (30%), Gaps = 29/379 (7%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDF-SSLPNITRLNLG 325
+ ++ L + +G +P + + L +L L + + +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISG 385
Q +D+ + S L +NS+ S+ +S T I N I+
Sbjct: 139 QKMRMHYQKTFVDYDPRE-DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+ + L + + + E N + + NL L
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDL 251
Query: 446 NSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--------L 497
+ + +P+ L + L+NV+ N+ + L+ +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPVGEKIQII 310
Query: 498 DLSSN-LISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
+ N L + + + +K L L+ N+ G++P S L L + N
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369
Query: 557 PSSLISLKSIEVLDLSCNNLSGQIPEYLE--DLSFLEYLNLSYNDFEGQVPTKGVFSNKT 614
+ + +E L + N L IP + +S + ++ SYN+ K
Sbjct: 370 ANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS-------VDGKN 421
Query: 615 RISLIENGKLCGGLDELHL 633
L + ++L
Sbjct: 422 FDPLDPTPFKGINVSSINL 440
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-34
Identities = 35/248 (14%), Positives = 80/248 (32%), Gaps = 13/248 (5%)
Query: 380 LNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHG----II 435
L+ + + + + L LE +G +P IG+L L+ L ++
Sbjct: 66 LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 436 PDSIGNLSTLNSLWLGFNNLQGNIPSSLG--NCKNLMLLNVSKNKLTGTLPPQILEITTL 493
P I + + Q + +L+ ++ + ++
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 494 SSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+ + SN I+ + V L L Q + + F E + EY
Sbjct: 186 TQI-GQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQY 238
Query: 554 GSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNK 613
+ +LK + +++ ++P +L+ L ++ +N++ N K +
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 614 TRISLIEN 621
+ E
Sbjct: 299 ADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 36/245 (14%), Positives = 68/245 (27%), Gaps = 30/245 (12%)
Query: 96 VGNLSFLRFINLASNNLHG-------EIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCS 148
++S + I+ + N + + + + + L N S S S
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 149 NLINFSVRRNNLTG-------EIPAYIGYYWLKLENLNVAENQLTGQLPPSI--GNISTL 199
L + ++ N LT + L ++++ N+LT L + L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKN-TYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 200 QQLGVGENKLYGIIPESLGQLRDL------NFLSVAENNFSGMLPP-IFNISSLEQISLL 252
+ + N P L N N P I SL Q+ +
Sbjct: 516 VGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 253 TNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID 312
+N + I P + +L + N + L + G D
Sbjct: 575 SNDIRK-VNEKI---TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD 630
Query: 313 FSSLP 317
+
Sbjct: 631 ALDIK 635
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 1e-89
Identities = 115/546 (21%), Positives = 201/546 (36%), Gaps = 35/546 (6%)
Query: 76 PRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNS 135
L L + S + L+ ++L+ + LS L L+L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 136 FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTG-QLPPSIG 194
S S+L NL IG+ L+ LNVA N + +LP
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH-LKTLKELNVAHNLIQSFKLPEYFS 146
Query: 195 NISTLQQLGVGENKLYGIIPESLGQLRDLNF----LSVAENNFSGMLPPIFNISSLEQIS 250
N++ L+ L + NK+ I L L + L ++ N + + P F L +++
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 251 LLTNRFEGRLPLNIGFNLPKLKIL------IVGQNNLTGSIPQSFSNASNLVILNLSGNH 304
L N + L L++ + NL + NL I +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 305 FSGKVGID---FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG 361
+ F+ L N++ +L + + + + L L + +FG
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQ 318
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT--GTIPYTIGELI 419
+ +L +T G +L ++ L L N L+ G +
Sbjct: 319 FPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS-LGNCKNLMLLNVSKNK 478
+L+ LD S N + + + L L L +NL+ S + +NL+ L++S
Sbjct: 374 SLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSI-PLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
+++L L ++ N + P + L+NL LD+S+ + PT +
Sbjct: 433 TRVAFNGIFNGLSSLEVL-KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL-SFLEYLNLS 596
S +SL+ L M N+F L S++VLD S N++ + L+ S L +LNL+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 597 YNDFEG 602
NDF
Sbjct: 552 QNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 5e-65
Identities = 96/463 (20%), Positives = 167/463 (36%), Gaps = 32/463 (6%)
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
N +IP + + +NL+++ N L S + LQ L + ++ I +
Sbjct: 17 LNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 218 GQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIV 276
L L+ L + N + F +SSL+++ + IG +L LK L V
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNV 131
Query: 277 GQNNLTG-SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIG 335
N + +P+ FSN +NL L+LS N D L + LNL +L +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-SLDLSLNPMN 190
Query: 336 DLDFITLLTNCSKLETLGLNSNRFGGSLPR-SIANLSTITIIAMGLNQISGTIPLE---- 390
+ +L L L +N ++ + I L+ + + + L + LE
Sbjct: 191 FIQPGAF--KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 391 --IRNLANIYALGLEYNQL---TGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+ L N+ L I L N+ + + + + S
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGW 306
Query: 446 NSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLIS 505
L L L + K L + G +++ +L L DLS N +S
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFL-DLSRNGLS 360
Query: 506 --GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI-S 562
G +L LD+S N + + LE+L Q ++ + S+ S
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 563 LKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605
L+++ LD+S + LS LE L ++ N F+
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 9e-62
Identities = 79/503 (15%), Positives = 164/503 (32%), Gaps = 61/503 (12%)
Query: 80 QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHG-EIPNELGRLSRLKVLVLDFNSFSG 138
+L ++ + +G+L L+ +N+A N + ++P L+ L+ L L N
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 139 TIPSNLSHCSNLINFSVR----RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI- 193
++L + ++ N + P ++L L + N + + +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKLTLRNNFDSLNVMKTCI 221
Query: 194 ---------------------------GNISTLQQLGVGENKL------YGIIPESLGQL 220
+ L L + E +L I + L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 221 RDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
+++ S+ + + + L+ +F P +L +L +
Sbjct: 282 TNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRLTF-----TS 334
Query: 281 LTGSIPQSFSNASNLVILNLSGNH--FSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
G S + +L L+LS N F G ++ L+L N + +
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT------- 387
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEIRNLANI 397
+ +LE L + S+ +L + + + L+++
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 398 YALGLEYNQLTGTI-PYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L + N P EL NL LD S L + P + +LS+L L + NN
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLV--VGN 514
+L +L+ S N + + ++ + + L+L+ N + + +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 515 LKNLIQLDISRNRFSGEIPTTLS 537
+K+ QL + R P+
Sbjct: 568 IKDQRQLLVEVERMECATPSDKQ 590
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-43
Identities = 74/425 (17%), Positives = 135/425 (31%), Gaps = 55/425 (12%)
Query: 91 FLSPYVGNLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGT------IPSN 143
F+ P L + L +N + + L+ L+V L F S
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 144 LSHCSNLI--NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQ 201
L NL F + + + + + + ++ + Q
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQH 308
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNR--FEGR 259
L + K L L+ L F S N ++ SLE + L N F+G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGN----AFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPN 318
+ F LK L + N + + +F L L+ ++ F SL N
Sbjct: 365 CSQSD-FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSL-PRSIANLSTITIIA 377
+ L++ + + + S LE L + N F + P L +T +
Sbjct: 423 LIYLDISHTHT-RVAFNGI-----FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 378 MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
+ Q+ P +L+++ L + +N + L +LQ LD+S N++
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 438 SIGNL-STLNSLWLGFNNLQGN--------------------------IPSSLGNCKNLM 470
+ + S+L L L N+ PS ++
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MPVL 595
Query: 471 LLNVS 475
LN++
Sbjct: 596 SLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 57/296 (19%), Positives = 101/296 (34%), Gaps = 29/296 (9%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
+P ++ + + + N + + + L L ++ L +L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
L + N + + + LS+L L NL +G+ K L LNV+ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 482 TLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNL----IQLDISRNRFSGEIPTT 535
P+ + L++L LDLSSN I + L + + LD+S N + P
Sbjct: 139 FKLPE--YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 536 LSSCTSLEYLKMQDNSFRGSIPSSLI-SLKSIEVLDLS------CNNLSGQIPEYLEDLS 588
L L +++N ++ + I L +EV L NL LE L
Sbjct: 197 FKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 589 FLEYLNLSYNDFEGQVP-TKGVFSNKT----------RISLIENGKLCGGLDELHL 633
L + + +F+ T I +++ G L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 1e-88
Identities = 109/579 (18%), Positives = 203/579 (35%), Gaps = 47/579 (8%)
Query: 80 QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGT 139
+L+L + S+ + L ++L+ N L +L L+ L+L N
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 140 IPSNLS--HCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIG--- 194
L S+L + N + P +L L + QL L +
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHA-IGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 195 NISTLQQLGVGENKLYGIIPESLGQLRD--LNFLSVAENNFSGMLPPIF-NISSLEQISL 251
++++ L + ++L + L+ L L ++ NN + + F + LE L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 252 LTNRFEGRLPLNIGFNLPKLKILIVGQN---------NLTGSIPQSFSNASNLVILNLSG 302
N + ++ L ++ L + ++ +L SF L LN+
Sbjct: 280 EYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 303 NHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS 362
N G F+ L N+ L+L + ++ + F++L S L L L N+
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKI 396
Query: 363 LPRSIANLSTITIIAMGLNQISGTIP-LEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
+ + L + ++ +GLN+I + E R L NI+ + L YN+ + + +L
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456
Query: 422 QALDFSANNLHGI--IPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
Q L L + P L L L L NN+ L + L +L++ N L
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 480 TGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSC 539
L + G + L +L L++ N F
Sbjct: 517 A-----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 540 TSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLED-LSFLEYLNLSYN 598
L+ + + N+ S + S++ L+L N ++ + L L++ +N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 599 DFEGQVPTKGVF-----SNKTRISLIENGKLCGGLDELH 632
F+ + F T I + + LC H
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 7e-83
Identities = 112/546 (20%), Positives = 198/546 (36%), Gaps = 49/546 (8%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L L + + + S L +++ N + P +L LKVL L N S
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWL-KLENLNVAENQLTGQLPPSIGNISTL 199
+ C+NL + N++ L L+++ N L+ + + L
Sbjct: 90 DKTFAFCTNLTELHLMSNSIQKIKNNPFV--KQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 200 QQLGVGENKLYGIIPESLG--QLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRF 256
Q+L + NK+ + E L L L ++ N P F I L + L +
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 257 EGRLPLNIGF--NLPKLKILIVGQNNLTGSIPQSFSN--ASNLVILNLSGNHFSGKVGID 312
L + ++ L + + L+ + +F +NL +L+LS N+ +
Sbjct: 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
Query: 313 FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST 372
F+ LP + L NN+ L + L L + S+
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHS------LHGLFNVRYLNLKRSFTKQSIS-------- 313
Query: 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN--N 430
L + + L + L +E N + G LINL+ L S + +
Sbjct: 314 -------LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 431 LHGIIPDSIGNL--STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
L + ++ +L S L+ L L N + + +L +L++ N++ L Q
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ-- 424
Query: 489 EITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG--EIPTTLSSCTSLEY 544
E L ++ + LS N + +L +L + R P+ +L
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484
Query: 545 LKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS--------GQIPEYLEDLSFLEYLNLS 596
L + +N+ L L+ +E+LDL NNL+ G +L+ LS L LNL
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 597 YNDFEG 602
N F+
Sbjct: 545 SNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 4e-81
Identities = 103/521 (19%), Positives = 180/521 (34%), Gaps = 51/521 (9%)
Query: 99 LSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRN 158
+ + +NL N L R S+L L + FN+ S P L +++ N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 159 NLTGEIPAYIGYYWL-KLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
L+ + L L++ N + L L + N L +
Sbjct: 84 ELSQLSDKTFA--FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
QL +L L ++ N + +I F LK L +
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDI----------------------FANSSLKKLELS 179
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFS---SLPNITRLNLGQNNLGSGSI 334
N + P F L L L+ + + +I L+L + L + S
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 335 GDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNL 394
+ + L L L+ N S A L + + N I + L
Sbjct: 240 TTFLGL----KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 395 A---------NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+ + L ++ L L+ L+ N++ GI + L L
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 446 NSLWLGFNNLQ-----GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLS 500
L L + SL + L +LN++KNK++ + L LDL
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEV-LDLG 413
Query: 501 SNLISGSIPLVV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG--SIP 557
N I + L+N+ ++ +S N++ + + SL+ L ++ + + S P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473
Query: 558 SSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
S L+++ +LDLS NN++ + LE L LE L+L +N
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-50
Identities = 83/443 (18%), Positives = 146/443 (32%), Gaps = 50/443 (11%)
Query: 72 GQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVL 131
G + + L L ++ + L L + L NN+ + L L ++ L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 132 DFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPP 191
+ +I + +FS L LE+LN+ +N + G
Sbjct: 304 KRSFTKQSISLA--SLPKIDDFSF--QWLK------------CLEHLNMEDNDIPGIKSN 347
Query: 192 SIGNISTLQQLGVGENKLYGIIPESLG----QLRDLNFLSVAENNFSGMLPPIF-NISSL 246
+ L+ L + + + L+ L++ +N S + F + L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 247 EQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
E + L N L L + + + N SF+ +L L L
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 307 GKVGID--FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLP 364
F L N+T L+L NN+ + D +L KLE L L N
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNI-ANINDD-----MLEGLEKLEILDLQHNN------ 515
Query: 365 RSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQAL 424
+ + + G ++ L++++ L LE N +L L+ +
Sbjct: 516 ----------LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 425 DFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLG-NCKNLMLLNVSKNKLTGTL 483
D NNL+ + N +L SL L N + G +NL L++ N T
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625
Query: 484 PPQILEITTLSSLLDLSSNLISG 506
I + ++ + I
Sbjct: 626 E----SIAWFVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-50
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 10/273 (3%)
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQ 406
+ + L L N+ + S +T + +G N IS P + L + L L++N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 407 LTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNC 466
L+ T NL L +N++ I + L +L L N L +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 467 KNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDIS 524
+NL L +S NK+ L + L+I SSL L+LSSN I P + L L ++
Sbjct: 145 ENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 525 RNRFSGEIPTTLS---SCTSLEYLKMQDNSFRGSIPSSLISLK--SIEVLDLSCNNLSGQ 579
+ + L + TS+ L + ++ + ++ + LK ++ +LDLS NNL+
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 580 IPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+ L LEY L YN+ +
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFS--HSLHG 294
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 42/196 (21%), Positives = 74/196 (37%), Gaps = 8/196 (4%)
Query: 419 INLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478
++ + D S L +PD + + + L L N L+ ++ L L+V N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS 538
++ P ++ L L+L N +S NL +L + N
Sbjct: 61 ISKLEPELCQKLPMLKV-LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL--SFLEYLNLS 596
+L L + N + + + L++++ L LS N + E L+ S L+ L LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 597 YNDFEGQVPTKGVFSN 612
N + P G F
Sbjct: 180 SNQIKEFSP--GCFHA 193
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-83
Identities = 100/302 (33%), Positives = 161/302 (53%), Gaps = 20/302 (6%)
Query: 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECE 752
S EL A++ FS N++G+G FG VY+G L D VAVK + + +G F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR 812
+ HRNL+++ C + + LVY YM +GS+ L++ + L+ +R
Sbjct: 80 MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPES-QPPLDWPKR 133
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
I++ A + YLH HC P I+H D+K +N+LLD + A V DFGLAK + + +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----KDT 189
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF---NDGLTLH 929
+ ++GT+G++APEY G S DV+ +G++LLE+ TG+R +D + L
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989
+VK L EK L+D + +E + ++++ +LC+ SP ER M++ V+
Sbjct: 250 DWVKGLLKEK-----KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 990 NL 991
L
Sbjct: 305 ML 306
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 287 bits (735), Expect = 4e-83
Identities = 103/614 (16%), Positives = 202/614 (32%), Gaps = 91/614 (14%)
Query: 33 NETDRVALLAIKSQLQ-----------DPMGITSSWNNSINVCQWTGVTCGQRHPRVIQL 81
D AL AI L + + +WN + + W
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD-------- 318
Query: 82 YLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIP 141
+ N + ++LA G +P+ +G+L+ LKVL +S + +
Sbjct: 319 --------------LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
Query: 142 SNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT-----GQLPPSIGNI 196
R++ + Y +L ++ ++ + +
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
Query: 197 STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRF 256
Q+G N++ I +++ +L L + A + F+ + E + +
Sbjct: 425 LKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVD----WEDANSDYAKQ 479
Query: 257 EGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSG--------- 307
L+ NL L + + +P + L LN++ N
Sbjct: 480 YENEELSWS-NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 308 KVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI 367
++ D + P I +G NNL L KL L N+ +
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEE-----FPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
Query: 368 ANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIP--YTIGELINLQAL 424
+T + + NQI IP + + LG +N+L IP + + + ++
Sbjct: 592 GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649
Query: 425 DFSANNLHGIIPD-----SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
DFS N + + +++ L +N +Q + + +S N +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
Query: 480 TGTLPPQIL-----EITTLSSL--LDLSSNLISGSIP--LVVGNLKNLIQLDISRNRFSG 530
T ++P L L +DL N ++ S+ L L +D+S N FS
Sbjct: 710 T-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS- 766
Query: 531 EIPTTLSSCTSLEYL------KMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYL 584
PT + + L+ + N P+ + + S+ L + N++ + E L
Sbjct: 767 SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL 825
Query: 585 EDLSFLEYLNLSYN 598
L L+++ N
Sbjct: 826 --TPQLYILDIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-49
Identities = 58/441 (13%), Positives = 125/441 (28%), Gaps = 32/441 (7%)
Query: 173 LKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENN 232
++ E+ V +N+LT + + + I + L
Sbjct: 239 VRGESFTVIDNKLTKD-----------ANVPIQLKETAEYIKDYKALKAIWEALDGKNWR 287
Query: 233 FSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNA 292
+ S + + + + +++ N ++ L + G +P +
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD-NNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 293 SNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETL 352
+ L +L+ + + + ++ + N S L
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 353 GLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIP 412
+N N + + T I N+I+ I I+ L + + + T
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 413 YTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLL 472
++ + + + S NL L + L +P L + L L
Sbjct: 466 -----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
Query: 473 NVSKNKLTGTLPPQIL------EITTLSSL--LDLSSNLISG-SIPLVVGNLKNLIQLDI 523
N++ N+ + + T + + N + + + L LD
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580
Query: 524 SRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEY 583
N+ + + L LK+ N +E L S N L IP
Sbjct: 581 VHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNI 637
Query: 584 LE--DLSFLEYLNLSYNDFEG 602
+ + ++ SYN
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGS 658
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-29
Identities = 36/238 (15%), Positives = 75/238 (31%), Gaps = 33/238 (13%)
Query: 403 EYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS 462
E + + + L + G +PD+IG L+ L L G ++ +
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 463 LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG---------------- 506
+ K+++ L+ +L DL + I+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426
Query: 507 ------------SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG 554
I + L L + + + F+ + + +Y
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYE 481
Query: 555 SIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+ S +LK + ++L Q+P++L DL L+ LN++ N K ++
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 33/260 (12%), Positives = 82/260 (31%), Gaps = 26/260 (10%)
Query: 370 LSTITIIAMGLNQISGTIPLEIRNLANIY-ALGLEYNQLTGTIPYTIGELINLQALDFSA 428
L+ + + L + + I + + L I+ AL + + +N +
Sbjct: 251 LTKDANVPIQLKETAEYIK-DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKEL 308
Query: 429 NNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
+ + N + L L +G +P ++G L +L+ + T +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 489 EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGE---IPTTLSSCTSLEYL 545
E T + + + + + L D+ ++ + P S SL+
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 546 KMQDNSFR-GSIPSSLISLKSIEVLDLSCNNLSG-------------------QIPEYLE 585
++ + + R I ++ L ++++ + + +
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
Query: 586 DLSFLEYLNLSYNDFEGQVP 605
+L L + L Q+P
Sbjct: 489 NLKDLTDVELYNCPNMTQLP 508
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 36/249 (14%), Positives = 67/249 (26%), Gaps = 43/249 (17%)
Query: 83 LRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFS----- 137
+ ++ S + L+ N + S + ++L N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 138 --GTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK-LENLNVAENQLTGQLPPSIG 194
N + L +R N LT + L L N++V+ N + P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 195 NISTLQQLGVGE------NKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQ 248
N S L+ G+ N++ P + L L + N+
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK------------- 820
Query: 249 ISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGK 308
+ + P+L IL + N S + L +
Sbjct: 821 -----------VDEKL---TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
Query: 309 VGIDFSSLP 317
G D +
Sbjct: 867 RGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 16/142 (11%), Positives = 41/142 (28%), Gaps = 1/142 (0%)
Query: 492 TLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNS 551
T + + + + I LD R+ + + +
Sbjct: 252 TKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDM 310
Query: 552 FRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFS 611
+ L + + L L+ G++P+ + L+ L+ L+ + G
Sbjct: 311 WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 612 NKTRISLIENGKLCGGLDELHL 633
+S ++ ++ L
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFL 392
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-77
Identities = 101/520 (19%), Positives = 192/520 (36%), Gaps = 26/520 (5%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
L L F++L ++ + RL LVL N + LS L +
Sbjct: 54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPES 216
+ ++ + LE+L + N ++ P L+ L N ++ + E
Sbjct: 114 QTGISSIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 217 LGQLRDLN--FLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFN-LPKLKI 273
+ L+ L++ N+ +G+ P F+ + + ++ + + + + + L +
Sbjct: 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 274 LIVGQNNLTGSIPQSFSN--ASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGS 331
+ P F ++ +NL ++F F + L+L +L
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE 292
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE- 390
+ L S L+ L L++N+F S +N ++T +++ N +
Sbjct: 293 -------LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 391 IRNLANIYALGLEYNQLT--GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
+ NL N+ L L ++ + + L +LQ+L+ S N + ++ L L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 449 WLGFNNLQGNIP-SSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLIS 505
L F L+ S N L +LN+S + L Q+ L +L L+L N
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLF--DGLPALQHLNLQGNHFP 462
Query: 506 GSIPLVVG---NLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLIS 562
L L L +S S +S + ++ + N S +L
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 563 LKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEG 602
LK I L+L+ N++S +P L LS +NL N +
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 4e-70
Identities = 101/533 (18%), Positives = 179/533 (33%), Gaps = 24/533 (4%)
Query: 99 LSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRN 158
+ + + N L RL L L L L + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 159 NLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLG 218
L + L++L + ++ + N TL+ L +G N + I
Sbjct: 92 PLIFMAETALSGP-KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 219 QLRDLNFLSVAENNFSGMLPPIF-NISSLEQISL-LTNRFEGRLPLNIGFNLPKLKILIV 276
L L N + ++ +SL L + F+ + L
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA-FDSAVFQSLNF 209
Query: 277 GQNNLTGSIPQSFSNAS--NLVILNLSGNHFSGKVGIDFSSLP--NITRLNLGQNNLGSG 332
G I + N++ +L + F L ++ +NL ++ +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 333 SIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIR 392
S S L+ L L + LP + LST+ + + N+ +
Sbjct: 270 SSN------TFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 393 NLANIYALGLEYNQLTGTI-PYTIGELINLQALDFSANNLHGI--IPDSIGNLSTLNSLW 449
N ++ L ++ N + + L NL+ LD S +++ + NLS L SL
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
L +N + C L LL+++ +L + L +L+LS +L+ S
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 510 LVVGNLKNLIQLDISRNRFSGEI---PTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSI 566
+ L L L++ N F +L + LE L + + SLK +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 567 EVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLI 619
+DLS N L+ E L L + YLNL+ N +P + ++ I
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP--SLLPILSQQRTI 552
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 6e-64
Identities = 91/492 (18%), Positives = 162/492 (32%), Gaps = 40/492 (8%)
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
L EIP + E L + N L + + L L + ++Y I +
Sbjct: 20 ENLGLN-EIPGTLP---NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKIL 274
+ L+ L + N M +L+ + + + N L+ L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESL 134
Query: 275 IVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITR--LNLGQNNLGSG 332
+G N+++ L +L+ N D SSL T LNL N++
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194
Query: 333 SIGDLDFITLLT-------------------NCSKLETLGLNSNRFGGSLPRSIANLSTI 373
G D + L P L +
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 374 TIIAMGL--NQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNL 431
++ ++ L + + + L L L+ +P + L L+ L SAN
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNKLTGTLPPQILEI 490
+ S N +L L + N + + + L N +NL L++S + + T L++
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQL 372
Query: 491 TTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSSCTSLEYLKM 547
LS L L+LS N L LD++ R + + + L+ L +
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 548 QDNSFRGSIPSSLISLKSIEVLDLSCNNLSG---QIPEYLEDLSFLEYLNLSYNDFEGQV 604
+ S L +++ L+L N+ Q L+ L LE L LS+ D
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-- 490
Query: 605 PTKGVFSNKTRI 616
+ F++ +
Sbjct: 491 IDQHAFTSLKMM 502
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-62
Identities = 91/489 (18%), Positives = 167/489 (34%), Gaps = 26/489 (5%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L L + + L+ + + L L+ L L N S
Sbjct: 86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGY-YWLKLENLNVAENQLTGQLPPSIGNISTL 199
L + N + + +LN+ N + G + P + +
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVF 204
Query: 200 QQLGVGENKLYGIIPESLG-----QLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTN 254
Q L G + +I + L L F + + + S + S+E I+L +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 255 RFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFS 314
F + N L+ L + +L+ +P S L L LS N F I S
Sbjct: 265 YFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322
Query: 315 SLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS--LPRSIANLST 372
+ P++T L++ N +G N L L L+ + S + NLS
Sbjct: 323 NFPSLTHLSIKGNTK-RLELGTGCL----ENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
Query: 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTI-GELINLQALDFSANNL 431
+ + + N+ + + L L + +L + L L+ L+ S + L
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
Query: 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNI---PSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
L L L L N+ +SL L +L +S L+ +
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAF 496
Query: 489 EITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLK 546
T+L + +DLS N ++ S + +LK + L+++ N S +P+ L + +
Sbjct: 497 --TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTIN 553
Query: 547 MQDNSFRGS 555
++ N +
Sbjct: 554 LRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-36
Identities = 77/389 (19%), Positives = 132/389 (33%), Gaps = 78/389 (20%)
Query: 72 GQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVL 131
G V + L+ S S L+ ++L + +L E+P+ L LS LK LVL
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 132 DFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT--GQL 189
N F + S+ +L + S++ N E+ L L+++ + +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 190 PPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQI 249
+ N+S LQ L + N+ + E+ + L L +A
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP-------- 420
Query: 250 SLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKV 309
F+ NL LK+L + + L S Q F L LNL GNHF
Sbjct: 421 ------FQ---------NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK-- 463
Query: 310 GIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIAN 369
G++ L +LE L L+
Sbjct: 464 -------------------------GNIQKTNSLQTLGRLEILVLSF------------- 485
Query: 370 LSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN 429
+S +L + + L +N+LT + + L + L+ ++N
Sbjct: 486 -----------CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASN 533
Query: 430 NLHGIIPDSIGNLSTLNSLWLGFNNLQGN 458
++ I+P + LS ++ L N L
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-74
Identities = 92/308 (29%), Positives = 144/308 (46%), Gaps = 37/308 (12%)
Query: 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA 753
+L +ATN F LIG G FG VY+G L D VA+K + I+ F E E
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
L RH +L+ +I C + L+Y YM++G+L+ L S+ +++ QRL
Sbjct: 89 LSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRL 142
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
I I A + YLH I+H D+K N+LLD + V ++DFG++K + +
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTH 196
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
S +KGT+GY+ PEY + G ++ DVYSFG++L E+ R +
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--------------IV 242
Query: 934 MALPEKVMEIVDFAL----------LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH 983
+LP +++ + ++A+ ++DP E L V C S +R
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 984 MADAVKNL 991
M D + L
Sbjct: 303 MGDVLWKL 310
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-70
Identities = 105/524 (20%), Positives = 188/524 (35%), Gaps = 39/524 (7%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
N S L++++L+ + L L L+L N P + S ++L N
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 157 RNNLTGEIPAYIGYYWL-KLENLNVAENQLTG-QLPPSIGNISTLQQLGVGENKLYGIIP 214
L IG L L+ LNVA N + +LP N++ L + + N + I
Sbjct: 113 ETKLASLESFPIG--QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 215 ESLGQLRDLNF----LSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPK 270
L LR+ L ++ N + F L +++L N + NL
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
Query: 271 LKIL------IVGQNNLTGSIPQSFSNASNLVI--LNLSGNHFSGKVGIDFSSLPNITRL 322
L + + NL P ++ I L+ + + F L N++ +
Sbjct: 231 LHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290
Query: 323 NLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQ 382
+L ++ + + K ++L + + + L ++T L
Sbjct: 291 SLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT-----LTM 337
Query: 383 ISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGEL--INLQALDFSANNLHGIIPDSIG 440
G+I + L ++ L L N L+ + + +L +L+ LD S N I+ +
Sbjct: 338 NKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFM 396
Query: 441 NLSTLNSLWLGFNNLQGNIP-SSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--L 497
L L L + L+ S+ + + L+ L++S I L+SL L
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK-IDFDGIFL--GLTSLNTL 453
Query: 498 DLSSN-LISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
++ N ++ V N NL LD+S+ + + L+ L M N+
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513
Query: 557 PSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
S L S+ LD S N + L + NL+ N
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-64
Identities = 96/519 (18%), Positives = 177/519 (34%), Gaps = 31/519 (5%)
Query: 100 SFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNN 159
S + I+L+ N L S L+ L L +L N + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 160 LTGEIPAYIGYYWLK-LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPESL 217
+ P L LENL E +L IG + TL++L V N ++ +P
Sbjct: 92 IQSFSPGSFS--GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 218 GQLRDLNFLSVAENNFSGMLPPIF-----NISSLEQISLLTNRFEGRLPLNIGFNLPKLK 272
L +L + ++ N + N + + N + + F KL
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQA-FQGIKLH 207
Query: 273 ILIVGQNNLTGSIPQ-SFSNASNLVILNLSGNHFSGK---VGIDFSSLPNITRLNLGQNN 328
L + N + +I + N + L + L F + + S + + + + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIP 388
L + D + + + + L + +++ Q+
Sbjct: 268 LTYTNDFSDDIVK-FHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ--- 321
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLST--LN 446
+L + +L L N+ +I + L +L LD S N L S +L T L
Sbjct: 322 FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLI 504
L L FN + ++ + L L+ + L +L L LD+S
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAF--LSLEKLLYLDISYTNT 436
Query: 505 SGSIPLVVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISL 563
+ L +L L ++ N F + ++ T+L +L + +L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 564 KSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEG 602
+++L++S NNL + L L L+ S+N E
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-57
Identities = 99/503 (19%), Positives = 176/503 (34%), Gaps = 55/503 (10%)
Query: 138 GTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIS 197
G++ + N+ + L+ ++P I +N++++ N L S N S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 198 TLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRF 256
LQ L + ++ I ++ L L+ L + N P F ++SLE + + +
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 257 EGRLPLNIGFNLPKLKILIVGQNNLTG-SIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
L L LK L V N + +P FSN +NLV ++LS N+ D
Sbjct: 117 AS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
Query: 316 LPNIT----RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR-SIANL 370
L L++ N + I D F KL L L N ++ + + NL
Sbjct: 176 LRENPQVNLSLDMSLNPI--DFIQDQAF-----QGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 371 STITIIAMGLNQISGTIPLEI------RNLANIYA--LGLEYNQLTGTIPYTIGELINLQ 422
+ + + + L + LEI L ++ L Y L N+
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 423 ALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNL-------------------QGNIPSSL 463
A+ + ++ + + + SL + L +G+I
Sbjct: 289 AMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKK 346
Query: 464 GNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQL 521
+L L++S+N L+ +SL LDLS N + L+ L L
Sbjct: 347 VALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHL 404
Query: 522 DISRNRFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI 580
D + S L YL + + + + L S+ L ++ N+
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
Query: 581 PEY-LEDLSFLEYLNLSYNDFEG 602
+ + L +L+LS E
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-48
Identities = 80/505 (15%), Positives = 138/505 (27%), Gaps = 87/505 (17%)
Query: 81 LYL-RNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLK----VLVLDFNS 135
L + N L Y NL+ L ++L+ N + N+L L L + N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 136 FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGN 195
I L ++R N + I L + +
Sbjct: 193 ID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK--------- 242
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNR 255
E L P + L D+ F ++ S +
Sbjct: 243 ---------DERNLEIFEPSIMEGLCDVTIDE-------------FRLTYTNDFSDDIVK 280
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
F L + + + ++ + L++
Sbjct: 281 FH---------CLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK---QFPTLD 326
Query: 316 LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITI 375
LP + L L N L L L+ N S S ++L
Sbjct: 327 LPFLKSLTLTMNK--------GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL----- 373
Query: 376 IAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGII 435
++ L L +N + L LQ LDF + L +
Sbjct: 374 -----------------GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT 415
Query: 436 PDS-IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLS 494
S +L L L + + N + + +L L ++ N + +
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF--ANTT 473
Query: 495 SL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSF 552
+L LDLS + V L L L++S N + + SL L N
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 553 RGSIPSSLISLKSIEVLDLSCNNLS 577
S KS+ +L+ N+++
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-36
Identities = 58/320 (18%), Positives = 106/320 (33%), Gaps = 32/320 (10%)
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQ 406
S + + L+ N S +N S + + + +I L ++ L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 407 LTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQG-NIPSSLGN 465
+ P + L +L+ L L + IG L TL L + N + +P+ N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 466 CKNLMLLNVSKNKLTGTLPPQIL----EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQL 521
NL+ +++S N + + L E ++ LD+S N I I L +L
Sbjct: 152 LTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209
Query: 522 DISRNRFSGEIP-TTLSSCTSLEYLKMQDNSFRGSIPSSLISLK--------SIEVLDLS 572
+ N S I T L + L ++ F+ + +I+ L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 573 CNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELH 632
N L+ + ++L+ I +E+ L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGV----------------SIKYLEDVPKHFKWQSLS 313
Query: 633 LPACHNTRPRKAKITILKVL 652
+ C + + LK L
Sbjct: 314 IIRCQLKQFPTLDLPFLKSL 333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 35/156 (22%), Positives = 53/156 (33%), Gaps = 6/156 (3%)
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLK 516
G++ + N+ KL+ +P I T +DLS N + N
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPDDIPSSTKN---IDLSFNPLKILKSYSFSNFS 56
Query: 517 NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNL 576
L LD+SR L L + N + P S L S+E L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 577 SGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+ + L L+ LN+++N FSN
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-09
Identities = 21/149 (14%), Positives = 49/149 (32%), Gaps = 3/149 (2%)
Query: 81 LYL-RNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGT 139
L + N LS N + L F++L+ L L RL++L + N+
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 140 IPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTL 199
S+ + +L N + + ++ L N+ N + + + +
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVAC-ICEHQKFLQWV 570
Query: 200 QQLGVGENKLYGIIPESLGQLRDLNFLSV 228
++ + + + ++ L
Sbjct: 571 KEQKQFLVNVEQMTCATPVEMNTSLVLDF 599
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-67
Identities = 81/315 (25%), Positives = 130/315 (41%), Gaps = 46/315 (14%)
Query: 694 SYAELNKATNEFS------LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS- 746
S+ EL TN F N +G+G FG VY+G + VAVK L I +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKK--LAAMVDITTE 71
Query: 747 -----FVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSND 801
F E + + +H NL++++ S D LVY YM +GSL D L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
L+ R I+ A+ I +LH + +H D+K +N+LLD A +SDFGLA+
Sbjct: 127 T--PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+ + I GT Y+APE + G ++ D+YSFG++LLE+ TG
Sbjct: 182 AS---EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 922 FNDGLTLHGFVKMALP-----EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSME 976
+ + + + + +D + + + C E
Sbjct: 238 REP----QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA-------MYSVASQCLHE 286
Query: 977 SPSERIHMADAVKNL 991
++R + + L
Sbjct: 287 KKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 7e-61
Identities = 66/313 (21%), Positives = 125/313 (39%), Gaps = 29/313 (9%)
Query: 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECE 752
L + L + +G FG V++ L E VAVK+ ++ K S + E
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY---VAVKIFPIQDKQSWQ-NEYEVY 70
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR 812
+L ++H N+++ I D L+ + + GSL D+L+ + ++ +
Sbjct: 71 SLPGMKHENILQFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFLKANV------VSWNEL 123
Query: 813 LNISIDVASAIEYLHHH-------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
+I+ +A + YLH +P I H D+K NVLL +++ A ++DFGLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-- 181
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGG-----NVSLTGDVYSFGILLLEMFTGRRPTHT 920
+++ + G GT Y+APE G + L D+Y+ G++L E+ +
Sbjct: 182 -EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 921 MFNDGLTLHGFVKMALP--EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESP 978
++ + P E + E+V + + + + C
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 979 SERIHMADAVKNL 991
R+ + +
Sbjct: 301 EARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 74/327 (22%), Positives = 130/327 (39%), Gaps = 46/327 (14%)
Query: 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECE 752
+ +E + + L LIG+G +G VY+G+L VAVKV + + ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP---VAVKVFS---FANRQNFINEKN 57
Query: 753 --ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLI 810
+ + H N+ + I + G LV +Y +GSL +L + +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWV 111
Query: 811 QRLNISIDVASAIEYLH------HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL- 863
++ V + YLH H +P I H DL NVL+ +D +SDFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 864 --FDRPIQETSSSSIGIKGTVGYVAPEYGMG-------GNVSLTGDVYSFGILLLEMFTG 914
E +++I GT+ Y+APE G + D+Y+ G++ E+F
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM- 230
Query: 915 RRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDP---GNERAKI-------EECLT 964
R T + + + +MA +V F + +R K +
Sbjct: 231 -RCTDLFPGESVPEY---QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286
Query: 965 AVVRIGVLCSMESPSERIHMADAVKNL 991
++ C + R+ A + +
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-55
Identities = 112/502 (22%), Positives = 197/502 (39%), Gaps = 49/502 (9%)
Query: 106 NLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIP 165
+ + +I L+ VL + + T+ + + R +
Sbjct: 7 TITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SI 61
Query: 166 AYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNF 225
+ Y L +N + NQLT + N++ L + + N++ I P L L +L
Sbjct: 62 DGVEY-LNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTG 116
Query: 226 LSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSI 285
L++ N + + P+ N+++L ++ L +N L+ L L+ L G N +T
Sbjct: 117 LTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISALS---GLTSLQQLSFG-NQVTDLK 171
Query: 286 PQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTN 345
P +N + L L++S N S + + L N+ L N + IT L
Sbjct: 172 P--LANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISD--------ITPLGI 219
Query: 346 CSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYN 405
+ L+ L LN N+ ++A+L+ +T + + NQIS PL L + L L N
Sbjct: 220 LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGAN 275
Query: 406 QLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGN 465
Q++ P + L L L+ + N L I P I NL L L L FNN+ P + +
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329
Query: 466 CKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDI 523
L L NK++ + + L+++ L N IS PL NL + QL +
Sbjct: 330 LTKLQRLFFYNNKVSD-----VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGL 382
Query: 524 SRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEY 583
+ ++ ++ + +K + P+++ S D++ N S E
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEV 439
Query: 584 LEDLSFLEYLNLSYNDFEGQVP 605
S + F G V
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-51
Identities = 102/452 (22%), Positives = 180/452 (39%), Gaps = 45/452 (9%)
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
L + + ++ Q+ ++ + +G+ + + L + L
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59
Query: 235 GMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASN 294
+ + +++L QI+ N+ PL NL KL +++ N + P +N +N
Sbjct: 60 S-IDGVEYLNNLTQINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITP--LANLTN 113
Query: 295 LVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
L L L N + +L N+ RL L N + I+ L+ + L+ L
Sbjct: 114 LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--------ISALSGLTSLQQLSF 163
Query: 355 NSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYT 414
+ + +ANL+T+ + + N++S L L N+ +L NQ++ P
Sbjct: 164 GNQVTD---LKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITP-- 216
Query: 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNV 474
+G L NL L + N L I ++ +L+ L L L N + P L L L +
Sbjct: 217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 475 SKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEI 532
N+++ I + L++L L+L+ N + P+ NLKNL L + N S
Sbjct: 273 GANQISN-----ISPLAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDIS 325
Query: 533 PTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEY 592
P +SS T L+ L +N S SSL +L +I L N +S P L +L+ +
Sbjct: 326 P--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379
Query: 593 LNLSYNDFEGQVPTKGVFSNKTRISLIENGKL 624
L L+ + + G L
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-49
Identities = 99/439 (22%), Positives = 181/439 (41%), Gaps = 42/439 (9%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
V L+ L IN ++N L P L L++L ++++ N + + L++ +NL ++
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTL 119
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
N +T P + L L ++ N ++ ++ +++LQQL G N++ + P
Sbjct: 120 FNNQITDIDP--LKNL-TNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP- 172
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L L L L ++ N S + + +++LE + N+ PL L L L
Sbjct: 173 -LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELS 227
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIG 335
+ N L + ++ +NL L+L+ N S S L +T L LG N + +
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISN---- 279
Query: 336 DLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA 395
I+ L + L L LN N+ P I+NL +T + + N IS P+ +L
Sbjct: 280 ----ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLT 331
Query: 396 NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNL 455
+ L N+++ ++ L N+ L N + + P + NL+ + L L
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 456 QGNIPSSLGNCKNLMLLNVSKNKLTGTLPP-QILEITTLSSLLDLSSNLISGSIPLVVGN 514
+ N+ + N KN + P I + + + D++ NL S V
Sbjct: 388 TNAPVNYK---ANVSIPNTVKNVTGALIAPATISDGGSYTE-PDITWNLPS-YTNEVSYT 442
Query: 515 LKNLIQLDISRNRFSGEIP 533
+ + FSG +
Sbjct: 443 FSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 40/217 (18%), Positives = 78/217 (35%), Gaps = 32/217 (14%)
Query: 94 PYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINF 153
+ L+ L + L +N + P L L+ L L L+ N P +S+ NL
Sbjct: 259 APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 154 SVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGII 213
++ NN++ P + KL+ L N+++ S+ N++ + L G N++ +
Sbjct: 315 TLYFNNISDISP--VSS-LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 214 PESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFE---------GRL-PLN 263
P L L + L + + ++ S+ G +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPD 427
Query: 264 IGFNLP-----------KLKILIVGQNNLTGSIPQSF 289
I +NLP + + G +G++ Q
Sbjct: 428 ITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 19/249 (7%)
Query: 672 RRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNL-GEDLLP 730
+ + +++ + ++ IG GSFG V+R G D
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--- 62
Query: 731 VAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQ 788
VAVK++ + + F+ E +K +RH N++ + + + + ++V +Y+
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEYLS 117
Query: 789 SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848
GSL L +S + L+ +RL+++ DVA + YLH+ PPIVH +LK N+L+D
Sbjct: 118 RGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174
Query: 849 DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
V DFGL++ T SS GT ++APE + DVYSFG++L
Sbjct: 175 KYTVKVCDFGLSRLK-----ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 909 LEMFTGRRP 917
E+ T ++P
Sbjct: 230 WELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 44/301 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
E + ++G+G+FG V + +D VA+K ++ + K+F+ E L + H N
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKD---VAIKQ--IESESERKAFIVELRQLSRVNHPN 62
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++K+ C + LV +Y + GSL + L + ++ + +
Sbjct: 63 IVKLYGACL------NPV-CLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQ 113
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YLH ++H DLKP N+LL V + DFG A + + KG
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--------QTHMTNNKG 165
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940
+ ++APE G N S DV+S+GI+L E+ T R+P + + V
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN------ 219
Query: 941 MEIVDFALLLDPGNERAKI-EECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999
R + + + + C + PS+R M + VK + +
Sbjct: 220 -------------GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266
Query: 1000 G 1000
G
Sbjct: 267 G 267
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-51
Identities = 102/513 (19%), Positives = 180/513 (35%), Gaps = 44/513 (8%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L L + S + L+ ++L+ + LS L L+L N
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWL-KLENLNVAENQLT-GQLPPSIGNIST 198
S S+L NL IG L L+ LNVA N + +LP N++
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIG--HLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNF----LSVAENNFSGMLPPIFNISSLEQISLLTN 254
L+ L + NK+ I L L + L ++ N + + P F L +++L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 255 RFEGRLPLNIGFNLPKLKIL------IVGQNNLTGSIPQSFSNASNLVILNLSGNH---F 305
+ L L++ + NL + NL I + +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 306 SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLT---------------NCSKLE 350
+ F+ L N++ +L + + D + L+
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 351 TLGLNSNRFGGSLPRSIANLSTITIIAMGLNQIS--GTIPLEIRNLANIYALGLEYNQLT 408
L SN+ G + S +L ++ + + N +S G ++ L L +N +
Sbjct: 329 RLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSI-GNLSTLNSLWLGFNNLQGNIPSSLGNCK 467
T+ L L+ LDF +NL + S+ +L L L + + +
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISR 525
+L +L ++ N P I T L +L LDLS + P +L +L L+++
Sbjct: 446 SLEVLKMAGNSFQENFLPDIF--TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 526 NRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPS 558
N+ TSL+ + + N + S P
Sbjct: 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-50
Identities = 93/515 (18%), Positives = 176/515 (34%), Gaps = 30/515 (5%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT 161
+ ++L+ N L L+VL L S+L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPESLGQL 220
+ L+ L E L IG++ TL++L V N + +PE L
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 221 RDLNFLSVAENNFSGMLPPIFN-----ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+L L ++ N + + L N + F +L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLHKLT 206
Query: 276 VGQNNLTGSIPQ-SFSNASNLVILNLSGNHFSGK---VGIDFSSLPNITRLNLGQNNLGS 331
+ N + ++ + + L + L F + D S+L + L + + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLE 390
D I L + + + L S S + ++ Q
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL---- 322
Query: 391 IRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH--GIIPDSIGNLSTLNSL 448
L ++ L N+ ++ +L +L+ LD S N L G S ++L L
Sbjct: 323 --KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 449 WLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISG 506
L FN + + S+ + L L+ + L + + +L +L LD+S
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSV-FLSLRNLIYLDISHTHTRV 435
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISLKS 565
+ + L +L L ++ N F + +L +L + P++ SL S
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 566 IEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
++VL+++ N L + L+ L+ + L N +
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-43
Identities = 101/488 (20%), Positives = 171/488 (35%), Gaps = 49/488 (10%)
Query: 149 NLINFSV--RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGE 206
+ N + N +IP + +NL+++ N L S + LQ L +
Sbjct: 6 VVPNITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 207 NKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIG 265
++ I + L L+ L + N + F +SSL+++ + L
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 266 FNLPKLKILIVGQNNLT-GSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNIT---- 320
+L LK L V N + +P+ FSN +NL L+LS N D L +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR-SIANLSTITIIAMG 379
L+L N + G I +L L L +N ++ + I L+ + + +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI-------RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 380 LNQISGTIPLE------IRNLANIYALGLEYNQLTG---TIPYTIGELINLQALDFSANN 430
L + LE + L N+ L I L N+ + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 431 LHGIIPDSI-GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE 489
+ + S L + F K+L L + NK
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN-----AFS 342
Query: 490 ITTLSSL--LDLSSNLIS--GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYL 545
L SL LDLS N +S G +L LD+S N + + LE+L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 546 KMQDNSFRGSIPSS-LISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQV 604
Q ++ + S +SL+++ LD+S + LS LE L ++ N F+
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 605 PTKGVFSN 612
+F+
Sbjct: 462 L-PDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 77/464 (16%), Positives = 152/464 (32%), Gaps = 49/464 (10%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNL-HGEIPNELGRLSRLKVLVLDFNSFSGT 139
L ++ + +G+L L+ +N+A N + ++P L+ L+ L L N
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 140 IPSNLSHCSNLINFSVR----RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPP-SIG 194
++L + ++ N + I ++L L + N + + I
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 195 NISTLQQL------GVGENKLYGIIPESLGQLRDLNFLSVAEN---NFSGMLPPIF-NIS 244
++ L+ E L +L L +L + + +F ++
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 245 SLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQS---------------- 288
++ SL++ E + F L+++ +S
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
Query: 289 FSNASNLVILNLSGN--HFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNC 346
+ +L L+LS N F G ++ L+L N + + +
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-------MSSNFLGL 395
Query: 347 SKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYN 405
+LE L + S+ +L + + + L+++ L + N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 406 QLTGTI-PYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLG 464
P EL NL LD S L + P + +LS+L L + N L+
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 465 NCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSI 508
+L + + N + P I LS L+ +S GS
Sbjct: 516 RLTSLQKIWLHTNPWDCSCP----RIDYLSRWLNKNSQKEQGSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 81/423 (19%), Positives = 154/423 (36%), Gaps = 47/423 (11%)
Query: 76 PRVIQLYL-RNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKV----LV 130
+ +L + N L Y NL+ L ++L+SN + +L L ++ + L
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 131 LDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYI--GYYWLKLENLNVAENQLTGQ 188
L N + I L ++R N + + G L++ L + E + G
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 189 L-PPSIGNISTLQQLGVGENKLYGI------IPESLGQLRDLNFLSVAENNFSGMLPPIF 241
L + L L + E +L + I + L +++ S+ + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 242 NIS--------------------SLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNL 281
N SL++++ +N+ +LP L+ L + +N L
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN---AFSEVDLPSLEFLDLSRNGL 359
Query: 282 T--GSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDF 339
+ G QS ++L L+LS N + +F L + L+ +NL +
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-----MSE 413
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIY 398
++ + L L ++ + LS++ ++ M N +I L N+
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN 458
L L QL P L +LQ L+ ++N L + L++L +WL N +
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 459 IPS 461
P
Sbjct: 534 CPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 63/304 (20%), Positives = 101/304 (33%), Gaps = 23/304 (7%)
Query: 371 STITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANN 430
+ + + N + + + L L ++ L +L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 431 LHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEI 490
+ + + LS+L L NL +G+ K L LNV+ N + P+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 491 TTLSSLLDLSSNLISGSIPLVVGNLKNL----IQLDISRNRFSGEIPTTLSSCTSLEYLK 546
T LDLSSN I + L + + LD+S N + I L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 547 MQDNSFRGSIPSSLIS-LKSIEVLDL------SCNNLSGQIPEYLEDLSFL--EYLNLSY 597
+++N ++ + I L +EV L + NL LE L L E L+Y
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 598 ND---------FEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITI 648
D F I +++ G L L C + K+
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 649 LKVL 652
LK L
Sbjct: 327 LKRL 330
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-19
Identities = 68/346 (19%), Positives = 122/346 (35%), Gaps = 37/346 (10%)
Query: 74 RHPRVIQLYLRNQSVGGFLSPYV-GNLSFLRFINLA------SNNLHGEIPNELGRLSRL 126
+ R+ +L LRN + L+ L L NL + L L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 127 KVLVLDFNS---FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN 183
+ + I + +N+ +FS+ + + W LE +N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 184 QLTGQLP----------------PSIGNISTLQQLGVGENKLY--GIIPESLGQLRDLNF 225
Q S ++ +L+ L + N L G +S L +
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 226 LSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSI 285
L ++ N M + LE + + + ++ +L L L + + +
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 286 PQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNITRLNLGQNNLGSGSIGDLDFITLLT 344
F+ S+L +L ++GN F D F+ L N+T L+L Q L + F +L
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL--EQLSPTAFNSL-- 493
Query: 345 NCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPL 389
S L+ L + SN+ S+P I L+++ I + N + P
Sbjct: 494 --SSLQVLNMASNQL-KSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-51
Identities = 77/321 (23%), Positives = 127/321 (39%), Gaps = 55/321 (17%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS-- 743
+FP L NE IG+G FG V++G L +D VA+K + L
Sbjct: 4 GGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 744 -----IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
+ F E + N+ H N++K+ + + +V +++ G L L
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLD 114
Query: 799 SNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-----HDMVAH 853
+ +L + +D+A IEY+ + PPIVH DL+ N+ L + A
Sbjct: 115 KAHP----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE--YGMGGNVSLTGDVYSFGILLLEM 911
V+DFGL++ ++ S G+ G ++APE + + D YSF ++L +
Sbjct: 170 VADFGLSQ--------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221
Query: 912 FTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKI-EECLTAVVRIG 970
TG P + K+ + E R I E+C + +
Sbjct: 222 LTGEGPFDEY--------SYGKIKFINMIRE----------EGLRPTIPEDCPPRLRNVI 263
Query: 971 VLCSMESPSERIHMADAVKNL 991
LC P +R H + VK L
Sbjct: 264 ELCWSGDPKKRPHFSYIVKEL 284
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-49
Identities = 108/563 (19%), Positives = 205/563 (36%), Gaps = 68/563 (12%)
Query: 103 RFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTG 162
R NL ++P L+ + L+L FN S+ L +
Sbjct: 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 163 EIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLY--GIIPESLGQ 219
I L L++ +++ L P + L +L + L +
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
Query: 220 LRDLNFLSVAENNFSGM-LPPIF-NISSLEQISLLTNRFEGRLPLNI--GFNLPKLKILI 275
L+ L L +++N + L P F ++SL+ I +N+ + + L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFS 180
Query: 276 VGQNNLTGSIPQSFSNASN------LVILNLSGNHFSGKVGIDFSS------------LP 317
+ N+L + + N L IL++SGN ++ + +FS+
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIA 377
+I G +N+ + + + L L+ R L + ++
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 378 MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
+ N+I+ L N+ L L YN L L + +D N++ I
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLL 497
+ L L +L L N L +++ ++ + +S NKL + +I ++L+
Sbjct: 357 TFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-----TLPKINLTANLI 406
Query: 498 DLSSNLISG-SIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSSCTSLEYLKMQDNSFRGS 555
LS N + I + + +L L +++NRFS T S SLE L + +N + +
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466
Query: 556 IPSSL-----ISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVF 610
+ L L ++VL L+ N L+ P L+ L L+L+ N
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN------------ 514
Query: 611 SNKTRISLIENGKLCGGLDELHL 633
R++++ + L L+ L +
Sbjct: 515 ----RLTVLSHNDLPANLEILDI 533
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-38
Identities = 108/593 (18%), Positives = 194/593 (32%), Gaps = 72/593 (12%)
Query: 97 GNLSFLRFINLASNNLHG-EIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCS--NLINF 153
NL L ++L+ N + + G+L+ LK + N L L F
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 154 SVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGII 213
S+ N+L + G N+ + ++ GN T+ G N +
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITGNFSNAISKSQ 232
Query: 214 PESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKI 273
SL + +N F G ++
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFA----------------------GLARSSVRH 270
Query: 274 LIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGS 333
L + + + F +L +LNL+ N + F L N+ LNL N L G
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL--GE 328
Query: 334 IGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRN 393
+ +F L K+ + L N ++ L + + + N ++ I
Sbjct: 329 LYSSNFYGL----PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHF 379
Query: 394 LANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI-IPDSIGNLSTLNSLWLGF 452
+ +I + L N+L T+P + + S N L + I + + L L L
Sbjct: 380 IPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 453 NNLQG-NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE--ITTLSSL--LDLSSNLISGS 507
N + + +L L + +N L ++ LS L L L+ N ++
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495
Query: 508 IPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIE 567
P V +L L L ++ NR + L + +LE L + N P +SL +
Sbjct: 496 PPGVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSVL- 552
Query: 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCG- 626
D++ N + E +F+ +LN + G I + G
Sbjct: 553 --DITHNKFICEC----ELSTFINWLNHTNVTIAG---------PPADIYCVYPDSFSGV 597
Query: 627 GLDELHLPACHNTRPRKAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQK 679
L L C K+ L ++ V + L ++++ + K
Sbjct: 598 SLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYK 650
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 5/120 (4%)
Query: 494 SSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+ ++ +P L +L +S N ++ L+ L++
Sbjct: 6 GRIAFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 554 GSI-PSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+I + +L ++ +LDL + + P+ + L L L L + V G F N
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 5e-49
Identities = 78/364 (21%), Positives = 149/364 (40%), Gaps = 37/364 (10%)
Query: 237 LPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLV 296
+ P +++ + L + L + L+V + SI +NL
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA-SIQ-GIEYLTNLE 69
Query: 297 ILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNS 356
LNL+GN + S+L +T L +G N + I+ L N + L L LN
Sbjct: 70 YLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITD--------ISALQNLTNLRELYLNE 119
Query: 357 NRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIG 416
+ P +ANL+ + + +G N + + N+ + L + +++ P I
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IA 174
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSK 476
L +L +L + N + I P + +L++L+ N + P + N L L +
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230
Query: 477 NKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPT 534
NK+T + + LS L L++ +N IS + +L L L++ N+ S +
Sbjct: 231 NKITD-----LSPLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNVGSNQISD--IS 281
Query: 535 TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLN 594
L++ + L L + +N + L ++ L LS N+++ P L LS ++ +
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339
Query: 595 LSYN 598
+
Sbjct: 340 FANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 8e-48
Identities = 82/355 (23%), Positives = 146/355 (41%), Gaps = 37/355 (10%)
Query: 246 LEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF 305
++ L P +L + ++ + ++T + ++ L ++G
Sbjct: 2 AATLATLPAPINQIFPDA---DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 306 SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR 365
+ GI L N+ LNL N + I+ L+N KL L + +N+ +
Sbjct: 57 ASIQGI--EYLTNLEYLNLNGNQITD--------ISPLSNLVKLTNLYIGTNKI--TDIS 104
Query: 366 SIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALD 425
++ NL+ + + + + IS PL NL +Y+L L N + + + L L
Sbjct: 105 ALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLT 161
Query: 426 FSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP 485
+ + + + P I NL+ L SL L +N ++ P L + +L N++T
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD---- 213
Query: 486 QILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLE 543
I + ++ L L + +N I+ PL NL L L+I N+ S + T L+
Sbjct: 214 -ITPVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLTKLK 268
Query: 544 YLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L + N S S L +L + L L+ N L + E + L+ L L LS N
Sbjct: 269 MLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 83/382 (21%), Positives = 153/382 (40%), Gaps = 40/382 (10%)
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEG 258
L + I P L + + + + + + + S+ ++ + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVAS 58
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLP 317
+ L L+ L + N +T P SN L L + N + I +L
Sbjct: 59 IQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD---ISALQNLT 110
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIA 377
N+ L L ++N+ I+ L N +K+ +L L +N S ++N++ + +
Sbjct: 111 NLRELYLNEDNISD--------ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161
Query: 378 MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
+ +++ P+ NL ++Y+L L YNQ+ P + L +L N + I P
Sbjct: 162 VTESKVKDVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP- 216
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL- 496
+ N++ LNSL +G N + S L N L L + N+++ I + L+ L
Sbjct: 217 -VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD-----INAVKDLTKLK 268
Query: 497 -LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
L++ SN IS L NL L L ++ N+ E + T+L L + N
Sbjct: 269 MLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 556 IPSSLISLKSIEVLDLSCNNLS 577
P L SL ++ D + +
Sbjct: 327 RP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-44
Identities = 83/383 (21%), Positives = 159/383 (41%), Gaps = 41/383 (10%)
Query: 126 LKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWL-KLENLNVAENQ 184
L + P + + I +++ ++T + L + L VA +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT----QEELESITKLVVAGEK 55
Query: 185 LTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNIS 244
+ I ++ L+ L + N++ I P L L L L + N + + + N++
Sbjct: 56 VAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-ISALQNLT 110
Query: 245 SLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNH 304
+L ++ L + PL NL K+ L +G N+ S SN + L L ++ +
Sbjct: 111 NLRELYLNEDNISDISPLA---NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166
Query: 305 FSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLP 364
++L ++ L+L N + I+ L + + L N+ P
Sbjct: 167 VKDV--TPIANLTDLYSLSLNYNQIED--------ISPLASLTSLHYFTAYVNQITDITP 216
Query: 365 RSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQAL 424
+AN++ + + +G N+I+ PL NL+ + L + NQ++ + +L L+ L
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 425 DFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLP 484
+ +N + I + NLS LNSL+L N L +G NL L +S+N +T
Sbjct: 271 NVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--- 325
Query: 485 PQILEITTLSSL--LDLSSNLIS 505
I + +LS + D ++ +I
Sbjct: 326 --IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-41
Identities = 71/337 (21%), Positives = 143/337 (42%), Gaps = 36/337 (10%)
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L + P ++ + + L + + L +IT+L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVA 57
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE 390
S I + + LE L LN N+ P ++NL +T + +G N+I T
Sbjct: 58 S--------IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISA 105
Query: 391 IRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWL 450
++NL N+ L L + ++ P + L + +L+ AN+ + + N++ LN L +
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTV 162
Query: 451 GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSI 508
+ ++ P + N +L L+++ N++ I + +L+SL N I+
Sbjct: 163 TESKVKDVTP--IANLTDLYSLSLNYNQIED-----ISPLASLTSLHYFTAYVNQITDIT 215
Query: 509 PLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEV 568
P+ N+ L L I N+ + P L++ + L +L++ N S +++ L +++
Sbjct: 216 PV--ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKM 269
Query: 569 LDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605
L++ N +S L +LS L L L+ N +
Sbjct: 270 LNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDM 304
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 77/316 (24%), Positives = 136/316 (43%), Gaps = 30/316 (9%)
Query: 94 PYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINF 153
+ L+ L ++NL N + P L L +L L + N T S L + +NL
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 154 SVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGII 213
+ +N++ P + K+ +LN+ N + N++ L L V E+K+ +
Sbjct: 116 YLNEDNISDISP--LANL-TKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVT 171
Query: 214 PESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKI 273
P + L DL LS+ N + P+ +++SL + N+ P+ N+ +L
Sbjct: 172 P--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITPVA---NMTRLNS 225
Query: 274 LIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNITRLNLGQNNLGSG 332
L +G N +T P +N S L L + N S I+ L + LN+G N +
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQIS---DINAVKDLTKLKMLNVGSNQISD- 279
Query: 333 SIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIR 392
I++L N S+L +L LN+N+ G I L+ +T + + N I+ PL
Sbjct: 280 -------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA-- 330
Query: 393 NLANIYALGLEYNQLT 408
+L+ + + +
Sbjct: 331 SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 33/196 (16%), Positives = 74/196 (37%), Gaps = 20/196 (10%)
Query: 445 LNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLI 504
+L + P + + + K +T + + L +++ L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEEL--ESITKL-VVAGEKV 56
Query: 505 SGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLK 564
+ + L NL L+++ N+ + P LS+ L L + N + S+L +L
Sbjct: 57 ASIQGI--EYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 565 SIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN-------KTRIS 617
++ L L+ +N+S L +L+ + LNL N + + ++++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVK 168
Query: 618 LIENGKLCGGLDELHL 633
+ L L L
Sbjct: 169 DVTPIANLTDLYSLSL 184
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRH 759
+ + + + G +++G G D + VKV+ ++ + + F EC L+ H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++ ++ C S L+ +M GSL + L + + V ++ Q + ++D+
Sbjct: 67 PNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDM 120
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A + +LH +P I L +V++D DM A +S + Q G
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSP-----GRM 169
Query: 880 GTVGYVAPEYGMGGNVSLTG---DVYSFGILLLEMFTGRRP 917
+VAPE D++SF +LL E+ T P
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-48
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 34/228 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLK----QKGSIKSFVAECEALKNI 757
E +L +IG G FG VYR G++ VAVK +I++ E + +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+H N+I + VC K + LV ++ + G L L + +N ++
Sbjct: 64 KHPNIIALRGVCL----KEPNL-CLVMEFARGGPLNRVLSGKR------IPPDILVNWAV 112
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLD--------HDMVAHVSDFGLAKFLFDRPIQ 869
+A + YLH PI+H DLK SN+L+ + + ++DFGLA+
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------- 165
Query: 870 ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
++ + G ++APE S DV+S+G+LL E+ TG P
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 39/284 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
+ ++ IG GSFG VY+G D VAVK++N+ +++F E L+ RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ + ++ A+V + + SL L S + + + ++I+ A
Sbjct: 81 NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTA 130
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
++YLH I+H DLK +N+ L D + DFGLA S + G
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW---SGSHQFEQLSG 184
Query: 881 TVGYVAPE---YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937
++ ++APE S DVY+FGI+L E+ TG+ P + +
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNR 231
Query: 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
++++E+V L ++ C + R+ C + ER
Sbjct: 232 DQIIEMVGRGSLSPDLSKVR--SNCPKRMKRLMAECLKKKRDER 273
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 66/298 (22%), Positives = 118/298 (39%), Gaps = 39/298 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
++ ++G+G FG + E + +K + + + ++F+ E + ++ + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+K I V K + +Y++ G+L ++ D QR++ + D+AS
Sbjct: 70 LKFIGVLY----KDKRL-NFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASG 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK--- 879
+ YLH I+H DL N L+ + V+DFGLA+ + D Q S+
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 880 ------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
G ++APE G + DV+SFGI+L E+
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--------------- 222
Query: 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
P+ + +DF L + +R C + I V C P +R L
Sbjct: 223 ---PDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 49/226 (21%), Positives = 93/226 (41%), Gaps = 27/226 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
+ + LIG+G FG VY G + VA+++I++++ + +K+F E A + RH
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ + C A++ + +L ++ + L++ + I+ ++
Sbjct: 90 NVVLFMGACM----SPPHL-AIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIV 140
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YLH I+H DLK NV D+ V ++DFGL G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 881 TVGYVAPEYGMGGNVSLTG---------DVYSFGILLLEMFTGRRP 917
+ ++APE + DV++ G + E+ P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-46
Identities = 96/521 (18%), Positives = 175/521 (33%), Gaps = 85/521 (16%)
Query: 91 FLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSH---- 146
F++P + +FL+ S+NL E+P E + ++ + P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 147 ---------CSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIS 197
+ L+ +P LE+L + N LT +LP ++
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP----HLESLVASCNSLT-ELPELPQSLK 114
Query: 198 TLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFE 257
+L L + P L +L V+ N LP + N S L+ I + N +
Sbjct: 115 SLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLK 166
Query: 258 GRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLP 317
+LP P L+ + G N L +P N L + N
Sbjct: 167 -KLP----DLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKL----PDLPL 215
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIA 377
++ + G N L + L N L T+ ++N +LP +L + +
Sbjct: 216 SLESIVAGNNILEE--------LPELQNLPFLTTIYADNNLL-KTLPDLPPSLEALNVRD 266
Query: 378 MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
L +P ++L + ++ L+ P NL L+ S+N + + D
Sbjct: 267 NYLTD----LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LCD 314
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLL 497
+L LN + N L +P+ L L S N L +P L L
Sbjct: 315 LPPSLEELN---VSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE---LPQNLKQ-L 362
Query: 498 DLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP 557
+ N + P + ++++L R + + +L+ L ++ N R P
Sbjct: 363 HVEYNPLR-EFPDIPESVEDL--------RMNSHLAEVPELPQNLKQLHVETNPLR-EFP 412
Query: 558 SSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
S++ L ++ + E LE ++
Sbjct: 413 DIPESVED---LRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 34/224 (15%)
Query: 411 IPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGN----- 465
I LQ ++NL +P N+ + + ++ + N P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 466 --------CKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKN 517
+ L ++ L+ +LP + + L S N ++ +P + +LK+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKS 115
Query: 518 LIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577
L+ + + S P LEYL + +N +P L + ++++D+ N+L
Sbjct: 116 LLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 578 GQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIEN 621
++P+ LE++ N E ++P T I N
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPFLTAIYADNN 205
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-14
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 36/221 (16%)
Query: 99 LSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPS----NLSHC------- 147
L +N+ N L ++P L+ L V F+ S P+ N S
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCD 314
Query: 148 --SNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVG 205
+L +V N L E+PA +LE L + N L ++P N L+QL V
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPP----RLERLIASFNHLA-EVPELPQN---LKQLHVE 365
Query: 206 ENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIG 265
N L P+ + DL N+ +P + +L+Q+ + TN P
Sbjct: 366 YNPLR-EFPDIPESVEDLRM-----NSHLAEVPEL--PQNLKQLHVETNPLR-EFPDIPE 416
Query: 266 FNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
++ L + + + L +H
Sbjct: 417 ----SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECE--ALKNIRHR 760
+ +L +G+G +G V+RG+ GE+ VAVK+ + + + KS+ E E +RH
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHE 62
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ I + L+ Y + GSL D+LQ + L+ + L I + +A
Sbjct: 63 NILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIA 115
Query: 821 SAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
S + +LH +P I H DLK N+L+ + ++D GLA + + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGN 174
Query: 876 IGIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRPT 918
GT Y+APE + D+++FG++L E+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-45
Identities = 99/532 (18%), Positives = 183/532 (34%), Gaps = 70/532 (13%)
Query: 106 NLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIP 165
+ S + IP+ L + +K L L FN + +L C+NL ++ + + I
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIE 66
Query: 166 AYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPESLGQLRDLN 224
Y LE+L++++N L+ G +S+L+ L + N + + L +L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 225 FLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGS 284
L + S + +I L L L + +L
Sbjct: 127 TLRIGNVE---------TFSEIRRIDFA--------------GLTSLNELEIKALSLRNY 163
Query: 285 IPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLT 344
QS + ++ L L + + + I L ++ L L NL L + +
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 345 NCSKLE----TLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA----- 395
KL L S L R I LS + LN + P E ++
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 396 ---NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGF 452
I L + L + L ++ + + + + +L +L L L
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 453 NNLQGNI---PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGS 507
N + + G +L L +S+N L ++ + TL +L LD+S N
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 508 IPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLK--- 564
+P + + L++S + T + +LE L + +N+ S L L+
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPRLQELY 457
Query: 565 ----------------SIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+ V+ +S N L + L+ L+ + L N +
Sbjct: 458 ISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-44
Identities = 95/517 (18%), Positives = 186/517 (35%), Gaps = 62/517 (11%)
Query: 147 CSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGE 206
C R + T IP+ + +++L+++ N++T + + LQ L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 207 NKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIG 265
+++ I ++ L L L +++N+ S + F +SSL+ ++L+ N ++ L +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSL 118
Query: 266 F-NLPKLKILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLN 323
F NL L+ L +G I F+ ++L L + S+ +I L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 324 LGQNNLGSGSIGDLDFIT---------------------LLTNCSKLETLGLNSNRFGG- 361
L + D ++ + S ++ L +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 362 ------SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA--------NIYALGLEYNQL 407
L R I LS + LN + P E ++ I L + L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 408 TGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI---PSSLG 464
+ L ++ + + + + +L +L L L N + + G
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 465 NCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLD 522
+L L +S+N L ++ + TL +L LD+S N +P + + L+
Sbjct: 359 AWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416
Query: 523 ISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582
+S + T + +LE L + +N+ S L L+ L +S N L +P+
Sbjct: 417 LSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPRLQ---ELYISRNKLK-TLPD 468
Query: 583 YLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLI 619
L + +S N + G+F T + I
Sbjct: 469 ASL-FPVLLVMKISRNQL--KSVPDGIFDRLTSLQKI 502
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-43
Identities = 86/486 (17%), Positives = 175/486 (36%), Gaps = 31/486 (6%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+ L+ + L S+ ++ + L L+ L L N S S S+L ++
Sbjct: 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPP-SIGNISTLQQLGVGENKLYGIIPES 216
N + L+ L + + ++ +++L +L + L +S
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167
Query: 217 LGQLRDLNFLSVAENNFSGMLPPIFNI-SSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L +RD++ L++ + + +L +I SS+ + L R + +
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMK 226
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIG 335
+ +SF+ L+ L + D +L + N +++ +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESD----VVS 278
Query: 336 DLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA 395
+L + +T + L + L + L + I + +++ ++L
Sbjct: 279 ELGKVETVT----IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 396 NIYALGLEYNQLTGTIPYT---IGELINLQALDFSANNLHGI--IPDSIGNLSTLNSLWL 450
++ L L N + G +LQ L S N+L + + + L L SL +
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 451 GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL 510
N +P S + + LN+S + + I + +LD+S+N + S L
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLE---VLDVSNNNLD-SFSL 448
Query: 511 VVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLD 570
L L +L ISRN+ +P S L +K+ N + L S++ +
Sbjct: 449 ---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 571 LSCNNL 576
L N
Sbjct: 504 LHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-28
Identities = 59/400 (14%), Positives = 125/400 (31%), Gaps = 49/400 (12%)
Query: 97 GNLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
NL+ L+ + + + EI L+ L L + S +L ++ + ++
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
+ + + L + + L + + + + E
Sbjct: 180 HLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 216 SLGQL-------RDLNFLSVAENNFSGMLP-------PIFNISSLEQISLLTNRFEG--- 258
S +L +L+ + + +G+ + + +E +++
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 259 -RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKV---GIDFS 314
+ L K+K + V + + + +L L+LS N +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358
Query: 315 SLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTIT 374
+ P++ L L QN+L S +TL L +L ++ N F +P S +
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTL----KNLTSLDISRNTFH-PMPDSCQWPEKMR 413
Query: 375 IIAMGLNQISGTIPLEI------------------RNLANIYALGLEYNQLTGTIPYTIG 416
+ + I + I L + L + N+L T+P
Sbjct: 414 FLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLP-DAS 470
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L + S N L + L++L +WL N
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-45
Identities = 76/304 (25%), Positives = 122/304 (40%), Gaps = 31/304 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECE--ALKNIRHR 760
+ + IG+G +G V+ G GE VAVKV ++ S+ E E +RH
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEE---ASWFRETEIYQTVLMRHE 91
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ I L+ DY ++GSL D+L+ + L+ L ++
Sbjct: 92 NILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSV 144
Query: 821 SAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
S + +LH +P I H DLK N+L+ + ++D GLA F E
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-KFISDTNEVDIPP 203
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTG-------DVYSFGILLLEMFTGRRPTHTMFNDGLTL 928
GT Y+ PE + +++ D+YSFG++L E+ + L
Sbjct: 204 NTRVGTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 929 HGFVKMALP-EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADA 987
H V E + EIV L R +ECL + ++ C +P+ R+
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 988 VKNL 991
K L
Sbjct: 323 KKTL 326
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 30/229 (13%)
Query: 704 EFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECE--ALKNIRHR 760
L IG+G FG V+RG GE+ VAVK+ + +++ +S+ E E +RH
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWRGEE---VAVKIFSSREE---RSWFREAEIYQTVMLRHE 96
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ I + + LV DY + GSL D+L + + + + +++ A
Sbjct: 97 NILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTA 149
Query: 821 SAIEYLH-----HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
S + +LH +P I H DLK N+L+ + ++D GLA D +
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-RHDSATDTIDIAP 208
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTG-------DVYSFGILLLEMFTGRRP 917
GT Y+APE + ++++ D+Y+ G++ E+
Sbjct: 209 NHRVGTKRYMAPEV-LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-42
Identities = 60/329 (18%), Positives = 111/329 (33%), Gaps = 29/329 (8%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
+ + L + S + + H N +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-------AWRQANSNNPQIET 62
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
G D + T L L S P LS + + + +
Sbjct: 63 RT-GRALKATADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGN----- 441
+P ++ A + L L N L +P +I L L+ L A +P+ + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 442 ----LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL- 496
L L SL L + ++ ++P+S+ N +NL L + + L+ L P I L L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP---AIHHLPKLE 232
Query: 497 -LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
LDL + P + G L +L + +P + T LE L ++
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 556 IPSSLISLKSIEVLDLSCNNLSGQIPEYL 584
+PS + L + ++ + +L Q+ ++
Sbjct: 293 LPSLIAQLPANCIILVP-PHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-39
Identities = 58/294 (19%), Positives = 99/294 (33%), Gaps = 28/294 (9%)
Query: 316 LPNITRLNL-GQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTIT 374
L G L + +L+ + N AN +
Sbjct: 11 SSGRENLYFQGSTALRP-------YHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQ 59
Query: 375 IIAMGLNQISGTIPLEIRNLA--NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
I + + + AL L L P L +LQ + A L
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQI----- 487
+PD++ + L +L L N L+ +P+S+ + L L++ LP +
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 488 -LEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEY 544
E L +L L L I S+P + NL+NL L I + S + + LE
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233
Query: 545 LKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L ++ + + P ++ L L + +P + L+ LE L+L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 56/367 (15%), Positives = 104/367 (28%), Gaps = 63/367 (17%)
Query: 143 NLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQL 202
+ H S N + + + + + A+ N + Q
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLS----QWQRHYNADRNRW-HSAWRQANSNNPQIE 61
Query: 203 GVGENKLYGIIPESLGQLRDLN--FLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRL 260
L + L L + F +S L+ +++ L
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 261 PLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNIT 320
P + L+ L + +N L ++P S ++ + L L++ + + LP
Sbjct: 120 PDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP-------ELTELPE-- 168
Query: 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGL 380
+ D L++L L SLP SIANL +
Sbjct: 169 ------------PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS----- 210
Query: 381 NQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIG 440
L + + L+ + I L L+ LD P G
Sbjct: 211 -------------------LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG 250
Query: 441 NLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LD 498
+ L L L + +P + L L++ LP I L + +
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS---LIAQLPANCIIL 307
Query: 499 LSSNLIS 505
+ +L +
Sbjct: 308 VPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 60/381 (15%), Positives = 113/381 (29%), Gaps = 62/381 (16%)
Query: 187 GQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSL 246
G + S + L + + L Q + + + S+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 247 EQISLLTNRFEGRLPLNIGF-NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF 305
QI T R + P L + L P S+L + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 306 SGKVGIDFSSLPNITRLNLGQNNLGS--GSIGDLDFITLLTNCSKLETLGLNSNRFGGSL 363
++ + L L +N L + SI + ++L L + + L
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRALPASIA---------SLNRLRELSIRACPELTEL 166
Query: 364 PRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQA 423
P +A+ E + L N+ +L LE+ + ++P +I L NL++
Sbjct: 167 PEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210
Query: 424 LDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVS-KNKLTGT 482
L + L + +I +L L L L N P G L L + + L T
Sbjct: 211 LKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268
Query: 483 LPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSL 542
LP I L L +LD+ +P+ ++ +
Sbjct: 269 LPLDI-------------------------HRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 543 EYLKMQDNSFRGSIPSSLISL 563
+ + + ++
Sbjct: 304 CIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 36/293 (12%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSR--LKVLVLDFNSFSGTIPSNLSHCSNLINFS 154
N + + L + L ++ L L P S+L + +
Sbjct: 53 ANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMT 110
Query: 155 VRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIP 214
+ L E+P + + LE L +A N L LP SI +++ L++L + +P
Sbjct: 111 IDAAGLM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 215 ESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKIL 274
E L + +L+ + L LP +I NL LK L
Sbjct: 168 EPLASTD--------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSL 211
Query: 275 IVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNL-GQNNLGS-- 331
+ + L+ ++ + + L L+L G F + RL L +NL +
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQIS 384
I ++LE L L LP IA L II + + +
Sbjct: 271 LDIH---------RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 40/214 (18%), Positives = 76/214 (35%), Gaps = 23/214 (10%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
L + + L + LA N L +P + L+RL+ L + +P L+
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
N L++L + + LP SI N+ L+ L + + L
Sbjct: 178 EHQGLVN----------------LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220
Query: 212 IIPESLGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLL-TNRFEGRLPLNIGFNLP 269
+ ++ L L L + PP + L+++ L + LPL+I L
Sbjct: 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH-RLT 277
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGN 303
+L+ L + +P + I+ + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 20/129 (15%), Positives = 44/129 (34%), Gaps = 2/129 (1%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
L + NL L+ + + ++ L + + L +L+ L L + P + L
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYG 211
++ + +P I +LE L++ +LP I + + V +
Sbjct: 257 RLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 212 IIPESLGQL 220
+
Sbjct: 316 LDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 13/168 (7%), Positives = 43/168 (25%), Gaps = 34/168 (20%)
Query: 436 PDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSS 495
+ S +L+ + L + + ++ +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-----AWRQANSNNPQ 59
Query: 496 LLDLSSNLISGSIPLVVGNLK--NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+ + + + ++ + + L++
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP------------------------ 94
Query: 554 GSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
P L ++ + + L ++P+ ++ + LE L L+ N
Sbjct: 95 -QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVL-DFNSFSGTIPSNLSHCSNL 150
L P + +L L ++L P G + LK L+L D ++ T+P ++ + L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279
Query: 151 INFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN---QLTGQLPPSIG 194
+R +P+ I + V + QL P +
Sbjct: 280 EKLDLRGCVNLSRLPSLIA-QLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 16/82 (19%), Positives = 32/82 (39%)
Query: 80 QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGT 139
+L LR + P G + L+ + L + +P ++ RL++L+ L L
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 140 IPSNLSHCSNLINFSVRRNNLT 161
+PS ++ V +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQA 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-38
Identities = 78/300 (26%), Positives = 120/300 (40%), Gaps = 39/300 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRN 761
+ L IG+G+FG V+ G L D VAVK F+ E LK H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++++I VC+ +V + +Q G +L+ L + L + D A+
Sbjct: 174 IVRLIGVCT-----QKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAA 224
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRP-IQETSSSSIGIKG 880
+EYL +H DL N L+ V +SDFG+++ D + +K
Sbjct: 225 GMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939
T APE G S DV+SFGILL E F+ G P + N ++
Sbjct: 282 T----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------------QQ 323
Query: 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999
E V+ L E C AV R+ C P +R + + L + R++++
Sbjct: 324 TREFVEKGGRLPCP------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-37
Identities = 61/228 (26%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN 756
E+ + + ++ + +G G +G VY G + L VAVK + + ++ F+ E +K
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 272
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
I+H NL++++ VC+ + F ++ ++M G+L D+L++ N Q ++ + L ++
Sbjct: 273 IKHPNLVQLLGVCT----REPPFY-IITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMA 324
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
++SA+EYL +H +L N L+ + + V+DFGL++ + + +
Sbjct: 325 TQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
IK T APE S+ DV++FG+LL E+ T G P +
Sbjct: 382 PIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 73/375 (19%), Positives = 136/375 (36%), Gaps = 34/375 (9%)
Query: 266 FNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLG 325
L KI+ + + + + +LNL+ F+ I +L +G
Sbjct: 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQIS 384
N + + N L L L N SLPR I N +T ++M N +
Sbjct: 102 FNAIRYLPPH------VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 385 GTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLS 443
I + + ++ L L N+LT + + + +L + S N L ++
Sbjct: 155 -RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPI 205
Query: 444 TLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSS 501
+ L N++ + + L +L + N LT + L +DLS
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-----DTAWLLNYPGLVEVDLSY 257
Query: 502 NLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI 561
N + + ++ L +L IS NR + +L+ L + N + +
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQP 315
Query: 562 SLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIEN 621
+E L L N++ + L L+ L LS+ND++ + +F N R ++ +
Sbjct: 316 QFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDA 371
Query: 622 GKLCGGLDELHLPAC 636
+ C +L C
Sbjct: 372 DQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 59/358 (16%), Positives = 127/358 (35%), Gaps = 27/358 (7%)
Query: 173 LKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENN 232
++++ ++ + + + + + L R + L++ +
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 80
Query: 233 FSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSN 291
+ F +++++ + N LP ++ N+P L +L++ +N+L+ F N
Sbjct: 81 IEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139
Query: 292 ASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLET 351
L L++S N+ F + ++ L L N L + + L
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI---------PSLFH 190
Query: 352 LGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTI 411
++ N ++A + + N I+ + + + L L++N LT
Sbjct: 191 ANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DT 241
Query: 412 PYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLML 471
+ L +D S N L I+ + L L++ N L + L +
Sbjct: 242 A-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 472 LNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFS 529
L++S N L + + L + L L N I ++ L L L +S N +
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 66/318 (20%), Positives = 118/318 (37%), Gaps = 27/318 (8%)
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLL 343
I + +++ G + +L N + + + LL
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA------LL 65
Query: 344 TNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGL 402
+ ++E L LN + + A TI + MG N I +P + +N+ + L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 403 EYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS 462
E N L+ L L S NNL I D+ ++L +L L N L ++
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-- 181
Query: 463 LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQ 520
L +L NVS N L+ + ++ LD S N I+ + L
Sbjct: 182 LSLIPSLFHANVSYNLLS--------TLAIPIAVEELDASHNSIN-VVR--GPVNVELTI 230
Query: 521 LDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI 580
L + N + + L + L + + N + + ++ +E L +S N L +
Sbjct: 231 LKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 581 PEYLEDLSFLEYLNLSYN 598
Y + + L+ L+LS+N
Sbjct: 288 NLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 63/411 (15%), Positives = 135/411 (32%), Gaps = 55/411 (13%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
+++ Q+ + L+ + + ++ + L ++++L L+ I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 141 PSN-LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNIST 198
+ ++ + + N + +P ++ L L + N L+ LP I N
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEG 258
L L + N L I ++ L L ++ N +
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------ 178
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPN 318
+ L+ +P L V N L+ + + + L+ S N + +
Sbjct: 179 HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVE 227
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378
+T L L NNL L N L + L+ N + + + + +
Sbjct: 228 LTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 379 GLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDS 438
N++ + L + + + L L +N L + + L+ L N++ +
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---K 334
Query: 439 IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE 489
+ TL +L L N+ N +L +N+ V + Q+
Sbjct: 335 LSTHHTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 46/259 (17%), Positives = 93/259 (35%), Gaps = 28/259 (10%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
+ ++ + + + E L N + + + + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
+ L+ + + I + T+ L++GFN ++ P N L +L + +N L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 482 TLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIP------ 533
+LP I L L +S+N + +L L +S NR + +
Sbjct: 131 SLPRGIF--HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 187
Query: 534 -----------TTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582
+TL+ ++E L NS + + + +L L NNL+
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW 243
Query: 583 YLEDLSFLEYLNLSYNDFE 601
L + L ++LSYN+ E
Sbjct: 244 -LLNYPGLVEVDLSYNELE 261
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 54/364 (14%), Positives = 110/364 (30%), Gaps = 28/364 (7%)
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILN 299
N + + + + + + ++ + +K L + N L+ + + L +LN
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 300 LSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRF 359
LS N +D SL + L+L N + L +ETL +N
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNY-----------VQELLVGPSIETLHAANNNI 111
Query: 360 GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG-TIPYTIGEL 418
I + N+I+ L+ + + L L+ N++
Sbjct: 112 SRVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 419 INLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478
L+ L+ N ++ + + L +L L N L + + + +++ NK
Sbjct: 169 DTLEHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS 538
L + + L DL N L KN +++
Sbjct: 226 LV-LIEKALRFSQNLEH-FDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
Query: 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF----LEYLN 594
CT L +++ + + + G E LE ++
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 595 LSYN 598
Sbjct: 343 ALKE 346
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-37
Identities = 65/346 (18%), Positives = 121/346 (34%), Gaps = 25/346 (7%)
Query: 264 IGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLN 323
I N + KI V ++L ++ +A N+ L+LSGN S D + + LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 324 LGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQI 383
L N L L + S L TL LN+N + + +I + N I
Sbjct: 65 LSSNVLYE--------TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI 111
Query: 384 SGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI-IPDSIGNL 442
S + + L N++T G +Q LD N + + + +
Sbjct: 112 SR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSN 502
TL L L +N + ++ + L L++S NKL + P+ ++ + L +N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNN 224
Query: 503 LISGSIPLVVGNLKNLIQLDISRNRFS-GEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI 561
+ I + +NL D+ N F G + S ++ + + + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEE 281
Query: 562 SLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTK 607
+ + + L L+ + +G +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-36
Identities = 62/429 (14%), Positives = 126/429 (29%), Gaps = 49/429 (11%)
Query: 174 KLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNF 233
+ + V ++ L L + +++L + N L I L L L+++ N
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 234 SGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNAS 293
+ ++S+L + L N + L P ++ L NN++
Sbjct: 71 YE-TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSRGQG-- 121
Query: 294 NLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLG 353
+ L+ N + +D + L+L N + + ++F L + LE L
Sbjct: 122 -KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----VNFAELAASSDTLEHLN 175
Query: 354 LNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPY 413
L N + + G + + L L N+L +
Sbjct: 176 LQYNF---------------------IYDVKGQVVFA-----KLKTLDLSSNKLA-FMGP 208
Query: 414 TIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLN 473
+ + N L +I ++ L L N KN +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQT 266
Query: 474 VSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG--- 530
V+K + L Q E T+ +L + L L + + + G
Sbjct: 267 VAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 531 -EIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF 589
+ + + +R I + ++ L+ L Q+ +
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 590 LEYLNLSYN 598
L+
Sbjct: 386 LDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 55/318 (17%), Positives = 111/318 (34%), Gaps = 27/318 (8%)
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLL 343
+I + N + I ++ + + S N+ L+L N L I D
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL--SQISAADL---- 54
Query: 344 TNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLE 403
+KLE L L+SN + +LST+ + + N + E+ +I L
Sbjct: 55 APFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107
Query: 404 YNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQG-NIPSS 462
N ++ + + + + N + + G S + L L N + N
Sbjct: 108 NNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 463 LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQ 520
+ L LN+ N + + Q++ + L LDLSSN ++ + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 521 LDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI 580
+ + N+ I L +LE+ ++ N F K+ V ++ +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLT 276
Query: 581 PEYLEDLSFLEYLNLSYN 598
+ E+ + +
Sbjct: 277 GQNEEECTVPTLGHYGAY 294
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 69/516 (13%), Positives = 147/516 (28%), Gaps = 81/516 (15%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
N + + + ++L + + +K L L N S ++L+ +
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK------- 59
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPES 216
LE LN++ N L + ++STL+ L + N + +
Sbjct: 60 ------------------LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QE 94
Query: 217 LGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIV 276
L + L A NN S R+ + K + +
Sbjct: 95 LLVGPSIETLHAANNNIS------------------------RVSCSR---GQGKKNIYL 127
Query: 277 GQNNLTGSIPQSFSNASNLVILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIG 335
N +T S + L+L N +S + LNL N +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD---- 183
Query: 336 DLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLA 395
+ +KL+TL L+SN+ + + + +T I++ N++ I +R
Sbjct: 184 ----VKGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 396 NIYALGLEYNQL-TGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
N+ L N GT+ + +Q + + + + + G
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 455 LQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQI-LEITTLSSL--LDLSSNLISGSIPLV 511
+ L + G+ ++ E + +D I V
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355
Query: 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDL 571
+ I L+ + ++ + L+ Q + + + +++L
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRA 414
Query: 572 SCNN----LSGQIPEYLEDLSFLEYLNLSYNDFEGQ 603
Q + + +
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEE 450
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-30
Identities = 44/243 (18%), Positives = 95/243 (39%), Gaps = 19/243 (7%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
++ N + I + + + + ++ N+ L L N L+ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
+ L+ S+N L+ + + +LSTL +L L N + L ++ L+ + N ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 482 TLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSS 538
+ + + L++N I+ L G + LD+ N +S
Sbjct: 114 ------VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+LE+L +Q N + + ++ LDLS N L+ + + + + +++L N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 599 DFE 601
Sbjct: 225 KLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 28/241 (11%), Positives = 71/241 (29%), Gaps = 12/241 (4%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
+ L +NL N ++ ++ ++ ++LK L L N + + + + S+
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQL-TGQLPPSIGNISTLQQLGVGENKLYGIIP 214
R N L I + + LE+ ++ N G L +Q + + + +
Sbjct: 222 RNNKLV-LIEKALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTG 277
Query: 215 ESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIG---FNLPK 270
++ + + P + +L++ +G + N +
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
+ + + I Q + L +V + +
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397
Query: 331 S 331
Sbjct: 398 E 398
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 21/218 (9%), Positives = 57/218 (26%), Gaps = 8/218 (3%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLI 151
+ + L +L N H + +V + + N C+
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 152 NFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTG----QLPPSIGNISTLQQLGVGEN 207
++PA + L+ A G +L N + +++ +
Sbjct: 288 LGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 208 KLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFN 267
+ +I + + + L + + + +L + L
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT-EE 405
Query: 268 LPKLKILIVGQNNLT-GSIPQSFSNASNLVILNLSGNH 304
L++L + Q + + ++ +
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 75/325 (23%), Positives = 132/325 (40%), Gaps = 16/325 (4%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
++P+ + +L+L N +F+S P++ L L +N + + G
Sbjct: 21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG--- 74
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLAN 396
N L TLGL SNR +P + LS +T + + N+I + + ++L N
Sbjct: 75 ---AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYN 129
Query: 397 IYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
+ +L + N L L +L+ L NL I +++ +L L L L N+
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP-LVVGNL 515
S L +L +S T+ P L L+SL ++ ++ ++P L V +L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL-SITHCNLT-AVPYLAVRHL 247
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNN 575
L L++S N S + L L+ +++ P + L + VL++S N
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 576 LSGQIPEYLEDLSFLEYLNLSYNDF 600
L+ + LE L L N
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 71/323 (21%), Positives = 124/323 (38%), Gaps = 18/323 (5%)
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPN 318
+P I + ++L +G+N + F++ +L L L+ N S F++L N
Sbjct: 25 AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378
+ L L N L +G + T S L L ++ N+ L +L + + +
Sbjct: 82 LRTLGLRSNRLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 379 GLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD 437
G N + I L ++ L LE LT + L L L N++ I
Sbjct: 136 GDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL- 496
S L L L + + + NL L+++ LT +P + L L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR--HLVYLR 251
Query: 497 -LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
L+LS N IS ++ L L ++ + + + P L L + N +
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-T 310
Query: 556 IPSSLI-SLKSIEVLDLSCNNLS 577
+ S+ S+ ++E L L N L+
Sbjct: 311 LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 61/336 (18%), Positives = 120/336 (35%), Gaps = 37/336 (11%)
Query: 100 SFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSVRRN 158
+ R ++L N + +E L+ L L+ N S + ++ NL +R N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 159 NLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESL 217
L IP + L L+++EN++ L + ++ L+ L VG+N L I +
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148
Query: 218 GQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIV 276
L L L++ + N + + ++ L + L + L +LK+L +
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEI 207
Query: 277 GQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGD 336
++ + NL L+++ + + + L + LNL N + +I
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI--STIEG 265
Query: 337 LDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLAN 396
+L+ + L + + ++ R L
Sbjct: 266 SML----HELLRLQEIQLVGGQ--------------LAVVEPYA----------FRGLNY 297
Query: 397 IYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
+ L + NQLT + NL+ L +N L
Sbjct: 298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 55/270 (20%), Positives = 97/270 (35%), Gaps = 27/270 (10%)
Query: 379 GLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDS 438
+ IP E R L L N++ +L+ L+ + N + + P +
Sbjct: 22 RFVAVPEGIPTETR------LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 439 IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL-- 496
NL L +L L N L+ NL L++S+NK+ L + + L +L
Sbjct: 76 FNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ--DLYNLKS 132
Query: 497 LDLSSNLISGSIPLVV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
L++ N + I L +L QL + + + LS L L+++ +
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 556 IPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN--- 612
S L ++VL++S + L L++++ + VP +
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY-LAVRHLVY 249
Query: 613 -------KTRISLIENGKLCG--GLDELHL 633
IS IE L L E+ L
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQL 279
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 57/264 (21%), Positives = 92/264 (34%), Gaps = 11/264 (4%)
Query: 98 NLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
NL LR + L SN L IP LS L L + N + NL + V
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPES 216
N+L I LE L + + LT ++ ++ L L + + I S
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 217 LGQLRDLNFLSVAENNFSGMLPP-IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+L L L ++ + + P +L +S+ +P +L L+ L
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIG 335
+ N ++ L + L G + F L + LN+ N L +
Sbjct: 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEES 314
Query: 336 DLDFITLLTNCSKLETLGLNSNRF 359
+ + LETL L+SN
Sbjct: 315 ------VFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 32/132 (24%), Positives = 52/132 (39%), Gaps = 7/132 (5%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGT 139
L + + ++P L +++ NL +P + L L+ L L +N S T
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 140 IPSN-LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNIS 197
I + L L + L + Y L LNV+ NQLT L S+ ++
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
Query: 198 TLQQLGVGENKL 209
L+ L + N L
Sbjct: 321 NLETLILDSNPL 332
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 68/330 (20%), Positives = 120/330 (36%), Gaps = 28/330 (8%)
Query: 264 IGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLN 323
I N + KI V ++L ++ +A N+ L+LSGN S D + + LN
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 324 LGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQI 383
L N L L + S L TL LN+N + + +I + N I
Sbjct: 65 LSSNVLYE--------TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI 111
Query: 384 SGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI-IPDSIGNL 442
S + + L N++T G +Q LD N + + + +
Sbjct: 112 S-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLS 500
TL L L +N + ++ + L L++S NKL + P E + + + + L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP---EFQSAAGVTWISLR 222
Query: 501 SNLISGSIPLVVGNLKNLIQLDISRNRFS-GEIPTTLSSCTSLEYLKMQDNSFRGSIPSS 559
+N + I + +NL D+ N F G + S ++ + Q
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 560 LISLKSIEVLD-LSCNNLSGQIPEYLEDLS 588
++ ++ C +L + L L
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 56/318 (17%), Positives = 114/318 (35%), Gaps = 27/318 (8%)
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLL 343
+I + N + I ++ + + S N+ L+L N L S L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 344 TNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLE 403
+KLE L L+SN + +LST+ + + N + E+ +I L
Sbjct: 55 APFTKLELLNLSSNVL-YETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107
Query: 404 YNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQG-NIPSS 462
N ++ + + G+ + + + N + + G S + L L N + N
Sbjct: 108 NNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 463 LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQ 520
+ L LN+ N + + Q++ + L LDLSSN ++ + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 521 LDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI 580
+ + N+ I L +LE+ ++ N F K+ V ++ +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 581 PEYLEDLSFLEYLNLSYN 598
+ E+ + +
Sbjct: 277 GQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 51/334 (15%), Positives = 102/334 (30%), Gaps = 24/334 (7%)
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILN 299
N + + + + + + ++ + +K L + N L+ + + L +LN
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 300 LSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRF 359
LS N +D SL + L+L N + L +ETL +N
Sbjct: 65 LSSNVLYET--LDLESLSTLRTLDLNNNY-----------VQELLVGPSIETLHAANNNI 111
Query: 360 GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG-TIPYTIGEL 418
+ S I + N+I+ L+ + + L L+ N++
Sbjct: 112 -SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 419 INLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478
L+ L+ N ++ + + L +L L N L + + + +++ NK
Sbjct: 169 DTLEHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS 538
L + + L DL N L KN +++
Sbjct: 226 LV-LIEKALRFSQNLEH-FDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
Query: 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLS 572
CT L ++
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 51/298 (17%), Positives = 103/298 (34%), Gaps = 23/298 (7%)
Query: 342 LLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALG 401
+ N ++ + + + +L + + + + N +S ++ + L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS 461
L N L + L L+ LD + N + + ++ +L NN+ +
Sbjct: 65 LSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC 116
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISG-SIPLVVGNLKNL 518
S G + + ++ NK+T L L+ S + LDL N I + + + L
Sbjct: 117 SRG--QGKKNIYLANNKIT-MLRD--LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 519 IQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSG 578
L++ N ++ L+ L + N + S + + L N L
Sbjct: 172 EHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 579 QIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKL--CGGLDELHLP 634
I + L LE+ +L N F + FS R+ + + G +E
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 44/243 (18%), Positives = 94/243 (38%), Gaps = 19/243 (7%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
++ N + I + + + + ++ N+ L L N L+ + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
+ L+ S+N L+ + + +LSTL +L L N + L ++ L+ + N ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 482 TLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSS 538
+ + L++N I+ L G + LD+ N +S
Sbjct: 113 RVSCSR-----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+LE+L +Q N + + ++ LDLS N L+ + + + + +++L N
Sbjct: 168 SDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 599 DFE 601
Sbjct: 225 KLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 57/360 (15%), Positives = 110/360 (30%), Gaps = 79/360 (21%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
N + + + ++L + + +K L L N S ++L+ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-------- 59
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
LE LN++ N L + ++STL+ L + N + + L
Sbjct: 60 -----------------LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QEL 95
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
+ L A NN S R+ + K + +
Sbjct: 96 LVGPSIETLHAANNNIS------------------------RVSCSR---GQGKKNIYLA 128
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIGD 336
N +T S + L+L N +S + LNL N +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD----- 183
Query: 337 LDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLAN 396
+ +KL+TL L+SN+ + + + +T I++ N++ I +R N
Sbjct: 184 ---VKGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 397 IYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
+ L N L+ + + ++ L+ N L
Sbjct: 239 LEHFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 46/234 (19%), Positives = 88/234 (37%), Gaps = 17/234 (7%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
+ L +NL+SN L+ E +L LS L+ L L+ N L ++
Sbjct: 55 APFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAA 107
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPE 215
NN++ + G +N+ +A N++T G S +Q L + N++ + E
Sbjct: 108 NNNIS-RVSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L L++ N + + L+ + L +N+ + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWIS 220
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFS-GKVGIDFSSLPNITRLNLGQNN 328
+ N L I ++ + NL +L GN F G + FS + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 32/211 (15%), Positives = 75/211 (35%), Gaps = 12/211 (5%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSG-TIPSNLSHCSNLINFSV 155
+ I LA+N + + G SR++ L L N + L + ++
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
+ N + ++ + + KL+ L+++ N+L + P + + + + + NKL +I +
Sbjct: 177 QYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEK 231
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+L ++L + N F F S +++ + + +L +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
G ++ L +H
Sbjct: 291 YGAYCCE-----DLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 19/177 (10%), Positives = 51/177 (28%), Gaps = 30/177 (16%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
+ L +NL N ++ ++ ++ ++LK L L N + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG------ 215
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
+ +++ N+L + ++ L+ + N +
Sbjct: 216 -------------------VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLK 272
++ +VA+ + ++ + LP L L
Sbjct: 256 DF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 72/290 (24%), Positives = 110/290 (37%), Gaps = 49/290 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVIN---LKQKGSIKSFVAECEALKN 756
+ L +G GSFG V RG + VAVK + L Q ++ F+ E A+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ HRNLI++ V + K +V + GSL D L++ G+ L +
Sbjct: 78 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYA 127
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ VA + YL +H DL N+LL + + DFGL + L
Sbjct: 128 VQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQEH 183
Query: 877 G---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFV 932
APE S D + FG+ L EMFT G+ P +
Sbjct: 184 RKVPFAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------- 230
Query: 933 KMALPEKVMEIVDFALLLDPGNER-AKIEECLTAVVRIGVLCSMESPSER 981
+I+ +D ER + E+C + + V C P +R
Sbjct: 231 --------SQILH---KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/223 (27%), Positives = 114/223 (51%), Gaps = 19/223 (8%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ ++ + +G G +G VY G + L VAVK + + ++ F+ E +K I+H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++++ VC+ + F ++ ++M G+L D+L++ N Q ++ + L ++ ++SA
Sbjct: 72 VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSA 123
Query: 823 IEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+EYL + +H DL N L+ + + V+DFGL++ + + + IK T
Sbjct: 124 MEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE S+ DV++FG+LL E+ T G P +
Sbjct: 180 ----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 71/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN 756
E+ + L +GQG FG V+ G VA+K + S ++F+ E + +K
Sbjct: 180 EIPR--ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKK 235
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+RH L+++ V S ++ +V +YM GSL D+L+ + L L Q ++++
Sbjct: 236 LRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMA 286
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+AS + Y+ VH DL+ +N+L+ ++V V+DFGLA+ + D +
Sbjct: 287 AQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
IK T APE + G ++ DV+SFGILL E+ T GR P M N
Sbjct: 344 PIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 75/224 (33%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
E L IG+G FG V G+ + VAVK +K + ++F+AE + +RH NL
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKC--IKNDATAQAFLAEASVMTQLRHSNL 76
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++++ V + +V +YM GSL D+L+ V L L S+DV A
Sbjct: 77 VQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEA 129
Query: 823 IEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS-IGIKG 880
+EYL ++ VH DL NVL+ D VA VSDFGL + T + + +K
Sbjct: 130 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 180
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
T APE S DV+SFGILL E+++ GR P +
Sbjct: 181 T----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIIT 767
IG+GSF VY+G E + VA + ++ K + F E E LK ++H N+++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
S KG LV + M SG+L+ +L++ + + + + +++LH
Sbjct: 93 SWESTV-KGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH 146
Query: 828 HHCQPPIVHGDLKPSNVLLDH-DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
PPI+H DLK N+ + + D GLA + + + + + GT ++A
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKA--VIGTPEFMA 198
Query: 887 PEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
PE + DVY+FG+ +LEM T P
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-36
Identities = 71/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN 756
E+ + L +GQG FG V+ G VA+K + S ++F+ E + +K
Sbjct: 263 EIPR--ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKK 318
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+RH L+++ V S ++ +V +YM GSL D+L+ + L L Q ++++
Sbjct: 319 LRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMA 369
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+AS + Y+ VH DL+ +N+L+ ++V V+DFGLA+ + D +
Sbjct: 370 AQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
IK T APE + G ++ DV+SFGILL E+ T GR P M N
Sbjct: 427 PIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGS----IKSFVAECEALK 755
N L ++G+G FG V GNL L VAVK +K S I+ F++E +K
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMK 91
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG-NLNLIQRLN 814
+ H N+I+++ VC + +G ++ +M+ G L +L S + ++ L L
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 815 ISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI-QETS 872
+D+A +EYL + + +H DL N +L DM V+DFGL+K ++ ++
Sbjct: 152 FMVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
+ + +K A E + DV++FG+ + E+ T G P
Sbjct: 208 IAKMPVKWI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 77/223 (34%), Positives = 108/223 (48%), Gaps = 27/223 (12%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN 756
LN E L IG+G FG V G+ + VAVK +K + ++F+AE +
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKC--IKNDATAQAFLAEASVMTQ 242
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+RH NL++++ V + +V +YM GSL D+L+ V L L S
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFS 295
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS- 875
+DV A+EYL + VH DL NVL+ D VA VSDFGL + T +
Sbjct: 296 LDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGK 347
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
+ +K T APE S DV+SFGILL E+++ GR P
Sbjct: 348 LPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLK---QKGSIKSFVAECEALK 755
EF ++G G+FG VY+G + +PVA+K L+ + K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
++ + ++ +++ +C + + L+ M G L D++++ N+ LN
Sbjct: 73 SVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH----KDNIGSQYLLNW 122
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+ +A + YL VH DL NVL+ ++DFGLAK L ++ +
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHA 176
Query: 875 SIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
G IK A E + + DV+S+G+ + E+ T G +P
Sbjct: 177 EGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 25/225 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHR 760
+ + +G G FG V G VA+K+I +GS+ F+ E + + N+ H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
L+++ VC+ K ++ +YM +G L ++L++ Q L + DV
Sbjct: 80 KLVQLYGVCT----KQRPI-FIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVC 130
Query: 821 SAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A+EYL +H DL N L++ V VSDFGL++++ D + S ++
Sbjct: 131 EAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ PE M S D+++FG+L+ E+++ G+ P N
Sbjct: 187 WS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 707 LSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRHR 760
+IG+G FG VY G ++ + A+K L + ++ F+ E ++ + H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ +I + + ++ YM G L +++ N + ++ + VA
Sbjct: 83 NVLALIGIML----PPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVA 134
Query: 821 SAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR---PIQETSSSSI 876
+EYL VH DL N +LD V+DFGLA+ + DR +Q+ + +
Sbjct: 135 RGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
+K T A E + DV+SFG+LL E+ T G P
Sbjct: 191 PVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS-FVAECEALKNIRHRN 761
+E + IG G FG V+ G + VA+K +++ + F+ E E + + H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
L+++ VC + LV ++M+ G L D+L+ G L + +DV
Sbjct: 65 LVQLYGVCL----EQAPI-CLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCE 115
Query: 822 AIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ YL +H DL N L+ + V VSDFG+ +F+ D ++ + +K
Sbjct: 116 GMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 171
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+PE S DV+SFG+L+ E+F+ G+ P N
Sbjct: 172 A----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 25/268 (9%)
Query: 663 SVGLIVVCTRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG 722
L Q + E+ + + +IG G G V G
Sbjct: 11 RENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYG 68
Query: 723 NL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKNIRHRNLIKIITVCSSIDFKG 776
L G+ +PVA+K LK + + F++E + H N+I++ V + +G
Sbjct: 69 RLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RG 122
Query: 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVH 836
+V +YM++GSL+ +L+ DG ++Q + + V + + YL VH
Sbjct: 123 RLA-MIVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVH 174
Query: 837 GDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVS 896
DL NVL+D ++V VSDFGL++ L D + + ++ G K + + APE S
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDD--PDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 897 LTGDVYSFGILLLEMFT-GRRPTHTMFN 923
DV+SFG+++ E+ G RP M N
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTN 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 64/297 (21%), Positives = 113/297 (38%), Gaps = 49/297 (16%)
Query: 706 SLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGS---IKSFVAECEALKNIRH 759
+ +IG+G FG VY G L + AVK L + + F+ E +K+ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++ ++ +C + + +V YM+ G L ++++ N + + + V
Sbjct: 86 PNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQV 137
Query: 820 ASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG- 877
A ++YL VH DL N +LD V+DFGLA+ ++D+ + +
Sbjct: 138 AKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 878 --IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKM 934
+K A E + DV+SFG+LL E+ T G P +
Sbjct: 194 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----------- 238
Query: 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ L G + E C + + + C R ++ V +
Sbjct: 239 ---FDITV------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 25/229 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKN 756
S+ ++G G FG V G L + + VA+K LK + K F+ E +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQ 102
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
H N+I++ V + K +V +YM++GSL+ +L++ D +IQ + +
Sbjct: 103 FDHPNIIRLEGVVT----KSKPV-MIVTEYMENGSLDSFLRKH----DAQFTVIQLVGML 153
Query: 817 IDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+AS ++YL VH DL N+L++ ++V VSDFGL + L D P E + ++
Sbjct: 154 RGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EAAYTT 207
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
G K + + +PE + DV+S+GI+L E+ + G RP M N
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 69/230 (30%), Positives = 121/230 (52%), Gaps = 26/230 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIK---SFVAECEALK 755
+ + +IG G FG VY+G L G+ +PVA+K LK + K F+ E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMG 101
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
H N+I++ V S K ++ +YM++G+L+ +L++ DG +++Q + +
Sbjct: 102 QFSHHNIIRLEGVIS----KYKPM-MIITEYMENGALDKFLREK----DGEFSVLQLVGM 152
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+A+ ++YL + + VH DL N+L++ ++V VSDFGL++ L D E + +
Sbjct: 153 LRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYT 206
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ G K + + APE + DV+SFGI++ E+ T G RP + N
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 21/228 (9%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKN 756
E+ + L +G G FG V+ VAVK + S+++F+AE +K
Sbjct: 184 EIPR--ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKT 239
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++H L+K+ V + + ++ ++M GSL D+L+ L + ++ S
Sbjct: 240 LQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFS 290
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+A + ++ +H DL+ +N+L+ +V ++DFGLA+ + D +
Sbjct: 291 AQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
IK T APE G+ ++ DV+SFGILL+E+ T GR P M N
Sbjct: 348 PIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 71/383 (18%), Positives = 135/383 (35%), Gaps = 63/383 (16%)
Query: 634 PACHNTRPR-KAKITILKVLIPVIVLLTILSVGLIVVCTRRRKQTQKSSTLLSMEQQFPM 692
P H+ + + ++ ++ + + I + + S L
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65
Query: 693 VSYAELN----KATNEF---------SLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVI 736
+ + LN +A + +IG+G FG VY G L + AVK
Sbjct: 66 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS- 124
Query: 737 NLKQKGS---IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLE 793
L + + F+ E +K+ H N++ ++ +C + + +V YM+ G L
Sbjct: 125 -LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLR 179
Query: 794 DWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVA 852
++++ N + + + VA +++L VH DL N +LD
Sbjct: 180 NFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTV 231
Query: 853 HVSDFGLAKFLFDRPIQETSSSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909
V+DFGLA+ ++D+ + + +K A E + DV+SFG+LL
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLW 287
Query: 910 EMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVR 968
E+ T G P + + L G + E C +
Sbjct: 288 ELMTRGAPPYPDVNT--------------FDITV------YLLQGRRLLQPEYCPDPLYE 327
Query: 969 IGVLCSMESPSERIHMADAVKNL 991
+ + C R ++ V +
Sbjct: 328 VMLKCWHPKAEMRPSFSELVSRI 350
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI--KSFVAECEALKNIRHR 760
E +L +G G FG V G VAVK+I +GS+ F E + + + H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQY-DVAVKMIK---EGSMSEDEFFQEAQTMMKLSHP 63
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
L+K VCS K +V +Y+ +G L ++L+ L Q L + DV
Sbjct: 64 KLVKFYGVCS----KEYPI-YIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVC 114
Query: 821 SAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
+ +L H +H DL N L+D D+ VSDFG+ +++ D + + +K
Sbjct: 115 EGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ APE S DV++FGIL+ E+F+ G+ P N
Sbjct: 171 WS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 52/229 (22%), Positives = 109/229 (47%), Gaps = 28/229 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKS---FVAECEALKN 756
+ L+ ++G+G FG VY G N + + VAVK K+ ++ + F++E +KN
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKN 69
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ H +++K+I + + ++ + G L +L+++ +L ++ + S
Sbjct: 70 LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYS 119
Query: 817 IDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ + A+ YL +C VH D+ N+L+ + DFGL++++ D + S +
Sbjct: 120 LQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ IK +PE + DV+ F + + E+ + G++P + N
Sbjct: 176 LPIKWM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 28/229 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKN 756
L IG+G FG V++G L VA+K K S F+ E ++
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQ 72
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
H +++K+I V + ++ ++ + G L +LQ +L+L + +
Sbjct: 73 FDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILYA 122
Query: 817 IDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+++A+ YL VH D+ NVL+ + + DFGL++++ D + S
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ IK APE + DV+ FG+ + E+ G +P + N
Sbjct: 179 LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 37/291 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKG--SIKSFVAECEALKN 756
+ +G+G+FG V VAVK L+ G + F E + LK
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKA 80
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ ++K V G LV +Y+ SG L D+LQ+ L+ + L S
Sbjct: 81 LHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRH----RARLDASRLLLYS 133
Query: 817 IDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ +EYL C VH DL N+L++ + ++DFGLAK L
Sbjct: 134 SQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 876 --IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP-THTMFNDGLTLHGF 931
I APE S DV+SFG++L E+FT + + + +
Sbjct: 190 GQSPIFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 932 VKMALPEKVMEIVDFALLLDPGNER-AKIEECLTAVVRIGVLCSMESPSER 981
AL ++E+++ +R C V + LC SP +R
Sbjct: 246 DVPALSR-LLELLE-------EGQRLPAPPACPAEVHELMKLCWAPSPQDR 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 73/302 (24%), Positives = 119/302 (39%), Gaps = 44/302 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGS----IKSFVAECEALK 755
+F+L ++G+G FG V L + VAVK+ LK I+ F+ E +K
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMK 80
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKAL-VYDYMQSGSLEDWLQQS-NDQVDGNLNLIQRL 813
H ++ K++ V KG + + +M+ G L +L S + NL L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 814 NISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
+D+A +EYL + +H DL N +L DM V+DFGL+ R I
Sbjct: 141 RFMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLS-----RKIYSGD 191
Query: 873 SSSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLH 929
G V ++A E ++ DV++FG+ + E+ T G+ P + N
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------ 245
Query: 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989
++ L GN + EC+ V + C P +R
Sbjct: 246 --------AEIYN------YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 990 NL 991
L
Sbjct: 292 EL 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 74/331 (22%), Positives = 132/331 (39%), Gaps = 28/331 (8%)
Query: 677 TQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNL----GEDLLPVA 732
T+ +M F + + +G+G+FG V VA
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74
Query: 733 VKVINLKQKGS--IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSG 790
VK L+ ++ F E E LK+++H N++K VC S G L+ +Y+ G
Sbjct: 75 VKK--LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYG 129
Query: 791 SLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHD 849
SL D+LQ+ ++ I+ L + + +EYL +H DL N+L++++
Sbjct: 130 SLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENE 181
Query: 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909
+ DFGL K L +E + + + APE S+ DV+SFG++L
Sbjct: 182 NRVKIGDFGLTKVLPQD--KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 910 EMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRI 969
E+FT + + + + + G + M + LL + + C + I
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGND----KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI 295
Query: 970 GVLCSMESPSERIHMADAVKNLCAAREKYKG 1000
C + ++R D + R++ G
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 88/482 (18%), Positives = 163/482 (33%), Gaps = 61/482 (12%)
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK-LENLNVAENQLTGQLPPSI-GNI 196
I SNL + + + + T ++ L + + + + +LP ++ +
Sbjct: 18 CIDSNLQYDCVFYDVHI--DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74
Query: 197 STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNR 255
++ L + + ++ I + + L + N + P +F N+ L + L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
LP I N PKL L + NNL +F ++L L LS N + +D S
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSL 190
Query: 316 LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITI 375
+P++ N+ N L + L +E L + N I +
Sbjct: 191 IPSLFHANVSYNLL-----------STLAIPIAVEELDASHNS--------------INV 225
Query: 376 IAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGII 435
+ +N + L L++N LT + L +D S N L I+
Sbjct: 226 VRGPVNV-------------ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIM 270
Query: 436 PDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSS 495
+ L L++ N L + L +L++S N L + + L +
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328
Query: 496 LLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
L L N I ++ L L L +S N + L ++ + D
Sbjct: 329 -LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDADQHCK 382
Query: 556 IPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTR 615
I L + D ++ +Y+ S +E + + V S
Sbjct: 383 IDYQLEHGLCCKESD---KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 616 IS 617
I+
Sbjct: 440 IT 441
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 73/524 (13%), Positives = 167/524 (31%), Gaps = 74/524 (14%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
+++ Q+ + L+ + + ++ + L ++++L L+ I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 141 PSN-LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNIST 198
+ ++ + + N + +P ++ L L + N L+ LP I N
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 148
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEG 258
L L + N L I ++ L L ++ N +
Sbjct: 149 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------ 184
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPN 318
+ L+ +P L V N L+ + + + L+ S N + +
Sbjct: 185 HVDLS---LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVNVE 233
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378
+T L L NNL L N L + L+ N + + + + +
Sbjct: 234 LTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285
Query: 379 GLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDS 438
N++ + L + + + L L +N L + + L+ L N++ +
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---K 340
Query: 439 IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLD 498
+ TL +L L N+ N + NV++ + ++ L
Sbjct: 341 LSTHHTLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393
Query: 499 LSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPS 558
S+ + + I+ ++ C++ + + +
Sbjct: 394 KESD----------KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQ 443
Query: 559 SLISLKSIEVLDLSCNNLSGQI----PEYLEDLSFLEYLNLSYN 598
+ L+ E L+ N L ++ E ++ L+ L+ +
Sbjct: 444 GGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 18/131 (13%), Positives = 35/131 (26%)
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNR 527
NV + L+ + + + L N + +
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL 587
L S +E L + D + +I+ L + N + P +++
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 588 SFLEYLNLSYN 598
L L L N
Sbjct: 123 PLLTVLVLERN 133
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 30/307 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGS--IKSFVAECEALKN 756
+G+G+FG V VAVK L+ ++ F E E LK+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKS 67
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++H N++K VC S G L+ +Y+ GSL D+LQ+ ++ I+ L +
Sbjct: 68 LQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYT 120
Query: 817 IDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ +EYL +H DL N+L++++ + DFGL K L
Sbjct: 121 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 876 --IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
I APE S+ DV+SFG++L E+FT + + + + + G
Sbjct: 177 GESPIFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND- 231
Query: 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993
+ M + LL + + C + I C + ++R D +
Sbjct: 232 ---KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 994 AREKYKG 1000
R+ G
Sbjct: 289 IRDNMAG 295
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
L +G G FG V+ G VAVK + + S +F+AE +K ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++ V + + ++ +YM++GSL D+L+ + L + + L+++ +A
Sbjct: 71 VRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEG 121
Query: 823 IEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ ++ + +H DL+ +N+L+ + ++DFGLA+ + D + IK T
Sbjct: 122 MAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE G ++ DV+SFGILL E+ T GR P M N
Sbjct: 178 ----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIKS---FVAECEALK 755
E ++G G FG V++G +PV +KV ++ K +S A+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIG 70
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
++ H ++++++ +C LV Y+ GSL D ++Q G L LN
Sbjct: 71 SLDHAHIVRLLGLCP------GSSLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNW 120
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ +A + YL H +VH +L NVLL V+DFG+A L + S
Sbjct: 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYS 175
Query: 876 IG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
IK A E G + DV+S+G+ + E+ T G P
Sbjct: 176 EAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 693 VSYAELNKATNEFSLSNL------IGQGSFGFVYRG--NLGEDLLPVAVKVI--NLKQKG 742
++ E+ L +G G+FG V +G + + + VAVK++
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 743 SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ 802
+AE ++ + + ++++I +C + + LV + + G L +LQQ+
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKYLQQN--- 111
Query: 803 VDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
++ + + V+ ++YL + VH DL NVLL A +SDFGL+K
Sbjct: 112 --RHVKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSK 165
Query: 862 FLFDRPIQETSSSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
L + + G +K APE S DV+SFG+L+ E F+ G++P
Sbjct: 166 ALRADE-NYYKAQTHGKWPVKWY----APECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 918 THTMFN 923
M
Sbjct: 221 YRGMKG 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 711 IGQGSFGFVYRG--NLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKI 765
+G G+FG V +G + + + VA+KV LK +K + + E + + + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
I VC + LV + G L +L + + + V+ ++Y
Sbjct: 76 IGVCQAEALM------LVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKY 125
Query: 826 L-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS--IGIKGTV 882
L + VH DL NVLL + A +SDFGL+K L T+ S+ +K
Sbjct: 126 LEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY- 180
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE S DV+S+G+ + E + G++P M
Sbjct: 181 ---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-34
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 42/259 (16%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLKQKGS---IKSFVAECEALKNIRH 759
+ I G G++Y D PV +K L G +AE + L + H
Sbjct: 84 VKGCIAHGGLGWIYLA---LDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
++++I D GD +V +Y+ SL+ L + + + +++
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEI 191
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A+ YLH +V+ DLKP N++L + + + D G I +
Sbjct: 192 LPALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAV-----SRINSFGY----LY 238
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK----MA 935
GT G+ APE G T D+Y+ G L + +G + G + +
Sbjct: 239 GTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPT----R-NGRYVDGLPEDDPVLK 292
Query: 936 LPEKVMEIVDFALLLDPGN 954
+ ++ A+ DP
Sbjct: 293 TYDSYGRLLRRAIDPDPRQ 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 66/290 (22%), Positives = 107/290 (36%), Gaps = 34/290 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIKS---FVAECEALK 755
+G+G FG V VAVK LK + E E L+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILR 78
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
N+ H N++K +C+ G + L+ +++ SGSL+++L ++ +NL Q+L
Sbjct: 79 NLYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKY 131
Query: 816 SIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPI--QETS 872
++ + ++YL VH DL NVL++ + + DFGL K +
Sbjct: 132 AVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGF 931
+ APE M + DV+SFG+ L E+ T + M
Sbjct: 188 DRDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF------L 237
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
+ M + L G C V ++ C PS R
Sbjct: 238 KMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLK---QKGSIKSFVAECEALK 755
EF ++G G+FG VY+G + +PVA+K L+ + K + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
++ + ++ +++ +C + + L+ M G L D++++ N+ LN
Sbjct: 73 SVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREH----KDNIGSQYLLNW 122
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ +A + YL +VH DL NVL+ ++DFGLAK L ++ +
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAE 177
Query: 876 IG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
G IK A E + + DV+S+G+ + E+ T G +P
Sbjct: 178 GGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 73/309 (23%), Positives = 114/309 (36%), Gaps = 36/309 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQKGSIKS---FVAECEALK 755
+G+G FG V VAVK LK + + E + L+
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILR 88
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+ H ++IK C G LV +Y+ GSL D+L + + + L Q L
Sbjct: 89 TLYHEHIIKYKGCCED---AGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLF 139
Query: 816 SIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+ + + YLH H +H DL NVLLD+D + + DFGLAK + +
Sbjct: 140 AQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 875 S--IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGF 931
+ APE DV+SFG+ L E+ T
Sbjct: 196 DGDSPVFWY----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT------KFL 245
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ + + M ++ LL+ G + ++C V + C S R + + L
Sbjct: 246 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 992 CAAREKYKG 1000
EKY+G
Sbjct: 306 KTVHEKYQG 314
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 48/239 (20%), Positives = 103/239 (43%), Gaps = 40/239 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-------GEDLLPVAVKVINLKQKGSIKSFVAECEALK 755
+ + +GQG+F +++G V +KV++ + +SF +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+ H++L+ VC GD+ LV ++++ GSL+ +L+++ +N++ +L +
Sbjct: 68 KLSHKHLVLNYGVCV----CGDEN-ILVQEFVKFGSLDTYLKKN----KNCINILWKLEV 118
Query: 816 SIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHD--------MVAHVSDFGLAKFLFDR 866
+ +A+A+ +L + +HG++ N+LL + +SD G++
Sbjct: 119 AKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-----I 169
Query: 867 PIQETSSSSIGIKGTVGYVAPE-YGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ I PE N++L D +SFG L E+ + G +P + +
Sbjct: 170 TVLPKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 71/400 (17%), Positives = 138/400 (34%), Gaps = 48/400 (12%)
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEG 258
++ S QL L L ++ + + I ++ L ++ +N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT 78
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPN 318
L L+ L L N LT ++ + + L LN N + +D S P
Sbjct: 79 -LDLS---QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK---LDVSQNPL 128
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378
+T LN +N L +D +++ ++L L + N+ L + + +T +
Sbjct: 129 LTYLNCARNTLTE-----ID----VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 379 GLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDS 438
N+I+ L++ + L + N +T + + + I L LD S+N L I
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---D 228
Query: 439 IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLD 498
+ L+ L N L + S L L+ + L +++T + L+
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL------EIDLTHNTQLIY 279
Query: 499 LSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPS 558
+ L V + L LD + E+ LS L YL + + +
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDV 335
Query: 559 SLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
S ++ L ++ + + L +
Sbjct: 336 S--HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 78/430 (18%), Positives = 150/430 (34%), Gaps = 52/430 (12%)
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
+ A ++ S ++TL L + + + + +L L L NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 235 GMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASN 294
+ + ++L ++ +N+ L + L KL L N LT + S
Sbjct: 78 TL--DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 295 LVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
L LN + N + ID S +T L+ N + +T ++L TL
Sbjct: 129 LTYLNCARNTLTE---IDVSHNTQLTELDCHLNKKIT--------KLDVTPQTQLTTLDC 177
Query: 355 NSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYT 414
+ N+ ++ + + N I+ L++ + L N+LT I
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID-- 228
Query: 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNV 474
+ L L D S N L + + LS L +L +L I L + L+
Sbjct: 229 VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282
Query: 475 SKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEI 532
+ + L++T + L LD + I+ L + L+ L ++ + E+
Sbjct: 283 EGCRKI-----KELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-EL 333
Query: 533 PTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEY 592
+S T L+ L + + S + + ++ + E L + S
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 593 LNLSYNDFEG 602
++ D G
Sbjct: 390 VSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 68/460 (14%), Positives = 142/460 (30%), Gaps = 84/460 (18%)
Query: 126 LKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQL 185
V T + + L + +++T ++ I L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKL-TGLTKLICTSNNI 76
Query: 186 TGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISS 245
T + + L L NKL + + L L +L+ N + + +
Sbjct: 77 TT---LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL--DVSQNPL 128
Query: 246 LEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF 305
L ++ N + ++ + +L L N + + + L L+ S N
Sbjct: 129 LTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 306 SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPR 365
+ +D S + RLN NN+ LD +L L +SN
Sbjct: 183 T---ELDVSQNKLLNRLNCDTNNITK-----LDL----NQNIQLTFLDCSSN-------- 222
Query: 366 SIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALD 425
L+ I ++ L + N LT + + L L L
Sbjct: 223 ---KLTEI----------------DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLH 260
Query: 426 FSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP 485
+L I + + + L + + + L LL+ +T
Sbjct: 261 CIQTDLLEI---DLTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLDCQAAGITE---- 311
Query: 486 QILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLE 543
L+++ L L L++ ++ + + + L L + ++ +L
Sbjct: 312 --LDLSQNPKLVYLYLNNTELT-ELDV--SHNTKLKSLSCVNAHIQ-DFS-SVGKIPALN 364
Query: 544 YLKMQDNSFRGSIPSSLISLKSI------EVLDLSCNNLS 577
+ ++P ++ S+ ++LD N ++
Sbjct: 365 NNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 65/352 (18%), Positives = 122/352 (34%), Gaps = 47/352 (13%)
Query: 261 PLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNIT 320
N F + + + S + L L+ + + GI L +T
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGI--EKLTGLT 67
Query: 321 RLNLGQNNLGSGSIGDLDFITLL------------TNCSKLETLGLNSNRFGGSLPRSIA 368
+L NN+ + + +T L T +KL L ++N+ L ++
Sbjct: 68 KLICTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL-TKLD--VS 124
Query: 369 NLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSA 428
+T + N ++ +++ + + L N+ + + L LD S
Sbjct: 125 QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 429 NNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQIL 488
N + + + LN L NN+ + L L L+ S NKLT +
Sbjct: 180 NKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE------I 227
Query: 489 EITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLK 546
++T L+ L D S N ++ + V L L L + EI L+ T L Y +
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQ 281
Query: 547 MQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+ + + + +LD ++ ++ L L YL L+
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 80/435 (18%), Positives = 156/435 (35%), Gaps = 55/435 (12%)
Query: 76 PRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNS 135
+ L N S+ + L+ L + SNN+ + L + + L L D N
Sbjct: 42 ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNK 96
Query: 136 FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGN 195
+ + ++ + L + N LT ++ L LN A N LT ++ + +
Sbjct: 97 LT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQN---PLLTYLNCARNTLT-EID--VSH 146
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNR 255
+ L +L NK I + L L + N + + + L +++ TN
Sbjct: 147 NTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL--DVSQNKLLNRLNCDTNN 202
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
+L LN +L L N LT I + + L + S N + +D S+
Sbjct: 203 IT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVST 252
Query: 316 LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITI 375
L +T L+ Q +L +D LT+ ++L R L + + + + +
Sbjct: 253 LSKLTTLHCIQTDLLE-----ID----LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYL 301
Query: 376 IAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGII 435
+ I+ L++ + L L +LT + + L++L ++
Sbjct: 302 LDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF- 354
Query: 436 PDSIGNLSTLNSLWLGFNNLQGNIPSSLGN-----CKNLMLLNVSKNKLTGTLPPQILEI 490
S+G + LN+ + +L N + LL+ N + + P +
Sbjct: 355 -SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGV 411
Query: 491 TTLSSLLDLSSNLIS 505
++ NL +
Sbjct: 412 YDQATNTITWENLST 426
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-33
Identities = 86/431 (19%), Positives = 151/431 (35%), Gaps = 65/431 (15%)
Query: 122 RLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVA 181
+ VL + + + T+P L +++ + NNLT +PA +L L V+
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP----ELRTLEVS 89
Query: 182 ENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF 241
NQLT LP + L L P L L + N + LP
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLTS-LPV-- 138
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
L+++S+ N+ LP +L L N LT S+P S L L++S
Sbjct: 139 LPPGLQELSVSDNQLA-SLPALPS----ELCKLWAYNNQLT-SLPMLPSG---LQELSVS 189
Query: 302 GNHFSGKVGIDFSSLP----NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
N + SLP + +L N L +L S L+ L ++ N
Sbjct: 190 DNQLA--------SLPTLPSELYKLWAYNNRL----------TSLPALPSGLKELIVSGN 231
Query: 358 RFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGE 417
R SLP + L + + N+++ ++P+ L + L + NQLT +P ++
Sbjct: 232 RLT-SLPVLPSELKELMV---SGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIH 282
Query: 418 LINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477
L + ++ N L ++ +++ S+ + L L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA---- 338
Query: 478 KLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
+P + E + + L + L + I F +I + L+
Sbjct: 339 -ADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET-ENFIKDAGFKAQISSWLA 396
Query: 538 SCTSLEYLKMQ 548
E L+
Sbjct: 397 QLAEDEALRAN 407
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 75/332 (22%), Positives = 131/332 (39%), Gaps = 51/332 (15%)
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
+L VG++ LT ++P ++ L + N+ + + + P + L + N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS---LP-ALPPELRTLEVSGNQL 93
Query: 330 GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPL 389
S L +L LP + L + I NQ++ ++P+
Sbjct: 94 TS-------LPVLPPGLLELSIFSNPLT----HLPALPSGLCKLWI---FGNQLT-SLPV 138
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
L L + NQL ++P EL L A + N L + P L L+
Sbjct: 139 LPPGLQE---LSVSDNQLA-SLPALPSELCKLWAYN---NQLTSL-PMLPSGLQELS--- 187
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
+ N L ++P+ L N N+LT +LP + L L +S N ++ S+P
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPA---LPSGLKEL-IVSGNRLT-SLP 237
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
++ LK L +S NR + +P + L L + N +P SLI L S +
Sbjct: 238 VLPSELKEL---MVSGNRLT-SLP---MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
+L N LS + + L +++ + F+
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 75/380 (19%), Positives = 133/380 (35%), Gaps = 56/380 (14%)
Query: 220 LRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQN 279
L+V E+ + + + + + + N LP +L+ L V N
Sbjct: 39 NNGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLT-SLPALPP----ELRTLEVSGN 91
Query: 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDF 339
LT S+P L I + H + + +L + N L S
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-------L 136
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYA 399
L L+ L ++ N+ SLP + L + NQ++ ++P+ L
Sbjct: 137 PVLPPG---LQELSVSDNQLA-SLPALPSELCKLWA---YNNQLT-SLPMLPSGLQE--- 185
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI 459
L + NQL ++P EL L A NN +P L L + N L ++
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPSGLKELI---VSGNRLT-SL 236
Query: 460 PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLI 519
P L L VS N+LT +LP + L SL + N ++ +P + +L +
Sbjct: 237 PVLPSE---LKELMVSGNRLT-SLPM---LPSGLLSL-SVYRNQLT-RLPESLIHLSSET 287
Query: 520 QLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQ 579
+++ N S L TS F + S + + L L+ +
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS---APRETRALHLAAADWLVP 344
Query: 580 IPEYLEDLSFLEYLNLSYND 599
E + + + ++ +
Sbjct: 345 ARE--GEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-28
Identities = 74/391 (18%), Positives = 126/391 (32%), Gaps = 79/391 (20%)
Query: 99 LSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRN 158
+ + + + NNL +P L+ L + N + ++P L FS
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 159 NLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLG 218
+L L L + NQLT LP LQ+L V +N+L +P
Sbjct: 115 HLPALPSG--------LCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQL-ASLPALPS 161
Query: 219 QLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQ 278
+L L N+ LP+ L+ L V
Sbjct: 162 ELCKLW--------------------------AYNNQLT-SLPMLPS----GLQELSVSD 190
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
N L S+P S L N + + L + N L S
Sbjct: 191 NQLA-SLPTLPSELYKLWAYNNRLTSLP-------ALPSGLKELIVSGNRLTS------- 235
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
L S+L+ L ++ NR SLP + L ++++ NQ++ +P + +L++
Sbjct: 236 ---LPVLPSELKELMVSGNRL-TSLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSET 287
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALD---FSANNLHGIIPDSIGNLSTLNSLWLGFNNL 455
+ LE N L+ + E+ + + P L + WL
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
Query: 456 QGNIP----SSLGNCKNLMLLNVSKNKLTGT 482
P G N ++ ++L+ T
Sbjct: 348 GEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 73/328 (22%), Positives = 115/328 (35%), Gaps = 43/328 (13%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSH----------- 146
LR + ++ N L +P L L + +PS L
Sbjct: 79 LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSL 136
Query: 147 ---CSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLG 203
L SV N L +PA +L L NQLT LP LQ+L
Sbjct: 137 PVLPPGLQELSVSDNQLA-SLPALPS----ELCKLWAYNNQLT-SLPMLPSG---LQELS 187
Query: 204 VGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLN 263
V +N+L +P +L L NN LP S L+++ + NR LP+
Sbjct: 188 VSDNQL-ASLPTLPSELYKLWAY----NNRLTSLPA--LPSGLKELIVSGNRLT-SLPVL 239
Query: 264 IGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLN 323
+LK L+V N LT S+P S L+ L++ N + ++ L + T +N
Sbjct: 240 PS----ELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 324 LGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQI 383
L N L ++ L IT S + R++ + ++ +
Sbjct: 291 LEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEP 350
Query: 384 SG-TIPLEIRNLANIYALGLEYNQLTGT 410
+ N A L ++L+ T
Sbjct: 351 APADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINL---KQKGSIKSFVAECEALKNIRHR 760
+ + +G G VY ED + VA+K I + +++ ++K F E + H+
Sbjct: 15 IVDKLGGGGMSTVYLA---EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ +I V DD LV +Y++ +L ++++ G L++ +N + +
Sbjct: 72 NIVSMIDVDEE-----DDCYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQIL 121
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
I++ H IVH D+KP N+L+D + + DFG+AK L + + +T+ + G
Sbjct: 122 DGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH----VLG 174
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
TV Y +PE G D+YS GI+L EM G P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-32
Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 28/229 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQKGSIKS---FVAECEALKN 756
L IG+G FG V++G + VA+K K S F+ E ++
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQ 447
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
H +++K+I V + ++ ++ + G L +LQ +L+L + +
Sbjct: 448 FDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVR----KFSLDLASLILYA 497
Query: 817 IDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+++A+ YL VH D+ NVL+ + + DFGL++++ D + S
Sbjct: 498 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
+ IK APE + DV+ FG+ + E+ G +P + N
Sbjct: 554 LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 85/488 (17%), Positives = 180/488 (36%), Gaps = 26/488 (5%)
Query: 104 FINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGE 163
++ + N L +P +L + +L + N S S++ S L + N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 164 IPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPESLGQLRD 222
+ + + +LE L+++ N+L + L+ L + N + I + G +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 223 LNFLSVAENNF-SGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLP--KLKILIVGQN 279
L FL ++ + + PI +++ + + +L + + + L I+
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN-NLGSGSIGDLD 338
+ S +NL + N+ K S L + N L +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 339 FITLLT--NCSKLETLGLNSNRFGGSLPRSIANLS-----TITIIAMGLNQISGTIPLEI 391
FI +L + + +++ + G L + S ++I + +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 392 RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLG 451
+N+ + ++ LDFS N L + ++ G+L+ L +L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 452 FNNLQ--GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
N L+ I K+L L++S+N ++ T L++SSN+++ +I
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP-SSLISLKSIEV 568
+ + LD+ N+ IP + +L+ L + N + S+P L S++
Sbjct: 417 RCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK 472
Query: 569 LDLSCNNL 576
+ L N
Sbjct: 473 IWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 86/511 (16%), Positives = 163/511 (31%), Gaps = 81/511 (15%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+LS LR + ++ N + + L+ L L N I
Sbjct: 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISC--------------- 86
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPS--IGNISTLQQLGVGENKLYGIIPE 215
+ L++L+++ N LP GN+S L+ LG+ L
Sbjct: 87 HPTV------------NLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+ L L V + P L+ + + L I+
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDP----EGLQDFNTES-----------------LHIVF 172
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN-NLGSGSI 334
+ S +NL + N+ K S L + N L +
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 335 GDLDFITLLT--NCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIR 392
FI +L + + +++ + G L + S
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG-------------------T 273
Query: 393 NLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGF 452
+L + + + Y N+ +F+ + + +S L
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 453 NNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPL 510
N L + + G+ L L + N+L L T + SL LD+S N +S
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 511 VV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
K+L+ L++S N + I L ++ L + N + SIP ++ L++++ L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+++ N L + L+ L+ + L N +
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 66/402 (16%), Positives = 129/402 (32%), Gaps = 31/402 (7%)
Query: 97 GNLSFLRFINLASNNLHG-EIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
L+ ++L+ N I E G +S+LK L L + ++H + V
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 156 RRNNLTGEIPAYI--GYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGII 213
+ + L + + L S+ ++ L+ +
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 214 PESLGQLRDLNFLSVAEN----------NFSGMLPPIFNISSLEQISLLTNRFEGRLPLN 263
L L L N N + + +++ S+ + +G+L
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 264 ----IGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNI 319
G +L L I V + + SN+ I N + + + S +
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 320 TRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI---ANLSTITII 376
L+ N L + +T +LETL L N+ L + + ++ +
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLT------ELETLILQMNQL-KELSKIAEMTTQMKSLQQL 379
Query: 377 AMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGII 435
+ N +S ++ +L + N LT TI + ++ LD +N + I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-I 436
Query: 436 PDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477
P + L L L + N L+ +L + + N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 71/452 (15%), Positives = 148/452 (32%), Gaps = 60/452 (13%)
Query: 178 LNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGML 237
++ ++N L +P + L + +N + + + L L L ++ N +
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 238 PPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVI 297
+F +L+ L + N L I NL
Sbjct: 62 ISVFK------------------------FNQELEYLDLSHNKLV-KIS--CHPTVNLKH 94
Query: 298 LNLSGNHF-SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNS 356
L+LS N F + + +F ++ + L L +L S+ + + + L L
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV-----LLVLGE 149
Query: 357 NRFGGSLPRSIANLSTIT-------------IIAMGLNQISGTIPLEIRNLANIYALGLE 403
P + + +T + I+ + + ++ I+ +
Sbjct: 150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF 209
Query: 404 YNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSL 463
+ L + L ++ + N+ I+ + +T+ + LQG +
Sbjct: 210 LSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRD 267
Query: 464 GNC-----KNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNL 518
+ K L + V + I EI + ++ + + + L +
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 519 IQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR--GSIPSSLISLKSIEVLDLSCNNL 576
+ LD S N + + T LE L +Q N + I +KS++ LD+S N++
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 577 SGQIPEYLED-LSFLEYLNLSYNDFEGQVPTK 607
S + L LN+S N +
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 61/350 (17%), Positives = 111/350 (31%), Gaps = 24/350 (6%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
+L KL+ILI+ N + F L L+LS N I N+ L+L
Sbjct: 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSF 99
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
N + + ++ L+ LGL++ S IA+L+ ++ +
Sbjct: 100 NAFDA--LPICKEFGNMSQ---LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
E L + L T + I ++ + +N+ ++ D+ +
Sbjct: 155 EDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL----LDLSSN 502
L N NL L N+ + Q++ TT+ + L
Sbjct: 213 LAKLQTNP----------KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ 262
Query: 503 LISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLIS 562
L +LK L + + F +++ + R
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322
Query: 563 LKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
+ LD S N L+ + E L+ LE L L N + + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 8/174 (4%)
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNR 527
+ L++ SKN L +P + + TT+ L++S N IS + +L L L IS NR
Sbjct: 1 SEFLVDRSKNGLI-HVPKDLSQKTTI---LNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNL-SGQIPEYLED 586
+ LEYL + N I +++ LDLS N + I + +
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGN 113
Query: 587 LSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTR 640
+S L++L LS E N +++ L+ D L +
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 6/179 (3%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFS--G 138
+S ++ ++N L + G L+ L+ L+L N
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIST 198
I + +L + +N+++ + + L +LN++ N LT + +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR 422
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRF 256
++ L + NK+ IP+ + +L L L+VA N + IF ++SL++I L TN +
Sbjct: 423 IKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 2e-32
Identities = 35/265 (13%), Positives = 75/265 (28%), Gaps = 40/265 (15%)
Query: 680 SSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK 739
++T+ + + S L++ + L + G V+ E L A+KV +
Sbjct: 41 TATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMG 98
Query: 740 QKGS---IKSFVAECEALKNIRHRNLIKII------------------TVCSSIDFKGDD 778
+ S ++ A + + + + D
Sbjct: 99 AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDY 158
Query: 779 FKALVYDYMQ--SGSLEDWLQQSNDQV--DGNLNLIQRLNISIDVASAIEYLHHHCQPPI 834
A M S LE + G+ ++ ++ + L +
Sbjct: 159 AVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215
Query: 835 VHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN 894
VHG P N+ + D + D + R + V Y E+
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASS--VPVTYAPREFLNAST 267
Query: 895 VSLTG--DVYSFGILLLEMFTGRRP 917
+ T + + G+ + ++ P
Sbjct: 268 ATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-32
Identities = 53/333 (15%), Positives = 107/333 (32%), Gaps = 58/333 (17%)
Query: 671 TRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGED 727
+ + S++L + Q F + S EL + ++GQ GE
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEATDQETGE- 104
Query: 728 LLPVAVKVINLKQKGS---IKSFVAECEALKNIRH----------------RNLIKIITV 768
V V ++ IK E L+ +R +L+K
Sbjct: 105 --SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 769 CSSIDFKGDDFKALVYDY-----MQSGSLEDWLQ--QSNDQVDGNLNLIQRLNISIDVAS 821
I + D+ V +L+ + + S+ +L RL +++ V
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG-IKG 880
+ LHH+ +VH L+P +++LD ++ F ++ S IG
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----VRDGASAVSPIGRGFA 274
Query: 881 TVGYVAPE-----YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM- 934
A ++ D ++ G+ + ++ P D L G +
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWIF 330
Query: 935 ----ALPEKVMEIVDFALLLDPGNERAKIEECL 963
+P+ V +++ L +R + +
Sbjct: 331 RSCKNIPQPVRALLEGFLRYPK-EDRLLPLQAM 362
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 43/284 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
+S+ IG G V++ L E A+K +NL++ ++ S+ E L ++
Sbjct: 28 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 761 NL--IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
+ I++ D + +V + L WL++ +++ +R + +
Sbjct: 87 SDKIIRLYDY-----EITDQYIYMVMECGN-IDLNSWLKK-----KKSIDPWERKSYWKN 135
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ A+ +H H IVH DLKP+N L+ M+ + DFG+A + S +
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-- 189
Query: 879 KGTVGYVAPE-----------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927
GTV Y+ PE +S DV+S G +L M G+ P + N
Sbjct: 190 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 928 LH----GFVKMALPEKV-MEIVDFA---LLLDPGNERAKIEECL 963
LH ++ P+ ++ D L DP +R I E L
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP-KQRISIPELL 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 72/310 (23%), Positives = 125/310 (40%), Gaps = 61/310 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAECEAL 754
+L +G G+FG VY G + L VAVK L + S + F+ E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALII 87
Query: 755 KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS--NDQVDGNLNLIQR 812
H+N+++ I V + ++ + M G L+ +L+++ +L ++
Sbjct: 88 SKFNHQNIVRCIGVSL----QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 813 LNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLFDRPI 868
L+++ D+A +YL +H +H D+ N LL VA + DFG+A R I
Sbjct: 143 LHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA-----RDI 193
Query: 869 QET------SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTM 921
+ + +K PE M G + D +SFG+LL E+F+ G P +
Sbjct: 194 YRASYYRKGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 922 FNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
N ++V+E + G + C V RI C P +R
Sbjct: 250 SN--------------QEVLE------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 982 IHMADAVKNL 991
+ A ++ +
Sbjct: 290 PNFAIILERI 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRN 761
+ + LS+++GQG+ V+RG + A+KV N + + E E LK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++K+ + + K L+ ++ GSL L++ L + L + DV
Sbjct: 69 IVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVG 123
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ +L + IVH ++KP N++ D V ++DFG A+ L D +
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS------ 174
Query: 878 IKGTVGYVAPE--------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y+ P+ T D++S G+ TG P
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 43/284 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
+S+ IG G V++ L E A+K +NL++ ++ S+ E L ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 761 NL--IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
+ I++ D + +V + L WL++ +++ +R + +
Sbjct: 68 SDKIIRLYDY-----EITDQYIYMVMECGN-IDLNSWLKK-----KKSIDPWERKSYWKN 116
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ A+ +H H IVH DLKP+N L+ M+ + DFG+A + S +
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-- 170
Query: 879 KGTVGYVAPE-----------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927
GTV Y+ PE +S DV+S G +L M G+ P + N
Sbjct: 171 -GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 928 LH----GFVKMALPEKV-MEIVDF---ALLLDPGNERAKIEECL 963
LH ++ P+ ++ D L DP +R I E L
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDP-KQRISIPELL 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 27/278 (9%)
Query: 699 NKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLK-QKGSIKSFVAECEAL 754
+ + + +G G FG+V R + GE VA+K + + + + E + +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGE---QVAIKQCRQELSPKNRERWCLEIQIM 66
Query: 755 KNIRHRNLIKIITVC-SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
K + H N++ V +D L +Y + G L +L Q + L
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIR 124
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLFDRPIQE 870
+ D++SA+ YLH + I+H DLKP N++L ++ + D G AK L +
Sbjct: 125 TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFNDG 925
GT+ Y+APE ++T D +SFG L E TG RP ++
Sbjct: 182 EF------VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + + + + V F+ +L N + I
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQ-----KGSIKSFVAECEALKNIR 758
L ++G G V+ DL VAVKV L+ F E + +
Sbjct: 16 LGEILGFGGMSEVHLA---RDLRDHRDVAVKV--LRADLARDPSFYLRFRREAQNAAALN 70
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H ++ + + + +V +Y+ +L D + +G + + + + D
Sbjct: 71 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 124
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
A+ + H + I+H D+KP+N+++ V DFG+A+ + D T ++++
Sbjct: 125 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV-- 179
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE G +V DVYS G +L E+ TG P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-31
Identities = 66/316 (20%), Positives = 121/316 (38%), Gaps = 43/316 (13%)
Query: 671 TRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLP 730
R+ + + + ++ +S+ IG G V++ L E
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQI 82
Query: 731 VAVKVINLKQ--KGSIKSFVAECEALKNIRHRNL--IKIITVCSSIDFKGDDFKALVYDY 786
A+K +NL++ ++ S+ E L ++ + I++ D + +V +
Sbjct: 83 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVMEC 137
Query: 787 MQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846
L WL++ +++ +R + ++ A+ +H H IVH DLKP+N L+
Sbjct: 138 GN-IDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188
Query: 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG------- 899
M+ + DFG+A + S + G V Y+ PE + S
Sbjct: 189 VDGML-KLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 900 ----DVYSFGILLLEMFTGRRPTHTMFNDGLTLH----GFVKMALPEKV-MEIVDF---A 947
DV+S G +L M G+ P + N LH ++ P+ ++ D
Sbjct: 245 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304
Query: 948 LLLDPGNERAKIEECL 963
L DP +R I E L
Sbjct: 305 LKRDP-KQRISIPELL 319
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 711 IGQGSFGFVYRGNL--GEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKI 765
+G G+FG V +G + + VA+KV LK +K + + E + + + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
I VC + LV + G L +L + + + V+ ++Y
Sbjct: 402 IGVCQAEALM------LVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKY 451
Query: 826 L-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS--IGIKGTV 882
L + VH +L NVLL + A +SDFGL+K L T+ S+ +K
Sbjct: 452 LEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY- 506
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFN 923
APE S DV+S+G+ + E + G++P M
Sbjct: 507 ---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINL---KQKGSIKSFVAECEALKNIRHR 760
L L+G+G G VY ED + VA+K+++ E ++
Sbjct: 38 LRRLVGRGGMGDVYEA---EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 761 NLIKIITVCSSIDFKGDDFKA-LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
+ ++ + DF D + + + L L++ G L + + I +
Sbjct: 95 H---VVPI---HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQI 143
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
SA++ H H D+KP N+L+ D A++ DFG+A D + + +
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN----TV 196
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+APE + + D+Y+ +L E TG P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-31
Identities = 73/314 (23%), Positives = 126/314 (40%), Gaps = 66/314 (21%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAE 750
E N+ +G G+FG VY G + L VAVK L + S + F+ E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLME 124
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS--NDQVDGNLN 808
+ H+N+++ I V + ++ + M G L+ +L+++ +L
Sbjct: 125 ALIISKFNHQNIVRCIGVSL----QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 809 LIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLD---HDMVAHVSDFGLAKFLF 864
++ L+++ D+A +YL +H +H D+ N LL VA + DFG+A
Sbjct: 180 MLDLLHVARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMA---- 231
Query: 865 DRPIQET------SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
R I + + +K PE M G + D +SFG+LL E+F+ G P
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 918 THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMES 977
+ N ++V+E + G + C V RI C
Sbjct: 287 YPSKSN--------------QEVLE------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQ 326
Query: 978 PSERIHMADAVKNL 991
P +R + A ++ +
Sbjct: 327 PEDRPNFAIILERI 340
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGS---IKSFVAE 750
E + + +GQGSFG VY G E VA+K + + S F+ E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNE 78
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----NDQVDG 805
+K ++++++ V S +G ++ + M G L+ +L+ N+ V
Sbjct: 79 ASVMKEFNCHHVVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 806 NLNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
+L + + ++ ++A + YL+ + VH DL N ++ D + DFG+
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMT---- 185
Query: 865 DRPIQETSSSSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
R I ET G KG V +++PE G + DV+SFG++L E+ T +P
Sbjct: 186 -RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVIN-LKQKGSIKSFVAECEALKNIR 758
+ + LS+++GQG+ V+RG G+ A+KV N + + + E E LK +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGD---LFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H+N++K+ + + K L+ ++ GSL L++ L + L + D
Sbjct: 66 HKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRD 120
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETSSS 874
V + +L + IVH ++KP N++ D V ++DFG A+ L D +
Sbjct: 121 VVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--- 174
Query: 875 SIGIKGTVGYVAPE--------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT Y+ P+ T D++S G+ TG P
Sbjct: 175 ---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 30/242 (12%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
++F ++GQG+FG V + D A+K I + + + ++E L ++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 762 LIKIITV-----CSSIDFKGDDFKALVY---DYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
+++ K+ ++ +Y ++G+L D + N N +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYW 119
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
+ + A+ Y+H I+H DLKP N+ +D + DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 874 SSIGIK---------GTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEM----FTGRRPTH 919
S GT YVA E G G+ + D+YS GI+ EM TG +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 920 TM 921
+
Sbjct: 237 IL 238
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 38/238 (15%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKSFVAECEA 753
++ +G+G+FG V+ +D + VAVK + + + + F E E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS----------NDQV 803
L ++H+++++ VC+ +G +V++YM+ G L +L+ D
Sbjct: 97 LTMLQHQHIVRFFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 804 DGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
G L L Q L ++ VA+ + YL H VH DL N L+ +V + DFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMS-- 205
Query: 863 LFDRPIQETSSSSIGIKGT--VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
R I T +G + + ++ PE + + DV+SFG++L E+FT G++P
Sbjct: 206 ---RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 42/241 (17%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAE 750
E SLS + +G+ FG VY+G+L GE VA+K LK K F E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHE 62
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ-----------S 799
++H N++ ++ V + K ++++ Y G L ++L
Sbjct: 63 AMLRARLQHPNVVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 800 NDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858
+ V L +++ +A+ +EYL HH VH DL NVL+ + +SD G
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLG 173
Query: 859 LAKFLFDRPIQETSSSS-IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRR 916
L + ++ + +S + I+ APE M G S+ D++S+G++L E+F+ G +
Sbjct: 174 LFREVYAADYYKLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 917 P 917
P
Sbjct: 230 P 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRN 761
+F +G+G FG V+ D A+K I L + + + + E +AL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 762 LIK----IITVCSSIDFKGDDFKALVY---DYMQSGSLEDWLQQSNDQVDGNLNLIQRLN 814
+++ + ++ + K +Y + +L+DW+ + ++ L+
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC--LH 122
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-FDRPIQETSS 873
I + +A A+E+LH ++H DLKPSN+ D V V DFGL + D Q +
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 874 SSIGIK------GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
GT Y++PE G + S D++S G++L E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 30/224 (13%)
Query: 704 EFSLSNLIGQGSFG-FVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRN 761
F +++G G+ G VYRG D VAVK I + E + L+ H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+I+ K F+ + + +L+++++Q D ++ + + S
Sbjct: 80 VIRYFCT-----EKDRQFQYIAIELCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTS 129
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ +LH IVH DLKP N+L+ + A +SDFGL K L + + S
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL--AVGRHSFSRRS 184
Query: 877 GIKGTVGYVAPEY---GMGGNVSLTGDVYSFGILLLEMFTGRRP 917
G+ GT G++APE N + T D++S G + + +
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 37/238 (15%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKSFVAECEA 753
++ +G+G+FG V+ +D + VAVK + + K F E E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQ 802
L N++H +++K VC GD +V++YM+ G L +L+ Q
Sbjct: 71 LTNLQHEHIVKFYGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 803 VDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
G L L Q L+I+ +AS + YL H VH DL N L+ +++ + DFG+++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 862 FLFDRPIQETSSSS-IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
++ + + I+ PE M + DV+SFG++L E+FT G++P
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 710 LIGQGSFGFVYRG-NL--GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKII 766
++G+G++G VY G +L +A+K I + + E K+++H+N I
Sbjct: 29 VLGKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----I 81
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
+ K + + + GSL L+ + N I + + ++YL
Sbjct: 82 VQYLGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIG--FYTKQILEGLKYL 138
Query: 827 HHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H + IVH D+K NVL++ + V +SDFG +K L + + GT+ Y+
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-----AGINPCTETFTGTLQYM 190
Query: 886 APEYGMGGNVSLTG--DVYSFGILLLEMFTGRRPTHTMFN 923
APE G D++S G ++EM TG+ P + +
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 6e-30
Identities = 51/335 (15%), Positives = 101/335 (30%), Gaps = 61/335 (18%)
Query: 672 RRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPV 731
+ + P +EL + ++GQ E
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 732 AVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA------- 781
V V ++ +IK E L+ +R K V F D K
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 782 ---------------LVYDYMQSGSLEDWLQQ--SNDQVDGNLNLIQRLNISIDVASAIE 824
+Y MQ +L+ + + S+ +L RL +++ V +
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
LHH+ +VH L+P +++LD ++ F SS + G+
Sbjct: 221 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-----VRDGARVVSS----VSRGF 268
Query: 885 VAPEY-----------GMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
PE ++ + D ++ G+++ ++ P L G
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAALGGSEW 324
Query: 934 -----MALPEKVMEIVDFALLLDPGNERAKIEECL 963
+P+ V +++ L +R + +
Sbjct: 325 IFRSCKNIPQPVRALLEGFLRYPK-EDRLLPLQAM 358
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 63/250 (25%), Positives = 100/250 (40%), Gaps = 27/250 (10%)
Query: 672 RRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDL 728
R +T+ + +L E+ P+ E + + + +G+GSFG V+R G
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDY--EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF-- 84
Query: 729 LPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQ 788
AVK + L+ E A + I +G + + ++
Sbjct: 85 -QCAVKKVRLEVFRV-----EELVACAGLSSPR----IVPLYGAVREGPWVN-IFMELLE 133
Query: 789 SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848
GSL ++Q G L + L +EYLH I+HGD+K NVLL
Sbjct: 134 GGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185
Query: 849 D-MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGIL 907
D A + DFG A L + ++ + I GT ++APE MG D++S +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 908 LLEMFTGRRP 917
+L M G P
Sbjct: 246 MLHMLNGCHP 255
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 47/232 (20%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+F LIG G FG V++ D +K + + + + E +AL + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66
Query: 763 IK--------IITVCSSIDFKGDDFKALVY---DYMQSGSLEDWLQQSNDQVDGNLNLIQ 811
+ +S ++ ++ G+LE W+++ + L+ +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVL 123
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
L + + ++Y+H +++ DLKPSN+ L + DFGL L +
Sbjct: 124 ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL------KN 174
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923
KGT+ Y++PE + D+Y+ G++L E+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 92/479 (19%), Positives = 171/479 (35%), Gaps = 40/479 (8%)
Query: 142 SNLSHCSNLINFSV--RRNNLT---GEIPAYIGYYWLKLENLNVAENQLTGQLPPS-IGN 195
+++ SN + V NLT ++P + + L++++N ++ +L I
Sbjct: 23 GSMTPFSNELESMVDYSNRNLTHVPKDLPP-------RTKALSLSQNSIS-ELRMPDISF 74
Query: 196 ISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNR 255
+S L+ L + N++ + +DL +L V+ N + ++SL + L N
Sbjct: 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNI--SCCPMASLRHLDLSFND 132
Query: 256 FEGRLPLNIGF-NLPKLKILIVGQNNLTGSIPQSFSNAS-NLVILNLSGNHFSGKVGIDF 313
F+ LP+ F NL KL L + ++ + ++L+L H G
Sbjct: 133 FD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
N T L+L + S+ + L +L + LN +
Sbjct: 192 QIP-NTTVLHLVFHPNSLFSVQVNMSVNALG-HLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 374 TIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT----------GTIPYTIGELINLQA 423
T++ + L I T ++ + +EY + Y+ L +L
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 424 LDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTL 483
+ +N L ++ + + LN ++N T
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DS 368
Query: 484 PPQILEITTLSSLLDLSSNLISGSIPLVVG---NLKNLIQLDISRNRF-SGEIPTTLSSC 539
Q L L N + + V N+ +L LD+S N S T +
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 540 TSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
S+ L + N GS+ L ++VLDL N + IP+ + L L+ LN++ N
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 88/487 (18%), Positives = 172/487 (35%), Gaps = 28/487 (5%)
Query: 104 FINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGE 163
++ ++ NL +P +L R K L L NS S ++S S L + N +
Sbjct: 35 MVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 164 IPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI-IPESLGQLRD 222
+ ++ + LE L+V+ N+L + +++L+ L + N + + + G L
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTK 147
Query: 223 LNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLT 282
L FL ++ F + L I L + + +P +L + + +
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207
Query: 283 GSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL--GSGSIGDLDFI 340
Q + + L L LS + + + + N+ +
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267
Query: 341 TLLTN--CSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-----RN 393
L +E L + + + R S + ++ + + + L
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 394 LANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFN 453
A + L + + L+F+ N + L L +L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 454 NLQ--GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP-- 509
L+ + N +L L+VS N L + +L+LSSN+++GS+
Sbjct: 388 GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP-SSLISLKSIEV 568
L + LD+ NR IP ++ +L+ L + N + S+P L S++
Sbjct: 448 LP----PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501
Query: 569 LDLSCNN 575
+ L N
Sbjct: 502 IWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 87/465 (18%), Positives = 171/465 (36%), Gaps = 31/465 (6%)
Query: 106 NLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNL-SHCSNLINFSVRRNNLTGEI 164
+L+ N++ ++ LS L+VL L N ++ ++ +L V N L I
Sbjct: 58 SLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NI 115
Query: 165 PAYIGYYWLK-LENLNVAENQLTGQLPPS--IGNISTLQQLGVGENKLYGIIPESLGQLR 221
+ L +L+++ N LP GN++ L LG+ K + + L
Sbjct: 116 SCC----PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 222 -DLNFLSVAENNFSGMLPPIFNISSLE--QISLLTNRFEGRLPLNIGFNLPKLKILIVGQ 278
L + + G I + + N L L++ +
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230
Query: 279 NNLTGSIPQSF-------SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGS 331
N+ +F N+ + ++ F + LN+ + +
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI-T 289
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI 391
I +F T L + + F S + + + I + ++ +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 392 RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI--IPDSIGNLSTLNSLW 449
+ ++ L N T ++ L LQ L N L + N+S+L +L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409
Query: 450 LGFNNLQGNIPSSL-GNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSI 508
+ N+L + +++++LN+S N LTG++ + + LDL +N I SI
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKV---LDLHNNRIM-SI 465
Query: 509 PLVVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQDNSF 552
P V +L+ L +L+++ N+ +P TSL+Y+ + DN +
Sbjct: 466 PKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 66/423 (15%), Positives = 140/423 (33%), Gaps = 50/423 (11%)
Query: 97 GNLSFLRFINLASNNLHGEIP--NELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFS 154
++ LR ++L+ N+ +P E G L++L L L F ++H L
Sbjct: 118 CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH---LHLSC 173
Query: 155 VRRNNLTGEIPAYIGYYW--LKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI 212
+ + ++ I L++ + + +++ L L
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL---------- 223
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIG--FNLPK 270
QL ++ L + +L ++L + + + F
Sbjct: 224 ------QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277
Query: 271 LKILIVGQNNLTGSIPQSFSNASN-----LVILNLSGNHFSGKVGIDFSSLPNITRLNLG 325
++ L + +T I + S L+I ++ F +S + L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISG 385
++ + + S L N F S+ + + L + + + N +
Sbjct: 338 ISDTPFIHMVCPP------SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390
Query: 386 TIPLEIRNLANIYALGLEYNQLT----GTIPYTIGELINLQALDFSANNLHGIIPDSIGN 441
N+ +L L T ++ L+ S+N L G + +
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-- 448
Query: 442 LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDL 499
+ L L N + +IP + + + L LNV+ N+L ++P + + L+SL + L
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFD--RLTSLQYIWL 504
Query: 500 SSN 502
N
Sbjct: 505 HDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 65/372 (17%), Positives = 123/372 (33%), Gaps = 32/372 (8%)
Query: 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID---FSSLPNITRLNLG 325
P+ K L + QN+++ S S L +L LS N +D F ++ L++
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS---LDFHVFLFNQDLEYLDVS 108
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRS--IANLSTITIIAMGLNQI 383
N L + S + L L L+ N F LP NL+ +T + + +
Sbjct: 109 HNRLQNISCCPMA---------SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 384 SGTIPLEIRNLA-NIYALGLEYNQLTGTIPYTIGEL-INLQALDFSANNLHGIIPDSIGN 441
L + +L + L L + G ++ + L F N+L + + N
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218
Query: 442 LST---LNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP-----QILEITTL 493
L+++ L N Q + + LLNV+ + T Q +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 494 SSL----LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQD 549
L L ++ + LK+L+ + F S + +
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 550 NSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGV 609
+ S S L+ + N + + + L L+ L L N + +
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM 398
Query: 610 FSNKTRISLIEN 621
N + + ++
Sbjct: 399 TKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 37/255 (14%), Positives = 68/255 (26%), Gaps = 60/255 (23%)
Query: 81 LYLRNQSVGGFLSPYVG---NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFS 137
L + + FL + + L+ ++ S L N F+
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366
Query: 138 GTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIS 197
++ S L ++RN L
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLK--------------------------NFFKVALMTK 400
Query: 198 TLQQLGVGENKL----YGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLT 253
+ L + L + + L+++ N LT
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM-------------------LT 441
Query: 254 NRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDF 313
LP PK+K+L + N + SIP+ ++ L LN++ N F
Sbjct: 442 GSVFRCLP-------PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVF 493
Query: 314 SSLPNITRLNLGQNN 328
L ++ + L N
Sbjct: 494 DRLTSLQYIWLHDNP 508
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 61/252 (24%), Positives = 111/252 (44%), Gaps = 50/252 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-------GEDLLPVAVKVINLKQKGS---IKSFVAECE 752
++ +L +G+G+FG V ++ + VAVK+ LK + + V+E E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEME 92
Query: 753 ALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------N 800
+K I +H+N+I ++ C+ + ++ +Y G+L ++L+ N
Sbjct: 93 MMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 801 DQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
+ + ++ + +A +EYL C +H DL NVL+ + V ++DFGL
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGL 203
Query: 860 AKFLFDRPIQETS---SSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
A R I ++ G +K APE + DV+SFG+L+ E+FT
Sbjct: 204 A-----RDINNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 914 -GRRPTHTMFND 924
G P + +
Sbjct: 255 LGGSPYPGIPVE 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 55/302 (18%), Positives = 118/302 (39%), Gaps = 43/302 (14%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+ +G+G F +V D A+K I ++ + E + + H N+++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 765 IITVCSSIDFKGDDFKA-LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
++ + +G +A L+ + + G+L + +++ D+ L Q L + + + +
Sbjct: 91 LVA--YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGL 147
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS----IGIK 879
E +H H DLKP+N+LL + + D G + + +
Sbjct: 148 EAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 880 GTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
T+ Y APE + + + DV+S G +L M G P ++ V
Sbjct: 205 CTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMVFQKGDSVA 257
Query: 934 MAL------------PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSER 981
+A+ + ++++ + +DP ++R I L+ L +++ P+
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDP-HQRPHIPLLLS------QLEALQPPAPG 310
Query: 982 IH 983
H
Sbjct: 311 QH 312
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 52/233 (22%), Positives = 96/233 (41%), Gaps = 22/233 (9%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITV 768
++ +G F FVY A+K + ++ ++ + E +K + H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 769 CSSIDFKGDDFKALVYDYMQ--SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYL 826
S + D +A + G L ++L++ + G L+ L I A++++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHM 152
Query: 827 HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK------- 879
H +PPI+H DLK N+LL + + DFG A + P S+ +
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 880 GTVGYVAPE----YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTL 928
T Y PE Y + D+++ G +L + + P F DG L
Sbjct: 212 TTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 60/243 (24%), Positives = 101/243 (41%), Gaps = 47/243 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGS---IKSFVAECEAL 754
+ L +G+G+FG V + VAVK+ LK+ + ++ ++E + L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKIL 84
Query: 755 KNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQ 802
+I H N++ ++ C+ K ++ ++ + G+L +L+ D
Sbjct: 85 IHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 803 VDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
L L + S VA +E+L C +H DL N+LL V + DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLA- 195
Query: 862 FLFDRPIQETS---SSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-G 914
R I + +K APE ++ DV+SFG+LL E+F+ G
Sbjct: 196 ----RDIYKDPDYVRKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 915 RRP 917
P
Sbjct: 248 ASP 250
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 67/278 (24%), Positives = 123/278 (44%), Gaps = 49/278 (17%)
Query: 673 RRKQTQKSSTLLSMEQQFPMVSYAELNKATN------EFSLSNL-----IGQGSFGFVYR 721
+ KQ K + + + SY ++ EF +NL +G G+FG V
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 722 GNL-----GEDLLPVAVKVINLKQKGS---IKSFVAECEALKNI-RHRNLIKIITVCSSI 772
+ +L VAVK+ LK ++ ++E + + ++ +H N++ ++ C+
Sbjct: 65 ATAFGLGKEDAVLKVAVKM--LKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-- 120
Query: 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN---------LNLIQRLNISIDVASAI 823
G ++ +Y G L ++L++ + ++ + + L+ S VA +
Sbjct: 121 --HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 824 EYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG-- 880
+L +C +H D+ NVLL + VA + DFGLA R I S+ +
Sbjct: 178 AFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA-----RDIMNDSNYIVKGNARL 228
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
V ++APE ++ DV+S+GILL E+F+ G P
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-29
Identities = 71/309 (22%), Positives = 124/309 (40%), Gaps = 74/309 (23%)
Query: 670 CTRRRKQTQKSSTLLSMEQQFPMVS-------------YAELNKATN------EFSLSNL 710
RR+ T + + SM P+V A +++ EF L
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL 83
Query: 711 -----IGQGSFGFVYRGNL-------GEDLLPVAVKVINLKQKGS---IKSFVAECEALK 755
+G+G FG V ++ + VAVK+ LK + + V+E E +K
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMK 141
Query: 756 NI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQV 803
I +H+N+I ++ C+ + ++ +Y G+L ++L+ N
Sbjct: 142 MIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 804 DGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+ + ++ + +A +EYL C +H DL NVL+ + V ++DFGLA
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA-- 250
Query: 863 LFDRPIQETS---SSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GR 915
R I ++ G +K APE + DV+SFG+L+ E+FT G
Sbjct: 251 ---RDINNIDYYKKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 916 RPTHTMFND 924
P + +
Sbjct: 304 SPYPGIPVE 312
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 41/282 (14%), Positives = 87/282 (30%), Gaps = 28/282 (9%)
Query: 697 ELNKATNEFSLSNLIGQGSFGFVYRG-----NLGEDLLPVAVKVINLKQKGSIKSFVAEC 751
E + + +L+G+G+F VY N ++ +KV
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 752 EALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ 811
E LK +K + + LV + G+L + + + + +
Sbjct: 119 ERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-----------VSDFGLA 860
++ ++ + IE +H I+HGD+KP N +L + + + D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920
+ P ++ T G+ E + D + + M G
Sbjct: 231 IDMKLFPKGTIFTAKC---ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 921 MFNDGLTLHGFVK-MALPEKVMEIVDFALLLDPGNERAKIEE 961
G + + + E L + + ++
Sbjct: 288 NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDL 329
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-29
Identities = 63/260 (24%), Positives = 104/260 (40%), Gaps = 60/260 (23%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGS---IKSFVAE 750
EF NL +G+G FG V + VAVK+ LK+ S ++ ++E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS----------- 799
LK + H ++IK+ CS + L+ +Y + GSL +L++S
Sbjct: 77 FNVLKQVNHPHVIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 800 --------NDQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDM 850
+ + L + ++ + ++ ++YL VH DL N+L+
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGR 187
Query: 851 VAHVSDFGLAKFLFDRPIQETS---SSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSF 904
+SDFGL+ R + E S G +K A E + DV+SF
Sbjct: 188 KMKISDFGLS-----RDVYEEDSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSF 238
Query: 905 GILLLEMFT-GRRPTHTMFN 923
G+LL E+ T G P +
Sbjct: 239 GVLLWEIVTLGGNPYPGIPP 258
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 62/311 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL--GEDLLPVAVKVINLKQKGS---IKSFVAECEALKNI 757
N+ ++IG+G+FG V + + + A+K +K+ S + F E E L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKL 82
Query: 758 -RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------NDQVDG 805
H N+I ++ C + L +Y G+L D+L++S +
Sbjct: 83 GHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 806 NLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
L+ Q L+ + DVA ++YL +H DL N+L+ + VA ++DFGL+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLS---- 189
Query: 865 DRPIQETSSSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHT 920
R + ++G ++ A E + DV+S+G+LL E+ + G P
Sbjct: 190 -RGQEVYVKKTMGRLPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
Query: 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE 980
M ++ E L G K C V + C E P E
Sbjct: 245 MTC--------------AELYE------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 284
Query: 981 RIHMADAVKNL 991
R A + +L
Sbjct: 285 RPSFAQILVSL 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 50/252 (19%)
Query: 703 NEFSLSNLIGQGSFGFVYRG-------NLGEDLLPVAVKVINLKQKGS---IKSFVAECE 752
+ L +G+G+FG V + + VAVK+ LK + + ++E E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM--LKSDATEKDLSDLISEME 126
Query: 753 ALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS-----------N 800
+K I +H+N+I ++ C+ + ++ +Y G+L ++LQ +
Sbjct: 127 MMKMIGKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 801 DQVDGNLNLIQRLNISIDVASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
+ L+ ++ + VA +EYL C +H DL NVL+ D V ++DFGL
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGL 237
Query: 860 AKFLFDRPIQETS---SSSIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
A R I ++ G +K APE + DV+SFG+LL E+FT
Sbjct: 238 A-----RDIHHIDYYKKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
Query: 914 -GRRPTHTMFND 924
G P + +
Sbjct: 289 LGGSPYPGVPVE 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 50/245 (20%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAECEAL 754
N S +G G+FG V + + VAVK+ LK + ++E + L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTEREALMSELKVL 80
Query: 755 KNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN------- 806
+ H N++ ++ C+ G ++ +Y G L ++L++ D +
Sbjct: 81 SYLGNHMNIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 807 ------LNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859
L+L L+ S VA + +L +C +H DL N+LL H + + DFGL
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGL 191
Query: 860 AKFLFDRPIQE------TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
A R I+ ++ + +K APE + DV+S+GI L E+F+
Sbjct: 192 A-----RDIKNDSNYVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 914 -GRRP 917
G P
Sbjct: 243 LGSSP 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 65/304 (21%), Positives = 112/304 (36%), Gaps = 43/304 (14%)
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVG-IDFSSLPN 318
LP+N F+L + N ++G+ FS L G + + V + +
Sbjct: 5 LPINNNFSLSQNSFY----NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 319 ITRLNLGQNNLGS--GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITII 376
+ L L + NL S ++ ++ L + N SLP A+L +
Sbjct: 61 FSELQLNRLNLSSLPDNLP-----------PQITVLEITQNALI-SLPELPASL---EYL 105
Query: 377 AMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP 436
N++S T+P +L + L ++ NQLT +P L+ ++ N L + P
Sbjct: 106 DACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPA---LLEYINADNNQLTML-P 156
Query: 437 DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL 496
+ +L L+ + N L +P + L L+VS N L +LP +
Sbjct: 157 ELPTSLEVLS---VRNNQLTF-LPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEET 208
Query: 497 ---LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
N I+ IP + +L + + N S I +LS T+ F
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 554 GSIP 557
S
Sbjct: 268 MSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 70/463 (15%), Positives = 138/463 (29%), Gaps = 83/463 (17%)
Query: 147 CSNLINFSV--RRNNLTGEIPAYIGYYWLKLENLNVAE---NQLTGQLPPSIGNISTLQQ 201
+N + S N ++ A W K E + N+ L + I+ +
Sbjct: 7 INNNFSLSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSE 63
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLP 261
L + L +P++L + L + +N LP
Sbjct: 64 LQLNRLNL-SSLPDNLPP--QITVLEITQNALI------------------------SLP 96
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLP---- 317
L+ L N L+ ++P+ ++L L++ N + LP
Sbjct: 97 ELPA----SLEYLDACDNRLS-TLPELP---ASLKHLDVDNNQ--------LTMLPELPA 140
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIA 377
+ +N N L L + LE L + +N+ LP +L +
Sbjct: 141 LLEYINADNNQLTM----------LPELPTSLEVLSVRNNQL-TFLPELPESL---EALD 186
Query: 378 MGLNQISGTIPLEIRNLAN----IYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHG 433
+ N + ++P + N++T IP I L + N L
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244
Query: 434 IIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
I +S+ T + G + ++ N + L + + +I
Sbjct: 245 RIRESLSQQ-TAQPDYHG-PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHA 302
Query: 494 SSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+ ++ + L + + R + + L ++ L+ Q +
Sbjct: 303 FEHEEHANTFSAFLDRL--SDTVSARNTSGFREQ----VAAWLEKLSASAELRQQSFAVA 356
Query: 554 GSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596
S ++ +L L Q E L D L+L
Sbjct: 357 ADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLG 399
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-23
Identities = 47/268 (17%), Positives = 97/268 (36%), Gaps = 37/268 (13%)
Query: 340 ITLLTNCSKLETLGLNS-----NRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNL 394
++++ + +L NS + + + N+ + + +
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
L L L+ ++P + + L+ + N L +P+ +L L+ N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDNR 111
Query: 455 LQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGN 514
L +P + K+L +V N+LT LP L + + +N ++ +P + +
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPE---LPALLEYI-NADNNQLT-MLPELPTS 161
Query: 515 LKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIE----VLD 570
L+ L + N+ + +P S LE L + N S+P+ + E
Sbjct: 162 LE---VLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 571 LSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
N ++ IPE + L + L N
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDN 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-17
Identities = 51/210 (24%), Positives = 75/210 (35%), Gaps = 29/210 (13%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT 161
+ + + N L +P L L N S T+P + +L V N LT
Sbjct: 82 ITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPASLKHL---DVDNNQLT 133
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLR 221
+P LE +N NQLT LP + L+ L V N+L +PE L
Sbjct: 134 -MLPELPA----LLEYINADNNQLT-MLPELPTS---LEVLSVRNNQL-TFLPELPESLE 183
Query: 222 DLNFLSVAENNFSGMLPP-IFNISSLEQ----ISLLTNRFEGRLPLNIGFNLPKLKILIV 276
L+ N LP E+ NR +P NI +L +I+
Sbjct: 184 ALD----VSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTCTIIL 237
Query: 277 GQNNLTGSIPQSFSNASNLVILNLSGNHFS 306
N L+ I +S S + + +FS
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 26/122 (21%), Positives = 44/122 (36%), Gaps = 12/122 (9%)
Query: 482 TLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSC-- 539
++ I +LS + N ISG+ + + E + L C
Sbjct: 2 SIMLPINNNFSLSQ--NSFYNTISGTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLI 58
Query: 540 TSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYND 599
L++ + S+P +L I VL+++ N L +PE L EYL+ N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASL---EYLDACDNR 111
Query: 600 FE 601
Sbjct: 112 LS 113
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
++ + IG GS+G + D + K ++ + + V+E L+ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N I+ I + + +V +Y + G L + + + L+ L + +
Sbjct: 66 N---IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLT 121
Query: 821 SAIEYLH--HHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
A++ H ++H DLKP+NV LD + DFGLA+ L +S +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKTF 176
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE + + D++S G LL E+ P
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 31/303 (10%)
Query: 671 TRRRKQTQKSSTLLSMEQQFPMVSYAELNKAT---NEFSLSNLIGQGSFGFVYRGNLGED 727
+ + Q ++ S + Y + F + +G GS+G V++ ED
Sbjct: 22 SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED 81
Query: 728 LLPVAVKVINLKQKGS--IKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVY 784
AVK +G +AE + + + +H +++ ++ L
Sbjct: 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQT 136
Query: 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNV 844
+ SL+ + +L Q D A+ +LH +VH D+KP+N+
Sbjct: 137 ELCG-PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANI 188
Query: 845 LLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSF 904
L + DFGL L T+ + +G Y+APE G DV+S
Sbjct: 189 FLGPRGRCKLGDFGLLVEL------GTAGAGEVQEGDPRYMAPELLQGSY-GTAADVFSL 241
Query: 905 GILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV-MEIVDF-ALLL--DPGNERAKIE 960
G+ +LE+ H G++ + E+ ++L DP RA E
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP-KLRATAE 300
Query: 961 ECL 963
L
Sbjct: 301 ALL 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 60/254 (23%)
Query: 704 EFSLSNL-----IGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGSIKS---FVAE 750
E+ +N+ IG+G+FG V++ E VAVK+ LK++ S F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS----------- 799
+ + N++K++ VC+ G L+++YM G L ++L+
Sbjct: 101 AALMAEFDNPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155
Query: 800 --------NDQVDGNLNLIQRLNISIDVASAIEYLH-HHCQPPIVHGDLKPSNVLLDHDM 850
+ L+ ++L I+ VA+ + YL VH DL N L+ +M
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENM 211
Query: 851 VAHVSDFGLAKFLFDRPIQET------SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSF 904
V ++DFGL+ R I + +I I+ PE + DV+++
Sbjct: 212 VVKIADFGLS-----RNIYSADYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAY 262
Query: 905 GILLLEMFT-GRRP 917
G++L E+F+ G +P
Sbjct: 263 GVVLWEIFSYGLQP 276
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 79/394 (20%), Positives = 137/394 (34%), Gaps = 41/394 (10%)
Query: 237 LPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFSNASNL 295
+P + + + + L N L L L+ L V Q I +F S+L
Sbjct: 25 VPELP--AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 296 VILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
+IL L N F + G F+ L N+ L L Q NL + F L + LE L L
Sbjct: 82 IILKLDYNQFLQLETGA-FNGLANLEVLTLTQCNLDGAVLSGNFFKPL----TSLEMLVL 136
Query: 355 NSNRFGGSLPRSI-ANLSTITIIAMGLNQIS----------GTIPLEIRNLANIYALGLE 403
N P S N+ ++ + N++ + L++I +
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 404 YNQLTGTIPYTIGELINLQALDFSANNLHGIIP---DSIGNLSTLNSLWLGFNN-----L 455
L + ++ LD S N + + + SL L +
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 456 QGNIPSSLGNC-------KNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSI 508
N + ++SK+K+ L + T L L+ N I+ I
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KI 314
Query: 509 PLVV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPS-SLISLKSI 566
L +L++L++S+N + LE L + N R ++ S + L ++
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNL 373
Query: 567 EVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+ L L N L + L+ L+ + L N +
Sbjct: 374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 78/399 (19%), Positives = 147/399 (36%), Gaps = 39/399 (9%)
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE-SLGQLRDLNFLSVAENNF 233
+ ++++ N + S + LQ L V + +I + L L L + N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 234 SGMLPPIF-NISSLEQISLLTNRF-EGRLPLNIGFNLPKLKILIVGQNNLTGSIPQS-FS 290
+ F +++LE ++L L N L L++L++ NN+ P S F
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 291 NASNLVILNLSGNHFSGKVGIDFSSLP--NITRLNLGQNNLGSGSIGDLDFIT--LLTNC 346
N +L+L+ N D + + T L L L + L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAM-----GLNQISGTIPLEIRNL------- 394
+ + TL L+ N F S+ + + T I N S ++
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 395 ---ANIYALGLEYNQLTGTIPYTI-GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWL 450
+ + L +++ + ++ +L+ L + N ++ I ++ L+ L L L
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330
Query: 451 GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSI 508
N L N L +L++S N + L Q L +L L L +N + S+
Sbjct: 331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF--LGLPNLKELALDTNQLK-SV 386
Query: 509 PLVV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLK 546
P + L +L ++ + N + SC ++YL
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLS 418
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 66/379 (17%), Positives = 129/379 (34%), Gaps = 32/379 (8%)
Query: 126 LKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQL 185
+ + L NS + ++ S +L V + I L L + NQ
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 186 TGQLPPSI-GNISTLQQLGVGENKL--YGIIPESLGQLRDLNFLSVAENNFSGMLPPIF- 241
QL ++ L+ L + + L + L L L + +NN + P F
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 242 -NISSLEQISLLTNRFEGRLPLNI----------GFNLPKLKILIVGQNNLTGSIPQSFS 290
N+ + L N+ + + L + + + + L +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 291 NASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITL--LTNC-- 346
+++ L+LSGN F + F T++ + N
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269
Query: 347 -----SKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLANIYA 399
S ++T L+ ++ +L +S+ ++ + + + + N+I+ I L ++
Sbjct: 270 KGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI 459
L L N L L L+ LD S N++ + S L L L L N L+ ++
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SV 386
Query: 460 PSS-LGNCKNLMLLNVSKN 477
P +L + + N
Sbjct: 387 PDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 45/285 (15%), Positives = 93/285 (32%), Gaps = 32/285 (11%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
N+ ++L N + +L +L +S L + +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI------TLQDMNEYWLGWEKC 205
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
N + L+++ N + + ++ + S
Sbjct: 206 GNPFKNT---------SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
G NF F G+ S ++ L ++ L ++ + L+ L +
Sbjct: 257 GH---TNFKDPDNFTFKGLEA-----SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLA 307
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDL 337
QN + +F ++L+ LNLS N F +L + L+L N++ +
Sbjct: 308 QNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ-- 365
Query: 338 DFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLN 381
L+ L L++N+ S+P I L+++ I + N
Sbjct: 366 ----SFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 22/97 (22%), Positives = 42/97 (43%), Gaps = 1/97 (1%)
Query: 517 NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI-SLKSIEVLDLSCNN 575
++ +D+S N + T+ S L++LK++ + I ++ L S+ +L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 576 LSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
L+ LE L L+ + +G V + F
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
++ IG+GSFG ED +K IN+ + + E L N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN------DQVDGNLNLIQRLN 814
N+++ F+ + +V DY + G L + DQ+ L+
Sbjct: 84 NIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI---------LD 129
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
+ + A++++H I+H D+K N+ L D + DFG+A+ L + ++ +
Sbjct: 130 WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARA- 184
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE + D+++ G +L E+ T +
Sbjct: 185 ---CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 61/287 (21%)
Query: 672 RRRKQTQKSSTLLSMEQQFPMVSYAELNKATN-EFSLSNL-----IGQGSFGFVYRGNL- 724
R Q Q S + ++ V + E EF NL +G G+FG V
Sbjct: 8 RYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAY 67
Query: 725 ----GEDLLPVAVKVINLKQKGS---IKSFVAECEALKNI-RHRNLIKIITVCSSIDFKG 776
+ VAVK+ LK+K ++ ++E + + + H N++ ++ C+
Sbjct: 68 GISKTGVSIQVAVKM--LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----LS 121
Query: 777 DDFKALVYDYMQSGSLEDWLQQS------------------NDQVDGNLNLIQRLNISID 818
L+++Y G L ++L+ ++ L L +
Sbjct: 122 GPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 819 VASAIEYL-HHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS---SS 874
VA +E+L C VH DL NVL+ H V + DFGLA R I S
Sbjct: 181 VAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA-----RDIMSDSNYVVR 231
Query: 875 SIG---IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
+K APE G ++ DV+S+GILL E+F+ G P
Sbjct: 232 GNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK---SFVAECEALKNIRH 759
F + IG+G F VYR D +PVA+K + + K + E + LK + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N +I +S F D+ +V + +G L ++ Q + + +
Sbjct: 92 PN---VIKYYAS--FIEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQL 145
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
SA+E++H ++H D+KP+NV + V + D GL +F ++++ +
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-----SSKTTAAHSLV 197
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE + D++S G LL EM + P
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-27
Identities = 65/298 (21%), Positives = 114/298 (38%), Gaps = 55/298 (18%)
Query: 703 NEFSLSNLIGQGSFG-FVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEAL-KNIRH 759
N ++G GS G V++G+ G PVAVK + + E + L ++ H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGR---PVAVKRML---IDFCDIALMEIKLLTESDDH 68
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI-- 817
N+I+ D F + + +L+D ++ N + + IS+
Sbjct: 69 PNVIRYYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-------------DMVAHVSDFGLAKFLF 864
+AS + +LH I+H DLKP N+L+ ++ +SDFGL K L
Sbjct: 123 QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL- 178
Query: 865 DRPIQETSSSSI-GIKGTVGYVAPEYGMGGNVSLTG-------DVYSFGILLLEMFT-GR 915
Q + +++ GT G+ APE N T D++S G + + + G+
Sbjct: 179 -DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 916 RP-------THTMFNDGLTLHGFVKMALPEKVMEIVDF--ALL-LDPGNERAKIEECL 963
P + +L + + E D ++ DP +R + L
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP-LKRPTAMKVL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 59/281 (20%), Positives = 99/281 (35%), Gaps = 65/281 (23%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRN 761
+F +G+G FG V+ D A+K I L + + + + E +AL + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 762 LIKIITVCSSIDFKGDD------------------------------------------- 778
+++ +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 779 ------FKALVYDYMQ---SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
K +Y MQ +L+DW+ + D + L+I I +A A+E+LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC--LHIFIQIAEAVEFLHSK 183
Query: 830 CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK-------GTV 882
++H DLKPSN+ D V V DFGL + ++T + + GT
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923
Y++PE G N S D++S G++L E+
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+F + +G+G FG VY + +A+KV+ L++ G E E ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++++ F L+ +Y G++ LQ+ + + ++
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITEL 118
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A+A+ Y H ++H D+KP N+LL ++DFG + +
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLC------ 168
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+ PE G D++S G+L E G+ P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 49/250 (19%), Positives = 96/250 (38%), Gaps = 54/250 (21%)
Query: 703 NEFSLSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLKQKGSIKSFVA------------ 749
N++ + + QG F + + A+K + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNK---FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 750 -----ECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVD 804
E + + +I++ + + I + + ++Y+YM++ S+ + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI---ITNYDEVY--IIYEYMENDSILKFDEYF----- 137
Query: 805 GNLNLIQRLNISIDVA--------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856
L+ I I V ++ Y+H+ I H D+KPSN+L+D + +SD
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSD 195
Query: 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTG 914
FG ++++ D+ I+ S +GT ++ PE D++S GI L MF
Sbjct: 196 FGESEYMVDKKIK-GS------RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
Query: 915 RRPTHTMFND 924
P F+
Sbjct: 249 VVP----FSL 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 44/218 (20%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHR 760
+ +G+G F + + + A K++ L + + E +++ H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
+++ F+ +DF +V + + SL + ++ L + +
Sbjct: 76 HVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIV 125
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL-FDRPIQETSSSSIGIK 879
+YLH + ++H DLK N+ L+ D+ + DFGLA + +D ++
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC------ 176
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE S DV+S G ++ + G+ P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
++F + +G+G FG VY ++ +A+KV+ L+++G E E ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++++ F L+ ++ G L LQ+ G + + ++
Sbjct: 74 PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEEL 123
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A A+ Y H ++H D+KP N+L+ + ++DFG + + T
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RRTMC------ 173
Query: 880 GTVGYVAPE----YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+ PE V D++ G+L E G P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRHR 760
+ +G+G F + + + A K++ L + + E +++ H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
+++ F+ +DF +V + + SL + ++ L + +
Sbjct: 102 HVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIV 151
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-KFLFDRPIQETSSSSIGIK 879
+YLH + ++H DLK N+ L+ D+ + DFGLA K +D ++
Sbjct: 152 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC------ 202
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE S DV+S G ++ + G+ P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 64/361 (17%), Positives = 117/361 (32%), Gaps = 72/361 (19%)
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
L + ++ L +P I L + N + + + L+ L L + N S
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 235 GMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASN 294
+ F+ L KL+ L + +N+L IP + S+
Sbjct: 92 KIHEKAFS------------------------PLRKLQKLYISKNHLV-EIPPNLP--SS 124
Query: 295 LVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
LV L + N FS L N+ + +G N L + F L KL L +
Sbjct: 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-----KLNYLRI 179
Query: 355 NSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYT 414
+ + +T I L + L L++N++
Sbjct: 180 SEAK--------------LTGIPKDL-------------PETLNELHLDHNKIQAIELED 212
Query: 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNV 474
+ L L N + I S+ L TL L L N L +P+ L + K L ++ +
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271
Query: 475 SKNKLTGTLPPQ----ILEITTLSSL--LDLSSNLISGSI--PLVVGNLKNLIQLDISRN 526
N +T + + + + L +N + P + + + +
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
Query: 527 R 527
+
Sbjct: 331 K 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 49/305 (16%)
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITII 376
P+ T L+L N++ + DF L L L L +N+ I+ I
Sbjct: 54 PDTTLLDLQNNDISE--LRKDDFKGL----QHLYALVLVNNK--------------ISKI 93
Query: 377 AMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP 436
L + L + N L IP +L L N + +
Sbjct: 94 HEKA----------FSPLRKLQKLYISKNHLV-EIP--PNLPSSLVELRIHDNRIRKVPK 140
Query: 437 DSIGNLSTLNSLWLGFNNLQ-GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSS 495
L +N + +G N L+ + L L +S+ KLT +P + TL+
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNE 197
Query: 496 LLDLSSNLISGSIPLVV-GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRG 554
L L N I +I L L +L + N+ +LS +L L + +N
Sbjct: 198 L-HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254
Query: 555 SIPSSLISLKSIEVLDLSCNNLSGQIPE-------YLEDLSFLEYLNLSYNDFEGQVPTK 607
+P+ L LK ++V+ L NN++ ++ + ++ ++L N
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 608 GVFSN 612
F
Sbjct: 314 ATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 13/239 (5%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
++P+ I+ T++ + N IS + + L ++YAL L N+++ L L
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
Q L S N+L I P+ S+L L + N ++ +N+ + + N L
Sbjct: 105 QKLYISKNHLVEIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN 161
Query: 482 T-LPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPT-TLSSC 539
+ P + L+ L +S ++ IP + L +L + N+ I L
Sbjct: 162 SGFEPGAFDGLKLN-YLRISEAKLT-GIP--KDLPETLNELHLDHNKIQ-AIELEDLLRY 216
Query: 540 TSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+ L L + N R SL L ++ L L N LS ++P L DL L+ + L N
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 56/261 (21%), Positives = 104/261 (39%), Gaps = 15/261 (5%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSVRRNNL 160
++L +N++ ++ L L LVL N S I S L + +N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 161 TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLY--GIIPESL 217
EIP + L L + +N++ ++P + + + + +G N L G P +
Sbjct: 115 V-EIPPNL---PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
L+ LN+L ++E +G+ + +L ++ L N+ + + L KL L +G
Sbjct: 170 DGLK-LNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDL 337
N + S S L L+L N S +V L + + L NN+ + D
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284
Query: 338 DFITLLTNCSKLETLGLNSNR 358
+ + + L +N
Sbjct: 285 CPVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 63/338 (18%), Positives = 118/338 (34%), Gaps = 50/338 (14%)
Query: 101 FLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNL 160
LR + + L +P E+ +L L N S + +L + N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 161 TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQL 220
+ +I KL+ L +++N L ++PP++ S+L +L + +N++ + L
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGL 146
Query: 221 RDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
R++N + + N LE F+G KL L + +
Sbjct: 147 RNMNCIEMGGNP-------------LENSGFEPGAFDGL----------KLNYLRISEAK 183
Query: 281 LTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFI 340
LTG L L+L N D + RL LG N + I +
Sbjct: 184 LTGIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI--RMIENGSL- 237
Query: 341 TLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIP-------LEIRN 393
+ L L L++N+ +P + +L + ++ + N I+ +
Sbjct: 238 ---SFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVK 292
Query: 394 LANIYALGLEYNQLTGTI--PYTIGELINLQALDFSAN 429
A + L N + P T + + A+ F
Sbjct: 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 50/267 (18%), Positives = 89/267 (33%), Gaps = 41/267 (15%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
L L+ + ++ N+L EIP L S L L + N S N+ +
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
N L + LKL L ++E +LT +P TL +L + NK+ I E L
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDL 213
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
+ L L + N + + LP L+ L +
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLS------------------------FLPTLRELHLD 249
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL------PNITRLNLGQNNLGS 331
N L+ +P + L ++ L N+ + DF + ++L N +
Sbjct: 250 NNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308
Query: 332 GSIGDLDFITLLTNCSKLETLGLNSNR 358
+ F + + + + +
Sbjct: 309 WEVQPATFRCV----TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 44/183 (24%), Positives = 70/183 (38%), Gaps = 20/183 (10%)
Query: 445 LNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSN 502
L + L+ +P + + LL++ N ++ L L L L L +N
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDF--KGLQHLYALVLVNN 88
Query: 503 LISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLIS 562
IS L+ L +L IS+N EIP L S SL L++ DN R
Sbjct: 89 KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIRKVPKGVFSG 145
Query: 563 LKSIEVLDLSCNNLSGQIPEYLEDLSF----LEYLNLSYNDFEGQVPTKGVFSNKTRISL 618
L+++ +++ N L E +F L YL +S +P K + + L
Sbjct: 146 LRNMNCIEMGGNPLE---NSGFEPGAFDGLKLNYLRISEAKLT-GIP-KDLPETLNELHL 200
Query: 619 IEN 621
N
Sbjct: 201 DHN 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 31/233 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINL-KQKGSIKSFVAECEALKNIR 758
+++ L +IG G+ V E VA+K INL K + S+ + E +A+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKE---KVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI- 817
H N++ S F D LV + GS+ D ++ + + ++ I+
Sbjct: 72 HPNIVSYY--TS---FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 818 --DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+V +EYLH + Q +H D+K N+LL D ++DFG++ FL +
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 876 IGIKGTVGYVAPE-------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
GT ++APE Y D++SFGI +E+ TG P H
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDF------KADIWSFGITAIELATGAAPYHKY 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 313 FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST 372
+ + NL + ++ + ++ + N++ S+ I L
Sbjct: 17 DDAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPN 66
Query: 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
+T + + N+++ PL NL N+ L L+ N++ + +L L++L N +
Sbjct: 67 VTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS 122
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITT 492
I + + +L L SL+LG N + + L L L++ N+++ I+ +
Sbjct: 123 DI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-----DIVPLAG 173
Query: 493 LSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550
L+ L L LS N IS L LKNL L++ + S+ +K D
Sbjct: 174 LTKLQNLYLSKNHISDLRAL--AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEG 602
S S + D N+ +PE+ ++SF+ Y ++ +
Sbjct: 232 SLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 3e-18
Identities = 51/306 (16%), Positives = 105/306 (34%), Gaps = 50/306 (16%)
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
+ + Q+ P + + + + + + +L ++ + ++
Sbjct: 1 MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 235 GMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASN 294
+ I + ++ ++ L N+ PL NL L L + +N + + S +
Sbjct: 57 -SVQGIQYLPNVTKLFLNGNKLTDIKPLT---NLKNLGWLFLDENKIK-DL-SSLKDLKK 110
Query: 295 LVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
L L+L N S G+ LP + L LG N + IT+L+ +KL+TL L
Sbjct: 111 LKSLSLEHNGISDINGL--VHLPQLESLYLGNNKITD--------ITVLSRLTKLDTLSL 160
Query: 355 NSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYT 414
N+ I+++ + L + L L N ++
Sbjct: 161 EDNQ--------ISDIV------------------PLAGLTKLQNLYLSKNHISDLRA-- 192
Query: 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNV 474
+ L NL L+ + + NL N++ +L P + + + NV
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNV 250
Query: 475 SKNKLT 480
+
Sbjct: 251 KWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 31/157 (19%), Positives = 63/157 (40%), Gaps = 10/157 (6%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+L L+ ++L N + +I L L +L+ L L N T + LS + L S+
Sbjct: 107 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 162
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
N ++ +I G KL+NL +++N ++ L + + L L + +
Sbjct: 163 NQIS-DIVPLAGLT--KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQ 217
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTN 254
L N + + + I + E+ ++ +
Sbjct: 218 SNLVVPNTVKNTDGSLV-TPEIISDDGDYEKPNVKWH 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 62/295 (21%), Positives = 110/295 (37%), Gaps = 25/295 (8%)
Query: 267 NLPK-LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLG 325
+LP +L + N +T F N NL L L N S F+ L + RL L
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQI-S 384
+N L + L+ L ++ N L+ + ++ +G N + S
Sbjct: 109 KNQLKELPEK------MPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 385 GTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLS 443
I + + + + + +T TIP G +L L N + + S+ L+
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDGNKITKVDAASLKGLN 216
Query: 444 TLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNL 503
L L L FN++ SL N +L L+++ NKL +P + + + + L +N
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-VYLHNNN 274
Query: 504 ISG------SIPLVVGNLKNLIQLDISRNRFS-GEI-PTTLSSCTSLEYLKMQDN 550
IS P + + + N EI P+T +++ +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 50/256 (19%), Positives = 91/256 (35%), Gaps = 36/256 (14%)
Query: 349 LETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT 408
L L +N+ NL + + + N+IS P L + L L NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI--PSSLGNC 466
+P LQ L N + + L+ + + LG N L+ + +
Sbjct: 114 -ELP--EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 467 KNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRN 526
K L + ++ +T T+P G +L +L + N
Sbjct: 171 KKLSYIRIADTNIT-TIPQ---------------------------GLPPSLTELHLDGN 202
Query: 527 RFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLE 585
+ + ++ +L +L L + NS SL + + L L+ N L ++P L
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260
Query: 586 DLSFLEYLNLSYNDFE 601
D +++ + L N+
Sbjct: 261 DHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 54/260 (20%), Positives = 106/260 (40%), Gaps = 12/260 (4%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT 161
++L +N + + L L L+L N S P + L + +N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKL--YGIIPESLG 218
E+P + L+ L V EN++T ++ S+ ++ + + +G N L GI +
Sbjct: 114 -ELPEKM---PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 219 QLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQ 278
++ L+++ +A+ N + + + SL ++ L N+ ++ L L L +
Sbjct: 169 GMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSF 225
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
N+++ S +N +L L+L+ N KV + I + L NN+ + D
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 339 FITLLTNCSKLETLGLNSNR 358
T + + L SN
Sbjct: 285 PPGYNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 42/274 (15%), Positives = 90/274 (32%), Gaps = 30/274 (10%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
NL L + L +N + P L +L+ L L N +P + L V
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHE 130
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLT-GQLPPSI-GNISTLQQLGVGENKLYGIIPE 215
N +T ++ + ++ + + N L + + L + + + + I
Sbjct: 131 NEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 189
Query: 216 SLGQLRDL-----NFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPK 270
L +L V + G+ ++L ++ L N + N P
Sbjct: 190 LPPSLTELHLDGNKITKVDAASLKGL-------NNLAKLGLSFNSIS-AVDNGSLANTPH 241
Query: 271 LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSG------KVGIDFSSLPNITRLNL 324
L+ L + N L +P ++ + ++ L N+ S + + + ++L
Sbjct: 242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300
Query: 325 GQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNR 358
N + I F + + L + +
Sbjct: 301 FSNPVQYWEIQPSTFRCV----YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 68/388 (17%), Positives = 131/388 (33%), Gaps = 99/388 (25%)
Query: 101 FLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNL 160
LR + + L ++P +L +L L N + + + NL + N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 161 TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQL 220
+ +I +KLE L +++NQL +LP + TLQ+L V EN++
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT---------- 134
Query: 221 RDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
V ++ F+G L ++ ++ +G N
Sbjct: 135 ------KVRKSVFNG--------------------------------LNQMIVVELGTNP 156
Query: 281 LTGSI--PQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L S +F L + ++ + + I P++T L+L N + +
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKI--TKVDAAS 211
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
+ L LGL+ N I+ + G + N ++
Sbjct: 212 L----KGLNNLAKLGLSFNS--------------ISAVDNGS----------LANTPHLR 243
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIG------NLSTLNSLWLGF 452
L L N+L +P + + +Q + NN+ I + ++ + + L
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 453 NNLQ-GNIPSSLGNC-KNLMLLNVSKNK 478
N +Q I S C + + K
Sbjct: 303 NPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 58/284 (20%), Positives = 95/284 (33%), Gaps = 57/284 (20%)
Query: 685 SMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---- 740
S ++ L + ++ L IGQGS+G V + A+K++N +
Sbjct: 8 SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67
Query: 741 -KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQS 799
++ E +K + H N+ ++ V ++ + + LV + G L D L
Sbjct: 68 NPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 800 NDQVDGNLNLIQRLNISI-----------------------------------DVASAIE 824
D G + + SA+
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIKGTV 882
YLH+ I H D+KP N L + + DFGL+K F + GT
Sbjct: 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-FYKLNNGEYYGMTTKAGTP 238
Query: 883 GYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
+VAPE + D +S G+LL + G P F
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPG 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 56/254 (22%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVIN----LKQKGSIKSFVA------ 749
N+++L + IG+GS+G V L + A+KV++ ++Q G +
Sbjct: 13 NQYTLKDEIGKGSYGVVK---LAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 750 ----------------ECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLE 793
E LK + H N++K++ V +D +D +V++ + G +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVM 126
Query: 794 DWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853
+ L+ Q D+ IEYLH+ I+H D+KPSN+L+ D
Sbjct: 127 EVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIK 177
Query: 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG---DVYSFGILLLE 910
++DFG++ F S++ GT ++APE +G DV++ G+ L
Sbjct: 178 IADFGVSN-EFKGSDALLSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 911 MFTGRRPTHTMFND 924
G+ P F D
Sbjct: 233 FVFGQCP----FMD 242
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+F + NL+G+GSF VYR L VA+K+I+ + + G ++ E + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL--NLIQRLNISI 817
+++++ F+ ++ LV + +G + +L+ N + + ++
Sbjct: 71 PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI---- 121
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA-KFLFDRPIQETSSSSI 876
+ + YLH H I+H DL SN+LL +M ++DFGLA + T
Sbjct: 122 --ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--- 173
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE L DV+S G + + GR P
Sbjct: 174 ---GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 61/278 (21%), Positives = 99/278 (35%), Gaps = 41/278 (14%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L+ +PQ SN LNL N+ F L ++ L LG+N++ +G
Sbjct: 64 RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG--- 117
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
+ L TL L N +T+I G L+ +
Sbjct: 118 ---AFNGLASLNTLELFDNW--------------LTVIPSGA----------FEYLSKLR 150
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFS-ANNLHGIIPDSIGNLSTLNSLWLGFNNLQG 457
L L N + Y + +L LD L I + L L L LG N++
Sbjct: 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209
Query: 458 NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNL 515
++P+ L L L +S N + P LSSL L + ++ +S L
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFP-EIRPGSF--HGLSSLKKLWVMNSQVSLIERNAFDGL 265
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+L++L+++ N S + L L + N +
Sbjct: 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 13/256 (5%)
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQ 406
++ + +P+ I S + + N I R+L ++ L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 407 LTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGN 465
+ L +L L+ N L I + LS L LWL N ++ +IPS +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 466 CKNLMLLNVSK-NKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLD 522
+LM L++ + KL + E L +L L+L I +P + L L +L+
Sbjct: 170 VPSLMRLDLGELKKLE-YISEGAFE--GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224
Query: 523 ISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582
+S N F P + +SL+ L + ++ ++ L S+ L+L+ NNLS +
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 583 YLEDLSFLEYLNLSYN 598
L +L L+L +N
Sbjct: 285 LFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 17/248 (6%)
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKL 271
+P+ + + +L++ ENN + F ++ LE + L N ++ + L L
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 272 KILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L + N LT IP +F S L L L N F+ +P++ RL+LG+
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELK-- 182
Query: 331 SGSIGDLDFIT--LLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIP 388
L++I+ L+ L L +P ++ L + + M N P
Sbjct: 183 -----KLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRP 235
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
L+++ L + +Q++ L +L L+ + NNL + D L L L
Sbjct: 236 GSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295
Query: 449 WLGFNNLQ 456
L N
Sbjct: 296 HLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 57/278 (20%), Positives = 100/278 (35%), Gaps = 39/278 (14%)
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPES 216
R L+ E+P I LN+ EN + + ++ L+ L +G N + I +
Sbjct: 63 RRGLS-EVPQGIPS---NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA 118
Query: 217 LGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L LN L + +N + + F +S L ++ L N E +P +P L L
Sbjct: 119 FNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLD 177
Query: 276 VGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSI 334
+G+ I +F NL LNL + + + + L + L + N+ I
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHF--PEI 233
Query: 335 GDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNL 394
F L S L+ L + +++ +++I L
Sbjct: 234 RPGSFHGL----SSLKKLWVMNSQ--------------VSLIERNA----------FDGL 265
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
A++ L L +N L+ L L L N +
Sbjct: 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 58/282 (20%), Positives = 99/282 (35%), Gaps = 39/282 (13%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT 161
+ L E+P + S + L L N+ H +L + RN++
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQL 220
+I L L + +N LT +P +S L++L + N + I + ++
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 221 RDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
L L + E + + FEG L LK L +G N
Sbjct: 171 PSLMRLDLGELK---------KLEYIS-----EGAFEG---------LFNLKYLNLGMCN 207
Query: 281 LTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFI 340
+ +P + + L L +SGNHF F L ++ +L + + + I F
Sbjct: 208 IK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV--SLIERNAFD 263
Query: 341 TLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLN 381
L + L L L N SLP + L + + + N
Sbjct: 264 GL----ASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 29/231 (12%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+ + L + P I S L L NN+Q + + +L +L + +N +
Sbjct: 55 QFSKVVCTRRGLSEV-PQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 480 TGTLPPQILEITTLSSL--LDLSSNLISGSIPLVV-GNLKNLIQLDISRNRFSGEIPT-T 535
+ L+SL L+L N ++ IP L L +L + N IP+
Sbjct: 112 R-QIEVGAFN--GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 536 LSSCTSLEYLKMQDNSFRGSIPS-SLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLN 594
+ SL L + + I + L +++ L+L N+ +P L L LE L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELE 224
Query: 595 LSYNDFEGQVPTKGVFSNKT----------RISLIENGKLCG--GLDELHL 633
+S N F G F + ++SLIE G L EL+L
Sbjct: 225 MSGNHF--PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-16
Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 30/234 (12%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+L L + L N++ L+ L L L N + IPS F
Sbjct: 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGA--------FE--- 144
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGE-NKLYGIIPE 215
L+ KL L + N + +P + +L +L +GE KL I
Sbjct: 145 -YLS------------KLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+ L +L +L++ N +P + + LE++ + N F + L LK L
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLW 248
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
V + ++ +F ++LV LNL+ N+ S F+ L + L+L N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 58/252 (23%), Positives = 111/252 (44%), Gaps = 35/252 (13%)
Query: 671 TRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLP 730
+Q ++ L+ +Q+ + ++F + +G G+ G V++ + L
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELK-------DDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 731 VAVKVINLKQKGS-IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA----LVYD 785
+A K+I+L+ K + + E + L ++ F G + + +
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICME 111
Query: 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVL 845
+M GSL+ L+++ G + +SI V + YL + I+H D+KPSN+L
Sbjct: 112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNIL 164
Query: 846 LDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFG 905
++ + DFG++ L S + GT Y++PE G + S+ D++S G
Sbjct: 165 VNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 217
Query: 906 ILLLEMFTGRRP 917
+ L+EM GR P
Sbjct: 218 LSLVEMAVGRYP 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIR 758
++ + ++G+GSFG V AVKVI+ +KQK +S + E + LK +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H N++K+ F+ + LV + G L D + + + I
Sbjct: 85 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQ 134
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
V S I Y+H + IVH DLKP N+LL D + DFGL+ E S
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------EASKKM 185
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + G DV+S G++L + +G P
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+F ++G+GSF V A+K++ + ++ + E + + + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI-- 817
+K+ + F+ D+ Y ++G L ++++ + +
Sbjct: 90 PFFVKLY--FT---FQDDEKLYFGLSYAKNGELLKYIRKI-----------GSFDETCTR 133
Query: 818 ----DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQET 871
++ SA+EYLH I+H DLKP N+LL+ DM H+ +DFG AK L Q
Sbjct: 134 FYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQAR 188
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
++S + GT YV+PE + + D+++ G ++ ++ G P
Sbjct: 189 ANSFV---GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN-LKQKGSIKSFVAECEALKNIRHRNLI 763
F +G G+FG V+ L +K IN + + ++ AE E LK++ H N+I
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
KI V F+ +V + + G L + + + + L+ + + +A+
Sbjct: 84 KIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 824 EYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
Y H +VH DLKP N+L + DFGLA+ G
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN------AAG 188
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T Y+APE +V+ D++S G+++ + TG P
Sbjct: 189 TALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
F ++G G+F V+ A+K I S E LK I+H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL------NLIQRLNI 815
++ + + ++ LV + G L D + + G +IQ
Sbjct: 68 IVTLEDI-----YESTTHYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQ---- 113
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETS 872
V SA++YLH + IVH DLKP N+L + + ++DFGL+K + +
Sbjct: 114 --QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFG----ILL 908
GT GYVAPE S D +S G ILL
Sbjct: 169 -------GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+ F + IG+GSFG V + A+K +N ++ +++ E + ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNI 815
L+ + S F+ ++ +V D + G L LQQ + V +L I
Sbjct: 75 PFLVNLW--YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV--------KLFI 121
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
++ A++YL + I+H D+KP N+LLD H++DF +A L + ++ +
Sbjct: 122 C-ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML--PRETQITTMA 175
Query: 876 IGIKGTVGYVAPE-----YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G G + ++ D +S G+ E+ GRRP
Sbjct: 176 ----GTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRP 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 25/221 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
+ + +G G++G V + A+K+I S + E LK + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++K+ F+ LV + + G L D + N + I V
Sbjct: 96 PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQV 145
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
S + YLH H IVH DLKP N+LL + D + + DFGL+ E
Sbjct: 146 LSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF------ENQKKMK 196
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + DV+S G++L + G P
Sbjct: 197 ERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 12/219 (5%)
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH--GIIPDSIGNLS 443
++P I ++ L LE N+L +L L L S+N L G S +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 444 TLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSS 501
+L L L FN + + S+ + L L+ + L + +L +L LD+S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF--LSLRNLIYLDISH 135
Query: 502 NLISGSIPLVVGNLKNLIQLDISRNRFSGEI-PTTLSSCTSLEYLKMQDNSFRGSIPS-S 559
+ + L +L L ++ N F P + +L +L + + +
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194
Query: 560 LISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
SL S++VL++S NN + L+ L+ L+ S N
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 55/251 (21%), Positives = 87/251 (34%), Gaps = 20/251 (7%)
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGK--VGIDFSSL 316
+P I L + N L F + L L+LS N S K
Sbjct: 21 SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITI 375
++ L+L N + + S +LE L + S+ +L +
Sbjct: 78 TSLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 376 IAMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTI-PYTIGELINLQALDFSANNLHG 433
+ + I L+++ L + N P EL NL LD S L
Sbjct: 131 LDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189
Query: 434 IIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
+ P + +LS+L L + NN +L +L+ S N + T Q L+
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ-HFP 247
Query: 494 SSL--LDLSSN 502
SSL L+L+ N
Sbjct: 248 SSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 53/261 (20%), Positives = 102/261 (39%), Gaps = 14/261 (5%)
Query: 103 RFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT- 161
I S L +P + S L L+ N + L S+ N L+
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL-GQL 220
+ + L+ L+++ N + + + + L+ L + L + S+ L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 221 RDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQN 279
R+L +L ++ + IF +SSLE + + N F+ +I L L L + Q
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 280 NLTGSIPQ-SFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L + +F++ S+L +LN+S N+F + L ++ L+ N++ + +
Sbjct: 186 QLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI--MTSKKQE 242
Query: 339 FITLLTNCSKLETLGLNSNRF 359
++ L L L N F
Sbjct: 243 LQHFPSS---LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 40/235 (17%), Positives = 76/235 (32%), Gaps = 53/235 (22%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+ L++++L+ N + + + L +L+ L ++ + S +L N
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF-SVFLSLRN----- 127
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
L L +
Sbjct: 128 -----------------------------------------LIYLDISHTHTRVAFNGIF 146
Query: 218 GQLRDLNFLSVAENNFSGMLPP-IF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L L L +A N+F P IF + +L + L + E +L +L L++L
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLP-NITRLNLGQNNL 329
+ NN + ++L +L+ S NH + P ++ LNL QN+
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 29/141 (20%), Positives = 57/141 (40%), Gaps = 7/141 (4%)
Query: 98 NLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSV 155
+L L +++++ + N LS L+VL + NSF + + NL +
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIP 214
+ L ++ L+ LN++ N L +++LQ L N +
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKK 240
Query: 215 ESLGQLRD-LNFLSVAENNFS 234
+ L L FL++ +N+F+
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 41/278 (14%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
NL +P S +N +LNL N F L ++ L L +N++ + IG
Sbjct: 53 KNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG--- 106
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
+ L TL L NR +T I G L+ +
Sbjct: 107 ---AFNGLANLNTLELFDNR--------------LTTIPNGA----------FVYLSKLK 139
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANN-LHGIIPDSIGNLSTLNSLWLGFNNLQG 457
L L N + Y + +L+ LD L I + LS L L L NL+
Sbjct: 140 ELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 458 NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNL 515
IP+ L L L++S N L+ + P L L L + + I NL
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLS-AIRPGSF--QGLMHLQKLWMIQSQIQVIERNAFDNL 254
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
++L++++++ N + + LE + + N +
Sbjct: 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 13/256 (5%)
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQ 406
++ + +P I + ++ + NQI ++L ++ L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 407 LTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSL-GN 465
+ L NL L+ N L I + LS L LWL N ++ +IPS
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 466 CKNLMLLNVSK-NKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLD 522
+L L++ + +L+ + E LS+L L+L+ + IP + L L +LD
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFE--GLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213
Query: 523 ISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582
+S N S P + L+ L M + + ++ +L+S+ ++L+ NNL+ +
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 583 YLEDLSFLEYLNLSYN 598
L LE ++L +N
Sbjct: 274 LFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 60/263 (22%), Positives = 89/263 (33%), Gaps = 38/263 (14%)
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITII 376
N LNL +N + I F L LE L L+ N I I
Sbjct: 64 TNTRLLNLHENQIQI--IKVNSFKHL----RHLEILQLSRNH--------------IRTI 103
Query: 377 AMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP 436
+G LAN+ L L N+LT L L+ L N + I
Sbjct: 104 EIGA----------FNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPS 153
Query: 437 DSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSS 495
+ + +L L LG I + NL LN++ L +I +T L
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-----EIPNLTPLIK 208
Query: 496 L--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
L LDLS N +S P L +L +L + +++ + SL + + N+
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
Query: 554 GSIPSSLISLKSIEVLDLSCNNL 576
L +E + L N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 34/275 (12%)
Query: 182 ENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF 241
L ++P I + + L + EN++ I S LR L L ++ N+
Sbjct: 52 RKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH--------- 99
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
I ++E F G L L L + N LT +F S L L L
Sbjct: 100 -IRTIE-----IGAFNG---------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 302 GNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG 361
N F+ +P++ RL+LG+ + + S L L L
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELK----RLSYIS-EGAFEGLSNLRYLNLAMCNLR- 198
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
+P ++ L + + + N +S P + L ++ L + +Q+ L +L
Sbjct: 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
++ + NNL + D L L + L N
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 39/278 (14%)
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPES 216
R NL E+P I LN+ ENQ+ S ++ L+ L + N + I +
Sbjct: 52 RKNLR-EVPDGIST---NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA 107
Query: 217 LGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L +LN L + +N + + F +S L+++ L N E +P +P L+ L
Sbjct: 108 FNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 276 VGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSI 334
+G+ I +F SNL LNL+ + ++ + + L + L+L N+L +I
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHL--SAI 222
Query: 335 GDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNL 394
F L L+ L + ++ I +I NL
Sbjct: 223 RPGSFQGL----MHLQKLWMIQSQ--------------IQVIERNA----------FDNL 254
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
++ + L +N LT L +L+ + N +
Sbjct: 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 51/234 (21%), Positives = 96/234 (41%), Gaps = 30/234 (12%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
+L L + L+ N++ L+ L L L N + TIP+ F
Sbjct: 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGA--------FV--- 133
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGE-NKLYGIIPE 215
L+ KL+ L + N + +P I +L++L +GE +L I
Sbjct: 134 -YLS------------KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+ L +L +L++A N +P + + L+++ L N + L L+ L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
+ Q+ + +F N +LV +NL+ N+ + F+ L ++ R++L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-16
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 17/198 (8%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+ NL + PD I + L L N +Q +S + ++L +L +S+N +
Sbjct: 44 QFSKVICVRKNLREV-PDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 480 TGTLPPQILEITTLSSL--LDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPT-T 535
T+ L++L L+L N ++ +IP L L +L + N IP+
Sbjct: 101 R-TIEIGAFN--GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155
Query: 536 LSSCTSLEYLKMQDNSFRGSIPS-SLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLN 594
+ SL L + + I + L ++ L+L+ NL +IP L L L+ L+
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213
Query: 595 LSYNDFEGQVPTKGVFSN 612
LS N G F
Sbjct: 214 LSGNHL--SAIRPGSFQG 229
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 47/260 (18%), Positives = 93/260 (35%), Gaps = 45/260 (17%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNI-R 758
T EF IG G FG V++ D A+K GS ++ + E A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H ++++ + + DD + +Y GSL D + + N ++ + ++ +
Sbjct: 70 HSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISE-NYRIMSYFKEAELKDLLLQ 123
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS-------------------DFGL 859
V + Y+H +VH D+KPSN+ + + + + D G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFTGRRPT 918
+ ++E G ++A E L D+++ + ++
Sbjct: 181 VTRISSPQVEE---------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL- 230
Query: 919 HTMFNDGLTLHGFVKMALPE 938
+G H + LP
Sbjct: 231 ---PRNGDQWHEIRQGRLPR 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 65/334 (19%), Positives = 125/334 (37%), Gaps = 44/334 (13%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
+N + + ++ + V + L IT L+ + + I + + L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--------IEGVQYLNNL 65
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG 409
L L N+ + + NL+ IT + + N + + L +I L L Q+T
Sbjct: 66 IGLELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITD 121
Query: 410 TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL 469
P + L NLQ L N + I P + L+ L L +G + ++ + L N L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKL 175
Query: 470 MLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNR 527
L NK++ I + +L +L + L +N IS PL N NL + ++
Sbjct: 176 TTLKADDNKIS-----DISPLASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQT 228
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSI-EVLDLSCNNLSGQIPEYLED 586
+ + ++ +K + I+ +I + + NL+ + ++ +
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSG--------APIAPATISDNGTYASPNLTWNLTSFINN 280
Query: 587 LSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIE 620
+S+ ++N T FS L E
Sbjct: 281 VSY------TFNQSVTFKNTTVPFSGTVTQPLTE 308
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 57/290 (19%), Positives = 110/290 (37%), Gaps = 28/290 (9%)
Query: 237 LPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLV 296
+ P +++ +I+ + + +L + L +T +I +NL+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIE-GVQYLNNLI 66
Query: 297 ILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNS 356
L L N + +L IT L L N L + ++ + ++TL L S
Sbjct: 67 GLELKDNQIT--DLAPLKNLTKITELELSGNPLKN--------VSAIAGLQSIKTLDLTS 116
Query: 357 NRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIG 416
+ P +A LS + ++ + LNQI+ PL L N+ L + Q++ P +
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTP--LA 170
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSK 476
L L L N + I P + +L L + L N + S L N NL ++ ++
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
Query: 477 NKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRN 526
+T + + + S I+ P + + +++ N
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 23/257 (8%)
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYA 399
I + + + ++ A+L IT ++ ++ ++ L N+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIG 67
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI 459
L L+ NQ+T P + L + L+ S N L + I L ++ +L L +
Sbjct: 68 LELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVT 123
Query: 460 PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKN 517
P L NL +L + N++T I + L++L L + + +S PL NL
Sbjct: 124 P--LAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSK 174
Query: 518 LIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577
L L N+ S P L+S +L + +++N S S L + ++ ++ L+ ++
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTIT 230
Query: 578 GQIPEYLEDLSFLEYLN 594
Q Y +L +
Sbjct: 231 NQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 57/393 (14%), Positives = 123/393 (31%), Gaps = 109/393 (27%)
Query: 142 SNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQ 201
+N I + ++N+T + ++ +
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT---------------------------QADLDGITT 45
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLP 261
L + I E + L +L L + +N I+ L +
Sbjct: 46 LSAFGTGVTTI--EGVQYLNNLIGLELKDN----------QITDLAPLK----------- 82
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITR 321
NL K+ L + N L + + ++ L+L+ + + L N+
Sbjct: 83 -----NLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQV 133
Query: 322 LNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLN 381
L L N + + I+ L + L+ L + + + +++L+
Sbjct: 134 LYLDLNQITN--------ISPLAGLTNLQYLSIGNAQ--------VSDLT---------- 167
Query: 382 QISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGN 441
+ NL+ + L + N+++ P + L NL + N + + P + N
Sbjct: 168 --------PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 442 LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSS 501
S L + L + NL++ NV K + T+S +S
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYN---NNLVVPNVVKGPSG-----APIAPATISDNGTYAS 267
Query: 502 NLISGSIPLVVGNL----KNLIQLDISRNRFSG 530
++ ++ + N+ + + FSG
Sbjct: 268 PNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 53/304 (17%), Positives = 113/304 (37%), Gaps = 29/304 (9%)
Query: 120 LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLN 179
L+ + ++ + T+ + + S +T I + Y L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYL-NNLIGLE 69
Query: 180 VAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP 239
+ +NQ+T + N++ + +L + N L + ++ L+ + L + + + P
Sbjct: 70 LKDNQITD--LAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP 124
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILN 299
+ +S+L+ + L N+ PL L L+ L +G ++ P +N S L L
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 300 LSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRF 359
N S + +SLPN+ ++L N + ++ L N S L + L +
Sbjct: 180 ADDNKISDISPL--ASLPNLIEVHLKNNQISD--------VSPLANTSNLFIVTLTNQTI 229
Query: 360 GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT--GTIPYTIGE 417
+ N + + + + P I + + L +N + + YT +
Sbjct: 230 --TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287
Query: 418 LINL 421
+
Sbjct: 288 SVTF 291
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 40/218 (18%), Positives = 83/218 (38%), Gaps = 22/218 (10%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
+ L ++ ++L S + ++ L LS L+VL LD N + S L+ +NL S+
Sbjct: 103 IAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSI 158
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
++ ++ KL L +N+++ + ++ L ++ + N++ +
Sbjct: 159 GNAQVS-DLTPLANLS--KLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDV--S 211
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L +L +++ + P +N + + + P I N
Sbjct: 212 PLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPSGAPIAPATISDN------GT 264
Query: 276 VGQNNLTGSIPQSFSNAS----NLVILNLSGNHFSGKV 309
NLT ++ +N S V + FSG V
Sbjct: 265 YASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTV 302
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 51/239 (21%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVA---------ECE 752
+S + +G G+FGFV+ D V VK I K+K ++ E
Sbjct: 26 YSTMSPLGSGAFGFVW---TAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIA 81
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGS-LEDWLQQSNDQVDGNLNLIQ 811
L + H N+IK++ + F+ F LV + SG L ++ + L+
Sbjct: 82 ILSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPL 131
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
I + SA+ YL I+H D+K N+++ D + DFG A +L + T
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 872 SSSSIGIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
GT+ Y APE Y G + +++S G+ L + P F +
Sbjct: 189 FC------GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENP----FCE 232
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVA-ECEALKNIRHRNLIKI 765
L+G+GS+G V E L AVK++ L++ + ++ V E + L+ +RH+N+I++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLE--DWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ V + + K + +V +Y G E D + + + Q + +
Sbjct: 72 VDVLYN-EEKQKMY--MVMEYCVCGMQEMLDSV------PEKRFPVCQAHGYFCQLIDGL 122
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
EYLH IVH D+KP N+LL +S G+A+ L +T +S G+
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSPA 176
Query: 884 YVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
+ PE G+ D++S G+ L + TG P F
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEG 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 711 IGQGSFGFVYRGNLGEDLL---PVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKI 765
IG+G+F V L +L VA+K+I+ Q S++ E +K + H N++K+
Sbjct: 23 IGKGNFAKVK---LARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
V I+ + + L+ +Y G + D+L G + + + + SA++Y
Sbjct: 80 FEV---IETEKTLY--LIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQY 129
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H IVH DLK N+LLD DM ++DFG + + G Y
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC------GAPPYA 180
Query: 886 APEYGMG-GNVSLTGDVYSFGILLLEMFTGRRP 917
APE G DV+S G++L + +G P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 12/218 (5%)
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+P+ I A + L N+++ + NL L +N L I + L+ L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 446 NSLWLGFNNLQGNIPSS-LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSN 502
L L N ++ + L L++ + L L P + L++L L L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR--GLAALQYLYLQDN 139
Query: 503 LISGSIP-LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI 561
+ ++P +L NL L + NR S SL+ L + N +
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 562 S-LKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L + L L NNLS E L L L+YL L+ N
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 54/220 (24%), Positives = 83/220 (37%), Gaps = 12/220 (5%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
++P I + I + N+IS R N+ L L N L L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 422 QALDFSANN-LHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNKL 479
+ LD S N L + P + L L++L L LQ + L L + N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 480 TGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
LP L +L L L N IS L +L +L + +NR + P
Sbjct: 142 Q-ALPDDTF--RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 538 SCTSLEYLKMQDNSFRGSIPSS-LISLKSIEVLDLSCNNL 576
L L + N+ ++P+ L L++++ L L+ N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 60/278 (21%), Positives = 95/278 (34%), Gaps = 63/278 (22%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L ++P + + L GN S F + N+T L L N L I
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR--IDAAA 75
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
F L + LE L L+ N Q+ ++
Sbjct: 76 FTGL----ALLEQLDLSDN-----------------------AQLR-SVD---------- 97
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN 458
P T L L L L + P L+ L L+L N LQ
Sbjct: 98 -------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-A 143
Query: 459 IPS-SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNL 515
+P + + NL L + N+++ ++P + L SL L L N ++ P +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRIS-SVPERAF--RGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
L+ L + N S L+ +L+YL++ DN +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 8/214 (3%)
Query: 244 SSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGN 303
++ ++I L NR +P L IL + N L +F+ + L L+LS N
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 304 HFSGKVGID-FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS 362
V F L + L+L + L G L + L+ L L N
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG------LFRGLAALQYLYLQDNALQAL 144
Query: 363 LPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQ 422
+ +L +T + + N+IS R L ++ L L N++ P+ +L L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 423 ALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L ANNL + +++ L L L L N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 42/206 (20%), Positives = 81/206 (39%), Gaps = 8/206 (3%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSVRRNNL 160
+ I L N + L +L L N + I + + + L + N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 161 TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQ 219
+ + +L L++ L +L P + ++ LQ L + +N L + ++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 220 LRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQ 278
L +L L + N S + F + SL+++ L NR + + +L +L L +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 279 NNLTGSIPQS-FSNASNLVILNLSGN 303
NNL+ ++P + L L L+ N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 14/222 (6%)
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNIS 197
+P + + + N ++ +PA L L + N L ++ + ++
Sbjct: 25 AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80
Query: 198 TLQQLGVGEN-KLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNR 255
L+QL + +N +L + P + L L+ L + + P +F +++L+ + L N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
+ LP + +L L L + N ++ ++F +L L L N + F
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 316 LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
L + L L NNL + L L+ L LN N
Sbjct: 200 LGRLMTLYLFANNLSALPTE------ALAPLRALQYLRLNDN 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
+++ ++G+GSFG V + AVKVIN + + E E LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++K+ + + +V + G L D + + + I V
Sbjct: 81 PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQV 130
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
S I Y+H H IVH DLKP N+LL + D + DFGL+ + ++
Sbjct: 131 FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF------QQNTKMK 181
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + G DV+S G++L + +G P
Sbjct: 182 DRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 49/247 (19%), Positives = 82/247 (33%), Gaps = 18/247 (7%)
Query: 369 NLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSA 428
+L +T+ A + L + ++ + L LE ++TGT P + E +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 429 NNLHGIIPDSIGN------LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGT 482
N+ D+ L L + + + L L++S N G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 483 LP-PQILEITTLSSL--LDLSSNL---ISGSIPLVVGNLKNLIQLDISRNRFSGEIP-TT 535
L +L L L + SG + L LD+S N +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 536 LSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNL 595
+ L L + + +P L + VLDLS N L P ++L + L+L
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS-PDELPQVGNLSL 303
Query: 596 SYNDFEG 602
N F
Sbjct: 304 KGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 46/279 (16%), Positives = 79/279 (28%), Gaps = 21/279 (7%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
S +L D ++ RL + + S + + S L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA---LRVLGISGL 97
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRN------LANIYALGLE 403
+ L L + G+ P + + + + L +S + L +
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 404 YNQLTGTIPYTIGELINLQALDFSANNL-------HGIIPDSIGNLSTLNSLWLGFNNLQ 456
+ L LD S N + P L L G
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLK 516
G + L L++S N L + + + L+LS + +P G
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP--KGLPA 274
Query: 517 NLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555
L LD+S NR P+ + L ++ N F S
Sbjct: 275 KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 45/284 (15%), Positives = 80/284 (28%), Gaps = 31/284 (10%)
Query: 97 GNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSH---CSNLINF 153
G S + ++ + LK L + I S L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 154 SVRRNNLTGEIPAYIG-YYWLKLENLNVAENQLTGQLPPSIGNIST-----LQQLGVGEN 207
++ +TG P + L LN+ + + L+ L + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQA 159
Query: 208 KLYGIIPESLGQLRDLNFLSVAENNFSGMLPPI-----FNISSLEQISLLTNRFEGRLPL 262
E + L+ L +++N G I +L+ ++L E
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSG 218
Query: 263 NIGF---NLPKLKILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPN 318
+L+ L + N+L + S S L LNLS +
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---QVPKGLPAK 275
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS 362
++ L+L N L ++ L L N F S
Sbjct: 276 LSVLDLSYNRLDR--------NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 47/252 (18%), Positives = 81/252 (32%), Gaps = 20/252 (7%)
Query: 369 NLSTITIIAMGLNQISGTIPLEIR-NLANIYALGLEYNQLTGTIPYT-IGELINLQALDF 426
N S G +E+ ++ L + +T I + ++L+ L
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 427 SANNLHGIIPDS---IGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLML--LNVSKNKLTG 481
A + I + +S L L L + G P L L LN+
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 482 TLPPQILEITTLSSL----LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
+ E+ L ++ V L LD+S N GE +
Sbjct: 136 -RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 538 SC----TSLEYLKMQDNSFR---GSIPSSLISLKSIEVLDLSCNNLSGQIPE-YLEDLSF 589
C +L+ L +++ G + + ++ LDLS N+L + S
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 590 LEYLNLSYNDFE 601
L LNLS+ +
Sbjct: 255 LNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 51/292 (17%), Positives = 89/292 (30%), Gaps = 56/292 (19%)
Query: 173 LKLENLNVAENQLTGQLPPS---IGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVA 229
L L+ L V ++ ++ + IS LQ+L + ++ G P L + + +
Sbjct: 68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 230 ENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSF 289
N S + L + P LK+L + Q + +
Sbjct: 128 LRNVSWATRDAW------------------LAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 290 SNASNLVILNLSGNHFSGKVGIDFS----SLPNITRLNLGQNNLGSGSIGDLDFITLLTN 345
L L+LS N G+ G+ + P + L L + + S L
Sbjct: 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS---GVCSALAAA 226
Query: 346 CSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYN 405
+L+ L L+ N + + + +L L +
Sbjct: 227 RVQLQGLDLSHNSLRDAAG-----------------------APSCDWPSQLNSLNLSFT 263
Query: 406 QLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQG 457
L +P + L LD S N L S L + +L L N
Sbjct: 264 GLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 40/264 (15%), Positives = 75/264 (28%), Gaps = 44/264 (16%)
Query: 58 NNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIP 117
I G + +L L N + G P
Sbjct: 77 AARIPSRILFGALRVLGISGLQELTLEN------------------------LEVTGTAP 112
Query: 118 NELGRLSRLKVLVLDFNSFS-GTIPSNLSHCSNLINFSVRR----NNLTGEIPAYIGYYW 172
L + + +L+ + S T + L+ + ++ + +
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172
Query: 173 LKLENLNVAENQLTGQLPPSI----GNISTLQQLGVGENK---LYGIIPESLGQLRDLNF 225
L L++++N G+ TLQ L + G+ L
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232
Query: 226 LSVAENNFSGMLPPIF--NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTG 283
L ++ N+ S L ++L + ++P + KL +L + N L
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL---PAKLSVLDLSYNRLD- 287
Query: 284 SIPQSFSNASNLVILNLSGNHFSG 307
P S + L+L GN F
Sbjct: 288 RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 23/216 (10%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
++L N IG+GS+G V + A K I + F E E +K++ H N+I+
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ F+ + LV + G L + + I DV SA+
Sbjct: 71 LYET-----FEDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVA 120
Query: 825 YLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
Y H + H DLKP N L D + DFGLA + T GT
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT------KVGT 171
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
YV+P+ + G D +S G+++ + G P
Sbjct: 172 PYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 50/231 (21%)
Query: 710 LIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVA-ECEALKNIRHRNLIKI 765
+G+G++G V L + + VAVK++++K+ + E K + H N++K
Sbjct: 14 TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA----- 820
+ L +Y G L D ++ + A
Sbjct: 71 YGHRRE---GNIQY--LFLEYCSGGELFDRIEPD-----------IGM--PEPDAQRFFH 112
Query: 821 ---SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ + YLH I H D+KP N+LLD +SDFGLA + +
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 878 IKGTVGYVAPEYGMG----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
GT+ YVAPE DV+S GI+L M G P ++
Sbjct: 169 --GTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELP----WDQ 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-22
Identities = 58/262 (22%), Positives = 97/262 (37%), Gaps = 36/262 (13%)
Query: 672 RRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPV 731
+++ + M + K + +G G++G V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 732 AVKVINLKQ-------------KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778
A+KVI Q + + E LK++ H N+IK+ V F+
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKK 119
Query: 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGD 838
+ LV ++ + G L + + + NI + S I YLH H IVH D
Sbjct: 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRD 171
Query: 839 LKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV 895
+KP N+LL + + + DFGL+ F GT Y+APE +
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFF------SKDYKLRDRLGTAYYIAPEV-LKKKY 224
Query: 896 SLTGDVYSFGILLLEMFTGRRP 917
+ DV+S G+++ + G P
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPP 246
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 71/233 (30%), Positives = 105/233 (45%), Gaps = 49/233 (21%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL---PVAVKVIN---LKQKGSIKSFVAECEALKNIRHR 760
L + +G G+FG V +GE L VAVK++N ++ + E + LK RH
Sbjct: 15 LGDTLGVGTFGKVK---IGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
++IK+ V I D F +V +Y+ G L D++ + R+ A
Sbjct: 72 HIIKLYQV---ISTPTDFF--MVMEYVSGGELFDYICKH-----------GRV--EEMEA 113
Query: 821 --------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
SA++Y H H +VH DLKP NVLLD M A ++DFGL+ + D TS
Sbjct: 114 RRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 873 SSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
G+ Y APE G D++S G++L + G P F+D
Sbjct: 171 C------GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP----FDD 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 9e-22
Identities = 70/290 (24%), Positives = 118/290 (40%), Gaps = 53/290 (18%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--------LKQKGSIKSFVAECEA 753
+E+ +S +G G+ G V + VA+++I+ ++ + E E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
LK + H +IKI + D+ +V + M+ G L D + + L
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGN-----KRLKEATCK 242
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQE 870
+ A++YLH + I+H DLKP NVLL + D + ++DFG +K L + +
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTG---DVYSFGILLLEMFTGRRPTHTMFNDGLT 927
T GT Y+APE + + D +S G++L +G P F++ T
Sbjct: 300 TLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEHRT 349
Query: 928 --------LHGFVKMALP------EKVMEIVDFALLLDPGNERAKIEECL 963
G EK +++V L++DP R EE L
Sbjct: 350 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP-KARFTTEEAL 398
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 55/242 (22%)
Query: 710 LIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKII 766
IG G+FG L D L VAVK I + ++ E +++RH N+++
Sbjct: 27 DIGSGNFGVAR---LMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA------ 820
V + A++ +Y G L + + + R S D A
Sbjct: 83 EVILT-----PTHLAIIMEYASGGELYERICNA-----------GRF--SEDEARFFFQQ 124
Query: 821 --SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLFDRPIQETSSSSI 876
S + Y H I H DLK N LLD + DFG +K +++
Sbjct: 125 LLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--- 178
Query: 877 GIKGTVGYVAPEYGMG----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932
GT Y+APE + G ++ DV+S G+ L M G P F D +
Sbjct: 179 ---GTPAYIAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYP----FEDPEEPRDYR 228
Query: 933 KM 934
K
Sbjct: 229 KT 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
+++ ++G+GSFG V + AVKVIN + + E E LK + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++K+ + + +V + G L D + + + I V
Sbjct: 81 PNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQV 130
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
S I Y+H H IVH DLKP N+LL + D + DFGL+ + +
Sbjct: 131 FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD--- 182
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + G DV+S G++L + +G P
Sbjct: 183 -RIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 47/232 (20%), Positives = 80/232 (34%), Gaps = 27/232 (11%)
Query: 702 TNEFSLSNLIGQG--SFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNI 757
+ L +IG+G V V V+ INL+ + E K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
H N++ F D+ +V +M GS +D + +N + I
Sbjct: 84 NHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQ 135
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
V A++Y+HH VH +K S++L+ D ++S + ++
Sbjct: 136 GVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 878 IK--GTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+ +++PE G D+YS GI E+ G P M
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVPFKDM 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 50/231 (21%)
Query: 710 LIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVA-ECEALKNIRHRNLIKI 765
+G+G++G V L + + VAVK++++K+ + E K + H N++K
Sbjct: 14 TLGEGAYGEVQ---LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA----- 820
+ L +Y G L D ++ + A
Sbjct: 71 YGHRRE---GNIQY--LFLEYCSGGELFDRIEPD-----------IGM--PEPDAQRFFH 112
Query: 821 ---SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ + YLH I H D+KP N+LLD +SDFGLA + +
Sbjct: 113 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 878 IKGTVGYVAPEYGMG----GNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
GT+ YVAPE DV+S GI+L M G P ++
Sbjct: 169 --GTLPYVAPELLKRREFHAEPV---DVWSCGIVLTAMLAGELP----WDQ 210
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 51/302 (16%), Positives = 100/302 (33%), Gaps = 33/302 (10%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
+L SIP + + L+LS N + D N+ L L N + +
Sbjct: 41 GSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED--- 94
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLAN 396
++ LE L L+ N +L S LS++T + + N + +L
Sbjct: 95 ---SFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150
Query: 397 IYALGLEYNQLTGTIPY-TIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNL 455
+ L + I L L+ L+ A++L P S+ ++ ++ L L
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
Query: 456 QGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNL 515
+ + ++ L + L ++ T S +
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI-----------------KK 253
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSS-LISLKSIEVLDLSCN 574
+ I+ ++ L+ + L L+ N + S+P L S++ + L N
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
Query: 575 NL 576
Sbjct: 312 PW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 57/302 (18%), Positives = 108/302 (35%), Gaps = 27/302 (8%)
Query: 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNN 328
+K L + N +T NL L L+ N + FSSL ++ L+L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTI 387
L + S S L L L N + S+ ++L+ + I+ +G I
Sbjct: 112 LSNLSSS------WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 388 PLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
+ L + L ++ + L P ++ + N+ L ++ + S++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 447 SLWLGFNNLQGN--------IPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLD 498
L L +L +SL + ++ L + + +I+ L L+
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLE-LE 283
Query: 499 LSSNLISGSIP-LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIP 557
S N + S+P + L +L ++ + N + SC ++YL N
Sbjct: 284 FSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLSRWLNKNSQKEQ 335
Query: 558 SS 559
S
Sbjct: 336 GS 337
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 43/273 (15%), Positives = 99/273 (36%), Gaps = 12/273 (4%)
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNIS 197
+IPS L+ + + + N +T I + L+ L + N + + ++
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLG 100
Query: 198 TLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF--NISSLEQISLLTNR 255
+L+ L + N L + L L FL++ N + + +++ L+ + +
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
++ L L+ L + ++L P+S + N+ L L + I
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDV 220
Query: 316 LPNITRLNLGQNNLGSGSIGDLDFIT--LLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
++ L L +L + +L L + + + + + +S +
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGL 279
Query: 374 TIIAMGLNQISGTIPLEI-RNLANIYALGLEYN 405
+ NQ+ ++P I L ++ + L N
Sbjct: 280 LELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 15/218 (6%)
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
+ +L L N++T + +NLQAL ++N ++ I DS +L +L L L +N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 455 LQGNIPSSL-GNCKNLMLLNVSKNKLTGTLPPQIL--EITTLSSLLDLSSNLISGSIPLV 511
L N+ SS +L LN+ N TL L +T L L + + +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLIS-LKSIEVLD 570
L L +L+I + P +L S ++ +L + + + S+E L+
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 571 LSCNNLSGQIPEYLEDLSF--------LEYLNLSYNDF 600
L +L L + ++
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 11/189 (5%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+++LD S N + I + L +L L N + S + +L L++S N L
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 480 TGTLPPQILEITTLSSL--LDLSSNLISGSIP--LVVGNLKNLIQLDISRNRFSGEIPT- 534
+ L LSSL L+L N ++ + +L L L + +I
Sbjct: 113 S-NLSSSWF--KPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 535 TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLED-LSFLEYL 593
+ T LE L++ + + P SL S++++ L L + E D S +E L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 594 NLSYNDFEG 602
L D +
Sbjct: 228 ELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 42/243 (17%), Positives = 85/243 (34%), Gaps = 38/243 (15%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNL-SHCSNLINFSVR 156
L+ + L SN ++ + L L+ L L +N S + S+ S+L ++
Sbjct: 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPE 215
N + + KL+ L V ++ ++ L++L + + L P+
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIF--NISSLEQISLLTNRFEG--------------- 258
SL +++++ L + +L IF SS+E + L +
Sbjct: 193 SLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 259 ---------------RLPLNIGFNLPKLKILIVGQNNLTGSIPQS-FSNASNLVILNLSG 302
+ + + L L +N L S+P F ++L + L
Sbjct: 252 KKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310
Query: 303 NHF 305
N +
Sbjct: 311 NPW 313
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 44/211 (20%), Positives = 79/211 (37%), Gaps = 24/211 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+ + + +G G+FG V+R K IN + E + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI--DV 819
LI + F+ L+ +++ G L D + + + + I+
Sbjct: 110 LINLHDA-----FEDKYEMVLILEFLSGGELFDRI------AAEDYKMSEAEVINYMRQA 158
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIG 877
++++H H IVH D+KP N++ + + V DFGLA L I +
Sbjct: 159 CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------ 209
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
T + APE V D+++ G+L
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS-IKSFVAECE-ALKNIRHR 760
+ IG+G++G V + +AVK I K + + + +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
I F+ D + + M S S + + + +D + I++
Sbjct: 82 Y----IVQFYGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A+ +L + + I+H D+KPSN+LLD + DFG++ L D + + + G
Sbjct: 136 KALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDA-G 187
Query: 881 TVGYVAPE----YGMGGNVSLTGDVYSFGILLLEMFTGRRP---THTMF 922
Y+APE + DV+S GI L E+ TGR P +++F
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 20/218 (9%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+ + + +G G+FG V+R A K + + ++ E + + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
L+ + F+ D+ ++Y++M G L + + ++ + + V
Sbjct: 216 LVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCK 266
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIK 879
+ ++H + VH DLKP N++ + DFGL L + S
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL------DPKQSVKVTT 317
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT + APE G V D++S G+L + +G P
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-21
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 25/236 (10%)
Query: 688 QQFPMVSYAELNKAT-NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGS 743
+F + E T N F ++G+G FG V + A K + +K++
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 744 IKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV 803
+ E + L+ + R + V + ++ D LV M G L+ +
Sbjct: 228 EAMALNEKQILEKVNSRFV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 804 DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAK 861
+ + + ++ +E LH IV+ DLKP N+LLD H+ SD GLA
Sbjct: 283 ---FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAV 334
Query: 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ + +T + GTVGY+APE + + D ++ G LL EM G+ P
Sbjct: 335 HVPEG---QTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 37/228 (16%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA---------ECEAL 754
++ + L+G G FG VY G D LPVA+K + K I + E L
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLL 100
Query: 755 KNIRHR--NLIKIITVCSSIDFKGDDFKALVYDYMQ-SGSLEDWLQQSNDQVDGNLNLIQ 811
K + +I+++ + L+ + + L D++ + G L
Sbjct: 101 KKVSSGFSGVIRLLDW---FERPDSFV--LILERPEPVQDLFDFITER-----GALQEEL 150
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQE 870
+ V A+ + H+ ++H D+K N+L+D + + DFG L D
Sbjct: 151 ARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-T 206
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRP 917
GT Y PE+ + V+S GILL +M G P
Sbjct: 207 DFD------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 64/298 (21%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
+ + NL + ++ + ++ + N++ S+ I L +
Sbjct: 21 DAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNV 70
Query: 374 TIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHG 433
T + + N+++ PL NL N+ L L+ N++ + +L L++L N +
Sbjct: 71 TKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD 126
Query: 434 IIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
I + + +L L SL+LG N + +I + L L L++ N+++ I+ + L
Sbjct: 127 I--NGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-----DIVPLAGL 177
Query: 494 SSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNS 551
+ L L LS N IS L LKNL L++ + S+ +K D
Sbjct: 178 TKLQNLYLSKNHISDLRAL--AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG- 234
Query: 552 FRGSIPSSLISLKSI-EVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYND----FEGQV 604
SL++ + I + D N+ +PE+ ++SF+ Y ++ F G+V
Sbjct: 235 -------SLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 48/260 (18%), Positives = 108/260 (41%), Gaps = 25/260 (9%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
+ + + ++T ++ Q+ +++ + + + GI LPN+T+L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFLNG 77
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
N L I L N L L L+ N+ S+ +L + +++ N IS
Sbjct: 78 NKLTD--------IKPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
L +L + +L L N++T + L L L N + I+P + L+ L
Sbjct: 128 NGLV--HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG 506
+L+L N++ ++ +L KNL +L + + + +++ + +L++
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT- 238
Query: 507 SIPLVVGNLKNLIQLDISRN 526
P ++ + + + ++ +
Sbjct: 239 --PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 51/318 (16%), Positives = 107/318 (33%), Gaps = 75/318 (23%)
Query: 142 SNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQ 201
+ + I ++++ ++T + ++ + + + + I + + +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQ---NELNSIDQIIANNSDIK-SVQG-IQYLPNVTK 72
Query: 202 LGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLP 261
L + NKL I + L L++L +L + EN + ++SSL+
Sbjct: 73 LFLNGNKLTDI--KPLANLKNLGWLFLDENK-------VKDLSSLK-------------- 109
Query: 262 LNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNIT 320
+L KLK L + N ++ I + L L L N + I S L +
Sbjct: 110 -----DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT---DITVLSRLTKLD 159
Query: 321 RLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGL 380
L+L N + I L +KL+ L L+ N I++L
Sbjct: 160 TLSLEDNQISD--------IVPLAGLTKLQNLYLSKNH--------ISDLR--------- 194
Query: 381 NQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIG 440
+ L N+ L L + L+ + + +L + P+ I
Sbjct: 195 ---------ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 243
Query: 441 NLSTLNSLWLGFNNLQGN 458
+ + ++ +
Sbjct: 244 DDGDYEKPNVKWHLPEFT 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 44/220 (20%), Positives = 87/220 (39%), Gaps = 25/220 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
++ ++ +G+G FG V+R K + + E L RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI--DV 819
++ + F+ + ++++++ + + + L +R +S V
Sbjct: 63 ILHLHES-----FESMEELVMIFEFISGLDIFERI------NTSAFELNEREIVSYVHQV 111
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIG 877
A+++LH H I H D++P N++ + + +FG A+ L +P
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL---- 162
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ Y APE VS D++S G L+ + +G P
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 26/217 (11%), Positives = 60/217 (27%), Gaps = 56/217 (25%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGS---IKSFVAECEALKNIRHR 760
L G ++ D VA+ ++ + ++ ++ L I
Sbjct: 35 LLIFHGGVPPLQFWQA---LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
+ +++ V +V ++++ GSL++ D + + + + +A
Sbjct: 92 GVARVLDVVH-----TRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLA 139
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+A + H + PS V + D G
Sbjct: 140 AAADAAHRA---GVALSIDHPSRVRVSID--------GDVVL-----------------A 171
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ + D+ G L + R P
Sbjct: 172 YPATMPD-------ANPQDDIRGIGASLYALLVNRWP 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKS---------FVAECE 752
+ ++G+G V R AVK+I++ GS + + E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 753 ALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ 811
L+ + H N+I++ ++ + F LV+D M+ G L D+L + L+ +
Sbjct: 76 ILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKE 125
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
I + I LH IVH DLKP N+LLD DM ++DFG + L P ++
Sbjct: 126 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKL 180
Query: 872 SSSSIGIKGTVGYVAPE 888
+ GT Y+APE
Sbjct: 181 R----EVCGTPSYLAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 75/301 (24%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--------LKQKGSIKSFVAECEA 753
+E+ +S +G G+ G V + VA+K+I+ ++ + E E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL------ 807
LK + H +IKI + D+ +V + M+ G L D + + L
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGN-----KRLKEATCK 117
Query: 808 NLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLF 864
+ A++YLH + I+H DLKP NVLL + D + ++DFG +K L
Sbjct: 118 LYFY------QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG---DVYSFGILLLEMFTGRRPTHTM 921
+ + T GT Y+APE + + D +S G++L +G P
Sbjct: 169 ETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 922 FNDGLTLHGFVKMALPEKVME-IVDFA------------------LLLDPGNERAKIEEC 962
F++ T L +++ +F L++DP R EE
Sbjct: 219 FSEHRTQVS-----LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP-KARFTTEEA 272
Query: 963 L 963
L
Sbjct: 273 L 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-21
Identities = 71/251 (28%), Positives = 110/251 (43%), Gaps = 51/251 (20%)
Query: 691 PMVSYAELNKATN--EFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVIN---LKQKG 742
PM + + + L + +G G+FG V +G+ L VAVK++N ++
Sbjct: 2 PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVK---VGKHELTGHKVAVKILNRQKIRSLD 58
Query: 743 SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ 802
+ E + LK RH ++IK+ V I D F +V +Y+ G L D++ ++
Sbjct: 59 VVGKIRREIQNLKLFRHPHIIKLYQV---ISTPSDIF--MVMEYVSGGELFDYICKN--- 110
Query: 803 VDGNLNLIQRLNISIDVA--------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
RL + S ++Y H H +VH DLKP NVLLD M A +
Sbjct: 111 --------GRL--DEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 157
Query: 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFT 913
+DFGL+ + D TS G+ Y APE G D++S G++L +
Sbjct: 158 ADFGLSNMMSDGEFLRTSC------GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 914 GRRPTHTMFND 924
G P F+D
Sbjct: 212 GTLP----FDD 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-21
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 49/234 (20%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNI 757
++ + +IG+G+FG V R + A+K+++ + ++ F E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKV--YAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
++++ + F+ D + +V +YM G L +NL+ ++
Sbjct: 127 NSPWVVQL--FYA---FQDDRYLYMVMEYMPGGDL--------------VNLMSNYDVPE 167
Query: 818 DVA--------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRP 867
A A++ +H +H D+KP N+LLD H+ +DFG +
Sbjct: 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEG 222
Query: 868 IQETSSSSIGIKGTVGYVAPE--YGMGGNVSLTGDV--YSFGILLLEMFTGRRP 917
+ ++ GT Y++PE GG+ + +S G+ L EM G P
Sbjct: 223 MVRCDTAV----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 671 TRRRKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLP 730
+ + ++ SM + + +A + ++ ++IG+G V R
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 731 VAVKVINLKQ--------KGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFKA 781
AVK++ + + ++ E L+ + H ++I +I S F
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----SSFMF 176
Query: 782 LVYDYMQSGSLEDWLQQSNDQVDGNL------NLIQRLNISIDVASAIEYLHHHCQPPIV 835
LV+D M+ G L D+L + L ++++ + A+ +LH + IV
Sbjct: 177 LVFDLMRKGELFDYLTEK-----VALSEKETRSIMR------SLLEAVSFLHANN---IV 222
Query: 836 HGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE 888
H DLKP N+LLD +M +SDFG + L P ++ + GT GY+APE
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLR----ELCGTPGYLAPE 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---------LKQKGSIKSFVAECEAL 754
E+ L L+G+G FG V+ G+ D L VA+KVI L + E L
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALL 88
Query: 755 KNIR----HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGS-LEDWLQQSNDQVDGNLNL 809
+ H +I+++ + + LV + L D++ + G L
Sbjct: 89 WKVGAGGGHPGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYITEK-----GPLGE 138
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLFDRPI 868
V +AI++ H +VH D+K N+L+D A + DFG L D P
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY 195
Query: 869 QETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRP 917
GT Y PE+ +L V+S GILL +M G P
Sbjct: 196 -TDFD------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/258 (21%), Positives = 107/258 (41%), Gaps = 29/258 (11%)
Query: 674 RKQTQKSSTLLSMEQQFPMVSYAELNKATNE----------FSLSNLIGQGSFGFVYRGN 723
+ ++ Q +V++ + A IG+GS G V
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 724 LGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALV 783
VAVK+++L+++ + E +++ +H N++++ G++ ++
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY----LVGEEL-WVL 120
Query: 784 YDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSN 843
+++Q G+L D + Q LN Q + V A+ YLH ++H D+K +
Sbjct: 121 MEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171
Query: 844 VLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYS 903
+LL D +SDFG + + S + GT ++APE + D++S
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 904 FGILLLEMFTGRRPTHTM 921
GI+++EM G P +
Sbjct: 227 LGIMVIEMVDGEPPYFSD 244
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 29/181 (16%), Positives = 65/181 (35%), Gaps = 12/181 (6%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+A + +++L + L N+ ++ + + N+ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 480 TGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS 537
T I+ LS+L L + ++ + L +L LDIS + I T ++
Sbjct: 79 TN-----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSY 597
+ + + + N I L +L ++ L++ + + +ED L L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 598 N 598
Sbjct: 191 Q 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 29/168 (17%), Positives = 64/168 (38%), Gaps = 12/168 (7%)
Query: 366 SIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALD 425
+ A ++++T I + ++ +E NI L + T P I L NL+ L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 426 FSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP 485
++ ++ L++L L + + +I + + + +++S N + P
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 486 QILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGE 531
+ TL L L++ + + + + L QL G+
Sbjct: 155 ----LKTLPELKSLNIQFDGVHDYRGI--EDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 34/195 (17%), Positives = 77/195 (39%), Gaps = 13/195 (6%)
Query: 263 NIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRL 322
N+ K + G + + + + ++L + L+ + + GI NI L
Sbjct: 14 NVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGI--EYAHNIKDL 71
Query: 323 NLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQ 382
+ + + + I+ L+N LE L + +++ L+++T++ + +
Sbjct: 72 TINNIH-----ATNYNPISGLSN---LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 383 ISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNL 442
+I +I L + ++ L YN I + L L++L+ + +H I +
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDF 180
Query: 443 STLNSLWLGFNNLQG 457
LN L+ + G
Sbjct: 181 PKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 33/198 (16%), Positives = 68/198 (34%), Gaps = 13/198 (6%)
Query: 381 NQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIG 440
+Q + IP L + T ++ +L + + N+ + I
Sbjct: 11 SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IE 63
Query: 441 NLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLS 500
+ L + + N + + NL L + +T P + +T+L+ L D+S
Sbjct: 64 YAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL-DIS 120
Query: 501 SNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSL 560
+ SI + L + +D+S N +I L + L+ L +Q + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGI 177
Query: 561 ISLKSIEVLDLSCNNLSG 578
+ L + G
Sbjct: 178 EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 36/174 (20%), Positives = 71/174 (40%), Gaps = 15/174 (8%)
Query: 427 SANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQ 486
A+ + IPDS + LG ++ + +L + ++ +T
Sbjct: 9 KASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----D 58
Query: 487 ILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEY 544
+ I ++ L +++ + P+ L NL +L I + + LS TSL
Sbjct: 59 LTGIEYAHNIKDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 545 LKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L + ++ SI + + +L + +DLS N I L+ L L+ LN+ ++
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 34/207 (16%), Positives = 77/207 (37%), Gaps = 15/207 (7%)
Query: 181 AENQLTGQLPPSIGNI--STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLP 238
A Q + NI ST + G + Q+ L ++++A N + L
Sbjct: 2 AAEQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-LT 60
Query: 239 PIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVIL 298
I +++ +++ P++ L L+ L + ++T + S ++L +L
Sbjct: 61 GIEYAHNIKDLTINNIHATNYNPIS---GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 299 NLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNR 358
++S + + ++LP + ++L N I D+ + L L++L + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGA----ITDIMPLKTLPE---LKSLNIQFDG 170
Query: 359 FGGSLPRSIANLSTITIIAMGLNQISG 385
I + + + I G
Sbjct: 171 VHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 27/185 (14%), Positives = 61/185 (32%), Gaps = 32/185 (17%)
Query: 123 LSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAE 182
++ L + L + + + + + N+ + ++ + T G LE L +
Sbjct: 43 MNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHAT-NYNPISGL--SNLERLRIMG 97
Query: 183 NQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN 242
+T P++ +++L L + + I + L +N + ++ N I +
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA------ITD 151
Query: 243 ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSG 302
I L+ LP+LK L + + + + L L
Sbjct: 152 IMPLK-------------------TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 303 NHFSG 307
G
Sbjct: 191 QTIGG 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLI 763
S + ++G G FG V++ L +A K+I + + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI--DVAS 821
++ F+ + LV +Y+ G L D + +D + NL + I +
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRI------IDESYNLTELDTILFMKQICE 198
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIK 879
I ++H I+H DLKP N+L + + DFGLA+ R +
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NF 249
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFG----ILL 908
GT ++APE VS D++S G +LL
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
++ IGQG+ G VY VA++ +NL+Q+ + + E ++ ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ GD+ +V +Y+ GSL D + + ++ Q + + A+E
Sbjct: 82 YLDSY----LVGDEL-WVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALE 130
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
+LH + ++H D+K N+LL D ++DFG + + ++ + GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-----MVGTPYW 182
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+APE D++S GI+ +EM G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLI 763
F+ IG+GSFG V++G VA+K+I+L++ + I+ E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
K S + D ++ +Y+ GS D L+ G L+ Q I ++ +
Sbjct: 84 KYY--GS---YLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGL 132
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
+YLH +H D+K +NVLL ++DFG+A L D I+ + GT
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-----FVGTPF 184
Query: 884 YVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
++APE D++S GI +E+ G P +
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+ + +G G+FG VY+ E A KVI K + ++ ++ E E L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
++ + ++ ++ G+++ + ++D L Q + + A+
Sbjct: 81 LLGAY----YHDGKL-WIMIEFCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALN 131
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
+LH I+H DLK NVL+ + ++DFG++ + S I GT +
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFI---GTPYW 183
Query: 885 VAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRPTHTM 921
+APE M + T D++S GI L+EM P H +
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-20
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 28/240 (11%)
Query: 687 EQQFPMVSYAELNKAT-NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKG 742
+F + E + F ++G+G FG V+ + A K +N LK++
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 743 SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ 802
+ + E + L + R + V + F+ LV M G + + + +
Sbjct: 228 GYQGAMVEKKILAKVHSRFI-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD-E 281
Query: 803 VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLA 860
+ + + + + S +E+LH I++ DLKP NVLLD D +V SD GLA
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLA 336
Query: 861 KFLFDRPIQETSSSSIGIK---GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
E + K GT G++APE +G + D ++ G+ L EM R P
Sbjct: 337 V--------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA-ECEALKNIR-HRNLIKIIT 767
++G+G+ V AVK+I KQ G I+S V E E L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLH 827
F+ +D LV++ M+ GS+ + + + N ++ + DVASA+++LH
Sbjct: 79 F-----FEEEDRFYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH 128
Query: 828 HHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK----G 880
+ I H DLKP N+L + + DF L + + + S S G
Sbjct: 129 NKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI--KLNGDCSPISTPELLTPCG 183
Query: 881 TVGYVAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRP 917
+ Y+APE + + D++S G++L + +G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 49/247 (19%), Positives = 95/247 (38%), Gaps = 33/247 (13%)
Query: 678 QKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN 737
+++ L Q++ N+ +G G+ G V++ + +AVK +
Sbjct: 8 KQTGYLTIGGQRYQAEI--------NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 738 LKQKGS-IKSFVAECEAL-KNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDW 795
K + + + + K+ I C D + + M + + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPY----IVQCFGTFITNTDVF-IAMELMGTCAEKLK 114
Query: 796 LQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855
+ + G + +++ + A+ YL ++H D+KPSN+LLD +
Sbjct: 115 KR-----MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLC 167
Query: 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPE-----YGMGGNVSLTGDVYSFGILLLE 910
DFG++ L D + G Y+APE + + DV+S GI L+E
Sbjct: 168 DFGISGRLVD-----DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 911 MFTGRRP 917
+ TG+ P
Sbjct: 222 LATGQFP 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 69/223 (30%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 710 LIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVA----ECEALKNIRHRNL 762
+G+GSFG V L VA+K I+ +Q E LK +RH ++
Sbjct: 16 TLGEGSFGKVK---LATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
IK+ V I D +V +Y G L D++ + + + + A
Sbjct: 72 IKLYDV---ITTPTDIV--MVIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
IEY H H IVH DLKP N+LLD ++ ++DFGL+ + D +TS G+
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC------GSP 171
Query: 883 GYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
Y APE G DV+S GI+L M GR P F+D
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP----FDD 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-20
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 43/273 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
++F + +IG+G+F V + + A+K++N + ++G + F E + L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
R + ++ + F+ +++ LV +Y G L L + +++ + R ++ ++
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLA-EI 171
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIG 877
AI+ +H VH D+KP N+LLD H+ +DFG + + + S+
Sbjct: 172 VMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCL----KLRADGTVRSLV 222
Query: 878 IKGTVGYVAPE--YGMGGNVSLTG-----DVYSFGILLLEMFTGRRP-----THTMFNDG 925
GT Y++PE +GG D ++ G+ EMF G+ P T + G
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--G 280
Query: 926 LTLHGFVKMALPEKVMEI----VDF--ALLLDP 952
+H ++LP + DF LL P
Sbjct: 281 KIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPP 313
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 44/192 (22%), Positives = 80/192 (41%), Gaps = 24/192 (12%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
++ + + +G+G+F V R L A K+IN K+ + E + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++++ + + F LV+D + G L + + + + +
Sbjct: 65 PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQI 114
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+I Y H + IVH +LKP N+LL ++DFGLA + +
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH---- 165
Query: 877 GIKGTVGYVAPE 888
G GT GY++PE
Sbjct: 166 GFAGTPGYLSPE 177
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNI 757
+F + +IG+G+FG V + + + A+K++N + ++ F E + L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKV--FAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+ + + + F+ D+ LV DY G L L + D++ + R ++
Sbjct: 132 DSKWITTLH--YA---FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLA- 182
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSS 875
++ AI+ +H VH D+KP N+L+D + H+ +DFG L + ++S +
Sbjct: 183 EMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRP 917
GT Y++PE D +S G+ + EM G P
Sbjct: 238 ----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKV------INLKQKGSIKSFVAECEALKN 756
+F + +G GSFG V+ + A+KV + LKQ E L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DERLMLSI 62
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQR 812
+ H +I++ + F+ ++ DY++ G L L++ N +
Sbjct: 63 VTHPFIIRMW--GT---FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA--------K 109
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQE 870
+ +V A+EYLH I++ DLKP N+LLD + H+ +DFG AK++ D
Sbjct: 110 FYAA-EVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYVPDV---- 159
Query: 871 TSSSSIGIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T + + GT Y+APE Y + D +SFGIL+ EM G P
Sbjct: 160 TYT----LCGTPDYIAPEVVSTKPYNK------SIDWWSFGILIYEMLAGYTP 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 48/238 (20%), Positives = 94/238 (39%), Gaps = 46/238 (19%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-----KGSIKSFVAECEALKN 756
+ + L +IG+G F V R E AVK++++ + S + E
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++H ++++++ SS D +V+++M L +++R +
Sbjct: 83 LKHPHIVELLETYSS-----DGMLYMVFEFMDGADLCF-------------EIVKRADAG 124
Query: 817 I------------DVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 861
+ A+ Y H + I+H D+KP VLL ++ + FG+A
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTH 919
+ E+ + G GT ++APE DV+ G++L + +G P +
Sbjct: 182 Q-----LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
F + +G+GS+G VY+ E VA+K + ++ ++ + E ++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
FK D +V +Y +GS+ D ++ N L + I +E
Sbjct: 89 YYGSY----FKNTDL-WIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLE 139
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH +H D+K N+LL+ + A ++DFG+A L D + + + GT +
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-----VIGTPFW 191
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM 921
+APE + D++S GI +EM G+ P +
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 39/222 (17%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
T E+ L +G+G+F V R A +IN K+ + E + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++++ S + L++D + G L + + + + +
Sbjct: 70 PNIVRLHDSISE-----EGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQI 119
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
A+ + H +VH +LKP N+LL ++DFGLA + Q
Sbjct: 120 LEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWF---- 171
Query: 877 GIKGTVGYVAPE------YGMGGNVSLTGDVYSFG----ILL 908
G GT GY++PE YG D+++ G ILL
Sbjct: 172 GFAGTPGYLSPEVLRKDPYG------KPVDLWACGVILYILL 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-19
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAE---CEALKN 756
N+FS+ +IG+G FG VY + A+K ++ +K K + E +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ VC S F D + + D M G L L Q G + +
Sbjct: 249 GDCPFI-----VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYA 298
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSS 874
++ +E++H+ +V+ DLKP+N+LLD HV SD GLA D ++ +S
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLAC---DFSKKKPHAS 350
Query: 875 SIGIKGTVGYVAPE---YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT GY+APE G+ + S D +S G +L ++ G P
Sbjct: 351 V----GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 52/228 (22%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRH 759
++ + + +G+G+F V R L A K+IN K+ + E + ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL------NLIQRL 813
N++++ + + F LV+D + G L + + + IQ
Sbjct: 88 PNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQ-- 135
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQE 870
+ +I Y H + IVH +LKP N+LL ++DFGLA + +
Sbjct: 136 ----QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEA 186
Query: 871 TSSSSIGIKGTVGYVAPE------YGMGGNVSLTGDVYSFG----ILL 908
G GT GY++PE Y D+++ G ILL
Sbjct: 187 WH----GFAGTPGYLSPEVLKKDPYS------KPVDIWACGVILYILL 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 46/229 (20%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVK------VINLKQKGSIKSFVAECEALKN 756
++F +G GSFG V E A+K V+ LKQ + E L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQA 97
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ L+K+ S FK + +V +Y+ G + L++ R +
Sbjct: 98 VNFPFLVKLE--FS---FKDNSNLYMVMEYVAGGEMFSHLRRI-----------GRFSEP 141
Query: 817 I------DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
+ EYLH +++ DLKP N+L+D V+DFG AK + R
Sbjct: 142 HARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 871 TSSSSIGIKGTVGYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T + + GT +APE G N ++ D ++ G+L+ EM G P
Sbjct: 195 TWT----LCGTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPP 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 21/228 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS-IKSFVAECE-ALKNIRHR 760
++ +G+G++G V + +AVK I K + + + +++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
F+ D + + M SL+ + +Q D+ + I++ +
Sbjct: 67 F----TVTFYGALFREGDVW-ICMELM-DTSLDKFYKQVIDK-GQTIPEDILGKIAVSIV 119
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A+E+LH ++H D+KPSNVL++ + DFG++ +L D + I G
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD-----DVAKDIDA-G 171
Query: 881 TVGYVAPE----YGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
Y+APE S+ D++S GI ++E+ R P +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 40/220 (18%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
++ F + + +G+G+ VYR P A+KV+ K E L + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN 109
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL------NLIQRLNI 815
+IK+ + F+ +LV + + G L D + + G + ++
Sbjct: 110 IIKLKEI-----FETPTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVK---- 155
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETS 872
+ A+ YLH + IVH DLKP N+L D ++DFGL+K + E
Sbjct: 156 --QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV------EHQ 204
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFG----ILL 908
+ GT GY APE G D++S G ILL
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 19/227 (8%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHR 760
F L L+G G++G VY+G + A+KV+++ + E LK HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81
Query: 761 NLIKIITVCSSIDFKGDDFKA-LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N+ + G D + LV ++ +GS+ D ++ + L I ++
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREI 138
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
+ +LH H ++H D+K NVLL + + DFG++ L T
Sbjct: 139 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRTVGRRNTFI 190
Query: 880 GTVGYVAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRPTHTM 921
GT ++APE D++S GI +EM G P M
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVC 769
+G+GSF + + AVK+I+ + + + + E ALK H N++K+ V
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74
Query: 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH 829
F LV + + G L + +++ + + + I + SA+ ++H
Sbjct: 75 ----FHDQLHTFLVMELLNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDV 125
Query: 830 CQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVA 886
+VH DLKP N+L + ++ + DFG A+ P + + T+ Y A
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLKTPC---FTLHYAA 177
Query: 887 PE------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
PE Y + D++S G++L M +G+ P
Sbjct: 178 PELLNQNGYD------ESCDLWSLGVILYTMLSGQVP 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 39/218 (17%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEAL-KNIRHR 760
T+ + + IG GS+ R + AVK+I+ K K E E L + +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHP 76
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N+I + V + + +V + M+ G L D + + + + + +
Sbjct: 77 NIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTIT 126
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+EYLH +VH DLKPSN+L + + DFG AK ++ + +
Sbjct: 127 KTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-----LRAENGLLM 178
Query: 877 GIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILL 908
T +VAPE Y D++S G+LL
Sbjct: 179 TPCYTANFVAPEVLERQGYD------AACDIWSLGVLL 210
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 76/388 (19%), Positives = 129/388 (33%), Gaps = 56/388 (14%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNA-----SNLVILNLSGNHFSGKVGIDFSSL----P 317
P L L + N L + L+L +G SS P
Sbjct: 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP 113
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFG----GSLPRSIANLSTI 373
+ L+L N LG + L LL +LE L L L +
Sbjct: 114 TLQELHLSDNLLGDAGLQLL-CEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 374 TIIAMGLNQISGTIPLEI-----RNLANIYALGLEYNQLTGTIPYTIGELI----NLQAL 424
+ + N I+ + + + AL LE +T + ++ +L+ L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 425 DFSANNLHG-----IIPDSIGNLSTLNSLWLGFNNLQ----GNIPSSLGNCKNLMLLNVS 475
+N L + P + S L +LW+ + G++ L ++L L+++
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292
Query: 476 KNKLTGTLPPQILEI-----TTLSSLLDLSSNLISG----SIPLVVGNLKNLIQLDISRN 526
N+L + E L SL + S + V+ + L++L IS N
Sbjct: 293 GNELGDEGARLLCETLLEPGCQLESL-WVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 527 RFSGEIPTTLS-----SCTSLEYLKMQDNSFR----GSIPSSLISLKSIEVLDLSCNNLS 577
R L + L L + D S+ ++L++ S+ LDLS N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
Query: 578 GQ----IPEYLEDL-SFLEYLNLSYNDF 600
+ E + LE L L +
Sbjct: 412 DAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-17
Identities = 69/401 (17%), Positives = 129/401 (32%), Gaps = 65/401 (16%)
Query: 244 SSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLT----GSIPQSFSNASNLVILN 299
++ + + + L + +++ + LT I + L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 300 LSGNHFSGKVGIDFSSL-----PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGL 354
L N I +L+L L G L + L L+ L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHL 120
Query: 355 NSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYT 414
+ N G + GL + + + + L LEY L+
Sbjct: 121 SDNLLGDA----------------GLQLLCEGL---LDPQCRLEKLQLEYCSLSAASCEP 161
Query: 415 IGELI----NLQALDFSANNL-----HGIIPDSIGNLSTLNSLWLGFNNLQ----GNIPS 461
+ ++ + + L S N++ + + L +L L + ++
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 462 SLGNCKNLMLLNVSKNKLTGT----LPPQILEITTLSSLLDLSSNLIS----GSIPLVVG 513
+ + +L L + NKL L P +L ++ L + I+ G + V+
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 514 NLKNLIQLDISRNRFSGE-----IPTTLSSCTSLEYLKMQDNSFRG----SIPSSLISLK 564
++L +L ++ N E T L LE L ++ SF S L +
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341
Query: 565 SIEVLDLSCNNLSG----QIPEYLED-LSFLEYLNLSYNDF 600
+ L +S N L ++ + L S L L L+ D
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 83/508 (16%), Positives = 166/508 (32%), Gaps = 104/508 (20%)
Query: 102 LRFINLASNNLHGEIPNELGR-LSRLKVLVLDFNSFSGT----IPSNLSHCSNLINFSVR 156
++ +++ L EL L + +V+ LD + I S L L ++R
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 157 RNNLTGE----IPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGI 212
N L + + K++ L++ LT G+
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT--------------------GAGCGV 104
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLK 272
+ +L L L L +++N + L+ + EG L +L+
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGD--------AGLQLLC------EGLLDPQ-----CRLE 145
Query: 273 ILIVGQNNLTGSIPQSFSNA----SNLVILNLSGNHFSGKVGIDFS-----SLPNITRLN 323
L + +L+ + + ++ + L +S N + S + L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 324 LGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQI 383
L + S + DL ++ + + L L L SN+ G G+ ++
Sbjct: 206 LESCGVTSDNCRDL--CGIVASKASLRELALGSNKLGDV----------------GMAEL 247
Query: 384 SGTIPLEIRNLANIYALGLEYNQLT----GTIPYTIGELINLQALDFSANNLHGIIPDSI 439
+ + + + L + +T G + + +L+ L + N L +
Sbjct: 248 CPGL---LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 440 GNL-----STLNSLWLGFNNLQG----NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE- 489
L SLW+ + + S L + L+ L +S N+L ++ +
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 490 -ITTLSSL--LDLSSNLIS----GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS----- 537
S L L L+ +S S+ + +L +LD+S N L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKS 565
LE L + D + + L +L+
Sbjct: 425 PGCLLEQLVLYDIYWSEEMEDRLQALEK 452
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 49/322 (15%), Positives = 103/322 (31%), Gaps = 54/322 (16%)
Query: 73 QRHPRVIQLYLRNQSVG----GFLSPYVGNLSFLRFINLASNNLHGEIPNELGRL----- 123
R+ +L L S+ L+ + + + +++N+++ L +
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198
Query: 124 SRLKVLVLDFNSFS----GTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK----L 175
+L+ L L+ + + ++ ++L ++ N L A + L L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 176 ENLNVAENQLTGQ----LPPSIGNISTLQQLGVGENKLYGIIPESLGQ-LRDLNFLSVAE 230
L + E +T + L + +L++L + N+L L + L +
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG------ 312
Query: 231 NNFSGMLPPIFNISSLEQISLLTNRF--EGRLPLNIGF-NLPKLKILIVGQNNLTGSIPQ 287
LE + + + F + L L + N L + +
Sbjct: 313 -------------CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 288 SFSNA-----SNLVILNLSGNHFSGKVGIDFSSL----PNITRLNLGQNNLGSGSIGDLD 338
S L +L L+ S ++ ++ L+L N LG I L
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL- 418
Query: 339 FITLLTNCSKLETLGLNSNRFG 360
++ LE L L +
Sbjct: 419 VESVRQPGCLLEQLVLYDIYWS 440
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 29/217 (13%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA------ECEALK 755
+ + + +G G F V + L A K I +Q + + V+ E L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+ H N+I + V ++ L+ + + G L D+L Q +L+ + +
Sbjct: 71 QVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQ-----KESLSEEEATSF 120
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQET 871
+ + YLH I H DLKP N++L + DFGLA + D +
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
I GT +VAPE + L D++S G++
Sbjct: 178 ------IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA------ECEALK 755
+ + + +G G F V + L A K I +Q + + V E L+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+ H N+I + V ++ L+ + + G L D+L Q +L+ + +
Sbjct: 71 QVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQ-----KESLSEEEATSF 120
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLL----DHDMVAHVSDFGLAKFLFDRPIQET 871
+ + YLH I H DLKP N++L + DFGLA + D +
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
I GT +VAPE + L D++S G++
Sbjct: 178 ------IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 3e-18
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 692 MVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQK--GSIKS 746
M Y +L K IG+G++G V++ E VA+K + L G S
Sbjct: 1 MQKYEKLEK----------IGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSS 47
Query: 747 FVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN 806
+ E LK ++H+N++++ V D LV+++ L+ + N +D
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLH-----SDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE 101
Query: 807 LN---LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863
+ L Q L + + H ++H DLKP N+L++ + +++FGLA+
Sbjct: 102 IVKSFLFQLL-------KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA- 150
Query: 864 FDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGRRP 917
F P++ S+ + T+ Y P+ G + T D++S G + E+ RP
Sbjct: 151 FGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 66/247 (26%), Positives = 110/247 (44%), Gaps = 36/247 (14%)
Query: 674 RKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG--NLGEDLLPV 731
SS ++ Q M Y +L K +G+G++G VY+ + G V
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGR---IV 48
Query: 732 AVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS 789
A+K I L + G + + E LK + H N++ +I V + LV+++M+
Sbjct: 49 ALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERCLTLVFEFMEK 103
Query: 790 GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD 849
L+ L D+ L Q + + + H H I+H DLKP N+L++ D
Sbjct: 104 -DLKKVL----DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSD 155
Query: 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILL 908
++DFGLA+ F P++ + + T+ Y AP+ MG T D++S G +
Sbjct: 156 GALKLADFGLARA-FGIPVRSYTHEVV----TLWYRAPDVLMGSKKYSTSVDIWSIGCIF 210
Query: 909 LEMFTGR 915
EM TG+
Sbjct: 211 AEMITGK 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 33/221 (14%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS------IKSFVAECEALK 755
+ + + +G G F V + A K I ++ S + E L+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
IRH N+I + + F+ L+ + + G L D+L + +L +
Sbjct: 64 EIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAE-----KESLTEDEATQF 113
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLAKFLFDRPIQET 871
+ + YLH I H DLKP N++L V + + DFG+A + E
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEF 168
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFG----ILL 908
I GT +VAPE + L D++S G ILL
Sbjct: 169 K----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK-GSIKSFVAECEALKNIRHRN 761
+ + +G+G++ VY+G VA+K I L+ + G+ + + E LK+++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN---LIQRLNISID 818
++ + + + + LV++Y+ L+ +L + ++ + L Q L
Sbjct: 62 IVTLHDIIHT-----EKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL----- 110
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ Y H ++H DLKP N+L++ ++DFGLA+ P + + +
Sbjct: 111 --RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVV-- 162
Query: 879 KGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
T+ Y P+ +G T D++ G + EM TGR
Sbjct: 163 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 29/226 (12%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVA------ECEALK 755
+ + +G G F V + L A K I ++ S + V+ E LK
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
I+H N+I + V ++ L+ + + G L D+L + +L +
Sbjct: 70 EIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAE-----KESLTEEEATEF 119
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VSDFGLAKFLFDRPIQET 871
+ + + YLH I H DLKP N++L V + DFGLA + +
Sbjct: 120 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
I GT +VAPE + L D++S G++ + +G P
Sbjct: 177 ------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 23/212 (10%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEAL-KNIRHRNLIKIITV 768
++G G G V A+K++ + + E + + +++ I+ V
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH 828
+ G ++ + M+ G L +Q+ + D + I D+ +AI++LH
Sbjct: 91 YEN-MHHGKRCLLIIMECMEGGELFSRIQE---RGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 829 HCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H I H D+KP N+L + D V ++DFG AK +Q T YV
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-------PCYTPYYV 196
Query: 886 APEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
APE + D++S G+++ + G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRH 759
NEF L+G+G+FG V A+K++ + K + + E L+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNI 815
L + S F+ D V +Y G L L + S D+ R
Sbjct: 208 PFLTALK--YS---FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA--------RFYG 254
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ ++ SA++YLH +V+ DLK N++LD D ++DFGL K I++ ++
Sbjct: 255 A-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMK 307
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + D + G+++ EM GR P
Sbjct: 308 T-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 692 MVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQK-GSIKSF 747
+ +L K +G G++ VY+G G VA+K + L + G+ +
Sbjct: 4 SSQFKQLEK----------LGNGTYATVYKGLNKTTGV---YVALKEVKLDSEEGTPSTA 50
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL-QQSNDQVDGN 806
+ E +K ++H N++++ V + ++ LV+++M + L+ ++ ++
Sbjct: 51 IREISLMKELKHENIVRLYDVIHT-----ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRG 104
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDR 866
L L + + + H + I+H DLKP N+L++ + DFGLA+ F
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA-FGI 160
Query: 867 PIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
P+ SS + T+ Y AP+ MG T D++S G +L EM TG+
Sbjct: 161 PVNTFSSEVV----TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 692 MVSYAELNKATNEFSLSNLIGQGSFGFVYRG--NLGEDLLPVAVKVINLKQK--GSIKSF 747
M Y L K IG+G++G VY+ N GE A+K I L+++ G +
Sbjct: 1 MEKYHGLEK----------IGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTT 47
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL 807
+ E LK ++H N++K+ V + LV++++ L+ L ++
Sbjct: 48 IREISILKELKHSNIVKLYDVIHT-----KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT 101
Query: 808 N---LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
L+Q L + I Y H ++H DLKP N+L++ + ++DFGLA+ F
Sbjct: 102 AKSFLLQLL-------NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA-F 150
Query: 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
P+++ + + T+ Y AP+ MG T D++S G + EM G
Sbjct: 151 GIPVRKYTHEIV----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 45/234 (19%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPV-AVKVIN----LKQKGSIKSFVAECEALK 755
F L ++G G++G V+ R G D + A+KV+ +++ + + E + L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQ 811
+IR + +T+ + F+ + L+ DY+ G L L Q + +V
Sbjct: 114 HIRQSPFL--VTLHYA--FQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------- 161
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQ 869
++ + ++ A+E+LH I++ D+K N+LLD + HV +DFGL+K +
Sbjct: 162 QIYVG-EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETE 215
Query: 870 ETSSSSIGIKGTVGYVAPE------YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT+ Y+AP+ G V D +S G+L+ E+ TG P
Sbjct: 216 RAYD----FCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 56/239 (23%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINL-KQK 741
M +Q+ V ++ +++ IGQG+FG V++ G+ VA+K + + +K
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEK 56
Query: 742 GSIKSF-VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA---LVYDYMQSGSLEDWLQ 797
+ E + L+ ++H N++ +I +C + + K LV+D+ + D L
Sbjct: 57 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LA 111
Query: 798 QSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857
V L + + + + + Y+H + I+H D+K +NVL+ D V ++DF
Sbjct: 112 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168
Query: 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
GLA+ F + T+ Y PE +G D++ G ++ EM+T
Sbjct: 169 GLARA-FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 49/213 (23%), Positives = 78/213 (36%), Gaps = 11/213 (5%)
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
+ L L +N L Y+ LQ LD S + I + +LS L++L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 455 LQGNIPSSL-GNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL--V 511
+Q ++ +L L + L +L + L+++ NLI S L
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144
Query: 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEY----LKMQDNSFRGSIPSSLISLKSIE 567
NL NL LD+S N+ T L + L + N I ++
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203
Query: 568 VLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
L L N L + L+ L+ + L N +
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 13/210 (6%)
Query: 349 LETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQL 407
+ L L+ N S + + ++ + +I TI ++L+++ L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 408 TGTIPYTI-GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS--LG 464
++ L +LQ L NL + IG+L TL L + N +Q +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 465 NCKNLMLLNVSKNKLTGTLPPQIL----EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQ 520
N NL L++S NK+ ++ L ++ L+ LDLS N ++ I L +
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 521 LDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550
L + N+ TSL+ + + N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 49/244 (20%), Positives = 86/244 (35%), Gaps = 38/244 (15%)
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKL 271
+P S L DL+F N + F + L+ + L + + +L L
Sbjct: 26 LPFSTKNL-DLSF-----NPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 272 KILIVGQNNLTGSIPQ-SFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
LI+ N + S+ +FS S+L L + + L + LN+ N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPL 389
S +N + LE L L+SN+ S+ + L + ++ + L+
Sbjct: 138 S-----FKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLD-------- 183
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
L N + I + I L+ L N L + L++L +W
Sbjct: 184 ------------LSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230
Query: 450 LGFN 453
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 46/209 (22%), Positives = 76/209 (36%), Gaps = 11/209 (5%)
Query: 126 LKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQL 185
K L L FN + L + R + I L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 186 TGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGM-LPPIF-N 242
L +S+LQ+L E L + +G L+ L L+VA N LP F N
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 243 ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIV----GQNNLTGSIPQSFSNASNLVIL 298
+++LE + L +N+ + + L ++ +L + N + P +F L L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKEL 205
Query: 299 NLSGNHFSGKVGIDFSSLPNITRLNLGQN 327
L N F L ++ ++ L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 41/206 (19%), Positives = 67/206 (32%), Gaps = 13/206 (6%)
Query: 106 NLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNL-SHCSNLINFSVRRNNLTGEI 164
+L+ N L L+VL L TI S+L + N + +
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SL 91
Query: 165 PAYIGYYWLKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGII-PESLGQLRD 222
L+ L E L L G++ TL++L V N + PE L +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 223 LNFLSVAENNFSGMLPPIF-NISSLE----QISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
L L ++ N + + + + L N + F +LK L +
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLKELALD 208
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGN 303
N L F ++L + L N
Sbjct: 209 TNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 45/237 (18%), Positives = 88/237 (37%), Gaps = 24/237 (10%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
+N V NL + V L + N +N+ S + + + L
Sbjct: 16 PGLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQS--------LAGMQFFTNL 65
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG 409
+ L L+ N+ S + +L+ + +++ N++ + L+ ++ L+ N+L
Sbjct: 66 KELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD 120
Query: 410 TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL 469
T + L NL+ L N L I +G LS L L L N + N L K +
Sbjct: 121 TDS--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKV 174
Query: 470 MLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRN 526
++++ K E+ +++ D IS P + N + + +
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 52/252 (20%), Positives = 94/252 (37%), Gaps = 27/252 (10%)
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYA 399
+ + L + S LS + + I ++ N+
Sbjct: 12 VFPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI 459
L L +NQ++ P + +L L+ L + N L + + + L+ L+L N L+
Sbjct: 68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD-- 120
Query: 460 PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKN 517
SL + KNL +L++ NKL I+ + LS L LDL N I+ + L LK
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGGL--TRLKK 173
Query: 518 LIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577
+ +D++ + E +K D I IS +
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR---WISPYYISNGGS----YVDGCVL 226
Query: 578 GQIPEYLEDLSF 589
++P Y +++S+
Sbjct: 227 WELPVYTDEVSY 238
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 16/140 (11%)
Query: 461 SSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNL 518
N + N+ K +T ++ LS + + ++ I + NL
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-----DLVSQKELSGVQNFNGDNSNIQSLAGM--QFFTNL 65
Query: 519 IQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSG 578
+L +S N+ S ++ + L T LE L + N + ++ + I + L L N L
Sbjct: 66 KELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD 120
Query: 579 QIPEYLEDLSFLEYLNLSYN 598
+ L L LE L++ N
Sbjct: 121 --TDSLIHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 41/226 (18%), Positives = 83/226 (36%), Gaps = 40/226 (17%)
Query: 120 LGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLN 179
L+ L S T + S + NF+ +N+ + + ++ L+ L+
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFT-NLKELH 69
Query: 180 VAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP 239
++ NQ++ L P + +++ L++L V N+L + L L + N
Sbjct: 70 LSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNE------- 117
Query: 240 IFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILN 299
+ + SL +L L+IL + N L SI S L +L+
Sbjct: 118 LRDTDSLI-------------------HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLD 156
Query: 300 LSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTN 345
L GN + G+ + L + ++L + + + +
Sbjct: 157 LHGNEITNTGGL--TRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 684 LSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS 743
++++ + Y +L+ +G+G F VY+ VA+K I L +
Sbjct: 1 MALDVKSRAKRYEKLDF----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE 50
Query: 744 IKSFVA-----ECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ 798
K + E + L+ + H N+I ++ F +LV+D+M++ LE +
Sbjct: 51 AKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKSNISLVFDFMET-DLEVII-- 102
Query: 799 SNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858
L + +EYLH H I+H DLKP+N+LLD + V ++DFG
Sbjct: 103 --KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157
Query: 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
LAK F P + + + T Y APE G + G D+++ G +L E+
Sbjct: 158 LAKS-FGSPNRAYTHQVV----TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 44/254 (17%), Positives = 76/254 (29%), Gaps = 33/254 (12%)
Query: 349 LETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLE-YNQ 406
L + + + + I + N + I ++ NL ++ + +E N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 407 LTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSL--G 464
L P L NLQ L S + + + L + N I + G
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
Query: 465 NCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDIS 524
++L ++KN + + T L L +N + V + LDIS
Sbjct: 152 LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 525 RNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYL 584
R R L + L S +LK + L+
Sbjct: 211 RTRIHSLPSYGLENLKKLRAR-------------STYNLKKLPTLE-------------- 243
Query: 585 EDLSFLEYLNLSYN 598
L L +L+Y
Sbjct: 244 -KLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 42/218 (19%), Positives = 77/218 (35%), Gaps = 9/218 (4%)
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI-GNLST 444
IP ++ N L +L +L+ ++ S N++ +I + NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 445 LNSLWL-GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNL 503
L+ + + NNL P + N NL L +S + LP + LLD+ N+
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 504 ISGSIPLVV--GNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI 561
+I G + L +++N + + E +N+
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 562 SLKSIEVLDLSCNNLSGQIPEY-LEDLSFLEYLNLSYN 598
+LD+S + +P Y LE+L L +
Sbjct: 200 GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 22/233 (9%)
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIP- 460
+ +++T IP + N L F L I + L + + N++ I
Sbjct: 16 CQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72
Query: 461 ---SSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIP-LVVGN 514
S+L + + N L + P+ L +L L +S+ I +P + +
Sbjct: 73 DVFSNLPKLHEIRIEKA--NNLL-YINPEAF--QNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 515 LKNLIQLDISRNRFSGEIPTTLSS--CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLS 572
+ LDI N I L + N + S+ + E+
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 573 CNNLSGQIPEY-LEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKL 624
NNL ++P S L++S +P+ N ++ L
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPS-YGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 47/245 (19%), Positives = 79/245 (32%), Gaps = 24/245 (9%)
Query: 267 NLPK-LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGID-FSSLPNITRLNL 324
+LP+ L L +FS +L + +S N + D FS+LP + + +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 325 GQNNLGSGSIGDLDFI--TLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQ 382
+ N +L +I N L+ L +++ + ++ + N
Sbjct: 87 EKAN-------NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139
Query: 383 ISGTIPLE-IRNL-ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANN-LHGIIPDSI 439
TI L L L N + I + L L+ S NN L + D
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 440 GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--L 497
S L + + L N K L + K LP + L +L
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT----LEKLVALMEA 251
Query: 498 DLSSN 502
L+
Sbjct: 252 SLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 45/244 (18%), Positives = 79/244 (32%), Gaps = 14/244 (5%)
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKL 271
IP L R+ L + F LE+I + N + ++ NLPKL
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 272 KILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
+ + + N I ++F N NL L +S + L++ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE 390
+I F+ L + L LN N + + N + +P +
Sbjct: 142 H-TIERNSFVGL---SFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPND 196
Query: 391 I-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
+ + L + ++ Y + L L+A S NL + + L L
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNLKKLPT--LEKLVALMEAS 252
Query: 450 LGFN 453
L +
Sbjct: 253 LTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 35/231 (15%), Positives = 69/231 (29%), Gaps = 11/231 (4%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSVRRNNL 160
+ L L+ + + N I ++ S+ L + + N
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 161 TGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIST-LQQLGVGENKLYGIIPESL-- 217
I L+ L ++ + LP S L + +N I +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
G + L + +N + FN + L++++L N LP ++ IL +
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 278 QNNLTGSIPQ-SFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN 327
+ + S+P N L + K L + +L
Sbjct: 211 RTRIH-SLPSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 45/261 (17%), Positives = 79/261 (30%), Gaps = 24/261 (9%)
Query: 105 INLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSVRRNNLTGE 163
+ + EIP++L L I S +L + +N++
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 164 IPAYIGYYWLKLENLNVAE-NQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLR 221
I A + KL + + + N L + P N+ LQ L + + +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 222 DLNFLSVAENNFSGMLPP-IFN--ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQ 278
L + +N + F + L N + + + FN +L L +
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA-FNGTQLDELNLSD 186
Query: 279 NNLTGSIPQ-SFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDL 337
NN +P F AS VIL++S +L + + NL
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK------ 238
Query: 338 DFITLLTNCSKLETLGLNSNR 358
+ L L L
Sbjct: 239 --LPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 34/214 (15%), Positives = 69/214 (32%), Gaps = 17/214 (7%)
Query: 98 NLSFLRFINLASNNLHGEIPNE----LGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLIN 152
L I ++ N++ I + L +L + + N+ I + NL
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI--RIEKANNLL-YINPEAFQNLPNLQY 108
Query: 153 FSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSI--GNISTLQQLGVGENKLY 210
+ + +P + L+ L++ +N + + G L + +N +
Sbjct: 109 LLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
Query: 211 GIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLP 269
I + + NN + +F S + + R LP NL
Sbjct: 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLK 226
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGN 303
KL+ NL +P + L+ +L+
Sbjct: 227 KLRAR--STYNLK-KLP-TLEKLVALMEASLTYP 256
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 37/235 (15%)
Query: 692 MVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINL-KQKGSIKSF 747
Y + + IG G++G VY+ + G VA+K + + G
Sbjct: 8 TSRYEPVAE----------IGVGAYGTVYKARDPHSGH---FVALKSVRVPNGGGGGGGL 54
Query: 748 -------VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN 800
VA L+ H N+++++ VC++ + LV++++ L +L ++
Sbjct: 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP 113
Query: 801 DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
L ++ +++LH +C IVH DLKP N+L+ ++DFGLA
Sbjct: 114 PP---GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
+ + + T T+ Y APE + + D++S G + EMF +
Sbjct: 168 RI-YSYQMALTPVVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 35/219 (15%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--IKSFVAECEALKNIRHR-NLIKIIT 767
+G+G F V + A K + +++G + E L+ + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 768 VCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNL------NLIQRLNISIDVAS 821
V ++ L+ +Y G + ++ + LI+ +
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIRLIK------QILE 142
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ YLH + IVH DLKP N+LL + DFG+++ + E I
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELR----EI 193
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE ++ D+++ GI+ + T P
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 4e-16
Identities = 36/263 (13%), Positives = 82/263 (31%), Gaps = 22/263 (8%)
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
L + + ++ + + L + D ++ + R L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC-RDSATDEQLFRCELSVEKS 361
Query: 330 GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPL 389
+ L +C +L+ L + L I + + + + L
Sbjct: 362 -------TVLQSELESCKELQELEPENKWC---LLTIILLMRALDPLLYEKETLQYFSTL 411
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
+ + L ++ E +++ L + +L + + L + L
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLD 469
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISG- 506
L N L+ +P +L + L +L S N L + + L L L L +N +
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-----NVDGVANLPRLQELLLCNNRLQQS 523
Query: 507 SIPLVVGNLKNLIQLDISRNRFS 529
+ + + L+ L++ N
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 39/261 (14%), Positives = 85/261 (32%), Gaps = 27/261 (10%)
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS 461
+ L + S ++ + + L L I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL 390
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQL 521
+ L+ + + + ++ + L DL S + ++ ++ L
Sbjct: 391 LMRALDPLLYEKETLQYFST---LKAVDPMRAAYLDDLRSKFLLE-NSVLKMEYADVRVL 446
Query: 522 DISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIP 581
++ + + L + +L + N R ++P +L +L+ +EVL S N L +
Sbjct: 447 HLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD 502
Query: 582 EYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHN--T 639
+ +L L+ L L N + + I+ C L L+L N
Sbjct: 503 G-VANLPRLQELLLCNNRLQQ-------------SAAIQPLVSCPRLVLLNL--QGNSLC 546
Query: 640 RPRKAKITILKVLIPVIVLLT 660
+ + + ++L V +LT
Sbjct: 547 QEEGIQERLAEMLPSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 44/238 (18%), Positives = 81/238 (34%), Gaps = 20/238 (8%)
Query: 92 LSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI---PSNLSHCS 148
L L S + +EL L+ L + TI L
Sbjct: 341 WCRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 149 NLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENK 208
+ L P ++ L+ ++ + + ++ L +
Sbjct: 400 YEKETLQYFSTLKAVDP-------MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 209 LYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNL 268
L + L QL + L ++ N + P + + LE + N E + + NL
Sbjct: 453 LTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVA-NL 507
Query: 269 PKLKILIVGQNNLTG-SIPQSFSNASNLVILNLSGNHFSGKVGID---FSSLPNITRL 322
P+L+ L++ N L + Q + LV+LNL GN + GI LP+++ +
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 31/192 (16%), Positives = 66/192 (34%), Gaps = 14/192 (7%)
Query: 16 WCVTLFLLNPDSCFALSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQWTGVTCGQRH 75
WC+ +L + L E + + + + S + + + +
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442
Query: 76 PRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNS 135
RV L+L ++ + ++ L + ++L+ N L +P L L L+VL N+
Sbjct: 443 VRV--LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497
Query: 136 FSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK-LENLNVAENQLTGQLPPSIG 194
+ +++ L + N L + A L LN+ N L Q
Sbjct: 498 LE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQE 553
Query: 195 NI----STLQQL 202
+ ++ +
Sbjct: 554 RLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 27/155 (17%), Positives = 61/155 (39%), Gaps = 10/155 (6%)
Query: 125 RLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQ 184
R L + F +++ + +LT + ++ L + +L+++ N+
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQL-LLVTHLDLSHNR 474
Query: 185 LTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGM--LPPIFN 242
L LPP++ + L+ L +N L + + + L L L + N + P+ +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 243 ISSLEQISLLTNRF--EGRLPLNIGFNLPKLKILI 275
L ++L N E + + LP + ++
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 43/225 (19%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 710 LIGQGSFGFVYRGNLGEDLL---PVAVKVINLKQKGSIKSFVAECEALKNIR-------- 758
+G G F V+ L +D++ VA+K++ + + ++ E + L+ +
Sbjct: 26 KLGWGHFSTVW---LAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKED 81
Query: 759 HRNLIKIITVCSSIDFKGDDFK--ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
I+ + + KG + +V++ + +L +++ + L +++ IS
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-PLIYVKQ--IS 137
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH------VSDFGLAKFLFDRPIQE 870
+ ++Y+H C I+H D+KP NVL++ ++D G A + +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
+ Y +PE +G D++S L+ E+ TG
Sbjct: 196 IQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 55/241 (22%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNL-IGQGSFGFVY--RGNLGEDLLPVAVKVINLKQKG 742
M+ F + +E + + F +G+G++G VY + G+D A+K I + G
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTG 60
Query: 743 SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQS---GSLEDWLQQS 799
S E L+ ++H N+I + V S D L++DY + ++
Sbjct: 61 ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYAEHDLWHIIKFHRASK 117
Query: 800 NDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH----VS 855
++ L ++ + I YLH + ++H DLKP+N+L+ + ++
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174
Query: 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTG 914
D G A+ LF+ P++ + + T Y APE +G D+++ G + E+ T
Sbjct: 175 DMGFAR-LFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
Query: 915 R 915
Sbjct: 233 E 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 53/254 (20%), Positives = 99/254 (38%), Gaps = 62/254 (24%)
Query: 686 MEQQFP---MVSYAELNKATNEFSLSNLIGQGSFGFVYRG----NLGEDLLPVAVKVINL 738
ME+ Y + + IG+G++G V++ N G VA+K + +
Sbjct: 1 MEKDGLCRADQQYECVAE----------IGEGAYGKVFKARDLKNGGR---FVALKRVRV 47
Query: 739 KQKGSIKSFVAECE--------------ALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784
+ E L+ H N++++ VC+ + LV+
Sbjct: 48 QT---------GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 98
Query: 785 DYMQ---SGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKP 841
+++ + L+ + + Q L +++LH H +VH DLKP
Sbjct: 99 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-------RGLDFLHSHR---VVHRDLKP 148
Query: 842 SNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDV 901
N+L+ ++DFGLA+ + + TS T+ Y APE + + + D+
Sbjct: 149 QNILVTSSGQIKLADFGLARI-YSFQMALTSVVV-----TLWYRAPEVLLQSSYATPVDL 202
Query: 902 YSFGILLLEMFTGR 915
+S G + EMF +
Sbjct: 203 WSVGCIFAEMFRRK 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS---IKSFVAECEALKNIRHRN 761
FS IG GSFG VY + VA+K ++ K S + + E L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 762 LIKIITVCSSIDFKGDDFKA----LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
I+ ++G + LV +Y GS D L+ L ++ ++
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAVTH 161
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ YLH H ++H D+K N+LL + + DFG A + +S +
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFV- 211
Query: 878 IKGTVGYVAPEYGMGGNVSLTG---DVYSFGILLLEMFTGRRPTHTM 921
GT ++APE + + DV+S GI +E+ + P M
Sbjct: 212 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 6e-16
Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 37/227 (16%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPV-AVKVI---NLKQKGSIKSFVAECEALKN 756
++F L ++GQGSFG V+ + G D + A+KV+ LK + +++ E + L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQR 812
+ H ++K+ + F+ + L+ D+++ G L L + + + V +
Sbjct: 83 VNHPFIVKLH--YA---FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV--------K 129
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQE 870
++ ++A A+++LH I++ DLKP N+LLD + H+ +DFGL+K D ++
Sbjct: 130 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDH--EK 181
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ S GTV Y+APE + + D +SFG+L+ EM TG P
Sbjct: 182 KAYS---FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 17/202 (8%)
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDL 337
+ NLT ++P + IL+LS N +T+LNL + L +
Sbjct: 19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG- 74
Query: 338 DFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLAN 396
L TL L+ N+ SLP L +T++ + N+++ ++PL R L
Sbjct: 75 -------TLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE 125
Query: 397 IYALGLEYNQLTGTIPYTI-GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNL 455
+ L L+ N+L T+P + L+ L + NNL + + L L++L L N+L
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 456 QGNIPSSLGNCKNLMLLNVSKN 477
IP L + N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 12/208 (5%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
++ +N NL +P +L +L L N + L + L ++ R
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
LT ++ L L+++ NQL LP + L L V N+L + +L
Sbjct: 65 AELT-KLQVDGTL--PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 218 GQLRDLNFLSVAENNFSGMLPP-IF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L +L L + N LPP + LE++SL N LP + L L L+
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGN 303
+ +N+L +IP+ F + L L GN
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 47/191 (24%), Positives = 71/191 (37%), Gaps = 17/191 (8%)
Query: 267 NLPK-LKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLG 325
+LPK IL + +N L + + L LNL + +LP + L+L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLS 85
Query: 326 QNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQIS 384
N L S L L L ++ NR SLP L + + + N++
Sbjct: 86 HNQLQSLP-------LLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK 137
Query: 385 GTIPLEI-RNLANIYALGLEYNQLTGTIPYTI-GELINLQALDFSANNLHGIIPDSIGNL 442
T+P + + L L N LT +P + L NL L N+L+ IP
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGS 194
Query: 443 STLNSLWLGFN 453
L +L N
Sbjct: 195 HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 20/217 (9%)
Query: 313 FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLST 372
S + + +N + NL + L + L L+ N ++ +
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPD------LPKD---TTILHLSENLLYTFSLATLMPYTR 56
Query: 373 ITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH 432
+T + + +++ + ++ L + L L +NQL ++P L L LD S N L
Sbjct: 57 LTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSL-GNCKNLMLLNVSKNKLTGTLPPQILEIT 491
+ ++ L L L+L N L+ +P L L L+++ N LT LP +L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLL--N 169
Query: 492 TLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRN 526
L +L L L N + +IP L + N
Sbjct: 170 GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 36/131 (27%), Positives = 59/131 (45%), Gaps = 7/131 (5%)
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNR 527
+ + +N K LT LPP + + TT+ L LS NL+ + L QL++ R
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLPKDTTI---LHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL 587
+ ++ + L L + N + S+P +L ++ VLD+S N L+ L L
Sbjct: 67 LT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 588 SFLEYLNLSYN 598
L+ L L N
Sbjct: 124 GELQELYLKGN 134
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 46/203 (22%), Positives = 73/203 (35%), Gaps = 15/203 (7%)
Query: 62 NVCQWTGVTCGQRH----PRVI-----QLYLRNQSVGGFLSPYVGNLSFLRFINLASNNL 112
V V C +R+ P + L+L + F + + L +NL L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 113 HGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYW 172
++ G L L L L N ++P L V N LT +P
Sbjct: 68 -TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 173 LKLENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAEN 231
+L+ L + N+L LPP + L++L + N L + L L +L+ L + EN
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 232 NFSGMLPPIFNISSLEQISLLTN 254
+ + F L L N
Sbjct: 183 SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF----VAECEALKNIRHR---NL 762
+IG+GSFG V + + VA+K++ + K F E L+++R + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG-NLNLIQRLNISIDVAS 821
+ +I + + F+ + ++ + S +L + ++++ Q G +L L+++ + +
Sbjct: 159 MNVIHMLENFTFRN--HICMTFELL-SMNLYELIKKNKFQ--GFSLPLVRK--FAHSILQ 211
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLFDRPIQETSSSSIGIK 879
++ LH + I+H DLKP N+LL + V DFG + + R S
Sbjct: 212 CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF---- 264
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
Y APE +G + D++S G +L E+ TG
Sbjct: 265 ----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 709 NLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKSFVA--ECEALKNIRHRNLI 763
L+G+GS+G V + + G VA+K + +A E + LK +RH NL+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGR---IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN---LIQRLNISIDVA 820
++ V K LV++++ ++ D L+ + +D + L Q +N
Sbjct: 88 NLLEV-----CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN------ 135
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
I + H H I+H D+KP N+L+ V + DFG A+ P +
Sbjct: 136 -GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA---- 186
Query: 881 TVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
T Y APE +G DV++ G L+ EMF G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRH 759
N+F L+G+G+FG V A+K++ + K + V E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNI 815
L + + F+ D V +Y G L L + + ++ R
Sbjct: 65 PFLTAL--KYA---FQTHDRLCFVMEYANGGELFFHLSRERVFTEERA--------RFYG 111
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSS 873
+ ++ SA+EYLH +V+ D+K N++LD D H+ +DFGL K I + ++
Sbjct: 112 A-EIVSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK----EGISDGAT 161
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + D + G+++ EM GR P
Sbjct: 162 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 79/284 (27%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQKGS---IKSFVAECEAL 754
+ L +G+G+FG V + VAVK+ LK+ + ++ ++E + L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKIL 79
Query: 755 KNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
+I H N++ ++ C+ K ++ ++ + G+L +L+ ++ R
Sbjct: 80 IHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 135
Query: 814 NISIDVASAI----------------------------------EYLHHHCQPPIVHGDL 839
D AI E + + L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 840 ------------------------KPSNVLLDHDMVAHVSDFGLAKFLFDRPI-QETSSS 874
N+LL V + DFGLA+ ++ P +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRP 917
+ +K APE ++ DV+SFG+LL E+F+ G P
Sbjct: 256 RLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 48/219 (21%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKI 765
S ++G G G V + A+K++ + + E E + ++++I
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRI 120
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV----DGNLNLIQRLNISIDVAS 821
+ V + + G +V + + G L +Q DQ + + I +
Sbjct: 121 VDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGE 172
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
AI+YLH I H D+KP N+L + + ++DFG AK T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT------P 223
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T YVAPE + D++S G+++ + G P
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 711 IGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKGSIKSFVA--ECEALKNIRHRNLIKI 765
IG+GS+G V++ + G+ VA+K + + +A E LK ++H NL+ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQ---IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
+ V F+ LV++Y ++ L + V +L++ +I+ A+ +
Sbjct: 68 LEV-----FRRKRRLHLVFEYCDH-TVLHELDRYQRGVP--EHLVK--SITWQTLQAVNF 117
Query: 826 LHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV 885
H H +H D+KP N+L+ V + DFG A+ L P T Y
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVA----TRWYR 169
Query: 886 APEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
+PE +G DV++ G + E+ +G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 53/240 (22%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 691 PMVSYAELNKATNEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVINLKQKG----- 742
+ Y + K +G+G++G VY+ E VA+K I L+ +
Sbjct: 32 SIDRYRRITK----------LGEGTYGEVYKAIDTVTNE---TVAIKRIRLEHEEEGVPG 78
Query: 743 -SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSND 801
+I+ E LK ++HRN+I++ +V + L+++Y ++ L+ ++ ++
Sbjct: 79 TAIR----EVSLLKELQHRNIIELKSVIH-----HNHRLHLIFEYAEN-DLKKYMDKN-- 126
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH-----VSD 856
++++ + + + + + H +H DLKP N+LL + + D
Sbjct: 127 ---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
FGLA+ F PI++ + I T+ Y PE +G T D++S + EM
Sbjct: 181 FGLARA-FGIPIRQFTHEII----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 703 NEFSLSNLIGQGSFGFVY--RGNLGEDLLPV-AVKVIN----LKQKGSIKSFVAECEALK 755
F L ++G+G +G V+ R G + + A+KV+ ++ AE L+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQ 811
++H ++ +I + F+ L+ +Y+ G L L++ D
Sbjct: 77 EVKHPFIVDLI--YA---FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------- 123
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQ 869
++ +++ A+ +LH I++ DLKP N++L+H HV +DFGL K
Sbjct: 124 CFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIH-DGT 176
Query: 870 ETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T + GT+ Y+APE M + D +S G L+ +M TG P
Sbjct: 177 VTHT----FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 60/361 (16%), Positives = 111/361 (30%), Gaps = 66/361 (18%)
Query: 319 ITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG----SLPRSIANLSTIT 374
I +L + + + + +L ++ + L+ N G L +IA+ +
Sbjct: 6 IEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 375 IIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNL--H 432
I G + EI + L L + S N
Sbjct: 64 IAEFSDIFT-GRVKDEIPEALRLLLQALLKCP-------------KLHTVRLSDNAFGPT 109
Query: 433 GIIP--DSIGNLSTLNSLWLGFNNL-------------QGNIPSSLGNCKNLMLLNVSKN 477
P D + + L L+L N L + + N L + +N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 478 KLTG----TLPPQILEITTLSSLLDLSSNLI-----SGSIPLVVGNLKNLIQLDISRNRF 528
+L L ++ + N I + + + L LD+ N F
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTV-KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 529 SGE----IPTTLSSCTSLEYLKMQDNSFRG----SIPSSLISL--KSIEVLDLSCNNLSG 578
+ + L S +L L + D ++ + L ++ L L N +
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 579 Q----IPEYLED-LSFLEYLNLSYNDF--EGQVPT--KGVFSNKTRISLIENGKLCGGLD 629
+ +++ + L +L L+ N F E V + VFS + R L E + D
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
Query: 630 E 630
E
Sbjct: 349 E 349
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 44/289 (15%), Positives = 89/289 (30%), Gaps = 50/289 (17%)
Query: 290 SNASNLVILNLSGNHFSGKVGID-----FSSLPNITRLNLGQNNLGS----GSIGDLDFI 340
++ + LSGN G +S ++ G +
Sbjct: 29 LEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 341 TLLTNCSKLETLGLNSNRFGGSLPRSIANL----STITIIAMGLNQIS------------ 384
L C KL T+ L+ N FG + + + + + + + N +
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 385 -GTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELI----NLQALDFSANNLH-----GI 434
+ + +N + ++ N+L + L + N + +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 435 IPDSIGNLSTLNSLWLGFNNL--QG--NIPSSLGNCKNLMLLNVSKNKLTGTLPPQI--- 487
+ + + L L L N G + +L + NL L ++ L+ +
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 488 LEITTLSSL--LDLSSNLIS--GSIPL---VVGNLKNLIQLDISRNRFS 529
L L L N I L + + +L+ L+++ NRFS
Sbjct: 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 21/135 (15%), Positives = 47/135 (34%), Gaps = 23/135 (17%)
Query: 488 LEITTLSSLLDLSSNLISG----SIPLVVGNLKNLIQLDISRNRFSGE----IPTTLSSC 539
+ ++ L + I+ S+ V+ ++ ++ +S N E + ++S
Sbjct: 1 MARFSIEGK-SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 540 TSLEYLKMQDNSFR----------GSIPSSLISLKSIEVLDLSCNNLSGQ----IPEYLE 585
LE + D + +L+ + + LS N + ++L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 586 DLSFLEYLNLSYNDF 600
+ LE+L L N
Sbjct: 120 KHTPLEHLYLHNNGL 134
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 56/328 (17%), Positives = 99/328 (30%), Gaps = 75/328 (22%)
Query: 96 VGNLSFLRFINLASNNLHGE----IPNELGRLSRLKVLVLDFNSFSGT----IPSNLSHC 147
+ S + +L + + E + L +K +VL N+ + N++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 148 SNLI------NFSVRRNNLTGEIPAYIGYYWLK---LENLNVAENQLTGQ----LPPSIG 194
+L F+ R + E + LK L + +++N L +
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 195 NISTLQQLGVGENKLYGIIPESLGQ-LRDLNFLSVAENNFSGMLPPIFNISSLEQISLLT 253
+ L+ L + N L + + L++L A+N L I
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNA-----------PPLRSIICGR 168
Query: 254 NRF--EGRLPLNIGF-NLPKLKILIVGQNNLT-----GSIPQSFSNASNLVILNLSGNHF 305
NR F + L + + QN + + + + L +L+L N F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 306 SGKVGIDFS----SLPNITRLNLGQNNLG-------SGSIGDLDFITLLT---------- 344
+ + S PN+ L L L + L+ I L T
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 345 ------------NCSKLETLGLNSNRFG 360
L L LN NRF
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS--------IKSFVAECEAL 754
N++ L IG G FG +Y A V+ ++ + + VA+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 755 KNIRHRNLIKIITV-----CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNL 809
K R + + + +FKG ++ +V + L+ Q+ G
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQKISGQN-----GTFKK 150
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLAK 861
L + I + +EY+H + VHGD+K +N+LL + +++D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEAL-KNIR 758
+F L ++G+GSFG V+ + A+K + + ++ + E L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H L + C+ F+ + V +Y+ G L +Q +L + + +
Sbjct: 77 HPFLTHM--FCT---FQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAE 126
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSI 876
+ +++LH IV+ DLK N+LLD D H+ +DFG+ K +T++
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK-ENMLGDAKTNT--- 177
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFN 923
GT Y+APE +G + + D +SFG+LL EM G+ P +F+
Sbjct: 178 -FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRHRN 761
F+ ++G+GSFG V AVK++ + Q ++ + E L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + C F+ D V +Y+ G L +QQ G + + ++A
Sbjct: 403 FLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAI 453
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIK 879
+ +L I++ DLK NV+LD + H+ +DFG+ K I + ++
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT-FC 503
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + D ++FG+LL EM G+ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEAL-KNIRHR 760
F +IG+GSFG V + + AVKV+ + +K K ++E L KN++H
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ----SNDQVDGNLNLIQRLNIS 816
L+ + S F+ D V DY+ G L LQ+ + R +
Sbjct: 100 FLVGL--HFS---FQTADKLYFVLDYINGGELFYHLQRERCFLEPRA--------RFYAA 146
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSS 874
++ASA+ YLH IV+ DLKP N+LLD H+ +DFGL K I+ S++
Sbjct: 147 -EIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHNSTT 196
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFN 923
S GT Y+APE T D + G +L EM G P T M++
Sbjct: 197 ST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 30/176 (17%), Positives = 67/176 (38%), Gaps = 25/176 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRG--------NLGEDLLPVAVKV--INLKQKGSIKSF--VAE 750
++ L + + + G +Y + G ++K+ + + F A+
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 751 CEALKNIRHRNLIKIITVCSSIDF--KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLN 808
+ + ++ + + + F D ++ LV SL+ L S V L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP-SLGRSLQSALDVSPKHV---LS 157
Query: 809 LIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 861
L ++ + A+E+LH + VHG++ N+ + D V ++ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 32/188 (17%), Positives = 67/188 (35%), Gaps = 13/188 (6%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNK 478
+ Q L +L I + NL ++ +++ + + S S N + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 479 LTGTLPPQILEITTLSSL--LDLSSNLISGSIP--LVVGNLKNLIQLDISRNRFSGEIPT 534
+ P L L L L + + + P V + L+I+ N + IP
Sbjct: 92 NLTYIDPDAL--KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 535 -TLSSCTS-LEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEY-LEDL-SFL 590
+ LK+ +N F S+ + ++ + L+ N I + + S
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 591 EYLNLSYN 598
L++S
Sbjct: 208 SLLDVSQT 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 36/211 (17%), Positives = 71/211 (33%), Gaps = 13/211 (6%)
Query: 244 SSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIP-QSFSNASNLVILNLSG 302
S + + L+ +P + NLP + + V + + SF N S + + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 303 NHFSGKVGID-FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG 361
+ D LP + L + L DL + L + N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKM--FPDLTKVYSTDI---FFILEITDNPYMT 144
Query: 362 SLP-RSIANLSTITI-IAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTI--GE 417
S+P + L T+ + + N + ++ N + A+ L N+ I G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 418 LINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
LD S ++ + + +L L +
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 51/264 (19%), Positives = 94/264 (35%), Gaps = 47/264 (17%)
Query: 146 HCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVG 205
C +F V ++ IP LPPS Q L +
Sbjct: 9 ECHQEEDFRVTCKDIQ-RIP----------------------SLPPS------TQTLKLI 39
Query: 206 ENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IF-NISSLEQISLLTNRFEGRLPLN 263
E L I + L +++ + V+ + L F N+S + I + R + +
Sbjct: 40 ETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPD 99
Query: 264 IGFNLPKLKILIVGQNNLTGSIPQ--SFSNASNLVILNLSGNHFSGKVGID-FSSLPNIT 320
LP LK L + L P + IL ++ N + + ++ F L N T
Sbjct: 100 ALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158
Query: 321 R-LNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANL-STITIIA 377
L L N S+ F N +KL+ + LN N++ + + + S +++
Sbjct: 159 LTLKLYNNGF--TSVQGYAF-----NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 378 MGLNQISGTIPLEI-RNLANIYAL 400
+ ++ +P + +L + A
Sbjct: 212 VSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 33/232 (14%), Positives = 65/232 (28%), Gaps = 53/232 (22%)
Query: 98 NLSFLRFINLASNNLHGEIPNEL-GRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
NL + I ++ + ++ + LS++ + + I +
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA--------LK-- 102
Query: 157 RNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPP--SIGNISTLQQLGVGENKLYGIIP 214
L L+ L + L P + + L + +N IP
Sbjct: 103 --ELP------------LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 215 ESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKIL 274
N F G+ + + L N F + FN KL +
Sbjct: 148 ---------------VNAFQGL------CNETLTLKLYNNGFT-SVQGYA-FNGTKLDAV 184
Query: 275 IVGQNNLTGSIPQ-SFSNA-SNLVILNLSGNHFSGKVGIDFSSLPNITRLNL 324
+ +N I + +F S +L++S + L + N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 53/254 (20%), Positives = 91/254 (35%), Gaps = 54/254 (21%)
Query: 686 MEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK 745
M + K + F + + GQG+FG V G + VA+K +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----P 60
Query: 746 SF----VAECEALKNIRHRNLIKIITV--CSSIDFKGDDFKALVYDYMQSGSLEDWLQQS 799
F + + L + H N++++ + + D + +V +Y+ + L +
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRC 115
Query: 800 NDQVDGNLNLIQRLNISID--------VASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDM 850
+++ + +I LH + H D+KP NVL++ D
Sbjct: 116 CRN-----YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADG 169
Query: 851 VAHVSDFGLAKFLF-DRPIQETSSSSIGIKGTVGYV------APEYGMGGNVSLTG--DV 901
+ DFG AK L P V Y+ APE + GN T D+
Sbjct: 170 TLKLCDFGSAKKLSPSEP-------------NVAYICSRYYRAPEL-IFGNQHYTTAVDI 215
Query: 902 YSFGILLLEMFTGR 915
+S G + EM G
Sbjct: 216 WSVGCIFAEMMLGE 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 46/231 (19%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
++ + +IG GSFG VY+ L + VA+K + ++ + E + ++ + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108
Query: 762 LIKIITV-CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID-- 818
++++ SS + K + + LV DY+ E + + + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRA-----KQTLPVIYV 158
Query: 819 ------VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLFDRPIQET 871
+ ++ Y+H I H D+KP N+LLD D V + DFG AK L
Sbjct: 159 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--- 212
Query: 872 SSSSIGIKGTVGYV------APEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
V Y+ APE G + DV+S G +L E+ G+
Sbjct: 213 ---------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRH 759
+ IG G+ G V VA+K ++ + + K E +K + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 760 RNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
+N+I ++ V + ++F+ +V + M + +L +Q D + L Q L
Sbjct: 84 KNIIGLLNVFTP-QKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--- 138
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
I++LH I+H DLKPSN+++ D + DFGLA R + +
Sbjct: 139 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPY 186
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
+ T Y APE +G D++S G ++ EM G
Sbjct: 187 V-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 33/237 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL--GEDL---LPVAVKVIN-----LKQKGSIKSFVAECE 752
+ + IGQG FG +Y ++ E + P VKV L + A+ E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 753 ALKNIRHRNLIKIITVCSSIDF-----KGDDFKALVYDYMQSG-SLEDWLQQSNDQVDGN 806
++ +K + V G ++ ++ D G L+ + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA----KR 148
Query: 807 LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGLAKFLF 864
+ L +S+ + +EY+H H VHGD+K SN+LL+ + ++ D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 865 D----RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
+ GT+ + + + G S GD+ G +++ TG P
Sbjct: 206 PEGVHKAYAADPKRC--HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 58/226 (25%)
Query: 711 IGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKII-TV 768
+G+G + V+ + V VK++ +K IK E + L+N+R N+I + V
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIV 100
Query: 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS------- 821
+ ALV++++ + D L Q L D+
Sbjct: 101 KDPVSRT----PALVFEHV-------------NNTDFK-QLYQTLT-DYDIRFYMYEILK 141
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A++Y H I+H D+KP NV++DH+ + D+GLA+F P QE +
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYN-------- 188
Query: 881 TVGYV------APEYGMGG---NVSLTGDVYSFGILLLEMFTGRRP 917
V PE + + SL D++S G +L M + P
Sbjct: 189 --VRVASRYFKGPELLVDYQMYDYSL--DMWSLGCMLASMIFRKEP 230
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 4e-13
Identities = 70/453 (15%), Positives = 146/453 (32%), Gaps = 53/453 (11%)
Query: 145 SHCSNLINFSVRR-NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIS----TL 199
+ +L + + + T + I + K++ L + E+ + + + ++ +L
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 200 QQLGVGENKLYGIIPESLGQL----RDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNR 255
+ L + I P+ L + R L + V + ++ ++LE+ +
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLN 254
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLT-GSIPQSFSNASNLVILNLSGNHFSGKVGID-F 313
+ +P + K+ +G + + +P F A+ + L+L +
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLI 314
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
PN+ L IGD L C +L+ L + + +S
Sbjct: 315 QKCPNLEVLET------RNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 374 TIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGE-LINLQALDFSANNLH 432
+IA+ + + + + + +T +IG L NL L
Sbjct: 369 GLIALA------------QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV--LLD 414
Query: 433 GIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN--KLTGTLPPQILEI 490
+ I +L N + S L CK L LT I +
Sbjct: 415 RE--ERITDLPLDNG-----------VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQY 461
Query: 491 TTLSSLLDLSSNLIS-GSIPLVVGNLKNLIQLDISRNRFSGE-IPTTLSSCTSLEYLKMQ 548
+ + L S + NL +L++ FS I ++ SL YL +Q
Sbjct: 462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQ 521
Query: 549 DNSFRGSIPSSLISLKS---IEVLDLS-CNNLS 577
+ + + IE++ ++
Sbjct: 522 GYRASMTGQDLMQMARPYWNIELIPSRRVPEVN 554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 54/387 (13%), Positives = 118/387 (30%), Gaps = 56/387 (14%)
Query: 290 SNASNLVILNLSGNHFS--GKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347
+N L ++ S + + ++ L L ++++T+C
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDGLLSIVTHCR 164
Query: 348 KLETLGLNSNRFG-------GSLPRSIANLSTITIIAMGLNQIS-GTIPLEIRNLANIYA 399
K++TL + + F L + +L + +IS + RN ++ +
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL-WLGFNNLQGN 458
+ + ++ + NL+ + N +P+ NL L LG + + N
Sbjct: 225 VKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283
Query: 459 -IPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNL 515
+P + L++ L + I +L L+ + + + ++
Sbjct: 284 EMPILFPFAAQIRKLDLLYALLETEDHCTL--IQKCPNLEVLETRNVIGDRGLEVLAQYC 341
Query: 516 KNLIQLDISRNRFSGEIPTTLS------------SCTSLEYL-----KMQDNSFRGSIPS 558
K L +L I R + C LEY+ + + S SI +
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE-SIGT 400
Query: 559 SLISLKSIEVLDLS-CNNLSGQ-----IPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSN 612
L +L ++ L ++ + L L
Sbjct: 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ-----------GG 449
Query: 613 KTRISLIENGKLCGGLDELHLPACHNT 639
T + L G+ + + L +
Sbjct: 450 LTDLGLSYIGQYSPNVRWMLLGYVGES 476
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 42/350 (12%), Positives = 94/350 (26%), Gaps = 73/350 (20%)
Query: 311 IDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANL 370
+ P NL N G + N +L+++ +
Sbjct: 78 LKLKGKPRAAMFNLIPENWGG--YVTPWVTEISNNLRQLKSV----------------HF 119
Query: 371 STITIIAMGLNQISGTIPLEIRNLANIYALGLEY-NQLTGTIPYTIGE-LINLQALDFSA 428
+ + + L++++ ++ L L+ + T +I ++ L
Sbjct: 120 RRMIVSDLDLDRLAK------ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEE 173
Query: 429 NNLHGI-------IPDSIGNLSTLNSLWLGFNNLQGNIPSSLG-NCKNLMLLNVSKNKLT 480
++ + +L LN F + ++ NC++L+ + V
Sbjct: 174 SSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD---- 229
Query: 481 GTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCT 540
EI L ++NL + ++ + E L
Sbjct: 230 -------FEILELVGFFKAAANL------------EEFCGGSLNEDIGMPEKYMNLVFPR 270
Query: 541 SLEYLKMQDNSFRGSIPSSLISLKSIEVLDLS-CNNLSGQIPEYLEDLSFLEYLNLSYND 599
L L + +P I LDL + ++ LE L
Sbjct: 271 KLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR--- 326
Query: 600 FEGQVPTKGVFSNKTRISLIENGKLCGGLDELHLPACHNTRPRKAKITIL 649
+ L + C L L + + + + + ++
Sbjct: 327 -----------NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV 365
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 685 SMEQQFPMVSYAELNKATNEFSLSN-----LIGQGSFGFVYRGNLGEDLLPVAVKVI--- 736
+E++ ++ E KA++ L + +IG+GS+ V L + A++V+
Sbjct: 29 GIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE 88
Query: 737 NLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWL 796
+ I E + + + + C F+ + V +Y+ G L +
Sbjct: 89 LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC----FQTESRLFFVIEYVNGGDLMFHM 144
Query: 797 QQSNDQVDGNLNLIQ-RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV- 854
Q+ L R + +++ A+ YLH I++ DLK NVLLD + H+
Sbjct: 145 QR-----QRKLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIK 193
Query: 855 -SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
+D+G+ K RP TS+ GT Y+APE G + + D ++ G+L+ EM
Sbjct: 194 LTDYGMCK-EGLRPGDTTST----FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 914 GRRP 917
GR P
Sbjct: 249 GRSP 252
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 48/244 (19%), Positives = 86/244 (35%), Gaps = 25/244 (10%)
Query: 379 GLNQISGTIPLEIRNLANIYALGLEYNQLTGTIP-YTIGELINLQALDFSANNLHGIIPD 437
L + ++P L L +N L+ +T L NL +L S N+L+ I +
Sbjct: 29 QLPNVPQSLPSYTALLD------LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE 82
Query: 438 SIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL 496
+ + L L L N+L + + + L +L + N + + ++ L
Sbjct: 83 AFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF--EDMAQL 138
Query: 497 --LDLSSNLISGSIP----LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSL--EYLKMQ 548
L LS N IS P L L+ LD+S N+ T L + L +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 549 DNSF----RGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQV 604
+N + S + + + +L + L ++ L++ N S
Sbjct: 198 NNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
Query: 605 PTKG 608
G
Sbjct: 258 AHLG 261
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 36/173 (20%), Positives = 62/173 (35%), Gaps = 16/173 (9%)
Query: 213 IPESLGQLR-DLNFLSV--AENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLP 269
+P L N LS AE + + ++L + L N + +P
Sbjct: 37 LPSYTALLDLSHNNLSRLRAEWTPTRL-------TNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 270 KLKILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNN 328
L+ L + N+L ++ FS+ L +L L NH F + + +L L QN
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 329 LGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLN 381
+ + + L KL L L+SN+ + L + L+
Sbjct: 148 ISRFPVELIKDGNKLP---KLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 34/161 (21%), Positives = 69/161 (42%), Gaps = 9/161 (5%)
Query: 175 LENLNVAENQLTGQLPPSI--GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENN 232
L+++ N L+ +L ++ L L + N L I E+ + +L +L ++ N+
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 233 FSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSN 291
+ +F ++ +LE + L N + N ++ +L+ L + QN ++ + +
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158
Query: 292 ASNLV---ILNLSGNHFSGKVGIDFSSLPNITRLNLG-QNN 328
+ L +L+LS N D LP + L NN
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 27/137 (19%), Positives = 53/137 (38%), Gaps = 10/137 (7%)
Query: 98 NLSFLRFINLASNNLHGEIPNE-LGRLSRLKVLVLDFNSFSGTIPSN-LSHCSNLINFSV 155
L+ L + L+ N+L+ I +E + L+ L L N T+ S L +
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPP----SIGNISTLQQLGVGENKLYG 211
N++ + +L+ L +++NQ++ + P + L L + NKL
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 212 IIPESLGQLRDLNFLSV 228
+ L +L +
Sbjct: 178 LPLTDLQKLPAWVKNGL 194
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRHRN 761
F ++G+GSFG V + E AVKV+ + Q ++ + E L R+
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + C F+ D V +++ G L +Q+S + + + ++ S
Sbjct: 85 FLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIIS 135
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIK 879
A+ +LH I++ DLK NVLLDH+ H +DFG+ K T++
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK-EGICNGVTTAT----FC 185
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE D ++ G+LL EM G P
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-13
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 49/223 (21%)
Query: 711 IGQGSFGFVYRGNL---GEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRHRNLIKI 765
IG GSFG V++ L E VA+K + + K E + ++ ++H N++ +
Sbjct: 48 IGNGSFGVVFQAKLVESDE----VAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDL 97
Query: 766 ITV-CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI---DVAS 821
S+ D K + F LV +Y+ E + +++ + L I + +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLAKFLF-DRPIQETSSSSIGIK 879
++ Y+H I H D+KP N+LLD V + DFG AK L P
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP------------ 197
Query: 880 GTVGYV------APEYGMGGNVSLTG-DVYSFGILLLEMFTGR 915
V Y+ APE G T D++S G ++ E+ G+
Sbjct: 198 -NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNIRH 759
+F L +IG+GS+ V L + A+KV+ + I E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ-RLNISID 818
+ + C F+ + V +Y+ G L +Q+ L R + +
Sbjct: 69 HPFLVGLHSC----FQTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSA-E 118
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSI 876
++ A+ YLH I++ DLK NVLLD + H+ +D+G+ K RP TS+
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK-EGLRPGDTTST--- 169
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE G + + D ++ G+L+ EM GR P
Sbjct: 170 -FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 49/277 (17%), Positives = 93/277 (33%), Gaps = 61/277 (22%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLP---VAVKVINLKQKGSIKSFVAECEALKNIR 758
+ + +G G F V+ L D+ VA+KV+ + + ++ + E LK++R
Sbjct: 36 NGRYHVIRKLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVR 91
Query: 759 -----HRNLIKIITVCSSIDFKG--DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQ 811
N ++ + G +V++ + L W+ +SN Q L ++
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGL-PLPCVK 149
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL--------DHDMVAHVSDFGLAKFL 863
+ I V ++YLH C+ I+H D+KP N+LL A A
Sbjct: 150 K--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 864 FDRPIQETSSSSIGIKG---------------------------------TVGYVAPEYG 890
+ +++ T Y + E
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265
Query: 891 MGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLT 927
+G + D++S + E+ TG + T
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT 302
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI---NLKQKGSIKSFVAECEALKNI---- 757
F+ ++G+GSFG V AVK++ + Q ++ + E K +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLALP 77
Query: 758 -RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ L ++ F+ D V +Y+ G L +QQ G + +
Sbjct: 78 GKPPFLTQLH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYA 127
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSS 874
++A + +L I++ DLK NV+LD + H+ +DFG+ K I + ++
Sbjct: 128 AEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTT 178
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y+APE + D ++FG+LL EM G+ P
Sbjct: 179 KT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF----VAECEALKNI 757
+ + + +LIG+GSFG V + + VA+K+I + K+F E L+ +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLLELM 107
Query: 758 RHR---NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG-NLNLIQRL 813
I+ + F+ LV++ + S +L D L+ +N + G +LNL ++
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRN--HLCLVFEML-SYNLYDLLRNTNFR--GVSLNLTRK- 161
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH--VSDFGLAKFLFDRPIQET 871
+ + +A+ +L + I+H DLKP N+LL + + + DFG + L R Q
Sbjct: 162 -FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
S Y +PE +G L D++S G +L+EM TG
Sbjct: 220 QSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 48/231 (20%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA-------- 753
+ IG G+ G V VA+K ++ + F + A
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 754 -LKNIRHRNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLNLI 810
+K + H+N+I ++ V + ++F+ LV + M + +L +Q D + L
Sbjct: 114 LMKCVNHKNIISLLNVFTP-QKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLY 171
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
Q L I++LH I+H DLKPSN+++ D + DFGLA R
Sbjct: 172 QMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGT 216
Query: 871 TSSSSIGIKGTVGYV------APEYGMGGNVSLTGDVYSFGILLLEMFTGR 915
+ + YV APE +G D++S G ++ EM +
Sbjct: 217 SFMMT-------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHR 760
+++F L +L+G+G++G V VA+K I K + E + LK+ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ-------SNDQVDGNLNLIQRL 813
N+I I + F+ + ++ + MQ+ D L + S+D + + Q L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQT----D-LHRVISTQMLSDDHI--QYFIYQTL 122
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
A++ LH ++H DLKPSN+L++ + V DFGLA+ + + +
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 874 SSIGIKGTVGYV------APEYGMGGNVSLTG--DVYSFGILLLEMFTGR 915
+ +V APE M + + DV+S G +L E+F R
Sbjct: 173 TGQQSGMV-EFVATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 54/253 (21%), Positives = 95/253 (37%), Gaps = 58/253 (22%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+ ++SL +G GSFG V E A+K + + + E + +K + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN------LNLIQ---- 811
+IK++ + + D+ + G + + + V N LN+I
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 812 -------------RLNISID--------VASAIEYLHHHCQPPIVHGDLKPSNVLLD-HD 849
+I ++ + A+ ++H I H D+KP N+L++ D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 850 MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYV------APEYGMGGNVSLTG-DVY 902
+ DFG AK L E S V Y+ APE +G D++
Sbjct: 179 NTLKLCDFGSAKKLIP---SEPS---------VAYICSRFYRAPELMLGATEYTPSIDLW 226
Query: 903 SFGILLLEMFTGR 915
S G + E+ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 13/186 (6%)
Query: 395 ANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
A+ L L+ N+L+ L L+ L + N L + L L +LW+ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 455 LQ---GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIP 509
LQ + L NL L + +N+L +LPP++ +L+ L L L N + S+P
Sbjct: 97 LQALPIGVFDQL---VNLAELRLDRNQLK-SLPPRVF--DSLTKLTYLSLGYNELQ-SLP 149
Query: 510 L-VVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEV 568
V L +L +L + N+ T L+ LK+ +N + + SL+ +++
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
Query: 569 LDLSCN 574
L L N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 175 LENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNF 233
+ L++ N+L+ LP ++ L+ L + +NKL + +L++L L V +N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 234 SGMLPP-IF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFS 290
LP +F + +L ++ L N+ + LP + +L KL L +G N L S+P+ F
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 291 NASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLE 350
++L L L N F L + L L N L G D + KL+
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD------SLEKLK 208
Query: 351 TLGLNSN 357
L L N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 9/183 (4%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSL-GNCKNLMLLNVSKNK 478
+ + LD +N L + + L+ L L+L N LQ +P+ + KNL L V+ NK
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPTTL- 536
L LP + + + L L N + S+P V +L L L + N +P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 537 SSCTSLEYLKMQDNSFRGSIPSSLI-SLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNL 595
TSL+ L++ +N + +P L ++ L L N L + L L+ L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 596 SYN 598
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 16/189 (8%)
Query: 222 DLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
D L + N S + F ++ L + L N+ + LP I L L+ L V N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 281 LTGSIPQS-FSNASNLVILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L ++P F NL L L N + F SL +T L+LG N L S G D
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRV-FDSLTKLTYLSLGYNELQSLPKGVFD 154
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLAN 396
+T L+ L L +N+ +P L+ + + + NQ+ +P +L
Sbjct: 155 KLT------SLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEK 206
Query: 397 IYALGLEYN 405
+ L L+ N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 7/181 (3%)
Query: 126 LKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQL 185
K L L N S + L + N L +PA I LE L V +N+L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 186 TGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPP-IF-N 242
LP + + L +L + N+L + P L L +LS+ N LP +F
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 243 ISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSG 302
++SL+++ L N+ + R+P L +LK L + N L +F + L +L L
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
Query: 303 N 303
N
Sbjct: 215 N 215
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 1e-11
Identities = 98/668 (14%), Positives = 197/668 (29%), Gaps = 208/668 (31%)
Query: 1 MLLIFISIRCLGTFVWCVTLFL---LNPDSCFALSNETDRVALLAIKSQLQDPMGITSSW 57
L +F ++ + V F+ L + F +S IK++ + P +T +
Sbjct: 64 TLRLFWTLLSKQEEM--VQKFVEEVLRINYKFLMS---------PIKTEQRQPSMMTRMY 112
Query: 58 NNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIP 117
+ +LY NQ + Y N++ + ++
Sbjct: 113 IEQRD-----------------RLYNDNQV----FAKY----------NVSRLQPYLKLR 141
Query: 118 NELGRLSRLKVLVLDFNSFSGTIPSNLSH----C--SNLINFSVRRNNLTGEIPAYIGYY 171
L L K +++ + + + ++ I +
Sbjct: 142 QALLELRPAKNVLI--------------DGVLGSGKTWVALDVCLSYKVQCKMDFKI--F 185
Query: 172 WLKLENLNVAE------NQLTGQLPPSI-----GNISTLQQLGVGENKLYGII-----PE 215
WL L+N N E +L Q+ P+ + + ++ + +L ++
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
L L ++ FN+S +I LLT RF+ + L
Sbjct: 246 CLLVLLNVQNAKAWN---------AFNLSC--KI-LLTTRFK-----QVTDFLSAATTTH 288
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIG 335
+ ++ + + + + LP R L N I
Sbjct: 289 ISLDHH----SMTLTPDEVKSL-------LLKYLDCRPQDLP---REVLTTNPRRLSIIA 334
Query: 336 DL--DFITLLTN-----CSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIP 388
+ D + N C KL TII LN + P
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLT-----------------------TIIESSLNVLE---P 368
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLS--TLN 446
E R + +++L + P S ++ L+
Sbjct: 369 AEYRKM---------FDRL-------------------------SVFPPSA-HIPTILLS 393
Query: 447 SLWLGFNNLQGNIPSSLGN-CKNLMLLNVSKNKLTGTLPPQILEIT-TLSSLLDLSSNLI 504
+W ++ + + N L+ + T ++P LE+ L + L +++
Sbjct: 394 LIW---FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450
Query: 505 SG-SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEY-LKMQDNSFRGSI-PSSLI 561
+IP K D+ + + + LK ++ R ++ +
Sbjct: 451 DHYNIP------KTFDSDDLIPPYLDQYF------YSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 562 SLKSIEV---LDLSCNNLSGQIPEYLEDLSFLE-YLNLSYNDFEGQVPTKGVFSNKTRIS 617
+ +E D + N SG I L+ L F + Y+ + +E V F K +
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558
Query: 618 LIENGKLC 625
LI +
Sbjct: 559 LICSKYTD 566
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 51/261 (19%), Positives = 90/261 (34%), Gaps = 52/261 (19%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRH 759
+ + + +LIG GS+G V + VA+K I + K + E L + H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQS---------GSLEDWLQQSNDQVDGNLNLI 810
+++K++ + D + D +V + S L + ++ L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL--------LY 163
Query: 811 QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQE 870
L ++Y+H I+H DLKP+N L++ D V DFGLA+ +
Sbjct: 164 NLLV-------GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 871 TSSSSIGIKGTVGYVAPEYGMGGNVSLTG-----------------------DVYSFGIL 907
+ + + V + LTG DV+S G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 908 LLEMFTGRRPTHTMFNDGLTL 928
E+ + D L
Sbjct: 274 FAELLNMIKENVAYHADRGPL 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 21/165 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
F + IG G+FG + G VA+K+ +K + E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP--QLHLEYRFYK-----QL 61
Query: 763 IKIITVCSSIDF-KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ F + A+V + + SLED + +L L I+I + S
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLE-LLGPSLEDLFDLCD----RTFSLKTVLMIAIQLIS 116
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDM-----VAHVSDFGLAK 861
+EY+H +++ D+KP N L+ V H+ DF LAK
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 53/233 (22%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRH 759
+ +G G++G V VA+K ++ + + K E LK+++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 760 RNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
N+I ++ V + +F LV +MQ+ +L I L S
Sbjct: 83 ENVIGLLDVFTP-ASSLRNFYDFYLVMPFMQT----------------DLQKIMGLKFSE 125
Query: 818 DVAS--------AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
+ ++Y+H +VH DLKP N+ ++ D + DFGLA R
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHAD 177
Query: 870 ETSSSSIGIKGTVGYV------APEYGMG-GNVSLTGDVYSFGILLLEMFTGR 915
+ GYV APE + + + T D++S G ++ EM TG+
Sbjct: 178 AEMT---------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI-KSFVAECEALKNIRHR 760
++ + IG+G++G V + + VA+K I+ + + + + E + L RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 761 NLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ---SNDQVDGNLNLI--QRL 813
N+I I + + + K +V D M++ D L + + + ++ Q L
Sbjct: 86 NIIGINDIIRAPTI--EQMKDVYIVQDLMET----D-LYKLLKTQHLSNDHICYFLYQIL 138
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
++Y+H ++H DLKPSN+LL+ + DFGLA R
Sbjct: 139 R-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA-----RVADPDHD 183
Query: 874 SSIGIKGTVG---YVAPEYGMGGNVSLTG--DVYSFGILLLEMFTGR 915
+ + V Y APE M + T D++S G +L EM + R
Sbjct: 184 HTGFLTEYVATRWYRAPEI-MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
N + L IG GSFG +Y G VA+K+ +K K E + K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQ---- 62
Query: 763 IKIITVCSSIDF-KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + + D+ +V + + SLED + +L L ++ + S
Sbjct: 63 -GGVGIPTIRWCGAEGDYNVMVME-LLGPSLEDLFNFCS----RKFSLKTVLLLADQMIS 116
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 861
IEY+H +H D+KP N L+ + ++ DFGLAK
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+ + +G G G V+ + VA+K I L S+K + E + ++ + H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 762 LIKIITV-------CSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ---SNDQVDGNLNL 809
++K+ + + + + +V +YM++ D L ++ + L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGPLLEEHARL 124
Query: 810 I--QRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDR 866
Q L ++Y+H ++H DLKP+N+ ++ D+V + DFGLA R
Sbjct: 125 FMYQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA-----R 169
Query: 867 PIQETSSSSIGIKGTVG---YVAPEYGMGGNVSLTG--DVYSFGILLLEMFTGR 915
+ S + + Y +P + + T D+++ G + EM TG+
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRL-LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 20/161 (12%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKI 765
S ++G G G V + A+K++ E E + ++++I
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 76
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR--LNISIDVASAI 823
+ V + + G +V + + G L +Q G+ +R I + AI
Sbjct: 77 VDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDR-----GDQAFTEREASEIMKSIGEAI 130
Query: 824 EYLHHHCQPPIVHGDLKPSNVLL---DHDMVAHVSDFGLAK 861
+YLH I H D+KP N+L + + ++DFG AK
Sbjct: 131 QYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 34/165 (20%), Positives = 62/165 (37%), Gaps = 21/165 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ + IG+GSFG ++ G + VA+K + E K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYK-----LL 62
Query: 763 IKIITVCSSIDF-KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + F + LV D + SLED L ++ + + +
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVID-LLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLA 117
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLL-----DHDMVAHVSDFGLAK 861
++ +H +V+ D+KP N L+ + + +V DFG+ K
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-11
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 298 LNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
L+L + F L +T LNL N L + S G D +T +L TLGL +N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT------ELGTLGLANN 93
Query: 358 RFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIPYTI 415
+ SLP + +L+ + + +G NQ+ ++P + L + L L NQL +IP
Sbjct: 94 QL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 416 -GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
+L NLQ L S N L + + L L ++ L F N
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 200 QQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN-ISSLEQISLLTNRFEG 258
++L + L + + L L +L++ N + +F+ ++ L + L N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 259 RLPLNIGFNLPKLKILIVGQNNLTGSIPQS-FSNASNLVILNLSGNHF-SGKVGIDFSSL 316
LPL + +L +L L +G N L S+P F + L L L+ N S G F L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGA-FDKL 154
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
N+ L+L N L S G D KL+T+ L N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFD------RLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 37/155 (23%), Positives = 57/155 (36%), Gaps = 9/155 (5%)
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ--- 456
L L+ L T L L L+ N L + +L+ L +L L N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL-VVGNL 515
+ L L L + N+L +LP + + T L L++N + SIP L
Sbjct: 100 LGVFDHL---TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550
NL L +S N+ L+ + + N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 13/159 (8%)
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ---GNIPSSLGNCKNLMLLNVSKNK 478
+ LD + L + + L+ L L L +N LQ + L L L ++ N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL---TELGTLGLANNQ 94
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPT-TL 536
L +LP + + T L L N + S+P V L L +L ++ N+ IP
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 537 SSCTSLEYLKMQDNSFRGSIP-SSLISLKSIEVLDLSCN 574
T+L+ L + N + S+P + L ++ + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 5/154 (3%)
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG 506
L L L ++ L LN+ N+L TL + + T L L++N ++
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS 97
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI-SLKS 565
V +L L +L + N+ T L+ L++ N + SIP+ L +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 566 IEVLDLSCNNLSGQIPEYLED-LSFLEYLNLSYN 598
++ L LS N L +P D L L+ + L N
Sbjct: 157 LQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 35/130 (26%), Positives = 53/130 (40%), Gaps = 9/130 (6%)
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLT 408
E L L S + L+ +T + + NQ+ T+ + +L + LGL NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 409 GTIPYTI-GELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS----SL 463
++P + L L L N L + L+ L L L N LQ +IP+ L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 464 GNCKNLMLLN 473
N + L L
Sbjct: 155 TNLQTLSLST 164
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 38/181 (20%), Positives = 65/181 (35%), Gaps = 29/181 (16%)
Query: 127 KVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT 186
+ L L + + + L ++ N L + A + +L L +A NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 187 GQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISS 245
LP + +++ L +L +G N+L + +L L L + N
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN-------------- 141
Query: 246 LEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFSNASNLVILNLSGNH 304
Q+ +P L L+ L + N L S+P +F L + L GN
Sbjct: 142 --QLQ--------SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
Query: 305 F 305
F
Sbjct: 191 F 191
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 62/323 (19%), Positives = 106/323 (32%), Gaps = 52/323 (16%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSL-----PNITRLNLGQNNLGSGSIGDLDFITLLT 344
+ +++ LNLSGN K + + N+T LNL N L S +L TL
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL-VKTLAA 106
Query: 345 NCSKLETLGLNSNRFGGSLPRSIANL-----STITIIAMGLNQISGT------IPLEIRN 393
+ L L N F ++IT + + N + L
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 394 LANIYALGLEYNQLTGTIPYTIGELI-----NLQALDFSANNL-----HGIIPDSIGNLS 443
AN+ +L L N L + + + ++ +LD SAN L + +
Sbjct: 167 -ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225
Query: 444 TLNSLWLGFNNLQG----NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEI----TTLSS 495
+ SL L N L G N+ + K+L + + + + Q + +
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285
Query: 496 L--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
+ +D + I S + + NL + L + + K Q N
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPS--------LLNQCLIFAQKHQTNIED 337
Query: 554 GSIPSSLISLKSIEVLDLSCNNL 576
+IP L +C L
Sbjct: 338 LNIPDELRE------SIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 57/342 (16%), Positives = 117/342 (34%), Gaps = 76/342 (22%)
Query: 293 SNLVILNLSGNHFSGKVGIDFSSL-----PNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347
+ L+LS N+ ++ ++T LNL N+LG + +L L +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDEL-VQILAAIPA 80
Query: 348 KLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQL 407
+ +L L+ N + + L I TI L L +N
Sbjct: 81 NVTSLNLSGNFLSYK---------SSDELVKTLAAIPFTI----------TVLDLGWNDF 121
Query: 408 TGTIPYTIGELI-----NLQALDFSANNLHGIIPDSIGNL-----STLNSLWLGFNNLQG 457
+ + ++ +L+ N+L D + + + +NSL L NNL
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL-- 179
Query: 458 NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLI--SGSIPL---VV 512
+S C L S +++SL DLS+NL+ L
Sbjct: 180 ---ASKN-CAELAKFLASIP-------------ASVTSL-DLSANLLGLKSYAELAYIFS 221
Query: 513 GNLKNLIQLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNSFRG-------SIPSSLI 561
+++ L++ N G + S L+ + + + + ++ ++
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 562 SLKSIEVLDLSCNNLSG----QIPEYLEDLSF-LEYLNLSYN 598
+++ I ++D + + I + +LS + +L
Sbjct: 282 NIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 47/243 (19%), Positives = 83/243 (34%), Gaps = 61/243 (25%)
Query: 702 TNEFSLSNLIGQGSFGFVYRG--NLGEDLLPVAVKVINLKQKGSIKSFVA---------- 749
+ +++ I GS+G V G + G PVA+K + +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGI---PVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 750 -ECEALKNIRHRNLIKIITVCSSIDFKGDDFKA--LVYDYMQS------GSLEDWLQQSN 800
E L + H N++ + + + LV + M++ + S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEE--PAMHKLYLVTELMRTDLAQVIHDQRIVI--SP 133
Query: 801 DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
+ + L + LH + +VH DL P N+LL + + DF LA
Sbjct: 134 QHI--QYFMYHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 861 KFLFDRPIQETSSSSIGIKGTVGYV------APEYGMGGNVSLTG--DVYSFGILLLEMF 912
R ++ + YV APE + T D++S G ++ EMF
Sbjct: 182 -----REDTADANKT-------HYVTHRWYRAPEL-VMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 913 TGR 915
+
Sbjct: 229 NRK 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 50/249 (20%), Positives = 96/249 (38%), Gaps = 53/249 (21%)
Query: 702 TNEFSLSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLKQKGSIKSF----VAECEALKN 756
+ + +G+G+FG V + VA+K+I ++ + E LK
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKK 72
Query: 757 IRHR---NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG-NLNLIQR 812
I+ + N + + +F G + ++ + + ++L+++N Q L ++
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQ--PYPLPHVRH 127
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH------------------- 853
++ + A+ +LH + + H DLKP N+L +
Sbjct: 128 --MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT 913
V+DFG A F E ++ + T Y PE + + DV+S G +L E +
Sbjct: 183 VADFGSATF-----DHEHHTTIV---ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 914 GRR--PTHT 920
G TH
Sbjct: 235 GFTLFQTHE 243
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 46/230 (20%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINL--KQKGSIKSFVAECEALKNIRH 759
+ + +G G++G V + L VAVK ++ + K E LK+++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 760 RNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ---SNDQVDGNLNLI--QR 812
N+I ++ V + ++F LV M + D L D ++ + Q
Sbjct: 88 ENVIGLLDVFTP-ARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLTDDHVQFLIYQI 141
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
L ++Y+H I+H DLKPSN+ ++ D + DFGLA R +
Sbjct: 142 LR-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTADEM 186
Query: 873 SSSIGIKGTVGYV------APEYGMG-GNVSLTGDVYSFGILLLEMFTGR 915
+ GYV APE + + + T D++S G ++ E+ TGR
Sbjct: 187 T---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 78/520 (15%), Positives = 158/520 (30%), Gaps = 90/520 (17%)
Query: 101 FLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSG-TIPSNLSHCSNLINFSVRRNN 159
RF + S L G+ + ++ + + I + S + L ++R
Sbjct: 62 IRRFPKVRSVELKGK-----PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116
Query: 160 LTGEIPAYIGYYWLKLENLNVAE-NQLTGQLPPSIG-NISTLQQLGVGENKLYGI----- 212
+T + I + + L ++ + +I L++L + E+ + +
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176
Query: 213 --IPESLGQLRDLNFLSVAEN-------------------------NFSGMLPPIFNISS 245
P++ L LN +A + +
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236
Query: 246 LEQISLLTNRFEGRLPLNIGF-----NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNL 300
LE++ E R + G +L+ L + + +P +S S L LNL
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296
Query: 301 SGNHFSGKVGIDF-SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRF 359
S + P + RL + I D L + C L L + +
Sbjct: 297 SYATVQSYDLVKLLCQCPKLQRLWV------LDYIEDAGLEVLASTCKDLRELRVFPS-- 348
Query: 360 GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELI 419
+ + GL +S + ++ Q+T
Sbjct: 349 -----EPFVMEPNVALTEQGLVSVS-------MGCPKLESVLYFCRQMTN---------- 386
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
AL A N + + + +L L + + +CK+L L++S L
Sbjct: 387 --AALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLL 443
Query: 480 TGTLPPQILEITTLSSLLDLSSNLISG-SIPLVVGNLKNLIQLDISRNRFSGE-IPTTLS 537
T + I +L ++ S + V+ +L +L+I F + + S
Sbjct: 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS 503
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577
++ L M S +S + ++L L+
Sbjct: 504 KLETMRSLWMSSCS---------VSFGACKLLGQKMPKLN 534
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 49/440 (11%), Positives = 116/440 (26%), Gaps = 67/440 (15%)
Query: 219 QLRDLNFLSVAENNFSGMLPPIF--NISSLEQISLLTNRFEGRLPLNIGFNLPKLKIL-I 275
D N + + + + LE+I L I + K+L +
Sbjct: 78 HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137
Query: 276 VGQNNLT-GSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL----PNITRLNLGQNNLG 330
+ + + NL L+L + G S ++ LN+
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC---L 194
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT---- 386
+ + L+T C L++L LN L + + + G
Sbjct: 195 ASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254
Query: 387 --IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNL--HGIIPDSIGNL 442
+ + + + L ++ + +P L L+ S + + ++ +
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVK-LLCQC 313
Query: 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSN 502
L LW+ + CK+L + L + + +
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDL----------------RELRVFPSEPFVMEPNV 357
Query: 503 LISG-SIPLVVGNLKNLIQLDISRNRFSGEIPTTLS-SCTSLEYLKMQD-NSFRGSIPSS 559
++ + V L + + + T++ + ++ ++ +
Sbjct: 358 ALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417
Query: 560 LISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLI 619
+ C +L L+LS T
Sbjct: 418 EPLDIGFGAIVEHCKDL--------------RRLSLSGLL--------------TDKVFE 449
Query: 620 ENGKLCGGLDELHLPACHNT 639
G ++ L + ++
Sbjct: 450 YIGTYAKKMEMLSVAFAGDS 469
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 63/473 (13%), Positives = 147/473 (31%), Gaps = 47/473 (9%)
Query: 143 NLSHCSNLINFSVRRNNLTGEIPA---YIGYYWLKLENLNVAENQLTGQLPPSIGNISTL 199
L + +F++ + G + + + LE + + +T L
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTD---------DCL 122
Query: 200 QQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFE-- 257
+ + +S + L S + G+ +L+++ L + +
Sbjct: 123 ELIA-----------KSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDV 171
Query: 258 -GRLPLNIGFNLPKLKILIVG--QNNLT-GSIPQSFSNASNLVILNLSGNHFSGKVGIDF 313
G + L L + + ++ ++ + + NL L L+ K+
Sbjct: 172 SGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLL 231
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
P + L G L+ C +L L + LP + S +
Sbjct: 232 QRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRL 291
Query: 374 TIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGE-LINLQALDFSANNL 431
T + + + +++ + L + + + + +L+ L +
Sbjct: 292 TTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRVFPSEP 350
Query: 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL---MLLNVSKN--KLTGTLPPQ 486
+ P+ L S+ +G L+ S L C+ + L+ +++N +T
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCPKLE----SVLYFCRQMTNAALITIARNRPNMTR----F 402
Query: 487 ILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLK 546
L I + L+ + +V + K+L +L +S + +E L
Sbjct: 403 RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLS 462
Query: 547 MQDNSFRG-SIPSSLISLKSIEVLDLS-CNNLSGQIPEYLEDLSFLEYLNLSY 597
+ + L S+ L++ C + L + L +S
Sbjct: 463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 32/246 (13%), Positives = 73/246 (29%), Gaps = 36/246 (14%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN-IPSSLGNCKNLMLLNVSKNK 478
+++++ + + N + G+ I + + L + + +
Sbjct: 67 KVRSVELKGK----------PHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116
Query: 479 LTGTLPPQILEITTLSSLLDLS--SNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTL 536
+T I + +L LS + + + +NL +LD+ + L
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176
Query: 537 S----SCTSLEYLKMQDNSFR---GSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF 589
S + TSL L + + ++ + +++ L L+ ++ L+
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236
Query: 590 LEYLNLSYNDFEGQVPTKGV----------------FSNKTRISLIENGKLCGGLDELHL 633
LE L E + F + L +C L L+L
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296
Query: 634 PACHNT 639
Sbjct: 297 SYATVQ 302
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 1e-09
Identities = 33/197 (16%), Positives = 57/197 (28%), Gaps = 40/197 (20%)
Query: 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVI--------NLKQKGSIKSFVAECE 752
T + IG+G FG V++ PVA+K+I N + + + + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 753 ALK---NIRHRNLIKIITVCSSIDF---KGDDFKAL--VYDYMQS--GSLEDWLQQSNDQ 802
K + + +G L +D+ S GS D D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 803 ------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNV 844
+L +I + +++ + H DL NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 845 LLDHDMVAHVSDFGLAK 861
LL + + K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 47/242 (19%), Positives = 96/242 (39%), Gaps = 55/242 (22%)
Query: 710 LIGQGSFGFVYRG-NLGEDLLPVAVKVINLKQKGSIKSF----VAECEALKNIRHR---N 761
+G+G+FG V + VAVK++ ++ + +E + L+++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + + + G +V++ + S D++++ N + L+ I++ ++ +
Sbjct: 76 TFRCVQMLEWFEHHG--HICIVFELL-GLSTYDFIKE-NGFLPFRLDHIRK--MAYQICK 129
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS-------------------DFGLAKF 862
++ +LH + + H DLKP N+L DFG A +
Sbjct: 130 SVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRR--PT 918
+ S+ Y APE +G + DV+S G +L+E + G PT
Sbjct: 187 DDEHHSTLVSTRH--------YRAPEVILALGWSQPC--DVWSIGCILIEYYLGFTVFPT 236
Query: 919 HT 920
H
Sbjct: 237 HD 238
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 47/240 (19%)
Query: 710 LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSF----VAECEALKNIRHR--NLI 763
+G G+FG V ++ AVKV+ +IK + E + LK I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDG-NLNLIQRLNISIDVASA 822
I+ + L+++ + SL + + ++N G ++ I+ I++ A
Sbjct: 97 NIVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYN--GFHIEDIKL--YCIEILKA 149
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK--- 879
+ YL + H DLKP N+LLD + + S+ GIK
Sbjct: 150 LNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLID 205
Query: 880 -G--------------TVGYVAPE--YGMGGNVSLTGDVYSFGILLLEMFTGRR--PTHT 920
G T Y APE +G +VS D++SFG +L E++TG TH
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS--DMWSFGCVLAELYTGSLLFRTHE 263
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 34/154 (22%)
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG 506
L ++ + ++L K L +S N I +SSL
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNN-----------IEKISSL---------- 66
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSI 566
++NL L + RN +I + +LE L + N S+ S + L ++
Sbjct: 67 ------SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNL 117
Query: 567 EVLDLSCNNLS--GQIPEYLEDLSFLEYLNLSYN 598
VL +S N ++ G+I + L L LE L L+ N
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 33/132 (25%), Positives = 52/132 (39%), Gaps = 11/132 (8%)
Query: 226 LSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSI 285
L M + + + + ++L TN E L+ + L+IL +G+N + I
Sbjct: 30 LHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLS---GMENLRILSLGRNLIK-KI 85
Query: 286 PQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTN 345
+ A L L +S N + GI+ L N+ L + N I + I L
Sbjct: 86 ENLDAVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSNNK-----ITNWGEIDKLAA 138
Query: 346 CSKLETLGLNSN 357
KLE L L N
Sbjct: 139 LDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 38/209 (18%), Positives = 61/209 (29%), Gaps = 50/209 (23%)
Query: 315 SLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTIT 374
++ L + I +D L+ + L L++N I++LS
Sbjct: 21 VATEAEKVEL---HGMIPPIEKMD--ATLSTLKACKHLALSTNNI-----EKISSLS--- 67
Query: 375 IIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGI 434
+ N+ L L N + I L+ L S N + +
Sbjct: 68 ------------------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL 108
Query: 435 IPDSIGNLSTLNSLWLGFNNLQG-NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
I L L L++ N + L L L ++ N L
Sbjct: 109 --SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE-------- 158
Query: 494 SSLLDLSSNLISGSIPLVVGNLKNLIQLD 522
+N S VV L NL +LD
Sbjct: 159 -------NNATSEYRIEVVKRLPNLKKLD 180
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 29/134 (21%), Positives = 54/134 (40%), Gaps = 3/134 (2%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+ + N + I P + L + L N + P + ++L L + NK+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 480 TGTLPPQILEITTLSSLLDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPTTLSS 538
T LP + E LL L++N I+ + + +L NL L + N+ T S
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 539 CTSLEYLKMQDNSF 552
+++ + + N F
Sbjct: 151 LRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 7/129 (5%)
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLT 408
+ L N P + + + I + NQIS + + + L ++ +L L N++T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIP----SSLG 464
L +LQ L +AN ++ + D+ +L LN L L N LQ I S L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152
Query: 465 NCKNLMLLN 473
+ + L
Sbjct: 153 AIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 30/148 (20%), Positives = 60/148 (40%), Gaps = 12/148 (8%)
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLL 343
IP + + + L N FS + R++L N + + L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ---GL 79
Query: 344 TNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLANIYALG 401
+ L +L L N+ LP+S+ L ++ ++ + N+I+ + ++ ++L N+ L
Sbjct: 80 RS---LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLS 134
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSAN 429
L N+L T L +Q + + N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 32/133 (24%), Positives = 61/133 (45%), Gaps = 4/133 (3%)
Query: 197 STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN-ISSLEQISLLTNR 255
T+ ++ + +N + I P + + L + ++ N S + P F + SL + L N+
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIP-QSFSNASNLVILNLSGNHFSGKVGIDFS 314
LP ++ L L++L++ N + + +F + NL +L+L N FS
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 315 SLPNITRLNLGQN 327
L I ++L QN
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 29/133 (21%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 176 ENLNVAENQLTGQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
+ + +N + +PP L+++ + N++ + P++ LR LN L + N +
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 235 GMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFSNA 292
+ +F + SL+ + L N+ L ++ +L L +L + N L +I + +FS
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 293 SNLVILNLSGNHF 305
+ ++L+ N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 12/135 (8%)
Query: 226 LSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGS 284
+ + +N + P F L +I L N+ L + L L L++ N +T
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94
Query: 285 IPQS-FSNASNLVILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITL 342
+P+S F +L +L L+ N + +V F L N+ L+L N L + + G
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINCLRVDA-FQDLHNLNLLSLYDNKLQTIAKGTFS---- 149
Query: 343 LTNCSKLETLGLNSN 357
++T+ L N
Sbjct: 150 --PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 26/157 (16%), Positives = 55/157 (35%), Gaps = 27/157 (17%)
Query: 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSN 502
T+ + L N ++ P + K L +++S N+++ L P +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ------------- 77
Query: 503 LISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLI- 561
L++L L + N+ + + SL+ L + N +
Sbjct: 78 -----------GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125
Query: 562 SLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L ++ +L L N L L ++ ++L+ N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 28/130 (21%), Positives = 57/130 (43%), Gaps = 4/130 (3%)
Query: 127 KVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT 186
+ L+ N+ P S L + N ++ E+ L +L + N++T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 187 GQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NIS 244
+LP S+ + +LQ L + NK+ + ++ L +LN LS+ +N + F +
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 245 SLEQISLLTN 254
+++ + L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-09
Identities = 31/116 (26%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
S ++++ L +R + +L+ L LT SI + + L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 302 GNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
N SG + + PN+T LNL N I DL I L L++L L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNK-----IKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 29/143 (20%), Positives = 51/143 (35%), Gaps = 24/143 (16%)
Query: 441 NLSTLNSLWL-GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--- 496
S + L L + +G + + L L+ LT I L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLPKLNKL 66
Query: 497 --LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSG-EIPTTLSSCTSLEYLKMQDN--- 550
L+LS N +SG + ++ NL L++S N+ L +L+ L + +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
Query: 551 ---SFRGSIPSSLISLKSIEVLD 570
+R ++ L + LD
Sbjct: 127 NLNDYRENV---FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 4/103 (3%)
Query: 497 LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
LD S + G + + + L L + I L L+ L++ DN G +
Sbjct: 24 LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80
Query: 557 PSSLISLKSIEVLDLSCNNLSG-QIPEYLEDLSFLEYLNLSYN 598
++ L+LS N + E L+ L L+ L+L
Sbjct: 81 EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 514 NLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSC 573
++K L+ LD SR+ G++ LE+L + SI ++L L ++ L+LS
Sbjct: 18 DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 574 NNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
N +SG + E L +LNLS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 13/140 (9%)
Query: 291 NASNLVILNLSGNHFS-GKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
S++ L L + + GK+ + L+ L S I L +KL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------IANLPKLNKL 66
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE-IRNLANIYALGLEYNQLT 408
+ L L+ NR G L +T + + N+I +E ++ L N+ +L L ++T
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
Query: 409 GTI---PYTIGELINLQALD 425
L L LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 19/167 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
N+F L IG GSFG +Y G + VA+K+ N+K K + E + + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKIYR-----IL 59
Query: 763 IKIITVCSSIDF-KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+ + F D+ LV D + SLED + L+L L ++ + +
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMD-LLGPSLEDLFNFCS----RKLSLKTVLMLADQMIN 114
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH---VSDFGLAKFLFD 865
+E++H +H D+KP N L+ A+ + DFGLAK D
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 47/265 (17%), Positives = 85/265 (32%), Gaps = 73/265 (27%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEA-------- 753
+ + + +LIG+GS+G+VY VA+K +N + F +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 754 -LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR 812
L ++ +I++ + D D +V + S +L + +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS----------------DLKKLFK 121
Query: 813 LNISIDVA----------SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
I + ++H + I+H DLKP+N LL+ D V DFGLA
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA-- 176
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTG----------------------- 899
R I ++I + LT
Sbjct: 177 ---RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
Query: 900 DVYSFGILLLEMFTGRRPTHTMFND 924
D++S G + E+ + +
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRH 759
+ +G G++G V G VA+K + + + K E LK++RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 760 RNLIKIITVCSSIDFKGDDFKA--LVYDYMQSGSLEDWLQQ---SNDQVDGNLNLI--QR 812
N+I ++ V + D DDF LV +M + D L + + + + Q
Sbjct: 84 ENVIGLLDVFTP-DETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQM 137
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
L + Y+H I+H DLKP N+ ++ D + DFGLA R
Sbjct: 138 LK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEM 182
Query: 873 SSSIGIKGTVGYV------APEYGMGGNVSLTG--DVYSFGILLLEMFTGR 915
+ GYV APE + + T D++S G ++ EM TG+
Sbjct: 183 T---------GYVVTRWYRAPEV-ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 7/116 (6%)
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
+++ ++ L + + L+ L + L S+ + L L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 302 GNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
N G + + LPN+T LNL N + D+ + L L++L L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNK-----LKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 30/144 (20%), Positives = 51/144 (35%), Gaps = 26/144 (18%)
Query: 441 NLSTLNSLWL-GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--- 496
+ + L L + G I NL L++ L ++ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPKLPKL 73
Query: 497 --LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFS--GEIPTTLSSCTSLEYLKMQDN-- 550
L+LS N I G + ++ L NL L++S N+ + L L+ L + +
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEV 132
Query: 551 ----SFRGSIPSSLISLKSIEVLD 570
+R S+ L + LD
Sbjct: 133 TNLNDYRESV---FKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 6/111 (5%)
Query: 489 EITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQ 548
+ L LD + G I + NL L + + + L L+ L++
Sbjct: 25 AVRELV--LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 549 DNSFRGSIPSSLISLKSIEVLDLSCNNLSG-QIPEYLEDLSFLEYLNLSYN 598
+N G + L ++ L+LS N L E L+ L L+ L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 13/141 (9%)
Query: 291 NASNLVILNLSGNHFS-GKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
+ + L L + GK+ + N+ L+L L S ++ L KL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--------VSNLPKLPKL 73
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE-IRNLANIYALGLEYNQLT 408
+ L L+ NR G L L +T + + N++ LE ++ L + +L L ++T
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
Query: 409 GTIPY---TIGELINLQALDF 426
Y L L LD
Sbjct: 134 NLNDYRESVFKLLPQLTYLDG 154
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 56/251 (22%), Positives = 100/251 (39%), Gaps = 67/251 (26%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR--- 758
++ L +G+G++G V++ VAVK I +F +A + R
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 759 -------HRNLIKIITVCSSIDFKGDDFKA--LVYDYMQ--------SGSLEDWLQQSND 801
H N++ ++ V + D+ + LV+DYM+ + LE +Q
Sbjct: 61 ILTELSGHENIVNLLNV-----LRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYV- 114
Query: 802 QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861
+ Q + I+YLH ++H D+KPSN+LL+ + V+DFGL++
Sbjct: 115 -------VYQLIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 862 FLFDRPIQETSSSSIGIKGTV----------GYV------APEYGMG-GNVSLTGDVYSF 904
+ + + T YV APE +G + D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 905 GILLLEMFTGR 915
G +L E+ G+
Sbjct: 218 GCILGEILCGK 228
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 26/137 (18%), Positives = 50/137 (36%), Gaps = 13/137 (9%)
Query: 244 SSLEQISLLTNRFEGRLPLNIGF-NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSG 302
++ L N F L F LP+L+ + N +T +F AS + + L+
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90
Query: 303 NHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGS 362
N F L ++ L L N + ++ + L L N+ +
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS------SVRLLSLYDNQI-TT 143
Query: 363 LPR----SIANLSTITI 375
+ ++ +LST+ +
Sbjct: 144 VAPGAFDTLHSLSTLNL 160
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 8/137 (5%)
Query: 420 NLQALDFSANNLHGIIPDSI-GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNK 478
L + N + I L L + N + + + + ++ N+
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 479 LTGTLPPQILEITTLSSL--LDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPTT 535
L + ++ + L SL L L SN I+ + L ++ L + N+ + P
Sbjct: 93 LE-NVQHKMFK--GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148
Query: 536 LSSCTSLEYLKMQDNSF 552
+ SL L + N F
Sbjct: 149 FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/135 (19%), Positives = 53/135 (39%), Gaps = 6/135 (4%)
Query: 371 STITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSAN 429
+ + N+ + I + L + + N++T + + ++N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 430 NLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILE 489
L + L +L +L L N + S ++ LL++ N++T T+ P +
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 490 ITTLSSL--LDLSSN 502
TL SL L+L +N
Sbjct: 151 --TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 30/134 (22%), Positives = 59/134 (44%), Gaps = 5/134 (3%)
Query: 197 STLQQLGVGENKLYGIIPESL-GQLRDLNFLSVAENNFSGMLPPIFN-ISSLEQISLLTN 254
+L + N+ + + +L L ++ + N + + F S + +I L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 255 RFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFSNASNLVILNLSGNHFSGKVGIDF 313
R E + + L LK L++ N +T + SF S++ +L+L N + F
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149
Query: 314 SSLPNITRLNLGQN 327
+L +++ LNL N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/146 (21%), Positives = 59/146 (40%), Gaps = 14/146 (9%)
Query: 435 IPDSIGNLSTLNSLWLGFNNLQGNIPSSL-GNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
IP+ I L L N + + L +N S NK+T + E
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFE--GA 80
Query: 494 SSL--LDLSSNLISGSIPL-VVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQD 549
S + + L+SN + ++ + L++L L + NR + + + +S+ L + D
Sbjct: 81 SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138
Query: 550 NSFRGSIP-SSLISLKSIEVLDLSCN 574
N ++ + +L S+ L+L N
Sbjct: 139 NQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 27/134 (20%), Positives = 56/134 (41%), Gaps = 7/134 (5%)
Query: 176 ENLNVAENQLTGQLPPSIG--NISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNF 233
L + N+ T L + + L+++ NK+ I + +N + + N
Sbjct: 35 AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 234 SGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQ-SFSN 291
+ +F + SL+ + L +NR + + L +++L + N +T ++ +F
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151
Query: 292 ASNLVILNLSGNHF 305
+L LNL N F
Sbjct: 152 LHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 28/148 (18%), Positives = 56/148 (37%), Gaps = 11/148 (7%)
Query: 475 SKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVV-GNLKNLIQLDISRNRFSGEIP 533
S KL +P I + T L L++N + + L L +++ S N+ +
Sbjct: 19 SNQKLN-KIPEHIPQYTAE---LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE 74
Query: 534 TTLSSCTSLEYLKMQDNSFRGSIPSSLI-SLKSIEVLDLSCNNLSGQIPEYL-EDLSFLE 591
+ + + + N ++ + L+S++ L L N ++ + LS +
Sbjct: 75 GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR 132
Query: 592 YLNLSYNDFEGQVPTKGVFSNKTRISLI 619
L+L N V G F +S +
Sbjct: 133 LLSLYDNQIT-TVA-PGAFDTLHSLSTL 158
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 176 ENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSG 235
N+ + +T ++++ Q+ + + + + + L ++ +L++ N
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD 77
Query: 236 MLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQS-FSNAS 293
+ +++L + L N+ + LP + L LK L++ +N L S+P F +
Sbjct: 78 I--SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133
Query: 294 NLVILNLSGNHF-SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETL 352
NL LNL+ N S G+ F L N+T L+L N L S G D +T +L+ L
Sbjct: 134 NLTYLNLAHNQLQSLPKGV-FDKLTNLTELDLSYNQLQSLPEGVFDKLT------QLKDL 186
Query: 353 GLNSNRFGGSLPRSI-ANLSTITII 376
L N+ S+P + L+++ I
Sbjct: 187 RLYQNQL-KSVPDGVFDRLTSLQYI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 49/191 (25%), Positives = 73/191 (38%), Gaps = 22/191 (11%)
Query: 344 TNCS-KLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGL 402
+ + L + L++I I + I I+ L N+ L L
Sbjct: 15 DDAFAETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLAL 70
Query: 403 EYNQLTGTIPYTIG---ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ--- 456
N+L I EL NL L + N L + L+ L L L N LQ
Sbjct: 71 GGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 457 GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPL-VVGNL 515
+ L NL LN++ N+L +LP + + T + LDLS N + S+P V L
Sbjct: 126 DGVFDKL---TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 516 KNLIQLDISRN 526
L L + +N
Sbjct: 181 TQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 17/174 (9%)
Query: 237 LPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLV 296
++S++QI + + + LP ++ L +G N L I + +NL
Sbjct: 34 AVTQNELNSIDQIIANNSDIKSVQGIQY---LPNVRYLALGGNKLH-DIS-ALKELTNLT 88
Query: 297 ILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLN 355
L L+GN G+ F L N+ L L +N L S G D +T L L L
Sbjct: 89 YLILTGNQLQSLPNGV-FDKLTNLKELVLVENQLQSLPDGVFDKLT------NLTYLNLA 141
Query: 356 SNRFGGSLPRSI-ANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQL 407
N+ SLP+ + L+ +T + + NQ+ ++P + L + L L NQL
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 43/158 (27%), Positives = 61/158 (38%), Gaps = 32/158 (20%)
Query: 297 ILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNS 356
IL L N + F SL N+ L LG N LG+ +G D LT L L L +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVLDLGT 97
Query: 357 NRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIG 416
N+ LP ++ + L ++ L + N+LT +P I
Sbjct: 98 NQL-TVLPSAVFD-----------------------RLVHLKELFMCCNKLT-ELPRGIE 132
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
L +L L N L I + LS+L +L F N
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 443 STLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSN 502
+ L+L N + P + NL L + N+L LP + + T ++LDL +N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 503 LISGSIPL-VVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPS--- 558
++ +P V L +L +L + N+ + E+P + T L +L + N + SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAF 155
Query: 559 -SLISLKSI 566
L SL
Sbjct: 156 DRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEI-RNLANIYALGLEYNQLT 408
+ L L+ N+ P +L + + +G NQ+ +P+ + +L + L L NQLT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS----SLG 464
L++L+ L N L +P I L+ L L L N L+ +IP L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 465 NCKNLMLLN 473
+ + L
Sbjct: 160 SLTHAYLFG 168
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 30/132 (22%), Positives = 53/132 (40%), Gaps = 8/132 (6%)
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ---GNIPSSLGNCKNLMLLNVSKNK 478
Q L N + + P +L L L+LG N L + SL L +L++ N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL---TQLTVLDLGTNQ 99
Query: 479 LTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS 538
LT LP + + L + N ++ +P + L +L L + +N+
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 539 CTSLEYLKMQDN 550
+SL + + N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 33/130 (25%), Positives = 56/130 (43%), Gaps = 5/130 (3%)
Query: 127 KVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT 186
++L L N + P NL + N L +P + +L L++ NQLT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 187 GQLPPSI-GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIF-NIS 244
LP ++ + L++L + NKL +P + +L L L++ +N + F +S
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 245 SLEQISLLTN 254
SL L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/132 (24%), Positives = 55/132 (41%), Gaps = 3/132 (2%)
Query: 197 STLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFN-ISSLEQISLLTNR 255
+ Q L + +N++ + P L +L L + N + +F+ ++ L + L TN+
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 256 FEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSS 315
LP + L LK L + N LT +P+ ++L L L N F
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 316 LPNITRLNLGQN 327
L ++T L N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 9/116 (7%)
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
N ++ L + + N+G L + + N + + F L L ++
Sbjct: 17 NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72
Query: 302 GNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
N +LP++T L L N+ + +L + L + L L + N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNS-----LVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 31/126 (24%), Positives = 43/126 (34%), Gaps = 10/126 (7%)
Query: 478 KLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPT- 534
KLT L Q + T LDL I I + L +D S N EI
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKL 57
Query: 535 -TLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSG-QIPEYLEDLSFLEY 592
L+ L + +N +L + L L+ N+L + L L L Y
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 593 LNLSYN 598
L + N
Sbjct: 118 LCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 18/102 (17%), Positives = 38/102 (37%), Gaps = 5/102 (4%)
Query: 497 LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
+ L++ LI + N +LD+ + I ++ + + DN R +
Sbjct: 2 VKLTAELIEQAAQY--TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 557 PSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
L+ ++ L ++ N + + L L L L+ N
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 25/144 (17%), Positives = 53/144 (36%), Gaps = 13/144 (9%)
Query: 287 QSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNC 346
++NA L+L G + ++L ++ N + +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIRK--------LDGFPLL 63
Query: 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE-IRNLANIYALGLEYN 405
+L+TL +N+NR L +T + + N + L+ + +L ++ L + N
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
Query: 406 ---QLTGTIPYTIGELINLQALDF 426
Y I ++ ++ LDF
Sbjct: 124 PVTNKKHYRLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/142 (17%), Positives = 46/142 (32%), Gaps = 28/142 (19%)
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYA 399
TN + L L + + I + L+Q + + ++
Sbjct: 12 AAQYTNAVRDRELDLRGYK-----------IPVIENLGATLDQ------FDAIDFSD--- 51
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQG-N 458
N++ + L L+ L + N + I L L L L N+L
Sbjct: 52 -----NEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 459 IPSSLGNCKNLMLLNVSKNKLT 480
L + K+L L + +N +T
Sbjct: 105 DLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 23/136 (16%), Positives = 50/136 (36%), Gaps = 14/136 (10%)
Query: 417 ELINLQALDFSANNLHGIIPDSIG-NLSTLNSLWLGFNNLQ--GNIPSSLGNCKNLMLLN 473
+ + LD + I +++G L +++ N ++ P + L L
Sbjct: 17 NAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLL 70
Query: 474 VSKNKLTGTLPPQILEITTLSSLLDLSSNLISG-SIPLVVGNLKNLIQLDISRNRFSGEI 532
V+ N++ + L+ L L++N + + +LK+L L I RN + +
Sbjct: 71 VNNNRICRIGEGLDQALPDLTE-LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
Query: 533 ---PTTLSSCTSLEYL 545
+ + L
Sbjct: 130 HYRLYVIYKVPQVRVL 145
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.5 bits (122), Expect = 7e-07
Identities = 26/161 (16%), Positives = 60/161 (37%), Gaps = 22/161 (13%)
Query: 456 QGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP--LVVG 513
Q ++ L L L + L L SL ++ S + S+ ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILGS 216
Query: 514 NLKNLIQLDI---SRNRFSGEIPTTLS------SCTSLEYLKMQDNSFRGSIPSSLIS-- 562
+L NL +L + + +L++L + D + + +
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 563 -LKSIEVLDLSCNNLSG----QIPEYLEDLSFLEYLNLSYN 598
L +E +D+S L+ + ++++ + L+++N+ YN
Sbjct: 277 ILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 3e-06
Identities = 19/128 (14%), Positives = 43/128 (33%), Gaps = 12/128 (9%)
Query: 293 SNLVILNLSGNHFSGKV--GIDFSSLPNITRLNL---GQNNLGSGSIGDLDFITLLTNCS 347
NL L + V I S LPN+ +L L ++ G + +
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 348 KLETLGLNSNRFGGSLPRSIAN---LSTITIIAMGLNQISGT----IPLEIRNLANIYAL 400
L+ LG+ + L + + + ++ + + + ++ +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 401 GLEYNQLT 408
++YN L+
Sbjct: 313 NMKYNYLS 320
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 48/285 (16%), Positives = 92/285 (32%), Gaps = 55/285 (19%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSS-LPNITRLNLGQNNLGSGSIGDLDFITLLTNCSK 348
S L +NL+ +L L N+LG + DL + LL + +
Sbjct: 98 SGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL-LLHDQCQ 156
Query: 349 LETLGLNSNRFGGS----LPRSIANLSTITIIAMGLNQIS--GTIPLEIRNLANIYALGL 402
+ TL L++N + L +A +++T +++ + G L A L
Sbjct: 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELL---------AAQL 207
Query: 403 EYNQLTGTIPYTIGELINLQALDFSANNLHG----IIPDSIGNLSTLNSLWLGFNNLQ-- 456
+ N+ LQ L+ + N + + +L L L FN L
Sbjct: 208 DRNR-------------QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254
Query: 457 -----GNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLV 511
++ + +++ ++ L ++ NL S V
Sbjct: 255 GRQVLRDLGGAAEGGARVVVSLTEGTAVS---------EYWSVILSEVQRNLNSWDRARV 305
Query: 512 VGNLKNLIQLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNSF 552
+L+ L+ D+ +R + L + L Q S
Sbjct: 306 QRHLE-LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 28/181 (15%), Positives = 62/181 (34%), Gaps = 22/181 (12%)
Query: 442 LSTLNSLWLGFNNLQGNIPSSLG-----NCKNLMLLNVSKNKLTGTLPPQILEITTLSSL 496
LS+L L L + + + L +N++ +L +L + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 497 LDLSSNLIS--GSIPLVVG---NLKNLIQLDISRNRFSGE----IPTTLSSCTSLEYLKM 547
L L N + L + + L +S N + + L+ TS+ +L +
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 548 QDNSFR----GSIPSSLISLKSIEVLDLSCNNLSGQ----IPEYLEDLSFLEYLNLSYND 599
+ + L + ++ L+++ N + + LE L+L +N+
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250
Query: 600 F 600
Sbjct: 251 L 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 39/293 (13%), Positives = 85/293 (29%), Gaps = 40/293 (13%)
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIAN-LST 372
L ++ +LNL + + + L + L+ + L S + + R++
Sbjct: 69 EVLSSLRQLNLAGVRMTPVKCTVVAAV-LGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127
Query: 373 ITIIAMGLNQIS--GTIPLE---IRNLANIYALGLEYNQLTGTIPYTIGELI----NLQA 423
+ + LN + L + + I L L N LT + E + ++
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187
Query: 424 LDFSANNLH----GIIPDSIGNLSTLNSLWLGFNNLQGN----IPSSLGNCKNLMLLNVS 475
L L ++ + L L + +N + + +L LL++
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247
Query: 476 KNKLTGT------LPPQILEITTLSSLLDLSSNLIS-GSIPLVVGNLKNLIQLDISRNRF 528
N+L+ E + +S ++ +NL D +R
Sbjct: 248 FNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRAR--- 304
Query: 529 SGEIPTTLSSCTSLEYLKMQDNSFR----GSIPSSLISLKSIEVLDLSCNNLS 577
+ L ++D+ L + L +
Sbjct: 305 -------VQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 26/189 (13%), Positives = 64/189 (33%), Gaps = 14/189 (7%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+ A + + + + + + L C L L++ +L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 130
Query: 480 TGTLPPQILEITTLSSL--LDLS--SNLISGSIPLVVGNLKNLIQLDISRNRF---SGEI 532
+ + + + S+L L+LS S ++ ++ + L +L++S
Sbjct: 131 SDPI---VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187
Query: 533 PTTLSSCTSLEYLKMQDNSFR---GSIPSSLISLKSIEVLDLS-CNNLSGQIPEYLEDLS 588
++ L + + + + ++ LDLS L + L+
Sbjct: 188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247
Query: 589 FLEYLNLSY 597
+L++L+LS
Sbjct: 248 YLQHLSLSR 256
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 39/205 (19%), Positives = 73/205 (35%), Gaps = 18/205 (8%)
Query: 441 NLSTLNSLWLGFNNLQGNI-PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDL 499
L++ SLW + N+ P G + ++ + P +DL
Sbjct: 41 RLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDL 100
Query: 500 SSNLIS-GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSF--RGSI 556
S+++I ++ ++ L L + R S I TL+ ++L L + S ++
Sbjct: 101 SNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL 160
Query: 557 PSSLISLKSIEVLDLS-CNNLSGQIPEYL--EDLSFLEYLNLSYNDFEGQVPTKGVFSNK 613
+ L S ++ L+LS C + + + + + LNLS G N
Sbjct: 161 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS-----------GYRKNL 209
Query: 614 TRISLIENGKLCGGLDELHLPACHN 638
+ L + C L L L
Sbjct: 210 QKSDLSTLVRRCPNLVHLDLSDSVM 234
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 11/112 (9%)
Query: 272 KILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSG-KVGIDFSSLPNITRLNLGQNNLG 330
L + N T +P+ SN +L +++LS N S FS++ + L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQS-FSNMTQLLTLILSYNRLR 91
Query: 331 SGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSI-ANLSTITIIAMGLN 381
D + L L L+ N +P +LS ++ +A+G N
Sbjct: 92 CIPPRTFDGLK------SLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/111 (21%), Positives = 42/111 (37%), Gaps = 17/111 (15%)
Query: 248 QISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF-S 306
Q +L+ L ++ + N ++ QSFSN + L+ L LS N
Sbjct: 42 QFTLVPKELSN---------YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 307 GKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
F L ++ L+L N++ G + + S L L + +N
Sbjct: 93 IPPRT-FDGLKSLRLLSLHGNDISVVPEGAFN------DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
LP+ I +T + + NQ + +P E+ N ++ + L N+++ + + L
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L S N L I P + L +L L L N++
Sbjct: 81 LTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 3e-05
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 507 SIPLVVGNLKNLIQLDISRNRFSGEIPT-TLSSCTSLEYLKMQDNSFRGSIPSSLISLKS 565
+ +NL +L I + + L L L + + R P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 566 IEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
+ L+LS N L + ++ LS L+ L LS N
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 2/102 (1%)
Query: 356 SNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE-IRNLANIYALGLEYNQLTGTIPYT 414
+ + +T + + Q + L +R L + L + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 415 IGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L L+ S N L + ++ LS L L L N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 18/98 (18%), Positives = 32/98 (32%), Gaps = 5/98 (5%)
Query: 458 NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNL 515
+ L +NL L + + L + L L L L + + + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLR--GLGELRNLTIVKSGLRFVAPDAFHFT 79
Query: 516 KNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553
L +L++S N + SL+ L + N
Sbjct: 80 PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 15/89 (16%), Positives = 27/89 (30%), Gaps = 7/89 (7%)
Query: 284 SIPQSFSNASNLVILNLSGNHFSGKV-GIDFSSLPNITRLNLGQNNLGSGSIGDLDFITL 342
A NL L + + D L + L + ++ L + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF--VAPDAF--- 76
Query: 343 LTNCSKLETLGLNSNRFGGSLPRSIANLS 371
+L L L+ N +++ LS
Sbjct: 77 -HFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 3/95 (3%)
Query: 435 IPDSIGNLSTLNSLWLGFNNLQGNIPS-SLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
+ L L++ ++ L L L + K+ L + P T
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 494 SSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRF 528
S L+LS N + S+ +L +L +S N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 1/100 (1%)
Query: 230 ENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSF 289
+ L + +L ++ + + L L L +L+ L + ++ L P +F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
L LNLS N L + L L N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 33/158 (20%)
Query: 298 LNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
L+L N F L ++T+L LG N L S G + +T L L L++N
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT------SLTYLNLSTN 86
Query: 358 RFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTI-G 416
+ SLP + + L + L L NQL ++P +
Sbjct: 87 QL-QSLPNGVFD-----------------------KLTQLKELALNTNQLQ-SLPDGVFD 121
Query: 417 ELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNN 454
+L L+ L N L + L++L +WL +N
Sbjct: 122 KLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL-HDN 158
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 8/112 (7%)
Query: 247 EQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHF- 305
++ L N + LP L L + +N LTG P +F AS++ L L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 306 SGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
+ F L + LNL N + G + + + L +L L SN
Sbjct: 92 EISNKM-FLGLHQLKTLNLYDNQISCVMPGSFE------HLNSLTSLNLASN 136
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 7/30 (23%), Positives = 11/30 (36%)
Query: 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
+ HGD N++ D + D G
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 11/46 (23%), Positives = 18/46 (39%), Gaps = 3/46 (6%)
Query: 818 DVASAIEYLHHH---CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
D ++L + HGDL SN+ + V+ D G +
Sbjct: 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1003 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-61
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
+ ++ IG GSFG VY+G D VAVK++N+ +++F E L+ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ + + A+V + + SL L +I+ ++I+ A
Sbjct: 65 NILLFMGYST------APQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTA 114
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
++YLH I+H DLK +N+ L D+ + DFGLA S + G
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK---SRWSGSHQFEQLSG 168
Query: 881 TVGYVAPEYGMGGN---VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937
++ ++APE + S DVY+FGI+L E+ TG+ P + +
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-------------YSNINNR 215
Query: 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
++++ +V L ++ C A+ R+ C + ER + ++
Sbjct: 216 DQIIFMVGRGYLSPDLSKVR--SNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 5e-59
Identities = 72/311 (23%), Positives = 139/311 (44%), Gaps = 44/311 (14%)
Query: 694 SYAELNKATNEFS---------LSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLKQ- 740
++ + N+A EF+ + +IG G FG V G+L G+ + VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 741 KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN 800
+ + F++E + H N+I + V + ++ ++M++GSL+ +L+Q++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 801 DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860
G +IQ + + +A+ ++YL VH DL N+L++ ++V VSDFGL+
Sbjct: 123 ----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT 920
+FL D T +S++G K + + APE + DV+S+GI++ E+ +
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--- 232
Query: 921 MFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSE 980
P M D ++ +C +A+ ++ + C + +
Sbjct: 233 ----------------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 981 RIHMADAVKNL 991
R V L
Sbjct: 277 RPKFGQIVNTL 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 68/289 (23%), Positives = 126/289 (43%), Gaps = 37/289 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
L +G G FG V+ G VAVK + + S +F+AE +K ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++ V + + ++ +YM++GSL D+L+ + L + + L+++ +A
Sbjct: 71 VRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEG 121
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ ++ +H DL+ +N+L+ + ++DFGLA+ + D G K +
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPI 174
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ APE G ++ DV+SFGILL E+ T R + M PE +
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP------------YPGMTNPEVIQN 222
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ ++ P + C + ++ LC E P +R L
Sbjct: 223 LERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 72/302 (23%), Positives = 117/302 (38%), Gaps = 25/302 (8%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-GEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
L IG+G FG V+RG GE VAVK+ + +++ S AE +RH N
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE---EVAVKIFSSREERSWF-REAEIYQTVMLRHEN 58
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++ I + + LV DY + GSL D+L + + + + +++ AS
Sbjct: 59 ILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTAS 111
Query: 822 AIEYLHHHC-----QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ +LH +P I H DLK N+L+ + ++D GLA D +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR-HDSATDTIDIAPN 170
Query: 877 GIKGTVGYVAPEY------GMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930
GT Y+APE D+Y+ G++ E+ + L +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 931 FVKMALPEKVMEIVDFALLLDPG-NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989
V + M V L P R + E L + +I C + + R+ K
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
Query: 990 NL 991
L
Sbjct: 291 TL 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-53
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 698 LNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-QKGSIKSFVAECEALKN 756
+ ++F + +G G+ G V++ + L +A K+I+L+ + + E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++ S D ++ ++M GSL+ L+++ G + +S
Sbjct: 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVS 110
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
I V + YL I+H D+KPSN+L++ + DFG++ L D S +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------SMAN 161
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
GT Y++PE G + S+ D++S G+ L+EM GR P
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 71/294 (24%), Positives = 135/294 (45%), Gaps = 38/294 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL----GEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI 757
+ + +IG G FG VY+G L G+ +PVA+K + + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 758 RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
H N+I++ V S ++ +YM++G+L+ +L++ DG +++Q + +
Sbjct: 67 SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLR 117
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+A+ + + VH DL N+L++ ++V VSDFGL++ L D P E + ++ G
Sbjct: 118 GIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EATYTTSG 172
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937
K + + APE + DV+SFGI++ E+ T + +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------N 219
Query: 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+VM+ + + G +C +A+ ++ + C + + R AD V L
Sbjct: 220 HEVMKAI------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-52
Identities = 58/299 (19%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 697 ELNKATNEFSLSNL-IGQGSFGFVYRG--NLGEDLLPVAVKVINLK-QKGSIKSFVAECE 752
+L + ++++ +G G+FG V +G + + + VA+KV+ +K + + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 753 ALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQR 812
+ + + ++++I VC + LV + G L +L + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR----EEIPVSNV 111
Query: 813 LNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETS 872
+ V+ ++YL VH DL NVLL + A +SDFGL+K L
Sbjct: 112 AELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL--GADDSYY 166
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932
++ K + + APE S DV+S+G+ + E + +
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--------------- 211
Query: 933 KMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
P K M+ + ++ G EC + + C + +R + +
Sbjct: 212 ----PYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 2e-52
Identities = 71/307 (23%), Positives = 141/307 (45%), Gaps = 37/307 (12%)
Query: 685 SMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI 744
+M+ P +Y + + ++ + +G G +G VY G + L VAVK + + +
Sbjct: 1 AMDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV 57
Query: 745 KSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVD 804
+ F+ E +K I+H NL++++ VC+ + ++ ++M G+L D+L++ N Q
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ-- 110
Query: 805 GNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
++ + L ++ ++SA+EYL +H DL N L+ + + V+DFGL++ +
Sbjct: 111 -EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFND 924
+T ++ G K + + APE S+ DV++FG+LL E+ T + +
Sbjct: 167 G----DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID- 221
Query: 925 GLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHM 984
+V E++ + + E C V + C +PS+R
Sbjct: 222 ------------LSQVYELL------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 263
Query: 985 ADAVKNL 991
A+ +
Sbjct: 264 AEIHQAF 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 40/290 (13%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNL 762
IG+GSF VY+G E + VA + ++ K + F E E LK ++H N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++ S KG LV + M SG+L+ +L++ + + + +
Sbjct: 71 VRFYDSWES-TVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKG 124
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLL-DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+++LH PPI+H DLK N+ + + D GLA +S + + GT
Sbjct: 125 LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-------RASFAKAVIGT 176
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941
++APE + DVY+FG+ +LEM T P N + +V
Sbjct: 177 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVT 226
Query: 942 EIVDFALLLDPGNERAK--IEECLTAVVRIGVLCSMESPSERIHMADAVK 989
V A K IE C+ ++ ER + D +
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIR-----------QNKDERYSIKDLLN 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-51
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 37/289 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+E + IG G FG V+ G + VA+K I + S + F+ E E + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++ VC LV+++M+ G L D+L+ L + +DV
Sbjct: 63 VQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEG 113
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ + + ++H DL N L+ + V VSDFG+ +F+ D + +SS G K V
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPV 166
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ +PE S DV+SFG+L+ E+F+ + + ++ E V +
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SEVVED 214
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
I L P T V +I C E P +R + ++ L
Sbjct: 215 ISTGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
L +GQG FG V+ G VA+K + S ++F+ E + +K +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++ V S ++ +V +YM GSL D+L+ + L Q ++++ +AS
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASG 125
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ Y+ VH DL+ +N+L+ ++V V+DFGLA+ + D ++ G K +
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPI 178
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ APE + G ++ DV+SFGILL E+ T R + +V++
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NREVLD 225
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
V + G EC ++ + C + P ER L
Sbjct: 226 QV------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 35/298 (11%)
Query: 707 LSNLIGQGSFGFVYRGNLGED---LLPVAVKVIN-LKQKGSIKSFVAECEALKNIRHRNL 762
+ +IG+G FG VY G L ++ + AVK +N + G + F+ E +K+ H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+ ++ +C + + +V YM+ G L ++++ N + + + VA
Sbjct: 91 LSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKG 142
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ VH DL N +LD V+DFGLA+ ++D+ + + G K V
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT-GAKLPV 198
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
++A E + DV+SFG+LL E+ T P P +
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVN 239
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000
D + L G + E C + + + C R ++ V + A + G
Sbjct: 240 TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 20/270 (7%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRN 761
++ + IG GS+G + D + K ++ + + V+E L+ ++H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+++ + + +V +Y + G L + + + L+ L + +
Sbjct: 65 IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTL 120
Query: 822 AIEYLHHH--CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A++ H ++H DLKP+NV LD + DFGLA+ L +S +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFAKAFV 175
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH------GFVK 933
GT Y++PE + + D++S G LL E+ P L +
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235
Query: 934 MALPEKVMEIVDFALLLDPGNERAKIEECL 963
+++ EI+ L L R +EE L
Sbjct: 236 YRYSDELNEIITRMLNLKD-YHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-51
Identities = 85/289 (29%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
E L IG+G FG V G+ + VAVK I K + ++F+AE + +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
++++ V + +V +YM GSL D+L+ V L L S+DV A
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEA 115
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+EYL + VH DL NVL+ D VA VSDFGL K SS+ K V
Sbjct: 116 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPV 164
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ APE S DV+SFGILL E+++ R P +
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIP 205
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ D ++ G + + C AV + C + R + L
Sbjct: 206 LKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 37/289 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ + +G G FG V G VA+K+I + S F+ E + + N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+++ VC+ ++ +YM +G L ++L++ Q L + DV A
Sbjct: 62 VQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEA 112
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+EYL +H DL N L++ V VSDFGL++++ D + +SS+G K V
Sbjct: 113 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPV 165
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942
+ PE M S D+++FG+L+ E+++ + + F + E
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------SETAEH 213
Query: 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
I L P V I C E ER + N+
Sbjct: 214 IAQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 39/287 (13%)
Query: 709 NLIGQGSFGFVYRGNL--GEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIK 764
+G G+FG V +G + + VAVK++ + +AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+I +C + LV + + G L +LQQ + ++ + + V+ ++
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMK 121
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YL VH DL NVLL A +SDFGL+K L + + K V +
Sbjct: 122 YLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH--GKWPVKW 176
Query: 885 VAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIV 944
APE S DV+SFG+L+ E F+ + P + M+
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGS 217
Query: 945 DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ +L+ G C + + LC R A L
Sbjct: 218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-49
Identities = 73/325 (22%), Positives = 129/325 (39%), Gaps = 55/325 (16%)
Query: 690 FPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS---IKS 746
+P++ + N+ ++IG+G+FG V + + +D L + + +K+ S +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 747 FVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN----- 800
F E E L + H N+I ++ C + + L +Y G+L D+L++S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 801 ------DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854
+ L+ Q L+ + DVA + + Q +H DL N+L+ + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG 914
+DFGL++ QE + V ++A E + DV+S+G+LL E+ +
Sbjct: 169 ADFGLSRG------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
Query: 915 RRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCS 974
P M + L G K C V + C
Sbjct: 223 GGT-------------------PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW 263
Query: 975 MESPSERIHMADAVKNLCAAREKYK 999
E P ER A + +L E+ K
Sbjct: 264 REKPYERPSFAQILVSLNRMLEERK 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 6e-49
Identities = 66/323 (20%), Positives = 124/323 (38%), Gaps = 55/323 (17%)
Query: 694 SYAELNKATNEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLK-QKGSIKSF 747
L N IG+G+FG V++ E VAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 748 VAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGN- 806
E + + N++K++ VC+ L+++YM G L ++L+ + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 807 ------------------LNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH 848
L+ ++L I+ VA+ + YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 849 DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILL 908
+MV ++DFGL++ ++ + + + ++ PE + DV+++G++L
Sbjct: 176 NMVVKIADFGLSRNIYS---ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 909 LEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVR 968
E+F+ + MA E + + D GN A E C +
Sbjct: 233 WEIFSYGLQP------------YYGMAHEEVIYYVRD-------GNILACPENCPLELYN 273
Query: 969 IGVLCSMESPSERIHMADAVKNL 991
+ LC + P++R + L
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 29/269 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+F + +G+G FG VY + +A+KV+ L++ G E E ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N++++ L+ +Y G++ LQ+ + + ++
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITEL 115
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
A+A+ Y H ++H D+KP N+LL ++DFG + SS +
Sbjct: 116 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-------PSSRRTTLC 165
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-THTMFNDGLTLHGFVKMALPE 938
GT+ Y+ PE G D++S G+L E G+ P + + V+ P+
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225
Query: 939 KV----MEIVDFALLLDPGNERAKIEECL 963
V +++ L +P ++R + E L
Sbjct: 226 FVTEGARDLISRLLKHNP-SQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-47
Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 33/273 (12%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+ + +G G+FG VY+ E + A KVI+ K + ++ ++ E + L + H N++K
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
++ ++ ++ ++ G+++ + + L Q + A+
Sbjct: 74 LLDAFYY-----ENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALN 124
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGY 884
YLH + I+H DLK N+L D ++DFG++ + S GT +
Sbjct: 125 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYW 176
Query: 885 VAPEYGMGGNVSLTG-----DVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---- 935
+APE M DV+S GI L+EM P H + N L K
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTL 235
Query: 936 -----LPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + L + + R + L
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNV-DARWTTSQLL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 59/271 (21%), Positives = 106/271 (39%), Gaps = 27/271 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRN 761
++ L +G+G++G V VAVK++++K+ ++ E K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++K + + + L +Y G L D ++ D + + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMA 114
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YLH I H D+KP N+LLD +SDFGLA + + + GT
Sbjct: 115 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK---MCGT 168
Query: 882 VGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM------ 934
+ YVAPE + DV+S GI+L M G P + + +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 935 --ALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + ++ L+ +P + R I +
Sbjct: 229 WKKIDSAPLALLHKILVENP-SARITIPDIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 3e-47
Identities = 62/272 (22%), Positives = 97/272 (35%), Gaps = 36/272 (13%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGS---IKSFVAECEALKNIRHRN 761
FS IG GSFG VY + VA+K ++ K S + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
I+ + LV +Y + + L ++ ++
Sbjct: 77 TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQ 126
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
+ YLH H ++H D+K N+LL + + DFG A + + + GT
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGT 174
Query: 882 VGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLH-------GF 931
++APE + G DV+S GI +E+ + P M H
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
E VD L P +R E L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 30/271 (11%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN 761
+++ IGQG+ G VY VA++ +NL+Q+ + + E ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
++ + D +V +Y+ GSL D + ++ Q + +
Sbjct: 79 IVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQ 127
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGT 881
A+E+LH + ++H D+K N+LL D ++DFG I S + GT
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-----ITPEQSKRSTMVGT 179
Query: 882 VGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA------ 935
++APE D++S GI+ +EM G P N L+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQN 238
Query: 936 ---LPEKVMEIVDFALLLDPGNERAKIEECL 963
L + ++ L +D +R +E L
Sbjct: 239 PEKLSAIFRDFLNRCLDMDV-EKRGSAKELL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-47
Identities = 59/329 (17%), Positives = 117/329 (35%), Gaps = 56/329 (17%)
Query: 688 QQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRG-----NLGEDLLPVAVKVINLK-QK 741
+++ E + ++G G+FG V + + VAVK++ K
Sbjct: 24 REYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
Query: 742 GSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSN 800
++ ++E + + + H N++ ++ C+ L+++Y G L ++L+
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 801 DQVD------------------GNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPS 842
++ L L + VA +E+L VH DL
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193
Query: 843 NVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVY 902
NVL+ H V + DFGLA+ + + V ++APE G ++ DV+
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMS---DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 903 SFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEEC 962
S+GILL E+F+ + + + +++ +D +
Sbjct: 251 SYGILLWEIFSLGVNP------------YPGIPVDANFYKLIQNGFKMD------QPFYA 292
Query: 963 LTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ I C +R + L
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 9e-47
Identities = 62/293 (21%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 704 EFSLSNLIGQGSFGFVYRGNLGED----LLPVAVKVINL-KQKGSIKSFVAECEALKNIR 758
EF ++G G+FG VY+G + +PVA+K + + K + E + ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
+ ++ +++ +C L+ M G L D++++ D + LN +
Sbjct: 70 NPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQ 119
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+A + YL +VH DL NVL+ ++DFGLAK L E + G
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGG 173
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938
K + ++A E + + DV+S+G+ + E+ T P
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PY 214
Query: 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ + + +L+ G + C V I V C M R + +
Sbjct: 215 DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-46
Identities = 61/309 (19%), Positives = 113/309 (36%), Gaps = 49/309 (15%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQK-GSIKSFVAECEALKN 756
N S +G G+FG V + + VAVK++ ++ ++E + L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 757 I-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQV------------ 803
+ H N++ ++ C+ ++ +Y G L ++L++ D
Sbjct: 83 LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 804 -DGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+ L+L L+ S VA + +L +H DL N+LL H + + DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF 922
+ + + V ++APE + DV+S+GI L E+F+ +
Sbjct: 195 IKN---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 923 NDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI 982
+ +K +L P E + I C P +R
Sbjct: 252 PVDSKFYKMIKEGFR-----------MLSP-------EHAPAEMYDIMKTCWDADPLKRP 293
Query: 983 HMADAVKNL 991
V+ +
Sbjct: 294 TFKQIVQLI 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 70/299 (23%), Positives = 110/299 (36%), Gaps = 39/299 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVIN---LKQKGSIKSFVAECEALKN 756
+ L +G GSFG V RG + VAVK + L Q ++ F+ E A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ HRNLI++ V + K +V + GSL D L++ G+ L +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYA 117
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
+ VA + YL +H DL N+LL + + DFGL + L
Sbjct: 118 VQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936
+ APE S D + FG+ L EMFT + N
Sbjct: 175 K--VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------------- 219
Query: 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995
+++ + G + E+C + + V C P +R L A+
Sbjct: 220 GSQILHKI-----DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (417), Expect = 3e-45
Identities = 54/272 (19%), Positives = 102/272 (37%), Gaps = 30/272 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ + + +G G+FG V+R A K + + ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+ + D+ ++Y++M G L + + + ++ + + V
Sbjct: 86 VNLHDAFED-----DNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKG 136
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIKG 880
+ ++H + VH DLKP N++ + DFGL L + S G
Sbjct: 137 LCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL------DPKQSVKVTTG 187
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP---------THTMFNDGLTLHGF 931
T + APE G V D++S G+L + +G P + + +
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ E + + LL DP N R I + L
Sbjct: 248 AFSGISEDGKDFIRKLLLADP-NTRMTIHQAL 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-45
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKN 756
K +F ++G+GSF V A+K++ + ++ + E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
+ H +K+ D+ Y ++G L ++++ G+ + +
Sbjct: 65 LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYT 114
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
++ SA+EYLH I+H DLKP N+LL+ DM ++DFG AK L Q ++S
Sbjct: 115 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-- 169
Query: 877 GIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA- 935
GT YV+PE + + D+++ G ++ ++ G P N+ L +K+
Sbjct: 170 -FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKLEY 227
Query: 936 -----LPEKVMEIVDFALLLDPGNERAKIEECLTA 965
K ++V+ L+LD +R EE
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDA-TKRLGCEEMEGY 261
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 60/300 (20%), Positives = 122/300 (40%), Gaps = 41/300 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQ-KGSIKSFVAECEALKN 756
+ ++S +GQGSFG VY G E VA+K +N F+ E +K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ-----SNDQVDGNLNLIQ 811
++++++ V S ++ + M G L+ +L+ +N+ V +L +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 812 RLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQET 871
+ ++ ++A + YL+ + VH DL N ++ D + DFG+ + +++ +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE---TDY 188
Query: 872 SSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931
V +++PE G + DV+SFG++L E+ T + ++
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------- 241
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991
+ VME G K + C + + +C +P R + + ++
Sbjct: 242 --EQVLRFVME----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 59/303 (19%), Positives = 114/303 (37%), Gaps = 40/303 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRG---NLGEDLLPVAVKVI-NLKQKGSIKSFVAECEALKNIR 758
L IG+G FG V++G + L VA+K N + F+ E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H +++K+I V + ++ ++ + G L +LQ +L+L + +
Sbjct: 67 HPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQ 116
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+++A L + VH D+ NVL+ + + DFGL++++ D + S
Sbjct: 117 LSTA---LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK----G 169
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938
K + ++APE + DV+ FG+ + E+ P
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------------PF 210
Query: 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998
+ ++ D ++ G C + + C PS R + L E+
Sbjct: 211 QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
Query: 999 KGR 1001
K +
Sbjct: 271 KAQ 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 8e-44
Identities = 59/280 (21%), Positives = 112/280 (40%), Gaps = 23/280 (8%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIR 758
++ + L ++G G V+ VAVKV+ + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H ++ + + + +V +Y+ +L D + +G + + + + D
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIAD 119
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
A+ + H + I+H D+KP+N+++ V DFG+A+ + D T ++++
Sbjct: 120 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV-- 174
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP---------THTMFNDGLTLH 929
GT Y++PE G +V DVYS G +L E+ TG P + +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234
Query: 930 GFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRI 969
L + +V AL +P N E +VR+
Sbjct: 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (394), Expect = 4e-42
Identities = 48/272 (17%), Positives = 94/272 (34%), Gaps = 30/272 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ + + +G G+FG V+R K IN + E + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
I + L+ +++ G L D + + ++ + +N
Sbjct: 89 INLHDAFED-----KYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEG 139
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIKG 880
++++H H IVH D+KP N++ + + V DFGLA L
Sbjct: 140 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL------NPDEIVKVTTA 190
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP---------THTMFNDGLTLHGF 931
T + APE V D+++ G+L + +G P +
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
++ + + + L +P +R + + L
Sbjct: 251 AFSSVSPEAKDFIKNLLQKEP-RKRLTVHDAL 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 66/309 (21%), Positives = 123/309 (39%), Gaps = 50/309 (16%)
Query: 703 NEFSLSNLIGQGSFGFVYRG-------NLGEDLLPVAVKVINLKQ-KGSIKSFVAECEAL 754
+ L +G+G+FG V + + VAVK++ + + ++E E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 755 KNI-RHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ-----------SNDQ 802
K I +H+N+I ++ C+ D ++ +Y G+L ++LQ +
Sbjct: 73 KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 803 VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862
+ L+ ++ + VA + + +H DL NVL+ D V ++DFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMF 922
+ + + + V ++APE + DV+SFG+LL E+FT
Sbjct: 185 IHH---IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----- 236
Query: 923 NDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI 982
P + + + LL G+ K C + + C PS+R
Sbjct: 237 --------------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 983 HMADAVKNL 991
V++L
Sbjct: 283 TFKQLVEDL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 59/306 (19%), Positives = 113/306 (36%), Gaps = 44/306 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNL-----GEDLLPVAVKVINLKQ-KGSIKSFVAECEALKN 756
+ L +G+G+FG V + VAVK++ ++ ++E + L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQ-----------SNDQVDG 805
I H + K ++ ++ + G+L +L+ D
Sbjct: 73 IGHHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 806 NLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFD 865
L L + S VA +E+L +H DL N+LL V + DFGLA+ ++
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 866 RPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG 925
+ + ++APE ++ DV+SFG+LL E+F+
Sbjct: 187 ---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------- 236
Query: 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA 985
+ + + E+ L G + + + + C PS+R +
Sbjct: 237 -----YPGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 986 DAVKNL 991
+ V++L
Sbjct: 286 ELVEHL 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 1e-39
Identities = 56/272 (20%), Positives = 91/272 (33%), Gaps = 27/272 (9%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHR 760
+ + +++G G+F V VA+K I K +G S E L I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++ + + S L+ + G L D + + G + V
Sbjct: 68 NIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVL 117
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A++YLH LD D +SDFGL+K + T G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST------ACG 171
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTM---------FNDGLTLHGF 931
T GYVAPE S D +S G++ + G P +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + + + + DP +R E+ L
Sbjct: 232 YWDDISDSAKDFIRHLMEKDP-EKRFTCEQAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-39
Identities = 58/270 (21%), Positives = 111/270 (41%), Gaps = 28/270 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEAL-KNIR 758
+F L ++G+GSFG V+ + A+K + + ++ + E L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H L + + + V +Y+ G L +Q +L + + +
Sbjct: 62 HPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAE 111
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ +++LH IV+ DLK N+LLD D ++DFG+ K + +
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----F 163
Query: 879 KGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP-----THTMFNDGLTLHGFVK 933
GT Y+APE +G + + D +SFG+LL EM G+ P +F+ + F
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 223
Query: 934 MALPEKVMEIVDFALLLDPGNERAKIEECL 963
L ++ +++ + +P +R + +
Sbjct: 224 RWLEKEAKDLLVKLFVREP-EKRLGVRGDI 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 31/270 (11%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+ ++ +G+G FG V+R K + +K E L RHRN++
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILH 65
Query: 765 IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIE 824
+ S + ++++++ + + + S LN + ++ V A++
Sbjct: 66 LHESFES-----MEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQ 116
Query: 825 YLHHHCQPPIVHGDLKPSNVLLDHDMVAHV--SDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+LH H I H D++P N++ + + +FG A+ L + + +
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL------KPGDNFRLLFTAP 167
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP---------THTMFNDGLTLHGFVK 933
Y APE VS D++S G L+ + +G P + N T
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 934 MALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + M+ VD L+ + R E L
Sbjct: 228 KEISIEAMDFVDRLLVKER-KSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 1e-38
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 45/284 (15%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSI---------KSFVAECEALK 755
+ ++G+G V R AVK+I++ GS ++ + E + L+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 756 NIR-HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN 814
+ H N+I++ + + F LV+D M+ G L D+L + L+ +
Sbjct: 65 KVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRK 114
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSS 874
I + I LH IVH DLKP N+LLD DM ++DFG + L +
Sbjct: 115 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL------DPGEK 165
Query: 875 SIGIKGTVGYVAPEYGMGGNVSLTG------DVYSFGILLLEMFTGRRP---------TH 919
+ GT Y+APE D++S G+++ + G P
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225
Query: 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + + V ++V L++ P +R EE L
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP-QKRYTAEEAL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 3e-38
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 41/277 (14%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
+F + +G GSFG V+ + A+KV+ + + ++ E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
+I++ ++ DY++ G L L++S + +V
Sbjct: 64 PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEV 113
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
L + I++ DLKP N+LLD + ++DFG AK++ D +
Sbjct: 114 C---LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT--------LC 162
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA---- 935
GT Y+APE + + D +SFGIL+ EM G P F D T+ + K+
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILNAEL 218
Query: 936 -----LPEKVMEIVDFALLLDP----GNERAKIEECL 963
E V +++ + D GN + E+
Sbjct: 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 6e-38
Identities = 58/280 (20%), Positives = 105/280 (37%), Gaps = 39/280 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK------QKGSIKSFVAECEALKN 756
N+FS+ +IG+G FG VY + A+K ++ K + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
++ + + D + + D M G L L Q G + +
Sbjct: 64 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYA 113
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSI 876
++ +E++H+ +V+ DLKP+N+LLD +SD GLA +
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-------SKKKPH 163
Query: 877 GIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRP--------THTMFNDGLT 927
GT GY+APE G + D +S G +L ++ G P H + LT
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
Query: 928 LHGFVKMALPEKVMEIVDFALLLDP----GNERAKIEECL 963
+ + + ++ +++ L D G +E
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 7e-38
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 35/280 (12%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
N + L IG GSFG +Y G VA+K+ +K K E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
I I C D+ +V + + + + S +L L ++ + S
Sbjct: 65 IPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISR 115
Query: 823 IEYLHHHCQPPIVHGDLKPSNVL---LDHDMVAHVSDFGLAKFLFDRPIQET--SSSSIG 877
IEY+H +H D+KP N L + ++ DFGLAK D + +
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 878 IKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA-- 935
+ GT Y + +G S D+ S G +L+ G + +++
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-SLPWQGLKAATKRQKYERISEK 231
Query: 936 ------------LPEKVMEIVDFALLLDPGNERAKIEECL 963
P + ++F L +++
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRF-DDKPDYSYLR 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 7e-37
Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 25/302 (8%)
Query: 700 KATNEFSLSNLIGQGSFGFVYRG-NLGEDLLPVAVKVINLK-----QKGSIKSFVAECEA 753
+A ++ IG+G++G V++ +L VA+K + ++ S VA
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 754 LKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
L+ H N++++ VC+ + LV++++ + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIK 119
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSS 873
++ + +++LH H +VH DLKP N+L+ ++DFGLA+ + +
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 174
Query: 874 SSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933
+ T+ Y APE + + + D++S G + EMF + +
Sbjct: 175 ----VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 934 MALP--EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGV----LCSMESPSERIHMADA 987
+ LP E V IE+ +T + +G C +P++RI A
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 988 VK 989
+
Sbjct: 291 LS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-37
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN-LKQKGSIKSFVAECEALKNIRHR 760
++ + IG+G++G V + + VA+K I+ + + + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N+I I + + + LV M L L+ +L+ +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT------QHLSNDHICYFLYQIL 119
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
++Y+H ++H DLKPSN+LL+ + DFGLA+ P + +
Sbjct: 120 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD--PDHDHTGFLTEYVA 174
Query: 881 TVGYVAPEYGMGGNVSLT-GDVYSFGILLLEMFTGRRP 917
T Y APE + D++S G +L EM + R
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-36
Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 26/296 (8%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
++ + +IG GSFG VY+ L + VA+K + + + E + ++ + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 765 IITVC-SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
+ SS + K + + LV DY+ S + L +I + ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSL 135
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
Y+H I H D+KP N+LLD D V + DFG AK L ++ +
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYICSR 186
Query: 883 GYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRP------THTMFNDGLTLHGFVKMA 935
Y APE G + + + DV+S G +L E+ G+ + L +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSM--ESPSERIHMADAVK 989
+ E +F + K+ T I + + +P+ R+ +A
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 56/274 (20%), Positives = 105/274 (38%), Gaps = 36/274 (13%)
Query: 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKI 765
S ++G G G V + A+K++ K E E + ++++I
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRI 70
Query: 766 ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEY 825
+ V ++ + G +V + + G L +Q DQ + I + AI+Y
Sbjct: 71 VDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQY 126
Query: 826 LHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
LH I H D+KP N+L + + ++DFG AK +S T
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------HNSLTTPCYTP 177
Query: 883 GYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM-------- 934
YVAPE + D++S G+++ + G P ++ ++ ++
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 935 -----ALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ E+V ++ L +P +R I E +
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEP-TQRMTITEFM 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 56/280 (20%), Positives = 100/280 (35%), Gaps = 39/280 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK------QKGSIKSFVAECEALKN 756
+ + +G G F V + L A K I + + S + E LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 757 IRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
I+H N+I + V + L+ + + G L D+L + +L +
Sbjct: 70 IQHPNVITLHEVYEN-----KTDVILILELVAGGELFDFLAE-----KESLTEEEATEFL 119
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVA----HVSDFGLAKFLFDRPIQETS 872
+ + +++ I H DLKP N++L V + DFGLA + +
Sbjct: 120 KQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI------DFG 170
Query: 873 SSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHT---------MFN 923
+ I GT +VAPE + L D++S G++ + +G P +
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 924 DGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + L+ DP +R I++ L
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDP-KKRMTIQDSL 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 65/304 (21%), Positives = 132/304 (43%), Gaps = 26/304 (8%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHR 760
+++ IGQG+FG V++ + VA+K + ++ ++G + + E + L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 761 NLIKIITVCSSIDFKGDDFKA---LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISI 817
N++ +I +C + + K LV+D+ + V L+ I+R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQML 126
Query: 818 DVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIG 877
+ L++ + I+H D+K +NVL+ D V ++DFGLA+ F +
Sbjct: 127 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTN 180
Query: 878 IKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHT-----MFNDGLTLHGF 931
T+ Y PE +G + D++ G ++ EM+T L G
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVR----IGVLCSM--ESPSERIHMA 985
+ + V + L ++ K+++ L A VR + ++ + P++RI
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 986 DAVK 989
DA+
Sbjct: 301 DALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 57/271 (21%), Positives = 100/271 (36%), Gaps = 31/271 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK------QKGSIKSFVAECEALKN 756
+++ + L+G G FG VY G D LPVA+K + + + E LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 757 IR--HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLN 814
+ +I+++ D L+ + + G L +
Sbjct: 64 VSSGFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER----GALQEELARS 114
Query: 815 ISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSS 873
V A+ + H+ ++H D+K N+L+D + + DFG L D +
Sbjct: 115 FFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--- 168
Query: 874 SSIGIKGTVGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFV 932
GT Y PE+ + V+S GILL +M G P + + F
Sbjct: 169 ----FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFF 223
Query: 933 KMALPEKVMEIVDFALLLDPGNERAKIEECL 963
+ + + ++ + L L P ++R EE
Sbjct: 224 RQRVSSECQHLIRWCLALRP-SDRPTFEEIQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-35
Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 30/273 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN---LKQKGSIKSFVAECEALKNIRH 759
N+F L+G+G+FG V A+K++ + K + V E L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 760 RNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
L + + D V +Y G L L + + ++
Sbjct: 65 PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEI 114
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
SA L + +V+ D+K N++LD D ++DFGL K ++
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGATMKTFC 166
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGL---TLHGFVKM-- 934
GT Y+APE + D + G+++ EM GR P + ++ L L ++
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
Query: 935 ALPEKVMEIVDFALLLDP----GNERAKIEECL 963
L + ++ L DP G + +E +
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 2e-34
Identities = 58/302 (19%), Positives = 115/302 (38%), Gaps = 37/302 (12%)
Query: 674 RKQTQKSSTLLSMEQQFPMVSYAELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAV 733
++ K+ + + P + A+L++ F +G GSFG V E A+
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQ----FDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 734 KVIN---LKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSG 790
K+++ + + I+ + E L+ + L+K+ V +Y+ G
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VMEYVAGG 126
Query: 791 SLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM 850
+ L++ G + + + EYLH +++ DLKP N+L+D
Sbjct: 127 EMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 851 VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910
V+DFG AK + R + GT +APE + + D ++ G+L+ E
Sbjct: 179 YIQVTDFGFAKRVKGRTWT--------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 911 MFTGRRP-----THTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDP----GNERAKIEE 961
M G P ++ ++ + +++ L +D GN + + +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 962 CL 963
Sbjct: 291 IK 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 65/295 (22%), Positives = 112/295 (37%), Gaps = 33/295 (11%)
Query: 709 NLIGQGSFGFVYRGNLGEDLLPVAVKVINLK-----QKGSIKSFVAECEALKNIRHRNLI 763
+ +G+G F VY+ VA+K I L + G ++ + E + L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 764 KIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAI 823
++ +LV+D+M++ S L + +
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGL 113
Query: 824 EYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVG 883
EYLH H I+H DLKP+N+LLD + V ++DFGLAK + + T
Sbjct: 114 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS-----FGSPNRAYTHQVVTRW 165
Query: 884 YVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRP------THTMFNDGLTLHGFVKMAL 936
Y APE G + + D+++ G +L E+ + TL +
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225
Query: 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSM--ESPSERIHMADAVK 989
P+ PG I + + ++ + +P RI A+K
Sbjct: 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL-LDLIQGLFLFNPCARITATQALK 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 3e-34
Identities = 45/304 (14%), Positives = 89/304 (29%), Gaps = 34/304 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNL 762
+ + IG+GSFG ++ G + VA+K + E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 62
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
I + + LV D + + ++ + + +
Sbjct: 63 IPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLAR 113
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLD-----HDMVAHVSDFGLAKFLFDRPIQETSS--SS 875
++ +H +V+ D+KP N L+ + + +V DFG+ KF D ++
Sbjct: 114 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935
+ GT Y++ +G S D+ + G + + G P G
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP----------WQGLKAAT 220
Query: 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAR 995
+K I + A E + +
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVL 277
Query: 996 EKYK 999
E+
Sbjct: 278 ERLN 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 54/300 (18%), Positives = 115/300 (38%), Gaps = 32/300 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHR 760
++ IG+G++G V++ E VA+K + L +G S + E LK ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 761 NLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVA 820
N++++ V S D LV+++ + + D +G+L+ + +
Sbjct: 62 NIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYF-----DSCNGDLDPEIVKSFLFQLL 111
Query: 821 SAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
+ + H ++H DLKP N+L++ + +++FGLA+ S +
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI----PVRCYSAEVVT 164
Query: 881 TVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940
S + D++S G + E+ RP + L ++
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSME-----------SPSERIHMADAVK 989
+ L P + + T++V + + +P +RI +A++
Sbjct: 225 EQWPSMTKL--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNL 762
F IG+G++G VY+ VA+K I L +G + + E LK + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 763 IKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASA 822
+K++ V + ++ LV++++ + + + L + +
Sbjct: 64 VKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQG 114
Query: 823 IEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTV 882
+ + H H ++H DLKP N+L++ + ++DFGLA+ + T+
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVVTL 166
Query: 883 GYVAPE-YGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
Y APE S D++S G + EM T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (306), Expect = 3e-31
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 703 NEFSLSNLIGQGSFGFVYRG--NLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIR 758
++ IG+G++G VY+ N GE A+K I L++ +G + + E LK ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 759 HRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISID 818
H N++K+ V + LV++++ + +G L + + +
Sbjct: 59 HSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQ 108
Query: 819 VASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGI 878
+ + + ++H DLKP N+L++ + ++DFGLA+
Sbjct: 109 LL---NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHE 160
Query: 879 KGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRP 917
T+ Y AP+ MG S T D++S G + EM G
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 697 ELNKATNE----FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAE 750
E+ K E + +G G++G V G VA+K + + + K E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 751 CEALKNIRHRNLIKIITVCSSIDFKGDDFK-ALVYDYMQSGSLEDWLQQSNDQVDGNLNL 809
LK++RH N+I ++ V + + D LV +M G+ L + L
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-----EKLGE 120
Query: 810 IQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQ 869
+ + + + Y+H H DLKP N+ ++ D + DFGLA+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA------ 171
Query: 870 ETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRP 917
S G T Y APE + + T D++S G ++ EM TG+
Sbjct: 172 --DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (308), Expect = 4e-31
Identities = 49/246 (19%), Positives = 98/246 (39%), Gaps = 26/246 (10%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRN 761
+++ L +G+G + V+ + V VK++ +K K E + L+N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 762 LIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVAS 821
+I + + ALV++++ + + Q L ++
Sbjct: 92 IITLADIVKDPV---SRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILK 140
Query: 822 AIEYLHHHCQPPIVHGDLKPSNVLLDHD-MVAHVSDFGLAKFLFDRPIQETSSSSIGIKG 880
A++Y H I+H D+KP NV++DH+ + D+GLA+F
Sbjct: 141 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY------HPGQEYNVRVA 191
Query: 881 TVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939
+ + PE + + D++S G +L M + P ++ L K+ E
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 940 VMEIVD 945
+ + +D
Sbjct: 252 LYDYID 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-31
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 24/234 (10%)
Query: 691 PMVSYAELNKA----TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSI 744
P ELNK + + +G G++G V + L VAVK ++ +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 745 KSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVD 804
K E LK+++H N+I ++ V + + + ++ L + ++
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------ 115
Query: 805 GNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864
L + + ++Y+H H DLKPSN+ ++ D + DFGLA+
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRP 917
T G T Y APE + + T D++S G ++ E+ TGR
Sbjct: 171 ------TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 38/283 (13%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVIN----LKQKGSIKSFVAECEALK 755
F L ++G G++G V+ A+KV+ +++ + + E + L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 756 NIRHRNLIKIITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNI 815
+IR + + F+ + L+ DY+ G L L Q +
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRE--------RFTEHEV 131
Query: 816 SIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSS 875
I V + L H + I++ D+K N+LLD + ++DFGL+K +
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA---- 187
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTG--DVYSFGILLLEMFTGRRP---------THTMFND 924
GT+ Y+AP+ GG+ D +S G+L+ E+ TG P +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247
Query: 925 GLTLHGFVKMALPEKVMEIVDFALLLDP----GNERAKIEECL 963
L + +++ L+ DP G +E
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 116 bits (289), Expect = 7e-29
Identities = 79/311 (25%), Positives = 123/311 (39%), Gaps = 13/311 (4%)
Query: 31 LSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQ--WTGVTC--GQRHPRVIQLYLRNQ 86
L N D+ ALL IK L +P SSW + + C W GV C + RV L L
Sbjct: 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 87 SVGGF--LSPYVGNLSFLRFINLASN-NLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSN 143
++ + + NL +L F+ + NL G IP + +L++L L + + SG IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 144 LSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQ-L 202
LS L+ N L+G +P I L + N+++G +P S G+ S L +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 203 GVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPL 262
+ N+L G IP + L + + ++I L N L
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 263 NIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRL 322
L N + G++PQ + L LN+S N+ G++ +L
Sbjct: 240 VGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 323 NLGQNNLGSGS 333
N GS
Sbjct: 297 AYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 4e-18
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 9/271 (3%)
Query: 369 NLSTITIIAMGLNQISG--TIPLEIRNLANIYALGLEYN-QLTGTIPYTIGELINLQALD 425
+ + + + IP + NL + L + L G IP I +L L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 426 FSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP 485
+ N+ G IPD + + TL +L +N L G +P S+ + NL+ + N+++G +P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 486 QILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYL 545
+ L + + +S N ++G IP NL S
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN--TQK 225
Query: 546 KMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605
+ + K++ LDL N + G +P+ L L FL LN+S+N+ G++P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 606 TKGVFSNKTRISLIENGKLCGGLDELHLPAC 636
G + N LCG LPAC
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 4/154 (2%)
Query: 425 DFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN--IPSSLGNCKNLMLLNVSKN-KLTG 481
D G++ D+ +N+L L NL IPSSL N L L + L G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 482 TLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTS 541
+PP I ++T L L ++ +SG+IP + +K L+ LD S N SG +P ++SS +
Sbjct: 92 PIPPAIAKLTQLHY-LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 542 LEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNN 575
L + N G+IP S S + N
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 4/138 (2%)
Query: 416 GELINLQALDFSANNLHGI--IPDSIGNLSTLNSLWL-GFNNLQGNIPSSLGNCKNLMLL 472
+ + LD S NL IP S+ NL LN L++ G NNL G IP ++ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 473 NVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEI 532
++ ++G +P + +I TL + LD S N +SG++P + +L NL+ + NR SG I
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVT-LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 533 PTTLSSCTSLEYLKMQDN 550
P + S + L
Sbjct: 166 PDSYGSFSKLFTSMTISR 183
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 6e-28
Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 20/218 (9%)
Query: 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVIN--LKQKGSIKSFVAECEALKNIRHR 760
+ IG G+ G V VA+K ++ + + K E +K + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 761 NLIKIITVCSSIDFKGDDFK-ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDV 819
N+I ++ V + + LV + M + + + + + + + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLLYQM 128
Query: 820 ASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIK 879
I++LH +H DLKPSN+++ D + DFGLA+ TS
Sbjct: 129 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART------AGTSFMMTPYV 179
Query: 880 GTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
T Y APE +G D++S G ++ EM +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (282), Expect = 2e-27
Identities = 47/222 (21%), Positives = 91/222 (40%), Gaps = 17/222 (7%)
Query: 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIK 764
+ L +G G F V+ + VA+K++ K ++ E + L+ + + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 765 --------IITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNIS 816
I+ + + KG + +V + G L + + L +++ IS
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--IS 131
Query: 817 IDVASAIEYLHHHCQPPIVHGDLKPSNVLLD-HDMVAHVSDFGLAKFLFDRPIQETSSSS 875
+ ++Y+H C I+H D+KP NVL++ D ++ +A E ++S
Sbjct: 132 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 876 IGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRP 917
I + Y +PE +G D++S L+ E+ TG
Sbjct: 190 IQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (253), Expect = 1e-23
Identities = 77/412 (18%), Positives = 142/412 (34%), Gaps = 56/412 (13%)
Query: 195 NISTLQQLGVGENKLYGIIPES-LGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLT 253
++ + +G+ + + ++ L Q+ L I S++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADR-------------LGIKSIDGVE--- 63
Query: 254 NRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDF 313
L L + N LT P N + LV + ++ N + +
Sbjct: 64 -------------YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN 108
Query: 314 SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTI 373
+ L Q + L + + + + S ++ +
Sbjct: 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL 168
Query: 374 TIIA-------MGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDF 426
+A + ++ + + L N+ +L NQ++ P I NL L
Sbjct: 169 KPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSL 226
Query: 427 SANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQ 486
+ N L I ++ +L+ L L L N + P L L L + N+++ P
Sbjct: 227 NGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 280
Query: 487 ILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLK 546
+ L++L +L N + NLKNL L + N S P +SS T L+ L
Sbjct: 281 ---LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335
Query: 547 MQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598
+N SSL +L +I L N +S P L +L+ + L L+
Sbjct: 336 FANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 3e-19
Identities = 79/391 (20%), Positives = 146/391 (37%), Gaps = 38/391 (9%)
Query: 98 NLSFLRFINLASNNLHGEIP-NELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR 156
L+ L N+ + +L +++ L+ L S G + + +NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 157 RNNLTGEIP---------AYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGEN 207
N LT P + + LTG + +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 208 KLYGIIPESLGQLRDLNFLSVAENNFSGMLP-PIFNISSLEQISLLTNRFEGRLPLNIGF 266
+ ++ + L+ L+ + G + +++L + L +++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
L L+ LI N ++ P +NL L+L+GN +SL N+T L+L
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT--LASLTNLTDLDLAN 250
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
N + + + L+ +KL L L +N+ P +A L+ +T + + NQ+
Sbjct: 251 NQISN--------LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 300
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
P I NL N+ L L +N ++ P + L LQ L F+ N + S+ NL+ +N
Sbjct: 301 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477
L G N + P L N + L ++
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.4 bits (215), Expect = 1e-18
Identities = 67/380 (17%), Positives = 135/380 (35%), Gaps = 41/380 (10%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
L + ++G+ N+T ++ Q+ + + L G+++ L N+T++N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEY--LNNLTQINFSN 75
Query: 327 NNL-GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISG 385
N L + +L + + + ++ N I +
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQAL----DFSANNLHGIIPDSIGN 441
+ L +++I AL + + + +L L L ++ +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 442 LSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSS 501
L+ L SL N + P NL L+++ N+L + +T L+ L DL++
Sbjct: 196 LTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDL-DLAN 250
Query: 502 NLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS--------------------CTS 541
N IS PL L L +L + N+ S P + +
Sbjct: 251 NQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 542 LEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
L YL + N+ P + SL ++ L + N +S L +L+ + +L+ +N
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 602 GQVPTKGVFSNKTRISLIEN 621
P + T++ L +
Sbjct: 365 DLTPLAN-LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.4 bits (202), Expect = 3e-17
Identities = 80/405 (19%), Positives = 152/405 (37%), Gaps = 45/405 (11%)
Query: 148 SNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGEN 207
+ + + + N+T + ++ L + + ++ L Q+ N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 208 KLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFN 267
+L I P L L L + + N + + P + T ++ N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGL----TLFNNQITDIDPLKN 130
Query: 268 LPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQN 327
L L L + N ++ S + + ++L + RL++ N
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSN 185
Query: 328 NLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTI 387
+ I++L + LE+L +N+ P I + + +++ NQ+
Sbjct: 186 K--------VSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233
Query: 388 PLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNS 447
+ +L N+ L L NQ++ P + L L L AN + I P + L+ L +
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 289
Query: 448 LWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLIS 505
L L N L+ P S N KNL L + N ++ P +++L+ L L ++N +S
Sbjct: 290 LELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP-----VSSLTKLQRLFFANNKVS 342
Query: 506 GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDN 550
+ NL N+ L N+ S P L++ T + L + D
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 55/282 (19%), Positives = 98/282 (34%), Gaps = 48/282 (17%)
Query: 368 ANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFS 427
L+ +G ++ T+ +L + L + + + L NL ++FS
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 74
Query: 428 ANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIP--------------------------- 460
N L I P + NL+ L + + N + P
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 461 ---------SSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLV 511
+++ + L L + G + + L++L L + S V
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDL 571
+ L NL L + N+ S P + T+L+ L + N + +L SL ++ LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 572 SCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNK 613
+ N +S P L L+ L L L N P G+ +
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT 288
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (220), Expect = 5e-20
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 6/255 (2%)
Query: 349 LETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT 408
+ + L+ NR S +TI+ + N ++ LA + L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 409 GTI-PYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCK 467
++ P T L L L L + P L+ L L+L N LQ + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNR 527
NL L + N+++ + +L L L N ++ P +L L+ L + N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLD-RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL 587
S L+ +L+YL++ DN + + + ++ S + + +P+ L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 588 SFLEYLNLSYNDFEG 602
L+ ND +G
Sbjct: 272 DL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 54/271 (19%), Positives = 97/271 (35%), Gaps = 13/271 (4%)
Query: 260 LPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNI 319
+P+ I + + + N ++ SF NL IL L N + F+ L +
Sbjct: 26 VPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 320 TRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMG 379
+L+L N S+ F +L TL L+ P L+ + + +
Sbjct: 83 EQLDLSDNAQ-LRSVDPATF----HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 380 LNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI 439
N + R+L N+ L L N+++ L +L L N + + P +
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 440 GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDL 499
+L L +L+L NNL +L + L L ++ N + +
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD--CRARPLWAWLQKFRG 255
Query: 500 SSNLISGSIPLVVGNLKNLIQLDISRNRFSG 530
SS+ + S+P L ++ N G
Sbjct: 256 SSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 50/304 (16%), Positives = 94/304 (30%), Gaps = 36/304 (11%)
Query: 178 LNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGML 237
+ + L +P I + Q++ + N++ + S R+L L + N + +
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 238 PPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVI 297
F ++ + L P +F L
Sbjct: 73 AAAFT-----------------------GLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109
Query: 298 LNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
L+L F L + L L N L + + L L L+ N
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGN 163
Query: 358 RFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGE 417
R R+ L ++ + + N+++ P R+L + L L N L+ +
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 418 LINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKN 477
L LQ L + N + + L + + ++P L L ++ N
Sbjct: 224 LRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAAN 279
Query: 478 KLTG 481
L G
Sbjct: 280 DLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 42/247 (17%), Positives = 72/247 (29%), Gaps = 26/247 (10%)
Query: 410 TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL 469
+P I Q + N + + S L LWL N L ++ L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 470 MLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFS 529
L++S N ++ P L L + P + L L L + N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 530 GEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSF 589
T +L +L + N + L S++ L L N ++ P DL
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 590 ------------------------LEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLC 625
L+YL L+ N + + +++ + + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 626 GGLDELH 632
L
Sbjct: 263 SLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 2e-12
Identities = 40/229 (17%), Positives = 80/229 (34%), Gaps = 3/229 (1%)
Query: 102 LRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLT 161
+ I L N + L +L L N + + + + L + N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 162 GEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLR 221
+ + +L L++ L P ++ LQ L + +N L + ++ L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 222 DLNFLSVAENNFSGMLPPIF-NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNN 280
+L L + N S + F + SL+++ L NR P +L +L L + NN
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF-RDLGRLMTLYLFANN 212
Query: 281 LTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNL 329
L+ ++ + L L L+ N + + + + +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 8e-08
Identities = 26/178 (14%), Positives = 51/178 (28%), Gaps = 27/178 (15%)
Query: 81 LYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTI 140
L+L + L+ L+++ L N L + L L L L N S
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 141 PSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWL-----------------------KLEN 177
+L + +N + P L+
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 178 LNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSG 235
L + +N + + LQ+ +++ +P+ L + +A N+ G
Sbjct: 230 LRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 1e-19
Identities = 53/256 (20%), Positives = 93/256 (36%), Gaps = 12/256 (4%)
Query: 349 LETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLT 408
L L +N+ NL + + + N+IS P L + L L NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKN 468
L L+ + + + + + + + L G + K
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 469 LMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRF 528
L + ++ +T T+P + +L+ L L N I+ + L NL +L +S N
Sbjct: 152 LSYIRIADTNIT-TIPQGLP--PSLTEL-HLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 529 SGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSG------QIPE 582
S +L++ L L + +N +P L K I+V+ L NN+S P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 583 YLEDLSFLEYLNLSYN 598
Y + ++L N
Sbjct: 267 YNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.9 bits (211), Expect = 1e-18
Identities = 48/236 (20%), Positives = 83/236 (35%), Gaps = 7/236 (2%)
Query: 386 TIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTL 445
+P ++ + L L+ N++T L NL L N + I P + L L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 446 NSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLIS 505
L+L N L+ + L + K+ ++ + ++ + L + S
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE--LGTNPLKSS 139
Query: 506 GSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKS 565
G +K L + I+ + IP L SL L + N +SL L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 566 IEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIEN 621
+ L LS N++S L + L L+L+ N + L N
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 9/208 (4%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
+ LD N + I NL L++L L N + P + L L +SKN+L
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 480 TGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDI--SRNRFSGEIPTTLS 537
LP ++ + L + N I+ V L +I +++ + + SG
Sbjct: 92 K-ELPEKMPKTLQE---LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 538 SCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSY 597
L Y+++ D + +IP L S+ L L N ++ L+ L+ L L LS+
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 598 NDFEGQVPTKGVFSNKTRISLIENGKLC 625
N + R + N KL
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 5e-18
Identities = 52/299 (17%), Positives = 90/299 (30%), Gaps = 33/299 (11%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
L +P+ + +L+L N + DF +L N+ L L N + S G
Sbjct: 20 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 76
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
KLE L L+ N+ LP + + N +
Sbjct: 77 ------PLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN 458
LG + +G + L + + N+ I G +L L L N +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKV 186
Query: 459 IPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNL 518
+SL NL L +S N ++ + L L ++ L+ +P + + K +
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK--VPGGLADHKYI 244
Query: 519 IQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577
+ + N S P S + L N +
Sbjct: 245 QVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.6 bits (200), Expect = 2e-17
Identities = 45/241 (18%), Positives = 94/241 (39%), Gaps = 8/241 (3%)
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
+P+ + ++ + N+I+ + +NL N++ L L N+++ P L+ L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
+ L S N L + L L ++ ++ + L + L K +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSG 140
Query: 482 TLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTS 541
+ LS + ++ I+ + G +L +L + N+ + +L +
Sbjct: 141 IENGAFQGMKKLS-YIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 542 LEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFE 601
L L + NS SL + + L L+ N L ++P L D +++ + L N+
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255
Query: 602 G 602
Sbjct: 256 A 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.6 bits (200), Expect = 3e-17
Identities = 43/299 (14%), Positives = 87/299 (29%), Gaps = 21/299 (7%)
Query: 64 CQWTGVTCGQRH---------PRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHG 114
C V C P L L+N + NL L + L +N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 115 EIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLK 174
P L +L+ L L N L + + + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 175 LENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFS 234
L + +G + + L + + + + I L +L+ + N +
Sbjct: 130 --ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKIT 184
Query: 235 GMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASN 294
+ + L+ + N P L+ L + N L +P ++
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 295 LVILNLSGNHFSGKVGIDF------SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCS 347
+ ++ L N+ S DF + + + ++L N + I F + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.2 bits (186), Expect = 2e-15
Identities = 46/263 (17%), Positives = 91/263 (34%), Gaps = 12/263 (4%)
Query: 244 SSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGN 303
+ L N+ + NL L LI+ N ++ P +F+ L L LS N
Sbjct: 31 PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 304 HFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSL 363
+L + + L+ + ++ + N + G
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-------NPLKSSGIE 142
Query: 364 PRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQA 423
+ + ++ I + I+ TIP + ++ L L+ N++T ++ L NL
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 424 LDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTL 483
L S N++ + S+ N L L L N L +P L + K + ++ + N ++
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 258
Query: 484 PPQILEITTLSSLLDLSSNLISG 506
+ S +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.1 bits (165), Expect = 9e-13
Identities = 53/297 (17%), Positives = 105/297 (35%), Gaps = 26/297 (8%)
Query: 139 TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNIST 198
+P +L + ++ N +T L L + N+++ P + +
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVK 80
Query: 199 LQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEG 258
L++L + +N+L + + L++L N + + +FN + + L
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLK 137
Query: 259 RLPLNIG--FNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL 316
+ G + KL + + N+T +IPQ +L L+L GN + L
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGL 194
Query: 317 PNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITII 376
N+ +L L N++ + G L L +N +P +A+ I ++
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELH-------LNNNKLVKVPGGLADHKYIQVV 247
Query: 377 AMGLNQISG------TIPLEIRNLANIYALGLEYNQLTGT--IPYTIGELINLQALD 425
+ N IS P A+ + L N + P T + A+
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 1e-17
Identities = 28/170 (16%), Positives = 54/170 (31%), Gaps = 32/170 (18%)
Query: 706 SLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIK----------SFVAECEALK 755
++ L+G+G V+ E VK + K F
Sbjct: 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 756 NIRHRNLIKI--ITVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRL 813
R L K+ + V ++G+ A++ + + + L +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRV------------RVENPD 106
Query: 814 NISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFL 863
+ + + +H IVHGDL NVL+ + + DF + +
Sbjct: 107 EVLDMILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 3e-11
Identities = 42/211 (19%), Positives = 78/211 (36%), Gaps = 8/211 (3%)
Query: 390 EIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLW 449
E+ +A+ + + LT +P + + + L S N L+ ++ + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 450 LGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIP 509
L + + G L L++S N+L D+S N ++
Sbjct: 62 L--DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL--DVSFNRLTSLPL 117
Query: 510 LVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVL 569
+ L L +L + N P L+ LE L + +N+ L L++++ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 570 DLSCNNLSGQIPEYLEDLSFLEYLNLSYNDF 600
L N+L IP+ L + L N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 42/210 (20%), Positives = 75/210 (35%), Gaps = 8/210 (3%)
Query: 96 VGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSV 155
V ++ +N NL +P +L + +L L N + L + L ++
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 156 RRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPE 215
R + L + + LP + L L V N+L +
Sbjct: 63 DRAE----LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 216 SLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILI 275
+L L +L L + N + P + + + L N LP + L L L+
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 276 VGQNNLTGSIPQSFSNASNLVILNLSGNHF 305
+ +N+L +IP+ F + L L GN +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 4e-09
Identities = 40/201 (19%), Positives = 69/201 (34%), Gaps = 13/201 (6%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
NLT ++P + IL+LS N +T+LNL + + L
Sbjct: 20 RNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-----LTKLQ 71
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
L L+ +T++ + N+++ +R L +
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQTLP----ALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 399 ALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGN 458
L L+ N+L P + L+ L + NNL + + L L++L L N+L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 459 IPSSLGNCKNLMLLNVSKNKL 479
IP L + N
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 3e-08
Identities = 47/212 (22%), Positives = 73/212 (34%), Gaps = 7/212 (3%)
Query: 414 TIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLN 473
+ ++ + ++ NL + P + L L N L ++L L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 474 VSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIP 533
+ + +LT L S+ S+PL+ L L LD+S NR +
Sbjct: 62 LDRAELTKLQVDGTLP----VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 534 TTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYL 593
L L+ L ++ N + P L +E L L+ NNL+ L L L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 594 NLSYNDFEGQVPTKGVFSNKTRISLIENGKLC 625
L N L N LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 40/215 (18%), Positives = 70/215 (32%), Gaps = 14/215 (6%)
Query: 242 NISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLS 301
++S +++ LP ++ + IL + +N L + + L LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 302 GNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG 361
+LP + L+L N L L L ++ NR
Sbjct: 64 --RAELTKLQVDGTLPVLGTLDLSHNQ-------LQSLPLLGQTLPALTVLDVSFNRLTS 114
Query: 362 SLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINL 421
++ L + + + N++ P + + L L N LT + L NL
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQ 456
L N+L+ IP L +L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 45/220 (20%), Positives = 77/220 (35%), Gaps = 24/220 (10%)
Query: 288 SFSNASNLVILNLSGNHFSGKVGIDFSSLP-----NITRLNLGQNNLGSGSIGDLDFITL 342
S ++ + +N + ++LP + T L+L +N L + S+
Sbjct: 5 EVSKVASHLEVNCDKR--------NLTALPPDLPKDTTILHLSENLLYTFSLAT------ 50
Query: 343 LTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGL 402
L ++L L L+ + + + ++PL + L + L +
Sbjct: 51 LMPYTRLTQLNLDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107
Query: 403 EYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS 462
+N+LT + L LQ L N L + P + L L L NNL
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 463 LGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSN 502
L +NL L + +N L T+P L L N
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF-AFLHGN 205
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 40/217 (18%), Positives = 70/217 (32%), Gaps = 21/217 (9%)
Query: 393 NLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGF 452
LAN + + +T T+ T +L + L + I + + L+ L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 453 NNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSS----------- 501
N + P + L+ + K + T + ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 502 --NLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSS 559
L I + +S T L++ + L LK DN P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 560 LISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596
L SL ++ + L N +S P L + S L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 36/245 (14%), Positives = 72/245 (29%), Gaps = 31/245 (12%)
Query: 284 SIPQSF--SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFIT 341
+I F +N + + ++ + + + L IT L+ + + I
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT--------IE 57
Query: 342 LLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALG 401
+ + L L L N+ P T ++ + I
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS 461
+ + L + + L G+ ++ +
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LT 167
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLSSNLISGSIPLVVGNLKNLI 519
L N L L NK++ I + +L +L + L +N IS PL N NL
Sbjct: 168 PLANLSKLTTLKADDNKISD-----ISPLASLPNLIEVHLKNNQISDVSPL--ANTSNLF 220
Query: 520 QLDIS 524
+ ++
Sbjct: 221 IVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 34/227 (14%), Positives = 63/227 (27%), Gaps = 19/227 (8%)
Query: 98 NLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRR 157
L+ I +N+ + L + L + + + +NLI ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 158 NNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESL 217
N I L + G S L
Sbjct: 73 NQ----ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 218 GQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVG 277
L+ L + I ++ L + L+ L NL KL L
Sbjct: 129 SNLQVLYL-------DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNL 324
N ++ P ++ NL+ ++L N S ++ N+ + L
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 35/236 (14%), Positives = 72/236 (30%), Gaps = 29/236 (12%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
L + G++N+T ++ Q+ + + L+ G + G+ + L N+ L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY--LNNLIGLELKD 72
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
N + + L + N+S I + +
Sbjct: 73 NQITDLAPLK----------------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTS 116
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
+ + I S N + NLS L
Sbjct: 117 TQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLT 176
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSL--LDLS 500
+L N + P L + NL+ +++ N+++ P + S+L + L+
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-----LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 32/222 (14%), Positives = 77/222 (34%), Gaps = 17/222 (7%)
Query: 237 LPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLV 296
+ P +++ +I+ + + +L + L +T +I +NL+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT-TIE-GVQYLNNLI 66
Query: 297 ILNLSGNHFSGKVGI-DFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLN 355
L L N + + + + + + N+ + + LT+ + L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 356 SNRFGGSLPRSIANLSTITIIAMG-------LNQISGTIPLEIRNLANIYALGLEYNQLT 408
L + ++ I+ +A + + + NL+ + L + N+++
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 409 GTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWL 450
P + L NL + N + + P + N S L + L
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 37/286 (12%), Positives = 96/286 (33%), Gaps = 21/286 (7%)
Query: 298 LNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSN 357
L+L+G + V + + + + +++ + L+++
Sbjct: 5 LDLTGKNLHPDV------TGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNS 56
Query: 358 RF-GGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEY--NQLTGTIPYT 414
+L ++ S + +++ ++S I + +N+ L L +
Sbjct: 57 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116
Query: 415 IGELINLQALDF------SANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKN 468
+ L L+ + ++ + ++ LN N + ++ + + C N
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 469 LMLLNVSKNKLTGTLPPQILEITTLSSLLDLSS-NLISGSIPLVVGNLKNLIQLDISRNR 527
L+ L++S + + Q L LS I L +G + L L +
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 528 FSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSC 573
G + + L++ + F ++ + K+ E+ + C
Sbjct: 237 PDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEIWGIKC 279
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 8e-08
Identities = 41/271 (15%), Positives = 78/271 (28%), Gaps = 19/271 (7%)
Query: 320 TRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMG 379
L+L NL G L ++ + L + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-------FRCPRSFMDQPLAEHFSPFRVQHMDLSN 55
Query: 380 LNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPD-- 437
T+ + + + L LE +L+ I T+ + NL L+ S +
Sbjct: 56 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115
Query: 438 ------SIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEIT 491
+ L+ ++Q + L L KN L +
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175
Query: 492 TLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISR-NRFSGEIPTTLSSCTSLEYLKMQDN 550
L L S ++ L L L +SR E L +L+ L++
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235
Query: 551 SFRGSIPSSLISLKSIEVLDLSCNNLSGQIP 581
G++ +L L ++C++ +
Sbjct: 236 VPDGTLQLLKEALPH---LQINCSHFTTIAR 263
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 40/273 (14%), Positives = 78/273 (28%), Gaps = 29/273 (10%)
Query: 109 SNNLHGEIPNELGRLSRLKVLVLDFNSFSG-TIPSNLSHCSNLINFSVRRNNLTGEIPAY 167
+ + E R++ + L + T+ LS CS L N S+ L+ I
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 168 IGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLS 227
+ L LN++ + L +L
Sbjct: 91 LAKNS-NLVRLNLSGC----------------SGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 228 VAENNFSGMLPPIFNISSLEQISLL-TNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIP 286
E + + + + +S N + L + + + + L
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 287 QSFSNASNLVILNLSG-NHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTN 345
Q F + L L+LS + ++ +P + L + G + D L
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV------FGIVPDGTLQLLKEA 247
Query: 346 CSKLETLGLNSNRFGGSLPRSIANLSTITIIAM 378
L+ +N + F +I N I +
Sbjct: 248 LPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 8e-06
Identities = 38/242 (15%), Positives = 85/242 (35%), Gaps = 12/242 (4%)
Query: 374 TIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHG 433
+ + + + + + + A + + + +Q +D S + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 434 I-IPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQI----- 487
+ + S L +L L L I ++L NL+ LN+S Q
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 488 --LEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYL 545
L+ LS D + + ++ V + L +N ++ T + C +L +L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 546 KMQDN-SFRGSIPSSLISLKSIEVLDLS-CNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQ 603
+ D+ + L ++ L LS C ++ + L ++ L+ L + +G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 604 VP 605
+
Sbjct: 241 LQ 242
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 1e-05
Identities = 38/254 (14%), Positives = 74/254 (29%), Gaps = 10/254 (3%)
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGK-VGIDFSSLPNITRLNLGQNN 328
+ ++ + + + FS + ++LS + + S + L+L
Sbjct: 24 GVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 329 LGSGSIGDLDFITLLT--NCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
L + L + L N S + + S + L+ +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLH-GIIPDSIGNLSTL 445
+ + + G N + + NL LD S + + L+ L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 446 NSLWL-GFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLI 504
L L ++ LG L L V GTL + L ++ +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ----LLKEALPHLQINCSHF 258
Query: 505 SGSIPLVVGNLKNL 518
+ +GN KN
Sbjct: 259 TTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 31/199 (15%), Positives = 52/199 (26%), Gaps = 6/199 (3%)
Query: 6 ISIRCLGTFVWCVTLFLLNPDSCFALSNETDRVALLAIKSQLQDPMGITSSWNNSINVCQ 65
+S + T L LN C S + L + L + +V
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR-LDELNLSWCFDFTEKHVQV 141
Query: 66 WTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRLSR 125
+ Y +N + + + S L + E +L+
Sbjct: 142 AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201
Query: 126 LKVLVLDF-NSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQ 184
L+ L L L L V G + L +L + +
Sbjct: 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE----ALPHLQINCSH 257
Query: 185 LTGQLPPSIGNISTLQQLG 203
T P+IGN + G
Sbjct: 258 FTTIARPTIGNKKNQEIWG 276
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 23/217 (10%)
Query: 386 TIPLEI------RNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSI 439
T+P I A L+ +T + T EL ++ + + +++ + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--I 64
Query: 440 GNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDL 499
L + L+L N L P L N KNL L + +NK+ + L+ S
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLS---- 118
Query: 500 SSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSS 559
+ + + L +L QL+ + T+ S + +++ I
Sbjct: 119 ----LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP- 173
Query: 560 LISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596
L L ++ L LS N++S L L L+ L L
Sbjct: 174 LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 36/209 (17%), Positives = 69/209 (33%), Gaps = 22/209 (10%)
Query: 267 NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQ 326
+ + + ++T ++ Q+ +++ + + + GI + LPN+T+L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNG 77
Query: 327 NNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGT 386
N LT+ L L F + L+
Sbjct: 78 NK--------------LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 387 IPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446
I + L T + L L L N + I+P + L+ L
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVS 475
+L+L N++ +L KNL +L +
Sbjct: 182 NLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 517 NLIQLDISRNRFSGE-IPTTLSSCTSLEYLKMQDNSFRG----SIPSSLISLKSIEVLDL 571
++ LDI S L + +++ D I S+L ++ L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 572 SCNNLSGQIPEYLEDL-----SFLEYLNLSYNDF 600
N L + ++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 5/86 (5%)
Query: 289 FSNASNLVILNLSGNHFSGKVGIDFSS----LPNITRLNLGQNNLGSGSIGDLDFITLLT 344
S L +L L+ S ++ ++ L+L N LG I L ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423
Query: 345 NCSKLETLGLNSNRFGGSLPRSIANL 370
LE L L + + + L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 13/78 (16%), Positives = 22/78 (28%), Gaps = 3/78 (3%)
Query: 294 NLVILNLSGNHFSGKVGID-FSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETL 352
++ L++ S + L + L L D+ + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 353 GLNSNRFGGSLPRSIANL 370
L SN G +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 9/83 (10%)
Query: 514 NLKNLIQLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNSFRGSIPSSLIS-----LK 564
L L ++ S + TL + SL L + +N + L+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 565 SIEVLDLSCNNLSGQIPEYLEDL 587
+E L L S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 17/79 (21%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 536 LSSCTSLEYLKMQDNSFRG----SIPSSLISLKSIEVLDLSCNNLSGQIPEYLED----- 586
+ L L + D S+ ++L++ S+ LDLS N L L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 587 LSFLEYLNLSYNDFEGQVP 605
LE L L + ++
Sbjct: 425 GCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 419 INLQALDFSANNL-HGIIPDSIGNLSTLNSLWLGFNNLQG----NIPSSLGNCKNLMLLN 473
+++Q+LD L + + L + L L +I S+L L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 474 VSKNKLTGTLPPQILEITTLSSL----LDLSSN 502
+ N+L +L+ S L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 10/92 (10%), Positives = 27/92 (29%), Gaps = 5/92 (5%)
Query: 497 LDLSSNLISGS-IPLVVGNLKNLIQLDISRNRFSGE----IPTTLSSCTSLEYLKMQDNS 551
LD+ +S + ++ L+ + + + I + L +L L ++ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 552 FRGSIPSSLISLKSIEVLDLSCNNLSGQIPEY 583
++ + +L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 5/68 (7%)
Query: 541 SLEYLKMQDNSFRGSIPSSLIS-LKSIEVLDLSCNNLSGQ----IPEYLEDLSFLEYLNL 595
++ L +Q + + L+ L+ +V+ L L+ I L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 596 SYNDFEGQ 603
N+
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 10/92 (10%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 468 NLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISG----SIPLVVGNLKNLIQLDI 523
++ L++ +L+ ++L + ++ L ++ I + L +L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 524 SRNRFSGEIPTTL-----SSCTSLEYLKMQDN 550
N + + ++ L +Q+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 9/77 (11%)
Query: 497 LDLSSNLISG----SIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS-----CTSLEYLKM 547
L L+ +S S+ + +L +LD+S N L LE L +
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 548 QDNSFRGSIPSSLISLK 564
D + + L +L+
Sbjct: 434 YDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 441 NLSTLNSLWLGFNNLQGN----IPSSLGNCKNLMLLNVSKNKLTGTLPPQILEI----TT 492
S L LWL ++ + + ++L +L L++S N L Q++E
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 493 LSSLLDLSSNLISGSIPLVVGNL-KNLIQLDI 523
L L L S + + L K+ L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 102 LRFINLASNNLHGEIPNEL-GRLSRLKVLVLDFNSFSG----TIPSNLSHCSNLINFSVR 156
++ +++ L EL L + +V+ LD + I S L L ++R
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 157 RNNLTGEIPAYIG----YYWLKLENLN 179
N L + K++ L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 8/100 (8%), Positives = 29/100 (29%), Gaps = 9/100 (9%)
Query: 318 NITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG----SLPRSIANLSTI 373
+I L++ + D + LL + + + L+ + ++ +
Sbjct: 3 DIQSLDIQCEE-----LSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 374 TIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPY 413
+ + N++ + + ++ L
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 10/80 (12%), Positives = 24/80 (30%), Gaps = 9/80 (11%)
Query: 420 NLQALDFSANNLHGI----IPDSIGNLSTLNSLWLGFNNLQGNIPSSLG-----NCKNLM 470
L+ L + ++ + ++ +L L L N L L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 471 LLNVSKNKLTGTLPPQILEI 490
L + + + ++ +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 10/91 (10%), Positives = 25/91 (27%), Gaps = 4/91 (4%)
Query: 245 SLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTG----SIPQSFSNASNLVILNL 300
++ + + + L + +++ + LT I + L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 301 SGNHFSGKVGIDFSSLPNITRLNLGQNNLGS 331
N + + +L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 13/81 (16%), Positives = 27/81 (33%), Gaps = 8/81 (9%)
Query: 124 SRLKVLVLDFNSFSGT----IPSNLSHCSNLINFSVRRNNLTGEIPAYIG----YYWLKL 175
S L+VL L S + + + L +L + N L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 176 ENLNVAENQLTGQLPPSIGNI 196
E L + + + ++ + +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 27/107 (25%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 497 LDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSI 556
L L+ ++ L L + LD+S NR P L++ LE L+ DN+
Sbjct: 3 LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--N 57
Query: 557 PSSLISLKSIEVLDLSCNNL-SGQIPEYLEDLSFLEYLNLSYNDFEG 602
+ +L ++ L L N L + L L LNL N
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 23/128 (17%), Positives = 43/128 (33%), Gaps = 10/128 (7%)
Query: 422 QALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG 481
+ L + +L + + L + L L N L+ P+ L + L +L S N L
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 482 TLPPQILEITTLSSLLDLSSNLI-SGSIPLVVGNLKNLIQLDISRNRFSGE---IPTTLS 537
L L L +N + + + + L+ L++ N E
Sbjct: 58 VDGVANLPRLQE---LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 538 SCTSLEYL 545
S+ +
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 9e-06
Identities = 27/114 (23%), Positives = 49/114 (42%), Gaps = 7/114 (6%)
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLK 272
+ L QL + L ++ N + P + + LE + ++ NLP+L+
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQ---ASDNALENVDGVANLPRLQ 68
Query: 273 ILIVGQNNLTG-SIPQSFSNASNLVILNLSGNHFSGKVGID---FSSLPNITRL 322
L++ N L + Q + LV+LNL GN + GI LP+++ +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 27/125 (21%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 400 LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNI 459
L L + LT + + +L+ + LD S N L + P ++ L L L ++
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 460 PSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLIS---GSIPLVVGNLK 516
+ N L L + N+L + Q L LL+L N + G + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 517 NLIQL 521
++ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 25/120 (20%), Positives = 49/120 (40%), Gaps = 8/120 (6%)
Query: 472 LNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGE 531
L+++ LT + ++ ++ L DLS N + P + L+ L L S N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHL-DLSHNRLRALPPAL-AALRCLEVLQASDNALENV 58
Query: 532 IPTTLSSCTSLEYLKMQDNSFRG-SIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFL 590
+ L+ L + +N + + L+S + +L+L N+L E L+ +
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 20/121 (16%), Positives = 42/121 (34%), Gaps = 7/121 (5%)
Query: 127 KVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLT 186
+VL L T+ +L + + + N L PA L++ +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--- 55
Query: 187 GQLPPSIGNISTLQQLGVGENKLYGI-IPESLGQLRDLNFLSVAENNFSGMLPPIFNISS 245
+ + N+ LQ+L + N+L + L L L++ N+ ++
Sbjct: 56 -ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 246 L 246
+
Sbjct: 115 M 115
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 22/92 (23%), Positives = 31/92 (33%), Gaps = 9/92 (9%)
Query: 402 LEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPS 461
N + I +L+ L+ S N L +P L L FN+L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPE 321
Query: 462 SLGNCKNLMLLNVSKNKLTGTLPPQILEITTL 493
N K L+V N L P + L
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 4e-06
Identities = 26/94 (27%), Positives = 33/94 (35%), Gaps = 10/94 (10%)
Query: 449 WLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSI 508
N I S +L LNVS NKL LP + L S N ++ +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHLA-EV 319
Query: 509 PLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSL 542
P +NL QL + N E P S L
Sbjct: 320 P---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 22/79 (27%), Positives = 36/79 (45%), Gaps = 8/79 (10%)
Query: 524 SRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEY 583
N S EI + SLE L + +N +P+ L E L S N+L+ ++PE
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPEL 322
Query: 584 LEDLSFLEYLNLSYNDFEG 602
++ L+ L++ YN
Sbjct: 323 PQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 21/124 (16%), Positives = 36/124 (29%), Gaps = 13/124 (10%)
Query: 57 WNNSINVCQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEI 116
+ + + L +N+++N L E+
Sbjct: 241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-EL 299
Query: 117 PNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLE 176
P RL+ L+ FN + +P NL V N L E P +E
Sbjct: 300 PALPP---RLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFPDIPE----SVE 347
Query: 177 NLNV 180
+L +
Sbjct: 348 DLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 18/95 (18%), Positives = 30/95 (31%), Gaps = 16/95 (16%)
Query: 278 QNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDL 337
N + I +L LN+S N + P + RL N+L
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLAE------ 318
Query: 338 DFITLLTNCSKLETLGLNSNRFGG--SLPRSIANL 370
+ L+ L + N +P S+ +L
Sbjct: 319 ----VPELPQNLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 8/101 (7%)
Query: 146 HCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVG 205
+ + ++ N + + LE LNV+ N+L +LP L++L
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIAS 312
Query: 206 ENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSL 246
N L +PE L+ L+ V N ++ L
Sbjct: 313 FNHL-AEVPELPQNLKQLH---VEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 18/100 (18%), Positives = 33/100 (33%), Gaps = 15/100 (15%)
Query: 299 NLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNR 358
N S ++ P++ LN+ N L I L +LE L + N
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNH 315
Query: 359 FGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
+P NL + + N + P ++ ++
Sbjct: 316 L-AEVPELPQNLKQLHV---EYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.003
Identities = 12/60 (20%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 420 NLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKL 479
L+ + L + P+ +L +L N+L +P + K+L++ N + L
Sbjct: 39 QAHELELNNLGLSSL-PELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 236 MLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNL 295
+ SLE++++ N+ + P+L+ LI N+L +P+ NL
Sbjct: 276 IRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EVPELP---QNL 326
Query: 296 VILNLSGNHFSGKVGIDFSSLPNITRLN 323
L++ N I S+ ++ R+N
Sbjct: 327 KQLHVEYNPLREFPDI-PESVEDL-RMN 352
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 26/140 (18%), Positives = 44/140 (31%), Gaps = 6/140 (4%)
Query: 389 LEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSL 448
+ N L L ++ I L A+DFS N + + D L L +L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68
Query: 449 WLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTG---TLPPQILEITTLSSLLDLSSNLIS 505
+ N + +L L ++ N L P L+ T +L
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 506 GSIPLVVGNLKNLIQLDISR 525
V+ + + LD +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 26/152 (17%), Positives = 53/152 (34%), Gaps = 14/152 (9%)
Query: 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDF 339
L Q ++NA L+L G + ++L ++ N +
Sbjct: 6 ELIEQAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE--------IRK 55
Query: 340 ITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLE----IRNLA 395
+ +L+TL +N+NR L +T + + N + L+ +++L
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 396 NIYALGLEYNQLTGTIPYTIGELINLQALDFS 427
+ L Y I ++ ++ LDF
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 2e-06
Identities = 17/108 (15%), Positives = 32/108 (29%), Gaps = 6/108 (5%)
Query: 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEIT 491
I L L +L L N + +P S + +L LN++ N
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--A 148
Query: 492 TLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSC 539
L+ P ++++ D+ + F + C
Sbjct: 149 EWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENS-EGC 192
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.5 bits (85), Expect = 0.004
Identities = 30/176 (17%), Positives = 50/176 (28%), Gaps = 29/176 (16%)
Query: 424 LDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTL 483
+D + L I P I L L N L L ++ K +
Sbjct: 13 VDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 484 PPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLE 543
P E + L L N I + L L L++ N+ S +P + SL
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 544 Y-----------------------LKMQDNSFRGSIPSSLISLKSIEVLDLSCNNL 576
+ + R PS + + +++ DL +
Sbjct: 130 SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 40/213 (18%), Positives = 72/213 (33%), Gaps = 19/213 (8%)
Query: 381 NQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIG 440
I+ LA L +T T+ + +L + L + I D +
Sbjct: 6 TPINQIFTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVE 59
Query: 441 NLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLS 500
L+ L + N L P +L+N ++ L +
Sbjct: 60 YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL-------T 112
Query: 501 SNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSL 560
+ + NL NL +L++S N I + ++ +S + + L
Sbjct: 113 LFNNQITDIDPLKNLTNLNRLELSSNT----ISDISALSGLTSLQQLNFSSNQVTDLKPL 168
Query: 561 ISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYL 593
+L ++E LD+S N +S L L+ LE L
Sbjct: 169 ANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 36/200 (18%), Positives = 69/200 (34%), Gaps = 17/200 (8%)
Query: 260 LPLNIGF---NLPKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSL 316
P+N F L + ++G+ N+T ++ Q ++ + L G+++ L
Sbjct: 6 TPINQIFTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSIDGVEY--L 61
Query: 317 PNITRLNLGQNNL-GSGSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITI 375
N+T++N N L + +L + + + ++ N I
Sbjct: 62 NNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 121
Query: 376 IAMG-------LNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSA 428
+ L S TI L ++ T + L L+ LD S+
Sbjct: 122 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 429 NNLHGIIPDSIGNLSTLNSL 448
N + I + L+ L SL
Sbjct: 182 NKVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 34/193 (17%), Positives = 62/193 (32%), Gaps = 23/193 (11%)
Query: 368 ANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFS 427
L+ +G ++ T+ +L + L + + + L NL ++FS
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 70
Query: 428 ANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQI 487
N L I P + + + + N + +
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 488 LEITTLSSLLDLSSNL---------------ISGSIPLVVGNLKNLIQLDISRNRFSGEI 532
+ S+ + S L ++ PL NL L +LDIS N+ S
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL--ANLTTLERLDISSNKVSD-- 186
Query: 533 PTTLSSCTSLEYL 545
+ L+ T+LE L
Sbjct: 187 ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 26/207 (12%), Positives = 57/207 (27%), Gaps = 22/207 (10%)
Query: 290 SNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKL 349
+ + + L + + + + L +T L + + S I + + L
Sbjct: 15 TALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKS--------IDGVEYLNNL 64
Query: 350 ETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTG 409
+ ++N+ P ++ + +
Sbjct: 65 TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 410 TIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNL 469
+ L I D + L F++ Q L N L
Sbjct: 125 KNLTNLNRL----------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 174
Query: 470 MLLNVSKNKLTGTLPPQILEITTLSSL 496
L++S NK++ + ++T L SL
Sbjct: 175 ERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 27/229 (11%), Positives = 53/229 (23%), Gaps = 28/229 (12%)
Query: 279 NNLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGSGSIGDLD 338
+ +T IP N + L FS ++ ++ + QN++ D+
Sbjct: 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 339 FITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIY 398
+ ++E + + + ++ +
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 399 A----------------------LGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIP 436
L L N + + NNL +
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 437 DSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP 485
D S L + + L N K L + K LP
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 35/232 (15%), Positives = 65/232 (28%), Gaps = 8/232 (3%)
Query: 103 RFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTG 162
R + + EIP++L L S +L + +N++
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 163 EIPAYIGYYWLKLENLNVAENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRD 222
I A + KL + + + + P Q + N +P+
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 223 LNFLSVAENNFSGMLPPIFNISSLEQIS---LLTNRFEGRLPLNIGFNLPKLKILIVGQN 279
L ++N + + L S L + ++ + N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 280 NLTGSIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLGS 331
NL F AS VIL++S +L + + NL
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK 237
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 30/259 (11%), Positives = 64/259 (24%), Gaps = 28/259 (10%)
Query: 64 CQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPNELGRL 123
C C + I L + L
Sbjct: 8 CSNRVFLCQESKVTEIPSDL---------------PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 124 SRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVR---RNNLTGEIPAYIGYYWLKLENLNV 180
L+ + + N I +++ ++ N L A+ L+ ++
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 181 AENQLTGQLPPSIGNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPI 240
+ + L + N +G + L + +N +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 241 FNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQNNLTGSIPQSFSNASNLVILNL 300
FN + L++++L N LP ++ IL + + + N L +
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 301 SGNHFSGKVGIDFSSLPNI 319
LP +
Sbjct: 233 YNL----------KKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 33/231 (14%), Positives = 69/231 (29%), Gaps = 9/231 (3%)
Query: 369 NLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSA 428
+ + +I +P N L +L +L+ ++ S
Sbjct: 9 SNRVFLCQESKVTEIPSDLP------RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 429 NNLHGIIPDSIGNLSTLNSLWLGF--NNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPP- 485
N++ +I + + NNL P + N NL L +S +
Sbjct: 63 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122
Query: 486 QILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYL 545
+I + + + + N+ + VG + L +++N + E
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 546 KMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLS 596
+N+ +LD+S + LE+L L +
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 39/314 (12%), Positives = 90/314 (28%), Gaps = 33/314 (10%)
Query: 321 RLNLGQNNLGSGSIGDLD---FITLLTNCSKLETLGLNSNRFGGSLPRSIA-------NL 370
R ++ +L +I D +L ++ + L+ N G R ++ +L
Sbjct: 2 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 371 STITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANN 430
+ ++ IP +R L + + + + S +
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 431 LHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEI 490
+ L + + + N L + +N+L + +
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 491 TTLSSLL------------DLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSS 538
LL + +L+ + +Q + + S + L S
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 539 CTSLEYLKMQDNSFRGSIPSSLI------SLKSIEVLDLSCNNLSGQIPEYLED-----L 587
+L L + D ++++ ++ L L N + L+ +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 588 SFLEYLNLSYNDFE 601
L +L L+ N F
Sbjct: 302 PDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 40/325 (12%), Positives = 79/325 (24%), Gaps = 34/325 (10%)
Query: 270 KLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSGK----VGIDFSSLPNITRLNLG 325
LK+ + + S+ ++ + LSGN + + + +S ++
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 326 QNNLGS-GSIGDLDFITLLTNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQIS 384
G LL K L I + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD----NAFGPTAQEPLIDFLSKHTPL 123
Query: 385 GTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLST 444
+ L L + + L+++ N L
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 445 LNSLWLGFNNLQGNIPSSLGNCKNLMLLN------------VSKNKLTGTLPPQILEITT 492
+ L +Q I L L + L + L+
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 493 LSSLLDLSSNLISGSIPLVVGN------LKNLIQLDISRNRFSGEIPTTLSS-----CTS 541
L L+ L+S V + L L + N + TL +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 542 LEYLKMQDNSFRGSIPSSLISLKSI 566
L +L++ N F + ++ +
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 7e-05
Identities = 19/136 (13%), Positives = 52/136 (38%), Gaps = 8/136 (5%)
Query: 458 NIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLS-SNLISGSIPLVVGNLK 516
+ + + + L ++ + + L+ + ++ ++ ++ N+
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIP 65
Query: 517 NLIQLDISRNRFSG--EIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCN 574
L+ L++S NR ++ + + +L+ L + N + I +E L L N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 575 NLSGQIPEYLEDLSFL 590
+LS + +S +
Sbjct: 126 SLSDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 28/143 (19%), Positives = 50/143 (34%), Gaps = 6/143 (4%)
Query: 213 IPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLK 272
+ + + D + ++ P + + ++ ++ I N+P+L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-SDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELL 68
Query: 273 ILIVGQNNLTG--SIPQSFSNASNLVILNLSGNHFSGKVGIDFSSLPNITRLNLGQNNLG 330
L + N L + A NL ILNLSGN + +D + L L N+L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 331 SGSIGDLDFI-TLLTNCSKLETL 352
+I + KL L
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRL 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1003 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.86 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.8 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.79 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.6 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.95 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.81 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.13 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.5 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.41 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=210.2
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++ .++...+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECCEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779-----8899989
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 86101049998899851389989998899999999999999999971699990742689996576799976990333441
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
+||||+++|+|.+++.. ..+++.+++.++.|++.|++|||++ ||+||||||+|||++.++.+||+|||+|+
T Consensus 94 ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEECCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf 99970379808988641------5999999999999999999999987---97226776888688789968642515641
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHHHH
Q ss_conf 03568755567652345566554475433799878644653177999998819999986567864065787750914699
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVM 941 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 941 (1003)
.+.... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+ ...
T Consensus 165 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------------~~~ 226 (293)
T d1yhwa1 165 QITPEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------------ALY 226 (293)
T ss_dssp ECCSTT-----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------------HHH
T ss_pred EECCCC-----CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-------------HHH
T ss_conf 321366-----64444444777368266447998801203137299999804889989979999-------------999
Q ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9998640369998256599999999999852123698999998999999
Q 001858 942 EIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 942 ~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
..... ..... .....+...+.+++.+||+.+|++||+++|+++|
T Consensus 227 ~~~~~-~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 227 LIATN-GTPEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHH-CSCCC----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHC-CCCCC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99857-99988----8855379999999999866996689099999649
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.04 Aligned_cols=265 Identities=27% Similarity=0.458 Sum_probs=212.6
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 710578668243046449999997899841999982011--455367999999998725898831696553105657897
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK--QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
..++|++.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|++++++++||||+++++++. ..
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred CCCCEEEEEEEEECCCCEEEEEEECC---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE------CC
T ss_conf 54518998898307885899999999---8999999734699899999999999998479987864567971------55
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEEEEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCC
T ss_conf 899999658998889998523----57899999999999999998887509---99516147899798189978875002
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 44103568755567652345566554475433799---878644653177999998819999986567864065787750
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG---NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 935 (1003)
+|+...... .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.....
T Consensus 150 la~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---------- 216 (276)
T d1uwha_ 150 LATVKSRWS---GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---------- 216 (276)
T ss_dssp CSCC---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------
T ss_pred CEEECCCCC---CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------
T ss_conf 213335567---7631256655743179999950568999953151635999999997889989989699----------
Q ss_pred CCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 9146999998640369998256599999999999852123698999998999999999775320
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 936 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~ 999 (1003)
.....+..... .| ........+++.+.+++.+||+.+|++|||++|++++|+.+.+..+
T Consensus 217 ---~~~~~~~~~~~-~p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 217 ---QIIFMVGRGYL-SP-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ---HHHHHHHHTSC-CC-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---HHHHHHHCCCC-CC-CCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ---99999965888-98-6000365554999999999758897689299999999999997098
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=362.99 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=215.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCC---EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCC
Q ss_conf 1057866824304644999999789984---1999982011-45536799999999872589883169655310565789
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL---PVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 777 (1003)
.++|++.+.||+|+||+||+|+++.+++ .||+|.+... .....+.|.+|+++++.++||||+++++++ ..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EEC
T ss_conf 004278569802788299999995799788999999978445989999999999999857998886189999-----628
Q ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCC
Q ss_conf 73578610104999889985138998999889999999999999999997169999074268999657679997699033
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 857 (1003)
+..++||||+++|+|.+++... .+.+++.++..++.|++.|++|||++ +|+||||||+|||++.++.+||+||
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CEEEEEEEECCCCCCEEEECCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 8779999722798530021045----67999999999999999988988527---9835761504489889991998884
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 34410356875556765234556655447543379987864465317799999881-99999865678640657877509
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 g~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
|+|+...+..............||+.|+|||.+.+..++.++||||+||++|||++ |+.||.+...
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------------- 239 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------------- 239 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------
T ss_pred CCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-------------
T ss_conf 4315756777765365025666883003878883699786121445357899998679999999999-------------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 1469999986403699982565999999999998521236989999989999999997753
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
......+.......+ ..+++..+.+++.+||+.+|++||++.|+++.|+.+.+.
T Consensus 240 -~~~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 -QDVINAIEQDYRLPP------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -HHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHHHCCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -999999973788999------742269999999997587976892999999999998418
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=363.67 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=210.1
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 71057866824304644999999789984199998201145536799999999872589883169655310565789735
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++ .++...
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCEE
T ss_conf 865758988984076819999998899989999998452431699999999999867997999299999-----989999
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC--CCCEEECCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679--9976990333
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH--DMVAHVSDFG 858 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~--~~~~kl~Dfg 858 (1003)
++||||+++|+|.+++... .+.+++..++.++.||+.|++|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 99 ~ivmE~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECC
T ss_conf 9999857998899999762----37899999999999999999999756---9760001546736416889869995452
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|+.+... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....
T Consensus 172 ~a~~~~~~------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------- 231 (350)
T d1koaa2 172 LTAHLDPK------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------------- 231 (350)
T ss_dssp TCEECCTT------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred HHEECCCC------CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 10442565------4320006862421889975899872676554659999998598998997999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6999998640369998256599999999999852123698999998999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.....+.. ............++..+.+++.+|+..||++|||++|+++|
T Consensus 232 ~~~~~i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 232 ETLRNVKS---CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHH---TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHH---CCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99999984---78898942235899999999999756896679089998629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.18 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=210.9
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCC
Q ss_conf 7105786682430464499999978998419999820114-553679999999987258988316965531056578973
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 779 (1003)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++ .++..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----EECCE
T ss_conf 7568889789712778099999998999699999987540978999999999999867999999499999-----98999
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 5786101049998899851389989998899999999999999999971-699990742689996576799976990333
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
.++||||+++|+|.+++.. .+.+++..++.++.|++.|+.|||+ + +|+||||||+|||++.++.+||+|||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECC
T ss_conf 9999976799868998742-----499999999999999999999999859---99714457799468789989995487
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH-----
Q ss_conf 441035687555676523455665544754337998786446531779999988199999865678640657877-----
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK----- 933 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~----- 933 (1003)
+|+.+.+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.............
T Consensus 151 la~~~~~~-------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 151 VSGQLIDS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp CCHHHHHH-------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred CCCCCCCC-------CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 76256788-------62111377141194687589989488899899999999988899899887899999988751775
Q ss_pred --------------------HHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------------------509146999998640369998256599999999999852123698999998999999
Q 001858 934 --------------------MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 934 --------------------~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
...+....+..+......+..... ......+.+++.+|+..||++|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 45774212333221111222354134778876650268766764--4489999999999868994679089999609
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=362.10 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=209.6
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|+++++.++||||++++++ +.++...+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCEEE
T ss_conf 4035998999317782999999989997999999887264679999999999986799798919999-----99899999
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC--CCCCEEECCCCC
Q ss_conf 861010499988998513899899988999999999999999999716999907426899965767--999769903334
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD--HDMVAHVSDFGL 859 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~--~~~~~kl~Dfg~ 859 (1003)
+||||+++|+|.+++... ...+++.+++.++.|++.|++|||++ ||+||||||+|||++ .++.+||+|||+
T Consensus 103 ivmE~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEECCCCCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCC
T ss_conf 999828998088889863----89989999999999999999999977---92651314455311346788489952563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHH
Q ss_conf 41035687555676523455665544754337998786446531779999988199999865678640657877509146
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|..+.... ......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.... .
T Consensus 176 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------~ 235 (352)
T d1koba_ 176 ATKLNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------------E 235 (352)
T ss_dssp CEECCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------------H
T ss_pred CEECCCCC------CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--------------H
T ss_conf 03437887------201004764534899974799897633389899999999688998997999--------------9
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999998640369998256599999999999852123698999998999999
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
....+.......+ ......++..+.+++.+|++.+|.+||+++|+++|
T Consensus 236 ~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 236 TLQNVKRCDWEFD---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHHCCCCCC---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHCCCCCC---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9999984788989---30024799999999999756996689189999609
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.54 Aligned_cols=266 Identities=25% Similarity=0.442 Sum_probs=216.2
Q ss_pred HHHHHHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCC
Q ss_conf 99997105786682430464499999978998419999820114553679999999987258988316965531056578
Q 001858 697 ELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 697 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 776 (1003)
.++...++|++.+.||+|+||+||+|+++.+++.||+|+++. +....+++.+|+++++.++||||+++++++ .+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TR 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCCCCEECCCCCE-----EE
T ss_conf 517457993986598208880899999999996999999777-610399999999999867999882677527-----45
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 97357861010499988998513899899988999999999999999999716999907426899965767999769903
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
+...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECC
T ss_conf 785478763146760677753035---54157999999999999978889878---930576045768998999289832
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 33441035687555676523455665544754337998786446531779999988199999865678640657877509
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
||+|+....... .......|++.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 159 FG~a~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------------ 222 (287)
T d1opja_ 159 FGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------ 222 (287)
T ss_dssp CCCTTTCCSSSS----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------
T ss_pred CCCEEECCCCCC----EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------------
T ss_conf 445465378872----2103556654666927872799981043021789999998679988774259------------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 1469999986403699982565999999999998521236989999989999999997753
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
....+.+........ ...++..+.+++.+||+.+|++||+++|+++.|+.+.++
T Consensus 223 -~~~~~~i~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 223 -SQVYELLEKDYRMER------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -HHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -HHHHHHHHCCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -999999855888888------743309999999997577976893999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.96 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=208.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.+.|++.+.||+|+||+||+|++..+++.||+|+++.......+.+.+|+++++.++||||+++++++ .++...+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-----EECCEEE
T ss_conf 03759847993077819999999999939999998728999999999999999867999988498898-----0099589
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 86101049998899851389989998899999999999999999971699990742689996576799976990333441
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
+||||+++|+|.+++... .+.+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|.
T Consensus 86 lvmEy~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHH
T ss_conf 999627998188999862----89999999999999999999999988---98871407003148789998997161230
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 035687555676523455665544754337-----998786446531779999988199999865678640657877509
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGM-----GGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
...... .......||+.|+|||++. +..++.++||||+||++|||++|+.||.+....+.
T Consensus 159 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---------- 223 (288)
T d2jfla1 159 KNTRTI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---------- 223 (288)
T ss_dssp ECHHHH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----------
T ss_pred CCCCCC-----CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----------
T ss_conf 357786-----41001025626479999832025788888066578789999998208899999899999----------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 146999998640369998256599999999999852123698999998999999
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
...... ..+ ........++..+.+++.+||+.||++|||++|+++|
T Consensus 224 ---~~~i~~----~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 224 ---LLKIAK----SEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---HHHHHH----SCC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---HHHHHC----CCC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---999970----799-8777656699999999999766996689199999629
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.82 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=207.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 10578668243046449999997899841999982011---455367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|+++++.++||||+++++++ .++.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE-----EECC
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999-----9899
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|+|.+++.. .+.+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCC
T ss_conf 98999850479858988750-----48999999999999999999999988---94652202344146689987115556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 152 ~a~~~~~~-------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------------- 210 (263)
T d2j4za1 152 WSVHAPSS-------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------- 210 (263)
T ss_dssp SCSCCCCC-------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------------
T ss_pred EEEECCCC-------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH--------------
T ss_conf 33544888-------523557887634999975899893144046759999983299998889999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6999998640369998256599999999999852123698999998999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.....+.......| ..++..+.+++.+|++.+|++|||++|+++|
T Consensus 211 ~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 211 ETYKRISRVEFTFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHHTTCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99999971899998-------6689999999999764797689099999719
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.60 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=208.7
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCC
Q ss_conf 7105786682430464499999978998419999820114-553679999999987258988316965531056578973
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 779 (1003)
..+.|++.+.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+.+++.++||||++++++ +.++..
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EEECCE
T ss_conf 766669988994065839999999999989999998157731289999999999986799899919899-----998998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC---CCCCEEECC
Q ss_conf 57861010499988998513899899988999999999999999999716999907426899965767---999769903
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLD---HDMVAHVSD 856 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~---~~~~~kl~D 856 (1003)
.++||||+++|+|.+++.. .+.+++.++..++.|++.|++|||++ +|+||||||+||++. .++.+||+|
T Consensus 82 ~~lvmE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEEC
T ss_conf 8898852689848886530-----36788789999999999998752413---055687046300110468882499831
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 33441035687555676523455665544754337998786446531779999988199999865678640657877509
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 154 FG~a~~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------------ 215 (307)
T d1a06a_ 154 FGLSKMEDPGS------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------------ 215 (307)
T ss_dssp C------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------------
T ss_pred CCEEEECCCCC------EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------------
T ss_conf 54358725897------044003284225918873799980787345159999998597999998999------------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 146999998640369998256599999999999852123698999998999999
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.....+ .........+....++..+.+++.+|++.+|++|||++|+++|
T Consensus 216 --~~~~~i---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 216 --KLFEQI---LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --HHHHHH---HTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHH---HCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --999998---6168777876666789999999999760897579189998629
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.25 Aligned_cols=255 Identities=25% Similarity=0.313 Sum_probs=207.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 105786682430464499999978998419999820114-5536799999999872589883169655310565789735
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.+.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++ .++...
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCCEE
T ss_conf 746089989721748099999999999799999984566412799999999999857998884696540-----467436
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 79 ~ivmEy~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEEEECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHH
T ss_conf 798864589808999753-----79999999999999999999999975---9835754689978878998798323142
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHH
Q ss_conf 10356875556765234556655447543379987-86446531779999988199999865678640657877509146
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+...... ........+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............
T Consensus 151 ~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~--------- 218 (271)
T d1nvra_ 151 TVFRYNN---RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--------- 218 (271)
T ss_dssp EECEETT---EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---------
T ss_pred EEECCCC---CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH---------
T ss_conf 2404688---6531113255747428728618999997101617379999998299788889859999999---------
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999998640369998256599999999999852123698999998999999
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
....... .......+..+.+++.+|++.+|++||+++|+++|
T Consensus 219 ---~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 ---WKEKKTY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---HHTTCTT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---HHCCCCC------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---8638887------88644699999999999767996689099999619
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.77 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=209.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC------CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 105786682430464499999978998419999820114------55367999999998725898831696553105657
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ------KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 775 (1003)
.++|++++.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+++++.++||||++++++ +.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-----EE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEE-----EE
T ss_conf 5677982798117895999999999998999999875663213406899999999999986799899938899-----99
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC----C
Q ss_conf 897357861010499988998513899899988999999999999999999716999907426899965767999----7
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM----V 851 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~----~ 851 (1003)
++...++||||+++|+|.+++.. .+.+++..++.++.|++.|++|||+. +|+||||||+||+++.++ .
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred ECCEEEEEEECCCCCCCCCHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCC
T ss_conf 79989999986778643100103-----56421557899999999998766625---42211333012798258986664
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 69903334410356875556765234556655447543379987864465317799999881999998656786406578
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 852 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 931 (1003)
+|++|||+|....... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 156 vkl~DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------- 222 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------- 222 (293)
T ss_dssp EEECCCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EEECCHHHHHHCCCCC------CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-------
T ss_conf 6964334421057776------312247777430999981899997665221409999997088998899999-------
Q ss_pred HHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 77509146999998640369998256599999999999852123698999998999999
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
+...................++..+.+++.+||+.+|++||+++|+++|
T Consensus 223 ----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 223 ----------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ----------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----------HHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----------9999998168888701047889999999999863896689199999619
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.44 Aligned_cols=263 Identities=23% Similarity=0.375 Sum_probs=211.6
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCC-----EEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEECC
Q ss_conf 71057866824304644999999789984-----1999982011-455367999999998725-8988316965531056
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLL-----PVAVKVINLK-QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSID 773 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~ 773 (1003)
..++|+++++||+|+||+||+|++...++ .||+|++... .......+.+|+.+++++ +||||+++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE----
T ss_conf 7899397019830788199999985788554204999999663358789999999999999715899686877888----
Q ss_pred CCCCCCEEEEEECCCCCCHHHHHHHCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf 57897357861010499988998513899------------------899988999999999999999999716999907
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQ------------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIV 835 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 835 (1003)
.+....++||||+++|+|.++++..+.. ....+++..++.++.|++.|++|||++ +|+
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -EECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEE
T ss_conf -6299589999727999599999862577751022100001222001257789999999999999999999739---905
Q ss_pred ECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-C
Q ss_conf 426899965767999769903334410356875556765234556655447543379987864465317799999881-9
Q 001858 836 HGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-G 914 (1003)
Q Consensus 836 H~Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g 914 (1003)
||||||+||+++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++||||+||++|||++ |
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCC---EEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCC
T ss_conf 052703214434598289851422220457786---15623435787657838872799996330300039999998389
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999865678640657877509146999998640369998256599999999999852123698999998999999999
Q 001858 915 RRPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 915 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~ 993 (1003)
+.||.+.... ......+........ ...++..+.+++.+||+.+|++|||++|++++|..
T Consensus 264 ~~Pf~~~~~~-------------~~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 264 VNPYPGIPVD-------------ANFYKLIQNGFKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSSTTCCCS-------------HHHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCHH-------------HHHHHHHHCCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9999998989-------------999999856998998------87678999999999758896689399999999748
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.76 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=208.9
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCC
Q ss_conf 105786682430464499999978998419999820114--553679999999987258988316965531056578973
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 779 (1003)
.++|++.+.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. .....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CCCCE
T ss_conf 333799679830889199999999999799999987465797999999999999997789998248999991---78998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCEECCCCCCCEEECCCCCEEECCC
Q ss_conf 578610104999889985138998999889999999999999999997169--999074268999657679997699033
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC--QPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~Nili~~~~~~kl~Df 857 (1003)
.++||||+++|+|.+++...... ...+++..++.++.|++.|++|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEECCCCCCHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEEC
T ss_conf 99999568999389999851545-78999999999999999999999971677887885867654257478885798001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 34410356875556765234556655447543379987864465317799999881999998656786406578775091
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP 937 (1003)
Q Consensus 858 g~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 937 (1003)
|+|+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 159 G~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------------- 220 (269)
T d2java1 159 GLARILNHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------------- 220 (269)
T ss_dssp HHHHHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------------
T ss_pred CCEEECCCCC-----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH-------------
T ss_conf 0003224577-----7556677882327999983999993898875278999980188998998999-------------
Q ss_pred HHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 46999998640369998256599999999999852123698999998999999
Q 001858 938 EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
+....+........ ...+++.+.+++.+||+.||++||+++|+++|
T Consensus 221 -~~~~~i~~~~~~~~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 221 -ELAGKIREGKFRRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -HHHHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHCCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -99999971899889------74359999999999767995579189999729
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.37 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=209.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||+||+|++. ++..||||+++. .....+++.+|+++++.++||||+++++++ ..+...+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-----~~~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCEE-----CCCCCEE
T ss_conf 699588889820888299999988-999999999878-867689999999999966899756535243-----1599337
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 86101049998899851389989998899999999999999999971699990742689996576799976990333441
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
+||||+++|+|.+++... ...+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++
T Consensus 77 lv~E~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHE
T ss_conf 999836999189975201----34788999999999999987765316---43104431532666688776865532100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHCCHHH
Q ss_conf 03568755567652345566554475433799878644653177999998819-99998656786406578775091469
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG-RRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
....... .......||+.|+|||++.+..++.++||||+|+++|||+++ ++||..... ...
T Consensus 150 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------------~~~ 211 (263)
T d1sm2a_ 150 FVLDDQY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------------SEV 211 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------------HHH
T ss_pred ECCCCCC----EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH--------------HHH
T ss_conf 2368873----3504300176667857860799984033210599999998789888778999--------------999
Q ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 999986403699982565999999999998521236989999989999999997753
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 941 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
...+........ +..++..+.+++.+||+.+|++||+++|++++|+.+.+.
T Consensus 212 ~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 212 VEDISTGFRLYK------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 999980688899------543679999999997657976891999999999999857
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.50 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=208.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 10578668243046449999997899841999982011---455367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|+.+++.++||||++++++ +.++.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCCC
T ss_conf 4742898898317684999999989998999999815654497999999999999986799988778764-----03564
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|+|.+++.. .+.+++..++.++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCCCCEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECC
T ss_conf 21110003579860555532-----56775999999999996521134315---96224647778476589988882056
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|+...... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 151 ~a~~~~~~~-----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------------- 211 (337)
T d1o6la_ 151 LCKEGISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------------- 211 (337)
T ss_dssp TCBCSCCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred CCCCCCCCC-----CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 520035678-----6205510088996666504898883331022306788998789999996999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 699999864036999825659999999999985212369899999-----8999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~eil~~ 990 (1003)
.+...+......-| ..++..+.+++.+|++.+|++|++ ++|+++|
T Consensus 212 ~~~~~i~~~~~~~p-------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 212 RLFELILMEEIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHCCCCCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 99999852899898-------668999999998666389344225652349999729
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.58 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=208.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 10578668243046449999997899841999982011---455367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++++.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||++++++ +.++.
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSS
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----EEECC
T ss_conf 9877898898508790999999989997999999865775577789999999999987688886179999-----99899
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|+|.+++.. .+.+++..++.++.|++.|++|+|+. +|+||||||+||+++.++.+|++|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCC
T ss_conf 88999970489877776531-----59999999999999999999762165---08847677412366888538860321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|+.+.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 154 ~a~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------------- 216 (288)
T d1uu3a_ 154 TAKVLSPES---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------------- 216 (288)
T ss_dssp TCEECC-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred CCEECCCCC---CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 024225677---643335556775525844002689896662304569999980388998995999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 69999986403699982565999999999998521236989999989999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNL 991 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L 991 (1003)
.....+...-..-| ..+...+.+++.+|++.||++|||++|+..+-
T Consensus 217 ~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 217 LIFQKIIKLEYDFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp HHHHHHHTTCCCCC-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred HHHHHHHCCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCH
T ss_conf 99999971899998-------54799999999998557976891978973778
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.84 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=200.9
Q ss_pred CCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEEE
Q ss_conf 786682430464499999978998419999820114--553679999999987258988316965531056578973578
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 705 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 782 (1003)
|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..+....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCCCEEEE
T ss_conf 8851697008284999999999995999999851227989999999999999857999850699998403-345888999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--CEECCCCCCCEEEC-CCCCEEECCCCC
Q ss_conf 610104999889985138998999889999999999999999997169999--07426899965767-999769903334
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPP--IVHGDLKPSNVLLD-HDMVAHVSDFGL 859 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~Nili~-~~~~~kl~Dfg~ 859 (1003)
||||+++|+|.+++.. ...+++..++.++.|++.|++|||++ + |+||||||+|||++ .++.+||+|||+
T Consensus 90 vmE~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEECCCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCC
T ss_conf 9957898948999751-----35546999999999999999999978---997996876743511667999889800576
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHH
Q ss_conf 41035687555676523455665544754337998786446531779999988199999865678640657877509146
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|+.... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||........
T Consensus 162 a~~~~~-------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------------- 220 (270)
T d1t4ha_ 162 ATLKRA-------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------------- 220 (270)
T ss_dssp GGGCCT-------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------------
T ss_pred CEECCC-------CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH-------------
T ss_conf 542368-------76677553813008988478-999867110079999999878899987655999-------------
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999998640369998256599999999999852123698999998999999
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 940 ~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
....+ ....+. ........+.+.+++.+||+.+|++|||++|+++|
T Consensus 221 ~~~~i---~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 221 IYRRV---TSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHH---TTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHH---HCCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99999---738998--65675578999999999763797589299999677
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.01 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=211.3
Q ss_pred HCCCCCCC-EEEECCCEEEEEEEECC--CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCC
Q ss_conf 10578668-24304644999999789--98419999820114-5536799999999872589883169655310565789
Q 001858 702 TNEFSLSN-LIGQGSFGFVYRGNLGE--DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 777 (1003)
.++|.+.+ +||+|+||+||+|.++. ++..||||+++... ....+.|.+|+++++.++||||+++++++. .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC------C
T ss_conf 4471887848730608099999996089768999999882039789999999999998679988806865603------6
Q ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCC
Q ss_conf 73578610104999889985138998999889999999999999999997169999074268999657679997699033
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 857 (1003)
+..++||||+++|+|.+++... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CEEEEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCC
T ss_conf 8079999807899689975212----56999999999999999987899868---8105767646604546885420331
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 34410356875556765234556655447543379987864465317799999881-99999865678640657877509
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 858 g~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
|+|+.+...... ........||+.|+|||++.+..++.++||||+||++|||++ |+.||......
T Consensus 154 Gla~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------------ 219 (285)
T d1u59a_ 154 GLSKALGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------ 219 (285)
T ss_dssp TTCEECTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------------
T ss_pred HHHHCCCCCCCC--CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH------------
T ss_conf 342115543432--113562113743358688727999954123220178999993899999997999------------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 1469999986403699982565999999999998521236989999989999999997753201
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~~ 1000 (1003)
+....+...... +.+..++..+.+++.+||+.+|++||++.++.+.|+........
T Consensus 220 --~~~~~i~~~~~~------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 220 --EVMAFIEQGKRM------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp --HHHHHHHTTCCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHCCCCC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf --999999818999------99976789999999997577976890999999999999998541
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.29 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=201.8
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 1057866824304644999999789984199998201145---5367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
...|+..+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++||||+++++++ .++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETT
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECC
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999-----9899
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|++..++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECC
T ss_conf 88999980699945789973-----79999999999999999999999868---97666788421798799978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 4410356875556765234556655447543379---9878644653177999998819999986567864065787750
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG---GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 935 (1003)
+|..... .....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+....
T Consensus 161 ~a~~~~~---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----------- 220 (309)
T d1u5ra_ 161 SASIMAP---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------- 220 (309)
T ss_dssp TCBSSSS---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------
T ss_pred CCCCCCC---------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-----------
T ss_conf 5334677---------87313476636889983467888672145455899999998788999997999-----------
Q ss_pred CCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9146999998640369998256599999999999852123698999998999999
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
+....... ...+.... ..++..+.+++.+||+.+|++|||++|+++|
T Consensus 221 --~~~~~i~~---~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 221 --SALYHIAQ---NESPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --HHHHHHHH---SCCCCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --HHHHHHHH---CCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --99999982---89998887---8889999999999773796579189999719
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.08 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=207.4
Q ss_pred HHHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCC
Q ss_conf 97105786682430464499999978998419999820114553679999999987258988316965531056578973
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 700 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 779 (1003)
...++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.+.+|++++++++||||+++++++. +..
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~ 81 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEP 81 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEC------CCC
T ss_conf 38899388679810798289999999-9999999998647-688899999999998679998857873104------597
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 57861010499988998513899899988999999999999999999716999907426899965767999769903334
Q 001858 780 KALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGL 859 (1003)
Q Consensus 780 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~ 859 (1003)
.++||||+++|+|.+++.... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEECCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCC
T ss_conf 699999578982888875147---89887889999999999999999748---954675642251562024404234101
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHH
Q ss_conf 41035687555676523455665544754337998786446531779999988199999865678640657877509146
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
|+...+.... ......|++.|+|||++.++.++.++||||+||++|||++|..|+...... ..
T Consensus 156 a~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------------~~ 218 (272)
T d1qpca_ 156 ARLIEDNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------------PE 218 (272)
T ss_dssp CEECSSSCEE----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HH
T ss_pred EEECCCCCCC----CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-------------HH
T ss_conf 4773588644----203567744445828983799982456452579999999689888888899-------------99
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 999998640369998256599999999999852123698999998999999999775
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 940 ~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~ 996 (1003)
....+....... ....++..+.+++.+||+.+|++|||++++++.|+.+..
T Consensus 219 ~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 219 VIQNLERGYRMV------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCC------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999997068888------965571999999999758897689399999998611321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.38 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=210.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCC----CEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCC
Q ss_conf 105786682430464499999978998----4199998201145-53679999999987258988316965531056578
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDL----LPVAVKVINLKQK-GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 776 (1003)
..+|+..+.||+|+||+||+|.++.++ ..||||+++.... .....|.+|+++++.++||||+++++++ .+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----EC
T ss_conf 8996861598117790999999968998787999999988445968999999999999856898783236778-----33
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 97357861010499988998513899899988999999999999999999716999907426899965767999769903
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
....++|+||+.++++.+++... ...+++.++..++.|++.|++|||+. +|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCCEEEEEEECCCCCCHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECC
T ss_conf 88038999721357402221023----45420899999999999854121212---342576564427888998499845
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 33441035687555676523455665544754337998786446531779999988199999865678640657877509
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
||+++........ ........||+.|+|||++.++.++.++||||+||++|||+++..|+......
T Consensus 154 FGla~~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------------ 219 (283)
T d1mqba_ 154 FGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------------ 219 (283)
T ss_dssp CCC-------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------
T ss_pred CCHHHCCCCCCCC--CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH------------
T ss_conf 5103003578765--26742677773434888870499997355634489899999679886556899------------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 14699999864036999825659999999999985212369899999899999999977532
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~ 998 (1003)
......+....... ....++..+.+++.+||+.+|++||++.|+++.|+.+.+.-
T Consensus 220 -~~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 220 -HEVMKAINDGFRLP------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -HHHHHHHHTTCCCC------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -HHHHHHHHCCCCCC------CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -99999986357899------85045799999999977679768939999999999986695
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.14 Aligned_cols=254 Identities=19% Similarity=0.292 Sum_probs=208.4
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 71057866824304644999999789984199998201145536799999999872589883169655310565789735
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++.+.||+|+||+||+|.++.+++.||+|+++.... ....+.+|+++++.++||||++++++ +.++...
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-----FESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEE-----EEECCEE
T ss_conf 70105887898317783999999989996999999757866-59999999999985799798909899-----9889988
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCC--CCEEECCCC
Q ss_conf 786101049998899851389989998899999999999999999971699990742689996576799--976990333
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHD--MVAHVSDFG 858 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~--~~~kl~Dfg 858 (1003)
++||||+++|+|.+++... ...+++.+++.++.|++.|++|||++ +|+||||||+||+++.+ ..+|++|||
T Consensus 77 ~lvmE~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEEECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 9999538998088998753----89999999999999999999999876---9975135544434437885189976441
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
++...... .......+++.|+|||...+..++.++||||+||++|+|++|+.||......
T Consensus 150 ~~~~~~~~------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------------- 209 (321)
T d1tkia_ 150 QARQLKPG------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------- 209 (321)
T ss_dssp TCEECCTT------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------------
T ss_pred HHHCCCCC------CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 11003467------7532122332223402104877784011302799999998289999998999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6999998640369998256599999999999852123698999998999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
+...................++..+.+++.+|+..||++||+++|+++|
T Consensus 210 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 210 ---QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---9999998389998802236789999999999866996689099999639
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.11 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=210.1
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.++||+|+||+||+|+++ +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++ .++...+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEE-----EECCCEE
T ss_conf 699799689820788399999988-9989999998747-57789999999999966898601588998-----5078169
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 86101049998899851389989998899999999999999999971699990742689996576799976990333441
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
+||||+++|++.+++... ...+++..+++++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 76 iv~Ey~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEEECCTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEECCCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHE
T ss_conf 999704899388864102----46776899999999999999987546---84346654135887699847988614420
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCHHH
Q ss_conf 0356875556765234556655447543379987864465317799999881-999998656786406578775091469
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
........ ......||+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ++
T Consensus 149 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------------~~ 210 (258)
T d1k2pa_ 149 YVLDDEYT----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------------ET 210 (258)
T ss_dssp BCSSSSCC----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------------HH
T ss_pred ECCCCCCE----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH--------------HH
T ss_conf 23578722----5246578877578078637998852103364324673975599998899999--------------99
Q ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99998640369998256599999999999852123698999998999999999
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCA 993 (1003)
Q Consensus 941 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~ 993 (1003)
...+........ +..++..+.+++.+||+.+|++|||+++++++|..
T Consensus 211 ~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 211 AEHIAQGLRLYR------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 999980797899------65465999999999766897689399999987418
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.05 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=204.6
Q ss_pred CEEEECCCEEEEEEEEC--CCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEEEEE
Q ss_conf 82430464499999978--998419999820114--55367999999998725898831696553105657897357861
Q 001858 709 NLIGQGSFGFVYRGNLG--EDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKALVY 784 (1003)
Q Consensus 709 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 784 (1003)
++||+|+||+||+|.+. ++++.||+|+++... ....+.+.+|++++++++||||+++++++. ....++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC------CCCEEEEE
T ss_conf 783458782999999816973859999998801089899999999999998679989852777750------59779999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 01049998899851389989998899999999999999999971699990742689996576799976990333441035
Q 001858 785 DYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLF 864 (1003)
Q Consensus 785 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~~~ 864 (1003)
||+++|+|.+++.. ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||+++...
T Consensus 87 E~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp ECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCC
T ss_conf 74788968999752-----25789999999999999997668747---95567776113102356751234134533134
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCHHHHHH
Q ss_conf 6875556765234556655447543379987864465317799999881-999998656786406578775091469999
Q 001858 865 DRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEKVMEI 943 (1003)
Q Consensus 865 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 943 (1003)
..... ........||+.|+|||++.+..++.++||||+|+++|||++ |+.||.+... .+....
T Consensus 159 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------------~~~~~~ 222 (277)
T d1xbba_ 159 ADENY--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SEVTAM 222 (277)
T ss_dssp TTCSE--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHHHHH
T ss_pred CCCCC--CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH--------------HHHHHH
T ss_conf 32344--32244567784203916653799984344303403132896589999999899--------------999999
Q ss_pred HHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9864036999825659999999999985212369899999899999999977532
Q 001858 944 VDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKY 998 (1003)
Q Consensus 944 i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~ 998 (1003)
+...... +....++..+.+++.+||+.+|++||+++++.+.|+....+.
T Consensus 223 i~~~~~~------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 223 LEKGERM------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHTTCCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHCCCCC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 9828999------998656799999999975889768909899999852887504
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=342.73 Aligned_cols=247 Identities=27% Similarity=0.329 Sum_probs=206.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 10578668243046449999997899841999982011---455367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|+.+++.++||||++++++ +.++.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSS
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEE-----EEECC
T ss_conf 5470888897207680899999989997999999845775488999999999999986369675330356-----85288
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|++.+++.. ...+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEEEEEECCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCC
T ss_conf 00567650378632234322-----22111007999999998765541247---67705568105038689988983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|+..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....
T Consensus 150 ~a~~~~~~--------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------- 207 (316)
T d1fota_ 150 FAKYVPDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------------- 207 (316)
T ss_dssp SCEECSSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------------
T ss_pred CCEEECCC--------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 21671245--------64345763435999983899980430465333689997598999996999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 69999986403699982565999999999998521236989999-----98999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~eil~~ 990 (1003)
.....+...-...| ..++..+.+++.+|+..+|++|+ +++++++|
T Consensus 208 ~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 208 KTYEKILNAELRFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHHCCCCCC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHCCCCCCC-------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 99999970898899-------778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=344.07 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=206.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 10578668243046449999997899841999982011---455367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|+++++.++||||++++++ +.+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCC-----CCCCC
T ss_conf 2370898896117680899999989998999999826774588999999999999997487727403444-----43222
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++|+|++.+|+|.+++.. .+.+++.+++.++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCCCCCCCCCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECE
T ss_conf 22322223346622666751-----58989999999999999989999859---98617679999360778978861010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+|+..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 187 ~a~~~~~~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------- 244 (350)
T d1rdqe_ 187 FAKRVKGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------------- 244 (350)
T ss_dssp TCEECSSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred EEEECCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 33322566--------64336763567889971799885331145007899997588998995999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 69999986403699982565999999999998521236989999-----98999999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~eil~~ 990 (1003)
.....+.......| ..++..+.+++.+|+..||++|+ +++|+++|
T Consensus 245 ~~~~~i~~~~~~~p-------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 245 QIYEKIVSGKVRFP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHCCCCCC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHCCCCCCC-------CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 99999861798897-------668999999999983409986065534549999719
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=346.41 Aligned_cols=267 Identities=21% Similarity=0.351 Sum_probs=215.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 1057866824304644999999789984199998201145---5367999999998725898831696553105657897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK---GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
.++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+++++.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CCCC
T ss_conf 620698689960899299999999999899999985566469899999999999998569998873114354326-8876
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++++|.+++.. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++..+++|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEEEECCCCCEEHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHH
T ss_conf 69999977889871011203-----58999999999999999999999857---95276346755665754320100344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
.+....... ..........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------------- 220 (277)
T d1o6ya_ 157 IARAIADSG--NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------------- 220 (277)
T ss_dssp TCEECC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------------
T ss_pred HHHHHCCCC--CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 432212354--4333346425762436999983999996632026528999997697998996999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 69999986403699982565999999999998521236989999-98999999999775
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-HMADAVKNLCAARE 996 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~eil~~L~~~~~ 996 (1003)
+.........+.........++..+.+++.+|++.||++|| +++++.+.|..++.
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 221 ---SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ---HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ---HHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf ---99999984699997100347899999999998667976777399999999999758
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.51 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=204.8
Q ss_pred HHCCCCCCC-EEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCCCCC
Q ss_conf 710578668-243046449999997899841999982011455367999999998725-898831696553105657897
Q 001858 701 ATNEFSLSN-LIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
..++|++.. .||+|+||.||+|++..+++.||+|+++.. ..+.+|+.++.++ +||||+++++++... +....
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~ 82 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRK 82 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEEC-CCCCC
T ss_conf 0148798107965454869999998899989999998974-----77999999999866999978298999503-46897
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC---CCCEEEC
Q ss_conf 3578610104999889985138998999889999999999999999997169999074268999657679---9976990
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVS 855 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~---~~~~kl~ 855 (1003)
..++||||+++|+|.+++.... ...+++.+++.++.|++.|++|||+. +|+||||||+||+++. .+.+|++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999997789984999998627---87757999999999999999999976---98644410022011355556631135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 33344103568755567652345566554475433799878644653177999998819999986567864065787750
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 856 Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 935 (1003)
|||+|+...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.......
T Consensus 157 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------- 222 (335)
T d2ozaa1 157 DFGFAKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------- 222 (335)
T ss_dssp CCTTCEECCCCC------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred CCCEEEECCCCC------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH--------
T ss_conf 455123336888------643226775637927774898888888876451677886588998898877889--------
Q ss_pred CCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9146999998640369998256599999999999852123698999998999999
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 936 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
................+....++..+.+++.+|++.+|++||++.|+++|
T Consensus 223 -----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 223 -----PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----99999985388888985434699999999999756996579099999709
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=343.49 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=199.8
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC---CCCHHHHHH---HHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 105786682430464499999978998419999820114---553679999---99998725898831696553105657
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ---KGSIKSFVA---ECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~---E~~~l~~l~h~ni~~~~~~~~~~~~~ 775 (1003)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+ ++.+++.++||||++++++ +.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEE-----EE
T ss_conf 7768510188428890999999999997999999845875426679999999999999850899858899999-----99
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEC
Q ss_conf 89735786101049998899851389989998899999999999999999971699990742689996576799976990
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~ 855 (1003)
+++..++||||+++|+|.+++.. ...+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred ECCEEEEEEEECCCCCHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEE
T ss_conf 89988999991489838999873-----25532789999999999999999977---96220444221678588967982
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 3334410356875556765234556655447543379-987864465317799999881999998656786406578775
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 856 Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 934 (1003)
|||+|+.+.... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.
T Consensus 150 DFGla~~~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------- 214 (364)
T d1omwa3 150 DLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------- 214 (364)
T ss_dssp CCTTCEECSSSC-------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--------
T ss_pred EECEEEECCCCC-------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH--------
T ss_conf 201023337886-------43311345542168760389998441046778999999859998888998999--------
Q ss_pred HCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 0914699999864036999825659999999999985212369899999-----8999999
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIH-----MADAVKN 990 (1003)
Q Consensus 935 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~eil~~ 990 (1003)
...........+. . ...++..+.+++.+|++.||++||+ ++|+++|
T Consensus 215 ------~~~~~~~~~~~~~-~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 215 ------HEIDRMTLTMAVE-L---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ------HHHHHHSSSCCCC-C---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ------HHHHHHCCCCCCC-C---CCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf ------9999860468887-8---8778999999999985669888088743579999749
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.76 Aligned_cols=260 Identities=24% Similarity=0.388 Sum_probs=210.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCC----EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCC
Q ss_conf 1057866824304644999999789984----1999982011-4553679999999987258988316965531056578
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLL----PVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 776 (1003)
..+|++.+.||+|+||+||+|++..+++ .||+|.++.. .....+.+.+|++++++++||||++++++|..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-----
T ss_conf 899978319820899299999995899889899999996513497999999999999986799888158999961-----
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 97357861010499988998513899899988999999999999999999716999907426899965767999769903
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
...++++|++.+|+|.+++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CCEEEEEEECCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEEC
T ss_conf -9836999842687401011133----45799999999999999999999876---950476212031167998758602
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 334410356875556765234556655447543379987864465317799999881-9999986567864065787750
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 935 (1003)
||+|+....... ........||+.|+|||++.++.++.++||||+||++|||+| |..||......
T Consensus 155 FGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----------- 220 (317)
T d1xkka_ 155 FGLAKLLGAEEK---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------- 220 (317)
T ss_dssp CSHHHHTTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------
T ss_pred CCCCEECCCCCC---CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------
T ss_conf 552223354445---322365105864467088746999835654407999999997799999999989-----------
Q ss_pred CCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 91469999986403699982565999999999998521236989999989999999997753
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 936 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
.+...+....... ..+.++..+.+++.+||+.+|++||++.|+++++..+.+.
T Consensus 221 ---~~~~~i~~~~~~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 221 ---EISSILEKGERLP------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---GHHHHHHHTCCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHHHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---9999997599899------9855689999999984789934691999999999998758
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.71 Aligned_cols=273 Identities=22% Similarity=0.368 Sum_probs=212.4
Q ss_pred HHHHHHHCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCCEEEEEE
Q ss_conf 8999971057866824304644999999789-----98419999820114-55367999999998725-89883169655
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITV 768 (1003)
Q Consensus 696 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~~~~~ 768 (1003)
+.++...++|++.++||+|+||.||+|++.. +++.||+|+++... ....+.+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 25261679979844984167839999998677755578399999986001717899999999998861499849974115
Q ss_pred EEECCCCCCCCEEEEEECCCCCCHHHHHHHCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEC
Q ss_conf 3105657897357861010499988998513899-----------89998899999999999999999971699990742
Q 001858 769 CSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHG 837 (1003)
Q Consensus 769 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 837 (1003)
+ .......++||||+++|+|.+++...... ....+++.++..++.|++.|++|||++ +|+||
T Consensus 86 ~----~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 86 C----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp E----CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred E----CCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCC
T ss_conf 4----0479757999984589929999985366666532220233214689999999999999999988737---97178
Q ss_pred CCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CC
Q ss_conf 68999657679997699033344103568755567652345566554475433799878644653177999998819-99
Q 001858 838 DLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG-RR 916 (1003)
Q Consensus 838 Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g-~~ 916 (1003)
||||+||+++.++.+||+|||+|+...... .........||+.|+|||++.+..++.++||||+||++|||++| ..
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCT---TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCCEEECCCCCEEECCCCCHHHCCCCC---CCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCC
T ss_conf 677310657799828984575200113566---52224751667210203686468899663221367899999868899
Q ss_pred CCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99865678640657877509146999998640369998256599999999999852123698999998999999999775
Q 001858 917 PTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 917 Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~ 996 (1003)
||...... +.....+........ ...+++.+.+++.+||+.+|++|||++|++++|+.+.+
T Consensus 236 p~~~~~~~-------------~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 236 PYPGVKID-------------EEFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SSTTCCCS-------------HHHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHH-------------HHHHHHHHCCCCCCC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99899989-------------999999963898888------86578999999999767796679199999999979986
Q ss_pred H
Q ss_conf 3
Q 001858 997 K 997 (1003)
Q Consensus 997 ~ 997 (1003)
.
T Consensus 297 ~ 297 (299)
T d1ywna1 297 A 297 (299)
T ss_dssp H
T ss_pred C
T ss_conf 7
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.37 Aligned_cols=286 Identities=23% Similarity=0.266 Sum_probs=210.7
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
..+|.+.+.||+|+||.||+|++. ++.||||+++.... .......|+..++.++||||+++++++.... ......+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC--CEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECC-CCCEEEE
T ss_conf 868999889820788199999999--98999999872004-6799999999996279986832688998379-8604899
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 861010499988998513899899988999999999999999999716-----999907426899965767999769903
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH-----CQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
+||||+++|+|.++++. ..+++.+++.++.|++.|++|+|+. ++++|+||||||+||+++.++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEECCCCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 99964669898999865------899989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 33441035687555676523455665544754337998------786446531779999988199999865678640657
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN------VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~ 930 (1003)
||++........ ..........||+.|+|||++.+.. ++.++||||+||++|||++|..||............
T Consensus 152 FGl~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATD-TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CTTCEEEETTTT-EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCCCCCCCCCCC-CEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf 386623467776-2001355250354767822105654546777675012201599999996289988766311241012
Q ss_pred HHHHHCC-HHHHHHH-HHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 8775091-4699999-8640369998256599999999999852123698999998999999999775320
Q 001858 931 FVKMALP-EKVMEIV-DFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 931 ~~~~~~~-~~~~~~i-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~ 999 (1003)
....... ......+ .....++. .......+....+.+++.+||+.+|++||++.|+++.|+++.++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCC-CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 255643099999987502468887-7655776899999999999760698589599999999998888659
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=340.99 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=206.3
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCC---------CHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 10578668243046449999997899841999982011455---------3679999999987258-9883169655310
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG---------SIKSFVAECEALKNIR-HRNLIKIITVCSS 771 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~ 771 (1003)
.++|++.+.||+|+||+||+|++..+++.||+|+++..... ..+.+.+|+.++++++ ||||++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~--- 78 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT--- 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE---
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEE---
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762---
Q ss_pred CCCCCCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCC
Q ss_conf 56578973578610104999889985138998999889999999999999999997169999074268999657679997
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMV 851 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~ 851 (1003)
+.+++..++||||+++|+|.++++. .+.+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 79 --~~~~~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 79 --YETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp --EECSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred --CCCCCCEEEEEECCCCCHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCC
T ss_conf --1467605999976898668999986-----59999999999999999999999875---9943234625489868998
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 69903334410356875556765234556655447543379------987864465317799999881999998656786
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG------GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDG 925 (1003)
Q Consensus 852 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~ 925 (1003)
+||+|||+++...+.. ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+....
T Consensus 149 ~kl~DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~- 221 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM- 221 (277)
T ss_dssp EEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred EEECCCHHEEECCCCC------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-
T ss_conf 3871240316726887------213452467888988860534456788992331856560231032288898899999-
Q ss_pred CHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 40657877509146999998640369998256599999999999852123698999998999999
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.....+.. .......+....+++.+.+++.+|++++|++||+++|+++|
T Consensus 222 -------------~~~~~i~~---~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 -------------LMLRMIMS---GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -------------HHHHHHHH---TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -------------HHHHHHHH---CCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------------99999981---89888985434689999999999765896689199999739
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.95 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=202.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCC---CCCCHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 0578668243046449999997899841999982011---4553679999999987-25898831696553105657897
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK---QKGSIKSFVAECEALK-NIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~-~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
++|++++.||+|+||+||+|+++.+++.||+|+++.. .....+.+..|..++. .++||||++++++ +.++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSS
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEE-----ECCCC
T ss_conf 9718865894087828999999999989999998055533848999999999999984799968789889-----70498
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..++||||+++|+|.+++.. .+.+++.+++.++.|++.|++|||++ +++||||||+|||++.++.+|++|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEECCCCCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCC
T ss_conf 31677750379808998640-----47899999999999999999999868---93403476540444489963015553
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 44103568755567652345566554475433799878644653177999998819999986567864065787750914
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 149 ~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------------- 209 (320)
T d1xjda_ 149 MCKENMLG-----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------------- 209 (320)
T ss_dssp TCBCCCCT-----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred HHHHCCCC-----CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--------------
T ss_conf 02323566-----53345457877768999982799883232011227898987388999998999--------------
Q ss_pred HHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 69999986403699982565999999999998521236989999989-9999
Q 001858 939 KVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMA-DAVK 989 (1003)
Q Consensus 939 ~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-eil~ 989 (1003)
.....+.. ..+.. ...++..+.+++.+|+..+|++||++. |+++
T Consensus 210 ~~~~~i~~---~~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 ELFHSIRM---DNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHH---CCCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHC---CCCCC----CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 99999971---89989----75679999999999654489878388999980
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.50 Aligned_cols=263 Identities=23% Similarity=0.365 Sum_probs=212.3
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCC---CEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCC
Q ss_conf 7105786682430464499999978998---419999820114-553679999999987258988316965531056578
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDL---LPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKG 776 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 776 (1003)
..++|++++.||+|+||.||+|++..++ ..||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 78 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 78 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE------
T ss_conf 88996987799307882999999936996449999999365668799999999999998689999856988995------
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 97357861010499988998513899899988999999999999999999716999907426899965767999769903
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
+...++||||+++|++.+++... ...+++..++.++.|++.|++|+|++ +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CCEEEEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECC
T ss_conf 37479999840698077654224----78999999999999998775230226---744141026553206789678765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 334410356875556765234556655447543379987864465317799999881-9999986567864065787750
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMA 935 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 935 (1003)
||+|+....... .......||+.|+|||++.+..++.++||||+||++|||++ |.+||......+
T Consensus 152 fG~a~~~~~~~~----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---------- 217 (273)
T d1mp8a_ 152 FGLSRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------- 217 (273)
T ss_dssp -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------
T ss_pred CHHHEECCCCCC----EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH----------
T ss_conf 034213367762----330540058310326675169988745244424789999826999988899999----------
Q ss_pred CCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf 91469999986403699982565999999999998521236989999989999999997753201
Q 001858 936 LPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKG 1000 (1003)
Q Consensus 936 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~~ 1000 (1003)
....+...... +....++..+.+++.+||+.+|++||++.|++++|+.+.++-++
T Consensus 218 ----~~~~i~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~ 272 (273)
T d1mp8a_ 218 ----VIGRIENGERL------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272 (273)
T ss_dssp ----HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHCCCCC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHC
T ss_conf ----99999818999------89877799999999997687976892999999999999778617
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=343.10 Aligned_cols=270 Identities=24% Similarity=0.393 Sum_probs=212.8
Q ss_pred HHHHHHHCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 8999971057866824304644999999789-----9841999982011455-367999999998725898831696553
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQKG-SIKSFVAECEALKNIRHRNLIKIITVC 769 (1003)
Q Consensus 696 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~~~~~~ 769 (1003)
.+++...++|++.+.||+|+||+||+|+++. ++..||||+++..... ..+++.+|+++++.++|||++++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred EECCCCCCCCEEEEEECCCCCCHHHHHHHCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 105657897357861010499988998513899-------------------8999889999999999999999997169
Q 001858 770 SSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------------------VDGNLNLIQRLNISIDVASAIEYLHHHC 830 (1003)
Q Consensus 770 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 830 (1003)
......++++|++++|+|.+++...... ....+++.+++.++.|++.|++|+|+.
T Consensus 86 -----~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~- 159 (301)
T d1lufa_ 86 -----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER- 159 (301)
T ss_dssp -----CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred -----CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC-
T ss_conf -----05980389998158992999998527554210000111001210346788989999999999999985541357-
Q ss_pred CCCCEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 99907426899965767999769903334410356875556765234556655447543379987864465317799999
Q 001858 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLE 910 (1003)
Q Consensus 831 ~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~e 910 (1003)
+++||||||+||+++.++.+||+|||+|+...+... ........|++.|+|||.+.+..++.++||||+||++||
T Consensus 160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --CEEEEEECCCCEEECCCCCEEECCCHHHEECCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHH
T ss_conf --868548840116898999289833144211367764---111577776767679899726889805630252362999
Q ss_pred HHHCC-CCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 88199-99986567864065787750914699999864036999825659999999999985212369899999899999
Q 001858 911 MFTGR-RPTHTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVK 989 (1003)
Q Consensus 911 ll~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~ 989 (1003)
|++|. +||...... +....+..... .+....++..+.+++..||+.+|++|||+.|+++
T Consensus 235 ll~~~~~p~~~~~~~--------------e~~~~v~~~~~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHE--------------EVIYYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHTTTCCTTTTSCHH--------------HHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCCCCCHH--------------HHHHHHHCCCC------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 980689999998999--------------99999973997------8887325299999999974889657939999999
Q ss_pred HHHHHHH
Q ss_conf 9999775
Q 001858 990 NLCAARE 996 (1003)
Q Consensus 990 ~L~~~~~ 996 (1003)
.|+.+.+
T Consensus 295 ~L~~i~~ 301 (301)
T d1lufa_ 295 ILQRMCE 301 (301)
T ss_dssp HHHHTTC
T ss_pred HHHHHCC
T ss_conf 9998429
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.30 Aligned_cols=264 Identities=25% Similarity=0.441 Sum_probs=210.1
Q ss_pred CCCEEEECCCEEEEEEEECCCC---CEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEEE
Q ss_conf 6682430464499999978998---41999982011-4553679999999987258988316965531056578973578
Q 001858 707 LSNLIGQGSFGFVYRGNLGEDL---LPVAVKVINLK-QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKAL 782 (1003)
Q Consensus 707 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 782 (1003)
+.++||+|+||+||+|++..++ ..||||+++.. .....++|.+|++++++++||||+++++++. ..+...++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE----ETTTEEEE
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE----ECCCCEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898----06994389
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 61010499988998513899899988999999999999999999716999907426899965767999769903334410
Q 001858 783 VYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 783 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~ 862 (1003)
||||+++|+|.+++... ....++..+..++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 107 v~E~~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEEEECCCHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHH
T ss_conf 99874067414421013----45404899999999988765200336---762577668757677999889910652322
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHHHHH
Q ss_conf 35687555676523455665544754337998786446531779999988199999865678640657877509146999
Q 001858 863 LFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKVME 942 (1003)
Q Consensus 863 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 942 (1003)
....... .........||..|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 180 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-------------~~ 245 (311)
T d1r0pa_ 180 MYDKEFD-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------------TV 245 (311)
T ss_dssp TTTTTCC-CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-------------HH
T ss_pred CCCCCCC-CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------------HH
T ss_conf 5566555-310025655564556768874379997457466199999999789999888999999-------------99
Q ss_pred HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHCC
Q ss_conf 99864036999825659999999999985212369899999899999999977532015
Q 001858 943 IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYKGR 1001 (1003)
Q Consensus 943 ~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~~~ 1001 (1003)
.+....... ....++..+.+++.+||+.||++||++.|++++|+.+...+.++
T Consensus 246 ~i~~g~~~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 246 YLLQGRRLL------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHCCCCCC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHH
T ss_conf 998089889------96447599999999976889768939999999999999752012
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.35 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=209.6
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 71057866824304644999999789984199998201145536799999999872589883169655310565789735
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++++.||+|+||+||+|+++.+ ..||+|+++.. ....+.|.+|+.++++++||||+++++++. .+..
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~ 86 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPI 86 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEE------CCCE
T ss_conf 779979846993079809999999999-99999998804-488899999999998666678868999982------3975
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++||||+++|++.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHH
T ss_conf 99999447994354200003---55305999999999999999987541---1433531230799989992998442555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCHHH
Q ss_conf 10356875556765234556655447543379987864465317799999881999998656786406578775091469
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPEKV 940 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 940 (1003)
+...+... .......||+.|+|||++..+.++.++||||+|+++|||++|..|+...... ...
T Consensus 161 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------------~~~ 223 (285)
T d1fmka3 161 RLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------REV 223 (285)
T ss_dssp C------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HHH
T ss_pred HHCCCCCC----EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH-------------HHH
T ss_conf 42568873----3524545566545808983799891774132358999998689999988889-------------999
Q ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 99998640369998256599999999999852123698999998999999999775320
Q 001858 941 MEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 941 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~ 999 (1003)
...+...... +....++..+.+++.+||+.+|++||+++++++.|+.......
T Consensus 224 ~~~i~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 224 LDQVERGYRM------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHTTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHCCCC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 9999826899------9983237999999999756697589199999998766623899
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=336.70 Aligned_cols=182 Identities=33% Similarity=0.599 Sum_probs=129.9
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC--CEEEEEECCCC--CCEEEEEEECCCCCC--CCCCCCCCCCCCCE
Q ss_conf 8997689999999983689989999999999997--20148968999--907999950578776--35755569998868
Q 001858 31 LSNETDRVALLAIKSQLQDPMGITSSWNNSINVC--QWTGVTCGQRH--PRVIQLYLRNQSVGG--FLSPYVGNLSFLRF 104 (1003)
Q Consensus 31 ~~~~~~~~al~~~k~~~~~~~~~~~sW~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~~~g--~~~~~l~~l~~L~~ 104 (1003)
.|.++||+||++||+++.||. .+++|..++||| .|+||+|+..+ +||+.|+|.++++.| .+|+++++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCC-CCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 989899999999999779998-6778899999988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 87478-98888884101044467588841632332469667578887444112454467888200001124553882376
Q 001858 105 INLAS-NNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNVAEN 183 (1003)
Q Consensus 105 L~L~~-n~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~L~~L~l~~n 183 (1003)
|+|++ |++.|.+|.+|+++++|++|+|++|++.+..|..+..+.+|+.++++.|.+.+.+|..++.+ +.++++++++|
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l-~~L~~l~l~~n 159 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL-PNLVGITFDGN 159 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCC-CCCCEEECCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067-40000002355
Q ss_pred CCCCCCCCCCCCCCCC-CEEEEECCCCCCCCC
Q ss_conf 3465569998888876-442100443679984
Q 001858 184 QLTGQLPPSIGNISTL-QQLGVGENKLYGIIP 214 (1003)
Q Consensus 184 ~l~~~~p~~l~~l~~L-~~L~l~~n~l~~~~p 214 (1003)
.+.+.+|..++.+..+ +.+++++|++++..|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~ 191 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 33562031214431123231022464353324
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.11 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=210.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCE--EEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCCCC
Q ss_conf 10578668243046449999997899841--999982011-455367999999998725-89883169655310565789
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLP--VAVKVINLK-QKGSIKSFVAECEALKNI-RHRNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 777 (1003)
.++|++.++||+|+||+||+|+++.++.. ||||.++.. .....+.+.+|+++++++ +||||+++++++. +.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~ 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred HHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-----CC
T ss_conf 7996887798207882899999989996999999997823385799999999999986228998836788884-----18
Q ss_pred CCEEEEEECCCCCCHHHHHHHCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEE
Q ss_conf 73578610104999889985138-----------9989998899999999999999999971699990742689996576
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSN-----------DQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili 846 (1003)
+..++||||+++|+|.++++... ......+++.++..++.|++.|+.|+|+. +++||||||+|||+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 160 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEE
T ss_conf 736999980289869999864035555512310123457899999999999999998766308---95455505204898
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCC
Q ss_conf 799976990333441035687555676523455665544754337998786446531779999988199-9998656786
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGR-RPTHTMFNDG 925 (1003)
Q Consensus 847 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~-~Pf~~~~~~~ 925 (1003)
+.++.+||+|||+++..... .......||..|+|||.+.++.++.++||||||+++|||++|. +||.+....
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~- 233 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 233 (309)
T ss_dssp CGGGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred CCCCCEEECCCCCCCCCCCC------CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH-
T ss_conf 68876387434432244422------34553013775555387526999962215313889999983689999999999-
Q ss_pred CHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 40657877509146999998640369998256599999999999852123698999998999999999775320
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~ 999 (1003)
.+...+.... ++ +....+++.+.+++.+||+.+|++||++.|++++|+.+.++.+
T Consensus 234 -------------~~~~~i~~~~--~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 -------------ELYEKLPQGY--RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -------------HHHHHGGGTC--CC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------------HHHHHHHHCC--CC----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf -------------9999998268--88----8876678999999999767896689499999999999986186
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.50 Aligned_cols=255 Identities=32% Similarity=0.421 Sum_probs=208.6
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 71057866824304644999999789984199998201145536799999999872589883169655310565789735
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
..++|++.+.||+|+||.||+|+++ +..||+|+++.. ...+.+.+|++++++++||||+++++++. .+....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~ 76 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 76 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CC
T ss_pred CHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEE----ECCCCE
T ss_conf 7899488579820798089999999--909999998857--77999999999998678989854987887----238928
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCC
T ss_conf 99996369998999987457---88889999999999998523211337---6553666567601468997763245600
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCHH
Q ss_conf 10356875556765234556655447543379987864465317799999881-99999865678640657877509146
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKMALPEK 939 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 939 (1003)
+..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 151 ~~~~~~--------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------------~ 208 (262)
T d1byga_ 151 KEASST--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------D 208 (262)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------------G
T ss_pred EECCCC--------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------------H
T ss_conf 344787--------765566646778178727988858877757999999997899999999999--------------9
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999986403699982565999999999998521236989999989999999997753
Q 001858 940 VMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 940 ~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
+...+...... +....++..+.+++.+||+.||++||++.+++++|+.++.+
T Consensus 209 ~~~~i~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 VVPRVEKGYKM------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCC------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99999808999------99765799999999997566976893999999999999867
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.03 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=213.4
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCC-------CEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCCEEEEEEEEE
Q ss_conf 7105786682430464499999978998-------4199998201145-5367999999998725-89883169655310
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDL-------LPVAVKVINLKQK-GSIKSFVAECEALKNI-RHRNLIKIITVCSS 771 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~ 771 (1003)
..++|++++.||+|+||.||+|++..++ ..||+|+++.... .....+.+|...+.++ +||||+++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-- 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCC--
T ss_conf 589969700985167828999998578755566754999999881128688999999999999813999697346522--
Q ss_pred CCCCCCCCEEEEEECCCCCCHHHHHHHCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCC
Q ss_conf 5657897357861010499988998513899-----------89998899999999999999999971699990742689
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-----------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLK 840 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 840 (1003)
.++...++||||+++|+|.+++...... ....+++.+++.++.|++.|++|||+. +|+|||||
T Consensus 89 ---~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiK 162 (299)
T d1fgka_ 89 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 162 (299)
T ss_dssp ---CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred ---CCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEEC
T ss_conf ---018868999973699909999986067764322233457434679999999999999999876637---97863022
Q ss_pred CCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCC
Q ss_conf 9965767999769903334410356875556765234556655447543379987864465317799999881-999998
Q 001858 841 PSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTH 919 (1003)
Q Consensus 841 p~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~ 919 (1003)
|+|||++.++.+||+|||+++....... ........|++.|+|||.+.++.++.++||||+|+++|||++ |..||.
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCT---TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCEEECCCCCEEECCCHHHCCCCCCCC---CCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 1022454789767622111011355555---4314667888466326675179888255547758888874017989899
Q ss_pred CCCCCCCHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 65678640657877509146999998640369998256599999999999852123698999998999999999775
Q 001858 920 TMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~ 996 (1003)
.... ......+........ ...+++.+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 240 ~~~~--------------~~~~~~i~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 GVPV--------------EELFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCH--------------HHHHHHHHTTCCCCC------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCH--------------HHHHHHHHCCCCCCC------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999--------------999999972888898------74352999999999766797679399999999988860
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.60 Aligned_cols=265 Identities=23% Similarity=0.258 Sum_probs=197.5
Q ss_pred CCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCC-----CHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 668243046449999997899841999982011455-----367999999998725898831696553105657897357
Q 001858 707 LSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKG-----SIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 707 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
..++||+|+||+||+|+++.+++.||+|+++..... ..+.+.+|+++++.++||||+++++++ ..++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----CCCCCEE
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542-----2587402
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 86101049998899851389989998899999999999999999971699990742689996576799976990333441
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
+||||+.++++...... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.|.
T Consensus 77 ivmE~~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEEECCSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EHHHHHCCHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCC
T ss_conf 20455345077655412-----66778999999999999999886316---35503577625885377841146576100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC--CH
Q ss_conf 03568755567652345566554475433799-8786446531779999988199999865678640657877509--14
Q 001858 862 FLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL--PE 938 (1003)
Q Consensus 862 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~~ 938 (1003)
...... ......+||+.|+|||++... .++.++||||+||++|||++|+.||.+....+... ...+... +.
T Consensus 149 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~-~i~~~~~~~~~ 222 (299)
T d1ua2a_ 149 SFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-RIFETLGTPTE 222 (299)
T ss_dssp TTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCT
T ss_pred CCCCCC-----CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHH-HHHHHCCCCCH
T ss_conf 057875-----543302047333639997267788805643630428999985969999999999999-99985189972
Q ss_pred -HHHHHHH----HHCCCCCC-CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -6999998----64036999-8256599999999999852123698999998999999
Q 001858 939 -KVMEIVD----FALLLDPG-NERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 -~~~~~i~----~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.+..... ......+. ............+.+++.+|++.||++|||++|+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5452100021344303478988678565689999999999763894569089999679
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.83 Aligned_cols=276 Identities=20% Similarity=0.278 Sum_probs=203.1
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCC-CCEEEEEEECCCC--CCCHHHHHHHHHHHHHC---CCCCCEEEEEEEEECCC
Q ss_conf 710578668243046449999997899-8419999820114--55367999999998725---89883169655310565
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGED-LLPVAVKVINLKQ--KGSIKSFVAECEALKNI---RHRNLIKIITVCSSIDF 774 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~h~ni~~~~~~~~~~~~ 774 (1003)
..++|++.++||+|+||+||+|++..+ ++.||+|+++... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred CCCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEE
Q ss_conf 78973578610104999889985138998999889999999999999999997169999074268999657679997699
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHV 854 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl 854 (1003)
......++++|+++++.+....... ...+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+|+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEE
T ss_conf 6674699999740587144444303----78999899999999999999999758---8983579862789858997542
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 03334410356875556765234556655447543379987864465317799999881999998656786406578775
Q 001858 855 SDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 855 ~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 934 (1003)
+|||.+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .......
T Consensus 158 ~dfg~~~~~~~~------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~ 230 (305)
T d1blxa_ 158 ADFGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDV 230 (305)
T ss_dssp CSCCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CCHHHHHHHCCC------CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHH
T ss_conf 100010110023------457776548511483100179888111000328999999878799899898999-9999984
Q ss_pred HC-C--HHHHH----HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 09-1--46999----998640369998256599999999999852123698999998999999
Q 001858 935 AL-P--EKVME----IVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ~~-~--~~~~~----~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.. + ..+.. .........+.............+.+++.+|++.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 079961105321111033302234564544044589999999999874896679189999669
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.53 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=213.7
Q ss_pred HHHCCCCCCCEEEECCCEEEEEEEEC-----CCCCEEEEEEECCCC-CCCHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 97105786682430464499999978-----998419999820114-55367999999998725-898831696553105
Q 001858 700 KATNEFSLSNLIGQGSFGFVYRGNLG-----EDLLPVAVKVINLKQ-KGSIKSFVAECEALKNI-RHRNLIKIITVCSSI 772 (1003)
Q Consensus 700 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~ 772 (1003)
...++|+++++||+|+||.||+|++. .+++.||||+++... ......+.+|+.+++.+ +||||+++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~--- 96 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--- 96 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE---
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898---
Q ss_pred CCCCCCCEEEEEECCCCCCHHHHHHHCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCC
Q ss_conf 657897357861010499988998513899-------------8999889999999999999999997169999074268
Q 001858 773 DFKGDDFKALVYDYMQSGSLEDWLQQSNDQ-------------VDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDL 839 (1003)
Q Consensus 773 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 839 (1003)
.++...++||||+++|+|.+++...... ....+++..+..++.|++.|++|||++ +++||||
T Consensus 97 --~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDL 171 (311)
T d1t46a_ 97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL 171 (311)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred --EECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCC
T ss_conf --31997899997379987999998535665444445332223345889999999999999999988757---9266624
Q ss_pred CCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCC
Q ss_conf 99965767999769903334410356875556765234556655447543379987864465317799999881-99999
Q 001858 840 KPSNVLLDHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPT 918 (1003)
Q Consensus 840 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf 918 (1003)
||+||+++.++.++++|||.++....... ........||+.|+|||++.+..++.++||||+|+++|||++ |.+||
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCCCCCCCCCCCCCCCCHHEECCCCCC---CEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 10210000257521023401023367886---158620135968767788617999974001025899999985899887
Q ss_pred CCCCCCCCHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8656786406578775091469999986403699982565999999999998521236989999989999999997753
Q 001858 919 HTMFNDGLTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
...... +.....++........ ..++..+.+++.+||+++|++||+++++++.|+++...
T Consensus 249 ~~~~~~-------------~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 249 PGMPVD-------------SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TTCCSS-------------HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHH-------------HHHHHHHHCCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 789989-------------9999998668988985------43659999999997577965792999999999876534
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.16 Aligned_cols=277 Identities=20% Similarity=0.195 Sum_probs=208.8
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 105786682430464499999978998419999820114-5536799999999872589883169655310565789735
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
..+|++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+++.++|||++++++++....+.....+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++++ ++.+|+|.+++.. ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~l~~-~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEE-ECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEE-EECCCCHHHHHHC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 9999-6259865664405------8999999999999999999999978---9867778764378879997787545705
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC---
Q ss_conf 10356875556765234556655447543379-98786446531779999988199999865678640657877509---
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL--- 936 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--- 936 (1003)
........ .........|++.|+|||++.. ..++.++||||+||++|+|++|+.||......+...........
T Consensus 157 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 157 RVADPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp EECCGGGC--BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred EECCCCCC--CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 65047776--4101011026520003878604788874101004670133776697997888889999987652069975
Q ss_pred -------CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------146999998640369998256599999999999852123698999998999999
Q 001858 937 -------PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 937 -------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
...............+.............+.+++.+|+..||++||+++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6642343322220244677557787778378999999999999764895679089998619
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.94 Aligned_cols=277 Identities=22% Similarity=0.292 Sum_probs=206.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 05786682430464499999978998419999820114--5536799999999872589883169655310565789735
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++ .++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC-----CCCCCE
T ss_conf 997765177237680999999999997999999802225758999999999999867998388744533-----224320
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++||||+.+ ++.+++.... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.|
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred EEEEEECCC-CHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCC
T ss_conf 378862377-4455544202---56888899999999999999986528---8992135711401134676210357861
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCC-H
Q ss_conf 1035687555676523455665544754337998-7864465317799999881999998656786406578775091-4
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP-E 938 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~ 938 (1003)
+..... ........||+.|+|||+..... ++.++|+||+||++|+|++|+.||.+....+...........+ +
T Consensus 150 ~~~~~~-----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 150 RAFGVP-----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224 (298)
T ss_dssp HHHCCC-----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EECCCC-----CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 343688-----641001036521541122136657774221033331342796687998988999999999983289833
Q ss_pred HHHHHHHHHC---C----CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHHH
Q ss_conf 6999998640---3----69998256599999999999852123698999998999999--999775
Q 001858 939 KVMEIVDFAL---L----LDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAARE 996 (1003)
Q Consensus 939 ~~~~~i~~~~---~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~--L~~~~~ 996 (1003)
.....+.... . ................+.+++.+|+..+|++|||++|+++| ++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 3144422242124345432222044416678999999999976399557918999967870146999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.40 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=206.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCC---CCEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC
Q ss_conf 10578668243046449999997899---841999982011---455367999999998725898831696553105657
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGED---LLPVAVKVINLK---QKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFK 775 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 775 (1003)
.++|++.+.||+|+||.||+|++..+ ...||+|++... .....++|.+|+.+++.++||||+++++++.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~----- 81 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL----- 81 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-----
T ss_conf 489199789803888399999998899907999999998355579899999999999998689999878987774-----
Q ss_pred CCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEC
Q ss_conf 89735786101049998899851389989998899999999999999999971699990742689996576799976990
Q 001858 776 GDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVS 855 (1003)
Q Consensus 776 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~ 855 (1003)
+ ...++|+||+++|++.+++... .+.+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred E-CCHHEEEEEECCCCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEEC
T ss_conf 0-1001146542386125444212----68999999999999999999875217---87520566888156556543325
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHH
Q ss_conf 3334410356875556765234556655447543379987864465317799999881-999998656786406578775
Q 001858 856 DFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFT-GRRPTHTMFNDGLTLHGFVKM 934 (1003)
Q Consensus 856 Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 934 (1003)
|||+++........ ........|+..|+|||++.+..++.++||||+|+++|||++ |+.||.+....
T Consensus 154 DfGl~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---------- 221 (273)
T d1u46a_ 154 DFGLMRALPQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------- 221 (273)
T ss_dssp CCTTCEECCC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred CCHHHHHCCCCCCC--CEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----------
T ss_conf 61155530358875--265476325731079999837999942156614899999996899999996999----------
Q ss_pred HCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 091469999986403699982565999999999998521236989999989999999997
Q 001858 935 ALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAA 994 (1003)
Q Consensus 935 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~ 994 (1003)
+....+.. .. .+.+....++..+.+++.+||+.+|++|||++|+.+.|.++
T Consensus 222 ----~~~~~i~~---~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 ----QILHKIDK---EG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----HHHHHHHT---SC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHH---CC--CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ----99999984---79--99998544539999999997688966792999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.91 Aligned_cols=269 Identities=23% Similarity=0.395 Sum_probs=211.4
Q ss_pred HHHHHCCCCCCCEEEECCCEEEEEEEECC-----CCCEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf 99971057866824304644999999789-----98419999820114-5536799999999872589883169655310
Q 001858 698 LNKATNEFSLSNLIGQGSFGFVYRGNLGE-----DLLPVAVKVINLKQ-KGSIKSFVAECEALKNIRHRNLIKIITVCSS 771 (1003)
Q Consensus 698 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 771 (1003)
++...++|++.+.||+|+||+||+|.++. ++..||||+++... ......+.+|++++++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-- 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-- 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE--
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE--
T ss_conf 042689918835982078818999998786447789689999987012868999999999999976999884125478--
Q ss_pred CCCCCCCCEEEEEECCCCCCHHHHHHHCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEE
Q ss_conf 565789735786101049998899851389-----989998899999999999999999971699990742689996576
Q 001858 772 IDFKGDDFKALVYDYMQSGSLEDWLQQSND-----QVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili 846 (1003)
..+...++||||+++|+|.+++..... .....+++..+..++.|++.|+.|||++ +|+||||||+|||+
T Consensus 93 ---~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 93 ---SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred ---ECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEE
T ss_conf ---428810677760489988999875033211344468879999999999999999987647---96543286775403
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf 79997699033344103568755567652345566554475433799878644653177999998819-99998656786
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTG-RRPTHTMFNDG 925 (1003)
Q Consensus 847 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g-~~Pf~~~~~~~ 925 (1003)
+.++.+||+|||+|+....... ........|++.|+|||.+.+..++.++||||+|+++|||++| +.||.+...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-- 241 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-- 241 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--
T ss_pred CCCCEEEEEECCCCEECCCCCC---EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--
T ss_conf 5996499942454202357763---03134023163237888873699883334443789999999689999999899--
Q ss_pred CHHHHHHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 406578775091469999986403699982565999999999998521236989999989999999997753
Q 001858 926 LTLHGFVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREK 997 (1003)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~ 997 (1003)
.+....+....... ....++..+.+++.+||+.+|++||++.+++++|+...+.
T Consensus 242 ------------~~~~~~i~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 242 ------------EQVLRFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ------------HHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ------------HHHHHHHHHCCCCC------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf ------------99999998088888------8633539999999997577965893999999997876177
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.57 Aligned_cols=275 Identities=21% Similarity=0.236 Sum_probs=207.7
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-CCCC
Q ss_conf 7105786682430464499999978998419999820114--553679999999987258988316965531056-5789
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGD 777 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-~~~~ 777 (1003)
..++|++.++||+|+||+||+|.++.+++.||+|+++... ....+.+.+|+++++.++|||++++++++.... ....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCC
Q ss_conf 73578610104999889985138998999889999999999999999997169999074268999657679997699033
Q 001858 778 DFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDF 857 (1003)
Q Consensus 778 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Df 857 (1003)
...++||||+ +.+|..+.+. ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CEEEEEEECC-CCCHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCC
T ss_conf 1599998405-5218999874------0226999999999999999998737---8764566851111210012211343
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH--H
Q ss_conf 34410356875556765234556655447543379-98786446531779999988199999865678640657877--5
Q 001858 858 GLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK--M 934 (1003)
Q Consensus 858 g~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--~ 934 (1003)
|.|+..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+... .... .
T Consensus 166 g~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~ 236 (346)
T d1cm8a_ 166 GLARQADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK-EIMKVTG 236 (346)
T ss_dssp TTCEECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHC
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHH-HHHHCCC
T ss_conf 102206876--------3102455333588998178789965010300389999997869988897689999-9985037
Q ss_pred HCC---------HHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 091---------46999998640369998256599999999999852123698999998999999--9997
Q 001858 935 ALP---------EKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAA 994 (1003)
Q Consensus 935 ~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~--L~~~ 994 (1003)
..+ ............................+.+++.+|+..||++|||++|+++| ++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 88488886530003443311578666556677556899999999999772995579299999639623758
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=323.97 Aligned_cols=268 Identities=22% Similarity=0.256 Sum_probs=205.6
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCEE
Q ss_conf 10578668243046449999997899841999982011455367999999998725898831696553105657897357
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFKA 781 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 781 (1003)
.++|++.+.||+|+||+||+|++..+++.||+|+...... .+.+..|+++++.++|++++..+..+ ..+....+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEE----EECCCEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999----95198778
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC---CCCEEECCCC
Q ss_conf 8610104999889985138998999889999999999999999997169999074268999657679---9976990333
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH---DMVAHVSDFG 858 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~---~~~~kl~Dfg 858 (1003)
+|||+++ +++.+.+... ...+++..+..++.|++.|++|||++ +|+||||||+||+++. +..++++|||
T Consensus 80 ivme~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEECCC-CBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEECC-CCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCC
T ss_conf 9998738-7133324430----68876899999999999999999979---94426678766064335777615650467
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 441035687555--676523455665544754337998786446531779999988199999865678640657877509
Q 001858 859 LAKFLFDRPIQE--TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMAL 936 (1003)
Q Consensus 859 ~a~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 936 (1003)
+|+.+....... .........||+.|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~------ 225 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ 225 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H------
T ss_pred CCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHH------
T ss_conf 51342554455410001357767873532999991899898321886177899998498766553057799999------
Q ss_pred CHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 146999998640369998256599999999999852123698999998999999999775
Q 001858 937 PEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAARE 996 (1003)
Q Consensus 937 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~ 996 (1003)
.......... ........++..+.+++..||+.+|++||+++++.+.|+.+..
T Consensus 226 ----~~~~~~~~~~---~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 226 ----ERISEKKMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHHHHHHHS---CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----HHHHCCCCCC---CHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----9852356789---8357534788999999999843995579199999999999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.11 Aligned_cols=278 Identities=19% Similarity=0.261 Sum_probs=205.4
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC---CCC
Q ss_conf 105786682430464499999978998419999820114--553679999999987258988316965531056---578
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSID---FKG 776 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~---~~~ 776 (1003)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+++.+|+++++.++|||++++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECC
Q ss_conf 97357861010499988998513899899988999999999999999999716999907426899965767999769903
Q 001858 777 DDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSD 856 (1003)
Q Consensus 777 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~D 856 (1003)
....++|||+++++.+..+... ...+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEECCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEE
T ss_conf 7638999853578741012220-----34433089999999999999885229---988567672220366899687631
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH-
Q ss_conf 3344103568755567652345566554475433799-87864465317799999881999998656786406578775-
Q 001858 857 FGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM- 934 (1003)
Q Consensus 857 fg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~- 934 (1003)
||++........ ..........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.. ......
T Consensus 161 fg~~~~~~~~~~-~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~i~~~~ 238 (318)
T d3blha1 161 FGLARAFSLAKN-SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLC 238 (318)
T ss_dssp CTTCEECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH
T ss_pred CCEEEECCCCCC-CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHH-HHHHHHC
T ss_conf 350022355444-32113566024978742899707999891787006786466174487998998999999-9999841
Q ss_pred -HCCH---------HHHHHHHHHCCCCCCCCHHH--HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -0914---------69999986403699982565--99999999999852123698999998999999
Q 001858 935 -ALPE---------KVMEIVDFALLLDPGNERAK--IEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 -~~~~---------~~~~~i~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
..+. .............+ ..... .......+.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHCCCCCHHHHHHHHCCCCCCCC-CCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8998255344320344433201334455-503340444599899999999873896589099999749
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.52 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=197.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCC------CCHHHHHHHHHHHHHCC--CCCCEEEEEEEEECC
Q ss_conf 1057866824304644999999789984199998201145------53679999999987258--988316965531056
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK------GSIKSFVAECEALKNIR--HRNLIKIITVCSSID 773 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~ 773 (1003)
.++|++++.||+|+||+||+|++..+++.||+|++..... ....++.+|+.+++.++ ||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~----- 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW----- 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEE-----
T ss_conf 883799679840878399999999999799999985688443345567999999999999743589881279999-----
Q ss_pred CCCCCCEEEEEECCCC-CCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC-CCC
Q ss_conf 5789735786101049-99889985138998999889999999999999999997169999074268999657679-997
Q 001858 774 FKGDDFKALVYDYMQS-GSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-DMV 851 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~-~~~ 851 (1003)
+.++...++|||++.+ +++.+++.. ...+++.+++.++.|++.|++|||+. +|+||||||+||+++. ++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred EEECCEEEEEEEECCCCCHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCE
T ss_conf 83099689999833686228999861-----58999999999999999999999877---97556676111477447884
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 69903334410356875556765234556655447543379987-86446531779999988199999865678640657
Q 001858 852 AHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNV-SLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHG 930 (1003)
Q Consensus 852 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~ 930 (1003)
+|++|||+|...... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 150 vkl~DFG~a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------- 214 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 214 (273)
T ss_dssp EEECCCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred EEECCCCCCEECCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH--------
T ss_conf 897754653532444-------55665658774799998489978865332554034536756889988736--------
Q ss_pred HHHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 877509146999998640369998256599999999999852123698999998999999
Q 001858 931 FVKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 931 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
+...... .-+. .++..+.+++.+|++.||++|||++|+++|
T Consensus 215 -----------~i~~~~~-~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 -----------EIIRGQV-FFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----------HHHHCCC-CCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------HHHHCCC-CCCC-------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----------7761544-7787-------799999999999760897589399998539
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=318.61 Aligned_cols=270 Identities=17% Similarity=0.207 Sum_probs=211.2
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCCCCCE
Q ss_conf 1057866824304644999999789984199998201145536799999999872589-883169655310565789735
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRH-RNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
.++|+++++||+|+||+||+|++..+++.||+|+...... .+.+.+|++.++.+.| ++++.+++++ ......
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEE-----ECCCCC
T ss_conf 9806997998417882999999988997999999750258--299999999999964899987799996-----018811
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC-----CCCEEEC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679-----9976990
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDH-----DMVAHVS 855 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~-----~~~~kl~ 855 (1003)
++|||++ +++|.+++... ...+++.++..++.|++.|++|+|+. ||+||||||+||+++. ++.+|++
T Consensus 77 ~~vme~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEEEC-CCCHHHHHHHH----CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEEC
T ss_conf 7999964-88879999752----03110689999999999999999977---9662667713152347543447956872
Q ss_pred CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 333441035687555--676523455665544754337998786446531779999988199999865678640657877
Q 001858 856 DFGLAKFLFDRPIQE--TSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVK 933 (1003)
Q Consensus 856 Dfg~a~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 933 (1003)
|||+|+.+.+..... .........||+.|+|||++.+..+++++||||+|+++|||++|+.||.+.........
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~---- 224 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---- 224 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----
T ss_pred CCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----
T ss_conf 3660577146766541110246762775102679896488888699989831999999869876788530219999----
Q ss_pred HHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 509146999998640369998256599999999999852123698999998999999999775320
Q 001858 934 MALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKNLCAAREKYK 999 (1003)
Q Consensus 934 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~L~~~~~~~~ 999 (1003)
...+....... ........+++.+.+++..|+..+|++||+++.+.+.++.+.++..
T Consensus 225 ------~~~i~~~~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 225 ------YERIGEKKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp ------HHHHHHHHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------HHHHHHCCCCC---CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf ------99997056799---9589657998999999999843993008599999999999999759
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=326.74 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=202.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 05786682430464499999978998419999820114--5536799999999872589883169655310565789735
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.++||+|+||+||+|+++ +++.||+|+++... ....+++.+|+.+++.++||||+++++++ .++...
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEC-----CCCCCE
T ss_conf 99634318722778189999968-999999999812326858999999999999867998687660120-----467731
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
++++|++.++.+..+.+. .+.+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+
T Consensus 76 ~i~~e~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp EEEEECCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred EEEEEEEHHHHHHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCC
T ss_conf 589974004567899860-----47751445689999999999986057---4882678775056868997873236643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCC--
Q ss_conf 103568755567652345566554475433799-87864465317799999881999998656786406578775091--
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP-- 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-- 937 (1003)
....... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+.... .......
T Consensus 148 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~-i~~~~~~~~ 221 (286)
T d1ob3a_ 148 RAFGIPV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPN 221 (286)
T ss_dssp HHHCC--------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCC
T ss_pred EECCCCC-----CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHH-HHHHHCCCC
T ss_conf 0114676-----5410102431101378871788888410021117589999779799898898999999-998638997
Q ss_pred -HHHHHHHH------HHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -46999998------640369998256599999999999852123698999998999999
Q 001858 938 -EKVMEIVD------FALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 -~~~~~~i~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
..+..... ......+.............+.+++.+|++.||++|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 110421233322143333356764666512589999999999866896689099998569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.75 Aligned_cols=276 Identities=22% Similarity=0.289 Sum_probs=199.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-CCCCCCEE
Q ss_conf 05786682430464499999978998419999820114553679999999987258988316965531056-57897357
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRNLIKIITVCSSID-FKGDDFKA 781 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~-~~~~~~~~ 781 (1003)
.+|+..++||+|+||+||+|++..+++.||+|++..... ...+|+++++.++||||+++++++.... ..+..+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 776751698217683999999999997999999881606----8999999998668989873878997447657731899
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC-CEEECCCCCC
Q ss_conf 861010499988998513899899988999999999999999999716999907426899965767999-7699033344
Q 001858 782 LVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGLA 860 (1003)
Q Consensus 782 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~-~~kl~Dfg~a 860 (1003)
+||||++++ +.+.+...... ...+++.+++.++.|++.|++|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 96 lv~Ey~~~~-~~~~l~~~~~~-~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 96 LVLDYVPET-VYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEECCSEE-HHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEECCCCC-CHHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 998416886-07888863103-68999999999999999999999866---87645788603787358971167336605
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH--CC
Q ss_conf 10356875556765234556655447543379-9878644653177999998819999986567864065787750--91
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMG-GNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMA--LP 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~ 937 (1003)
....... ......|+..|+|||...+ ..++.++||||+||++|||++|+.||......+. .....+.. .+
T Consensus 171 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 171 KQLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPT 243 (350)
T ss_dssp EECCTTS------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCC
T ss_pred HHCCCCC------CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH-HHHHHHHHCCCH
T ss_conf 4404776------532002555556827764046888210002465277855028799898799999-999999748981
Q ss_pred HH-HHHHHHHHCCCC-CC----C-CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 46-999998640369-99----8-256599999999999852123698999998999999--9997
Q 001858 938 EK-VMEIVDFALLLD-PG----N-ERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN--LCAA 994 (1003)
Q Consensus 938 ~~-~~~~i~~~~~~~-~~----~-~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~--L~~~ 994 (1003)
.. +........... +. . ...........+.+++.+|+..||++|||+.|+++| ++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 776543062101103554456744443156899999999999765895579299999669845246
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.83 Aligned_cols=266 Identities=18% Similarity=0.246 Sum_probs=202.0
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCCCCCCE
Q ss_conf 105786682430464499999978998419999820114553679999999987258-9883169655310565789735
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
.++|++.++||+|+||+||+|++..+++.||+|+++.. ..+++.+|+++++.++ ||||+++++++.. ......
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEE---CCCCCE
T ss_conf 86718978983174819999998899979999998889---999999999999851579987679999981---687712
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC-CEEECCCCC
Q ss_conf 7861010499988998513899899988999999999999999999716999907426899965767999-769903334
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDM-VAHVSDFGL 859 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~-~~kl~Dfg~ 859 (1003)
++||||+++++|.++. +.+++..++.++.|++.|++|||++ ||+||||||+|||++.++ .+|++|||+
T Consensus 108 ~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEEEECCCCCHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCC
T ss_conf 6888631798589974--------6899999999999999999887643---3443456441237748998366415654
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCCH
Q ss_conf 4103568755567652345566554475433799-878644653177999998819999986567864065787750914
Q 001858 860 AKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALPE 938 (1003)
Q Consensus 860 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 938 (1003)
|+...+.. ......+|+.|+|||.+.+. .++.++|+||+||++|+|++|+.||...................+
T Consensus 177 a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 177 AEFYHPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp CEECCTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred CEECCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 26646887------444322486424761026888888452323354555876048899988760189999999987884
Q ss_pred HHHHHHHHHCCC-----------CCCCC------HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 699999864036-----------99982------56599999999999852123698999998999999
Q 001858 939 KVMEIVDFALLL-----------DPGNE------RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 939 ~~~~~i~~~~~~-----------~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
............ .+... ......+..++.+++.+|+..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 155555422544474300000333433112115521124489999999999866995689089999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.09 Aligned_cols=271 Identities=21% Similarity=0.190 Sum_probs=207.5
Q ss_pred HCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC-CCCC
Q ss_conf 105786682430464499999978998419999820114--5536799999999872589883169655310565-7897
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDF-KGDD 778 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-~~~~ 778 (1003)
.++|++.++||+|+||+||+|.+..+++.||+|++.... ....+++.+|+.+++.++||||+++++++..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..|+||||+.+ ++.+.+. ..+++..++.++.|++.|++|||+. ||+||||||+||+++.++.++++|||
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEECCCH-HHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 26999841446-7787650-------3899999999999999999886522---11245677632113654431320102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH----
Q ss_conf 4410356875556765234556655447543379987864465317799999881999998656786406578775----
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKM---- 934 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---- 934 (1003)
.++.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+......... ....
T Consensus 165 ~~~~~~~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~-i~~~~~~~ 237 (355)
T d2b1pa1 165 LARTAGT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLGTP 237 (355)
T ss_dssp C---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCC
T ss_pred HHHCCCC------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHH-HHHHCCCC
T ss_conf 3211466------6553322146555581331477778774333566257898659899888977889999-99720589
Q ss_pred ------HCCHHHHHHHHHHCCCCC------------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------091469999986403699------------98256599999999999852123698999998999999
Q 001858 935 ------ALPEKVMEIVDFALLLDP------------GNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 935 ------~~~~~~~~~i~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.................. .............+.+++.+|+..||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 87999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.99 Aligned_cols=272 Identities=22% Similarity=0.242 Sum_probs=204.6
Q ss_pred HHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCC
Q ss_conf 71057866824304644999999789984199998201145--5367999999998725898831696553105657897
Q 001858 701 ATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK--GSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDD 778 (1003)
Q Consensus 701 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 778 (1003)
..++|++.++||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+++++.++|||++++++++......+..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 35786101049998899851389989998899999999999999999971699990742689996576799976990333
Q 001858 779 FKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFG 858 (1003)
Q Consensus 779 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg 858 (1003)
..+++++++.+|+|.+++.. +.+++..++.++.|++.|++|||++ ||+||||||+||+++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred CEEEEEEEECCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 64999996258862320022------4530999999999999999999738---87651667763345543220013210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHH------
Q ss_conf 44103568755567652345566554475433799-87864465317799999881999998656786406578------
Q 001858 859 LAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG-NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF------ 931 (1003)
Q Consensus 859 ~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~------ 931 (1003)
.+..... ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+...........
T Consensus 167 ~a~~~~~--------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 167 LARHTDD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp ---CCTG--------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred HHCCCCC--------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 0012575--------44443454355583553377567855124320589999976889978898899999999730799
Q ss_pred ----HHHHCCHHHHHHHHHHCCCCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----775091469999986403699982-56599999999999852123698999998999999
Q 001858 932 ----VKMALPEKVMEIVDFALLLDPGNE-RAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 932 ----~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
.............. .....+... ..........+.+++.+|+..||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHCCCHHHHHHHH-HCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 757732001024454443-035578755566267899999999999775883459389998559
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.66 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=202.7
Q ss_pred HCCCCCCCEEEECCCEEEEEEEE---CCCCCEEEEEEECCC----CCCCHHHHHHHHHHHHHCCC-CCCEEEEEEEEECC
Q ss_conf 10578668243046449999997---899841999982011----45536799999999872589-88316965531056
Q 001858 702 TNEFSLSNLIGQGSFGFVYRGNL---GEDLLPVAVKVINLK----QKGSIKSFVAECEALKNIRH-RNLIKIITVCSSID 773 (1003)
Q Consensus 702 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~h-~ni~~~~~~~~~~~ 773 (1003)
.++|++.++||+|+||+||+|++ +.+++.||+|+++.. .....+.+.+|++++++++| |||++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~----- 97 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----- 97 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE-----
T ss_conf 102599989832878399999987658879489999983677210168999999999999864679839996200-----
Q ss_pred CCCCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEE
Q ss_conf 57897357861010499988998513899899988999999999999999999716999907426899965767999769
Q 001858 774 FKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAH 853 (1003)
Q Consensus 774 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~k 853 (1003)
+.+....++++||+.+|+|.+++... +..++..++.++.|++.|++|+|+. +|+||||||+||+++.++.+|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ECCCCCEEEEEECCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEE
T ss_conf 02487300123123411799998730-----4543788888899999999885149---989654773201246999888
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 9033344103568755567652345566554475433799--87864465317799999881999998656786406578
Q 001858 854 VSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGG--NVSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGF 931 (1003)
Q Consensus 854 l~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 931 (1003)
|+|||++..+..... .......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||......+...
T Consensus 170 L~DFG~a~~~~~~~~----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--- 242 (322)
T d1vzoa_ 170 LTDFGLSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--- 242 (322)
T ss_dssp ESCSSEEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---
T ss_pred EEECCCHHHHCCCCC----CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---
T ss_conf 741320222034444----3221222333331068760577688713251777799999976899988887777999---
Q ss_pred HHHHCCHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 775091469999986403699982565999999999998521236989999-----98999999
Q 001858 932 VKMALPEKVMEIVDFALLLDPGNERAKIEECLTAVVRIGVLCSMESPSERI-----HMADAVKN 990 (1003)
Q Consensus 932 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~eil~~ 990 (1003)
.+........+. ....+...+.+++.+|++++|++|| +++|+++|
T Consensus 243 ----------~i~~~~~~~~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 243 ----------EISRRILKSEPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------HHHHHHHHCCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------HHHHHCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf ----------999833568998----86547999999999974458988199974509999749
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.59 Aligned_cols=270 Identities=19% Similarity=0.273 Sum_probs=204.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCCCE
Q ss_conf 05786682430464499999978998419999820114--5536799999999872589883169655310565789735
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQ--KGSIKSFVAECEALKNIRHRNLIKIITVCSSIDFKGDDFK 780 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 780 (1003)
++|++.++||+|+||+||+|++..+++.||+|+++... .....++.+|+.+++.++||||+++++++ .+....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCC-----CCCCCE
T ss_conf 997862697128681999999999996999999803217868999999999999856757888213544-----444311
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 78610104999889985138998999889999999999999999997169999074268999657679997699033344
Q 001858 781 ALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLA 860 (1003)
Q Consensus 781 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a 860 (1003)
+++++++.++++..++.. .+.+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.+
T Consensus 77 ~iv~~~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEECCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEECCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHH
T ss_conf 588630233222112123-----56540367899999999998774339---9860014676121133782665204601
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHCC--
Q ss_conf 1035687555676523455665544754337998-7864465317799999881999998656786406578775091--
Q 001858 861 KFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGN-VSLTGDVYSFGILLLEMFTGRRPTHTMFNDGLTLHGFVKMALP-- 937 (1003)
Q Consensus 861 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-- 937 (1003)
....... .......++..|+|||.+.... ++.++||||+||++|||++|+.||....+.............+
T Consensus 149 ~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 149 RAFGIPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp EECCSCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred HCCCCCC-----CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 1046887-----51001034431014667506988880444026541889985189999889999999999986118997
Q ss_pred H-HHHHHHHHHC------CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4-6999998640------369998256599999999999852123698999998999999
Q 001858 938 E-KVMEIVDFAL------LLDPGNERAKIEECLTAVVRIGVLCSMESPSERIHMADAVKN 990 (1003)
Q Consensus 938 ~-~~~~~i~~~~------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~eil~~ 990 (1003)
. .......... .................+.+++.+|++.||.+|||++|+++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 355134432221133444544310433065689999999999864996689099999649
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=280.44 Aligned_cols=270 Identities=19% Similarity=0.246 Sum_probs=192.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 05786682430464499999978998419999820114553679999999987258-----------9883169655310
Q 001858 703 NEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-----------HRNLIKIITVCSS 771 (1003)
Q Consensus 703 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni~~~~~~~~~ 771 (1003)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.++ |+|++++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred CCCCCCCCEEEEEECCCCCC-HHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCEECCCCCCCEEECCC
Q ss_conf 56578973578610104999-8899851389989998899999999999999999971-699990742689996576799
Q 001858 772 IDFKGDDFKALVYDYMQSGS-LEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHD 849 (1003)
Q Consensus 772 ~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nili~~~ 849 (1003)
.+....+.+++++..+. ......... ....++..++.++.|++.|++|||+ . +|+||||||+|||++.+
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred ---CCCCCEEEEEEECCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECC
T ss_conf ---256520234320003542000001223---467868999999999999988876405---86465677057056305
Q ss_pred C------CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9------7699033344103568755567652345566554475433799878644653177999998819999986567
Q 001858 850 M------VAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLLEMFTGRRPTHTMFN 923 (1003)
Q Consensus 850 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ell~g~~Pf~~~~~ 923 (1003)
+ .++++|||.+...... .....|++.|+|||++....++.++|+||+||++++|++|+.||.....
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CCCCCCCEEEEEECCCCCCCCCC--------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 76564430567531442123445--------4223665210571321466777643201237899999878899898755
Q ss_pred CCCH-----HHHHHH--HHCCHHHHHHH---HHH-----CCCC-CC-C----------CHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 8640-----657877--50914699999---864-----0369-99-8----------2565999999999998521236
Q 001858 924 DGLT-----LHGFVK--MALPEKVMEIV---DFA-----LLLD-PG-N----------ERAKIEECLTAVVRIGVLCSME 976 (1003)
Q Consensus 924 ~~~~-----~~~~~~--~~~~~~~~~~i---~~~-----~~~~-~~-~----------~~~~~~~~~~~l~~l~~~cl~~ 976 (1003)
.... ...... ...+....... ... .... .. . ...........+.+++.+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred CCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 43210268999999983799878862453220001320122024323577644421000156743589999999998779
Q ss_pred CCCCCCCHHHHHHH
Q ss_conf 98999998999999
Q 001858 977 SPSERIHMADAVKN 990 (1003)
Q Consensus 977 ~P~~Rps~~eil~~ 990 (1003)
||.+|||++|+++|
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CHHHCCCHHHHHCC
T ss_conf 94579089999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.4e-42 Score=248.73 Aligned_cols=245 Identities=30% Similarity=0.490 Sum_probs=183.3
Q ss_pred CCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 310025878734898136-5421127875111133350103351115225644337776564625565366568943548
Q 001858 387 IPLEIRNLANIYALGLEY-NQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGN 465 (1003)
Q Consensus 387 ~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 465 (1003)
+|..++++++|++|+|++ |++.+.+|..++.+++|++|+|++|++.+..+..+..+..|+.++++.|.+.+.+|..+..
T Consensus 68 lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~ 147 (313)
T d1ogqa_ 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCC
T ss_conf 98478467533520202654333002431145420011020356434433222220111001111224555568512206
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 99987265268320699954465213322223488773336543112333334300243341222368534675666389
Q 001858 466 CKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYL 545 (1003)
Q Consensus 466 l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 545 (1003)
++.++.+++++|.+++.+|..+..+..+.+.+++++|.+++..+..+..+.. ..+++++|...+.+|..+..+++++.+
T Consensus 148 l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l 226 (313)
T d1ogqa_ 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKI 226 (313)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEE
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 7400000023553356203121443112323102246435332433222222-233333343322222222222221112
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 93388763347800004467686514675303689300037996334855899352368999966787520112698756
Q 001858 546 KMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVPTKGVFSNKTRISLIENGKLC 625 (1003)
Q Consensus 546 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c 625 (1003)
++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+..+++|++|++++|+++|.+|..+.+..+..+.+.+|+.+|
T Consensus 227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred CCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 222222222222-2224554444447657066608768847999998979588351668986667998978868895001
Q ss_pred CCCCCCCCCCCC
Q ss_conf 897777899778
Q 001858 626 GGLDELHLPACH 637 (1003)
Q Consensus 626 ~~~~~l~~~~~~ 637 (1003)
|.|+ |.|+
T Consensus 306 g~pl----p~c~ 313 (313)
T d1ogqa_ 306 GSPL----PACT 313 (313)
T ss_dssp STTS----SCCC
T ss_pred CCCC----CCCC
T ss_conf 9898----8989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=8.6e-39 Score=230.31 Aligned_cols=191 Identities=31% Similarity=0.421 Sum_probs=113.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 00356202011546445576310025878734898136542112787511113335010335111522564433777656
Q 001858 367 IANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLN 446 (1003)
Q Consensus 367 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 446 (1003)
+..++.+..+++++|.+.+..+ +...++|+.|++++|+++. + ..+..+++|+.+++++|.+++..+ +..+++|+
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~ 266 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 266 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCC
T ss_conf 0223532333035774478786--4445778788887777789-6-134325653410044674478775--35546687
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 46255653665689435489998726526832069995446521332222348877333654311233333430024334
Q 001858 447 SLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRN 526 (1003)
Q Consensus 447 ~L~L~~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 526 (1003)
.+++++|.+++.. .+..++.++.+.++.|.+++ + ..+..+++++.|++++|
T Consensus 267 ~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~--------------------------~~~~~~~~l~~L~ls~n 317 (384)
T d2omza2 267 ELKLGANQISNIS--PLAGLTALTNLELNENQLED-I--------------------------SPISNLKNLTYLTLYFN 317 (384)
T ss_dssp EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C--------------------------GGGGGCTTCSEEECCSS
T ss_pred EEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C--------------------------CCCCHHCCCCEEECCCC
T ss_conf 7545674457877--32356522223323233333-2--------------------------21000024676777788
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCC
Q ss_conf 122236853467566638993388763347800004467686514675303689300037996334855899
Q 001858 527 RFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYN 598 (1003)
Q Consensus 527 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 598 (1003)
++++.. .+..+++|+.|++++|++++ ++ .+.++++|+.|++++|++++..| +..+++|+.|++++|
T Consensus 318 ~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 318 NISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 778984--53668988989898998999-74-67089999989897995899800--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1e-36 Score=218.74 Aligned_cols=191 Identities=26% Similarity=0.404 Sum_probs=124.5
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 27777747524676789988500003562020115464455763100258787348981365421127875111133350
Q 001858 344 TNCSKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGTIPYTIGELINLQA 423 (1003)
Q Consensus 344 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 423 (1003)
..+++++.+++++|.+.+..+ +....+|+.|++++|+++.. ..+..+++|+.+++++|.+++..+ +..+++|+.
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~ 267 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred CCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCE
T ss_conf 223532333035774478786--44457787888877777896--134325653410044674478775--355466877
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCC
Q ss_conf 10335111522564433777656462556536656894354899987265268320699954465213322223488773
Q 001858 424 LDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVSKNKLTGTLPPQILEITTLSSLLDLSSNL 503 (1003)
Q Consensus 424 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~n~ 503 (1003)
|++++|.+.+.. .+..+..++.+.++.|.+++ ...+..+++++.|++++|++++ ++
T Consensus 268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~------------------- 323 (384)
T d2omza2 268 LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-IS------------------- 323 (384)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CG-------------------
T ss_pred EECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCC-CC-------------------
T ss_conf 545674457877--32356522223323233333--2210000246767777887789-84-------------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCE
Q ss_conf 336543112333334300243341222368534675666389933887633478000044676865146753
Q 001858 504 ISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNN 575 (1003)
Q Consensus 504 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 575 (1003)
.+..+++|+.|++++|+++ .++ .+..+++|++|++++|++++..| +.++++|+.|+|++|-
T Consensus 324 -------~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 324 -------PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp -------GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred -------CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf -------5366898898989899899-974-67089999989897995899800--0039999996397895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-34 Score=207.09 Aligned_cols=82 Identities=21% Similarity=0.346 Sum_probs=36.7
Q ss_pred CCEEEEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHCCCCCCCEEEECCCCCCCCCCC
Q ss_conf 7201489689999079999505787763575556999886887478988888841-010444675888416323324696
Q 001858 64 CQWTGVTCGQRHPRVIQLYLRNQSVGGFLSPYVGNLSFLRFINLASNNLHGEIPN-ELGRLSRLKVLVLDFNSFSGTIPS 142 (1003)
Q Consensus 64 c~w~gv~c~~~~~~v~~l~l~~~~~~g~~~~~l~~l~~L~~L~L~~n~~~~~ip~-~~~~l~~L~~L~L~~n~l~~~~p~ 142 (1003)
|.|++|.|+.. +++ .+|+.+. +.+++|+|++|+++ .+|+ .|..+++|++|++++|.+....|.
T Consensus 10 c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 10 CHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred ECCCEEEECCC------------CCC-CCCCCCC--CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf 55999985599------------988-5198889--99798978499189-86965760465652311234434452356
Q ss_pred CCCCCCCCCEEECCCCCCC
Q ss_conf 6757888744411245446
Q 001858 143 NLSHCSNLINFSVRRNNLT 161 (1003)
Q Consensus 143 ~l~~l~~L~~L~l~~n~l~ 161 (1003)
.+.++++|+.|++++|+++
T Consensus 74 ~f~~l~~L~~L~l~~n~l~ 92 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLK 92 (305)
T ss_dssp TTTTCTTCCEEECCSSCCS
T ss_pred HHHCCCCCCEECCCCCCCC
T ss_conf 6527985578315687567
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-34 Score=203.08 Aligned_cols=84 Identities=25% Similarity=0.370 Sum_probs=31.7
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 73489813654211278751111333501033511152256443377765646255653665689435489998726526
Q 001858 396 NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVS 475 (1003)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ls 475 (1003)
+++.|++++|......+..+..++.++.|++++|.+.+..+..+..+++|++|+|++|.++ .+|..+..+++|+.|+++
T Consensus 172 ~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls 250 (305)
T d1xkua_ 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 250 (305)
T ss_dssp TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECC
T ss_conf 6678989788677888267641341330154455332223454334433224302554002-463110334678989898
Q ss_pred CCCCC
Q ss_conf 83206
Q 001858 476 KNKLT 480 (1003)
Q Consensus 476 ~N~l~ 480 (1003)
+|+|+
T Consensus 251 ~N~i~ 255 (305)
T d1xkua_ 251 NNNIS 255 (305)
T ss_dssp SSCCC
T ss_pred CCCCC
T ss_conf 98657
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=205.70 Aligned_cols=95 Identities=28% Similarity=0.313 Sum_probs=45.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCC
Q ss_conf 23333343002433412223685346756663899338876334780000446768651467530368930003799633
Q 001858 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLE 591 (1003)
Q Consensus 512 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 591 (1003)
|..+++|+.|++++|.++...+..|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..+..+..+++|+
T Consensus 149 f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred HCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 40434050223141765662566654656341314211434662816766532000233333522100000235546568
Q ss_pred EEECCCCCCCCCCCC
Q ss_conf 485589935236899
Q 001858 592 YLNLSYNDFEGQVPT 606 (1003)
Q Consensus 592 ~L~l~~N~l~~~~~~ 606 (1003)
+|++++|++.|.++.
T Consensus 229 ~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 229 YLRLNDNPWVCDCRA 243 (284)
T ss_dssp EEECCSSCEECSGGG
T ss_pred EEEECCCCCCCCCCC
T ss_conf 898119988787564
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-32 Score=192.96 Aligned_cols=88 Identities=24% Similarity=0.293 Sum_probs=33.3
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 87873489813654211278751111333501033511152256443377765646255653665689435489998726
Q 001858 393 NLANIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLL 472 (1003)
Q Consensus 393 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 472 (1003)
.+++|+.|++++|++....+..|..+++|+.+++++|++.+..|..|..+++|++|++++|.+.+..+..|..+++|+.|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred CCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 43405022314176566256665465634131421143466281676653200023333352210000023554656889
Q ss_pred ECCCCCCC
Q ss_conf 52683206
Q 001858 473 NVSKNKLT 480 (1003)
Q Consensus 473 ~ls~N~l~ 480 (1003)
++++|++.
T Consensus 231 ~l~~N~l~ 238 (284)
T d1ozna_ 231 RLNDNPWV 238 (284)
T ss_dssp ECCSSCEE
T ss_pred EECCCCCC
T ss_conf 81199887
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.5e-31 Score=186.28 Aligned_cols=181 Identities=25% Similarity=0.240 Sum_probs=100.4
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 73489813654211278751111333501033511152256443377765646255653665689435489998726526
Q 001858 396 NIYALGLEYNQLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLMLLNVS 475 (1003)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ls 475 (1003)
+++.|+|++|++++..+..|..+++|++|+|++|+|+.. + .++.+++|+.|++++|+++ ..+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 889898849928985977863456552213566544443-1-1111223211111222221-111121222222222222
Q ss_pred CCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 83206999544652133222234887733365431123333343002433412223685346756663899338876334
Q 001858 476 KNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGS 555 (1003)
Q Consensus 476 ~N~l~~~~p~~~~~~~~l~~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 555 (1003)
+|.+.. ..+..+..+.+++.|++++|.++...+..+..++.|+.+++++|++++.
T Consensus 109 ~~~~~~-------------------------~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 109 FNRLTS-------------------------LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp SSCCCC-------------------------CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCCCE-------------------------EECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCC
T ss_conf 231101-------------------------1001122221111221243421022123332211100000001565223
Q ss_pred CCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 78000044676865146753036893000379963348558993523689
Q 001858 556 IPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNLSYNDFEGQVP 605 (1003)
Q Consensus 556 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 605 (1003)
.+..|..+++|+.|+|++|+|+ .+|+.+..+++|+.|++++|+|.|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCCC
T ss_conf 7200134212423430139785-568667778889999836999878864
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.97 E-value=3.2e-27 Score=165.61 Aligned_cols=59 Identities=25% Similarity=0.422 Sum_probs=29.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCC
Q ss_conf 33343002433412223685346756663899338876334780000446768651467530368930
Q 001858 515 LKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPE 582 (1003)
Q Consensus 515 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 582 (1003)
+++|++|++++|+++ .+|.. +++|+.|+|++|+|+ .+|+. +++|+.|++++|+|+ .+|+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC
T ss_conf 898898979799168-35665---487998989999687-54532---288898987699189-7776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=8.5e-27 Score=163.25 Aligned_cols=95 Identities=31% Similarity=0.375 Sum_probs=43.5
Q ss_pred CCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88688747898888884101044467588841632332469667578887444112454467888200001124553882
Q 001858 101 FLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKLENLNV 180 (1003)
Q Consensus 101 ~L~~L~L~~n~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~L~~L~l 180 (1003)
.++.|||++++++ .+|+. +++|++|+|++|+++ .+|+.+ .+|+.|++++|.++ .++.. .+.|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l----p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL----PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC----CTTCCEEEC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHH----CCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-336203---32033266551432-03210----221111133
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 376346556999888887644210044367
Q 001858 181 AENQLTGQLPPSIGNISTLQQLGVGENKLY 210 (1003)
Q Consensus 181 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~ 210 (1003)
++|.+. .+|. ++.+++|+.|++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred CCCCCC-CCCC-HHHHCCCEEECCCCCCCC
T ss_conf 455432-2210-011013123113565100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.9e-31 Score=186.11 Aligned_cols=113 Identities=19% Similarity=0.233 Sum_probs=63.9
Q ss_pred CCCEEECCCCCCCCC-CCHHHCCCCCCCEEEECCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 886887478988888-84101044467588841632332----4696675788874441124544678882000011245
Q 001858 101 FLRFINLASNNLHGE-IPNELGRLSRLKVLVLDFNSFSG----TIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYWLKL 175 (1003)
Q Consensus 101 ~L~~L~L~~n~~~~~-ip~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~L 175 (1003)
+|+.||++.|++++. +..-++.+++++.|+|++|.++. .++..+..+++|+.|||++|.++..--..+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~------ 76 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL------ 76 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH------
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHH------
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999------
Q ss_pred CEEECCCCCCCCCCCCCCC-CCCCCCEEEEECCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 5388237634655699988-888764421004436799----8422257999991764786688
Q 001858 176 ENLNVAENQLTGQLPPSIG-NISTLQQLGVGENKLYGI----IPESLGQLRDLNFLSVAENNFS 234 (1003)
Q Consensus 176 ~~L~l~~n~l~~~~p~~l~-~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 234 (1003)
..+. ...+|++|++++|.++.. ++..+..+++|++|++++|.++
T Consensus 77 ---------------~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 77 ---------------QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp ---------------HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred ---------------HHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf ---------------9984378877887788877543221012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.3e-30 Score=183.16 Aligned_cols=89 Identities=26% Similarity=0.256 Sum_probs=43.9
Q ss_pred CCCCCCCCCCCCCCCCCC----CCCCCC-CCCCCCEEEECCCCCCCC----CCCCCCCCCCCCEEECCCCEECCCCCC--
Q ss_conf 333343002433412223----685346-756663899338876334----780000446768651467530368930--
Q 001858 514 NLKNLIQLDISRNRFSGE----IPTTLS-SCTSLEYLKMQDNSFRGS----IPSSLISLKSIEVLDLSCNNLSGQIPE-- 582 (1003)
Q Consensus 514 ~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~-- 582 (1003)
..++|++|+|++|.+++. ++..+. ..+.|+.|+|++|.++.. ++..+...++|+.||+++|+|+.....
T Consensus 338 ~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l 417 (460)
T d1z7xw1 338 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417 (460)
T ss_dssp HCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHH
T ss_pred CCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHH
T ss_conf 10111132012101357664001112204567778898979979759999999999629988989899996987999999
Q ss_pred --CCC-CCCCCCEEECCCCCCCC
Q ss_conf --003-79963348558993523
Q 001858 583 --YLE-DLSFLEYLNLSYNDFEG 602 (1003)
Q Consensus 583 --~l~-~l~~L~~L~l~~N~l~~ 602 (1003)
.+. ....|+.|++.+|.+..
T Consensus 418 ~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 418 VESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHCCCCCCEEECCCCCCCH
T ss_conf 99997478866789898987898
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.3e-26 Score=158.80 Aligned_cols=171 Identities=19% Similarity=0.194 Sum_probs=118.6
Q ss_pred CCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCC------------------CCHHHHHHHHHHHHHCCCCCCEEEE
Q ss_conf 7866824304644999999789984199998201145------------------5367999999998725898831696
Q 001858 705 FSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQK------------------GSIKSFVAECEALKNIRHRNLIKII 766 (1003)
Q Consensus 705 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ni~~~~ 766 (1003)
+.++++||+|+||+||+|++. +++.||+|+++.... ........|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCCCCCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEE
Q ss_conf 55310565789735786101049998899851389989998899999999999999999971699990742689996576
Q 001858 767 TVCSSIDFKGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHCQPPIVHGDLKPSNVLL 846 (1003)
Q Consensus 767 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nili 846 (1003)
++. ..+++||+++++.+.+ ++......++.|++.+++|||+. +|+||||||+||++
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred EEC---------CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEE
T ss_conf 862---------8889999504565420------------01578999999999999998268---88983689036114
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 799976990333441035687555676523455665544754337998786446531779999
Q 001858 847 DHDMVAHVSDFGLAKFLFDRPIQETSSSSIGIKGTVGYVAPEYGMGGNVSLTGDVYSFGILLL 909 (1003)
Q Consensus 847 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~il~ 909 (1003)
+++ .++++|||.|........... ...+... -.+. ....|+.++|+||..--+.
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~~------l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWREI------LERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHHH------HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECC-CEEEEECCCCCCCCCCCCHHH------HHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 289-899987788430899870999------9877999-9999-7578998446899999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.7e-24 Score=149.28 Aligned_cols=12 Identities=8% Similarity=0.011 Sum_probs=4.3
Q ss_pred CCEEEECCCCCC
Q ss_conf 758884163233
Q 001858 126 LKVLVLDFNSFS 137 (1003)
Q Consensus 126 L~~L~L~~n~l~ 137 (1003)
+++|++++|.++
T Consensus 31 l~~L~Ls~n~i~ 42 (242)
T d1xwdc1 31 AIELRFVLTKLR 42 (242)
T ss_dssp CSEEEEESCCCC
T ss_pred CCEEECCCCCCC
T ss_conf 899987699189
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=2.3e-23 Score=144.09 Aligned_cols=76 Identities=30% Similarity=0.328 Sum_probs=28.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEE
Q ss_conf 33343002433412223685346756663899338876334780000446768651467530368930003799633485
Q 001858 515 LKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLN 594 (1003)
Q Consensus 515 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 594 (1003)
.++|+.|++++|.+.... .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++++.. .+..+++|+.|+
T Consensus 150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ 223 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVT 223 (227)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCC--CCCCCCCCCEEE
T ss_conf 211100233333333100--10564633564458884177-85-3447999998979599689980--203699989897
Q ss_pred CC
Q ss_conf 58
Q 001858 595 LS 596 (1003)
Q Consensus 595 l~ 596 (1003)
++
T Consensus 224 ls 225 (227)
T d1h6ua2 224 LT 225 (227)
T ss_dssp EE
T ss_pred EE
T ss_conf 12
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=2e-23 Score=144.35 Aligned_cols=55 Identities=24% Similarity=0.379 Sum_probs=21.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 33334300243341222368534675666389933887633478000044676865146
Q 001858 514 NLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLS 572 (1003)
Q Consensus 514 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 572 (1003)
.+++|+.|++++|++++ ++ .+..+++|++|++++|+++.. + .+.++++|+.|+++
T Consensus 171 ~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 171 NLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp TCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred CCCCCEECCCCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCEEEEE
T ss_conf 64633564458884177-85-344799999897959968998-0-20369998989712
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.9e-23 Score=142.82 Aligned_cols=36 Identities=11% Similarity=0.113 Sum_probs=15.1
Q ss_pred CCCEEECCCCCCCCCCCH-HHCCCCCCCEEEECCCCCC
Q ss_conf 886887478988888841-0104446758884163233
Q 001858 101 FLRFINLASNNLHGEIPN-ELGRLSRLKVLVLDFNSFS 137 (1003)
Q Consensus 101 ~L~~L~L~~n~~~~~ip~-~~~~l~~L~~L~L~~n~l~ 137 (1003)
++++|+|++|.+. .+|. .|.++++|++|++++|.+.
T Consensus 30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~ 66 (242)
T d1xwdc1 30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 66 (242)
T ss_dssp CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTC
T ss_pred CCCEEECCCCCCC-CCCHHHHHCCCHHHHHHHCCCCCC
T ss_conf 8899987699189-649668614643232110221124
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=1e-22 Score=140.49 Aligned_cols=39 Identities=26% Similarity=0.419 Sum_probs=12.6
Q ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 888876442100443679984222579999917647866
Q 001858 194 GNISTLQQLGVGENKLYGIIPESLGQLRDLNFLSVAENN 232 (1003)
Q Consensus 194 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 232 (1003)
.++++|++|+|++|+|++..++.|..+++|++|++++|.
T Consensus 99 ~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~ 137 (192)
T d1w8aa_ 99 LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP 137 (192)
T ss_dssp TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred HCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 079746552457745353597785687533420003644
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.86 E-value=1e-21 Score=134.92 Aligned_cols=42 Identities=26% Similarity=0.396 Sum_probs=15.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 233333430024334122236853467566638993388763
Q 001858 512 VGNLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFR 553 (1003)
Q Consensus 512 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 553 (1003)
|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 98 F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 98 FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp STTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 807974655245774535359778568753342000364434
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.1e-21 Score=134.59 Aligned_cols=53 Identities=34% Similarity=0.446 Sum_probs=17.7
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEEC
Q ss_conf 566638993388763347800004467686514675303689300037996334855
Q 001858 539 CTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDLSFLEYLNL 595 (1003)
Q Consensus 539 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 595 (1003)
+++|+.+++++|++++ ++ .+.++++|+.|++++|+|+. ++ .+..+++|++|++
T Consensus 155 l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L 207 (210)
T d1h6ta2 155 LTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 207 (210)
T ss_dssp CTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEE
T ss_pred CCCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEEC
T ss_conf 1332100134643025-64-53678989999897998998-72-1169999899971
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.4e-21 Score=134.03 Aligned_cols=34 Identities=32% Similarity=0.541 Sum_probs=11.7
Q ss_pred CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 467566638993388763347800004467686514
Q 001858 536 LSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDL 571 (1003)
Q Consensus 536 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 571 (1003)
+..+++|+.|++++|+++. ++ .+.++++|+.|+|
T Consensus 174 l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L 207 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 207 (210)
T ss_dssp GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEE
T ss_pred CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEEC
T ss_conf 3678989999897998998-72-1169999899971
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=3.4e-21 Score=131.91 Aligned_cols=59 Identities=39% Similarity=0.541 Sum_probs=21.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEEC
Q ss_conf 333430024334122236853467566638993388763347800004467686514675303
Q 001858 515 LKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLS 577 (1003)
Q Consensus 515 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 577 (1003)
+++|+.|++++|++. .++ .+..+++|+.|++++|++++. + .+.++++|+.|++++|+++
T Consensus 127 l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 127 LTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCC
T ss_conf 223677643111100-234-333211111122345555677-0-1167998999978799799
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.80 E-value=1.1e-21 Score=134.70 Aligned_cols=265 Identities=17% Similarity=0.181 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCHHHH
Q ss_conf 334143326852346768665553322101123862457----5576667778444785478889999----98871457
Q 001858 269 PKLKILIVGQNNLTGSIPQSFSNASNLVILNLSGNHFSG----KVGIDFSSLPNITRLNLGQNNLGSG----SIGDLDFI 340 (1003)
Q Consensus 269 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~ 340 (1003)
.+|+.=.+....+. .+...+.....++.|+|++|.+.. .....+...++|+.++++++..... +.+...+.
T Consensus 8 ~~L~l~~~~~e~~~-~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~ 86 (344)
T d2ca6a1 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 86 (344)
T ss_dssp CCCEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH
T ss_pred CCCCCCCCCHHHHH-HHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHH
T ss_conf 88877889987899-99999963899788978498377899999999998589988888877754334542106787999
Q ss_pred HHHCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------------CCCCCCCEEECC
Q ss_conf 5212777774752467678998----85000035620201154644557631002-------------587873489813
Q 001858 341 TLLTNCSKLETLGLNSNRFGGS----LPRSIANLSTITIIAMGLNQISGTIPLEI-------------RNLANIYALGLE 403 (1003)
Q Consensus 341 ~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-------------~~l~~L~~L~L~ 403 (1003)
..+..+++|+.|++++|.++.. +...+...++|+.|++++|.+.......+ ...+.|+.+.++
T Consensus 87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~ 166 (344)
T d2ca6a1 87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166 (344)
T ss_dssp HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
T ss_conf 88754777563300001345543331011100234321000002466665431111212222110001467642111013
Q ss_pred CCCCC----CCCCCCCCCCCCCCEECCCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCC
Q ss_conf 65421----12787511113335010335111522-----564433777656462556536656----894354899987
Q 001858 404 YNQLT----GTIPYTIGELINLQALDFSANNLHGI-----IPDSIGNLSTLNSLWLGFNNLQGN----IPSSLGNCKNLM 470 (1003)
Q Consensus 404 ~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~ 470 (1003)
+|.+. ..+...+...+.|+.|++++|.+... ....+...++|+.|++++|.++.. +...+..+++|+
T Consensus 167 ~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~ 246 (344)
T d2ca6a1 167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246 (344)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred CCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 65013554332211112333213354333222222232002433211012112223333222222223444332322111
Q ss_pred EEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCEE
Q ss_conf 2652683206999544652133222234887733365431123333343002433412223685346-----75666389
Q 001858 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIPTTLS-----SCTSLEYL 545 (1003)
Q Consensus 471 ~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L 545 (1003)
+|++++|.+++.-...+..... -...+.|+.|++++|.+.......+. ..+.|+.|
T Consensus 247 ~L~Ls~n~i~~~g~~~l~~~l~-------------------~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L 307 (344)
T d2ca6a1 247 ELGLNDCLLSARGAAAVVDAFS-------------------KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307 (344)
T ss_dssp EEECTTCCCCHHHHHHHHHHHH-------------------TCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred HHHHHCCCCCCHHHHHHHHHHH-------------------HCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEE
T ss_conf 1030047567156678887763-------------------156888898989898698089999999997038999989
Q ss_pred EECCCCCC
Q ss_conf 93388763
Q 001858 546 KMQDNSFR 553 (1003)
Q Consensus 546 ~L~~N~l~ 553 (1003)
++++|++.
T Consensus 308 ~l~~N~~~ 315 (344)
T d2ca6a1 308 ELNGNRFS 315 (344)
T ss_dssp ECTTSBSC
T ss_pred ECCCCCCC
T ss_conf 78798089
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.4e-21 Score=130.81 Aligned_cols=261 Identities=19% Similarity=0.173 Sum_probs=0.0
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 44210044367998422257999991764786688899986467843477200245678788321258633414332685
Q 001858 200 QQLGVGENKLYGIIPESLGQLRDLNFLSVAENNFSGMLPPIFNISSLEQISLLTNRFEGRLPLNIGFNLPKLKILIVGQN 279 (1003)
Q Consensus 200 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~N 279 (1003)
+.+|++++.+.......+.. ..+..+.++...............+|++|++++|.+.......++.++++|++|.+.++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCCHHHHHHHH-CCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 77978999788147999874-55427465233345522442567878878898984577799999974877651452346
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCC-CCCCCCCCCCC-CCCCCCCEEECCCCCCCCCCCCCHHHHHHHCCC-CCCCEEECCC
Q ss_conf 23467686655533221011238-62457557666-777844478547888999998871457521277-7774752467
Q 001858 280 NLTGSIPQSFSNASNLVILNLSG-NHFSGKVGIDF-SSLPNITRLNLGQNNLGSGSIGDLDFITLLTNC-SKLETLGLNS 356 (1003)
Q Consensus 280 ~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-~~L~~L~L~~ 356 (1003)
.+++..+..+..+++|++|++++ +.++...-..+ ..+++|++|+++++.. .........+... ++|+.|++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~----~~~~~~~~~~~~~~~~L~~L~l~~ 157 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD----FTEKHVQVAVAHVSETITQLNLSG 157 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT----CCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCC----CCCCCCHHHHCCCCCCCCHHHHCC
T ss_conf 7986789998518997571510013412355403657887435652245332----333220001000111110122135
Q ss_pred CCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 6789---9885000035620201154644-5576310025878734898136-542112787511113335010335111
Q 001858 357 NRFG---GSLPRSIANLSTITIIAMGLNQ-ISGTIPLEIRNLANIYALGLEY-NQLTGTIPYTIGELINLQALDFSANNL 431 (1003)
Q Consensus 357 N~l~---~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l 431 (1003)
+... ..+.....++++|+.|++++|. +++.....+..+++|++|++++ +.+++.....++.+++|+.|+++++.-
T Consensus 158 ~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~ 237 (284)
T d2astb2 158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237 (284)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECCCC
T ss_conf 54244444343423232221235532234778303333213576877989999978737899972699989896448889
Q ss_pred CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 5225644337776564625565366568943548999
Q 001858 432 HGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKN 468 (1003)
Q Consensus 432 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 468 (1003)
.+........+++|+. ..+.++...+..+++...
T Consensus 238 d~~l~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~ 271 (284)
T d2astb2 238 DGTLQLLKEALPHLQI---NCSHFTTIARPTIGNKKN 271 (284)
T ss_dssp TTCHHHHHHHSTTSEE---SCCCSCCTTCSSCSSTTC
T ss_pred HHHHHHHHHHCCCCCC---CCCCCCCCCCCCCCCCCC
T ss_conf 8999999976843661---686587777885476664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.3e-17 Score=111.91 Aligned_cols=129 Identities=16% Similarity=0.163 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 75556999886887478988888841010444675888416323324696675788874441124544678882000011
Q 001858 93 SPYVGNLSFLRFINLASNNLHGEIPNELGRLSRLKVLVLDFNSFSGTIPSNLSHCSNLINFSVRRNNLTGEIPAYIGYYW 172 (1003)
Q Consensus 93 ~~~l~~l~~L~~L~L~~n~~~~~ip~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 172 (1003)
.+.+.+...++.|||++|+++ .+|..+..+.+|++|+|++|.++ .+ +.+..+++|+.|++++|+++ .+|..+...+
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l 86 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL 86 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHC
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CC-CCCCCCCCHHHHHCCCCCCC-CCCCCCCCCC
T ss_conf 175168574848978899788-65762004145998989799787-64-77445761306431021345-7776322334
Q ss_pred CCCCEEECCCCCCCCCCCC--CCCCCCCCCEEEEECCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf 2455388237634655699--988888764421004436799842----225799999176
Q 001858 173 LKLENLNVAENQLTGQLPP--SIGNISTLQQLGVGENKLYGIIPE----SLGQLRDLNFLS 227 (1003)
Q Consensus 173 ~~L~~L~l~~n~l~~~~p~--~l~~l~~L~~L~l~~n~l~~~~p~----~l~~l~~L~~L~ 227 (1003)
++|++|++++|+++ .+++ .+..+++|++|++++|.+. ..|. .+..+++|++||
T Consensus 87 ~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 87 PDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCCEECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 53443420300016-6542110013653206640799634-56106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.66 E-value=2.1e-16 Score=105.17 Aligned_cols=14 Identities=29% Similarity=0.256 Sum_probs=4.4
Q ss_pred CCCCCEEEECCCCC
Q ss_conf 44675888416323
Q 001858 123 LSRLKVLVLDFNSF 136 (1003)
Q Consensus 123 l~~L~~L~L~~n~l 136 (1003)
+..|++|++++|.+
T Consensus 19 l~~L~~L~ls~N~l 32 (124)
T d1dcea3 19 LLLVTHLDLSHNRL 32 (124)
T ss_dssp GTTCCEEECCSSCC
T ss_pred CCCCCEEECCCCCC
T ss_conf 89889897978716
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.6e-15 Score=100.22 Aligned_cols=85 Identities=28% Similarity=0.367 Sum_probs=28.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCC-CCCCCCCCCCCE
Q ss_conf 3333430024334122236853467566638993388763347800004467686514675303689-300037996334
Q 001858 514 NLKNLIQLDISRNRFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQI-PEYLEDLSFLEY 592 (1003)
Q Consensus 514 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~ 592 (1003)
.+++|++|++++|+++ .+|..+..+++|+.|++++|.++. ++ .+..+++|+.|++++|+|+... ...+..+++|++
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred CCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCE
T ss_conf 5898898979787168-652156554313545324321123-57-41233555768888986588888256537999999
Q ss_pred EECCCCCCC
Q ss_conf 855899352
Q 001858 593 LNLSYNDFE 601 (1003)
Q Consensus 593 L~l~~N~l~ 601 (1003)
+++++|+++
T Consensus 95 L~l~~N~i~ 103 (124)
T d1dcea3 95 LNLQGNSLC 103 (124)
T ss_dssp EECTTSGGG
T ss_pred EECCCCCCC
T ss_conf 989799688
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.1e-15 Score=99.53 Aligned_cols=124 Identities=19% Similarity=0.159 Sum_probs=74.4
Q ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCCCCC
Q ss_conf 311233333430024334-1222368534675666389933887633478000044676865146753036893000379
Q 001858 509 PLVVGNLKNLIQLDISRN-RFSGEIPTTLSSCTSLEYLKMQDNSFRGSIPSSLISLKSIEVLDLSCNNLSGQIPEYLEDL 587 (1003)
Q Consensus 509 ~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 587 (1003)
|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+...+.+|..+++|+.|+|++|+|+...+..+..+
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~ 103 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL 103 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC
T ss_conf 60025765657431689866443692122566666721620212477420111245543333226787851574563353
Q ss_pred CCCCEEECCCCCCCCCCCCCCC--CCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 9633485589935236899996--678752011269875689777789
Q 001858 588 SFLEYLNLSYNDFEGQVPTKGV--FSNKTRISLIENGKLCGGLDELHL 633 (1003)
Q Consensus 588 ~~L~~L~l~~N~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~~l~~ 633 (1003)
.|+.|++++|+|.+.+...+. +..........+...|.++..+..
T Consensus 104 -~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~ 150 (156)
T d2ifga3 104 -SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150 (156)
T ss_dssp -CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSC
T ss_pred -CCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEECCCHHHCC
T ss_conf -21243357986338811799999998565766757857796868884
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.59 E-value=1.5e-17 Score=111.62 Aligned_cols=147 Identities=23% Similarity=0.253 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCC--CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8787348981365--42112787511113335010335111522564433777656462556536656894354899987
Q 001858 393 NLANIYALGLEYN--QLTGTIPYTIGELINLQALDFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSSLGNCKNLM 470 (1003)
Q Consensus 393 ~l~~L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 470 (1003)
....++.+++.++ .+. .++..+..+++|+.|+|++|.|+.+ ..+..+++|+.|++++|.++ .++..+..+++|+
T Consensus 21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 545331002555568520-0246776260461519944689986--44247825357341353432-1000033221233
Q ss_pred EEECCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCEEEECC
Q ss_conf 265268320699954465213322223488773336543112333334300243341222368-5346756663899338
Q 001858 471 LLNVSKNKLTGTLPPQILEITTLSSLLDLSSNLISGSIPLVVGNLKNLIQLDISRNRFSGEIP-TTLSSCTSLEYLKMQD 549 (1003)
Q Consensus 471 ~L~ls~N~l~~~~p~~~~~~~~l~~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~ 549 (1003)
.|++++|+++ .++. +..+++|+.|++++|+++.... ..+..+++|+.|++++
T Consensus 97 ~L~l~~N~i~--------------------------~l~~-~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~ 149 (198)
T d1m9la_ 97 ELWISYNQIA--------------------------SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp EEECSEEECC--------------------------CHHH-HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred CCCCCCCCCC--------------------------CCCC-CCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCC
T ss_conf 3333332222--------------------------2222-222223411123410212554221236777630234279
Q ss_pred CCCCCCCCCC----------CCCCCCCCEEE
Q ss_conf 8763347800----------00446768651
Q 001858 550 NSFRGSIPSS----------LISLKSIEVLD 570 (1003)
Q Consensus 550 N~l~~~~~~~----------~~~l~~L~~L~ 570 (1003)
|++....+.. +..+++|+.||
T Consensus 150 N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 150 NPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCEEC
T ss_conf 8434676322220558999998788958769
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.95 E-value=3.8e-09 Score=64.58 Aligned_cols=150 Identities=17% Similarity=0.149 Sum_probs=99.5
Q ss_pred HHHHHHHCCCCCCCEEEECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf 899997105786682430464499999978998419999820114553679999999987258-9883169655310565
Q 001858 696 AELNKATNEFSLSNLIGQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDF 774 (1003)
Q Consensus 696 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~ 774 (1003)
.+++.....|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +-.+.+++.+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----- 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----- 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEE-----
T ss_conf 99997513527997678998771899990--89869999848876532556999999999876069987289997-----
Q ss_pred CCCCCEEEEEECCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------
Q ss_conf 78973578610104999889985138998999889999999999999999997169------------------------
Q 001858 775 KGDDFKALVYDYMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHHC------------------------ 830 (1003)
Q Consensus 775 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------ 830 (1003)
.+++..++||++.+|.++.+..... . ....++.+++..++.+|+..
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~-------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDE-------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTC-------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred ECCCCEEEEEEECCCCCCCCCCCCC-------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 5089649999860433435433440-------2---69999998999999985568421435764465655577899877
Q ss_pred --------------------------------CCCCEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf --------------------------------99907426899965767999769903334410
Q 001858 831 --------------------------------QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 831 --------------------------------~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~ 862 (1003)
...++|+|+.|.||++++++..-+.||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 6555543033232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=3.8e-10 Score=70.19 Aligned_cols=122 Identities=19% Similarity=0.223 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEE
Q ss_conf 7774752467678998850000356202011546445576310025878734898136542112--78751111333501
Q 001858 347 SKLETLGLNSNRFGGSLPRSIANLSTITIIAMGLNQISGTIPLEIRNLANIYALGLEYNQLTGT--IPYTIGELINLQAL 424 (1003)
Q Consensus 347 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L 424 (1003)
...+.|+++++.... .+..+..+..+....+... .....+..+++|++|+|++|+|+.. .+..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l~~~~----~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGLRSDP----DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCCSSCT----TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCCCCCC----HHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 330865343598982----1554664011225556766-60788974878788637776666773158898658856100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 03351115225644337776564625565366568943-------54899987265
Q 001858 425 DFSANNLHGIIPDSIGNLSTLNSLWLGFNNLQGNIPSS-------LGNCKNLMLLN 473 (1003)
Q Consensus 425 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------l~~l~~L~~L~ 473 (1003)
++++|.++...+-.+....+|+.+++++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.59 E-value=3.1e-07 Score=53.91 Aligned_cols=77 Identities=16% Similarity=0.135 Sum_probs=51.4
Q ss_pred CCEEEECCCEEEEEEEECCCCCEEEEEEECCC----C---CCCHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCCCCC
Q ss_conf 68243046449999997899841999982011----4---553679999999987258-9--883169655310565789
Q 001858 708 SNLIGQGSFGFVYRGNLGEDLLPVAVKVINLK----Q---KGSIKSFVAECEALKNIR-H--RNLIKIITVCSSIDFKGD 777 (1003)
Q Consensus 708 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~ni~~~~~~~~~~~~~~~ 777 (1003)
.+.+|.|....||++....+++.+++|..... . +....+...|++.++.+. + ..+.+++.+ ++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-------d~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-------DT 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-------ET
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE-------CC
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998-------59
Q ss_pred CCEEEEEECCCCCC
Q ss_conf 73578610104999
Q 001858 778 DFKALVYDYMQSGS 791 (1003)
Q Consensus 778 ~~~~lv~e~~~~gs 791 (1003)
...++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEECCCCCC
T ss_conf 88779871357765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=2.5e-06 Score=48.83 Aligned_cols=131 Identities=16% Similarity=0.082 Sum_probs=79.0
Q ss_pred CEEEECCC-EEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCCEEEEEEEEECCCCCCCCEEEEEE
Q ss_conf 82430464-499999978998419999820114553679999999987258--988316965531056578973578610
Q 001858 709 NLIGQGSF-GFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIR--HRNLIKIITVCSSIDFKGDDFKALVYD 785 (1003)
Q Consensus 709 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~~~~~~~~~~~~~~~~~~lv~e 785 (1003)
+.+..|.. +.||+.... .+..+++|....... ..+..|...++.+. .-.+.+++.+. .+++..+++|+
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~ 86 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLG 86 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEE
T ss_pred EECCCCCCCCEEEEEEEC-CCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEEC-----CCCCCEEEEEE
T ss_conf 876786547758999938-987899995896677---689999999999986599988613222-----45661599987
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q ss_conf 10499988998513899899988999999999999999999716------------------------------------
Q 001858 786 YMQSGSLEDWLQQSNDQVDGNLNLIQRLNISIDVASAIEYLHHH------------------------------------ 829 (1003)
Q Consensus 786 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------ 829 (1003)
+++|.++.+. .... ...+.++...++.||+.
T Consensus 87 ~i~G~~~~~~----------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 87 EVPGQDLLSS----------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CCSSEETTTS----------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEECCCCCCC----------CCCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHH
T ss_conf 4413554322----------1268---99999999999987368854488755412468899999987541101134011
Q ss_pred -------------------CCCCCEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf -------------------99990742689996576799976990333441
Q 001858 830 -------------------CQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAK 861 (1003)
Q Consensus 830 -------------------~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~ 861 (1003)
.++.++|+|+.|.||+++.+..+-++||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 213799999999871876579567867888763577379658999853326
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.13 E-value=1.4e-05 Score=44.67 Aligned_cols=145 Identities=12% Similarity=0.063 Sum_probs=77.0
Q ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC--CCEEEEEEEEECCCCCCCCEEEEEECCCCCC
Q ss_conf 46449999997899841999982011455367999999998725898--8316965531056578973578610104999
Q 001858 714 GSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHR--NLIKIITVCSSIDFKGDDFKALVYDYMQSGS 791 (1003)
Q Consensus 714 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~~~~~~~~~~~~~~~~~~lv~e~~~~gs 791 (1003)
+..-.||++... +|..|++|+.+.. ....+.+..|...+..+... .++..+.......+...+..+.++++.+|..
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCCEEEEEECC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 612026999838-9997999984787-78899999999999999855998787520689805665347999986527768
Q ss_pred H------------------HHHHHHCCCCCCCCCCH-------------------H---HHHHHHHHHHHHHHHHH-HCC
Q ss_conf 8------------------89985138998999889-------------------9---99999999999999997-169
Q 001858 792 L------------------EDWLQQSNDQVDGNLNL-------------------I---QRLNISIDVASAIEYLH-HHC 830 (1003)
Q Consensus 792 L------------------~~~l~~~~~~~~~~l~~-------------------~---~~~~i~~~i~~~l~~LH-~~~ 830 (1003)
+ +..............+. . .....+.++...+...- +..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 89999999999899999988630357865567789788766568999874769988989999999999999998454568
Q ss_pred CCCCEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 99907426899965767999769903334410
Q 001858 831 QPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 831 ~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~ 862 (1003)
..+++|+|+.+.||+++++ ..++||+.++.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 7120247888042878389--35886520146
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.00 E-value=3.7e-07 Score=53.45 Aligned_cols=115 Identities=16% Similarity=0.236 Sum_probs=0.0
Q ss_pred CCCCCCHHHHCCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCC---
Q ss_conf 5533221011238-624575----57666777844478547888999998871457521277777475246767899---
Q 001858 290 SNASNLVILNLSG-NHFSGK----VGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG--- 361 (1003)
Q Consensus 290 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~--- 361 (1003)
.+.++|++|+|++ +.++.. ....+...+.|++|++++|.+...... .+...+...+.|+.|++++|.++.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~--~la~~L~~n~~L~~L~L~~n~i~~~g~ 89 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR--GLIELIETSPSLRVLNVESNFLTPELL 89 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT--THHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHH--HHHHHHHHCCCCCCEEEEHHHCCHHHH
T ss_conf 289998197827999989899999999976377645401201562156798--875310002343300330102145999
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf -8850000356202011546445576-------31002587873489813654
Q 001858 362 -SLPRSIANLSTITIIAMGLNQISGT-------IPLEIRNLANIYALGLEYNQ 406 (1003)
Q Consensus 362 -~~~~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~L~~N~ 406 (1003)
.+...+...++|+.|++++|.+... +...+...+.|+.|+++.+.
T Consensus 90 ~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 90 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999998489389877887768886579999999999729985386486888
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.90 E-value=8.2e-05 Score=40.35 Aligned_cols=167 Identities=10% Similarity=0.060 Sum_probs=81.3
Q ss_pred CCCHHHHHHHHCCCCCCCEE-----EECCCEEEEEEEECCCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--CEE
Q ss_conf 53488999971057866824-----30464499999978998419999820114553679999999987258988--316
Q 001858 692 MVSYAELNKATNEFSLSNLI-----GQGSFGFVYRGNLGEDLLPVAVKVINLKQKGSIKSFVAECEALKNIRHRN--LIK 764 (1003)
Q Consensus 692 ~~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~ 764 (1003)
.++.++++....+|.+++.. ..|.--+.|..+..+ ..+++|++..... .+.+..|.+.+..+...+ +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECC--CCEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 8899999999986799985685237888526738999789--7289998078999--88999999998754302555455
Q ss_pred EEEEEE-ECCCCCCCCEEEEEECCCCCCHH--------------HHHHHCCCCC----CCCCCHH---------------
Q ss_conf 965531-05657897357861010499988--------------9985138998----9998899---------------
Q 001858 765 IITVCS-SIDFKGDDFKALVYDYMQSGSLE--------------DWLQQSNDQV----DGNLNLI--------------- 810 (1003)
Q Consensus 765 ~~~~~~-~~~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~~----~~~l~~~--------------- 810 (1003)
.+.... .....-......++.+..+.... ..++...... .......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred CCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHH
T ss_conf 64104897621341255024531146553332046788888998764544432024531011101200245677776531
Q ss_pred ---HHHHHHHHHHHHHHHHHH-CCCCCCEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf ---999999999999999971-6999907426899965767999769903334410
Q 001858 811 ---QRLNISIDVASAIEYLHH-HCQPPIVHGDLKPSNVLLDHDMVAHVSDFGLAKF 862 (1003)
Q Consensus 811 ---~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~Nili~~~~~~kl~Dfg~a~~ 862 (1003)
.....+......+..... ..+.|++|+|+.+.|++++.+...-+.||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 14127999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.80 E-value=0.00013 Score=39.33 Aligned_cols=73 Identities=18% Similarity=0.150 Sum_probs=47.8
Q ss_pred CCEEEECCCEEEEEEEECCC-------CCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCCCCCC
Q ss_conf 68243046449999997899-------8419999820114553679999999987258-988316965531056578973
Q 001858 708 SNLIGQGSFGFVYRGNLGED-------LLPVAVKVINLKQKGSIKSFVAECEALKNIR-HRNLIKIITVCSSIDFKGDDF 779 (1003)
Q Consensus 708 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~ 779 (1003)
.+.++.|-.-.+|++..... ...|.+++.. . ........+|..+++.+. +.-..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC--------
T ss_conf 9991785334348999688775445789817999659-9-61165899999999999757999808998189--------
Q ss_pred EEEEEECCCCCC
Q ss_conf 578610104999
Q 001858 780 KALVYDYMQSGS 791 (1003)
Q Consensus 780 ~~lv~e~~~~gs 791 (1003)
..|+||++|.+
T Consensus 117 -g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 -GRLEEYIPSRP 127 (395)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEECCCC
T ss_conf -56999734554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.50 E-value=5.1e-06 Score=47.10 Aligned_cols=115 Identities=13% Similarity=0.210 Sum_probs=0.0
Q ss_pred CCCCCCHHHHCCC-CCCC----CCCCCCCCCCCCCCEEECCCCCCCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCC---
Q ss_conf 5533221011238-6245----7557666777844478547888999998871457521277777475246767899---
Q 001858 290 SNASNLVILNLSG-NHFS----GKVGIDFSSLPNITRLNLGQNNLGSGSIGDLDFITLLTNCSKLETLGLNSNRFGG--- 361 (1003)
Q Consensus 290 ~~l~~L~~L~Ls~-N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~--- 361 (1003)
.+.++|++|++++ +.++ ......+...+.|++|++++|.++..... .....+...+.++.+++++|.++.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~--~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF--ALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH--HHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHH--HHHHHHHHCCCCHHHHHCCCCCCCHHH
T ss_conf 559998688768999989899999998884198257430158961177899--999877521221012102543220147
Q ss_pred -CCCCCCCCCCCCCC--CCCCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf -88500003562020--1154644557----631002587873489813654
Q 001858 362 -SLPRSIANLSTITI--IAMGLNQISG----TIPLEIRNLANIYALGLEYNQ 406 (1003)
Q Consensus 362 -~~~~~~~~l~~L~~--L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~N~ 406 (1003)
.+...+...++|+. |++..|.+.. .+...+...++|+.|+++.+.
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 8899999848652477321677867679999999999849984788581898
|